data_1oq3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1oq3 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 110.601 -0.148 . . . . 0.93 110.601 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -152.38 162.32 41.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.597 0.713 . . . . 3.54 111.642 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.4 150.2 25.5 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.492 1.517 . . . . 3.75 109.006 166.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 tp -129.48 156.47 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.352 -1.721 . . . . 2.29 106.352 162.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.88 130.78 24.46 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.711 1.204 . . . . 1.7 108.442 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.84 171.63 19.94 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.238 0.472 . . . . 1.79 111.956 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.22 153.7 19.12 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.516 0.726 . . . . 1.97 110.009 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -118.51 158.06 19.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 123.903 0.881 . . . . 1.77 109.402 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.45 -0.472 0 C-N-CA 124.319 1.048 . . . . 1.45 108.178 176.618 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 112.051 0.389 . . . . 1.68 112.051 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.91 -41.73 99.55 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.444 0.566 . . . . 5.4 111.221 177.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.4 mt -51.71 -60.16 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.612 -1.255 . . . . 1.69 107.612 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.73 -34.49 69.61 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.372 -0.831 . . . . 2.6 111.516 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -56.39 -36.84 69.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.116 -0.99 . . . . 2.33 110.963 174.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.28 -49.18 60.98 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.765 -0.934 . . . . 0.3 110.765 168.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.8 mt -65.14 -30.9 71.87 Favored 'General case' 0 C--O 1.225 -0.207 0 O-C-N 121.544 -0.974 . . . . 1.64 112.882 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt -58.85 -17.55 24.88 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.145 0.884 . . . . 2.02 111.257 171.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -93.77 4.35 54.06 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.962 1.097 . . . . 6.46 113.962 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.0 mmt -82.03 136.4 47.22 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 120.702 1.592 . . . . 3.77 112.605 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.17 98.25 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.8 3.0 . . . . 0.38 110.111 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.74 -14.96 4.12 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.588 -1.005 . . . . 0.24 110.588 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 p -69.45 152.74 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 117.524 0.662 . . . . 1.68 110.434 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.53 -57.48 2.21 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.159 1.384 . . . . 2.16 109.48 170.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -144.51 158.09 43.92 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 122.973 0.509 . . . . 3.18 110.39 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.65 127.6 33.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.272 1.829 . . . . 1.66 107.926 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.09 113.31 8.37 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.854 0.861 . . . . 1.48 109.164 -174.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -89.73 140.34 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.098 0.959 . . . . 2.03 111.72 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -131.72 67.22 1.52 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.169 1.788 . . . . 1.71 111.581 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.74 -16.68 64.01 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 113.131 0.789 . . . . 1.9 113.131 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.03 -23.94 15.31 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.637 0.375 . . . . 1.61 110.748 168.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.5 m -126.62 18.31 7.42 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.073 1.349 . . . . 1.44 110.008 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 45.35 38.96 3.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.616 1.166 . . . . 2.48 111.869 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.9 m -136.17 154.63 50.9 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.28 -1.378 . . . . 1.5 107.28 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.55 150.02 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.588 -0.893 . . . . 1.65 108.588 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.41 150.08 41.35 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.739 -0.837 . . . . 2.83 108.739 171.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.94 139.63 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 107.146 -1.427 . . . . 1.6 107.146 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.1 mt -108.09 131.63 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.019 -1.474 . . . . 2.2 107.019 -175.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -154.2 167.78 28.74 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 123.257 0.348 . . . . 3.13 111.767 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 53' ' ' ALA . 18.6 t70 -102.75 110.85 64.15 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 124.508 1.123 . . . . 1.62 109.856 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -74.74 30.12 0.35 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.94 3.093 . . . . 0.82 112.752 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 51' ' ' ASP . . . -95.13 -50.21 5.17 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.044 -1.465 . . . . 1.65 107.044 167.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -87.24 -46.71 9.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.689 1.196 . . . . 2.65 110.269 173.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.6 m -140.88 136.42 32.31 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 117.591 2.441 . . . . 1.75 117.591 -148.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.85 -161.31 23.05 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 109.102 -1.599 . . . . 0.67 109.102 164.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 t -38.15 -43.53 0.77 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.833 2.453 . . . . 1.43 112.427 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.32 -57.43 4.62 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.809 0.844 . . . . 1.74 112.72 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.56 -37.56 65.49 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.873 0.844 . . . . 1.5 109.328 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mt -61.56 -59.46 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-N 114.466 -1.243 . . . . 2.1 109.341 -171.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.94 -50.36 27.33 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.099 1.318 . . . . 0.8 110.846 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.28 -52.58 9.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.205 1.002 . . . . 2.39 111.988 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -43.84 69.07 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.984 -0.686 . . . . 2.99 111.373 177.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.7 mm -52.53 -45.28 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 118.985 0.811 . . . . 1.97 110.284 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -49.3 -47.35 47.06 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.895 0.379 . . . . 1.62 110.646 173.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -71.96 -33.23 68.03 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.954 1.094 . . . . 3.61 113.954 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.49 -24.59 21.09 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.268 0.486 . . . . 1.83 110.205 166.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.66 29.29 6.64 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.114 -1.194 . . . . 0.27 110.114 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -140.73 162.08 36.27 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.01 -1.478 . . . . 2.87 107.01 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.79 133.72 55.21 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.118 -1.808 . . . . 5.39 106.118 170.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 p -100.73 148.53 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.39 0.676 . . . . 1.88 109.948 170.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.569 0 CA-C-N 118.594 0.634 . . . . 2.06 109.738 167.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.288 0.089 . . . . 1.22 110.939 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.98 154.77 41.64 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.68 0.752 . . . . 4.26 110.878 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -86.97 137.06 32.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.837 -1.529 . . . . 2.18 108.993 166.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.0 tp -112.07 155.64 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 105.917 -1.883 . . . . 2.31 105.917 162.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.55 130.55 21.84 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 108.072 -1.085 . . . . 1.67 108.072 172.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.62 173.47 16.89 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.177 0.899 . . . . 1.56 111.4 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.93 149.47 22.37 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.434 0.694 . . . . 1.82 109.599 -172.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.34 143.78 37.69 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.059 0 C-N-CA 122.708 0.403 . . . . 1.54 110.883 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.45 -0.428 0 C-N-CA 124.343 1.057 . . . . 1.66 109.31 175.613 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 109.469 -0.567 . . . . 1.65 109.469 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -49.99 -49.66 49.81 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.707 0.685 . . . . 7.86 111.652 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.431 HG12 ' CD1' ' A' ' 69' ' ' TYR . 90.5 mt -44.02 -62.62 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 123.432 0.693 . . . . 2.23 109.324 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.42 -35.37 65.82 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.303 0.573 . . . . 2.36 112.394 -172.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -58.2 -36.43 73.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.955 -1.091 . . . . 2.11 110.722 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.59 -51.01 51.13 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.564 -1.014 . . . . 0.35 110.564 166.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.71 -33.6 76.0 Favored 'General case' 0 C--O 1.221 -0.417 0 O-C-N 121.579 -0.954 . . . . 1.75 112.444 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -57.79 -18.61 22.81 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.28 0.946 . . . . 2.48 112.058 172.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -85.33 -11.78 53.83 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.822 1.415 . . . . 5.4 114.822 169.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.8 mmt -69.63 143.51 92.8 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 120.85 1.659 . . . . 2.78 112.074 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.74 106.63 1.51 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.39 2.06 . . . . 0.57 109.537 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.09 -13.41 5.75 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.079 1.323 . . . . 0.29 110.784 171.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.1 p -70.27 160.56 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 O-C-N 121.939 -0.742 . . . . 1.52 111.517 171.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.49 -65.7 1.15 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.84 1.256 . . . . 1.63 108.212 165.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -144.43 147.43 33.34 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.349 -0.387 . . . . 3.25 111.793 -162.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.27 138.29 50.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.24 1.416 . . . . 1.67 108.587 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -140.0 118.45 12.18 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.975 0.91 . . . . 1.86 109.408 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -86.4 136.35 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.99 0.916 . . . . 2.0 111.054 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -129.23 69.68 1.41 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.318 1.847 . . . . 1.66 110.994 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.2 mt -64.09 -18.63 64.57 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.848 0.685 . . . . 1.98 112.848 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.84 -18.21 8.15 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.124 0.42 . . . . 2.02 110.977 170.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.7 m -131.87 18.06 4.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.823 1.249 . . . . 1.72 109.872 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 41.12 39.24 0.86 Allowed 'General case' 0 C--N 1.346 0.419 0 C-N-CA 124.895 1.278 . . . . 2.6 112.128 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.4 m -129.59 152.46 49.09 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.16 -1.422 . . . . 1.63 107.16 -171.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 p -133.85 146.85 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 107.143 -1.429 . . . . 1.61 107.143 173.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.75 145.8 46.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 123.93 0.769 . . . . 2.6 109.39 173.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -144.0 136.66 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.615 -0.883 . . . . 1.5 108.615 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.0 mt -103.61 118.87 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.704 2.002 . . . . 2.32 107.145 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -146.17 169.0 19.63 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.74 0.781 . . . . 3.18 110.415 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -96.71 125.3 47.32 Favored Pre-proline 0 N--CA 1.439 -1.003 0 CA-C-N 114.316 -1.311 . . . . 1.35 109.502 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.41 6.69 2.56 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.778 2.318 . . . . 0.92 113.315 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.19 -54.47 4.59 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 119.358 0.981 . . . . 1.76 108.95 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -85.43 -55.86 3.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.312 1.445 . . . . 3.13 109.297 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.8 m -86.93 160.16 18.78 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 126.366 1.867 . . . . 2.25 112.984 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.24 161.25 35.07 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 104.859 -3.296 . . . . 2.15 104.859 168.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 t -51.29 -32.24 24.24 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 117.192 0.496 . . . . 2.0 110.288 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -36.26 -61.32 0.51 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.97 1.708 . . . . 1.7 114.449 164.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.89 -37.97 73.03 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.938 -1.134 . . . . 1.65 107.938 -172.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -55.62 -62.29 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-N 114.315 -1.311 . . . . 2.45 109.214 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -46.9 -54.1 10.75 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.354 1.434 . . . . 1.19 110.676 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -41.05 -57.0 2.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.663 0.785 . . . . 2.52 112.767 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.64 -40.46 69.7 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 119.917 -0.713 . . . . 2.97 110.046 -176.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.5 mm -52.61 -47.18 49.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 119.188 0.903 . . . . 1.66 109.994 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -53.28 -42.54 66.66 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.637 0.375 . . . . 1.69 110.754 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -71.04 -38.96 72.56 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.422 -0.799 . . . . 3.64 110.915 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -54.96 -25.09 27.24 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.715 0.806 . . . . 1.87 110.263 171.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.17 29.66 6.3 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.331 -1.108 . . . . 0.47 110.331 172.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.431 ' CD1' HG12 ' A' ' 24' ' ' ILE . 44.0 m-85 -140.76 166.25 25.27 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.968 -1.123 . . . . 3.14 107.968 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.17 122.0 38.18 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 104.679 -2.341 . . . . 4.46 104.679 -173.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.54 142.51 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.182 -0.673 . . . . 1.72 109.182 173.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--O 1.226 -0.17 0 N-CA-C 108.545 -0.909 . . . . 2.12 108.545 173.472 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 110.697 -0.112 . . . . 0.61 110.697 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -146.14 157.17 43.83 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.013 -0.736 . . . . 4.64 109.013 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.68 127.94 35.59 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.625 1.57 . . . . 3.71 109.5 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 tp -106.73 152.17 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.767 -1.568 . . . . 1.92 106.767 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.81 132.65 27.51 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.258 -1.386 . . . . 1.45 107.258 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -156.41 163.16 39.8 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.072 0.549 . . . . 2.21 110.68 -170.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.77 154.56 18.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.343 -1.355 . . . . 2.26 107.343 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.4 163.43 14.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.064 -1.087 . . . . 1.75 108.064 173.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 107.555 -1.276 . . . . 2.17 107.555 173.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 110.529 -0.174 . . . . 1.7 110.529 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -62.79 -48.1 80.58 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 122.89 0.476 . . . . 4.68 110.752 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.1 mt -49.62 -56.74 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.437 -0.579 . . . . 1.83 109.437 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.78 -42.89 76.78 Favored 'General case' 0 C--O 1.219 -0.522 0 C-N-CA 120.208 -0.597 . . . . 3.48 109.567 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -49.51 -36.77 24.23 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.406 -1.434 . . . . 3.06 111.691 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.17 -51.71 39.93 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 112.191 -0.364 . . . . 0.44 112.191 167.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.4 -28.34 67.01 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 121.401 -1.058 . . . . 1.95 113.043 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.281 21.5 ttmt -62.7 -15.04 50.84 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.965 1.257 . . . . 3.27 110.238 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -25.63 60.12 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.217 1.192 . . . . 4.91 114.217 166.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.18 134.83 93.55 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 120.14 1.336 . . . . 3.73 111.939 -169.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -65.58 100.79 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.303 2.669 . . . . 0.44 109.52 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.6 -17.68 3.48 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.405 -1.078 . . . . 0.3 110.405 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.17 154.65 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 121.965 -0.727 . . . . 1.6 110.385 169.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.18 -57.22 2.23 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 123.009 0.524 . . . . 1.83 109.666 171.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -148.49 157.45 43.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.516 -0.55 . . . . 2.56 109.516 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.72 136.11 33.85 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 127.232 2.213 . . . . 1.82 108.325 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -137.87 117.71 13.23 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 125.222 1.576 . . . . 1.76 107.931 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -84.32 144.15 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.159 0.984 . . . . 1.82 110.847 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -137.73 64.36 1.52 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.321 1.449 . . . . 1.85 112.124 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.55 -16.97 64.21 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 112.523 0.564 . . . . 2.16 112.523 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.05 59.42 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.227 0.467 . . . . 2.03 110.82 168.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.9 m -118.63 16.45 13.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.231 1.412 . . . . 1.94 109.962 176.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 48.28 36.37 6.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.601 1.161 . . . . 2.33 111.769 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.4 m -138.04 155.3 48.95 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.747 -1.205 . . . . 1.59 107.747 -168.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 p -136.48 150.36 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 108.825 -0.805 . . . . 1.68 108.825 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.98 153.01 44.94 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 123.852 0.72 . . . . 2.72 110.224 175.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.78 136.8 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.998 -0.742 . . . . 1.67 108.998 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.8 114.14 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.065 -1.457 . . . . 2.35 107.065 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -137.67 167.24 22.09 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.515 0.726 . . . . 3.33 111.118 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -102.73 113.91 65.61 Favored Pre-proline 0 N--CA 1.443 -0.805 0 C-N-CA 124.475 1.11 . . . . 1.31 110.612 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.8 17.89 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.529 2.819 . . . . 0.68 113.724 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.47 -51.76 7.08 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 107.646 -1.242 . . . . 1.72 107.646 168.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -81.47 -46.23 14.85 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.257 1.023 . . . . 2.95 110.265 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.9 m -142.37 129.61 21.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 118.295 2.702 . . . . 1.48 118.295 -143.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.08 -160.55 20.88 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.024 -1.23 . . . . 0.79 110.024 162.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 t -29.43 -48.73 0.08 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 129.544 3.137 . . . . 1.72 112.9 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.2 -55.9 7.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.719 0.808 . . . . 1.38 112.39 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.53 -38.0 65.42 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 122.149 0.976 . . . . 1.58 109.432 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mt -63.55 -56.63 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 114.408 -1.269 . . . . 1.9 110.017 -169.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.51 -53.49 14.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.81 1.186 . . . . 0.77 110.41 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -41.81 -54.05 3.51 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.245 1.018 . . . . 2.44 112.266 175.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -41.39 68.06 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 118.179 -0.915 . . . . 2.74 110.791 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.4 mm -53.75 -46.54 62.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.871 1.214 . . . . 1.7 110.216 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -51.83 -42.9 62.89 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.333 0.587 . . . . 1.54 109.946 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -37.19 73.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.594 0.758 . . . . 5.41 112.174 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -56.05 -19.95 14.91 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.149 0.579 . . . . 1.84 110.731 168.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.51 27.76 12.56 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 110.405 -1.078 . . . . 0.49 110.405 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -136.07 169.55 17.42 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 108.256 -1.016 . . . . 3.47 108.256 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.5 123.85 43.02 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.036 -1.098 . . . . 5.84 108.036 176.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 p -91.61 153.29 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.969 1.308 . . . . 1.77 109.712 173.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.173 0 C-N-CA 122.929 0.492 . . . . 2.16 110.222 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.215 0.055 . . . . 0.79 111.05 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -153.46 159.44 42.32 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.356 0.598 . . . . 3.41 111.697 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -84.87 124.92 32.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.665 2.386 . . . . 2.16 108.31 169.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 tp -104.06 147.92 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 106.878 -1.526 . . . . 2.41 106.878 161.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.47 129.35 37.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.651 -1.24 . . . . 1.6 107.651 173.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -155.41 170.19 22.51 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.799 -0.445 . . . . 2.8 109.799 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -97.1 148.69 22.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.272 1.029 . . . . 3.09 108.879 -174.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.03 160.57 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 C-N-CA 123.783 0.833 . . . . 2.08 109.573 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 109.0 -0.741 . . . . 1.67 109.0 165.313 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.737 0 CA-C-O 118.861 -0.59 . . . . 1.72 110.615 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -61.8 -48.7 79.45 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.243 0.929 . . . . 4.5 111.415 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.3 mt -42.34 -62.82 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 124.716 1.206 . . . . 2.43 108.388 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -32.71 64.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 119.458 -0.897 . . . . 2.56 112.664 -174.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -57.16 -37.7 72.46 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.95 -1.094 . . . . 3.22 110.434 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.69 -50.7 56.74 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 110.476 -1.05 . . . . 0.47 110.476 169.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.7 mt -62.29 -31.57 72.18 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 121.896 -0.767 . . . . 1.66 112.12 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.414 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 21.8 ttmt -62.51 -15.59 51.24 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 119.155 0.889 . . . . 3.54 110.722 175.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.27 -3.17 44.56 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.043 1.127 . . . . 5.21 114.043 169.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 75.1 mmm -74.07 138.91 75.82 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 120.786 1.63 . . . . 3.13 111.768 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.64 90.39 0.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.31 2.673 . . . . 0.64 110.971 -173.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.99 -9.04 4.19 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.122 1.344 . . . . 0.32 111.347 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.4 p -64.69 161.87 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.399 1.099 . . . . 1.65 110.251 164.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.21 -53.61 2.13 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.738 1.215 . . . . 1.54 110.373 166.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.414 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 18.8 t70 -148.25 163.77 36.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.467 -0.568 . . . . 3.05 109.467 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.24 141.99 26.75 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.979 1.712 . . . . 2.01 108.627 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -152.19 119.63 6.0 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.887 0.875 . . . . 1.43 108.754 -165.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -84.98 145.72 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.318 1.047 . . . . 2.16 112.376 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -134.32 69.95 1.45 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.968 1.707 . . . . 1.79 112.345 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.4 mt -61.57 -22.26 65.04 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 112.295 0.48 . . . . 2.66 112.295 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.61 -16.44 25.79 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.406 0.548 . . . . 1.98 111.174 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.9 m -132.66 18.24 4.28 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.918 0.887 . . . . 1.61 109.529 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 43.95 45.5 6.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.902 0.881 . . . . 2.41 111.505 -175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.8 m -136.37 159.92 40.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.95 1.3 . . . . 1.65 108.145 -170.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.61 149.65 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.378 -0.971 . . . . 2.03 108.378 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -117.58 139.45 50.95 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.922 1.289 . . . . 2.5 109.301 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.29 132.85 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.274 0.63 . . . . 1.64 109.841 174.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.72 125.12 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.295 1.438 . . . . 2.23 107.542 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -146.24 169.72 18.2 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.314 0.646 . . . . 3.27 110.983 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -107.73 121.4 44.24 Favored Pre-proline 0 N--CA 1.447 -0.619 0 C-N-CA 124.726 1.21 . . . . 2.09 110.982 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -71.94 10.85 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.349 3.366 . . . . 0.98 113.684 -176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.74 -50.32 12.63 Favored 'General case' 0 N--CA 1.458 -0.037 0 N-CA-C 107.409 -1.33 . . . . 1.78 107.409 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -96.03 -40.16 9.39 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.019 1.728 . . . . 3.0 110.557 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.4 m -136.08 131.15 34.46 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 117.929 2.566 . . . . 1.23 117.929 -153.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.99 -168.62 24.16 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.866 -1.293 . . . . 0.68 109.866 160.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.1 t -38.69 -40.35 0.59 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.947 2.499 . . . . 1.73 112.243 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.17 -56.43 6.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.569 0.748 . . . . 1.36 112.593 173.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.25 -34.48 68.3 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 122.562 1.172 . . . . 1.54 109.323 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.26 -52.51 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 113.943 -1.481 . . . . 1.84 111.161 -169.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -50.69 59.39 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.322 1.419 . . . . 0.79 109.641 173.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.47 -53.88 16.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.32 1.048 . . . . 4.92 111.193 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -67.22 -41.93 84.9 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 121.703 -0.623 . . . . 3.38 111.531 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 mm -55.19 -45.27 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.054 0.942 . . . . 1.74 110.191 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -48.96 -47.01 44.31 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.305 0.574 . . . . 1.58 110.596 171.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -32.71 69.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.378 0.881 . . . . 3.91 113.378 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.63 -25.54 18.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.321 0.509 . . . . 1.85 110.118 166.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.13 29.67 5.67 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.256 -1.138 . . . . 0.5 110.256 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -146.23 159.55 43.18 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 106.84 -1.541 . . . . 3.16 106.84 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.79 135.37 54.03 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.776 0.798 . . . . 5.28 109.324 171.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.9 p -99.34 152.54 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.478 1.511 . . . . 1.67 109.751 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 C--O 1.226 -0.174 0 N-CA-C 109.4 -0.593 . . . . 2.03 109.4 175.208 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 119.662 -0.209 . . . . 1.06 111.076 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -146.84 151.53 37.25 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 122.689 1.233 . . . . 4.32 112.724 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -84.83 106.08 16.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 131.21 3.804 . . . . 2.43 107.858 171.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.09 148.3 4.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 N-CA-C 107.199 -1.408 . . . . 2.22 107.199 165.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.54 126.28 29.01 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 124.775 1.23 . . . . 1.6 107.73 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -156.52 165.48 36.17 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.525 -0.546 . . . . 1.63 109.525 -170.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.72 155.2 16.87 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 108.827 -0.805 . . . . 2.02 108.827 -174.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.11 163.06 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 108.218 -1.03 . . . . 1.89 108.218 175.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 107.085 -1.45 . . . . 1.44 107.085 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.564 0 CA-C-O 119.369 -0.348 . . . . 1.62 111.633 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -58.79 -41.49 86.82 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.592 0.633 . . . . 6.48 111.145 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.2 mt -54.51 -59.74 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.592 -1.262 . . . . 2.17 107.592 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.37 -36.14 73.97 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.431 -0.804 . . . . 2.54 110.501 -171.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -56.12 -36.47 68.25 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.199 -0.938 . . . . 3.08 110.961 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.2 -48.04 48.12 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.007 -0.837 . . . . 0.48 111.007 166.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.2 mt -68.01 -30.55 69.83 Favored 'General case' 0 C--O 1.224 -0.241 0 O-C-N 121.351 -1.088 . . . . 1.66 111.842 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -60.33 -19.1 54.03 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.712 1.142 . . . . 2.22 111.468 172.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -25.21 62.02 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.95 -1.094 . . . . 5.07 113.349 168.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 92.1 mmm -72.6 134.02 82.23 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 119.784 1.174 . . . . 2.95 112.448 -167.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.03 101.44 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.902 3.068 . . . . 0.38 110.653 -172.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.22 -15.35 3.97 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.667 -0.973 . . . . 0.28 110.667 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.48 154.71 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 O-C-N 122.081 -0.658 . . . . 1.55 111.158 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.65 -53.78 2.08 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.784 1.234 . . . . 1.63 109.801 171.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -142.44 153.46 43.73 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 113.606 0.965 . . . . 2.93 113.606 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.65 125.4 38.02 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.596 1.958 . . . . 1.74 107.971 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.13 109.39 6.88 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.043 1.337 . . . . 1.42 108.857 -168.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.3 145.26 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.928 0.891 . . . . 1.89 112.372 -172.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -135.6 67.73 1.47 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.121 1.768 . . . . 1.81 111.622 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.5 mt -68.0 -14.6 63.09 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 113.159 0.8 . . . . 1.69 113.159 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.15 -14.1 3.7 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.822 0.449 . . . . 1.54 111.355 166.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 m -137.27 19.34 2.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.477 1.111 . . . . 1.61 109.422 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 47.44 36.98 5.57 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.262 1.025 . . . . 2.71 111.232 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.9 m -132.22 156.27 46.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.781 -1.192 . . . . 1.47 107.781 -168.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.81 148.2 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 108.828 -0.804 . . . . 1.61 108.828 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -116.55 138.2 51.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.796 -1.187 . . . . 2.48 107.796 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.87 131.09 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.275 -1.009 . . . . 1.53 108.275 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.91 115.76 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.803 -1.554 . . . . 2.57 106.803 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -141.49 170.59 15.43 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.177 0.991 . . . . 3.55 110.323 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -104.56 111.47 65.21 Favored Pre-proline 0 N--CA 1.443 -0.814 0 C-N-CA 124.36 1.064 . . . . 1.37 110.012 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.06 11.65 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.738 2.959 . . . . 0.81 113.852 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.55 -48.0 12.37 Favored 'General case' 0 C--N 1.337 0.051 0 N-CA-C 107.416 -1.327 . . . . 2.01 107.416 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -84.28 -47.35 10.87 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.999 1.32 . . . . 2.48 109.471 171.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.6 m -144.22 127.22 16.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 118.509 2.781 . . . . 1.54 118.509 -146.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.44 -152.78 7.64 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.687 -0.965 . . . . 0.82 110.687 158.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -28.76 -48.78 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 129.08 2.952 . . . . 1.67 113.804 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.23 -55.37 18.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.705 0.684 . . . . 1.53 112.527 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -40.24 63.78 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 122.425 1.107 . . . . 1.61 108.418 -176.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.57 -49.98 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-N 114.131 -1.395 . . . . 2.39 111.312 -169.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.08 -51.1 56.62 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.592 1.542 . . . . 0.86 110.279 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -45.38 -53.55 8.47 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.057 0.943 . . . . 2.38 111.94 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -43.47 71.13 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 118.2 -0.905 . . . . 2.96 111.222 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.7 mm -50.88 -47.35 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.53 1.059 . . . . 1.81 109.156 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -51.86 -48.02 64.2 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.978 0.418 . . . . 1.48 110.43 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -69.1 -34.56 75.29 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.437 -0.789 . . . . 4.12 112.575 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.95 -21.96 13.46 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 122.97 0.508 . . . . 2.13 110.605 168.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.78 29.93 8.34 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.169 -1.172 . . . . 0.42 110.169 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -137.67 170.88 15.3 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.372 -1.344 . . . . 3.56 107.372 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.83 127.68 45.36 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.882 0.873 . . . . 5.39 108.964 172.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.43 149.38 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 125.911 1.684 . . . . 1.85 109.541 172.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.527 0.088 0 C-N-CA 123.797 0.839 . . . . 2.05 109.828 176.554 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.548 0.213 . . . . 0.66 111.101 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -147.53 162.55 38.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.186 0.517 . . . . 3.34 110.752 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -83.07 143.44 30.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 113.596 -1.638 . . . . 2.59 107.359 163.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -125.33 148.2 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 105.609 -1.997 . . . . 2.23 105.609 161.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.89 124.34 20.73 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.772 1.229 . . . . 1.47 108.543 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -156.33 161.63 40.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.425 0.29 . . . . 1.95 111.62 -170.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.11 146.71 24.43 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.56 1.144 . . . . 1.74 109.934 -169.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.75 141.35 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.094 0.558 . . . . 1.47 110.273 -176.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 107.372 -1.344 . . . . 1.14 107.372 170.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 119.566 -0.254 . . . . 1.58 110.924 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -58.28 -49.55 76.74 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.339 0.655 . . . . 4.79 111.609 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.6 mt -47.38 -59.24 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.094 1.358 . . . . 1.91 109.056 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.0 -44.31 76.88 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 119.868 -0.733 . . . . 3.71 109.038 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -50.64 -36.66 36.55 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.701 -1.249 . . . . 2.56 112.289 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.22 -48.07 82.89 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 112.011 -0.435 . . . . 0.47 112.011 168.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.0 mt -64.38 -30.04 71.09 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 120.846 -1.385 . . . . 2.17 112.154 174.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.27 16.6 ttmt -59.27 -18.6 38.85 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.821 1.191 . . . . 1.9 111.666 171.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -17.89 59.95 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.9 -1.125 . . . . 4.04 114.022 168.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 92.9 mmm -74.65 135.07 75.17 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 120.419 1.463 . . . . 3.04 112.901 -172.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.73 95.21 0.63 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.934 3.089 . . . . 0.46 111.737 -171.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.53 -18.95 2.24 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.55 -1.02 . . . . 0.21 110.55 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 p -66.88 155.25 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 O-C-N 121.939 -0.741 . . . . 1.69 110.817 168.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.7 -59.99 1.76 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.065 0.946 . . . . 1.79 109.776 168.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -146.25 142.1 28.02 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 114.309 1.226 . . . . 2.28 114.309 -171.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.53 139.44 48.97 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.233 1.813 . . . . 1.96 109.888 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -143.77 113.48 7.1 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.864 -0.791 . . . . 1.59 108.864 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -81.57 142.25 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.295 0.638 . . . . 2.36 110.414 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -129.79 68.8 1.43 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.582 1.553 . . . . 1.84 111.333 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.5 mt -62.09 -21.42 64.96 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 121.896 -0.503 . . . . 2.55 112.353 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.17 -20.21 16.84 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.806 0.442 . . . . 1.92 111.179 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 m -130.71 18.5 5.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.316 1.046 . . . . 1.63 110.041 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 35.23 55.85 0.81 Allowed 'General case' 0 C--N 1.345 0.382 0 C-N-CA 124.404 1.082 . . . . 3.84 111.659 -170.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.5 m -143.89 154.36 43.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.423 -1.695 . . . . 1.8 106.423 -175.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.56 146.97 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.167 -0.679 . . . . 1.74 109.167 171.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -115.96 143.87 44.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.999 1.32 . . . . 2.48 108.525 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.39 141.1 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 109.699 -0.482 . . . . 1.56 109.699 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.4 mt -100.64 122.26 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.53 1.932 . . . . 1.8 106.99 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -146.7 167.52 23.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.681 0.792 . . . . 3.06 110.337 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -100.54 113.02 65.44 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 114.786 -1.097 . . . . 2.12 110.432 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -69.26 10.24 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.246 3.297 . . . . 0.69 114.107 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.43 -50.76 8.52 Favored 'General case' 0 N--CA 1.458 -0.073 0 N-CA-C 107.436 -1.32 . . . . 1.68 107.436 173.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -92.19 -35.08 14.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.635 1.574 . . . . 3.32 111.076 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.9 m -146.4 130.25 17.17 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 117.742 2.497 . . . . 1.71 117.742 -157.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.94 -156.66 10.75 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.983 -1.247 . . . . 0.81 109.983 155.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -29.21 -51.4 0.1 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.867 2.867 . . . . 1.53 112.744 175.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.9 -55.69 9.29 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.074 0.768 . . . . 1.66 113.074 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -38.58 64.83 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 122.047 0.927 . . . . 1.55 108.726 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.5 mt -65.25 -54.0 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 114.37 -1.286 . . . . 2.05 110.894 -169.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.53 -51.86 25.4 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.101 1.319 . . . . 0.74 110.158 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -48.53 -47.78 38.87 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.916 1.286 . . . . 4.73 112.195 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.66 -42.85 63.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 118.774 -0.631 . . . . 3.53 112.479 174.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.1 mm -52.24 -45.13 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 119.544 1.065 . . . . 1.67 109.974 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -49.06 -44.38 41.78 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.31 0.576 . . . . 1.58 110.71 173.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -38.61 75.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.79 0.836 . . . . 4.48 111.799 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.42 -25.71 26.4 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 119.431 -0.318 . . . . 1.77 110.636 170.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.1 25.87 5.69 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 124.469 1.033 . . . . 0.4 111.264 169.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -145.58 164.81 30.52 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 106.748 -1.575 . . . . 3.63 106.748 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 129.12 54.99 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 103.747 -2.686 . . . . 4.29 103.747 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.62 139.14 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.106 -0.701 . . . . 1.7 109.106 171.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.226 -0.154 0 N-CA-C 109.212 -0.662 . . . . 2.67 109.212 176.032 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 111.677 0.251 . . . . 0.91 111.677 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.97 162.5 39.2 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.411 1.1 . . . . 3.6 111.685 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -84.24 143.96 29.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 130.252 3.421 . . . . 2.82 106.727 170.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 tp -130.1 151.66 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.309 -1.737 . . . . 2.0 106.309 162.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.78 129.12 24.03 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.461 1.104 . . . . 1.56 108.981 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.69 173.58 16.75 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 119.384 -0.341 . . . . 1.95 111.87 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.64 155.91 18.5 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 109.077 -0.712 . . . . 2.12 109.077 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.01 157.35 16.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 N-CA-C 108.124 -1.065 . . . . 1.78 108.124 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 108.31 -0.996 . . . . 1.83 108.31 175.513 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.475 0 CA-C-O 119.432 -0.318 . . . . 1.78 111.023 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.7 mtp-105 -63.14 -45.66 90.91 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.583 0.629 . . . . 6.27 110.58 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -49.64 -59.63 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 108.192 -1.04 . . . . 1.85 108.192 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.94 -35.53 72.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.72 -0.673 . . . . 2.61 110.665 -171.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -56.2 -36.1 68.03 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 120.894 -1.129 . . . . 2.2 111.155 171.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.52 -47.34 57.43 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.658 -0.977 . . . . 0.33 110.658 167.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.68 -28.73 67.94 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.384 -1.068 . . . . 1.56 112.747 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -58.49 -17.71 23.22 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.403 1.002 . . . . 2.81 111.398 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -91.42 6.27 46.12 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.97 1.1 . . . . 4.13 113.97 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 34.4 mmt -85.57 135.28 38.56 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 120.499 1.5 . . . . 3.42 112.45 171.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.03 84.11 1.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.666 2.911 . . . . 0.78 112.301 -168.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.01 -16.43 0.91 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.486 1.041 . . . . 0.34 111.832 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.22 154.23 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.647 -0.914 . . . . 1.64 111.501 168.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.69 -61.32 1.76 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.787 1.235 . . . . 1.7 108.926 169.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -149.77 149.53 30.68 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 114.329 1.233 . . . . 2.56 114.329 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.65 119.91 25.57 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.025 1.73 . . . . 1.71 109.334 -170.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -134.28 111.72 10.46 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.151 0.98 . . . . 1.69 108.431 -172.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -84.28 139.02 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 123.072 0.549 . . . . 2.09 110.824 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -125.74 64.6 1.19 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.839 2.056 . . . . 1.74 110.636 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.8 mt -65.9 -16.96 64.32 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 112.67 0.618 . . . . 1.77 112.67 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.1 -22.77 11.78 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.69 0.396 . . . . 1.67 110.712 168.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.4 m -127.14 17.78 7.15 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.268 1.427 . . . . 1.73 110.163 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 47.66 35.8 4.88 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.138 0.975 . . . . 2.42 112.374 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.7 m -131.79 153.29 50.26 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.434 -1.321 . . . . 1.58 107.434 -169.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.95 146.48 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.013 -0.736 . . . . 1.85 109.013 173.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -115.91 137.44 52.1 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.687 -1.227 . . . . 2.49 107.687 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.95 140.69 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 108.683 -0.858 . . . . 1.6 108.683 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.6 mt -105.2 132.07 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.814 1.645 . . . . 2.28 106.836 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -152.59 163.93 38.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.62 0.768 . . . . 3.23 110.774 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -92.82 110.57 46.43 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 124.158 0.983 . . . . 1.45 109.517 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.6 15.56 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.638 2.892 . . . . 0.71 113.501 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.8 -52.72 5.84 Favored 'General case' 0 CA--C 1.526 0.049 0 N-CA-C 107.57 -1.27 . . . . 1.74 107.57 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -88.96 -45.75 9.43 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.538 1.535 . . . . 2.97 110.406 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.6 m -131.59 129.24 40.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 116.886 2.18 . . . . 1.4 116.886 -158.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.83 -162.6 16.2 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 110.181 -1.168 . . . . 0.68 110.181 159.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.9 t -35.93 -41.67 0.24 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.523 2.729 . . . . 1.62 112.732 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.19 -56.22 9.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.305 0.642 . . . . 1.58 112.46 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.22 -39.03 65.83 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 122.201 1.001 . . . . 1.66 108.99 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.45 -56.66 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.275 -1.33 . . . . 1.94 109.872 -171.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.84 -54.21 8.46 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.557 1.071 . . . . 0.84 110.428 174.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 1.4 tm-20 -44.59 -52.1 8.4 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.628 0.728 . . . . 2.19 111.547 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -45.06 64.18 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 117.958 -1.02 . . . . 2.96 110.735 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.3 mm -51.29 -46.89 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 120.024 1.284 . . . . 1.82 110.173 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -52.0 -47.06 65.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.492 0.717 . . . . 1.8 109.753 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.401 ' NZ ' ' OE2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -68.99 -37.61 78.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.275 0.63 . . . . 5.58 111.522 -176.387 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -55.97 -22.38 26.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.068 0.947 . . . . 2.07 110.665 170.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.41 29.79 6.52 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 124.289 0.947 . . . . 0.35 110.868 173.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -141.4 174.22 10.75 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 108.619 -0.882 . . . . 2.9 108.619 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.13 117.54 18.43 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.815 -1.179 . . . . 5.81 107.815 -175.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 p -84.2 145.29 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.247 -0.888 . . . . 1.82 108.731 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.399 0 C-N-CA 124.649 1.18 . . . . 2.3 110.237 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.897 -0.409 . . . . 0.83 109.897 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -146.24 157.66 43.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.573 0.701 . . . . 3.54 111.367 -173.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -83.89 144.82 28.96 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 125.469 1.508 . . . . 2.49 108.318 167.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 tp -122.13 153.31 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.056 -1.831 . . . . 2.08 106.056 160.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.0 126.17 19.89 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.998 1.319 . . . . 1.67 107.85 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.26 165.9 35.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.453 0.701 . . . . 2.57 112.16 -174.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.66 147.58 23.75 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.608 1.163 . . . . 1.76 109.044 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -115.63 164.11 12.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 123.438 0.695 . . . . 1.39 109.776 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.454 -0.242 0 C-N-CA 123.538 0.735 . . . . 1.54 109.36 176.234 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.609 0 CA-C-O 119.569 -0.253 . . . . 1.56 111.046 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 mtm105 -65.06 -41.45 95.09 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 118.258 0.481 . . . . 8.37 111.175 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.0 mt -51.72 -59.13 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.127 -1.064 . . . . 1.7 108.127 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.94 -36.77 72.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 120.046 -0.662 . . . . 2.28 111.147 -171.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -50.99 -40.33 57.78 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.318 -0.864 . . . . 2.57 110.558 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.79 -48.09 57.55 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.127 -0.789 . . . . 0.38 111.127 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.9 mt -67.93 -32.4 72.83 Favored 'General case' 0 CA--C 1.519 -0.25 0 O-C-N 121.244 -1.15 . . . . 1.67 112.693 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -59.54 -17.1 29.45 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.949 0.795 . . . . 2.76 110.63 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 mtt-85 -91.86 -0.05 57.5 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.747 -1.221 . . . . 4.22 113.622 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mmt -78.67 142.68 61.79 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 120.804 1.638 . . . . 2.98 111.959 174.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.92 102.92 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.942 2.428 . . . . 0.42 110.381 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.11 -4.34 6.37 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.326 1.441 . . . . 0.36 110.941 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.88 157.21 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.848 -0.795 . . . . 1.55 110.658 164.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.91 -63.91 1.38 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 107.623 -1.251 . . . . 1.49 107.623 165.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -141.85 157.35 45.1 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 112.004 0.372 . . . . 2.84 112.004 -170.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.46 137.07 40.02 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.26 1.824 . . . . 1.7 107.414 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -139.55 114.89 9.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.902 1.281 . . . . 1.42 108.63 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -83.93 138.2 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.96 0.904 . . . . 1.72 110.339 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -132.88 63.71 1.63 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.607 1.563 . . . . 1.66 111.376 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.1 mt -67.42 -15.56 63.74 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 113.062 0.764 . . . . 1.95 113.062 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.66 -25.63 18.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 117.947 0.34 . . . . 1.8 110.529 166.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.5 m -122.65 17.33 10.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.303 1.441 . . . . 1.44 110.216 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 47.2 38.32 6.74 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.361 0.982 . . . . 2.74 111.836 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.1 m -137.34 154.43 50.05 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.432 -1.322 . . . . 1.64 107.432 -171.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.52 152.58 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.238 -1.023 . . . . 1.64 108.238 170.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.44 150.63 48.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 123.58 0.55 . . . . 2.74 109.701 174.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.19 138.07 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.398 -0.964 . . . . 1.54 108.398 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.43 119.99 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 126.05 1.74 . . . . 2.53 108.166 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -145.84 172.79 12.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.635 1.174 . . . . 3.28 110.631 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -111.87 118.94 45.59 Favored Pre-proline 0 N--CA 1.447 -0.609 0 C-N-CA 124.186 0.994 . . . . 1.4 110.815 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.27 9.73 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.91 3.74 . . . . 0.64 114.248 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.21 -40.48 37.36 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 108.437 -0.949 . . . . 1.72 108.437 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -112.09 -49.54 2.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.716 1.606 . . . . 3.04 110.25 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.6 m -111.04 128.33 55.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.593 2.757 . . . . 1.51 117.145 -168.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.21 -175.48 25.48 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.952 -0.859 . . . . 0.84 110.952 156.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -29.17 -45.2 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 128.302 2.641 . . . . 1.55 112.958 167.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.23 -55.11 13.64 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.756 0.65 . . . . 1.48 112.756 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.23 -40.06 65.0 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 122.256 1.026 . . . . 1.57 108.91 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.27 -57.12 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-N 113.918 -1.492 . . . . 1.81 110.241 -171.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.45 -51.09 28.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.621 1.1 . . . . 0.78 110.595 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -48.51 -50.19 32.9 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.737 0.815 . . . . 2.51 111.287 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -46.15 64.96 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 118.638 -0.696 . . . . 3.29 110.888 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.7 mm -49.79 -47.61 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 119.069 0.85 . . . . 1.57 109.875 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -48.3 -50.4 30.2 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.449 0.642 . . . . 1.48 110.03 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.03 -33.22 70.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 121.671 -0.643 . . . . 4.41 112.278 -176.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.83 -25.22 10.83 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 119.337 -0.364 . . . . 2.16 110.285 168.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.84 30.58 4.5 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.527 1.06 . . . . 0.31 110.675 170.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -148.4 165.75 30.17 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 105.61 -1.996 . . . . 2.89 105.61 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -120.63 140.38 51.64 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 119.1 0.864 . . . . 4.59 109.113 166.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.6 p -94.94 141.37 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.803 1.641 . . . . 1.65 108.581 172.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.225 -0.21 0 N-CA-C 108.891 -0.781 . . . . 2.76 108.891 173.86 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 120.361 0.125 . . . . 1.23 111.068 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -150.47 164.29 36.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.386 0.612 . . . . 3.94 111.095 172.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -83.47 144.94 29.22 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.94 -1.482 . . . . 2.43 108.019 163.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -124.05 148.85 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 105.145 -2.169 . . . . 2.29 105.145 162.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.53 120.45 15.46 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 125.302 1.441 . . . . 1.72 108.097 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.1 ptt? -156.7 165.14 37.08 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.202 0.455 . . . . 1.62 111.117 -169.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.84 151.96 19.16 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.859 0.864 . . . . 1.76 109.239 -171.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.36 164.59 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 123.519 0.728 . . . . 1.68 109.582 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.454 -0.23 0 C-N-CA 124.866 1.266 . . . . 1.47 109.05 175.682 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 119.117 -0.468 . . . . 1.69 111.18 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -63.42 -46.24 87.27 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.22 0.918 . . . . 4.26 110.455 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.8 mt -48.47 -58.53 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.172 -0.677 . . . . 2.0 109.172 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -37.37 73.87 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.206 -0.452 . . . . 3.81 110.579 -172.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -55.7 -33.92 64.61 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 120.727 -1.233 . . . . 2.15 111.404 174.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.45 -48.91 53.83 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 111.301 -0.719 . . . . 0.38 111.301 166.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.38 -32.75 74.5 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 118.247 1.023 . . . . 1.56 113.202 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.26 8.9 ttmt -56.15 -17.73 8.04 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.105 0.866 . . . . 1.92 111.575 170.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 8.73 44.05 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.506 1.299 . . . . 5.93 114.506 172.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mtp -85.43 140.58 36.27 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 121.085 1.766 . . . . 3.01 110.971 167.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.6 106.28 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.701 2.934 . . . . 0.49 111.206 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.44 -18.95 3.63 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.48 -1.048 . . . . 0.34 110.48 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.42 152.22 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.595 0.758 . . . . 1.53 110.87 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -58.29 2.16 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.679 1.192 . . . . 1.89 109.516 171.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -145.25 150.48 36.76 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 113.01 0.745 . . . . 2.7 113.01 -175.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.65 148.45 25.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.907 2.083 . . . . 2.46 109.408 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.38 90.23 1.32 Allowed 'General case' 0 CA--C 1.527 0.074 0 CA-C-O 121.965 0.888 . . . . 2.3 110.176 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.24 135.5 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.744 0.818 . . . . 1.82 110.445 -173.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -136.74 65.96 1.49 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.0 1.32 . . . . 1.75 111.305 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.93 -18.69 65.44 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 115.917 -0.583 . . . . 2.38 112.512 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.58 -27.85 58.92 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.242 0.474 . . . . 2.03 110.668 169.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 m -115.94 18.23 15.64 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.347 1.459 . . . . 2.07 110.109 177.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 48.6 35.56 6.31 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.515 1.126 . . . . 2.07 112.066 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -143.04 151.97 41.38 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.053 -1.091 . . . . 1.64 108.053 -165.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.18 148.95 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 109.416 -0.587 . . . . 1.68 109.416 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.18 126.38 46.88 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.036 1.334 . . . . 2.49 108.148 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.35 138.66 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.938 -0.764 . . . . 1.52 108.938 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.4 mt -99.85 126.9 53.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 107.818 -1.179 . . . . 2.42 107.818 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -150.3 170.15 19.69 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.914 0.486 . . . . 3.29 111.096 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -108.49 116.22 56.65 Favored Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 124.34 1.056 . . . . 1.34 111.13 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -67.58 5.12 1.06 Allowed 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.916 3.077 . . . . 0.58 113.875 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.32 -46.9 25.55 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 107.971 -1.122 . . . . 1.58 107.971 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -95.41 -33.21 12.57 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.161 1.384 . . . . 3.46 111.027 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.7 m -155.82 129.97 8.76 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 119.447 3.129 . . . . 1.48 119.447 -152.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.78 -163.14 12.59 Favored Glycine 0 N--CA 1.438 -1.217 0 N-CA-C 108.78 -1.728 . . . . 0.69 108.78 154.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 t -34.04 -40.21 0.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.976 2.91 . . . . 1.56 113.332 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.83 -56.23 7.93 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.081 0.855 . . . . 1.75 113.083 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.83 -34.48 66.84 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 123.022 1.392 . . . . 1.51 109.261 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.252 0.9 OUTLIER -70.03 -51.44 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 CA-C-N 113.506 -1.679 . . . . 1.65 111.007 -170.5 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -49.66 55.24 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.982 1.719 . . . . 0.83 110.348 173.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -42.88 -58.37 2.41 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 121.775 0.798 . . . . 2.33 111.971 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.29 -40.93 73.99 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 119.889 -0.724 . . . . 3.21 110.974 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.1 mm -52.59 -46.0 48.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.315 1.046 . . . . 1.75 110.283 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -51.38 -47.39 62.87 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.52 -0.548 . . . . 1.87 109.52 174.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -70.09 -34.44 73.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 121.416 -0.802 . . . . 4.48 112.789 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.96 -22.0 13.68 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.066 0.394 . . . . 2.12 110.751 167.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.91 24.5 8.55 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 124.778 1.18 . . . . 0.4 110.739 173.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -140.95 167.72 21.51 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.59 -0.893 . . . . 2.99 108.59 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.95 122.44 40.17 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 103.84 -2.652 . . . . 4.73 103.84 -175.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.1 p -100.43 141.39 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 109.663 -0.495 . . . . 1.78 109.663 170.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 C--O 1.225 -0.194 0 N-CA-C 109.199 -0.667 . . . . 2.58 109.199 175.158 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 109.452 -0.574 . . . . 0.6 109.452 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -145.83 157.0 43.94 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.686 0.755 . . . . 3.49 111.077 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.68 145.73 31.46 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.452 1.901 . . . . 2.3 108.054 165.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 tp -127.84 157.11 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.138 -1.801 . . . . 1.97 106.138 165.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.05 121.33 9.57 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.884 0.874 . . . . 1.49 108.952 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -156.74 167.85 29.22 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.264 0.484 . . . . 1.75 111.396 -174.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.59 156.98 16.75 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.807 0.843 . . . . 1.81 111.156 -172.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.79 132.66 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 C-N-CA 123.468 0.707 . . . . 1.77 110.517 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 108.91 -0.774 . . . . 1.85 108.91 173.372 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.604 0 CA-C-O 119.591 -0.242 . . . . 1.68 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -56.8 -49.36 75.59 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 118.926 -0.559 . . . . 6.04 111.705 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -48.33 -59.29 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 108.252 -1.018 . . . . 1.95 108.252 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -70.06 -35.57 74.33 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.864 -0.734 . . . . 2.55 110.39 -171.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp -61.02 -27.35 68.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.908 -1.12 . . . . 2.06 111.44 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.19 -52.56 48.65 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.248 -1.141 . . . . 0.49 110.248 162.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.43 -31.8 73.06 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 113.673 0.99 . . . . 1.75 113.673 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -51.1 -19.23 1.04 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.98 0.912 . . . . 2.82 111.705 169.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -91.25 -7.23 51.78 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.372 0.878 . . . . 4.62 113.372 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.3 mtp -76.07 139.6 69.22 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 120.212 1.369 . . . . 3.26 112.43 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.81 88.99 0.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.603 2.869 . . . . 0.46 111.363 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.68 -15.36 2.0 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.745 1.164 . . . . 0.3 111.125 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.3 p -65.46 154.51 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 O-C-N 121.422 -1.046 . . . . 1.56 110.934 169.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.24 -63.93 1.38 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.564 1.146 . . . . 1.67 108.084 167.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -150.55 137.39 19.12 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 112.368 0.507 . . . . 3.18 112.368 -168.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.16 150.66 23.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.806 1.642 . . . . 1.81 109.664 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.74 105.66 3.45 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.654 1.182 . . . . 1.92 108.684 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.37 137.79 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.212 0.605 . . . . 1.77 110.698 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -131.76 66.57 1.54 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.701 1.601 . . . . 1.71 111.083 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.1 mt -67.0 -19.09 65.66 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 115.918 -0.583 . . . . 2.1 112.17 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.76 -11.66 8.29 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.629 0.772 . . . . 1.8 111.665 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 m -135.31 17.82 3.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.37 1.068 . . . . 1.63 109.525 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 44.85 39.53 3.64 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.058 1.343 . . . . 3.31 111.957 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.1 m -134.37 155.28 50.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.542 -1.281 . . . . 1.54 107.542 -170.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 p -131.96 143.13 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 109.136 -0.69 . . . . 1.65 109.136 172.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.36 141.68 43.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.651 1.58 . . . . 2.65 106.836 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.44 144.19 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 108.501 -0.926 . . . . 1.63 108.501 171.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.7 mt -112.13 121.21 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 125.996 1.718 . . . . 1.94 107.069 -174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -144.39 166.1 26.05 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.892 0.877 . . . . 3.39 110.818 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -95.38 109.71 46.7 Favored Pre-proline 0 N--CA 1.445 -0.701 0 C-N-CA 124.727 1.211 . . . . 1.45 109.564 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -71.18 12.89 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.688 2.925 . . . . 0.75 113.659 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.75 -48.47 10.08 Favored 'General case' 0 C--N 1.337 0.025 0 N-CA-C 107.647 -1.242 . . . . 1.71 107.647 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -89.5 -40.33 12.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.886 1.275 . . . . 2.62 111.026 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.1 m -143.79 126.85 16.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 117.5 2.407 . . . . 1.74 117.5 -152.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.72 -159.55 10.23 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 109.207 -1.557 . . . . 0.77 109.207 156.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.4 t -33.71 -42.93 0.12 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.248 2.619 . . . . 1.47 113.134 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.49 -56.25 8.79 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.977 0.808 . . . . 1.55 112.683 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.76 -35.89 62.58 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 122.113 0.959 . . . . 1.49 109.369 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.254 0.8 OUTLIER -64.93 -55.52 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 114.358 -1.292 . . . . 1.74 110.245 -174.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -49.88 45.83 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 120.553 1.524 . . . . 0.84 111.315 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -38.82 -57.35 1.23 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.051 0.929 . . . . 2.72 112.902 171.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -71.77 -41.53 68.25 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.606 -0.725 . . . . 3.14 109.827 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.8 mm -55.13 -45.09 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 119.413 1.006 . . . . 1.75 110.436 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -52.35 -54.18 34.99 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.547 1.139 . . . . 1.64 109.241 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -45.94 85.15 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.479 0.548 . . . . 5.06 112.479 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mp -55.07 -19.32 6.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.815 1.646 . . . . 3.6 111.789 172.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.72 24.91 7.9 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.343 0.973 . . . . 0.44 111.346 169.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -139.22 175.44 9.56 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 108.879 -0.786 . . . . 3.67 108.879 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 123.05 27.51 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.51 -1.663 . . . . 5.62 106.51 175.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -87.96 145.42 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.19 -0.67 . . . . 1.92 109.19 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 108.904 -0.776 . . . . 2.34 108.904 168.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 120.42 0.152 . . . . 1.0 110.609 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -150.54 156.64 41.79 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.372 0.606 . . . . 3.67 110.093 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -84.07 114.15 21.55 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.867 2.067 . . . . 2.3 106.683 169.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -96.96 155.37 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 106.416 -1.698 . . . . 2.12 106.416 167.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.93 137.69 34.99 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.855 -0.794 . . . . 1.61 108.855 170.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.18 169.25 25.2 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.638 0.586 . . . . 1.77 111.995 175.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.56 153.46 19.74 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.498 1.119 . . . . 1.91 110.723 -175.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.85 134.99 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 123.098 0.559 . . . . 1.84 111.656 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.452 -0.331 0 C-N-CA 124.112 0.965 . . . . 1.55 109.293 175.024 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 111.598 0.221 . . . . 1.79 111.598 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -69.9 -45.86 66.69 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.488 0.715 . . . . 5.5 110.099 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -50.75 -54.14 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.367 -0.605 . . . . 2.11 109.367 177.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -69.62 -42.92 73.69 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.505 -0.554 . . . . 3.79 109.505 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -51.61 -36.93 47.78 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.175 -1.578 . . . . 2.72 111.809 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.28 -52.96 37.25 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 111.543 -0.623 . . . . 0.58 111.543 166.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.3 -29.46 69.89 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.1 -1.236 . . . . 1.63 113.289 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -59.9 -18.75 47.21 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.151 1.342 . . . . 2.42 111.715 172.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -16.55 57.83 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.885 1.068 . . . . 5.36 113.885 169.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 83.8 mmm -72.12 135.79 82.3 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 120.031 1.287 . . . . 3.04 111.431 -174.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.58 101.32 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.042 2.494 . . . . 0.4 110.711 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.31 -15.12 3.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 119.459 1.027 . . . . 0.25 110.809 176.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.17 153.31 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 O-C-N 122.312 -0.523 . . . . 1.66 109.941 166.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.65 -61.04 1.76 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.126 -1.064 . . . . 1.6 108.126 162.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -141.42 145.98 35.98 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 113.527 0.936 . . . . 3.39 113.527 -168.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.64 150.9 26.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.758 1.623 . . . . 2.06 108.551 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.86 101.54 2.91 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.77 0.828 . . . . 1.96 108.785 175.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.95 141.54 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.828 0.851 . . . . 2.14 110.997 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -139.11 66.04 1.43 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.137 1.375 . . . . 1.75 111.429 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.2 mt -67.04 -13.82 62.29 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 113.342 0.867 . . . . 2.26 113.342 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.36 -25.52 9.98 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.578 0.351 . . . . 1.86 110.886 165.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.8 m -125.17 17.92 8.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.343 1.457 . . . . 1.6 110.157 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 48.18 33.39 3.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.414 1.086 . . . . 2.48 112.156 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -131.66 149.24 52.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.29 -1.004 . . . . 1.57 108.29 -168.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -134.02 144.45 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 109.399 -0.593 . . . . 1.66 109.399 174.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -112.11 145.08 40.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.052 1.741 . . . . 2.38 108.096 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.52 136.44 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.011 -0.737 . . . . 1.61 109.011 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.36 119.17 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.694 1.597 . . . . 2.31 107.535 178.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -144.49 167.81 21.61 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.009 0.923 . . . . 3.11 110.712 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -108.26 122.88 39.16 Favored Pre-proline 0 N--CA 1.451 -0.416 0 O-C-N 124.211 0.944 . . . . 1.47 110.888 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.79 5.05 1.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.931 3.088 . . . . 0.7 113.544 -177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.74 -55.28 6.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.419 -1.326 . . . . 1.47 107.419 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -84.04 -42.57 16.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.526 1.13 . . . . 3.68 110.54 172.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.8 m -143.27 131.6 22.11 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 119.175 3.028 . . . . 1.38 119.175 -143.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.06 -159.55 18.67 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.13 -1.188 . . . . 0.74 110.13 159.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -30.66 -47.63 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.839 2.855 . . . . 1.67 112.845 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.86 -56.27 7.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.396 0.678 . . . . 1.37 112.488 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.65 -38.49 64.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.197 0.999 . . . . 1.48 109.393 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mt -64.75 -55.36 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.465 -1.243 . . . . 1.87 110.377 -170.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.98 -50.02 59.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.923 1.238 . . . . 0.77 110.695 177.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -43.7 -56.14 3.96 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.712 0.805 . . . . 2.13 112.023 175.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -41.48 72.57 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.559 -0.856 . . . . 2.66 110.586 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.6 mm -52.42 -46.05 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 119.489 1.04 . . . . 1.71 110.019 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -50.82 -46.69 59.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.041 0.448 . . . . 1.86 110.098 174.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -32.89 70.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 114.015 1.117 . . . . 3.8 114.015 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.65 -21.23 25.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.548 0.613 . . . . 1.84 110.571 166.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.93 27.3 8.4 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.768 -0.933 . . . . 0.33 110.768 173.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -140.39 173.67 11.28 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.181 -1.044 . . . . 2.92 108.181 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 122.88 31.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.702 -1.592 . . . . 5.49 106.702 176.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 p -89.92 145.78 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.906 -0.776 . . . . 1.83 108.906 171.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 109.289 -0.634 . . . . 1.93 109.289 170.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 120.42 0.152 . . . . 1.0 110.609 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -150.54 156.64 41.79 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.372 0.606 . . . . 3.67 110.093 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -84.07 114.15 21.55 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.867 2.067 . . . . 2.3 106.683 169.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -96.96 155.37 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 106.416 -1.698 . . . . 2.12 106.416 167.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.93 137.69 34.99 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.855 -0.794 . . . . 1.61 108.855 170.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.18 169.25 25.2 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.638 0.586 . . . . 1.77 111.995 175.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.56 153.46 19.74 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.498 1.119 . . . . 1.91 110.723 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.85 134.99 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 123.098 0.559 . . . . 1.84 111.656 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.452 -0.331 0 C-N-CA 124.112 0.965 . . . . 1.55 109.293 175.024 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 111.598 0.221 . . . . 1.79 111.598 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -69.9 -45.86 66.69 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.488 0.715 . . . . 5.5 110.099 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -50.75 -54.14 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.367 -0.605 . . . . 2.11 109.367 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -69.62 -42.92 73.69 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.505 -0.554 . . . . 3.79 109.505 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -51.61 -36.93 47.78 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.175 -1.578 . . . . 2.72 111.809 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.28 -52.96 37.25 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 111.543 -0.623 . . . . 0.58 111.543 166.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.3 -29.46 69.89 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.1 -1.236 . . . . 1.63 113.289 174.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -59.9 -18.75 47.21 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.151 1.342 . . . . 2.42 111.715 172.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -16.55 57.83 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.885 1.068 . . . . 5.36 113.885 169.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 83.8 mmm -72.12 135.79 82.3 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 120.031 1.287 . . . . 3.04 111.431 -174.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.58 101.32 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.042 2.494 . . . . 0.4 110.711 -174.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.31 -15.12 3.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 119.459 1.027 . . . . 0.25 110.809 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.17 153.31 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 O-C-N 122.312 -0.523 . . . . 1.66 109.941 166.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.65 -61.04 1.76 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.126 -1.064 . . . . 1.6 108.126 162.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -141.42 145.98 35.98 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 113.527 0.936 . . . . 3.39 113.527 -168.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.64 150.9 26.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.758 1.623 . . . . 2.06 108.551 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.86 101.54 2.91 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.77 0.828 . . . . 1.96 108.785 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.95 141.54 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.828 0.851 . . . . 2.14 110.997 -175.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -139.11 66.04 1.43 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.137 1.375 . . . . 1.75 111.429 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.2 mt -67.04 -13.82 62.29 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 113.342 0.867 . . . . 2.26 113.342 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.36 -25.52 9.98 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.578 0.351 . . . . 1.86 110.886 165.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.8 m -125.17 17.92 8.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.343 1.457 . . . . 1.6 110.157 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 48.18 33.39 3.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.414 1.086 . . . . 2.48 112.156 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -131.66 149.24 52.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.29 -1.004 . . . . 1.57 108.29 -168.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -134.02 144.45 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 109.399 -0.593 . . . . 1.66 109.399 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -112.11 145.08 40.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.052 1.741 . . . . 2.38 108.096 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.52 136.44 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.011 -0.737 . . . . 1.61 109.011 174.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.36 119.17 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.694 1.597 . . . . 2.31 107.535 178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -144.49 167.81 21.61 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.009 0.923 . . . . 3.11 110.712 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -108.26 122.88 39.16 Favored Pre-proline 0 N--CA 1.451 -0.416 0 O-C-N 124.211 0.944 . . . . 1.47 110.888 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.79 5.05 1.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.931 3.088 . . . . 0.7 113.544 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.74 -55.28 6.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.419 -1.326 . . . . 1.47 107.419 175.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -84.04 -42.57 16.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.526 1.13 . . . . 3.68 110.54 172.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.8 m -143.27 131.6 22.11 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 119.175 3.028 . . . . 1.38 119.175 -143.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.06 -159.55 18.67 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.13 -1.188 . . . . 0.74 110.13 159.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -30.66 -47.63 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.839 2.855 . . . . 1.67 112.845 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.86 -56.27 7.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.396 0.678 . . . . 1.37 112.488 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.65 -38.49 64.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.197 0.999 . . . . 1.48 109.393 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mt -64.75 -55.36 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.465 -1.243 . . . . 1.87 110.377 -170.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.98 -50.02 59.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.923 1.238 . . . . 0.77 110.695 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -43.7 -56.14 3.96 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.712 0.805 . . . . 2.13 112.023 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -41.48 72.57 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.559 -0.856 . . . . 2.66 110.586 -178.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.6 mm -52.42 -46.05 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 119.489 1.04 . . . . 1.71 110.019 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -50.82 -46.69 59.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.041 0.448 . . . . 1.86 110.098 174.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -32.89 70.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 114.015 1.117 . . . . 3.8 114.015 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.65 -21.23 25.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.548 0.613 . . . . 1.84 110.571 166.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.93 27.3 8.4 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.768 -0.933 . . . . 0.33 110.768 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -140.39 173.67 11.28 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.181 -1.044 . . . . 2.92 108.181 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 122.88 31.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.702 -1.592 . . . . 5.49 106.702 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 p -89.92 145.78 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.906 -0.776 . . . . 1.83 108.906 171.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 109.289 -0.634 . . . . 1.93 109.289 170.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 N--CA 1.45 -0.434 0 CA-C-O 120.56 0.219 . . . . 0.94 111.289 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.32 161.55 40.07 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.998 -0.371 . . . . 4.56 109.998 172.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.41 136.29 33.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.627 -1.17 . . . . 3.39 107.935 161.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 tp -107.4 153.91 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.051 -1.833 . . . . 2.11 106.051 162.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.58 128.56 17.49 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.589 1.156 . . . . 1.5 108.44 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.78 172.33 18.81 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.506 0.594 . . . . 2.72 111.939 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.62 157.38 17.51 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.278 -0.638 . . . . 2.28 109.278 -176.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.34 132.12 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 O-C-N 123.492 0.495 . . . . 1.49 110.315 177.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 107.922 -1.14 . . . . 1.47 107.922 172.464 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 CA-C-O 118.579 -0.724 . . . . 1.53 110.609 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -52.98 -44.38 67.14 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 119.347 0.976 . . . . 6.53 111.451 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.4 mt -44.66 -61.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 123.494 0.717 . . . . 1.99 109.15 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.01 -37.99 66.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.809 -0.632 . . . . 2.4 112.177 -175.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -57.5 -34.63 69.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.328 -0.858 . . . . 2.47 110.691 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.81 -49.82 64.23 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 110.781 -0.928 . . . . 0.4 110.781 167.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.41 -32.72 74.45 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 118.302 1.051 . . . . 1.81 112.311 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -57.83 -16.43 11.62 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.151 0.887 . . . . 2.4 112.094 171.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -97.85 -0.47 45.03 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.178 0.899 . . . . 4.09 112.744 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 53.7 mmm -79.99 135.56 55.03 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 119.895 1.225 . . . . 3.42 110.629 174.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.09 116.94 3.89 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.421 2.08 . . . . 0.82 109.448 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.35 -17.18 6.61 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.929 1.252 . . . . 0.4 110.146 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.7 p -75.7 158.69 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.305 0.642 . . . . 1.59 111.366 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.38 -63.05 1.4 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.581 1.152 . . . . 1.78 108.099 165.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -135.36 151.86 50.89 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 112.441 0.534 . . . . 3.11 112.441 -169.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.32 140.09 41.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.928 1.291 . . . . 1.71 107.558 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -147.63 129.98 15.7 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.201 -0.666 . . . . 1.74 109.201 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.89 134.87 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 123.98 0.912 . . . . 1.71 110.593 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -124.82 65.2 1.11 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.008 1.723 . . . . 1.68 110.201 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.97 -20.36 63.77 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 116.071 -0.513 . . . . 2.18 112.334 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.52 -24.69 21.75 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.997 0.519 . . . . 1.85 110.996 171.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.4 m -125.61 16.24 8.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.96 1.304 . . . . 1.68 109.935 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 45.93 38.39 4.5 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.339 1.056 . . . . 2.01 111.44 -175.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.4 m -131.86 153.05 50.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.11 -1.441 . . . . 1.62 107.11 -171.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 p -133.2 149.86 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.721 -1.214 . . . . 1.61 107.721 174.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.22 148.45 48.64 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 123.967 0.792 . . . . 2.9 109.565 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.3 131.26 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 121.576 0.703 . . . . 1.61 109.266 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mt -95.38 120.12 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.508 1.923 . . . . 2.32 107.361 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -149.33 170.15 19.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.455 0.702 . . . . 3.12 110.188 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -104.44 121.29 47.78 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 114.36 -1.291 . . . . 2.03 111.22 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.18 2.69 1.67 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.683 3.589 . . . . 0.62 114.203 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.92 -51.16 10.85 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 119.268 0.94 . . . . 1.48 108.864 176.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -90.7 -44.27 9.59 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.545 1.538 . . . . 3.04 109.633 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.2 m -127.07 121.83 32.62 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 116.865 2.172 . . . . 1.46 116.865 -157.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.09 169.63 27.41 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 106.223 -2.751 . . . . 1.46 106.223 173.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.304 0.0 OUTLIER -39.52 -40.05 0.8 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.324 1.849 . . . . 2.07 113.248 177.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -38.3 -59.76 0.85 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.331 1.052 . . . . 1.94 113.245 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.51 -35.61 65.64 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 122.012 0.911 . . . . 1.59 109.246 -173.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.75 -60.09 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-N 114.189 -1.368 . . . . 2.57 108.237 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.72 -51.88 26.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.162 0.892 . . . . 1.13 110.436 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.68 -51.31 12.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.929 0.892 . . . . 2.38 112.01 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -46.01 65.31 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.911 -0.716 . . . . 2.83 110.938 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.3 mm -52.41 -44.53 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 118.94 0.791 . . . . 2.3 110.73 -175.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -48.85 -51.3 30.43 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.327 0.585 . . . . 1.59 109.939 173.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -73.31 -28.75 62.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.602 0.761 . . . . 5.18 112.85 -175.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.46 -25.45 25.29 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.155 0.434 . . . . 2.21 110.254 165.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.02 29.93 5.61 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 124.891 1.234 . . . . 0.57 110.566 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -144.12 169.26 18.19 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 108.198 -1.038 . . . . 3.46 108.198 -176.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.95 120.47 30.44 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.103 -1.073 . . . . 5.67 108.103 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.8 p -87.49 149.64 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.835 -0.432 . . . . 1.72 109.835 172.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.26 0 C-N-CA 124.181 0.992 . . . . 2.11 110.217 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 109.846 -0.427 . . . . 0.69 109.846 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -147.98 162.1 40.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.248 1.023 . . . . 4.0 111.395 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.16 146.93 30.28 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 112.647 -2.069 . . . . 3.34 107.807 164.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -132.25 158.06 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.401 -2.074 . . . . 2.37 105.401 165.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.73 144.1 32.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.062 0.945 . . . . 1.77 109.129 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.9 169.82 23.73 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.252 0.621 . . . . 2.17 110.609 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.1 155.01 19.72 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.367 -0.975 . . . . 2.32 108.367 176.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -116.54 160.85 15.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.283 -1.006 . . . . 1.63 108.283 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.445 -0.701 0 N-CA-C 107.452 -1.314 . . . . 1.27 107.452 175.148 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.547 0 CA-C-O 118.586 -0.721 . . . . 1.72 110.937 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.69 -48.33 66.64 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.176 0.898 . . . . 4.79 110.543 172.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.0 mt -49.03 -61.13 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.24 0 N-CA-C 109.054 -0.721 . . . . 1.73 109.054 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -71.2 -35.1 71.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.077 -0.649 . . . . 2.37 110.895 -171.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -54.57 -37.99 66.15 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 121.02 -1.05 . . . . 2.49 110.688 171.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.37 -51.52 36.57 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.584 -1.006 . . . . 0.48 110.584 168.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.79 -29.91 70.9 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 121.702 -0.881 . . . . 1.62 112.367 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.1 -18.07 63.01 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 118.984 0.811 . . . . 2.83 109.809 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.83 -23.08 63.25 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.219 -1.551 . . . . 3.88 113.934 168.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.03 133.19 89.99 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 120.214 1.37 . . . . 2.44 110.463 -172.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.24 100.12 0.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.822 2.348 . . . . 0.54 110.19 -176.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.57 -21.82 2.37 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.588 -1.005 . . . . 0.3 110.588 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.37 153.7 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 122.293 -0.533 . . . . 1.64 110.675 170.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.25 -61.07 1.77 Allowed 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.467 -0.938 . . . . 1.71 108.467 167.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.26 152.93 39.12 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.645 0.259 . . . . 2.76 111.315 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.13 135.28 46.29 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.901 2.08 . . . . 1.75 107.77 -173.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -144.7 121.67 11.36 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.408 0.683 . . . . 1.57 109.73 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -97.8 137.59 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 112.937 0.717 . . . . 1.99 112.937 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -126.33 69.79 1.23 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.401 2.281 . . . . 1.8 111.181 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.9 mt -65.08 -17.98 64.92 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 112.692 0.627 . . . . 2.0 112.692 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.89 -10.0 5.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.154 0.434 . . . . 1.57 111.44 169.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 m -138.17 17.18 2.8 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.23 1.012 . . . . 1.46 109.758 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mp0 51.2 30.6 5.89 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.048 0.84 . . . . 2.89 111.935 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.7 m -128.98 153.66 47.34 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.804 -1.184 . . . . 1.67 107.804 -168.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.02 147.46 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.951 -1.129 . . . . 1.62 107.951 174.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.46 151.73 41.0 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 124.209 0.943 . . . . 2.84 109.154 175.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.5 140.2 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.142 -1.059 . . . . 1.58 108.142 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.46 124.89 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.531 1.532 . . . . 2.14 107.438 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -148.46 165.99 29.49 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.387 0.675 . . . . 3.21 110.622 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -97.98 110.84 57.42 Favored Pre-proline 0 N--CA 1.447 -0.611 0 C-N-CA 124.673 1.189 . . . . 2.05 110.247 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -72.25 13.25 0.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.963 3.108 . . . . 0.72 113.716 -177.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.41 -51.26 8.02 Favored 'General case' 0 C--N 1.337 0.059 0 N-CA-C 107.257 -1.386 . . . . 1.91 107.257 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -80.83 -47.98 13.06 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.273 1.429 . . . . 2.74 109.637 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.5 m -143.04 125.7 15.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 117.252 2.316 . . . . 1.59 117.252 -145.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.51 -159.74 13.65 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 109.857 -1.297 . . . . 0.71 109.857 165.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.4 t -29.47 -50.04 0.1 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 129.138 2.975 . . . . 1.61 112.632 177.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.05 -56.33 6.68 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.025 0.93 . . . . 1.43 112.654 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -38.47 64.88 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 122.248 1.023 . . . . 1.51 109.403 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mt -63.29 -56.26 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.242 -1.345 . . . . 1.75 110.216 -170.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.21 -52.69 19.87 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.174 1.352 . . . . 0.76 110.611 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' OE1' ' NZ ' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -44.09 -51.95 7.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.683 1.193 . . . . 2.51 111.968 176.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -70.81 -43.44 68.61 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 118.248 -0.882 . . . . 3.21 111.464 177.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.7 mm -52.58 -45.55 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 119.77 1.168 . . . . 1.53 110.075 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -50.38 -49.2 55.05 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.763 0.316 . . . . 1.82 110.183 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -70.77 -30.67 67.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 114.279 1.214 . . . . 4.08 114.279 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.27 -21.0 12.75 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.532 0.606 . . . . 1.82 110.635 166.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.24 28.74 9.52 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.998 -1.241 . . . . 0.3 109.998 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -137.44 168.3 19.91 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.735 -0.839 . . . . 2.91 108.735 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.33 123.1 42.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.746 -1.576 . . . . 5.81 106.746 175.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -91.65 152.99 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.46 -0.57 . . . . 1.68 109.46 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.103 0 CA-C-O 121.305 0.574 . . . . 1.79 110.305 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 109.546 -0.539 . . . . 0.99 109.546 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.45 162.22 41.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.238 0.542 . . . . 5.88 110.878 176.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -82.83 155.03 24.38 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.222 1.809 . . . . 3.71 109.765 168.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.7 142.84 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 104.847 -2.279 . . . . 4.28 104.847 162.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.52 130.72 51.14 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.689 1.196 . . . . 1.49 107.869 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -155.53 174.78 14.77 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.876 0.47 . . . . 2.06 110.381 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.431 ' N ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -104.87 150.31 24.96 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.753 -1.203 . . . . 1.9 107.753 -176.379 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.42 161.52 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 107.502 -1.296 . . . . 1.41 107.502 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 107.609 -1.256 . . . . 1.31 107.609 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 119.489 -0.291 . . . . 1.58 110.24 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -58.4 -45.14 88.95 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 118.778 -0.629 . . . . 4.29 111.997 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.2 mt -49.06 -60.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.041 -0.725 . . . . 1.82 109.041 176.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.86 -33.98 71.17 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.16 0.505 . . . . 2.64 110.336 -170.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -60.15 -31.29 69.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.864 -1.147 . . . . 3.6 111.234 171.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.67 -51.82 31.74 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.515 -1.034 . . . . 0.35 110.515 162.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -65.2 -32.66 74.45 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 121.253 -1.145 . . . . 1.66 113.023 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -54.97 -21.22 11.08 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.373 0.988 . . . . 2.73 111.458 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -76.02 -24.32 55.25 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.788 1.033 . . . . 3.71 113.788 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 mtp -69.7 132.83 88.82 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 120.375 1.443 . . . . 3.22 112.478 -172.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.6 95.38 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.644 2.896 . . . . 0.46 110.716 -172.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.44 -20.8 2.23 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.696 -0.962 . . . . 0.27 110.696 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.62 144.54 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 121.966 -0.726 . . . . 1.58 110.954 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.12 -61.79 1.34 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.629 1.172 . . . . 2.02 109.269 167.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -149.41 147.98 28.92 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 114.315 1.228 . . . . 2.87 114.315 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.46 121.3 41.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.84 2.056 . . . . 1.76 108.331 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.99 107.42 6.15 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.921 0.889 . . . . 1.49 108.986 -170.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 p -85.4 143.6 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.91 0.884 . . . . 2.0 112.058 -172.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -133.49 65.78 1.57 Allowed 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.226 1.811 . . . . 1.8 111.163 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.6 mt -65.61 -16.35 63.63 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 121.685 -0.634 . . . . 1.86 112.704 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.4 -19.65 15.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.645 0.378 . . . . 1.59 110.902 168.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.4 m -129.19 19.33 5.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.088 1.355 . . . . 1.63 109.685 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 50.24 35.14 9.84 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.138 0.975 . . . . 2.44 111.846 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.89 158.08 44.86 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 108.847 -0.797 . . . . 2.57 108.847 -169.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.96 148.85 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.081 -0.711 . . . . 1.67 109.081 176.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -115.81 134.41 55.04 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.95 -1.5 . . . . 2.5 106.95 176.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.43 140.07 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.284 -0.635 . . . . 1.67 109.284 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.0 mt -105.58 132.67 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 126.201 1.8 . . . . 2.2 106.945 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.01 167.42 28.48 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.959 0.409 . . . . 3.42 111.498 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -98.25 114.16 64.86 Favored Pre-proline 0 N--CA 1.442 -0.829 0 C-N-CA 124.752 1.221 . . . . 1.46 109.839 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -69.48 9.87 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 124.289 3.326 . . . . 0.61 113.971 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.39 -51.59 8.18 Favored 'General case' 0 N--CA 1.458 -0.058 0 N-CA-C 107.411 -1.329 . . . . 1.52 107.411 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -93.67 -29.75 15.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.579 1.552 . . . . 3.12 111.289 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.7 m -150.2 130.25 13.5 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 118.031 2.604 . . . . 1.23 118.031 -156.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.33 -165.25 17.79 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 110.453 -1.059 . . . . 0.62 110.453 156.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.4 t -39.88 -38.31 0.67 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.291 2.636 . . . . 1.69 112.138 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.65 -56.0 9.71 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.181 0.808 . . . . 1.58 113.181 174.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.56 -37.82 65.41 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.838 1.304 . . . . 1.52 108.904 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.269 0.8 OUTLIER -64.04 -53.6 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 113.708 -1.587 . . . . 1.78 111.013 -173.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.87 -53.07 12.91 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.766 1.621 . . . . 0.97 111.048 173.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -39.75 -58.12 1.4 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.829 0.823 . . . . 2.52 113.106 172.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -70.34 -40.28 74.2 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 119.465 -0.894 . . . . 3.88 110.224 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.3 mm -54.12 -46.74 67.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.506 1.048 . . . . 1.5 110.114 178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -53.13 -45.53 68.4 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.289 0.636 . . . . 1.57 109.927 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -38.99 86.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.456 -0.778 . . . . 4.78 111.23 -177.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.6 -19.85 18.11 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.656 1.182 . . . . 2.14 110.898 170.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.01 28.54 9.25 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 124.187 0.899 . . . . 0.39 110.938 173.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -138.06 165.31 26.91 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.041 -1.096 . . . . 3.0 108.041 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.69 129.3 55.2 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.752 0.821 . . . . 5.21 108.943 173.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.3 p -96.14 148.52 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 125.276 1.431 . . . . 1.63 110.22 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.463 0.177 0 C-N-CA 123.594 0.758 . . . . 1.75 110.376 -178.311 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 119.92 -0.085 . . . . 0.66 111.182 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -143.67 157.0 44.72 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.599 0.714 . . . . 3.12 111.399 174.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -84.28 125.68 32.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.244 1.818 . . . . 2.33 107.035 163.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 tp -103.64 149.18 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.278 -1.749 . . . . 1.99 106.278 163.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.82 129.11 40.06 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.674 -1.232 . . . . 1.46 107.674 172.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -155.75 168.63 26.58 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.841 0.456 . . . . 1.69 110.553 -172.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -91.57 151.51 20.69 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.811 -0.811 . . . . 2.9 108.811 -173.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -117.96 160.84 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 108.922 -0.769 . . . . 1.74 108.922 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.445 -0.685 0 N-CA-C 107.839 -1.171 . . . . 1.76 107.839 174.194 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.676 0 CA-C-O 118.68 -0.676 . . . . 1.61 111.935 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -57.48 -47.11 82.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.357 0.98 . . . . 4.59 110.753 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 mp -48.7 -61.62 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.413 -0.958 . . . . 3.09 108.413 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.56 -33.57 66.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.433 -0.507 . . . . 2.57 112.003 -172.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -56.29 -39.8 73.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.149 -0.969 . . . . 2.91 110.026 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.01 -55.5 11.61 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.937 -1.265 . . . . 0.35 109.937 167.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.5 -31.39 72.54 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 113.439 0.903 . . . . 1.64 113.439 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.26 14.0 ttpt -61.62 -17.14 53.99 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.656 1.116 . . . . 3.07 111.116 172.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.92 -12.8 52.6 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.154 1.168 . . . . 4.63 114.154 168.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.44 137.58 83.68 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 120.827 1.649 . . . . 4.48 111.241 -173.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.48 94.48 0.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.113 2.542 . . . . 0.44 110.433 -175.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.42 -12.78 3.5 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.74 1.162 . . . . 0.25 111.193 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.7 p -67.38 160.57 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 117.791 0.795 . . . . 1.46 110.526 167.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.77 -55.44 1.9 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.358 1.063 . . . . 1.6 110.152 165.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -143.99 162.26 36.64 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.068 0.395 . . . . 2.26 111.815 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.44 135.73 28.77 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 126.072 1.749 . . . . 1.72 109.607 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -142.47 110.25 5.83 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 125.439 1.496 . . . . 1.73 108.746 -173.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.0 p -84.14 140.93 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.555 0.742 . . . . 1.88 111.728 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -132.48 69.06 1.48 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.991 1.717 . . . . 1.73 112.328 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.9 mt -63.38 -18.97 64.25 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 113.087 0.773 . . . . 1.91 113.087 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.83 -21.93 12.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.264 0.484 . . . . 1.55 110.933 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 m -125.65 10.19 7.77 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.919 1.288 . . . . 1.55 110.605 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 45.52 44.68 10.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.176 0.991 . . . . 3.29 112.266 -169.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.9 m -134.31 155.29 50.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.411 -1.329 . . . . 1.87 107.411 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.3 p -134.12 146.92 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.559 -0.904 . . . . 1.59 108.559 172.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -115.3 134.65 54.93 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 124.498 1.124 . . . . 2.38 108.244 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -138.56 135.48 43.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.11 -0.7 . . . . 1.89 109.11 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.9 mp -102.02 120.88 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.765 1.626 . . . . 2.42 107.178 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -147.28 167.29 24.63 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.484 0.714 . . . . 3.24 110.619 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -105.54 119.2 53.5 Favored Pre-proline 0 N--CA 1.443 -0.799 0 O-C-N 124.135 0.897 . . . . 1.37 109.677 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -67.95 7.72 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 124.464 3.443 . . . . 0.5 113.83 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.44 -57.0 4.12 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.201 -1.407 . . . . 1.64 107.201 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.0 mp0 -87.84 -37.14 16.79 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.303 1.041 . . . . 3.78 112.161 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.3 m -138.08 129.38 27.6 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 118.649 2.833 . . . . 1.3 118.649 -155.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.41 -163.62 17.86 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.475 -1.05 . . . . 0.62 110.475 155.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -29.29 -47.91 0.07 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.512 2.725 . . . . 1.52 112.863 172.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.15 -54.41 16.47 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.114 0.565 . . . . 1.52 112.487 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.3 -41.62 60.86 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 122.201 1.0 . . . . 1.53 109.182 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mt -61.36 -60.25 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 114.137 -1.392 . . . . 1.85 109.266 -170.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.98 -53.81 7.28 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.506 1.048 . . . . 0.79 110.397 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -44.47 -54.44 5.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.624 1.17 . . . . 2.59 111.363 176.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -40.7 76.04 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.987 -0.685 . . . . 3.37 111.355 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.7 mm -55.41 -44.27 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 119.233 0.924 . . . . 1.94 109.947 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -52.67 -42.85 65.12 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.109 0.48 . . . . 1.82 110.721 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -37.08 73.9 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.008 -1.057 . . . . 4.44 111.016 -177.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.83 -21.0 17.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.538 0.735 . . . . 2.13 110.911 169.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.08 27.39 16.23 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.588 -1.005 . . . . 0.41 110.588 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -135.51 169.51 17.4 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 107.942 -1.133 . . . . 3.49 107.942 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.4 114.79 16.0 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 107.84 -1.17 . . . . 6.05 107.84 -174.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.41 144.11 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 123.795 0.838 . . . . 1.72 108.803 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.431 0 C-N-CA 124.461 1.104 . . . . 2.9 109.373 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 120.256 0.074 . . . . 1.11 111.087 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.47 160.52 43.25 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.318 0.58 . . . . 4.87 111.725 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -84.4 127.01 33.75 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.445 1.498 . . . . 2.49 108.303 166.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tp -108.8 155.88 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.313 -1.736 . . . . 2.03 106.313 162.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.86 140.27 23.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.091 0.557 . . . . 1.74 109.816 175.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -157.75 169.41 24.68 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 123.647 0.592 . . . . 3.11 111.189 -177.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.5 152.85 23.67 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 108.105 -1.072 . . . . 2.44 108.105 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.17 139.0 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.867 0.365 . . . . 2.04 110.289 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.446 -0.657 0 C-N-CA 124.512 1.125 . . . . 1.16 108.188 -178.278 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 119.108 -0.473 . . . . 1.55 110.563 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -57.24 -44.65 84.02 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.965 0.802 . . . . 7.62 111.527 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.7 mt -46.74 -61.19 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 108.882 -0.784 . . . . 1.93 108.882 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.14 -35.48 69.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.968 -0.56 . . . . 2.6 111.787 -172.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -57.34 -35.68 70.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.094 -1.004 . . . . 2.47 110.786 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.26 -53.57 15.14 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.821 -0.911 . . . . 0.56 110.821 165.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' CD2' HG12 ' A' ' 60' ' ' ILE . 89.4 mt -65.05 -31.06 72.1 Favored 'General case' 0 C--O 1.223 -0.314 0 O-C-N 121.778 -0.837 . . . . 1.91 112.151 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.275 14.1 ttmt -58.87 -17.76 26.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.405 1.002 . . . . 2.02 112.104 171.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -20.24 47.66 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.66 1.118 . . . . 4.42 113.726 168.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 94.4 mmm -74.33 137.54 75.02 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 119.99 1.268 . . . . 3.08 111.924 -169.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.49 91.17 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.671 2.914 . . . . 0.44 111.403 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.59 -13.65 2.23 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.941 1.257 . . . . 0.31 111.522 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.8 p -66.18 159.68 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 121.709 -0.877 . . . . 1.66 111.635 168.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.22 -56.39 1.63 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.135 1.374 . . . . 1.8 110.76 168.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -143.73 157.1 44.63 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 122.299 -0.251 . . . . 2.52 111.62 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.34 131.22 31.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.885 1.274 . . . . 1.79 109.389 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -136.98 117.74 14.04 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.639 0.776 . . . . 1.59 110.009 -176.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -84.32 140.62 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.448 1.099 . . . . 1.83 110.732 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -130.36 65.0 1.53 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.591 1.557 . . . . 1.67 110.777 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.5 mt -64.37 -15.3 60.17 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 113.201 0.815 . . . . 1.6 113.201 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.27 -20.07 3.84 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.274 0.63 . . . . 1.71 111.514 167.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.6 m -134.45 18.66 3.64 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.421 1.488 . . . . 1.59 109.957 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.8 mp0 47.28 34.84 3.37 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.299 1.04 . . . . 2.81 111.815 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -132.5 153.17 51.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.744 -1.576 . . . . 1.68 106.744 -170.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -139.3 153.24 24.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.382 -0.97 . . . . 2.31 108.382 173.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.12 151.73 36.98 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 124.342 1.026 . . . . 2.74 109.815 176.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.16 136.04 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 108.598 -0.89 . . . . 1.57 108.598 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 mt -101.01 116.64 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.767 2.027 . . . . 1.89 106.08 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -144.44 167.48 22.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.682 0.793 . . . . 3.26 109.971 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -103.26 115.76 63.36 Favored Pre-proline 0 N--CA 1.443 -0.78 0 CA-C-N 114.726 -1.124 . . . . 1.41 110.618 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -69.92 8.86 0.71 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 124.258 3.305 . . . . 0.59 113.953 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.38 -49.06 12.96 Favored 'General case' 0 CA--C 1.526 0.046 0 N-CA-C 107.943 -1.132 . . . . 1.52 107.943 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -96.05 -36.22 11.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.979 1.712 . . . . 2.66 110.693 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 m -142.19 129.07 20.62 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 117.708 2.484 . . . . 1.24 117.708 -159.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.11 -161.37 13.12 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.885 -0.886 . . . . 0.62 110.885 157.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -32.92 -43.68 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 128.379 2.672 . . . . 1.66 113.394 176.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.83 -57.19 7.87 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.041 0.536 . . . . 1.43 112.145 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.85 -39.79 63.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 122.337 1.065 . . . . 1.51 108.88 -177.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.401 HG12 ' CD2' ' A' ' 28' ' ' LEU . 1.8 mt -63.75 -53.44 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 114.359 -1.292 . . . . 1.82 110.551 -169.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -51.67 58.19 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.623 1.101 . . . . 0.8 110.454 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -46.29 -54.43 8.92 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.222 1.009 . . . . 2.18 111.121 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -43.16 78.9 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 119.475 -0.89 . . . . 4.05 111.263 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.9 mm -53.91 -45.17 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 123.822 0.849 . . . . 1.54 110.429 -177.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -48.79 -47.64 41.86 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.915 -0.402 . . . . 1.62 109.915 173.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -71.91 -30.04 64.95 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.642 0.979 . . . . 4.1 113.642 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.97 -23.11 12.03 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.493 0.588 . . . . 1.7 110.56 165.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.67 28.82 8.13 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 109.888 -1.285 . . . . 0.37 109.888 175.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -139.96 164.2 30.64 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 108.122 -1.066 . . . . 2.97 108.122 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.48 121.21 36.04 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.367 -1.346 . . . . 5.87 107.367 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.4 p -86.77 159.35 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 124.838 1.255 . . . . 2.12 108.951 174.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 121.412 0.625 . . . . 1.97 111.322 176.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 110.248 -0.279 . . . . 0.8 110.248 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -149.22 162.63 39.63 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.198 0.523 . . . . 3.94 111.518 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.09 139.4 32.5 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.527 1.931 . . . . 2.26 108.269 170.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 tp -118.32 151.7 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.202 -1.777 . . . . 1.96 106.202 163.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.57 120.19 11.79 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.249 1.419 . . . . 1.86 107.944 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.5 ptt? -156.51 167.71 29.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.296 0.498 . . . . 1.63 110.105 -171.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.08 156.95 16.41 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.422 0.689 . . . . 1.79 110.282 -173.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -115.26 160.6 14.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 C-N-CA 123.043 0.537 . . . . 1.57 109.919 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 124.933 1.293 . . . . 1.31 108.316 174.882 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 119.15 -0.452 . . . . 1.71 110.791 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.2 mmt-85 -54.81 -49.79 70.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.683 0.674 . . . . 5.49 111.048 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.0 mt -48.45 -60.68 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.944 -0.762 . . . . 1.81 108.944 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -69.19 -38.79 78.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 118.8 -1.16 . . . . 3.42 109.801 -173.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -58.3 -28.37 64.93 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.086 -1.633 . . . . 2.11 112.365 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.53 -52.08 52.48 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 110.732 -0.947 . . . . 0.37 110.732 165.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.03 -29.93 71.04 Favored 'General case' 0 C--O 1.223 -0.29 0 O-C-N 121.551 -0.97 . . . . 1.65 112.966 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -55.08 -18.7 5.82 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.596 1.089 . . . . 2.83 111.957 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -86.18 -14.82 42.85 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.753 1.16 . . . . 3.63 114.042 171.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 82.2 mmm -73.12 138.43 79.0 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 120.01 1.277 . . . . 3.14 112.313 -170.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.06 91.88 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.801 3.001 . . . . 0.6 111.268 -171.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.57 -11.0 4.03 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.606 -0.998 . . . . 0.25 110.606 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.5 p -61.92 145.97 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 118.286 1.043 . . . . 1.52 110.507 168.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.07 -67.79 0.89 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.09 -1.078 . . . . 1.72 108.09 162.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -149.86 126.83 11.17 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 113.628 0.973 . . . . 3.53 113.628 -163.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.14 150.76 21.25 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.367 1.867 . . . . 1.92 110.4 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.78 100.06 2.19 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.46 0.704 . . . . 1.86 109.266 174.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.83 140.73 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.535 0.734 . . . . 1.85 111.476 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -136.79 69.52 1.41 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.701 1.6 . . . . 1.73 111.566 -174.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.6 mt -65.61 -15.58 62.88 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 113.32 0.859 . . . . 1.77 113.32 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.93 -17.08 5.68 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.715 0.406 . . . . 1.63 111.292 168.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.1 m -136.59 18.91 3.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.923 1.289 . . . . 1.61 109.735 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 47.67 32.36 2.51 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.716 1.206 . . . . 3.03 112.164 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 m -127.97 151.53 49.01 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.806 -1.183 . . . . 1.76 107.806 -168.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.0 142.41 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 109.003 -0.74 . . . . 1.8 109.003 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -116.59 142.53 46.76 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.294 -1.372 . . . . 2.57 107.294 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.38 140.38 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.945 -0.391 . . . . 1.84 109.945 172.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.4 mt -100.68 127.47 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.725 -1.583 . . . . 2.29 106.725 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -149.82 171.42 16.77 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.914 0.886 . . . . 3.03 110.565 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 53' ' ' ALA . 59.2 t0 -105.11 106.4 55.49 Favored Pre-proline 0 N--CA 1.446 -0.649 0 C-N-CA 124.951 1.3 . . . . 1.79 110.606 -177.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -70.79 20.98 0.21 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 124.016 3.144 . . . . 0.65 113.322 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 51' ' ' ASP . . . -86.93 -41.38 14.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.926 -1.139 . . . . 1.47 107.926 168.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -103.64 -50.04 3.52 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.502 1.521 . . . . 2.76 110.433 176.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 m -127.29 131.84 50.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 128.506 2.722 . . . . 1.38 117.978 -160.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.65 -161.46 12.26 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 108.998 -1.641 . . . . 0.76 108.998 154.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 t -31.5 -44.97 0.08 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.888 2.875 . . . . 1.62 113.34 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.37 -56.84 6.09 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.857 0.753 . . . . 1.69 112.674 174.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.78 -36.38 65.06 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 122.535 1.16 . . . . 1.59 109.261 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mt -64.36 -54.88 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.165 -1.38 . . . . 1.84 110.72 -172.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -51.01 37.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.144 1.338 . . . . 0.73 110.756 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -42.93 -56.36 3.32 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.09 0.956 . . . . 2.36 112.44 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -41.89 74.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.901 -0.719 . . . . 2.71 111.189 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.9 mm -53.18 -44.92 53.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.368 0.667 . . . . 1.8 110.357 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -50.8 -52.93 36.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.247 0.619 . . . . 1.61 110.077 174.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -37.54 87.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.662 0.785 . . . . 6.63 112.511 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.44 -19.92 6.57 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.554 0.742 . . . . 3.54 111.862 168.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.65 28.69 6.92 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.343 0.973 . . . . 0.36 110.844 170.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -142.98 171.51 13.96 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.975 -1.12 . . . . 2.96 107.975 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.07 128.81 47.96 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.679 -1.6 . . . . 5.56 106.679 173.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.42 142.25 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 119.021 -0.514 . . . . 1.89 109.629 170.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 109.222 -0.658 . . . . 2.22 109.222 173.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 110.758 -0.09 . . . . 0.81 110.758 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -149.6 160.89 43.12 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.24 0.543 . . . . 2.91 111.466 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -84.61 144.82 28.37 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.399 1.48 . . . . 2.21 109.133 168.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 tp -124.47 154.32 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.234 -1.765 . . . . 2.17 106.234 165.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.0 129.56 21.41 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.498 1.119 . . . . 1.7 109.088 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -156.86 173.5 16.89 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.511 0.725 . . . . 2.19 110.756 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -100.67 148.52 24.77 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.045 1.338 . . . . 3.37 109.781 -174.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -118.46 161.99 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.19 0.996 . . . . 1.44 109.346 -176.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.451 -0.389 0 C-N-CA 124.245 1.018 . . . . 1.24 108.901 179.413 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 119.639 -0.22 . . . . 1.7 111.508 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -64.1 -47.19 81.0 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.21 0.604 . . . . 5.39 110.043 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.0 mt -48.11 -60.09 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.283 -1.006 . . . . 1.86 108.283 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -70.3 -35.63 73.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.168 -0.613 . . . . 2.34 110.689 -171.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -58.01 -33.22 68.71 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 120.664 -1.272 . . . . 2.21 111.308 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.3 -47.26 83.61 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 110.366 -1.093 . . . . 0.37 110.366 167.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.21 -29.22 70.34 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 118.625 1.212 . . . . 1.69 112.428 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -59.89 -17.38 36.69 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.513 1.052 . . . . 2.98 111.243 173.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.75 -16.24 57.44 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.067 1.136 . . . . 4.68 114.067 169.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.77 136.82 66.74 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 120.809 1.641 . . . . 3.7 112.425 -171.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.71 99.32 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.867 3.045 . . . . 0.57 110.995 -173.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.66 -15.79 4.08 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.304 -1.119 . . . . 0.25 110.304 177.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.81 150.93 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 O-C-N 122.047 -0.678 . . . . 1.59 110.943 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.78 -65.3 1.19 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.812 -1.181 . . . . 1.57 107.812 165.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -147.03 132.66 18.8 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 112.702 0.63 . . . . 3.36 112.702 -163.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.8 136.77 50.63 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.902 1.681 . . . . 1.59 108.55 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -139.73 112.96 8.25 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.591 1.156 . . . . 1.5 108.325 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -84.5 141.07 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.183 0.993 . . . . 1.67 110.444 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -137.03 65.32 1.51 Allowed 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.544 -1.28 . . . . 3.6 107.544 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 47.6 mt -63.23 -17.38 62.39 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 121.671 -0.643 . . . . 1.77 112.281 174.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.28 -16.28 8.16 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.482 0.713 . . . . 1.76 111.551 169.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.4 m -136.07 19.16 3.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.626 1.171 . . . . 1.52 109.325 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 48.27 40.86 15.12 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.114 0.966 . . . . 3.4 111.46 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.8 m -137.85 155.55 48.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.275 -1.38 . . . . 1.55 107.275 -171.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.8 p -134.37 148.85 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 107.635 -1.246 . . . . 1.62 107.635 170.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.73 150.23 43.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.973 0.796 . . . . 2.68 109.273 171.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.99 142.73 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.841 -0.8 . . . . 1.64 108.841 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.2 mt -104.01 127.57 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 126.675 1.99 . . . . 2.26 106.781 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -152.14 170.23 20.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.311 0.645 . . . . 3.05 110.143 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -104.21 113.09 65.53 Favored Pre-proline 0 N--CA 1.44 -0.961 0 CA-C-N 115.01 -0.996 . . . . 1.31 110.145 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -68.8 10.35 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.799 3.0 . . . . 0.53 113.634 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.57 -43.05 21.25 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 108.353 -0.98 . . . . 1.47 108.353 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -98.53 -44.97 6.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.319 1.447 . . . . 2.85 110.0 176.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 m -138.04 130.91 29.87 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 118.915 2.931 . . . . 1.59 118.915 -155.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.6 -157.82 9.27 Favored Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 108.385 -1.886 . . . . 0.78 108.385 155.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.272 0.0 OUTLIER -32.17 -46.09 0.12 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.285 2.634 . . . . 1.91 113.504 175.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.81 -57.43 4.9 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.001 0.741 . . . . 1.4 113.001 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.02 -38.33 64.09 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 122.091 0.948 . . . . 1.5 109.225 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mt -63.11 -58.87 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 114.347 -1.297 . . . . 1.91 109.601 -172.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.6 -51.74 15.06 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.753 1.16 . . . . 0.81 110.971 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -42.81 -55.49 3.64 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.15 0.98 . . . . 2.17 112.066 174.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.56 -40.5 73.3 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.146 -0.622 . . . . 2.92 110.82 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.5 mm -54.56 -45.99 71.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 118.863 0.756 . . . . 1.81 110.007 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -50.49 -51.9 43.15 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.232 0.539 . . . . 2.23 109.792 172.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -42.3 98.91 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.559 0.577 . . . . 4.9 112.559 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mp -52.45 -19.69 2.37 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.917 1.287 . . . . 3.67 111.875 169.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.21 29.26 9.08 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.327 -1.109 . . . . 0.38 110.327 173.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -137.98 162.88 32.95 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.098 -1.445 . . . . 2.9 107.098 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.84 134.6 54.83 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.122 -1.807 . . . . 5.16 106.122 171.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.63 150.04 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.604 0.762 . . . . 1.77 110.444 168.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.758 0 C-N-CA 123.672 0.789 . . . . 1.78 109.532 171.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 120.67 0.271 . . . . 0.83 111.357 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -149.08 158.55 44.27 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.109 -0.7 . . . . 3.38 109.109 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -91.03 141.0 29.31 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.685 -1.143 . . . . 2.89 109.51 168.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.95 138.08 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 105.407 -2.072 . . . . 4.28 105.407 170.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.55 125.65 48.35 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.421 1.488 . . . . 1.71 108.036 176.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -154.88 164.69 38.48 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.485 0.584 . . . . 1.76 110.697 -175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.47 151.59 19.42 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.09 0.956 . . . . 1.76 109.575 -173.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 t -116.1 161.21 15.01 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 C-N-CA 123.139 0.575 . . . . 1.7 109.904 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.451 -0.4 0 C-N-CA 124.963 1.305 . . . . 1.34 108.711 175.581 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.688 0 CA-C-O 118.717 -0.659 . . . . 1.54 110.798 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.3 mmp_? -58.91 -47.91 83.32 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.449 1.022 . . . . 5.65 110.321 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.0 mt -47.21 -60.8 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.809 -0.811 . . . . 1.57 108.809 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -72.11 -34.15 68.38 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 119.968 -0.693 . . . . 2.55 111.707 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm -55.69 -36.65 67.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 120.858 -1.151 . . . . 3.7 111.028 175.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.46 -54.64 12.55 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.187 -1.165 . . . . 0.34 110.187 166.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.74 -32.73 74.32 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 112.885 0.698 . . . . 1.42 112.885 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -57.62 -17.54 15.04 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.229 0.922 . . . . 2.06 111.796 172.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.7 -11.3 48.68 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.694 1.368 . . . . 5.16 114.694 170.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.24 138.62 86.96 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 121.278 1.854 . . . . 4.42 111.856 -177.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.52 90.69 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.605 2.87 . . . . 0.49 111.079 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.82 -7.67 3.57 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.756 1.17 . . . . 0.3 111.341 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -67.4 160.29 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 118.271 1.035 . . . . 1.58 110.806 164.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.73 -59.55 1.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.767 1.227 . . . . 1.74 108.659 168.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -145.13 162.91 35.9 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 112.477 0.547 . . . . 2.31 112.477 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.54 123.51 12.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.086 1.754 . . . . 1.7 109.625 -173.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -135.64 119.62 17.48 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.423 1.489 . . . . 1.56 109.284 -172.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -91.93 139.13 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.127 0.971 . . . . 1.64 110.545 -176.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -131.08 66.69 1.53 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.833 1.653 . . . . 1.69 111.143 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.4 mt -67.01 -15.92 64.03 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 113.113 0.782 . . . . 1.89 113.113 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.81 -24.84 9.74 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.66 0.384 . . . . 1.88 110.622 167.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.0 m -128.55 19.99 6.18 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.213 1.405 . . . . 1.63 110.044 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 47.58 35.01 3.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.188 0.995 . . . . 2.8 112.145 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.4 m -132.52 152.03 51.71 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.118 -1.068 . . . . 1.61 108.118 -168.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.2 p -133.96 147.47 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.367 0.667 . . . . 1.79 109.389 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -121.34 129.13 52.91 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.1 1.36 . . . . 2.6 108.464 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.92 137.1 51.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.021 -0.733 . . . . 1.96 109.021 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.4 mp -108.55 120.77 60.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.012 1.325 . . . . 2.61 108.134 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -144.36 171.37 14.42 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.186 0.994 . . . . 3.04 110.877 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -108.39 111.73 61.36 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 124.979 1.312 . . . . 1.79 111.15 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -76.83 30.13 0.41 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.747 2.964 . . . . 0.71 112.711 -172.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.96 -50.16 5.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.77 -1.567 . . . . 1.63 106.77 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.16 -43.52 7.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.16 1.784 . . . . 2.87 110.495 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.6 m -133.93 127.3 32.17 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 116.45 2.019 . . . . 1.62 116.45 -159.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.89 -164.23 13.32 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 108.898 -1.681 . . . . 0.65 108.898 153.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.2 t -34.78 -40.39 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.706 2.802 . . . . 1.63 112.831 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.0 -54.46 8.34 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.907 0.883 . . . . 1.78 113.233 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.63 -36.83 65.49 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.924 1.345 . . . . 1.72 109.642 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.82 -50.16 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 113.309 -1.768 . . . . 1.72 110.903 -164.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.75 -52.34 49.46 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.388 1.449 . . . . 0.76 109.034 172.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.46 -45.66 46.98 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.708 1.203 . . . . 5.04 112.294 -177.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -44.59 60.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.247 -1.533 . . . . 4.04 112.823 172.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 mm -51.43 -44.93 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.986 1.315 . . . . 1.73 110.707 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -49.73 -47.53 50.64 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.453 0.644 . . . . 1.56 110.361 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -32.65 67.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.249 1.02 . . . . 6.36 112.292 -177.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.45 -25.62 37.47 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 119.385 -0.34 . . . . 1.87 110.239 166.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.31 29.22 5.78 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.542 1.068 . . . . 0.37 110.823 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -142.86 165.73 26.57 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.273 -1.01 . . . . 2.94 108.273 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.95 125.68 48.02 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.267 -1.753 . . . . 5.64 106.267 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -96.78 143.06 13.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 O-C-N 123.751 0.657 . . . . 1.63 109.894 172.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.466 0.338 0 N-CA-C 109.425 -0.583 . . . . 2.35 109.425 175.187 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 120.726 0.298 . . . . 0.97 111.437 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -154.68 158.49 39.7 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 122.011 0.91 . . . . 4.33 111.177 178.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -84.03 114.13 21.51 Favored 'General case' 0 N--CA 1.452 -0.332 1 C-N-CA 131.984 4.113 . . . . 2.3 107.363 174.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.48 149.3 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 105.803 -1.925 . . . . 3.85 105.803 164.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.73 123.73 18.94 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.602 1.561 . . . . 1.59 108.261 176.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -157.49 166.71 32.23 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.941 0.496 . . . . 2.13 111.78 -171.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -101.44 140.09 36.2 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.069 1.748 . . . . 3.28 108.855 -169.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.92 142.12 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 123.487 0.715 . . . . 1.73 110.166 -177.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 108.136 -1.061 . . . . 1.52 108.136 173.514 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 119.546 -0.264 . . . . 1.69 111.22 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -59.08 -49.85 76.33 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.425 0.557 . . . . 4.52 110.74 177.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.7 mt -45.67 -59.88 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.767 1.227 . . . . 1.69 108.723 177.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -70.84 -35.74 72.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.383 -0.371 . . . . 2.31 110.715 -173.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -59.15 -30.44 68.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.06 -1.025 . . . . 2.09 110.872 174.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.56 -52.33 48.8 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 110.743 -0.943 . . . . 0.34 110.743 164.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.0 -29.93 71.2 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.268 -1.136 . . . . 1.7 113.13 177.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -54.74 -18.96 5.32 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.246 0.93 . . . . 3.14 111.924 170.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.29 -15.03 48.13 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.022 1.119 . . . . 3.5 114.022 171.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.2 mmm -76.89 137.8 65.94 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 120.252 1.387 . . . . 2.91 112.424 -172.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.71 101.08 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.513 2.808 . . . . 0.55 110.922 -173.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.39 -13.29 5.16 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 124.981 1.277 . . . . 0.27 110.151 175.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.01 147.51 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 117.806 0.803 . . . . 1.59 110.676 169.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.67 -60.44 1.82 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.986 1.315 . . . . 1.66 110.407 168.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -154.43 148.88 26.2 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 115.401 1.63 . . . . 2.53 115.401 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.3 142.23 42.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.265 1.426 . . . . 1.73 110.825 -176.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -145.38 102.3 3.7 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.171 -1.048 . . . . 3.78 108.171 -170.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.5 p -83.79 134.32 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.296 0.638 . . . . 1.99 110.889 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -131.12 70.12 1.47 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.075 -1.083 . . . . 3.62 108.075 -177.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.4 mt -64.02 -24.65 67.79 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.502 -0.749 . . . . 2.39 111.954 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.38 -24.25 28.79 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.08 0.552 . . . . 1.87 111.03 171.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.6 m -118.97 11.44 12.5 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.372 1.469 . . . . 2.11 110.309 -179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 46.4 47.96 13.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.053 0.842 . . . . 2.23 111.673 -178.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.47 159.02 39.47 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.12 -1.067 . . . . 2.23 108.12 -174.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.2 p -125.68 146.92 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 108.558 -0.905 . . . . 1.86 108.558 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -117.44 141.5 48.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.711 1.205 . . . . 2.43 108.351 176.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.05 132.24 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.695 -0.483 . . . . 1.76 109.695 173.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.5 mt -91.86 126.2 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.387 1.875 . . . . 1.77 106.871 176.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -147.5 173.86 12.26 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.428 0.691 . . . . 3.36 111.114 176.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -110.44 120.03 45.14 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 124.366 1.066 . . . . 1.43 110.965 -178.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -69.33 7.28 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 124.596 3.531 . . . . 0.67 113.575 -178.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.49 -37.22 37.27 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 108.644 -0.873 . . . . 1.63 108.644 176.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -114.88 -53.82 2.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.571 1.549 . . . . 2.77 110.041 -179.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 m -104.34 129.99 52.2 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 128.233 2.613 . . . . 2.21 117.343 -172.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.25 -173.36 22.44 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 109.779 -1.328 . . . . 0.71 109.779 151.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.3 t -35.24 -41.14 0.15 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.556 2.742 . . . . 1.43 112.414 174.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.77 -57.19 5.9 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.981 0.734 . . . . 1.47 112.981 173.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.47 66.43 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 122.338 1.066 . . . . 1.54 108.835 -176.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.02 -58.04 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 114.012 -1.449 . . . . 1.8 110.082 -174.4 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.47 -51.1 15.93 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.681 1.128 . . . . 0.78 110.823 175.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.517 ' CD ' ' HZ1' ' A' ' 66' ' ' LYS . 1.9 tm-20 -45.31 -51.85 10.48 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.406 0.683 . . . . 2.34 112.342 177.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -43.68 67.37 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 118.17 -0.919 . . . . 3.05 111.667 177.338 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 mm -52.4 -45.71 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 119.698 1.135 . . . . 1.54 110.196 -179.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -49.46 -47.04 48.62 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.26 0.624 . . . . 1.63 110.11 172.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.517 ' HZ1' ' CD ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -70.38 -36.57 74.2 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.674 0.79 . . . . 5.27 112.318 -178.452 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -54.46 -22.76 13.62 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.837 0.455 . . . . 1.72 110.41 169.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.13 28.51 5.81 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 110.444 -1.063 . . . . 0.39 110.444 170.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -144.61 169.17 18.49 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.638 -1.245 . . . . 3.46 107.638 -177.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.08 135.53 54.59 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.358 -1.719 . . . . 5.16 106.358 172.038 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -98.36 147.67 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.056 0.942 . . . . 1.74 109.549 167.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 109.032 -0.729 . . . . 1.94 109.032 169.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 119.876 -0.107 . . . . 0.81 110.738 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.76 159.88 40.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.764 0.792 . . . . 4.68 111.854 -179.341 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.12 135.77 34.26 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.496 -1.684 . . . . 2.49 108.232 169.248 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 tp -109.44 151.04 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 105.843 -1.91 . . . . 1.96 105.843 161.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.62 123.65 16.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.997 1.319 . . . . 1.86 107.85 176.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.6 ptt? -157.7 172.16 19.01 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.713 0.405 . . . . 1.88 110.292 -170.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -102.74 150.08 23.82 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.401 1.08 . . . . 3.2 110.123 -171.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.71 167.89 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 C-N-CA 123.684 0.794 . . . . 1.68 109.706 -178.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.451 -0.401 0 C-N-CA 124.287 1.035 . . . . 1.74 108.829 176.569 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 109.686 -0.487 . . . . 1.57 109.686 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -59.4 -45.1 92.43 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 118.481 -0.771 . . . . 4.3 111.99 174.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.7 mt -46.96 -59.95 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.359 -0.608 . . . . 1.61 109.359 176.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -70.13 -41.18 74.26 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 119.634 -0.826 . . . . 3.58 109.993 -173.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -52.15 -35.6 48.99 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 120.423 -1.423 . . . . 2.81 112.089 179.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.26 -52.12 33.42 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 110.921 -0.872 . . . . 0.38 110.921 167.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.1 mt -66.94 -27.76 67.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 118.51 -0.757 . . . . 1.69 112.587 177.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.445 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 20.9 ttmt -59.87 -16.99 33.43 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 119.614 1.097 . . . . 2.23 110.566 171.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.36 -8.83 58.25 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.013 1.116 . . . . 3.97 114.013 171.297 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.5 mmt -71.75 138.67 82.91 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 120.304 1.411 . . . . 3.15 111.722 -175.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.28 90.82 0.57 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.263 2.642 . . . . 0.52 110.793 -175.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.27 -16.33 2.1 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.483 1.04 . . . . 0.25 111.495 -179.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 p -70.82 156.02 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 O-C-N 121.674 -0.897 . . . . 1.59 111.409 171.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.22 -62.58 1.57 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.424 1.09 . . . . 1.73 109.126 166.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.445 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 2.5 m-20 -147.76 142.25 26.45 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 112.502 0.556 . . . . 3.02 112.502 -169.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.86 157.09 17.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.237 1.815 . . . . 1.89 109.333 178.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.54 95.82 1.83 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.042 -1.095 . . . . 2.05 108.042 177.046 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.12 140.24 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 121.917 -0.49 . . . . 1.95 111.449 -178.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -137.02 69.94 1.41 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.148 1.379 . . . . 3.54 109.092 -174.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 68.7 mt -65.69 -16.56 63.87 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 115.565 -0.743 . . . . 1.85 112.932 177.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.6 -22.5 8.72 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.543 0.737 . . . . 1.61 110.741 169.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.9 m -133.05 21.22 4.1 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.938 0.895 . . . . 2.18 109.854 179.064 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 50.37 34.7 9.46 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.058 0.844 . . . . 3.05 112.069 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.6 m -128.53 152.57 48.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.644 1.178 . . . . 1.5 107.876 -168.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 p -135.14 143.57 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.844 -0.798 . . . . 1.89 108.844 173.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -119.24 145.27 46.21 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.848 1.259 . . . . 2.47 107.969 176.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.86 139.03 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.629 -0.508 . . . . 1.6 109.629 174.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.9 mt -101.05 119.2 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 126.96 2.104 . . . . 2.11 107.196 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -146.35 168.87 20.06 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.398 1.079 . . . . 3.34 109.593 -178.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -101.65 115.63 64.63 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 118.385 -0.817 . . . . 2.07 109.278 177.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -68.63 7.6 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.747 2.965 . . . . 0.79 113.646 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.21 -55.54 5.18 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 107.441 -1.318 . . . . 1.89 107.441 172.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -88.18 -30.75 19.53 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.435 1.094 . . . . 3.93 112.109 176.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.9 m -148.47 121.4 8.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 117.677 2.473 . . . . 1.81 117.677 -157.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.69 -166.79 23.14 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.588 -1.005 . . . . 0.75 110.588 159.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 t -29.61 -46.68 0.06 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.499 3.119 . . . . 1.76 112.841 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.42 -58.42 3.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.048 0.939 . . . . 1.86 113.155 173.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.18 -34.19 65.86 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 122.511 1.148 . . . . 1.52 109.554 -178.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -52.86 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 117.199 -1.381 . . . . 2.08 110.928 -171.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -50.16 40.44 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 121.04 1.746 . . . . 0.84 110.922 175.229 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -39.73 -60.27 1.01 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.904 0.882 . . . . 2.68 112.634 172.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -70.73 -40.43 72.76 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.202 -0.999 . . . . 2.84 110.82 -177.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.8 mm -53.31 -44.68 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 119.034 0.834 . . . . 1.69 110.046 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -53.81 -45.66 70.85 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.129 0.49 . . . . 1.82 109.772 174.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.62 -39.74 91.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.485 -0.76 . . . . 3.74 111.354 -179.19 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.4 -23.58 16.32 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.443 0.697 . . . . 1.76 110.786 171.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.95 26.93 7.25 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 124.466 1.031 . . . . 0.37 110.9 173.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -144.8 176.34 9.52 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 122.025 0.916 . . . . 2.9 109.617 -175.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.68 117.24 23.06 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 106.035 -1.839 . . . . 5.03 106.035 -171.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.9 p -96.13 142.45 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.868 -0.79 . . . . 1.67 108.868 165.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.287 0 N-CA-C 108.764 -0.828 . . . . 2.65 108.764 173.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 120.787 0.327 . . . . 0.99 111.515 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -139.67 152.83 47.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.521 0.677 . . . . 3.4 109.822 179.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -90.34 125.92 35.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 127.036 2.134 . . . . 2.25 106.762 168.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 tp -109.21 151.29 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.167 -1.42 . . . . 1.98 107.167 167.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.52 133.93 36.99 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.731 -1.211 . . . . 1.42 107.731 170.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.75 170.92 21.34 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.439 0.462 . . . . 1.64 111.195 175.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.65 152.81 19.35 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.854 0.861 . . . . 1.98 110.362 -176.498 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.57 171.56 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 123.7 0.8 . . . . 1.78 110.034 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 CA--C 1.53 0.194 0 C-N-CA 123.782 0.833 . . . . 1.54 110.603 176.934 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 119.389 -0.339 . . . . 1.66 110.664 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -54.63 -45.24 73.7 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.574 -0.726 . . . . 5.07 111.444 173.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.4 mt -52.46 -60.89 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.391 -0.966 . . . . 2.06 108.391 177.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.62 -33.96 73.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.4 -0.92 . . . . 2.36 110.615 -168.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -56.24 -36.76 68.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.092 -1.005 . . . . 2.3 111.263 171.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.5 -44.51 90.45 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.054 -0.818 . . . . 0.36 111.054 168.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.3 mt -65.6 -30.66 71.41 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 119.407 1.603 . . . . 1.69 112.514 175.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -56.62 -18.41 11.97 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.13 0.877 . . . . 2.16 112.03 170.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 mtp85 -87.88 -5.29 58.65 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.891 -1.13 . . . . 5.49 112.694 174.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 95.1 mmm -82.74 136.62 44.69 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 120.389 1.45 . . . . 2.91 111.748 179.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.8 100.73 0.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.506 2.804 . . . . 0.36 111.262 -173.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.37 -13.03 3.77 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.58 1.086 . . . . 0.21 111.173 176.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.9 152.97 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.836 0.854 . . . . 1.61 111.182 169.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.1 -60.5 1.87 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.582 1.153 . . . . 1.59 109.356 166.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -148.66 141.59 24.76 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.239 0.459 . . . . 3.14 112.239 -169.138 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.61 136.71 53.11 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.779 1.632 . . . . 1.63 108.632 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -142.05 108.9 5.41 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.577 1.151 . . . . 1.64 108.5 -177.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.4 p -89.92 142.7 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.742 0.817 . . . . 1.64 111.772 -175.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -137.71 68.99 1.4 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.364 1.465 . . . . 1.68 111.011 -175.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.4 mt -66.71 -14.91 63.1 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 112.948 0.721 . . . . 1.82 112.948 177.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.5 -13.34 5.35 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.983 0.356 . . . . 1.62 111.221 167.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.5 m -138.38 18.46 2.75 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.387 1.075 . . . . 1.75 109.572 177.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 51.76 30.75 7.22 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.14 0.882 . . . . 3.14 112.035 -179.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.4 m -129.66 153.42 48.14 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.069 -1.086 . . . . 1.49 108.069 -167.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.4 144.47 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 108.802 -0.814 . . . . 1.61 108.802 173.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -112.78 139.99 47.94 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.744 1.218 . . . . 2.46 108.055 176.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.44 141.2 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.249 -0.649 . . . . 1.52 109.249 171.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 mt -104.74 127.37 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.971 1.708 . . . . 2.23 106.533 -179.054 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -152.3 171.78 17.45 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.946 0.498 . . . . 3.28 110.098 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -111.07 120.51 43.1 Favored Pre-proline 0 N--CA 1.448 -0.563 0 O-C-N 123.944 0.777 . . . . 2.09 111.187 -177.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.14 19.39 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.072 3.181 . . . . 0.64 113.681 -178.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.63 -50.74 7.91 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.256 -1.387 . . . . 1.77 107.256 169.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -96.33 -39.81 9.44 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.099 1.36 . . . . 3.55 111.4 176.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.5 m -132.41 129.89 39.9 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 117.748 2.499 . . . . 1.76 117.748 -155.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.76 -172.09 22.91 Favored Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 110.043 -1.223 . . . . 0.72 110.043 157.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.272 0.1 OUTLIER -29.31 -43.09 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 128.633 2.773 . . . . 1.74 113.902 169.241 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.64 -55.35 16.79 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.868 0.758 . . . . 1.5 112.671 175.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.08 -36.24 66.78 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 122.557 1.17 . . . . 1.48 108.966 -176.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.257 0.9 OUTLIER -65.47 -56.56 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 113.852 -1.522 . . . . 1.69 110.351 -172.617 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -49.61 47.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.171 1.35 . . . . 0.74 110.913 177.255 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -42.48 -58.4 2.26 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.74 0.816 . . . . 2.28 112.094 173.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -42.36 73.39 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 119.548 -0.861 . . . . 3.26 111.421 -177.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.3 mm -51.21 -47.6 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.67 0.788 . . . . 1.76 109.832 177.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -50.6 -53.47 30.38 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 121.426 0.632 . . . . 1.61 109.678 175.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -29.3 70.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.028 0.531 . . . . 6.16 112.412 -178.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -63.85 -20.02 65.49 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.23 0.612 . . . . 3.21 109.783 173.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.26 28.76 6.65 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 125.075 1.321 . . . . 0.36 110.618 173.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -143.85 168.47 19.88 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.122 -1.436 . . . . 2.85 107.122 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.83 135.97 54.66 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.428 -1.693 . . . . 5.52 106.428 169.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -100.63 142.92 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.331 1.052 . . . . 1.99 109.722 166.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 108.692 -0.855 . . . . 2.31 108.692 173.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 120.854 0.359 . . . . 0.65 111.518 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -148.8 161.75 41.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.687 -0.857 . . . . 3.63 108.687 173.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -82.91 138.46 33.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.522 -1.288 . . . . 2.63 107.522 162.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 tp -107.14 153.48 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 2.21 105.713 157.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.53 128.21 17.18 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.917 -1.142 . . . . 1.68 107.917 173.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.48 175.86 13.41 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.189 0.45 . . . . 2.09 110.866 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -94.19 149.37 21.3 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.287 1.035 . . . . 3.07 109.279 -174.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.21 165.59 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.854 -0.795 . . . . 1.62 108.854 177.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 107.643 -1.243 . . . . 1.4 107.643 171.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.627 0 CA-C-O 118.757 -0.64 . . . . 1.6 111.04 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -61.07 -45.42 94.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.279 0.945 . . . . 4.53 110.598 176.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.9 mt -48.35 -60.94 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.319 -0.993 . . . . 1.77 108.319 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.28 -34.1 67.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 119.945 -0.702 . . . . 2.58 111.838 -173.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -55.94 -37.73 69.37 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.121 -0.987 . . . . 2.73 110.736 176.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.5 -52.75 27.49 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.458 -1.057 . . . . 0.38 110.458 167.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.0 mt -64.62 -31.1 72.17 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.591 -0.946 . . . . 1.65 112.503 179.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.25 23.3 ttmt -59.03 -13.73 7.52 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 119.209 0.913 . . . . 2.56 111.69 170.514 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 -1.63 40.23 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.553 -1.342 . . . . 6.11 114.001 170.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.91 139.3 61.67 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 120.815 1.643 . . . . 4.19 111.489 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.78 92.78 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.588 2.858 . . . . 0.45 110.429 -174.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.33 -9.65 3.79 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.562 1.077 . . . . 0.26 111.633 177.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -66.73 157.42 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 118.054 0.927 . . . . 1.6 110.884 167.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.74 -56.41 2.12 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.989 1.316 . . . . 1.54 110.229 168.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -143.17 157.35 44.59 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 123.081 0.553 . . . . 3.14 109.917 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.63 134.84 39.67 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.936 1.694 . . . . 1.69 108.165 174.413 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -142.07 116.86 9.82 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.499 1.119 . . . . 1.42 108.833 -173.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.73 139.54 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.429 1.092 . . . . 1.88 111.541 -175.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -132.37 67.77 1.52 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.628 1.571 . . . . 1.7 111.913 179.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.3 mt -65.86 -16.01 63.44 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 113.281 0.845 . . . . 1.78 113.281 178.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.16 -19.66 8.31 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.073 0.397 . . . . 1.84 110.997 168.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.3 m -130.48 14.9 5.51 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.907 1.283 . . . . 1.61 110.373 178.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 51.44 35.28 13.81 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.037 0.835 . . . . 2.75 112.048 -177.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 m -134.01 153.59 51.69 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 107.88 -1.156 . . . . 1.62 107.88 -170.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.16 151.38 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.374 -0.973 . . . . 1.51 108.374 174.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.17 150.29 42.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 124.178 0.924 . . . . 2.75 109.895 172.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.61 134.0 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.346 -0.983 . . . . 1.68 108.346 177.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.5 127.84 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.923 -1.51 . . . . 2.13 106.923 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -150.29 170.09 19.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.024 0.529 . . . . 3.45 110.348 -178.142 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.8 120.47 47.06 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 124.311 1.044 . . . . 1.39 111.002 -179.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -69.93 8.4 0.82 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.48 3.453 . . . . 0.81 113.914 -177.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.8 -44.61 26.97 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 108.162 -1.051 . . . . 1.66 108.162 175.303 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -102.68 -42.67 5.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.293 1.837 . . . . 3.03 110.249 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.6 m -129.53 127.45 40.79 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 117.57 2.433 . . . . 1.71 117.57 -158.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.42 -173.24 22.42 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 109.607 -1.397 . . . . 0.77 109.607 158.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 t -41.64 -34.03 0.55 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.282 2.633 . . . . 1.46 112.195 178.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.8 -57.59 7.04 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.915 0.709 . . . . 1.37 112.915 171.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.61 -35.88 67.95 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 122.581 1.182 . . . . 1.64 108.759 -176.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -58.3 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 113.896 -1.502 . . . . 1.75 109.551 -173.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -50.67 24.6 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.412 1.46 . . . . 0.78 111.065 177.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -41.41 -58.45 1.87 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.667 0.787 . . . . 2.46 112.693 173.31 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -41.32 77.63 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 119.31 -0.956 . . . . 2.74 111.417 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.0 mm -52.56 -47.0 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.056 0.844 . . . . 1.75 110.319 -179.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -51.25 -46.59 62.42 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.217 0.532 . . . . 1.82 109.854 173.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -34.6 71.73 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.349 -0.844 . . . . 5.36 112.88 -176.454 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.98 -22.5 5.73 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.563 0.745 . . . . 2.09 110.486 167.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.56 26.99 8.8 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.315 -1.114 . . . . 0.29 110.315 174.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -139.34 160.83 38.9 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.278 -1.008 . . . . 3.47 108.278 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 122.94 43.05 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.008 -1.479 . . . . 5.84 107.008 178.144 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.57 151.67 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 124.534 1.134 . . . . 1.61 109.793 173.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.224 -0.263 0 N-CA-C 108.815 -0.809 . . . . 1.96 108.815 179.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.584 -0.524 . . . . 0.72 109.584 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -142.37 154.49 44.68 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.848 0.832 . . . . 3.79 112.189 176.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -89.78 108.13 19.51 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 128.186 2.594 . . . . 2.53 107.322 171.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.64 154.53 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.86 -1.163 . . . . 2.69 107.86 165.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.8 132.9 37.31 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.502 -1.666 . . . . 1.48 106.502 173.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -155.67 166.44 33.5 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 123.273 0.629 . . . . 1.64 109.781 -173.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -93.56 156.18 16.88 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.026 -0.731 . . . . 2.96 109.026 -172.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.28 161.57 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 120.952 0.406 . . . . 1.6 110.656 177.012 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 126.946 2.098 . . . . 1.5 107.731 172.449 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 CA-C-O 118.913 -0.565 . . . . 1.57 112.442 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -59.22 -40.79 86.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.197 0.908 . . . . 4.05 110.894 176.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.41 HG12 ' CD1' ' A' ' 69' ' ' TYR . 57.2 mt -54.13 -60.6 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.207 -1.405 . . . . 1.96 107.207 -177.016 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -32.9 65.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.022 -0.99 . . . . 2.52 112.11 -175.34 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -55.16 -38.79 68.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.083 -1.011 . . . . 2.86 110.478 172.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.1 -51.74 39.43 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.791 -0.923 . . . . 0.59 110.791 168.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.33 -33.97 76.69 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.553 -0.969 . . . . 1.71 112.232 178.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.425 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP 0.259 0.9 OUTLIER -59.99 -18.11 43.39 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 118.986 0.812 . . . . 2.32 110.81 172.609 . . . . . . . . 4 4 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.22 -14.71 43.07 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.463 -1.398 . . . . 4.89 114.384 167.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.3 mtp -74.97 134.85 74.35 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 121.102 1.773 . . . . 3.11 111.26 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.06 114.19 2.34 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.06 2.507 . . . . 0.73 109.589 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.84 -16.02 6.19 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 124.852 1.215 . . . . 0.26 110.09 174.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.9 p -67.75 154.2 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 O-C-N 122.401 -0.47 . . . . 1.62 110.481 169.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.32 -54.24 2.48 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.735 1.214 . . . . 1.48 109.571 166.387 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.425 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 44.0 t0 -145.91 157.56 43.89 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.556 0.162 . . . . 2.58 110.909 -177.612 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.76 127.27 16.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.531 1.533 . . . . 2.03 108.82 -175.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -143.14 115.69 8.6 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.811 0.844 . . . . 2.03 109.537 -168.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -92.1 139.14 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 112.86 0.689 . . . . 2.06 112.86 -176.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -128.7 68.79 1.38 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.906 2.083 . . . . 1.65 111.246 -176.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.3 mt -64.62 -16.81 63.33 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 113.038 0.755 . . . . 1.86 113.038 178.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.76 -19.92 4.92 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.967 0.507 . . . . 1.64 111.121 169.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.1 m -136.33 18.0 3.16 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.834 1.253 . . . . 1.53 109.976 -178.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 48.46 32.93 3.59 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.19 0.996 . . . . 2.75 112.181 -176.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.9 m -124.73 153.1 42.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.239 -1.393 . . . . 1.68 107.239 -169.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 p -134.79 144.58 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.593 -0.892 . . . . 1.71 108.593 173.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -108.19 140.34 41.54 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.066 1.347 . . . . 2.87 107.822 175.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.83 134.71 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.825 -0.806 . . . . 1.63 108.825 167.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.8 mt -103.93 117.73 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 126.2 1.8 . . . . 1.97 106.331 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -145.19 173.24 12.11 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.164 0.586 . . . . 3.23 110.115 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -110.59 123.16 36.37 Favored Pre-proline 0 N--CA 1.443 -0.778 0 C-N-CA 124.618 1.167 . . . . 1.49 111.154 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -66.45 3.54 1.36 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.758 3.638 . . . . 0.96 114.384 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.07 -44.74 45.81 Favored 'General case' 0 C--N 1.335 -0.057 0 N-CA-C 108.483 -0.932 . . . . 2.06 108.483 176.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -101.37 -37.0 8.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.779 1.631 . . . . 3.26 110.366 178.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.3 m -138.64 131.52 29.48 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 118.71 2.855 . . . . 1.98 118.71 -150.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.81 -171.76 30.45 Favored Glycine 0 N--CA 1.435 -1.42 0 N-CA-C 109.417 -1.473 . . . . 0.74 109.417 164.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -35.04 -43.82 0.21 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.927 2.491 . . . . 1.69 112.088 176.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.55 -58.73 3.17 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.249 0.833 . . . . 1.46 113.249 173.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.35 -38.14 65.83 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.914 -0.772 . . . . 1.54 108.914 -176.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -61.14 -59.69 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.719 -1.128 . . . . 2.7 108.424 -173.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.92 -52.23 14.99 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.151 0.887 . . . . 0.87 110.644 -178.32 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -43.36 -55.0 4.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.621 1.168 . . . . 2.55 112.632 174.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -43.42 72.67 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 118.434 -0.793 . . . . 2.71 111.338 178.283 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.9 mm -52.32 -46.17 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 119.051 0.841 . . . . 1.63 109.725 -177.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -51.17 -50.24 59.37 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.014 0.435 . . . . 1.61 110.335 174.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -71.07 -31.37 67.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.42 -0.8 . . . . 4.2 112.444 -174.464 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.98 -21.77 12.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 122.967 0.507 . . . . 1.86 110.68 167.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.24 26.91 9.71 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 124.532 1.063 . . . . 0.46 110.488 174.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.41 ' CD1' HG12 ' A' ' 24' ' ' ILE . 71.2 m-85 -138.88 164.77 28.81 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 117.324 0.562 . . . . 2.88 109.588 -178.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 120.17 37.96 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.576 -1.268 . . . . 5.99 107.576 -179.156 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.65 150.5 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 109.305 -0.628 . . . . 1.74 109.305 170.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.237 0 C-N-CA 124.37 1.068 . . . . 2.74 108.854 179.325 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 120.568 0.223 . . . . 0.63 110.84 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -150.45 162.93 39.63 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.835 -0.432 . . . . 3.19 109.835 174.29 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -83.75 153.28 24.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.521 -1.218 . . . . 2.95 109.112 164.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 tp -131.48 155.07 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 106.416 -1.698 . . . . 2.0 106.416 161.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.09 131.88 31.23 Favored 'General case' 0 N--CA 1.458 -0.036 0 C-N-CA 125.139 1.376 . . . . 1.76 108.359 175.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.9 ptp -156.5 169.54 24.4 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.899 0.772 . . . . 3.18 111.144 -176.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.74 146.04 32.67 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.974 0.91 . . . . 2.1 109.477 -171.709 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.09 160.66 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 124.212 1.005 . . . . 1.88 111.228 -172.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 121.109 0.48 . . . . 2.11 111.381 166.446 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 119.358 -0.353 . . . . 1.51 111.091 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -56.0 -52.52 63.92 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.412 0.551 . . . . 4.22 110.885 175.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.9 mt -45.19 -60.64 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.893 1.277 . . . . 1.76 109.12 178.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -71.47 -36.46 71.17 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 120.83 0.348 . . . . 2.34 111.153 -172.102 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -56.12 -35.79 67.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.117 -0.989 . . . . 2.3 110.448 173.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.64 -49.6 46.08 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 111.471 -0.651 . . . . 0.33 111.471 166.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.83 -30.76 71.43 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 121.107 -1.231 . . . . 1.55 112.615 176.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -57.57 -17.72 15.65 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.21 0.913 . . . . 2.51 111.811 170.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -88.28 -3.72 58.81 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.164 1.172 . . . . 4.88 114.164 171.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 95.2 mmm -84.25 135.78 41.3 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 120.45 1.477 . . . . 3.11 111.408 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.95 99.43 0.56 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.769 2.98 . . . . 0.45 111.135 -172.03 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.2 -12.93 3.82 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.785 -0.926 . . . . 0.23 110.785 177.102 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.33 153.68 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 123.523 0.729 . . . . 1.58 111.206 171.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.95 -60.16 1.92 Allowed 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.457 1.103 . . . . 1.6 109.027 167.184 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -147.32 142.97 27.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 112.187 0.439 . . . . 3.23 112.187 -169.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.21 136.1 53.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.165 1.786 . . . . 1.59 108.27 179.163 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -137.71 111.97 8.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.46 1.104 . . . . 1.75 108.652 -178.443 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.2 141.67 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.438 1.095 . . . . 2.2 111.118 -178.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -136.57 65.46 1.52 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.903 1.281 . . . . 1.65 111.445 178.156 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -59.63 -23.71 63.24 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.946 -0.471 . . . . 2.02 112.115 177.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.39 -22.59 43.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.385 0.539 . . . . 1.69 111.207 174.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 m -121.75 16.01 11.02 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.802 1.241 . . . . 1.54 110.294 179.092 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 44.02 46.24 6.92 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.124 0.969 . . . . 2.83 110.876 -174.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.9 m -145.77 154.3 41.89 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.027 -1.472 . . . . 1.78 107.027 -171.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -132.69 151.9 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.306 -0.998 . . . . 1.78 108.306 170.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.54 150.77 47.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.296 -0.631 . . . . 2.71 109.296 175.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.87 146.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.512 -0.922 . . . . 1.58 108.512 -176.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.2 mt -114.75 125.95 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.523 1.929 . . . . 2.01 106.58 -173.373 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -152.37 170.1 20.93 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.223 0.609 . . . . 3.25 110.363 -175.671 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -109.21 115.77 56.13 Favored Pre-proline 0 N--CA 1.44 -0.943 0 O-C-N 124.276 0.985 . . . . 1.48 110.469 -177.064 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.37 8.55 0.5 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.172 3.248 . . . . 0.62 113.752 -178.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.99 -44.73 38.2 Favored 'General case' 0 N--CA 1.458 -0.026 0 N-CA-C 108.087 -1.079 . . . . 1.77 108.087 172.36 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -102.05 -38.32 7.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.291 1.436 . . . . 3.02 111.074 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 m -143.56 133.95 24.7 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 119.284 3.068 . . . . 1.86 119.284 -156.431 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.31 -149.74 6.28 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 108.88 -1.688 . . . . 0.81 108.88 154.34 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -44.82 -35.37 2.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.955 2.102 . . . . 1.61 112.833 -175.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.18 -55.1 26.86 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.658 -0.651 . . . . 1.74 111.821 174.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.41 -41.78 60.34 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.686 1.231 . . . . 1.65 109.323 -175.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mt -62.85 -52.57 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 113.967 -1.469 . . . . 1.68 111.502 -169.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -55.92 -47.04 78.21 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.471 1.032 . . . . 3.03 110.429 179.135 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -42.59 -60.06 1.68 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.113 0.965 . . . . 2.23 112.781 171.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -37.54 81.24 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 119.217 -0.993 . . . . 3.69 110.726 -177.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.1 mm -56.23 -44.09 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 118.154 0.434 . . . . 1.69 110.301 -178.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -48.06 -49.16 32.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.158 0.504 . . . . 1.53 110.279 172.08 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -71.88 -31.28 66.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.941 0.896 . . . . 4.21 113.128 -175.411 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -53.48 -24.35 12.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 119.441 -0.314 . . . . 2.13 110.616 165.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.36 29.23 4.58 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.37 0.986 . . . . 0.37 110.778 167.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -148.12 159.55 43.81 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.739 -1.578 . . . . 3.51 106.739 -177.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.79 147.27 27.07 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 105.819 -1.919 . . . . 4.84 105.819 170.283 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.9 p -110.9 157.56 11.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 125.494 1.518 . . . . 2.2 109.804 169.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.409 0 C-N-CA 124.355 1.062 . . . . 2.27 111.359 178.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 119.63 -0.224 . . . . 0.87 111.056 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -155.54 168.04 28.42 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.954 0.407 . . . . 5.24 110.73 178.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -84.37 133.08 34.53 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.444 2.298 . . . . 2.09 109.188 175.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.28 148.73 16.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.067 0 N-CA-C 106.286 -1.746 . . . . 2.61 106.286 162.462 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.78 133.04 44.3 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.256 1.422 . . . . 1.69 108.245 176.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.6 168.84 25.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 122.028 0.918 . . . . 2.77 112.887 -176.168 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.433 ' N ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -104.06 96.68 6.82 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 104.293 -2.484 . . . . 2.06 104.293 -164.201 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.81 141.11 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 108.294 -1.002 . . . . 2.7 108.294 175.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.678 -0.489 . . . . 1.66 109.678 178.337 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.771 0 CA-C-O 119.454 -0.308 . . . . 1.59 111.191 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -60.94 -47.99 83.86 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.576 0.625 . . . . 5.18 111.567 177.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.3 mt -43.36 -60.86 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 125.089 1.356 . . . . 1.74 108.324 175.198 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -71.37 -37.43 71.62 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.139 -0.482 . . . . 2.4 111.213 -172.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -57.54 -32.61 67.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.261 -0.9 . . . . 2.26 110.857 175.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.56 -51.15 54.02 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.663 -0.975 . . . . 0.33 110.663 165.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.6 -28.63 70.05 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 118.967 1.384 . . . . 1.7 112.597 176.17 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.29 21.2 ttmt -61.66 -15.2 37.76 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 119.854 1.206 . . . . 1.92 111.859 171.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -18.18 42.52 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.367 -1.458 . . . . 5.55 114.657 165.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.27 128.19 90.52 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 120.332 1.423 . . . . 3.66 110.936 -170.722 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -60.87 104.37 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.981 2.454 . . . . 0.6 111.032 -176.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.74 -3.45 8.63 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.715 2.103 . . . . 0.34 110.555 172.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.88 158.22 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 121.576 -0.955 . . . . 1.73 111.361 164.06 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.33 -58.15 1.72 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.251 1.42 . . . . 1.75 110.448 169.094 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -139.37 154.25 47.82 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 112.102 0.408 . . . . 3.13 112.102 -176.388 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.3 129.72 46.76 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.483 1.913 . . . . 1.69 108.731 174.393 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.65 113.14 7.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.881 1.272 . . . . 1.37 109.518 -174.625 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.78 148.76 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.975 0.91 . . . . 2.28 111.689 -174.304 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -140.74 67.55 1.36 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-O 122.789 1.28 . . . . 3.86 108.059 178.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.4 mt -62.14 -16.01 49.71 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.502 -0.772 . . . . 2.47 112.366 175.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.64 -12.55 4.27 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.477 1.111 . . . . 2.08 111.467 170.027 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.3 m -144.17 27.25 1.44 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.49 0.716 . . . . 1.64 109.201 178.026 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 36.93 59.64 1.04 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 125.213 1.405 . . . . 3.27 111.218 -176.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -156.52 157.51 35.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.021 -1.474 . . . . 1.8 107.021 -172.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.89 154.56 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 109.245 -0.65 . . . . 2.59 109.245 171.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -119.38 145.85 45.85 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.167 1.387 . . . . 2.58 109.247 -178.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.15 134.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.911 0.885 . . . . 1.5 109.055 179.036 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 78.5 mt -95.2 128.09 46.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.047 -1.464 . . . . 2.42 107.047 174.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -149.84 171.96 15.92 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.352 0.661 . . . . 3.07 110.491 177.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -108.02 121.99 42.12 Favored Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 124.002 0.921 . . . . 1.94 111.655 -176.358 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.93 23.0 0.35 Allowed 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 124.718 3.612 . . . . 0.81 113.489 -176.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.56 -48.93 6.13 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 107.714 -1.217 . . . . 1.69 107.714 171.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -99.43 -48.95 4.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.317 1.447 . . . . 2.71 110.687 178.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.2 m -111.11 133.03 53.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.07 1.748 . . . . 1.45 114.759 -164.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.1 177.28 32.42 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 108.638 -1.785 . . . . 1.08 108.638 163.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -34.15 -47.95 0.3 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.587 1.955 . . . . 2.09 111.082 172.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -41.26 -58.35 1.85 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.594 1.158 . . . . 1.75 113.402 173.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.05 -38.52 66.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.854 -0.795 . . . . 1.65 108.854 -176.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.78 -61.21 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-N 114.696 -1.138 . . . . 2.38 109.84 179.2 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -45.36 -52.58 9.71 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.003 1.274 . . . . 1.47 110.373 178.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.65 -51.46 12.23 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.573 0.749 . . . . 2.54 112.603 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -48.03 57.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.764 -0.774 . . . . 2.64 111.495 174.647 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.5 mm -49.6 -44.07 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.855 0.862 . . . . 1.53 110.662 -176.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -50.86 -52.57 40.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.446 0.698 . . . . 1.59 110.027 175.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -71.58 -29.12 64.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 114.048 1.129 . . . . 4.29 114.048 -178.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -53.9 -25.03 18.19 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.426 0.557 . . . . 1.76 110.388 165.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.68 27.82 3.94 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 124.507 1.051 . . . . 0.4 111.067 166.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -151.16 174.51 13.15 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.806 -1.183 . . . . 3.04 107.806 -173.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.33 141.05 48.79 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.066 -1.087 . . . . 4.65 108.066 171.64 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.94 142.3 15.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 113.542 -1.663 . . . . 2.02 107.969 162.085 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.117 -0.697 . . . . 2.26 109.117 173.612 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 112.423 0.527 . . . . 0.77 112.423 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.09 165.87 31.48 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.99 0.9 . . . . 4.0 111.803 169.35 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -82.15 141.12 33.35 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.062 2.145 . . . . 2.28 107.721 167.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.68 150.92 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 106.022 -1.844 . . . . 2.61 106.022 164.016 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.61 128.3 23.19 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.292 1.437 . . . . 1.67 107.955 176.286 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -155.91 173.17 17.17 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.994 0.518 . . . . 1.78 110.251 -172.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.22 152.25 21.26 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.951 0.9 . . . . 1.83 109.371 -176.426 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 t -115.02 162.89 12.78 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.06 0 C-N-CA 123.432 0.693 . . . . 1.74 109.834 178.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.45 -0.453 0 C-N-CA 125.303 1.441 . . . . 1.52 108.565 175.503 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 119.232 -0.413 . . . . 1.6 110.369 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -53.93 -45.58 71.26 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 118.817 -0.611 . . . . 4.3 111.36 174.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -49.24 -61.96 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.15 -0.685 . . . . 1.78 109.15 177.547 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -72.18 -33.12 67.43 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.015 -0.674 . . . . 2.46 111.017 -170.193 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.5 mmtt -54.42 -39.51 67.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 121.029 -1.045 . . . . 2.66 110.703 170.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.51 -53.04 34.06 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.889 -1.284 . . . . 0.42 109.889 168.757 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.66 -33.15 72.39 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 117.811 -1.09 . . . . 1.8 112.543 178.252 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.285 13.8 ttpt -56.43 -19.33 14.57 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 120.08 1.309 . . . . 3.18 111.678 175.499 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.46 -14.94 54.23 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.094 1.516 . . . . 4.06 115.094 170.284 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.6 mmt -73.54 134.59 79.16 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 120.165 1.348 . . . . 3.72 111.88 -175.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.85 94.35 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.291 2.661 . . . . 0.48 111.549 -176.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.84 -13.7 2.88 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.719 1.152 . . . . 0.44 111.092 171.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.23 152.84 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 121.678 -0.896 . . . . 2.39 109.121 162.623 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.19 -57.03 2.09 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.668 1.187 . . . . 1.55 110.374 169.064 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -154.67 158.07 39.08 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 117.903 0.319 . . . . 2.69 111.61 -177.047 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.36 132.43 47.07 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 127.494 2.317 . . . . 1.56 109.986 -171.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -138.35 104.34 5.15 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.819 1.248 . . . . 1.46 108.798 -176.539 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.9 p -83.67 141.55 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.74 0.816 . . . . 1.96 111.371 -178.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -136.83 67.84 1.44 Allowed 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.715 1.606 . . . . 1.61 111.535 -175.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.81 -16.98 62.63 Favored 'General case' 0 C--O 1.228 -0.045 0 N-CA-C 113.146 0.795 . . . . 1.9 113.146 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.45 -26.09 11.84 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.17 0.441 . . . . 1.75 110.612 169.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.6 m -125.45 18.56 8.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.319 1.448 . . . . 1.87 110.315 -179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 46.46 39.66 6.95 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.202 1.001 . . . . 2.66 111.973 -177.352 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.37 156.82 46.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.596 -0.89 . . . . 2.58 108.596 -169.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.59 145.66 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.349 -0.841 . . . . 1.62 108.809 174.335 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -116.06 139.01 50.72 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.022 -1.473 . . . . 2.48 107.022 176.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.59 138.34 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.489 -0.93 . . . . 1.81 108.489 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 79.9 mt -105.11 125.3 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.196 -1.409 . . . . 2.11 107.196 -177.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -146.12 166.36 26.38 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 122.945 0.498 . . . . 3.18 111.227 -179.418 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -103.68 115.62 63.22 Favored Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 114.31 -1.313 . . . . 1.34 110.245 176.324 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -68.46 6.73 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.674 2.916 . . . . 0.56 113.706 -179.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.62 -43.24 48.98 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 119.381 0.991 . . . . 1.7 108.438 174.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -100.86 -40.82 7.11 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.27 1.828 . . . . 2.99 109.906 178.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.6 m -138.82 127.3 23.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 118.568 2.803 . . . . 1.31 118.568 -154.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -159.0 -164.68 14.74 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 109.752 -1.339 . . . . 0.64 109.752 156.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.273 0.1 OUTLIER -29.28 -44.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 129.357 3.063 . . . . 1.69 114.13 173.245 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.48 -57.09 8.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.195 0.907 . . . . 1.66 112.546 175.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.26 -39.36 63.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 122.181 0.991 . . . . 1.59 108.933 -176.12 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mt -60.87 -59.24 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-N 114.149 -1.387 . . . . 1.79 109.279 -174.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.65 -51.48 12.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.914 1.234 . . . . 0.75 111.279 177.728 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -42.48 -56.07 3.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.893 0.701 . . . . 2.44 112.893 174.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -44.27 71.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 119.056 -1.058 . . . . 2.78 111.347 178.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.8 mm -51.01 -46.33 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.65 0.78 . . . . 1.67 110.456 -178.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -50.11 -50.56 48.1 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.328 0.585 . . . . 1.42 110.07 174.092 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -72.35 -30.79 65.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.904 0.705 . . . . 3.85 112.904 -175.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.51 -25.34 24.97 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.68 0.392 . . . . 1.74 110.383 165.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.25 28.78 5.38 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 124.656 1.122 . . . . 0.39 110.859 172.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -145.52 163.52 34.47 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 107.943 -1.132 . . . . 3.45 107.943 -176.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.01 126.58 50.28 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.977 -1.49 . . . . 5.65 106.977 177.781 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.0 p -94.74 141.58 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 122.92 0.488 . . . . 1.7 109.771 172.22 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.466 0.357 0 N-CA-C 108.987 -0.746 . . . . 2.09 108.987 173.393 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 120.664 0.268 . . . . 0.83 110.962 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -147.9 156.56 42.83 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.982 0.896 . . . . 4.57 110.763 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.28 111.14 18.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.848 2.459 . . . . 2.19 108.991 173.251 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.02 151.89 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 107.203 -1.406 . . . . 2.71 107.203 162.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.02 127.82 19.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.431 1.492 . . . . 1.47 107.899 175.317 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -157.03 164.5 37.9 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.163 0.438 . . . . 1.87 110.727 -171.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.34 145.89 27.61 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.074 0.95 . . . . 1.83 109.066 -172.089 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.71 159.25 19.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 C-N-CA 123.127 0.571 . . . . 1.75 110.053 -176.087 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.448 -0.563 0 C-N-CA 124.909 1.284 . . . . 1.26 108.096 177.081 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 118.812 -0.613 . . . . 1.59 111.581 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -57.98 -43.4 86.53 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.848 0.749 . . . . 4.08 110.696 177.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.5 mt -53.47 -59.45 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 107.96 -1.126 . . . . 1.84 107.96 -176.799 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -70.58 -41.17 72.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.818 -0.628 . . . . 3.36 109.811 -176.03 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -49.66 -38.49 32.79 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.39 -1.444 . . . . 2.4 112.005 179.084 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.42 -51.79 40.78 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 111.548 -0.621 . . . . 0.4 111.548 169.064 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.6 mt -67.1 -27.7 67.56 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.639 -0.918 . . . . 2.0 112.666 177.476 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -62.09 -15.82 47.81 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.758 1.163 . . . . 3.57 110.004 172.146 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -96.89 4.97 51.35 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.162 1.171 . . . . 4.97 114.162 170.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 81.5 mmm -83.12 138.81 42.35 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 120.498 1.499 . . . . 3.12 111.529 176.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.68 94.26 0.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.387 2.724 . . . . 0.41 111.228 -172.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.87 -13.81 2.87 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.514 1.054 . . . . 0.22 111.327 178.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.3 p -69.22 160.59 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 117.735 0.767 . . . . 1.61 110.889 168.076 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.25 -56.37 1.82 Allowed 'General case' 0 C--N 1.335 -0.058 0 C-N-CA 124.055 0.942 . . . . 1.68 109.967 168.793 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -145.01 157.54 44.09 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.968 -0.382 . . . . 2.85 109.968 -179.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.22 136.12 39.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.504 2.322 . . . . 1.67 107.854 176.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.57 115.19 9.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.658 1.583 . . . . 1.42 108.193 -174.155 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.57 143.6 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.859 0.863 . . . . 1.83 112.062 -177.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -133.14 67.72 1.52 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.335 1.854 . . . . 1.7 111.86 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.5 mt -67.37 -16.89 64.5 Favored 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 113.085 0.772 . . . . 1.81 113.085 -179.046 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.83 -22.06 13.29 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.654 0.382 . . . . 1.58 110.875 168.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.1 m -127.82 17.79 6.78 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.741 1.216 . . . . 1.66 110.032 178.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 44.68 40.52 4.19 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.558 1.143 . . . . 2.75 111.632 -175.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.8 m -134.72 155.66 50.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.22 -1.4 . . . . 1.58 107.22 -169.132 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.8 148.9 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.773 -0.825 . . . . 1.46 108.773 173.012 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.25 153.11 36.81 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 124.047 0.842 . . . . 2.83 110.168 174.374 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.98 133.64 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 123.617 0.767 . . . . 1.64 109.382 -177.139 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.5 mt -100.01 112.04 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.755 1.622 . . . . 2.06 106.794 179.375 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -135.84 167.41 21.23 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.276 1.03 . . . . 3.16 110.998 178.335 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.91 119.85 54.28 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 124.726 1.21 . . . . 1.34 110.998 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.14 8.83 1.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.72 2.947 . . . . 0.56 113.586 -175.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.4 -53.25 6.78 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 107.585 -1.265 . . . . 1.63 107.585 175.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -85.48 -41.87 14.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.273 1.429 . . . . 2.87 110.429 175.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.0 m -138.14 126.61 23.34 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 117.925 2.565 . . . . 1.67 117.925 -151.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.83 -165.35 19.76 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.909 -1.041 . . . . 0.64 110.731 155.458 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.5 t -31.5 -43.22 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 129.386 3.075 . . . . 1.62 112.987 176.776 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.0 -56.87 7.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.785 0.72 . . . . 1.47 112.831 174.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.57 -37.05 65.65 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 122.29 1.043 . . . . 1.69 109.198 -179.517 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mt -64.79 -54.64 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 114.348 -1.296 . . . . 1.76 110.338 -171.516 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.74 -51.47 22.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.011 1.278 . . . . 0.77 110.882 174.711 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -43.42 -53.84 5.13 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 113.025 0.75 . . . . 2.26 113.025 173.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.14 -45.56 66.57 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 118.419 -0.8 . . . . 3.09 110.862 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.2 mm -50.1 -47.5 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.641 1.176 . . . . 1.58 110.384 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -51.22 -47.53 62.31 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.427 0.632 . . . . 1.53 110.053 174.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -33.06 67.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.75 0.82 . . . . 4.39 112.42 -177.001 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.64 -22.62 23.65 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.883 0.473 . . . . 2.09 110.395 166.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.19 30.88 7.55 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.225 -1.15 . . . . 0.45 110.225 175.325 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -137.32 163.62 30.55 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.615 -1.254 . . . . 3.6 107.615 178.511 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.24 130.88 56.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.104 -1.443 . . . . 5.23 107.104 174.119 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -99.4 146.72 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.629 0.771 . . . . 1.68 111.111 171.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 C-N-CA 123.987 0.915 . . . . 2.28 109.738 171.077 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.671 -0.492 . . . . 0.68 109.671 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.1 mttp -149.72 162.98 39.17 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.357 0.599 . . . . 5.25 110.56 178.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -84.11 133.62 34.62 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.779 1.632 . . . . 2.04 107.768 166.849 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 tp -106.29 154.14 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.104 -1.813 . . . . 1.92 106.104 160.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.9 131.45 30.98 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.894 -1.521 . . . . 1.55 106.894 171.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -156.46 165.85 35.12 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.278 0.631 . . . . 1.81 110.428 -174.005 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -93.92 148.56 22.03 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.04 1.336 . . . . 2.99 107.785 -171.294 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.13 141.07 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 118.956 0.798 . . . . 1.87 110.522 178.705 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 106.893 -1.521 . . . . 1.69 106.893 173.239 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 118.587 -0.72 . . . . 1.5 110.208 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -52.41 -48.76 65.52 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.389 0.995 . . . . 4.85 111.381 173.168 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.444 HG12 ' CD1' ' A' ' 69' ' ' TYR . 80.1 mt -43.68 -61.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.284 0 N-CA-C 108.856 -0.794 . . . . 1.97 108.856 179.78 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -36.08 66.3 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.773 -0.649 . . . . 2.43 112.427 -174.473 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -54.72 -37.63 66.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.941 -1.099 . . . . 3.63 111.009 176.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.51 -45.09 77.81 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.983 -0.847 . . . . 0.46 110.983 169.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.9 mt -67.25 -31.18 71.35 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.128 -1.219 . . . . 1.55 111.517 176.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -60.47 -17.5 45.32 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.221 0.918 . . . . 2.08 111.215 172.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -81.38 -16.22 52.91 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.928 -1.107 . . . . 4.41 113.674 169.378 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 14.8 mmt -73.71 137.73 77.05 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 120.785 1.63 . . . . 3.23 112.744 -173.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.74 87.82 0.8 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.903 3.069 . . . . 0.79 111.284 -172.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.05 -22.82 0.99 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.994 -0.843 . . . . 0.48 110.994 -174.302 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.09 159.65 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 O-C-N 121.845 -0.797 . . . . 1.71 111.939 175.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.54 -57.36 1.47 Allowed 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.652 1.181 . . . . 1.74 109.344 169.49 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -138.97 154.84 48.34 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 113.884 1.068 . . . . 3.07 113.884 178.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.13 124.06 18.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.071 1.748 . . . . 1.74 108.025 -175.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -143.44 119.97 11.04 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.584 0.754 . . . . 1.64 109.166 -166.111 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -96.63 128.17 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.466 0.707 . . . . 2.2 111.529 -173.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -113.91 69.51 0.71 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.032 -1.47 . . . . 3.68 107.032 177.158 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 72.9 mt -61.57 -21.79 64.62 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.893 -0.594 . . . . 1.89 111.641 175.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.71 -25.05 16.67 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.872 0.869 . . . . 1.61 111.405 170.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 m -124.96 15.39 8.54 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.123 1.369 . . . . 2.12 109.886 -179.308 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 47.02 37.04 4.6 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.407 1.083 . . . . 2.46 111.632 -176.348 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.0 m -133.78 150.59 51.45 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.807 -1.553 . . . . 1.61 106.807 -170.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.3 p -128.96 146.9 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 107.684 -1.228 . . . . 1.6 107.684 174.492 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.32 149.08 44.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 123.895 0.747 . . . . 2.75 109.114 173.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.26 133.78 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.393 -0.965 . . . . 1.85 108.393 -179.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.2 mt -101.69 120.25 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 127.231 2.212 . . . . 1.8 106.501 -176.462 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -149.68 166.15 30.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.656 0.782 . . . . 3.08 110.548 -177.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -95.22 108.08 36.45 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 125.228 1.411 . . . . 2.26 110.611 175.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -70.34 12.82 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.229 3.286 . . . . 0.95 114.117 -179.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.97 -49.66 6.92 Favored 'General case' 0 N--CA 1.459 0.023 0 N-CA-C 107.105 -1.443 . . . . 1.73 107.105 171.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -85.6 -34.09 21.51 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.18 1.392 . . . . 2.47 111.037 178.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.9 m -154.39 122.15 5.87 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 117.112 2.264 . . . . 1.59 117.112 -156.601 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.97 -171.68 24.2 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 121.69 -0.631 . . . . 0.66 112.222 165.383 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.96 -44.66 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.942 2.897 . . . . 1.52 112.531 176.499 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.4 -55.78 9.91 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.062 0.764 . . . . 1.6 113.062 175.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.18 -38.7 63.59 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 122.644 1.211 . . . . 1.65 109.127 178.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.95 -48.61 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 114.407 -1.27 . . . . 1.62 110.619 -169.063 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -50.53 60.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.164 1.347 . . . . 0.9 110.355 173.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -43.32 -57.95 2.78 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.852 0.834 . . . . 2.4 112.879 171.846 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -42.27 83.66 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 118.595 -0.717 . . . . 2.8 111.418 -178.228 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.47 -47.8 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 119.355 0.98 . . . . 1.76 110.047 177.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -51.72 -46.29 63.91 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.103 0.478 . . . . 1.66 110.026 173.083 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -37.7 84.27 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.482 -0.761 . . . . 4.47 112.01 -178.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.97 -21.95 34.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.75 0.82 . . . . 2.09 110.517 170.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.83 28.5 7.8 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 124.409 1.004 . . . . 0.51 110.97 173.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.444 ' CD1' HG12 ' A' ' 24' ' ' ILE . 47.5 m-85 -141.23 175.11 9.91 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.042 -1.095 . . . . 3.64 108.042 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 111.43 7.39 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.232 -1.025 . . . . 6.11 108.232 -171.525 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.49 147.21 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.466 -0.788 . . . . 1.7 109.74 -179.007 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 C-N-CA 125.449 1.499 . . . . 2.82 110.15 -174.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 118.662 -0.685 . . . . 16.46 109.162 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.43 -76.75 0.1 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.003 -0.74 . . . . 8.89 109.003 171.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 m -66.29 159.88 25.68 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 122.044 -0.41 . . . . 3.82 110.603 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -133.74 113.92 12.85 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.929 -1.878 . . . . 2.65 105.929 172.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -91.74 172.09 8.71 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.995 0.918 . . . . 0.93 110.601 -175.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -152.38 162.32 41.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.597 0.713 . . . . 3.54 111.642 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.4 150.2 25.5 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.492 1.517 . . . . 3.75 109.006 166.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 tp -129.48 156.47 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.352 -1.721 . . . . 2.29 106.352 162.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.88 130.78 24.46 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.711 1.204 . . . . 1.7 108.442 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.84 171.63 19.94 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.238 0.472 . . . . 1.79 111.956 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.22 153.7 19.12 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.516 0.726 . . . . 1.97 110.009 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -118.51 158.06 19.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 123.903 0.881 . . . . 1.77 109.402 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -121.62 125.38 46.56 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.319 1.048 . . . . 1.45 108.178 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.73 -11.8 13.65 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.233 0.92 . . . . 1.38 113.202 172.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.36 151.17 16.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.752 1.276 . . . . 3.95 111.669 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 p -134.23 32.86 3.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.802 1.241 . . . . 4.02 110.006 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.0 t 60.54 -142.09 0.54 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.248 1.019 . . . . 4.51 110.573 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 34.03 53.6 0.53 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.878 2.071 . . . . 3.02 115.108 171.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.09 19.89 9.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.775 1.23 . . . . 2.6 113.949 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.4 m -73.32 -61.51 1.8 Allowed 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 123.515 0.726 . . . . 2.19 109.315 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.23 -34.66 68.8 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 121.693 0.759 . . . . 1.91 111.842 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.35 -41.52 19.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 122.951 0.5 . . . . 1.68 112.051 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.91 -41.73 99.55 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.444 0.566 . . . . 5.4 111.221 177.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.4 mt -51.71 -60.16 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.612 -1.255 . . . . 1.69 107.612 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.73 -34.49 69.61 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.372 -0.831 . . . . 2.6 111.516 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -56.39 -36.84 69.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.116 -0.99 . . . . 2.33 110.963 174.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.28 -49.18 60.98 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.765 -0.934 . . . . 0.3 110.765 168.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.8 mt -65.14 -30.9 71.87 Favored 'General case' 0 C--O 1.225 -0.207 0 O-C-N 121.544 -0.974 . . . . 1.64 112.882 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt -58.85 -17.55 24.88 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.145 0.884 . . . . 2.02 111.257 171.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -93.77 4.35 54.06 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.962 1.097 . . . . 6.46 113.962 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.0 mmt -82.03 136.4 47.22 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 120.702 1.592 . . . . 3.77 112.605 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.17 98.25 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.8 3.0 . . . . 0.38 110.111 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.74 -14.96 4.12 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.588 -1.005 . . . . 0.24 110.588 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 p -69.45 152.74 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 117.524 0.662 . . . . 1.68 110.434 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.53 -57.48 2.21 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.159 1.384 . . . . 2.16 109.48 170.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -144.51 158.09 43.92 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 122.973 0.509 . . . . 3.18 110.39 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.65 127.6 33.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.272 1.829 . . . . 1.66 107.926 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.09 113.31 8.37 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.854 0.861 . . . . 1.48 109.164 -174.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -89.73 140.34 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.098 0.959 . . . . 2.03 111.72 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -131.72 67.22 1.52 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.169 1.788 . . . . 1.71 111.581 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.74 -16.68 64.01 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 113.131 0.789 . . . . 1.9 113.131 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.03 -23.94 15.31 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.637 0.375 . . . . 1.61 110.748 168.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.5 m -126.62 18.31 7.42 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.073 1.349 . . . . 1.44 110.008 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 45.35 38.96 3.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.616 1.166 . . . . 2.48 111.869 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.9 m -136.17 154.63 50.9 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.28 -1.378 . . . . 1.5 107.28 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.55 150.02 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.588 -0.893 . . . . 1.65 108.588 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.41 150.08 41.35 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.739 -0.837 . . . . 2.83 108.739 171.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.94 139.63 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 107.146 -1.427 . . . . 1.6 107.146 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.1 mt -108.09 131.63 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.019 -1.474 . . . . 2.2 107.019 -175.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -154.2 167.78 28.74 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 123.257 0.348 . . . . 3.13 111.767 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 53' ' ' ALA . 18.6 t70 -102.75 110.85 64.15 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 124.508 1.123 . . . . 1.62 109.856 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -74.74 30.12 0.35 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.94 3.093 . . . . 0.82 112.752 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 51' ' ' ASP . . . -95.13 -50.21 5.17 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.044 -1.465 . . . . 1.65 107.044 167.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -87.24 -46.71 9.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.689 1.196 . . . . 2.65 110.269 173.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.6 m -140.88 136.42 32.31 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 117.591 2.441 . . . . 1.75 117.591 -148.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.85 -161.31 23.05 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 109.102 -1.599 . . . . 0.67 109.102 164.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 t -38.15 -43.53 0.77 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.833 2.453 . . . . 1.43 112.427 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.32 -57.43 4.62 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.809 0.844 . . . . 1.74 112.72 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.56 -37.56 65.49 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.873 0.844 . . . . 1.5 109.328 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mt -61.56 -59.46 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-N 114.466 -1.243 . . . . 2.1 109.341 -171.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.94 -50.36 27.33 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.099 1.318 . . . . 0.8 110.846 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.28 -52.58 9.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.205 1.002 . . . . 2.39 111.988 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -43.84 69.07 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.984 -0.686 . . . . 2.99 111.373 177.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.7 mm -52.53 -45.28 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 118.985 0.811 . . . . 1.97 110.284 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -49.3 -47.35 47.06 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.895 0.379 . . . . 1.62 110.646 173.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -71.96 -33.23 68.03 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.954 1.094 . . . . 3.61 113.954 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.49 -24.59 21.09 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.268 0.486 . . . . 1.83 110.205 166.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.66 29.29 6.64 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.114 -1.194 . . . . 0.27 110.114 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -140.73 162.08 36.27 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.01 -1.478 . . . . 2.87 107.01 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.79 133.72 55.21 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.118 -1.808 . . . . 5.39 106.118 170.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 p -100.73 148.53 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.39 0.676 . . . . 1.88 109.948 170.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.58 166.43 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.594 0.634 . . . . 2.06 109.738 167.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 35.3 mm -118.7 108.19 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 105.209 -2.145 . . . . 2.03 105.209 165.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -52.99 99.43 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.622 0.769 . . . . 7.38 111.319 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.69 -172.75 38.82 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 121.37 0.428 . . . . 5.39 112.082 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.174 0 CA-C-O 117.205 -1.379 . . . . 9.87 110.586 -172.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttm . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 119.138 -0.458 . . . . 10.41 111.503 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.2 tp -133.04 67.58 1.53 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.375 -1.342 . . . . 10.12 107.375 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.7 p 60.21 171.95 0.09 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.348 1.459 . . . . 4.69 110.155 -153.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -179.12 117.26 0.07 Allowed 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.9 2.08 . . . . 3.25 106.021 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -95.23 174.35 7.09 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 123.442 0.697 . . . . 1.22 110.939 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.98 154.77 41.64 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.68 0.752 . . . . 4.26 110.878 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -86.97 137.06 32.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.837 -1.529 . . . . 2.18 108.993 166.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.0 tp -112.07 155.64 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 105.917 -1.883 . . . . 2.31 105.917 162.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.55 130.55 21.84 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 108.072 -1.085 . . . . 1.67 108.072 172.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.62 173.47 16.89 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.177 0.899 . . . . 1.56 111.4 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.93 149.47 22.37 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.434 0.694 . . . . 1.82 109.599 -172.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.34 143.78 37.69 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.059 0 C-N-CA 122.708 0.403 . . . . 1.54 110.883 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t -101.4 149.68 23.8 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.343 1.057 . . . . 1.66 109.31 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.4 30.78 9.52 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.726 0.679 . . . . 1.47 112.894 174.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.97 77.66 0.32 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 118.506 1.153 . . . . 7.32 110.624 173.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 p -76.47 -1.89 29.43 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.048 0.939 . . . . 4.83 112.762 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t 78.08 175.54 0.17 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.855 1.662 . . . . 4.74 110.481 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.77 63.97 0.58 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.848 1.259 . . . . 3.37 112.396 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.34 23.21 11.66 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.992 1.317 . . . . 2.32 113.081 172.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -73.09 -52.28 14.89 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 121.744 -0.597 . . . . 2.93 110.214 -173.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.3 66.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.641 0.734 . . . . 1.79 110.968 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.96 -49.85 70.92 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.743 -0.598 . . . . 1.65 109.469 169.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -49.99 -49.66 49.81 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.707 0.685 . . . . 7.86 111.652 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.431 HG12 ' CD1' ' A' ' 69' ' ' TYR . 90.5 mt -44.02 -62.62 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 123.432 0.693 . . . . 2.23 109.324 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.42 -35.37 65.82 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.303 0.573 . . . . 2.36 112.394 -172.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -58.2 -36.43 73.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.955 -1.091 . . . . 2.11 110.722 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.59 -51.01 51.13 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.564 -1.014 . . . . 0.35 110.564 166.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.71 -33.6 76.0 Favored 'General case' 0 C--O 1.221 -0.417 0 O-C-N 121.579 -0.954 . . . . 1.75 112.444 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -57.79 -18.61 22.81 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.28 0.946 . . . . 2.48 112.058 172.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -85.33 -11.78 53.83 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.822 1.415 . . . . 5.4 114.822 169.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.8 mmt -69.63 143.51 92.8 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 120.85 1.659 . . . . 2.78 112.074 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.74 106.63 1.51 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.39 2.06 . . . . 0.57 109.537 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.09 -13.41 5.75 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.079 1.323 . . . . 0.29 110.784 171.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.1 p -70.27 160.56 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 O-C-N 121.939 -0.742 . . . . 1.52 111.517 171.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.49 -65.7 1.15 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.84 1.256 . . . . 1.63 108.212 165.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -144.43 147.43 33.34 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.349 -0.387 . . . . 3.25 111.793 -162.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.27 138.29 50.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.24 1.416 . . . . 1.67 108.587 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -140.0 118.45 12.18 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.975 0.91 . . . . 1.86 109.408 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -86.4 136.35 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.99 0.916 . . . . 2.0 111.054 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -129.23 69.68 1.41 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.318 1.847 . . . . 1.66 110.994 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.2 mt -64.09 -18.63 64.57 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.848 0.685 . . . . 1.98 112.848 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.84 -18.21 8.15 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.124 0.42 . . . . 2.02 110.977 170.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.7 m -131.87 18.06 4.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.823 1.249 . . . . 1.72 109.872 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 41.12 39.24 0.86 Allowed 'General case' 0 C--N 1.346 0.419 0 C-N-CA 124.895 1.278 . . . . 2.6 112.128 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.4 m -129.59 152.46 49.09 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.16 -1.422 . . . . 1.63 107.16 -171.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 p -133.85 146.85 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 107.143 -1.429 . . . . 1.61 107.143 173.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.75 145.8 46.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 123.93 0.769 . . . . 2.6 109.39 173.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -144.0 136.66 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.615 -0.883 . . . . 1.5 108.615 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.0 mt -103.61 118.87 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.704 2.002 . . . . 2.32 107.145 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -146.17 169.0 19.63 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.74 0.781 . . . . 3.18 110.415 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -96.71 125.3 47.32 Favored Pre-proline 0 N--CA 1.439 -1.003 0 CA-C-N 114.316 -1.311 . . . . 1.35 109.502 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.41 6.69 2.56 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.778 2.318 . . . . 0.92 113.315 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.19 -54.47 4.59 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 119.358 0.981 . . . . 1.76 108.95 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -85.43 -55.86 3.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.312 1.445 . . . . 3.13 109.297 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.8 m -86.93 160.16 18.78 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 126.366 1.867 . . . . 2.25 112.984 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.24 161.25 35.07 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 104.859 -3.296 . . . . 2.15 104.859 168.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 t -51.29 -32.24 24.24 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 117.192 0.496 . . . . 2.0 110.288 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -36.26 -61.32 0.51 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.97 1.708 . . . . 1.7 114.449 164.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.89 -37.97 73.03 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.938 -1.134 . . . . 1.65 107.938 -172.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -55.62 -62.29 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-N 114.315 -1.311 . . . . 2.45 109.214 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -46.9 -54.1 10.75 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.354 1.434 . . . . 1.19 110.676 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -41.05 -57.0 2.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.663 0.785 . . . . 2.52 112.767 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.64 -40.46 69.7 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 119.917 -0.713 . . . . 2.97 110.046 -176.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.5 mm -52.61 -47.18 49.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 119.188 0.903 . . . . 1.66 109.994 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -53.28 -42.54 66.66 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.637 0.375 . . . . 1.69 110.754 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -71.04 -38.96 72.56 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.422 -0.799 . . . . 3.64 110.915 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -54.96 -25.09 27.24 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.715 0.806 . . . . 1.87 110.263 171.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.17 29.66 6.3 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.331 -1.108 . . . . 0.47 110.331 172.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.431 ' CD1' HG12 ' A' ' 24' ' ' ILE . 44.0 m-85 -140.76 166.25 25.27 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.968 -1.123 . . . . 3.14 107.968 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.17 122.0 38.18 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 104.679 -2.341 . . . . 4.46 104.679 -173.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.54 142.51 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.182 -0.673 . . . . 1.72 109.182 173.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -104.26 151.87 6.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 N-CA-C 108.545 -0.909 . . . . 2.12 108.545 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.0 mm -124.84 67.68 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.388 -1.338 . . . . 2.0 107.388 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -87.61 100.81 13.07 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 106.937 -1.505 . . . . 4.62 106.937 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 23.77 66.63 0.03 OUTLIER Glycine 0 CA--C 1.53 0.983 0 C-N-CA 127.774 2.607 . . . . 3.66 115.509 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.342 0 CA-C-O 115.507 -2.187 . . . . 11.68 109.544 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 mtt . . . . . 0 N--CA 1.472 0.675 0 N-CA-C 106.392 -1.707 . . . . 11.11 106.392 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 tp -169.61 89.44 0.18 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.534 -0.913 . . . . 8.08 108.534 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 p -170.42 81.52 0.1 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.308 -0.997 . . . . 3.87 108.308 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -122.47 133.47 54.6 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.816 -1.92 . . . . 3.97 105.816 170.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -93.18 163.05 13.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.473 1.109 . . . . 0.61 110.697 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -146.14 157.17 43.83 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.013 -0.736 . . . . 4.64 109.013 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.68 127.94 35.59 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.625 1.57 . . . . 3.71 109.5 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 tp -106.73 152.17 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.767 -1.568 . . . . 1.92 106.767 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.81 132.65 27.51 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.258 -1.386 . . . . 1.45 107.258 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -156.41 163.16 39.8 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.072 0.549 . . . . 2.21 110.68 -170.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.77 154.56 18.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.343 -1.355 . . . . 2.26 107.343 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.4 163.43 14.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.064 -1.087 . . . . 1.75 108.064 173.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.99 142.65 51.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.555 -1.276 . . . . 2.17 107.555 173.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.33 -10.96 56.78 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.89 0.757 . . . . 1.42 113.722 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.6 157.37 11.78 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.282 1.541 . . . . 4.11 110.635 172.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -131.21 33.81 4.08 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.523 0.729 . . . . 5.01 109.223 169.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.5 t 69.91 -49.39 0.63 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.298 1.839 . . . . 4.35 113.633 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.4 86.14 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.358 1.463 . . . . 2.81 111.765 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.53 13.56 4.26 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.36 1.864 . . . . 2.44 113.63 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.7 m -72.13 -63.9 1.05 Allowed 'General case' 0 CA--C 1.519 -0.236 0 O-C-N 121.78 -0.575 . . . . 1.97 110.522 -167.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.85 -27.52 68.93 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.79 -0.364 . . . . 2.23 111.064 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.61 -54.94 34.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.725 0.41 . . . . 1.7 110.529 169.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -62.79 -48.1 80.58 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 122.89 0.476 . . . . 4.68 110.752 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.1 mt -49.62 -56.74 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.437 -0.579 . . . . 1.83 109.437 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.78 -42.89 76.78 Favored 'General case' 0 C--O 1.219 -0.522 0 C-N-CA 120.208 -0.597 . . . . 3.48 109.567 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -49.51 -36.77 24.23 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.406 -1.434 . . . . 3.06 111.691 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.17 -51.71 39.93 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 112.191 -0.364 . . . . 0.44 112.191 167.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.4 -28.34 67.01 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 121.401 -1.058 . . . . 1.95 113.043 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.281 21.5 ttmt -62.7 -15.04 50.84 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.965 1.257 . . . . 3.27 110.238 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -25.63 60.12 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.217 1.192 . . . . 4.91 114.217 166.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.18 134.83 93.55 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 120.14 1.336 . . . . 3.73 111.939 -169.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -65.58 100.79 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.303 2.669 . . . . 0.44 109.52 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.6 -17.68 3.48 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.405 -1.078 . . . . 0.3 110.405 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.17 154.65 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 121.965 -0.727 . . . . 1.6 110.385 169.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.18 -57.22 2.23 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 123.009 0.524 . . . . 1.83 109.666 171.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -148.49 157.45 43.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.516 -0.55 . . . . 2.56 109.516 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.72 136.11 33.85 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 127.232 2.213 . . . . 1.82 108.325 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -137.87 117.71 13.23 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 125.222 1.576 . . . . 1.76 107.931 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -84.32 144.15 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.159 0.984 . . . . 1.82 110.847 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -137.73 64.36 1.52 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.321 1.449 . . . . 1.85 112.124 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.55 -16.97 64.21 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 112.523 0.564 . . . . 2.16 112.523 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.05 59.42 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.227 0.467 . . . . 2.03 110.82 168.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.9 m -118.63 16.45 13.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.231 1.412 . . . . 1.94 109.962 176.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 48.28 36.37 6.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.601 1.161 . . . . 2.33 111.769 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.4 m -138.04 155.3 48.95 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.747 -1.205 . . . . 1.59 107.747 -168.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 p -136.48 150.36 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 108.825 -0.805 . . . . 1.68 108.825 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.98 153.01 44.94 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 123.852 0.72 . . . . 2.72 110.224 175.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.78 136.8 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.998 -0.742 . . . . 1.67 108.998 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.8 114.14 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.065 -1.457 . . . . 2.35 107.065 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -137.67 167.24 22.09 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.515 0.726 . . . . 3.33 111.118 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -102.73 113.91 65.61 Favored Pre-proline 0 N--CA 1.443 -0.805 0 C-N-CA 124.475 1.11 . . . . 1.31 110.612 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.8 17.89 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.529 2.819 . . . . 0.68 113.724 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.47 -51.76 7.08 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 107.646 -1.242 . . . . 1.72 107.646 168.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -81.47 -46.23 14.85 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.257 1.023 . . . . 2.95 110.265 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.9 m -142.37 129.61 21.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 118.295 2.702 . . . . 1.48 118.295 -143.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.08 -160.55 20.88 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.024 -1.23 . . . . 0.79 110.024 162.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 t -29.43 -48.73 0.08 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 129.544 3.137 . . . . 1.72 112.9 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.2 -55.9 7.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.719 0.808 . . . . 1.38 112.39 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.53 -38.0 65.42 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 122.149 0.976 . . . . 1.58 109.432 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mt -63.55 -56.63 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 114.408 -1.269 . . . . 1.9 110.017 -169.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.51 -53.49 14.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.81 1.186 . . . . 0.77 110.41 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -41.81 -54.05 3.51 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.245 1.018 . . . . 2.44 112.266 175.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -41.39 68.06 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 118.179 -0.915 . . . . 2.74 110.791 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.4 mm -53.75 -46.54 62.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.871 1.214 . . . . 1.7 110.216 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -51.83 -42.9 62.89 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.333 0.587 . . . . 1.54 109.946 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -37.19 73.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.594 0.758 . . . . 5.41 112.174 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -56.05 -19.95 14.91 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.149 0.579 . . . . 1.84 110.731 168.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.51 27.76 12.56 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 110.405 -1.078 . . . . 0.49 110.405 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -136.07 169.55 17.42 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 108.256 -1.016 . . . . 3.47 108.256 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.5 123.85 43.02 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.036 -1.098 . . . . 5.84 108.036 176.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 p -91.61 153.29 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.969 1.308 . . . . 1.77 109.712 173.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.78 104.15 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 122.929 0.492 . . . . 2.16 110.222 178.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mt -107.31 91.2 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 124.02 0.928 . . . . 2.8 108.566 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -149.48 115.62 5.74 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.204 -2.146 . . . . 6.86 105.204 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.58 -88.53 0.1 OUTLIER Glycine 0 CA--C 1.528 0.875 0 CA-C-N 118.935 0.788 . . . . 3.52 113.005 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.191 -1.385 . . . . 10.96 110.255 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.4 mtt . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 107.54 -1.281 . . . . 9.78 107.54 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.3 pp -62.36 165.72 5.76 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.14 -0.319 . . . . 6.71 110.14 165.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.5 t -124.84 159.62 30.64 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.079 -1.822 . . . . 3.91 106.079 167.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -157.47 144.51 18.33 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.507 -1.294 . . . . 3.86 107.507 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -84.26 166.02 17.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.569 0.747 . . . . 0.79 111.05 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -153.46 159.44 42.32 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.356 0.598 . . . . 3.41 111.697 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -84.87 124.92 32.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.665 2.386 . . . . 2.16 108.31 169.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 tp -104.06 147.92 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 106.878 -1.526 . . . . 2.41 106.878 161.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.47 129.35 37.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.651 -1.24 . . . . 1.6 107.651 173.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -155.41 170.19 22.51 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.799 -0.445 . . . . 2.8 109.799 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -97.1 148.69 22.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.272 1.029 . . . . 3.09 108.879 -174.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.03 160.57 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 C-N-CA 123.783 0.833 . . . . 2.08 109.573 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -94.84 149.63 21.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.0 -0.741 . . . . 1.67 109.0 165.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.17 82.19 0.26 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.701 -0.56 . . . . 2.71 111.701 173.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.8 ptp -144.57 178.26 8.09 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.906 1.282 . . . . 4.23 108.876 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 m 57.92 35.34 25.26 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.346 0.593 . . . . 8.26 110.391 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.28 59.47 1.7 Allowed 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 107.904 -1.147 . . . . 7.0 107.904 -174.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 63.31 82.24 0.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.056 1.342 . . . . 3.49 111.593 -175.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 57.85 31.59 20.73 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.488 1.115 . . . . 1.92 113.232 170.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -70.14 -61.26 1.85 Allowed 'General case' 0 C--O 1.226 -0.159 0 O-C-N 121.677 -0.639 . . . . 1.76 110.474 -173.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.26 -36.1 72.72 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 122.255 1.026 . . . . 1.85 110.913 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.4 -49.44 77.79 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.53 -0.759 . . . . 1.72 110.615 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -61.8 -48.7 79.45 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.243 0.929 . . . . 4.5 111.415 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.3 mt -42.34 -62.82 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 124.716 1.206 . . . . 2.43 108.388 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -32.71 64.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 119.458 -0.897 . . . . 2.56 112.664 -174.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -57.16 -37.7 72.46 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.95 -1.094 . . . . 3.22 110.434 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.69 -50.7 56.74 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 110.476 -1.05 . . . . 0.47 110.476 169.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.7 mt -62.29 -31.57 72.18 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 121.896 -0.767 . . . . 1.66 112.12 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.414 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 21.8 ttmt -62.51 -15.59 51.24 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 119.155 0.889 . . . . 3.54 110.722 175.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.27 -3.17 44.56 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.043 1.127 . . . . 5.21 114.043 169.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 75.1 mmm -74.07 138.91 75.82 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 120.786 1.63 . . . . 3.13 111.768 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.64 90.39 0.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.31 2.673 . . . . 0.64 110.971 -173.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.99 -9.04 4.19 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.122 1.344 . . . . 0.32 111.347 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.4 p -64.69 161.87 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.399 1.099 . . . . 1.65 110.251 164.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.21 -53.61 2.13 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.738 1.215 . . . . 1.54 110.373 166.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.414 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 18.8 t70 -148.25 163.77 36.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.467 -0.568 . . . . 3.05 109.467 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.24 141.99 26.75 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.979 1.712 . . . . 2.01 108.627 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -152.19 119.63 6.0 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.887 0.875 . . . . 1.43 108.754 -165.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -84.98 145.72 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.318 1.047 . . . . 2.16 112.376 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -134.32 69.95 1.45 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.968 1.707 . . . . 1.79 112.345 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.4 mt -61.57 -22.26 65.04 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 112.295 0.48 . . . . 2.66 112.295 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.61 -16.44 25.79 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.406 0.548 . . . . 1.98 111.174 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.9 m -132.66 18.24 4.28 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.918 0.887 . . . . 1.61 109.529 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 43.95 45.5 6.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.902 0.881 . . . . 2.41 111.505 -175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.8 m -136.37 159.92 40.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.95 1.3 . . . . 1.65 108.145 -170.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.61 149.65 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.378 -0.971 . . . . 2.03 108.378 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -117.58 139.45 50.95 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.922 1.289 . . . . 2.5 109.301 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.29 132.85 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.274 0.63 . . . . 1.64 109.841 174.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.72 125.12 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.295 1.438 . . . . 2.23 107.542 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -146.24 169.72 18.2 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.314 0.646 . . . . 3.27 110.983 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -107.73 121.4 44.24 Favored Pre-proline 0 N--CA 1.447 -0.619 0 C-N-CA 124.726 1.21 . . . . 2.09 110.982 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -71.94 10.85 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.349 3.366 . . . . 0.98 113.684 -176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.74 -50.32 12.63 Favored 'General case' 0 N--CA 1.458 -0.037 0 N-CA-C 107.409 -1.33 . . . . 1.78 107.409 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -96.03 -40.16 9.39 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.019 1.728 . . . . 3.0 110.557 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.4 m -136.08 131.15 34.46 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 117.929 2.566 . . . . 1.23 117.929 -153.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.99 -168.62 24.16 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.866 -1.293 . . . . 0.68 109.866 160.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.1 t -38.69 -40.35 0.59 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.947 2.499 . . . . 1.73 112.243 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.17 -56.43 6.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.569 0.748 . . . . 1.36 112.593 173.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.25 -34.48 68.3 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 122.562 1.172 . . . . 1.54 109.323 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.26 -52.51 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 113.943 -1.481 . . . . 1.84 111.161 -169.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -50.69 59.39 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.322 1.419 . . . . 0.79 109.641 173.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.47 -53.88 16.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.32 1.048 . . . . 4.92 111.193 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -67.22 -41.93 84.9 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 121.703 -0.623 . . . . 3.38 111.531 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 mm -55.19 -45.27 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.054 0.942 . . . . 1.74 110.191 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -48.96 -47.01 44.31 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.305 0.574 . . . . 1.58 110.596 171.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -32.71 69.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.378 0.881 . . . . 3.91 113.378 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.63 -25.54 18.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.321 0.509 . . . . 1.85 110.118 166.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.13 29.67 5.67 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.256 -1.138 . . . . 0.5 110.256 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -146.23 159.55 43.18 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 106.84 -1.541 . . . . 3.16 106.84 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.79 135.37 54.03 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.776 0.798 . . . . 5.28 109.324 171.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.9 p -99.34 152.54 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.478 1.511 . . . . 1.67 109.751 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m -115.42 153.62 16.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 N-CA-C 109.4 -0.593 . . . . 2.03 109.4 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.3 mm -109.04 93.5 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 106.425 -1.694 . . . . 2.53 106.425 173.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -133.96 138.29 45.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.899 -2.26 . . . . 4.22 104.899 168.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.78 52.84 3.73 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 123.819 0.699 . . . . 5.04 113.041 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 . . . . . 0 C--O 1.251 1.136 0 C-N-CA 126.316 1.847 . . . . 9.36 110.556 176.365 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.4 mtt . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 109.388 -0.597 . . . . 9.51 109.388 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.51 170.18 3.01 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 105.979 -1.86 . . . . 6.96 105.979 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.5 m -100.92 148.83 24.54 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.692 -1.225 . . . . 3.16 107.692 171.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -153.57 139.67 18.34 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.163 -1.421 . . . . 3.28 107.163 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -101.17 164.52 11.75 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.525 0.73 . . . . 1.06 111.076 -170.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -146.84 151.53 37.25 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 122.689 1.233 . . . . 4.32 112.724 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -84.83 106.08 16.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 131.21 3.804 . . . . 2.43 107.858 171.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.09 148.3 4.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 N-CA-C 107.199 -1.408 . . . . 2.22 107.199 165.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.54 126.28 29.01 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 124.775 1.23 . . . . 1.6 107.73 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -156.52 165.48 36.17 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.525 -0.546 . . . . 1.63 109.525 -170.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.72 155.2 16.87 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 108.827 -0.805 . . . . 2.02 108.827 -174.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.11 163.06 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 108.218 -1.03 . . . . 1.89 108.218 175.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.23 135.82 48.54 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.085 -1.45 . . . . 1.44 107.085 176.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.33 -12.6 30.97 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.346 0.974 . . . . 1.34 113.62 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.4 153.15 16.26 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.051 1.425 . . . . 4.29 111.682 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 p -138.17 33.64 2.34 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.255 1.022 . . . . 3.84 110.097 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.0 t 53.74 -146.1 0.56 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 117.447 -1.263 . . . . 4.73 111.655 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 37.41 51.72 1.19 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.578 1.551 . . . . 2.8 114.218 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 65.06 14.21 9.21 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.208 1.403 . . . . 1.97 114.262 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.0 m -72.16 -60.79 2.05 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.383 -0.823 . . . . 2.19 109.019 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.79 -42.21 62.27 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 122.139 0.971 . . . . 1.82 111.448 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.74 -43.02 47.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.064 0.946 . . . . 1.62 111.633 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -58.79 -41.49 86.82 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.592 0.633 . . . . 6.48 111.145 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.2 mt -54.51 -59.74 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.592 -1.262 . . . . 2.17 107.592 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.37 -36.14 73.97 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.431 -0.804 . . . . 2.54 110.501 -171.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -56.12 -36.47 68.25 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.199 -0.938 . . . . 3.08 110.961 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.2 -48.04 48.12 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.007 -0.837 . . . . 0.48 111.007 166.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.2 mt -68.01 -30.55 69.83 Favored 'General case' 0 C--O 1.224 -0.241 0 O-C-N 121.351 -1.088 . . . . 1.66 111.842 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -60.33 -19.1 54.03 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.712 1.142 . . . . 2.22 111.468 172.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -25.21 62.02 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.95 -1.094 . . . . 5.07 113.349 168.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 92.1 mmm -72.6 134.02 82.23 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 119.784 1.174 . . . . 2.95 112.448 -167.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.03 101.44 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.902 3.068 . . . . 0.38 110.653 -172.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.22 -15.35 3.97 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.667 -0.973 . . . . 0.28 110.667 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.48 154.71 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 O-C-N 122.081 -0.658 . . . . 1.55 111.158 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.65 -53.78 2.08 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.784 1.234 . . . . 1.63 109.801 171.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -142.44 153.46 43.73 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 113.606 0.965 . . . . 2.93 113.606 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.65 125.4 38.02 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.596 1.958 . . . . 1.74 107.971 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.13 109.39 6.88 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.043 1.337 . . . . 1.42 108.857 -168.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.3 145.26 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.928 0.891 . . . . 1.89 112.372 -172.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -135.6 67.73 1.47 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.121 1.768 . . . . 1.81 111.622 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.5 mt -68.0 -14.6 63.09 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 113.159 0.8 . . . . 1.69 113.159 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.15 -14.1 3.7 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.822 0.449 . . . . 1.54 111.355 166.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 m -137.27 19.34 2.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.477 1.111 . . . . 1.61 109.422 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 47.44 36.98 5.57 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.262 1.025 . . . . 2.71 111.232 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.9 m -132.22 156.27 46.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.781 -1.192 . . . . 1.47 107.781 -168.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.81 148.2 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 108.828 -0.804 . . . . 1.61 108.828 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -116.55 138.2 51.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.796 -1.187 . . . . 2.48 107.796 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.87 131.09 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.275 -1.009 . . . . 1.53 108.275 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.91 115.76 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.803 -1.554 . . . . 2.57 106.803 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -141.49 170.59 15.43 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.177 0.991 . . . . 3.55 110.323 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -104.56 111.47 65.21 Favored Pre-proline 0 N--CA 1.443 -0.814 0 C-N-CA 124.36 1.064 . . . . 1.37 110.012 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.06 11.65 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.738 2.959 . . . . 0.81 113.852 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.55 -48.0 12.37 Favored 'General case' 0 C--N 1.337 0.051 0 N-CA-C 107.416 -1.327 . . . . 2.01 107.416 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -84.28 -47.35 10.87 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.999 1.32 . . . . 2.48 109.471 171.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.6 m -144.22 127.22 16.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 118.509 2.781 . . . . 1.54 118.509 -146.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.44 -152.78 7.64 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.687 -0.965 . . . . 0.82 110.687 158.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -28.76 -48.78 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 129.08 2.952 . . . . 1.67 113.804 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.23 -55.37 18.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.705 0.684 . . . . 1.53 112.527 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -40.24 63.78 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 122.425 1.107 . . . . 1.61 108.418 -176.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.57 -49.98 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-N 114.131 -1.395 . . . . 2.39 111.312 -169.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.08 -51.1 56.62 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.592 1.542 . . . . 0.86 110.279 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -45.38 -53.55 8.47 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.057 0.943 . . . . 2.38 111.94 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -43.47 71.13 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 118.2 -0.905 . . . . 2.96 111.222 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.7 mm -50.88 -47.35 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.53 1.059 . . . . 1.81 109.156 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -51.86 -48.02 64.2 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.978 0.418 . . . . 1.48 110.43 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -69.1 -34.56 75.29 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.437 -0.789 . . . . 4.12 112.575 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.95 -21.96 13.46 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 122.97 0.508 . . . . 2.13 110.605 168.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.78 29.93 8.34 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.169 -1.172 . . . . 0.42 110.169 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -137.67 170.88 15.3 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.372 -1.344 . . . . 3.56 107.372 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.83 127.68 45.36 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.882 0.873 . . . . 5.39 108.964 172.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.43 149.38 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 125.911 1.684 . . . . 1.85 109.541 172.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.2 m -118.44 134.18 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 C-N-CA 123.797 0.839 . . . . 2.05 109.828 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.1 mm -107.17 91.39 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.207 -1.405 . . . . 2.07 107.207 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -140.12 149.24 42.8 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.845 -2.28 . . . . 4.62 104.845 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 143.68 -65.31 0.47 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.815 -1.314 . . . . 4.01 109.815 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 . . . . . 0 C--O 1.25 1.089 0 C-N-CA 126.784 2.034 . . . . 10.07 105.565 176.06 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 106.722 -1.585 . . . . 11.93 106.722 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mp -149.2 171.21 16.84 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 105.658 -1.978 . . . . 6.4 105.658 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 p -151.13 153.06 34.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.102 -1.814 . . . . 3.44 106.102 172.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -162.96 138.88 7.05 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.76 -1.571 . . . . 3.64 106.76 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -106.8 172.69 6.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.465 0.706 . . . . 0.66 111.101 -172.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -147.53 162.55 38.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.186 0.517 . . . . 3.34 110.752 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -83.07 143.44 30.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 113.596 -1.638 . . . . 2.59 107.359 163.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -125.33 148.2 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 105.609 -1.997 . . . . 2.23 105.609 161.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.89 124.34 20.73 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.772 1.229 . . . . 1.47 108.543 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -156.33 161.63 40.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.425 0.29 . . . . 1.95 111.62 -170.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.11 146.71 24.43 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.56 1.144 . . . . 1.74 109.934 -169.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.75 141.35 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.094 0.558 . . . . 1.47 110.273 -176.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -84.4 117.82 23.86 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.372 -1.344 . . . . 1.14 107.372 170.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.79 77.16 1.25 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.029 -0.828 . . . . 2.66 111.029 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.7 ptm -135.42 -171.96 2.96 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.59 1.556 . . . . 4.83 107.744 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.0 t 49.12 29.55 2.57 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.955 1.302 . . . . 7.4 114.388 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.1 t -125.65 48.25 2.09 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.28 0.562 . . . . 7.04 110.036 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 84.14 79.52 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.534 2.334 . . . . 3.68 111.794 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 57.34 29.28 16.6 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.956 1.302 . . . . 1.69 112.853 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.5 m -71.27 -62.13 1.51 Allowed 'General case' 0 C--O 1.222 -0.361 0 O-C-N 122.064 -0.398 . . . . 2.47 110.017 -170.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.2 -39.92 67.11 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.089 0.404 . . . . 2.23 111.063 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.69 -58.73 6.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 122.929 0.492 . . . . 1.58 110.924 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -58.28 -49.55 76.74 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.339 0.655 . . . . 4.79 111.609 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.6 mt -47.38 -59.24 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.094 1.358 . . . . 1.91 109.056 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.0 -44.31 76.88 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 119.868 -0.733 . . . . 3.71 109.038 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -50.64 -36.66 36.55 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.701 -1.249 . . . . 2.56 112.289 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.22 -48.07 82.89 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 112.011 -0.435 . . . . 0.47 112.011 168.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.0 mt -64.38 -30.04 71.09 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 120.846 -1.385 . . . . 2.17 112.154 174.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.27 16.6 ttmt -59.27 -18.6 38.85 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.821 1.191 . . . . 1.9 111.666 171.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -17.89 59.95 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.9 -1.125 . . . . 4.04 114.022 168.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 92.9 mmm -74.65 135.07 75.17 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 120.419 1.463 . . . . 3.04 112.901 -172.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.73 95.21 0.63 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.934 3.089 . . . . 0.46 111.737 -171.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.53 -18.95 2.24 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.55 -1.02 . . . . 0.21 110.55 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 p -66.88 155.25 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 O-C-N 121.939 -0.741 . . . . 1.69 110.817 168.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.7 -59.99 1.76 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.065 0.946 . . . . 1.79 109.776 168.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -146.25 142.1 28.02 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 114.309 1.226 . . . . 2.28 114.309 -171.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.53 139.44 48.97 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.233 1.813 . . . . 1.96 109.888 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -143.77 113.48 7.1 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.864 -0.791 . . . . 1.59 108.864 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -81.57 142.25 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.295 0.638 . . . . 2.36 110.414 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -129.79 68.8 1.43 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.582 1.553 . . . . 1.84 111.333 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.5 mt -62.09 -21.42 64.96 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 121.896 -0.503 . . . . 2.55 112.353 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.17 -20.21 16.84 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.806 0.442 . . . . 1.92 111.179 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 m -130.71 18.5 5.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.316 1.046 . . . . 1.63 110.041 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 35.23 55.85 0.81 Allowed 'General case' 0 C--N 1.345 0.382 0 C-N-CA 124.404 1.082 . . . . 3.84 111.659 -170.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.5 m -143.89 154.36 43.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.423 -1.695 . . . . 1.8 106.423 -175.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.56 146.97 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.167 -0.679 . . . . 1.74 109.167 171.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -115.96 143.87 44.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.999 1.32 . . . . 2.48 108.525 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.39 141.1 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 109.699 -0.482 . . . . 1.56 109.699 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.4 mt -100.64 122.26 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.53 1.932 . . . . 1.8 106.99 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -146.7 167.52 23.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.681 0.792 . . . . 3.06 110.337 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -100.54 113.02 65.44 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 114.786 -1.097 . . . . 2.12 110.432 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -69.26 10.24 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.246 3.297 . . . . 0.69 114.107 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.43 -50.76 8.52 Favored 'General case' 0 N--CA 1.458 -0.073 0 N-CA-C 107.436 -1.32 . . . . 1.68 107.436 173.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -92.19 -35.08 14.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.635 1.574 . . . . 3.32 111.076 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.9 m -146.4 130.25 17.17 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 117.742 2.497 . . . . 1.71 117.742 -157.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.94 -156.66 10.75 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.983 -1.247 . . . . 0.81 109.983 155.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -29.21 -51.4 0.1 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.867 2.867 . . . . 1.53 112.744 175.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.9 -55.69 9.29 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.074 0.768 . . . . 1.66 113.074 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -38.58 64.83 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 122.047 0.927 . . . . 1.55 108.726 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.5 mt -65.25 -54.0 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 114.37 -1.286 . . . . 2.05 110.894 -169.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.53 -51.86 25.4 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.101 1.319 . . . . 0.74 110.158 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -48.53 -47.78 38.87 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.916 1.286 . . . . 4.73 112.195 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.66 -42.85 63.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 118.774 -0.631 . . . . 3.53 112.479 174.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.1 mm -52.24 -45.13 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 119.544 1.065 . . . . 1.67 109.974 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -49.06 -44.38 41.78 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.31 0.576 . . . . 1.58 110.71 173.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -38.61 75.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.79 0.836 . . . . 4.48 111.799 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.42 -25.71 26.4 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 119.431 -0.318 . . . . 1.77 110.636 170.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.1 25.87 5.69 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 124.469 1.033 . . . . 0.4 111.264 169.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -145.58 164.81 30.52 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 106.748 -1.575 . . . . 3.63 106.748 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 129.12 54.99 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 103.747 -2.686 . . . . 4.29 103.747 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.62 139.14 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.106 -0.701 . . . . 1.7 109.106 171.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -93.92 164.06 2.15 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 109.212 -0.662 . . . . 2.67 109.212 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.6 mm -128.24 77.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.025 -1.102 . . . . 1.92 108.025 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -129.44 146.82 51.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.86 1.264 . . . . 4.99 108.156 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.46 -69.63 0.07 OUTLIER Glycine 0 CA--C 1.527 0.813 0 N-CA-C 107.447 -2.261 . . . . 4.69 107.447 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 116.821 -1.561 . . . . 11.98 110.776 178.552 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.4 mtt . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 118.113 -0.946 . . . . 12.66 113.492 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 tt -164.56 -49.03 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.978 1.263 . . . . 6.96 109.972 -164.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.9 p -140.32 127.48 21.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.333 -1.729 . . . . 3.32 106.333 170.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -153.11 141.56 20.73 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.278 -1.008 . . . . 4.28 108.278 -175.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -87.97 171.69 10.13 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.252 1.021 . . . . 0.91 111.677 -170.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.97 162.5 39.2 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.411 1.1 . . . . 3.6 111.685 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -84.24 143.96 29.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 130.252 3.421 . . . . 2.82 106.727 170.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 tp -130.1 151.66 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.309 -1.737 . . . . 2.0 106.309 162.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.78 129.12 24.03 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.461 1.104 . . . . 1.56 108.981 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.69 173.58 16.75 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 119.384 -0.341 . . . . 1.95 111.87 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.64 155.91 18.5 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 109.077 -0.712 . . . . 2.12 109.077 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.01 157.35 16.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 N-CA-C 108.124 -1.065 . . . . 1.78 108.124 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t -129.07 126.08 38.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.31 -0.996 . . . . 1.83 108.31 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.1 -18.05 12.48 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.088 1.328 . . . . 1.43 113.205 174.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.82 146.63 10.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.161 0.984 . . . . 4.29 112.384 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.7 p -125.03 29.78 6.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.747 1.219 . . . . 3.93 110.769 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.6 t 49.89 -137.63 1.04 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.477 -1.249 . . . . 4.49 111.535 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 37.31 55.13 1.36 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.658 1.572 . . . . 2.69 113.051 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.38 20.35 4.65 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.2 1.4 . . . . 2.16 114.062 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.6 m -73.67 -60.21 2.36 Favored 'General case' 0 CA--C 1.521 -0.166 0 O-C-N 121.292 -0.88 . . . . 2.77 109.81 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.33 -30.89 67.06 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 121.344 0.592 . . . . 1.86 111.856 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.28 -42.87 64.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 122.014 -0.429 . . . . 1.78 111.023 170.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.7 mtp-105 -63.14 -45.66 90.91 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.583 0.629 . . . . 6.27 110.58 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -49.64 -59.63 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 108.192 -1.04 . . . . 1.85 108.192 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.94 -35.53 72.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.72 -0.673 . . . . 2.61 110.665 -171.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -56.2 -36.1 68.03 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 120.894 -1.129 . . . . 2.2 111.155 171.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.52 -47.34 57.43 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.658 -0.977 . . . . 0.33 110.658 167.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.68 -28.73 67.94 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.384 -1.068 . . . . 1.56 112.747 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -58.49 -17.71 23.22 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.403 1.002 . . . . 2.81 111.398 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -91.42 6.27 46.12 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.97 1.1 . . . . 4.13 113.97 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 34.4 mmt -85.57 135.28 38.56 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 120.499 1.5 . . . . 3.42 112.45 171.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.03 84.11 1.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.666 2.911 . . . . 0.78 112.301 -168.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.01 -16.43 0.91 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.486 1.041 . . . . 0.34 111.832 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.22 154.23 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.647 -0.914 . . . . 1.64 111.501 168.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.69 -61.32 1.76 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.787 1.235 . . . . 1.7 108.926 169.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -149.77 149.53 30.68 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 114.329 1.233 . . . . 2.56 114.329 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.65 119.91 25.57 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.025 1.73 . . . . 1.71 109.334 -170.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -134.28 111.72 10.46 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.151 0.98 . . . . 1.69 108.431 -172.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -84.28 139.02 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 123.072 0.549 . . . . 2.09 110.824 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -125.74 64.6 1.19 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.839 2.056 . . . . 1.74 110.636 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.8 mt -65.9 -16.96 64.32 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 112.67 0.618 . . . . 1.77 112.67 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.1 -22.77 11.78 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.69 0.396 . . . . 1.67 110.712 168.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.4 m -127.14 17.78 7.15 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.268 1.427 . . . . 1.73 110.163 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 47.66 35.8 4.88 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.138 0.975 . . . . 2.42 112.374 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.7 m -131.79 153.29 50.26 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.434 -1.321 . . . . 1.58 107.434 -169.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.95 146.48 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.013 -0.736 . . . . 1.85 109.013 173.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -115.91 137.44 52.1 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.687 -1.227 . . . . 2.49 107.687 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.95 140.69 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 108.683 -0.858 . . . . 1.6 108.683 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.6 mt -105.2 132.07 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.814 1.645 . . . . 2.28 106.836 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -152.59 163.93 38.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.62 0.768 . . . . 3.23 110.774 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -92.82 110.57 46.43 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 124.158 0.983 . . . . 1.45 109.517 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.6 15.56 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.638 2.892 . . . . 0.71 113.501 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.8 -52.72 5.84 Favored 'General case' 0 CA--C 1.526 0.049 0 N-CA-C 107.57 -1.27 . . . . 1.74 107.57 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -88.96 -45.75 9.43 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.538 1.535 . . . . 2.97 110.406 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.6 m -131.59 129.24 40.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 116.886 2.18 . . . . 1.4 116.886 -158.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.83 -162.6 16.2 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 110.181 -1.168 . . . . 0.68 110.181 159.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.9 t -35.93 -41.67 0.24 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.523 2.729 . . . . 1.62 112.732 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.19 -56.22 9.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.305 0.642 . . . . 1.58 112.46 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.22 -39.03 65.83 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 122.201 1.001 . . . . 1.66 108.99 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.45 -56.66 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.275 -1.33 . . . . 1.94 109.872 -171.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.84 -54.21 8.46 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.557 1.071 . . . . 0.84 110.428 174.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 1.4 tm-20 -44.59 -52.1 8.4 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.628 0.728 . . . . 2.19 111.547 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -45.06 64.18 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 117.958 -1.02 . . . . 2.96 110.735 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.3 mm -51.29 -46.89 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 120.024 1.284 . . . . 1.82 110.173 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -52.0 -47.06 65.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.492 0.717 . . . . 1.8 109.753 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.401 ' NZ ' ' OE2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -68.99 -37.61 78.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.275 0.63 . . . . 5.58 111.522 -176.387 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -55.97 -22.38 26.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.068 0.947 . . . . 2.07 110.665 170.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.41 29.79 6.52 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 124.289 0.947 . . . . 0.35 110.868 173.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -141.4 174.22 10.75 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 108.619 -0.882 . . . . 2.9 108.619 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.13 117.54 18.43 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.815 -1.179 . . . . 5.81 107.815 -175.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 p -84.2 145.29 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.247 -0.888 . . . . 1.82 108.731 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.78 112.37 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 124.649 1.18 . . . . 2.3 110.237 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.8 mt -120.34 96.4 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 126.481 1.913 . . . . 2.82 106.698 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -112.92 117.0 30.88 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.467 -1.308 . . . . 5.13 107.467 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.72 -145.29 16.81 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.22 0.914 . . . . 5.33 110.949 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.168 0 CA-C-O 116.072 -1.918 . . . . 9.75 106.188 172.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mtt . . . . . 0 N--CA 1.474 0.775 0 CA-C-O 118.655 -0.688 . . . . 9.71 109.659 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 tp -108.58 -79.55 0.58 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.461 -0.94 . . . . 7.51 108.461 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 p -166.19 153.04 9.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 105.427 -2.064 . . . . 3.6 105.427 171.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -170.2 139.0 1.7 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.195 -2.15 . . . . 3.98 105.195 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -117.95 160.88 20.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.33 0.652 . . . . 0.83 109.897 -171.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -146.24 157.66 43.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.573 0.701 . . . . 3.54 111.367 -173.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -83.89 144.82 28.96 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 125.469 1.508 . . . . 2.49 108.318 167.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 tp -122.13 153.31 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.056 -1.831 . . . . 2.08 106.056 160.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.0 126.17 19.89 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.998 1.319 . . . . 1.67 107.85 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.26 165.9 35.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.453 0.701 . . . . 2.57 112.16 -174.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.66 147.58 23.75 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.608 1.163 . . . . 1.76 109.044 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -115.63 164.11 12.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 123.438 0.695 . . . . 1.39 109.776 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -128.27 130.83 48.48 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.538 0.735 . . . . 1.54 109.36 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.24 -16.57 24.74 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.538 1.066 . . . . 1.49 113.164 173.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.55 150.89 14.54 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.097 0.948 . . . . 3.73 111.724 176.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.8 p -130.0 33.63 4.36 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.761 0.791 . . . . 3.76 110.556 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.5 t 58.47 -130.57 1.29 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 117.776 -1.107 . . . . 4.45 110.05 -172.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 29.21 59.16 0.15 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.286 1.834 . . . . 2.76 114.441 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.58 24.09 2.93 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.32 1.448 . . . . 2.11 114.19 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.9 m -73.51 -61.81 1.7 Allowed 'General case' 0 CA--C 1.521 -0.137 0 O-C-N 121.311 -0.868 . . . . 2.6 110.009 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.05 -28.16 69.9 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 121.586 0.708 . . . . 1.9 111.608 -175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.03 -44.08 41.18 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.09 -0.504 . . . . 1.56 111.046 169.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 mtm105 -65.06 -41.45 95.09 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 118.258 0.481 . . . . 8.37 111.175 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.0 mt -51.72 -59.13 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.127 -1.064 . . . . 1.7 108.127 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.94 -36.77 72.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 120.046 -0.662 . . . . 2.28 111.147 -171.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -50.99 -40.33 57.78 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.318 -0.864 . . . . 2.57 110.558 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.79 -48.09 57.55 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.127 -0.789 . . . . 0.38 111.127 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.9 mt -67.93 -32.4 72.83 Favored 'General case' 0 CA--C 1.519 -0.25 0 O-C-N 121.244 -1.15 . . . . 1.67 112.693 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -59.54 -17.1 29.45 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.949 0.795 . . . . 2.76 110.63 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 mtt-85 -91.86 -0.05 57.5 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.747 -1.221 . . . . 4.22 113.622 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mmt -78.67 142.68 61.79 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 120.804 1.638 . . . . 2.98 111.959 174.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.92 102.92 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.942 2.428 . . . . 0.42 110.381 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.11 -4.34 6.37 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.326 1.441 . . . . 0.36 110.941 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.88 157.21 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.848 -0.795 . . . . 1.55 110.658 164.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.91 -63.91 1.38 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 107.623 -1.251 . . . . 1.49 107.623 165.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -141.85 157.35 45.1 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 112.004 0.372 . . . . 2.84 112.004 -170.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.46 137.07 40.02 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.26 1.824 . . . . 1.7 107.414 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -139.55 114.89 9.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.902 1.281 . . . . 1.42 108.63 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -83.93 138.2 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.96 0.904 . . . . 1.72 110.339 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -132.88 63.71 1.63 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.607 1.563 . . . . 1.66 111.376 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.1 mt -67.42 -15.56 63.74 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 113.062 0.764 . . . . 1.95 113.062 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.66 -25.63 18.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 117.947 0.34 . . . . 1.8 110.529 166.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.5 m -122.65 17.33 10.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.303 1.441 . . . . 1.44 110.216 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 47.2 38.32 6.74 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.361 0.982 . . . . 2.74 111.836 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.1 m -137.34 154.43 50.05 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.432 -1.322 . . . . 1.64 107.432 -171.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.52 152.58 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.238 -1.023 . . . . 1.64 108.238 170.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.44 150.63 48.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 123.58 0.55 . . . . 2.74 109.701 174.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.19 138.07 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.398 -0.964 . . . . 1.54 108.398 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.43 119.99 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 126.05 1.74 . . . . 2.53 108.166 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -145.84 172.79 12.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.635 1.174 . . . . 3.28 110.631 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -111.87 118.94 45.59 Favored Pre-proline 0 N--CA 1.447 -0.609 0 C-N-CA 124.186 0.994 . . . . 1.4 110.815 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.27 9.73 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.91 3.74 . . . . 0.64 114.248 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.21 -40.48 37.36 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 108.437 -0.949 . . . . 1.72 108.437 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -112.09 -49.54 2.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.716 1.606 . . . . 3.04 110.25 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.6 m -111.04 128.33 55.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.593 2.757 . . . . 1.51 117.145 -168.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.21 -175.48 25.48 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.952 -0.859 . . . . 0.84 110.952 156.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -29.17 -45.2 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 128.302 2.641 . . . . 1.55 112.958 167.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.23 -55.11 13.64 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.756 0.65 . . . . 1.48 112.756 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.23 -40.06 65.0 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 122.256 1.026 . . . . 1.57 108.91 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.27 -57.12 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-N 113.918 -1.492 . . . . 1.81 110.241 -171.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.45 -51.09 28.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.621 1.1 . . . . 0.78 110.595 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -48.51 -50.19 32.9 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.737 0.815 . . . . 2.51 111.287 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -46.15 64.96 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 118.638 -0.696 . . . . 3.29 110.888 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.7 mm -49.79 -47.61 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 119.069 0.85 . . . . 1.57 109.875 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -48.3 -50.4 30.2 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.449 0.642 . . . . 1.48 110.03 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.03 -33.22 70.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 121.671 -0.643 . . . . 4.41 112.278 -176.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.83 -25.22 10.83 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 119.337 -0.364 . . . . 2.16 110.285 168.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.84 30.58 4.5 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.527 1.06 . . . . 0.31 110.675 170.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -148.4 165.75 30.17 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 105.61 -1.996 . . . . 2.89 105.61 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -120.63 140.38 51.64 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 119.1 0.864 . . . . 4.59 109.113 166.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.6 p -94.94 141.37 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.803 1.641 . . . . 1.65 108.581 172.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 m -97.34 165.64 2.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 108.891 -0.781 . . . . 2.76 108.891 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.7 mm -128.42 77.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.353 -0.98 . . . . 2.0 108.353 175.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -111.06 129.63 55.85 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 105.401 -2.074 . . . . 4.3 105.401 156.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.14 -125.85 1.15 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 108.994 -1.642 . . . . 4.0 108.994 -171.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 . . . . . 0 C--O 1.249 1.042 0 N-CA-C 105.036 -2.209 . . . . 10.98 105.036 175.606 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 117.995 -1.002 . . . . 12.68 108.497 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 mt 168.37 163.84 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 129.24 3.016 . . . . 7.05 105.175 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.5 m 63.65 92.2 0.07 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.673 1.189 . . . . 3.99 111.363 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -142.5 150.83 41.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.707 -1.22 . . . . 2.92 107.707 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -95.61 175.23 6.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.536 1.134 . . . . 1.23 111.068 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -150.47 164.29 36.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.386 0.612 . . . . 3.94 111.095 172.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -83.47 144.94 29.22 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.94 -1.482 . . . . 2.43 108.019 163.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -124.05 148.85 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 105.145 -2.169 . . . . 2.29 105.145 162.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.53 120.45 15.46 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 125.302 1.441 . . . . 1.72 108.097 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.1 ptt? -156.7 165.14 37.08 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.202 0.455 . . . . 1.62 111.117 -169.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.84 151.96 19.16 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.859 0.864 . . . . 1.76 109.239 -171.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.36 164.59 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 123.519 0.728 . . . . 1.68 109.582 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -124.88 124.02 41.17 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.866 1.266 . . . . 1.47 109.05 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.66 -16.53 14.02 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.724 1.154 . . . . 1.43 113.466 170.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.14 143.15 28.28 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.145 0.973 . . . . 3.87 111.916 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.0 p -114.0 21.88 14.43 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.804 0.842 . . . . 3.98 111.324 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.3 t 71.2 -49.13 0.68 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.561 1.545 . . . . 4.78 112.794 -175.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.83 81.32 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.979 1.712 . . . . 2.83 112.42 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.67 11.43 3.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.995 2.118 . . . . 1.81 113.89 171.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.65 -64.11 0.99 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.542 -0.724 . . . . 1.94 110.832 -164.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.3 -28.8 69.46 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.019 -0.537 . . . . 2.25 110.35 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.14 -54.36 47.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 119.117 -0.468 . . . . 1.69 111.18 173.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -63.42 -46.24 87.27 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.22 0.918 . . . . 4.26 110.455 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.8 mt -48.47 -58.53 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.172 -0.677 . . . . 2.0 109.172 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -37.37 73.87 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.206 -0.452 . . . . 3.81 110.579 -172.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -55.7 -33.92 64.61 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 120.727 -1.233 . . . . 2.15 111.404 174.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.45 -48.91 53.83 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 111.301 -0.719 . . . . 0.38 111.301 166.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.38 -32.75 74.5 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 118.247 1.023 . . . . 1.56 113.202 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.26 8.9 ttmt -56.15 -17.73 8.04 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.105 0.866 . . . . 1.92 111.575 170.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 8.73 44.05 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.506 1.299 . . . . 5.93 114.506 172.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mtp -85.43 140.58 36.27 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 121.085 1.766 . . . . 3.01 110.971 167.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.6 106.28 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.701 2.934 . . . . 0.49 111.206 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.44 -18.95 3.63 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.48 -1.048 . . . . 0.34 110.48 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.42 152.22 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.595 0.758 . . . . 1.53 110.87 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -58.29 2.16 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.679 1.192 . . . . 1.89 109.516 171.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -145.25 150.48 36.76 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 113.01 0.745 . . . . 2.7 113.01 -175.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.65 148.45 25.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.907 2.083 . . . . 2.46 109.408 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.38 90.23 1.32 Allowed 'General case' 0 CA--C 1.527 0.074 0 CA-C-O 121.965 0.888 . . . . 2.3 110.176 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.24 135.5 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.744 0.818 . . . . 1.82 110.445 -173.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -136.74 65.96 1.49 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.0 1.32 . . . . 1.75 111.305 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.93 -18.69 65.44 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 115.917 -0.583 . . . . 2.38 112.512 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.58 -27.85 58.92 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.242 0.474 . . . . 2.03 110.668 169.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 m -115.94 18.23 15.64 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.347 1.459 . . . . 2.07 110.109 177.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 48.6 35.56 6.31 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.515 1.126 . . . . 2.07 112.066 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -143.04 151.97 41.38 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.053 -1.091 . . . . 1.64 108.053 -165.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.18 148.95 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 109.416 -0.587 . . . . 1.68 109.416 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.18 126.38 46.88 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.036 1.334 . . . . 2.49 108.148 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.35 138.66 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.938 -0.764 . . . . 1.52 108.938 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.4 mt -99.85 126.9 53.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 107.818 -1.179 . . . . 2.42 107.818 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -150.3 170.15 19.69 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.914 0.486 . . . . 3.29 111.096 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -108.49 116.22 56.65 Favored Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 124.34 1.056 . . . . 1.34 111.13 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -67.58 5.12 1.06 Allowed 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.916 3.077 . . . . 0.58 113.875 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.32 -46.9 25.55 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 107.971 -1.122 . . . . 1.58 107.971 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -95.41 -33.21 12.57 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.161 1.384 . . . . 3.46 111.027 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.7 m -155.82 129.97 8.76 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 119.447 3.129 . . . . 1.48 119.447 -152.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.78 -163.14 12.59 Favored Glycine 0 N--CA 1.438 -1.217 0 N-CA-C 108.78 -1.728 . . . . 0.69 108.78 154.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 t -34.04 -40.21 0.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.976 2.91 . . . . 1.56 113.332 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.83 -56.23 7.93 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.081 0.855 . . . . 1.75 113.083 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.83 -34.48 66.84 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 123.022 1.392 . . . . 1.51 109.261 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.252 0.9 OUTLIER -70.03 -51.44 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 CA-C-N 113.506 -1.679 . . . . 1.65 111.007 -170.5 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -49.66 55.24 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.982 1.719 . . . . 0.83 110.348 173.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -42.88 -58.37 2.41 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 121.775 0.798 . . . . 2.33 111.971 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.29 -40.93 73.99 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 119.889 -0.724 . . . . 3.21 110.974 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.1 mm -52.59 -46.0 48.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.315 1.046 . . . . 1.75 110.283 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -51.38 -47.39 62.87 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.52 -0.548 . . . . 1.87 109.52 174.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -70.09 -34.44 73.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 121.416 -0.802 . . . . 4.48 112.789 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.96 -22.0 13.68 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.066 0.394 . . . . 2.12 110.751 167.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.91 24.5 8.55 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 124.778 1.18 . . . . 0.4 110.739 173.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -140.95 167.72 21.51 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.59 -0.893 . . . . 2.99 108.59 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.95 122.44 40.17 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 103.84 -2.652 . . . . 4.73 103.84 -175.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.1 p -100.43 141.39 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 109.663 -0.495 . . . . 1.78 109.663 170.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.4 m -98.79 161.65 3.0 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 109.199 -0.667 . . . . 2.58 109.199 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.1 mm -128.24 77.56 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 107.455 -1.313 . . . . 2.1 107.455 176.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -120.07 118.39 30.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.615 -1.624 . . . . 4.18 106.615 174.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.49 141.56 2.82 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.741 1.162 . . . . 4.85 111.051 -171.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.122 0 C-N-CA 127.17 2.188 . . . . 8.88 106.056 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 106.606 -1.627 . . . . 12.33 106.606 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.5 174.0 11.79 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.946 0.794 . . . . 8.01 109.149 171.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -55.57 147.34 18.24 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.852 0.461 . . . . 3.21 110.667 174.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -139.94 160.41 39.98 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.602 -1.629 . . . . 3.25 106.602 170.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -112.98 169.74 8.7 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.851 1.26 . . . . 0.6 109.452 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -145.83 157.0 43.94 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.686 0.755 . . . . 3.49 111.077 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.68 145.73 31.46 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.452 1.901 . . . . 2.3 108.054 165.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 tp -127.84 157.11 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.138 -1.801 . . . . 1.97 106.138 165.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.05 121.33 9.57 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.884 0.874 . . . . 1.49 108.952 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -156.74 167.85 29.22 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.264 0.484 . . . . 1.75 111.396 -174.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.59 156.98 16.75 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.807 0.843 . . . . 1.81 111.156 -172.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.79 132.66 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 C-N-CA 123.468 0.707 . . . . 1.77 110.517 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -84.44 124.19 31.06 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.91 -0.774 . . . . 1.85 108.91 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.07 -76.2 0.41 Allowed Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.822 -1.311 . . . . 2.81 109.822 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 8.2 tmm? 38.71 70.09 0.23 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.819 1.648 . . . . 5.28 112.703 173.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 p -81.68 18.25 1.28 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.509 1.123 . . . . 4.65 111.364 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.3 t 54.86 -138.98 1.04 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.422 1.489 . . . . 4.17 111.719 175.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 56.07 -83.13 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.472 1.909 . . . . 3.09 112.149 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.19 16.61 0.74 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.956 1.302 . . . . 2.63 110.969 176.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.5 m -72.65 -60.56 2.17 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.478 -0.764 . . . . 2.03 110.039 -166.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.24 -40.25 67.55 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.643 0.735 . . . . 1.76 111.364 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.93 -53.0 62.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.841 -0.618 . . . . 1.68 110.875 173.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -56.8 -49.36 75.59 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 118.926 -0.559 . . . . 6.04 111.705 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -48.33 -59.29 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 108.252 -1.018 . . . . 1.95 108.252 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -70.06 -35.57 74.33 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.864 -0.734 . . . . 2.55 110.39 -171.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp -61.02 -27.35 68.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.908 -1.12 . . . . 2.06 111.44 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.19 -52.56 48.65 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.248 -1.141 . . . . 0.49 110.248 162.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.43 -31.8 73.06 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 113.673 0.99 . . . . 1.75 113.673 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -51.1 -19.23 1.04 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.98 0.912 . . . . 2.82 111.705 169.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -91.25 -7.23 51.78 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.372 0.878 . . . . 4.62 113.372 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.3 mtp -76.07 139.6 69.22 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 120.212 1.369 . . . . 3.26 112.43 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.81 88.99 0.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.603 2.869 . . . . 0.46 111.363 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.68 -15.36 2.0 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.745 1.164 . . . . 0.3 111.125 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.3 p -65.46 154.51 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 O-C-N 121.422 -1.046 . . . . 1.56 110.934 169.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.24 -63.93 1.38 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.564 1.146 . . . . 1.67 108.084 167.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -150.55 137.39 19.12 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 112.368 0.507 . . . . 3.18 112.368 -168.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.16 150.66 23.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.806 1.642 . . . . 1.81 109.664 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.74 105.66 3.45 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.654 1.182 . . . . 1.92 108.684 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.37 137.79 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.212 0.605 . . . . 1.77 110.698 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -131.76 66.57 1.54 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.701 1.601 . . . . 1.71 111.083 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.1 mt -67.0 -19.09 65.66 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 115.918 -0.583 . . . . 2.1 112.17 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.76 -11.66 8.29 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.629 0.772 . . . . 1.8 111.665 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 m -135.31 17.82 3.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.37 1.068 . . . . 1.63 109.525 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 44.85 39.53 3.64 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.058 1.343 . . . . 3.31 111.957 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.1 m -134.37 155.28 50.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.542 -1.281 . . . . 1.54 107.542 -170.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 p -131.96 143.13 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 109.136 -0.69 . . . . 1.65 109.136 172.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.36 141.68 43.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.651 1.58 . . . . 2.65 106.836 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.44 144.19 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 108.501 -0.926 . . . . 1.63 108.501 171.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.7 mt -112.13 121.21 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 125.996 1.718 . . . . 1.94 107.069 -174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -144.39 166.1 26.05 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.892 0.877 . . . . 3.39 110.818 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -95.38 109.71 46.7 Favored Pre-proline 0 N--CA 1.445 -0.701 0 C-N-CA 124.727 1.211 . . . . 1.45 109.564 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -71.18 12.89 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.688 2.925 . . . . 0.75 113.659 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.75 -48.47 10.08 Favored 'General case' 0 C--N 1.337 0.025 0 N-CA-C 107.647 -1.242 . . . . 1.71 107.647 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -89.5 -40.33 12.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.886 1.275 . . . . 2.62 111.026 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.1 m -143.79 126.85 16.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 117.5 2.407 . . . . 1.74 117.5 -152.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.72 -159.55 10.23 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 109.207 -1.557 . . . . 0.77 109.207 156.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.4 t -33.71 -42.93 0.12 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.248 2.619 . . . . 1.47 113.134 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.49 -56.25 8.79 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.977 0.808 . . . . 1.55 112.683 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.76 -35.89 62.58 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 122.113 0.959 . . . . 1.49 109.369 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.254 0.8 OUTLIER -64.93 -55.52 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 114.358 -1.292 . . . . 1.74 110.245 -174.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -49.88 45.83 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 120.553 1.524 . . . . 0.84 111.315 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -38.82 -57.35 1.23 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.051 0.929 . . . . 2.72 112.902 171.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -71.77 -41.53 68.25 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.606 -0.725 . . . . 3.14 109.827 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.8 mm -55.13 -45.09 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 119.413 1.006 . . . . 1.75 110.436 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -52.35 -54.18 34.99 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.547 1.139 . . . . 1.64 109.241 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -45.94 85.15 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.479 0.548 . . . . 5.06 112.479 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mp -55.07 -19.32 6.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.815 1.646 . . . . 3.6 111.789 172.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.72 24.91 7.9 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.343 0.973 . . . . 0.44 111.346 169.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -139.22 175.44 9.56 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 108.879 -0.786 . . . . 3.67 108.879 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 123.05 27.51 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.51 -1.663 . . . . 5.62 106.51 175.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -87.96 145.42 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.19 -0.67 . . . . 1.92 109.19 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.33 166.95 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.904 -0.776 . . . . 2.34 108.904 168.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.1 mm -127.03 89.1 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 107.442 -1.318 . . . . 2.11 107.442 168.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -147.39 88.89 1.74 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.341 -1.726 . . . . 4.2 106.341 176.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.77 50.58 0.04 OUTLIER Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.612 -0.595 . . . . 5.61 111.612 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 . . . . . 0 C--O 1.251 1.168 0 CA-C-O 117.904 -1.046 . . . . 10.97 109.728 -169.633 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtm . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 105.893 -1.892 . . . . 10.83 105.893 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 mp -95.72 118.27 32.07 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 120.115 1.325 . . . . 7.88 109.041 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.5 t -145.27 152.67 40.3 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 104.476 -2.416 . . . . 4.59 104.476 161.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -157.4 147.58 20.81 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.114 -1.439 . . . . 4.09 107.114 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -84.1 162.45 20.29 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 123.541 0.526 . . . . 1.0 110.609 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -150.54 156.64 41.79 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.372 0.606 . . . . 3.67 110.093 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -84.07 114.15 21.55 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.867 2.067 . . . . 2.3 106.683 169.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -96.96 155.37 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 106.416 -1.698 . . . . 2.12 106.416 167.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.93 137.69 34.99 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.855 -0.794 . . . . 1.61 108.855 170.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.18 169.25 25.2 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.638 0.586 . . . . 1.77 111.995 175.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.56 153.46 19.74 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.498 1.119 . . . . 1.91 110.723 -175.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.85 134.99 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 123.098 0.559 . . . . 1.84 111.656 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.3 t -92.06 130.96 37.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.112 0.965 . . . . 1.55 109.293 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.77 -13.22 24.82 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.324 0.964 . . . . 1.45 113.336 172.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -48.77 114.47 0.99 Allowed 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.225 1.01 . . . . 5.5 110.65 172.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -139.98 24.8 2.35 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.797 0.839 . . . . 4.8 110.676 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.4 m -138.98 -154.25 0.51 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.124 1.37 . . . . 7.61 108.087 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.65 -3.1 14.37 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.982 0.913 . . . . 5.6 112.281 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.79 38.47 0.42 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.873 0.761 . . . . 2.85 111.827 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -71.58 -61.99 1.58 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.152 0.581 . . . . 1.91 109.549 172.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.82 -36.49 48.16 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 123.473 0.709 . . . . 2.52 111.3 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.02 -54.16 22.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.009 0.523 . . . . 1.79 111.598 173.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -69.9 -45.86 66.69 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.488 0.715 . . . . 5.5 110.099 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -50.75 -54.14 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.367 -0.605 . . . . 2.11 109.367 177.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -69.62 -42.92 73.69 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.505 -0.554 . . . . 3.79 109.505 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -51.61 -36.93 47.78 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.175 -1.578 . . . . 2.72 111.809 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.28 -52.96 37.25 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 111.543 -0.623 . . . . 0.58 111.543 166.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.3 -29.46 69.89 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.1 -1.236 . . . . 1.63 113.289 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -59.9 -18.75 47.21 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.151 1.342 . . . . 2.42 111.715 172.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -16.55 57.83 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.885 1.068 . . . . 5.36 113.885 169.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 83.8 mmm -72.12 135.79 82.3 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 120.031 1.287 . . . . 3.04 111.431 -174.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.58 101.32 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.042 2.494 . . . . 0.4 110.711 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.31 -15.12 3.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 119.459 1.027 . . . . 0.25 110.809 176.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.17 153.31 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 O-C-N 122.312 -0.523 . . . . 1.66 109.941 166.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.65 -61.04 1.76 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.126 -1.064 . . . . 1.6 108.126 162.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -141.42 145.98 35.98 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 113.527 0.936 . . . . 3.39 113.527 -168.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.64 150.9 26.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.758 1.623 . . . . 2.06 108.551 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.86 101.54 2.91 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.77 0.828 . . . . 1.96 108.785 175.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.95 141.54 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.828 0.851 . . . . 2.14 110.997 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -139.11 66.04 1.43 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.137 1.375 . . . . 1.75 111.429 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.2 mt -67.04 -13.82 62.29 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 113.342 0.867 . . . . 2.26 113.342 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.36 -25.52 9.98 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.578 0.351 . . . . 1.86 110.886 165.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.8 m -125.17 17.92 8.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.343 1.457 . . . . 1.6 110.157 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 48.18 33.39 3.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.414 1.086 . . . . 2.48 112.156 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -131.66 149.24 52.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.29 -1.004 . . . . 1.57 108.29 -168.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -134.02 144.45 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 109.399 -0.593 . . . . 1.66 109.399 174.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -112.11 145.08 40.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.052 1.741 . . . . 2.38 108.096 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.52 136.44 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.011 -0.737 . . . . 1.61 109.011 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.36 119.17 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.694 1.597 . . . . 2.31 107.535 178.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -144.49 167.81 21.61 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.009 0.923 . . . . 3.11 110.712 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -108.26 122.88 39.16 Favored Pre-proline 0 N--CA 1.451 -0.416 0 O-C-N 124.211 0.944 . . . . 1.47 110.888 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.79 5.05 1.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.931 3.088 . . . . 0.7 113.544 -177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.74 -55.28 6.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.419 -1.326 . . . . 1.47 107.419 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -84.04 -42.57 16.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.526 1.13 . . . . 3.68 110.54 172.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.8 m -143.27 131.6 22.11 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 119.175 3.028 . . . . 1.38 119.175 -143.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.06 -159.55 18.67 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.13 -1.188 . . . . 0.74 110.13 159.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -30.66 -47.63 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.839 2.855 . . . . 1.67 112.845 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.86 -56.27 7.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.396 0.678 . . . . 1.37 112.488 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.65 -38.49 64.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.197 0.999 . . . . 1.48 109.393 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mt -64.75 -55.36 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.465 -1.243 . . . . 1.87 110.377 -170.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.98 -50.02 59.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.923 1.238 . . . . 0.77 110.695 177.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -43.7 -56.14 3.96 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.712 0.805 . . . . 2.13 112.023 175.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -41.48 72.57 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.559 -0.856 . . . . 2.66 110.586 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.6 mm -52.42 -46.05 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 119.489 1.04 . . . . 1.71 110.019 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -50.82 -46.69 59.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.041 0.448 . . . . 1.86 110.098 174.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -32.89 70.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 114.015 1.117 . . . . 3.8 114.015 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.65 -21.23 25.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.548 0.613 . . . . 1.84 110.571 166.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.93 27.3 8.4 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.768 -0.933 . . . . 0.33 110.768 173.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -140.39 173.67 11.28 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.181 -1.044 . . . . 2.92 108.181 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 122.88 31.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.702 -1.592 . . . . 5.49 106.702 176.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 p -89.92 145.78 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.906 -0.776 . . . . 1.83 108.906 171.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.81 164.16 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.289 -0.634 . . . . 1.93 109.289 170.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.4 mm -123.17 104.16 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.023 -1.843 . . . . 1.74 106.023 165.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.12 71.16 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.047 1.339 . . . . 7.99 112.614 173.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.37 -58.53 0.2 Allowed Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.22 -0.925 . . . . 6.2 113.856 169.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.0 ttp85 . . . . . 0 C--O 1.251 1.177 0 CA-C-O 117.249 -1.358 . . . . 13.97 108.531 -168.097 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtm . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 105.893 -1.892 . . . . 10.83 105.893 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 mp -95.72 118.27 32.07 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 120.115 1.325 . . . . 7.88 109.041 174.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.5 t -145.27 152.67 40.3 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 104.476 -2.416 . . . . 4.59 104.476 161.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -157.4 147.58 20.81 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.114 -1.439 . . . . 4.09 107.114 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -84.1 162.45 20.29 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 123.541 0.526 . . . . 1.0 110.609 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -150.54 156.64 41.79 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.372 0.606 . . . . 3.67 110.093 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -84.07 114.15 21.55 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.867 2.067 . . . . 2.3 106.683 169.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -96.96 155.37 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 106.416 -1.698 . . . . 2.12 106.416 167.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.93 137.69 34.99 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.855 -0.794 . . . . 1.61 108.855 170.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.18 169.25 25.2 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.638 0.586 . . . . 1.77 111.995 175.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.56 153.46 19.74 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.498 1.119 . . . . 1.91 110.723 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.85 134.99 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 123.098 0.559 . . . . 1.84 111.656 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.3 t -92.06 130.96 37.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.112 0.965 . . . . 1.55 109.293 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.77 -13.22 24.82 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.324 0.964 . . . . 1.45 113.336 172.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -48.77 114.47 0.99 Allowed 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.225 1.01 . . . . 5.5 110.65 172.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -139.98 24.8 2.35 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.797 0.839 . . . . 4.8 110.676 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.4 m -138.98 -154.25 0.51 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.124 1.37 . . . . 7.61 108.087 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.65 -3.1 14.37 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.982 0.913 . . . . 5.6 112.281 171.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.79 38.47 0.42 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.873 0.761 . . . . 2.85 111.827 -174.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -71.58 -61.99 1.58 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.152 0.581 . . . . 1.91 109.549 172.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.82 -36.49 48.16 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 123.473 0.709 . . . . 2.52 111.3 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.02 -54.16 22.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.009 0.523 . . . . 1.79 111.598 173.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -69.9 -45.86 66.69 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.488 0.715 . . . . 5.5 110.099 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -50.75 -54.14 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.367 -0.605 . . . . 2.11 109.367 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -69.62 -42.92 73.69 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.505 -0.554 . . . . 3.79 109.505 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -51.61 -36.93 47.78 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.175 -1.578 . . . . 2.72 111.809 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.28 -52.96 37.25 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 111.543 -0.623 . . . . 0.58 111.543 166.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.3 -29.46 69.89 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.1 -1.236 . . . . 1.63 113.289 174.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -59.9 -18.75 47.21 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.151 1.342 . . . . 2.42 111.715 172.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -16.55 57.83 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.885 1.068 . . . . 5.36 113.885 169.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 83.8 mmm -72.12 135.79 82.3 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 120.031 1.287 . . . . 3.04 111.431 -174.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.58 101.32 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.042 2.494 . . . . 0.4 110.711 -174.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.31 -15.12 3.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 119.459 1.027 . . . . 0.25 110.809 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.17 153.31 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 O-C-N 122.312 -0.523 . . . . 1.66 109.941 166.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.65 -61.04 1.76 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.126 -1.064 . . . . 1.6 108.126 162.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -141.42 145.98 35.98 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 113.527 0.936 . . . . 3.39 113.527 -168.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.64 150.9 26.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.758 1.623 . . . . 2.06 108.551 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.86 101.54 2.91 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.77 0.828 . . . . 1.96 108.785 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.95 141.54 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.828 0.851 . . . . 2.14 110.997 -175.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -139.11 66.04 1.43 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.137 1.375 . . . . 1.75 111.429 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.2 mt -67.04 -13.82 62.29 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 113.342 0.867 . . . . 2.26 113.342 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.36 -25.52 9.98 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.578 0.351 . . . . 1.86 110.886 165.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.8 m -125.17 17.92 8.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.343 1.457 . . . . 1.6 110.157 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 48.18 33.39 3.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.414 1.086 . . . . 2.48 112.156 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -131.66 149.24 52.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.29 -1.004 . . . . 1.57 108.29 -168.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -134.02 144.45 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 109.399 -0.593 . . . . 1.66 109.399 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -112.11 145.08 40.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.052 1.741 . . . . 2.38 108.096 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.52 136.44 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.011 -0.737 . . . . 1.61 109.011 174.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.36 119.17 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.694 1.597 . . . . 2.31 107.535 178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -144.49 167.81 21.61 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.009 0.923 . . . . 3.11 110.712 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -108.26 122.88 39.16 Favored Pre-proline 0 N--CA 1.451 -0.416 0 O-C-N 124.211 0.944 . . . . 1.47 110.888 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.79 5.05 1.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.931 3.088 . . . . 0.7 113.544 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.74 -55.28 6.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.419 -1.326 . . . . 1.47 107.419 175.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -84.04 -42.57 16.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.526 1.13 . . . . 3.68 110.54 172.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.8 m -143.27 131.6 22.11 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 119.175 3.028 . . . . 1.38 119.175 -143.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.06 -159.55 18.67 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.13 -1.188 . . . . 0.74 110.13 159.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -30.66 -47.63 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.839 2.855 . . . . 1.67 112.845 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.86 -56.27 7.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.396 0.678 . . . . 1.37 112.488 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.65 -38.49 64.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.197 0.999 . . . . 1.48 109.393 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mt -64.75 -55.36 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.465 -1.243 . . . . 1.87 110.377 -170.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.98 -50.02 59.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.923 1.238 . . . . 0.77 110.695 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -43.7 -56.14 3.96 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.712 0.805 . . . . 2.13 112.023 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -41.48 72.57 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.559 -0.856 . . . . 2.66 110.586 -178.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.6 mm -52.42 -46.05 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 119.489 1.04 . . . . 1.71 110.019 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -50.82 -46.69 59.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.041 0.448 . . . . 1.86 110.098 174.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -32.89 70.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 114.015 1.117 . . . . 3.8 114.015 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.65 -21.23 25.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.548 0.613 . . . . 1.84 110.571 166.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.93 27.3 8.4 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.768 -0.933 . . . . 0.33 110.768 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -140.39 173.67 11.28 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.181 -1.044 . . . . 2.92 108.181 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 122.88 31.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.702 -1.592 . . . . 5.49 106.702 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 p -89.92 145.78 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.906 -0.776 . . . . 1.83 108.906 171.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.81 164.16 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.289 -0.634 . . . . 1.93 109.289 170.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.4 mm -123.17 104.16 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.023 -1.843 . . . . 1.74 106.023 165.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.12 71.16 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.047 1.339 . . . . 7.99 112.614 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.37 -58.53 0.2 Allowed Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.22 -0.925 . . . . 6.2 113.856 169.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.0 ttp85 . . . . . 0 C--O 1.251 1.177 0 CA-C-O 117.249 -1.358 . . . . 13.97 108.531 -168.097 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 mtt . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 108.481 -0.933 . . . . 9.36 108.481 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 tp -66.53 174.43 2.79 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.155 -0.683 . . . . 7.28 109.155 166.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 t -139.27 163.32 32.79 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 105.946 -1.872 . . . . 3.76 105.946 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -159.55 152.37 21.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.88 -1.156 . . . . 3.42 107.88 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -88.34 174.7 8.01 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.51 -0.768 . . . . 0.94 111.289 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.32 161.55 40.07 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.998 -0.371 . . . . 4.56 109.998 172.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.41 136.29 33.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.627 -1.17 . . . . 3.39 107.935 161.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 tp -107.4 153.91 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.051 -1.833 . . . . 2.11 106.051 162.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.58 128.56 17.49 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.589 1.156 . . . . 1.5 108.44 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.78 172.33 18.81 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.506 0.594 . . . . 2.72 111.939 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.62 157.38 17.51 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.278 -0.638 . . . . 2.28 109.278 -176.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.34 132.12 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 O-C-N 123.492 0.495 . . . . 1.49 110.315 177.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 t -88.22 118.72 28.0 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.922 -1.14 . . . . 1.47 107.922 172.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.81 -83.48 0.19 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.252 1.406 . . . . 2.74 110.152 175.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 50.61 58.26 5.72 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 122.822 1.296 . . . . 6.55 110.82 173.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 m -70.26 -16.14 63.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.476 -1.238 . . . . 5.31 111.583 175.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.2 t 74.1 178.77 0.21 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.326 1.451 . . . . 3.81 110.073 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 60.3 59.26 2.35 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.681 1.128 . . . . 3.13 111.115 -174.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 65.92 15.29 10.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.457 1.503 . . . . 2.32 113.408 175.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.66 -58.88 3.09 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.606 -0.887 . . . . 2.95 108.606 -173.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.69 -28.83 61.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.756 -1.111 . . . . 2.04 111.709 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.14 -47.0 69.29 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.579 -0.724 . . . . 1.53 110.609 173.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -52.98 -44.38 67.14 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 119.347 0.976 . . . . 6.53 111.451 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.4 mt -44.66 -61.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 123.494 0.717 . . . . 1.99 109.15 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.01 -37.99 66.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.809 -0.632 . . . . 2.4 112.177 -175.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -57.5 -34.63 69.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.328 -0.858 . . . . 2.47 110.691 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.81 -49.82 64.23 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 110.781 -0.928 . . . . 0.4 110.781 167.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.41 -32.72 74.45 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 118.302 1.051 . . . . 1.81 112.311 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -57.83 -16.43 11.62 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.151 0.887 . . . . 2.4 112.094 171.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -97.85 -0.47 45.03 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.178 0.899 . . . . 4.09 112.744 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 53.7 mmm -79.99 135.56 55.03 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 119.895 1.225 . . . . 3.42 110.629 174.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.09 116.94 3.89 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.421 2.08 . . . . 0.82 109.448 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.35 -17.18 6.61 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.929 1.252 . . . . 0.4 110.146 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.7 p -75.7 158.69 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.305 0.642 . . . . 1.59 111.366 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.38 -63.05 1.4 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.581 1.152 . . . . 1.78 108.099 165.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -135.36 151.86 50.89 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 112.441 0.534 . . . . 3.11 112.441 -169.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.32 140.09 41.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.928 1.291 . . . . 1.71 107.558 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -147.63 129.98 15.7 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.201 -0.666 . . . . 1.74 109.201 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.89 134.87 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 123.98 0.912 . . . . 1.71 110.593 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -124.82 65.2 1.11 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.008 1.723 . . . . 1.68 110.201 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.97 -20.36 63.77 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 116.071 -0.513 . . . . 2.18 112.334 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.52 -24.69 21.75 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.997 0.519 . . . . 1.85 110.996 171.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.4 m -125.61 16.24 8.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.96 1.304 . . . . 1.68 109.935 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 45.93 38.39 4.5 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.339 1.056 . . . . 2.01 111.44 -175.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.4 m -131.86 153.05 50.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.11 -1.441 . . . . 1.62 107.11 -171.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 p -133.2 149.86 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.721 -1.214 . . . . 1.61 107.721 174.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.22 148.45 48.64 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 123.967 0.792 . . . . 2.9 109.565 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.3 131.26 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 121.576 0.703 . . . . 1.61 109.266 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mt -95.38 120.12 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.508 1.923 . . . . 2.32 107.361 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -149.33 170.15 19.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.455 0.702 . . . . 3.12 110.188 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -104.44 121.29 47.78 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 114.36 -1.291 . . . . 2.03 111.22 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.18 2.69 1.67 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.683 3.589 . . . . 0.62 114.203 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.92 -51.16 10.85 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 119.268 0.94 . . . . 1.48 108.864 176.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -90.7 -44.27 9.59 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.545 1.538 . . . . 3.04 109.633 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.2 m -127.07 121.83 32.62 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 116.865 2.172 . . . . 1.46 116.865 -157.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.09 169.63 27.41 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 106.223 -2.751 . . . . 1.46 106.223 173.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.304 0.0 OUTLIER -39.52 -40.05 0.8 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.324 1.849 . . . . 2.07 113.248 177.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -38.3 -59.76 0.85 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.331 1.052 . . . . 1.94 113.245 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.51 -35.61 65.64 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 122.012 0.911 . . . . 1.59 109.246 -173.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.75 -60.09 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-N 114.189 -1.368 . . . . 2.57 108.237 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.72 -51.88 26.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.162 0.892 . . . . 1.13 110.436 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.68 -51.31 12.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.929 0.892 . . . . 2.38 112.01 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -46.01 65.31 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.911 -0.716 . . . . 2.83 110.938 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.3 mm -52.41 -44.53 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 118.94 0.791 . . . . 2.3 110.73 -175.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -48.85 -51.3 30.43 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.327 0.585 . . . . 1.59 109.939 173.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -73.31 -28.75 62.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.602 0.761 . . . . 5.18 112.85 -175.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.46 -25.45 25.29 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.155 0.434 . . . . 2.21 110.254 165.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.02 29.93 5.61 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 124.891 1.234 . . . . 0.57 110.566 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -144.12 169.26 18.19 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 108.198 -1.038 . . . . 3.46 108.198 -176.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.95 120.47 30.44 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.103 -1.073 . . . . 5.67 108.103 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.8 p -87.49 149.64 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.835 -0.432 . . . . 1.72 109.835 172.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.48 109.06 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.181 0.992 . . . . 2.11 110.217 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.6 mt -112.53 79.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 124.67 1.188 . . . . 3.13 108.299 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -127.75 150.67 49.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.748 -1.945 . . . . 7.37 105.748 172.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.44 -49.57 0.14 Allowed Glycine 0 CA--C 1.524 0.618 0 CA-C-N 119.226 0.921 . . . . 4.66 112.884 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.315 0 CA-C-O 115.794 -2.05 . . . . 8.43 106.312 163.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 109.103 -0.703 . . . . 11.47 109.103 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 39.5 tp -166.63 120.1 1.05 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.697 -1.594 . . . . 6.78 106.697 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 p -85.43 149.07 25.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.159 -1.052 . . . . 4.08 108.159 169.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -145.55 140.0 27.13 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 104.583 -2.377 . . . . 2.92 104.583 168.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -109.96 169.69 8.56 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.702 0.801 . . . . 0.69 109.846 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -147.98 162.1 40.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.248 1.023 . . . . 4.0 111.395 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.16 146.93 30.28 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 112.647 -2.069 . . . . 3.34 107.807 164.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -132.25 158.06 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.401 -2.074 . . . . 2.37 105.401 165.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.73 144.1 32.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.062 0.945 . . . . 1.77 109.129 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.9 169.82 23.73 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.252 0.621 . . . . 2.17 110.609 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.1 155.01 19.72 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.367 -0.975 . . . . 2.32 108.367 176.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -116.54 160.85 15.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.283 -1.006 . . . . 1.63 108.283 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.1 t -126.79 133.44 50.8 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.452 -1.314 . . . . 1.27 107.452 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.84 -25.32 14.81 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.435 1.017 . . . . 1.36 113.687 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.21 142.78 6.75 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.402 1.101 . . . . 3.88 113.29 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.9 p -134.81 39.05 3.01 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.309 1.043 . . . . 3.78 110.511 176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t 52.16 -141.93 0.79 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.171 -1.395 . . . . 4.8 110.916 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 38.55 56.01 1.85 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 121.147 1.794 . . . . 2.72 112.886 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.67 11.01 3.67 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.456 1.502 . . . . 1.64 114.389 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 91.5 m -72.05 -60.24 2.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.737 -1.209 . . . . 2.39 107.737 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.72 -37.1 70.49 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.432 -0.804 . . . . 1.87 110.997 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.78 -47.73 84.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.586 -0.721 . . . . 1.72 110.937 172.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.69 -48.33 66.64 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.176 0.898 . . . . 4.79 110.543 172.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.0 mt -49.03 -61.13 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.24 0 N-CA-C 109.054 -0.721 . . . . 1.73 109.054 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -71.2 -35.1 71.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.077 -0.649 . . . . 2.37 110.895 -171.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -54.57 -37.99 66.15 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 121.02 -1.05 . . . . 2.49 110.688 171.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.37 -51.52 36.57 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.584 -1.006 . . . . 0.48 110.584 168.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.79 -29.91 70.9 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 121.702 -0.881 . . . . 1.62 112.367 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.1 -18.07 63.01 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 118.984 0.811 . . . . 2.83 109.809 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.83 -23.08 63.25 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.219 -1.551 . . . . 3.88 113.934 168.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.03 133.19 89.99 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 120.214 1.37 . . . . 2.44 110.463 -172.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.24 100.12 0.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.822 2.348 . . . . 0.54 110.19 -176.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.57 -21.82 2.37 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.588 -1.005 . . . . 0.3 110.588 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.37 153.7 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 122.293 -0.533 . . . . 1.64 110.675 170.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.25 -61.07 1.77 Allowed 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.467 -0.938 . . . . 1.71 108.467 167.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.26 152.93 39.12 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.645 0.259 . . . . 2.76 111.315 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.13 135.28 46.29 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.901 2.08 . . . . 1.75 107.77 -173.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -144.7 121.67 11.36 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.408 0.683 . . . . 1.57 109.73 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -97.8 137.59 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 112.937 0.717 . . . . 1.99 112.937 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -126.33 69.79 1.23 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.401 2.281 . . . . 1.8 111.181 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.9 mt -65.08 -17.98 64.92 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 112.692 0.627 . . . . 2.0 112.692 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.89 -10.0 5.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.154 0.434 . . . . 1.57 111.44 169.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 m -138.17 17.18 2.8 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.23 1.012 . . . . 1.46 109.758 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mp0 51.2 30.6 5.89 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.048 0.84 . . . . 2.89 111.935 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.7 m -128.98 153.66 47.34 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.804 -1.184 . . . . 1.67 107.804 -168.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.02 147.46 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.951 -1.129 . . . . 1.62 107.951 174.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.46 151.73 41.0 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 124.209 0.943 . . . . 2.84 109.154 175.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.5 140.2 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.142 -1.059 . . . . 1.58 108.142 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.46 124.89 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.531 1.532 . . . . 2.14 107.438 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -148.46 165.99 29.49 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.387 0.675 . . . . 3.21 110.622 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -97.98 110.84 57.42 Favored Pre-proline 0 N--CA 1.447 -0.611 0 C-N-CA 124.673 1.189 . . . . 2.05 110.247 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -72.25 13.25 0.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.963 3.108 . . . . 0.72 113.716 -177.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.41 -51.26 8.02 Favored 'General case' 0 C--N 1.337 0.059 0 N-CA-C 107.257 -1.386 . . . . 1.91 107.257 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -80.83 -47.98 13.06 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.273 1.429 . . . . 2.74 109.637 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.5 m -143.04 125.7 15.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 117.252 2.316 . . . . 1.59 117.252 -145.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.51 -159.74 13.65 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 109.857 -1.297 . . . . 0.71 109.857 165.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.4 t -29.47 -50.04 0.1 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 129.138 2.975 . . . . 1.61 112.632 177.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.05 -56.33 6.68 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.025 0.93 . . . . 1.43 112.654 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -38.47 64.88 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 122.248 1.023 . . . . 1.51 109.403 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mt -63.29 -56.26 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.242 -1.345 . . . . 1.75 110.216 -170.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.21 -52.69 19.87 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.174 1.352 . . . . 0.76 110.611 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' OE1' ' NZ ' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -44.09 -51.95 7.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.683 1.193 . . . . 2.51 111.968 176.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -70.81 -43.44 68.61 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 118.248 -0.882 . . . . 3.21 111.464 177.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.7 mm -52.58 -45.55 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 119.77 1.168 . . . . 1.53 110.075 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -50.38 -49.2 55.05 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.763 0.316 . . . . 1.82 110.183 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -70.77 -30.67 67.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 114.279 1.214 . . . . 4.08 114.279 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.27 -21.0 12.75 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.532 0.606 . . . . 1.82 110.635 166.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.24 28.74 9.52 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.998 -1.241 . . . . 0.3 109.998 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -137.44 168.3 19.91 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.735 -0.839 . . . . 2.91 108.735 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.33 123.1 42.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.746 -1.576 . . . . 5.81 106.746 175.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -91.65 152.99 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.46 -0.57 . . . . 1.68 109.46 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.01 96.61 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-O 121.305 0.574 . . . . 1.79 110.305 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.8 mt -95.8 94.35 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.249 -1.019 . . . . 2.69 108.249 172.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.42 166.78 29.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.481 -1.303 . . . . 5.02 107.481 167.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.69 -88.06 1.52 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.877 -0.889 . . . . 3.64 110.877 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 116.725 -1.607 . . . . 10.02 107.122 -172.683 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptt? . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 107.348 -1.353 . . . . 8.96 107.348 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.98 147.64 0.59 Allowed 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 105.899 -1.889 . . . . 7.55 105.899 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 p -81.85 145.17 30.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.37 -0.974 . . . . 3.87 108.37 171.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -149.15 154.93 39.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.049 -1.463 . . . . 2.79 107.049 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -113.02 170.93 7.85 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.444 1.498 . . . . 0.99 109.546 -176.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.45 162.22 41.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.238 0.542 . . . . 5.88 110.878 176.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -82.83 155.03 24.38 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.222 1.809 . . . . 3.71 109.765 168.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.7 142.84 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 104.847 -2.279 . . . . 4.28 104.847 162.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.52 130.72 51.14 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.689 1.196 . . . . 1.49 107.869 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -155.53 174.78 14.77 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.876 0.47 . . . . 2.06 110.381 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.431 ' N ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -104.87 150.31 24.96 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.753 -1.203 . . . . 1.9 107.753 -176.379 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.42 161.52 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 107.502 -1.296 . . . . 1.41 107.502 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.67 131.07 46.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.609 -1.256 . . . . 1.31 107.609 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.0 -15.95 25.64 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.375 0.988 . . . . 1.4 113.785 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.38 145.21 18.6 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.575 1.188 . . . . 3.9 111.75 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.5 p -125.8 36.36 4.55 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.791 0.836 . . . . 3.95 110.28 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.9 t 50.58 -137.62 1.1 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.98 0.912 . . . . 4.76 111.914 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 54.95 -80.18 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.607 1.963 . . . . 3.38 112.334 -176.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.01 13.57 0.7 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.56 1.144 . . . . 2.0 112.039 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.33 -62.09 1.53 Allowed 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 121.299 -0.876 . . . . 2.75 109.502 -167.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.83 -32.87 72.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.891 0.377 . . . . 1.65 111.168 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.11 -53.4 57.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 119.489 -0.291 . . . . 1.58 110.24 170.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -58.4 -45.14 88.95 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 118.778 -0.629 . . . . 4.29 111.997 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.2 mt -49.06 -60.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.041 -0.725 . . . . 1.82 109.041 176.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.86 -33.98 71.17 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.16 0.505 . . . . 2.64 110.336 -170.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -60.15 -31.29 69.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.864 -1.147 . . . . 3.6 111.234 171.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.67 -51.82 31.74 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.515 -1.034 . . . . 0.35 110.515 162.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -65.2 -32.66 74.45 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 121.253 -1.145 . . . . 1.66 113.023 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -54.97 -21.22 11.08 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.373 0.988 . . . . 2.73 111.458 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -76.02 -24.32 55.25 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.788 1.033 . . . . 3.71 113.788 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 mtp -69.7 132.83 88.82 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 120.375 1.443 . . . . 3.22 112.478 -172.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.6 95.38 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.644 2.896 . . . . 0.46 110.716 -172.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.44 -20.8 2.23 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.696 -0.962 . . . . 0.27 110.696 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.62 144.54 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 121.966 -0.726 . . . . 1.58 110.954 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.12 -61.79 1.34 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.629 1.172 . . . . 2.02 109.269 167.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -149.41 147.98 28.92 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 114.315 1.228 . . . . 2.87 114.315 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.46 121.3 41.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.84 2.056 . . . . 1.76 108.331 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.99 107.42 6.15 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.921 0.889 . . . . 1.49 108.986 -170.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 p -85.4 143.6 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.91 0.884 . . . . 2.0 112.058 -172.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -133.49 65.78 1.57 Allowed 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.226 1.811 . . . . 1.8 111.163 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.6 mt -65.61 -16.35 63.63 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 121.685 -0.634 . . . . 1.86 112.704 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.4 -19.65 15.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.645 0.378 . . . . 1.59 110.902 168.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.4 m -129.19 19.33 5.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.088 1.355 . . . . 1.63 109.685 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 50.24 35.14 9.84 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.138 0.975 . . . . 2.44 111.846 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.89 158.08 44.86 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 108.847 -0.797 . . . . 2.57 108.847 -169.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.96 148.85 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.081 -0.711 . . . . 1.67 109.081 176.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -115.81 134.41 55.04 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.95 -1.5 . . . . 2.5 106.95 176.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.43 140.07 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.284 -0.635 . . . . 1.67 109.284 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.0 mt -105.58 132.67 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 126.201 1.8 . . . . 2.2 106.945 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.01 167.42 28.48 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.959 0.409 . . . . 3.42 111.498 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -98.25 114.16 64.86 Favored Pre-proline 0 N--CA 1.442 -0.829 0 C-N-CA 124.752 1.221 . . . . 1.46 109.839 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -69.48 9.87 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 124.289 3.326 . . . . 0.61 113.971 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.39 -51.59 8.18 Favored 'General case' 0 N--CA 1.458 -0.058 0 N-CA-C 107.411 -1.329 . . . . 1.52 107.411 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -93.67 -29.75 15.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.579 1.552 . . . . 3.12 111.289 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.7 m -150.2 130.25 13.5 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 118.031 2.604 . . . . 1.23 118.031 -156.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.33 -165.25 17.79 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 110.453 -1.059 . . . . 0.62 110.453 156.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.4 t -39.88 -38.31 0.67 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.291 2.636 . . . . 1.69 112.138 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.65 -56.0 9.71 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.181 0.808 . . . . 1.58 113.181 174.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.56 -37.82 65.41 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.838 1.304 . . . . 1.52 108.904 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.269 0.8 OUTLIER -64.04 -53.6 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 113.708 -1.587 . . . . 1.78 111.013 -173.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.87 -53.07 12.91 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.766 1.621 . . . . 0.97 111.048 173.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -39.75 -58.12 1.4 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.829 0.823 . . . . 2.52 113.106 172.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -70.34 -40.28 74.2 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 119.465 -0.894 . . . . 3.88 110.224 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.3 mm -54.12 -46.74 67.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.506 1.048 . . . . 1.5 110.114 178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -53.13 -45.53 68.4 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.289 0.636 . . . . 1.57 109.927 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -38.99 86.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.456 -0.778 . . . . 4.78 111.23 -177.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.6 -19.85 18.11 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.656 1.182 . . . . 2.14 110.898 170.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.01 28.54 9.25 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 124.187 0.899 . . . . 0.39 110.938 173.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -138.06 165.31 26.91 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.041 -1.096 . . . . 3.0 108.041 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.69 129.3 55.2 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.752 0.821 . . . . 5.21 108.943 173.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.3 p -96.14 148.52 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 125.276 1.431 . . . . 1.63 110.22 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.9 m -116.41 132.76 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 123.594 0.758 . . . . 1.75 110.376 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.0 mm -102.91 82.84 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.862 -1.162 . . . . 2.25 107.862 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -135.67 151.8 50.57 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 105.945 -1.872 . . . . 4.5 105.945 166.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.18 -113.1 0.72 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 107.763 -2.135 . . . . 3.83 107.763 -169.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 . . . . . 0 C--O 1.251 1.175 0 CA-C-O 116.993 -1.479 . . . . 8.89 109.952 -172.045 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.0 mtp . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 105.945 -1.872 . . . . 11.29 105.945 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.05 55.71 9.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.165 0.983 . . . . 6.39 110.058 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 p -148.26 118.98 7.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.927 1.691 . . . . 3.78 106.705 -165.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -136.54 147.91 47.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.308 -1.367 . . . . 3.07 107.308 176.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -110.68 167.89 9.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.598 1.159 . . . . 0.66 111.182 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -143.67 157.0 44.72 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.599 0.714 . . . . 3.12 111.399 174.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -84.28 125.68 32.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.244 1.818 . . . . 2.33 107.035 163.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 tp -103.64 149.18 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.278 -1.749 . . . . 1.99 106.278 163.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.82 129.11 40.06 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.674 -1.232 . . . . 1.46 107.674 172.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -155.75 168.63 26.58 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.841 0.456 . . . . 1.69 110.553 -172.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -91.57 151.51 20.69 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.811 -0.811 . . . . 2.9 108.811 -173.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -117.96 160.84 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 108.922 -0.769 . . . . 1.74 108.922 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -133.49 125.31 28.67 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.839 -1.171 . . . . 1.76 107.839 174.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.89 -21.23 6.63 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.035 1.302 . . . . 1.34 113.228 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.33 154.48 3.3 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.348 1.074 . . . . 4.12 112.809 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.1 p -142.52 39.39 1.55 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.554 0.742 . . . . 3.92 110.728 174.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.41 ' HA ' ' CD1' ' A' ' 41' ' ' LEU . 5.3 t 56.03 -147.56 0.52 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 117.404 -1.284 . . . . 4.71 110.464 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 41.77 47.63 3.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.741 1.61 . . . . 2.64 114.138 173.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.95 15.88 6.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.872 1.269 . . . . 1.96 113.788 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.1 m -73.11 -60.61 2.16 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.23 -1.396 . . . . 2.09 107.23 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.75 -39.5 11.8 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.067 1.347 . . . . 2.29 112.031 176.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.29 -38.51 87.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.385 -0.825 . . . . 1.61 111.935 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -57.48 -47.11 82.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.357 0.98 . . . . 4.59 110.753 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 mp -48.7 -61.62 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.413 -0.958 . . . . 3.09 108.413 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.56 -33.57 66.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.433 -0.507 . . . . 2.57 112.003 -172.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -56.29 -39.8 73.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.149 -0.969 . . . . 2.91 110.026 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.01 -55.5 11.61 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.937 -1.265 . . . . 0.35 109.937 167.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.5 -31.39 72.54 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 113.439 0.903 . . . . 1.64 113.439 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.26 14.0 ttpt -61.62 -17.14 53.99 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.656 1.116 . . . . 3.07 111.116 172.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.92 -12.8 52.6 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.154 1.168 . . . . 4.63 114.154 168.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.44 137.58 83.68 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 120.827 1.649 . . . . 4.48 111.241 -173.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.48 94.48 0.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.113 2.542 . . . . 0.44 110.433 -175.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.42 -12.78 3.5 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.74 1.162 . . . . 0.25 111.193 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.7 p -67.38 160.57 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 117.791 0.795 . . . . 1.46 110.526 167.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.77 -55.44 1.9 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.358 1.063 . . . . 1.6 110.152 165.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -143.99 162.26 36.64 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.068 0.395 . . . . 2.26 111.815 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.44 135.73 28.77 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 126.072 1.749 . . . . 1.72 109.607 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -142.47 110.25 5.83 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 125.439 1.496 . . . . 1.73 108.746 -173.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.0 p -84.14 140.93 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.555 0.742 . . . . 1.88 111.728 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -132.48 69.06 1.48 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.991 1.717 . . . . 1.73 112.328 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 17' ' ' CYS . 41.9 mt -63.38 -18.97 64.25 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 113.087 0.773 . . . . 1.91 113.087 177.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.83 -21.93 12.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.264 0.484 . . . . 1.55 110.933 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 m -125.65 10.19 7.77 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.919 1.288 . . . . 1.55 110.605 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 45.52 44.68 10.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.176 0.991 . . . . 3.29 112.266 -169.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.9 m -134.31 155.29 50.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.411 -1.329 . . . . 1.87 107.411 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.3 p -134.12 146.92 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.559 -0.904 . . . . 1.59 108.559 172.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -115.3 134.65 54.93 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 124.498 1.124 . . . . 2.38 108.244 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -138.56 135.48 43.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.11 -0.7 . . . . 1.89 109.11 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.9 mp -102.02 120.88 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.765 1.626 . . . . 2.42 107.178 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -147.28 167.29 24.63 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.484 0.714 . . . . 3.24 110.619 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -105.54 119.2 53.5 Favored Pre-proline 0 N--CA 1.443 -0.799 0 O-C-N 124.135 0.897 . . . . 1.37 109.677 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -67.95 7.72 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 124.464 3.443 . . . . 0.5 113.83 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.44 -57.0 4.12 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.201 -1.407 . . . . 1.64 107.201 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.0 mp0 -87.84 -37.14 16.79 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.303 1.041 . . . . 3.78 112.161 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.3 m -138.08 129.38 27.6 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 118.649 2.833 . . . . 1.3 118.649 -155.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.41 -163.62 17.86 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.475 -1.05 . . . . 0.62 110.475 155.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -29.29 -47.91 0.07 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.512 2.725 . . . . 1.52 112.863 172.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.15 -54.41 16.47 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.114 0.565 . . . . 1.52 112.487 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.3 -41.62 60.86 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 122.201 1.0 . . . . 1.53 109.182 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mt -61.36 -60.25 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 114.137 -1.392 . . . . 1.85 109.266 -170.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.98 -53.81 7.28 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.506 1.048 . . . . 0.79 110.397 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -44.47 -54.44 5.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.624 1.17 . . . . 2.59 111.363 176.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -40.7 76.04 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.987 -0.685 . . . . 3.37 111.355 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.7 mm -55.41 -44.27 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 119.233 0.924 . . . . 1.94 109.947 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -52.67 -42.85 65.12 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.109 0.48 . . . . 1.82 110.721 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -37.08 73.9 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.008 -1.057 . . . . 4.44 111.016 -177.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.83 -21.0 17.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.538 0.735 . . . . 2.13 110.911 169.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.08 27.39 16.23 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.588 -1.005 . . . . 0.41 110.588 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -135.51 169.51 17.4 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 107.942 -1.133 . . . . 3.49 107.942 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.4 114.79 16.0 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 107.84 -1.17 . . . . 6.05 107.84 -174.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.41 144.11 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 123.795 0.838 . . . . 1.72 108.803 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.18 108.23 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.461 1.104 . . . . 2.9 109.373 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.2 mt -106.21 72.69 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.212 1.405 . . . . 2.68 108.645 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -90.68 120.33 31.65 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.547 -1.649 . . . . 4.73 106.547 163.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.04 161.13 35.04 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.546 0.593 . . . . 4.08 112.619 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 . . . . . 0 C--O 1.254 1.304 0 C-N-CA 128.44 2.696 . . . . 10.49 104.494 167.488 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 mtp . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 116.977 -1.487 . . . . 9.87 107.082 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mt 29.86 76.19 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.824 1.65 . . . . 6.6 112.403 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 t -133.4 143.88 49.19 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.372 -1.714 . . . . 3.77 106.372 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -157.51 145.81 19.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.768 -1.568 . . . . 3.32 106.768 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -84.73 177.23 8.1 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.909 -0.587 . . . . 1.11 111.087 -176.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.47 160.52 43.25 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.318 0.58 . . . . 4.87 111.725 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -84.4 127.01 33.75 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.445 1.498 . . . . 2.49 108.303 166.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tp -108.8 155.88 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.313 -1.736 . . . . 2.03 106.313 162.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.86 140.27 23.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.091 0.557 . . . . 1.74 109.816 175.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -157.75 169.41 24.68 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 123.647 0.592 . . . . 3.11 111.189 -177.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.5 152.85 23.67 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 108.105 -1.072 . . . . 2.44 108.105 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.17 139.0 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.867 0.365 . . . . 2.04 110.289 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t -101.23 136.77 40.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.512 1.125 . . . . 1.16 108.188 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.45 2.76 40.95 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.856 1.217 . . . . 1.44 112.741 -173.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.0 tmm? -46.11 104.05 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.444 1.898 . . . . 5.93 111.507 172.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.89 13.56 17.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.808 1.643 . . . . 4.28 110.669 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.8 t 55.68 -145.52 0.62 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.367 1.467 . . . . 4.37 111.386 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 54.66 -80.83 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.257 1.823 . . . . 3.46 112.162 -174.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -152.74 18.48 0.6 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.54 1.136 . . . . 1.98 111.445 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.62 -59.61 2.66 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 120.864 -1.147 . . . . 2.07 109.304 -168.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.52 -34.18 66.76 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.478 -0.783 . . . . 1.78 111.312 177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.85 -47.0 87.51 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 121.88 -0.512 . . . . 1.55 110.563 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -57.24 -44.65 84.02 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.965 0.802 . . . . 7.62 111.527 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.7 mt -46.74 -61.19 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 108.882 -0.784 . . . . 1.93 108.882 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.14 -35.48 69.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.968 -0.56 . . . . 2.6 111.787 -172.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -57.34 -35.68 70.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.094 -1.004 . . . . 2.47 110.786 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.26 -53.57 15.14 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.821 -0.911 . . . . 0.56 110.821 165.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' CD2' HG12 ' A' ' 60' ' ' ILE . 89.4 mt -65.05 -31.06 72.1 Favored 'General case' 0 C--O 1.223 -0.314 0 O-C-N 121.778 -0.837 . . . . 1.91 112.151 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.275 14.1 ttmt -58.87 -17.76 26.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.405 1.002 . . . . 2.02 112.104 171.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -20.24 47.66 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.66 1.118 . . . . 4.42 113.726 168.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 94.4 mmm -74.33 137.54 75.02 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 119.99 1.268 . . . . 3.08 111.924 -169.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.49 91.17 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.671 2.914 . . . . 0.44 111.403 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.59 -13.65 2.23 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.941 1.257 . . . . 0.31 111.522 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.8 p -66.18 159.68 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 121.709 -0.877 . . . . 1.66 111.635 168.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.22 -56.39 1.63 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.135 1.374 . . . . 1.8 110.76 168.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -143.73 157.1 44.63 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 122.299 -0.251 . . . . 2.52 111.62 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.34 131.22 31.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.885 1.274 . . . . 1.79 109.389 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -136.98 117.74 14.04 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.639 0.776 . . . . 1.59 110.009 -176.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -84.32 140.62 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.448 1.099 . . . . 1.83 110.732 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -130.36 65.0 1.53 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.591 1.557 . . . . 1.67 110.777 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.5 mt -64.37 -15.3 60.17 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 113.201 0.815 . . . . 1.6 113.201 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.27 -20.07 3.84 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.274 0.63 . . . . 1.71 111.514 167.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.6 m -134.45 18.66 3.64 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.421 1.488 . . . . 1.59 109.957 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.8 mp0 47.28 34.84 3.37 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.299 1.04 . . . . 2.81 111.815 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -132.5 153.17 51.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.744 -1.576 . . . . 1.68 106.744 -170.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -139.3 153.24 24.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.382 -0.97 . . . . 2.31 108.382 173.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.12 151.73 36.98 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 124.342 1.026 . . . . 2.74 109.815 176.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.16 136.04 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 108.598 -0.89 . . . . 1.57 108.598 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 mt -101.01 116.64 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.767 2.027 . . . . 1.89 106.08 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -144.44 167.48 22.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.682 0.793 . . . . 3.26 109.971 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -103.26 115.76 63.36 Favored Pre-proline 0 N--CA 1.443 -0.78 0 CA-C-N 114.726 -1.124 . . . . 1.41 110.618 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -69.92 8.86 0.71 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 124.258 3.305 . . . . 0.59 113.953 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.38 -49.06 12.96 Favored 'General case' 0 CA--C 1.526 0.046 0 N-CA-C 107.943 -1.132 . . . . 1.52 107.943 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -96.05 -36.22 11.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.979 1.712 . . . . 2.66 110.693 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 m -142.19 129.07 20.62 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 117.708 2.484 . . . . 1.24 117.708 -159.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.11 -161.37 13.12 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.885 -0.886 . . . . 0.62 110.885 157.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -32.92 -43.68 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 128.379 2.672 . . . . 1.66 113.394 176.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.83 -57.19 7.87 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.041 0.536 . . . . 1.43 112.145 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.85 -39.79 63.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 122.337 1.065 . . . . 1.51 108.88 -177.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.401 HG12 ' CD2' ' A' ' 28' ' ' LEU . 1.8 mt -63.75 -53.44 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 114.359 -1.292 . . . . 1.82 110.551 -169.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -51.67 58.19 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.623 1.101 . . . . 0.8 110.454 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -46.29 -54.43 8.92 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.222 1.009 . . . . 2.18 111.121 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -43.16 78.9 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 119.475 -0.89 . . . . 4.05 111.263 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.9 mm -53.91 -45.17 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 123.822 0.849 . . . . 1.54 110.429 -177.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -48.79 -47.64 41.86 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.915 -0.402 . . . . 1.62 109.915 173.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -71.91 -30.04 64.95 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.642 0.979 . . . . 4.1 113.642 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.97 -23.11 12.03 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.493 0.588 . . . . 1.7 110.56 165.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.67 28.82 8.13 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 109.888 -1.285 . . . . 0.37 109.888 175.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -139.96 164.2 30.64 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 108.122 -1.066 . . . . 2.97 108.122 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.48 121.21 36.04 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.367 -1.346 . . . . 5.87 107.367 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.4 p -86.77 159.35 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 124.838 1.255 . . . . 2.12 108.951 174.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.97 95.08 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.412 0.625 . . . . 1.97 111.322 176.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 37.9 mt -95.38 97.68 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 124.484 1.114 . . . . 2.86 108.296 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -144.23 131.82 21.12 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.431 -2.063 . . . . 5.6 105.431 168.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.68 -45.03 0.8 Allowed Glycine 0 CA--C 1.529 0.964 0 CA-C-N 118.639 0.654 . . . . 3.9 113.831 175.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.205 0 N-CA-C 104.914 -2.254 . . . . 8.02 104.914 -172.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mtm . . . . . 0 N--CA 1.474 0.752 0 CA-C-O 118.618 -0.706 . . . . 11.58 109.481 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.24 165.72 26.62 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.308 0.643 . . . . 6.72 109.401 174.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 75.64 130.89 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.98 2.112 . . . . 3.27 109.604 -172.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.83 148.57 27.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.311 -1.366 . . . . 2.79 107.311 174.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -90.33 168.67 11.71 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.0 0.92 . . . . 0.8 110.248 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -149.22 162.63 39.63 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.198 0.523 . . . . 3.94 111.518 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.09 139.4 32.5 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.527 1.931 . . . . 2.26 108.269 170.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 tp -118.32 151.7 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.202 -1.777 . . . . 1.96 106.202 163.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.57 120.19 11.79 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.249 1.419 . . . . 1.86 107.944 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.5 ptt? -156.51 167.71 29.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.296 0.498 . . . . 1.63 110.105 -171.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.08 156.95 16.41 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.422 0.689 . . . . 1.79 110.282 -173.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -115.26 160.6 14.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 C-N-CA 123.043 0.537 . . . . 1.57 109.919 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 t -126.74 123.24 36.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.933 1.293 . . . . 1.31 108.316 174.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.72 -18.58 11.65 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.531 1.062 . . . . 1.41 113.221 170.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.81 141.93 3.67 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.944 1.298 . . . . 4.69 112.443 175.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.2 p -127.12 23.01 6.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.57 1.148 . . . . 4.08 110.718 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.6 t 58.46 -136.42 0.91 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.613 0.765 . . . . 4.56 111.049 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 52.91 -81.19 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.829 1.652 . . . . 3.08 112.317 -171.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.61 13.78 0.94 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.662 1.185 . . . . 2.35 111.727 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.3 m -71.6 -61.36 1.81 Allowed 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 121.255 -0.903 . . . . 1.73 109.393 -167.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.1 -33.26 71.86 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.278 0.561 . . . . 1.68 111.552 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.26 -53.41 57.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 119.15 -0.452 . . . . 1.71 110.791 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.2 mmt-85 -54.81 -49.79 70.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.683 0.674 . . . . 5.49 111.048 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.0 mt -48.45 -60.68 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.944 -0.762 . . . . 1.81 108.944 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -69.19 -38.79 78.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 118.8 -1.16 . . . . 3.42 109.801 -173.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -58.3 -28.37 64.93 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.086 -1.633 . . . . 2.11 112.365 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.53 -52.08 52.48 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 110.732 -0.947 . . . . 0.37 110.732 165.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.03 -29.93 71.04 Favored 'General case' 0 C--O 1.223 -0.29 0 O-C-N 121.551 -0.97 . . . . 1.65 112.966 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -55.08 -18.7 5.82 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.596 1.089 . . . . 2.83 111.957 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -86.18 -14.82 42.85 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.753 1.16 . . . . 3.63 114.042 171.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 82.2 mmm -73.12 138.43 79.0 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 120.01 1.277 . . . . 3.14 112.313 -170.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.06 91.88 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.801 3.001 . . . . 0.6 111.268 -171.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.57 -11.0 4.03 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.606 -0.998 . . . . 0.25 110.606 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.5 p -61.92 145.97 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 118.286 1.043 . . . . 1.52 110.507 168.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.07 -67.79 0.89 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.09 -1.078 . . . . 1.72 108.09 162.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -149.86 126.83 11.17 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 113.628 0.973 . . . . 3.53 113.628 -163.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.14 150.76 21.25 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.367 1.867 . . . . 1.92 110.4 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.78 100.06 2.19 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.46 0.704 . . . . 1.86 109.266 174.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.83 140.73 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.535 0.734 . . . . 1.85 111.476 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -136.79 69.52 1.41 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.701 1.6 . . . . 1.73 111.566 -174.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.6 mt -65.61 -15.58 62.88 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 113.32 0.859 . . . . 1.77 113.32 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.93 -17.08 5.68 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.715 0.406 . . . . 1.63 111.292 168.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.1 m -136.59 18.91 3.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.923 1.289 . . . . 1.61 109.735 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 47.67 32.36 2.51 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.716 1.206 . . . . 3.03 112.164 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 m -127.97 151.53 49.01 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.806 -1.183 . . . . 1.76 107.806 -168.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.0 142.41 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 109.003 -0.74 . . . . 1.8 109.003 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -116.59 142.53 46.76 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.294 -1.372 . . . . 2.57 107.294 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.38 140.38 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.945 -0.391 . . . . 1.84 109.945 172.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.4 mt -100.68 127.47 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.725 -1.583 . . . . 2.29 106.725 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -149.82 171.42 16.77 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.914 0.886 . . . . 3.03 110.565 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 53' ' ' ALA . 59.2 t0 -105.11 106.4 55.49 Favored Pre-proline 0 N--CA 1.446 -0.649 0 C-N-CA 124.951 1.3 . . . . 1.79 110.606 -177.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -70.79 20.98 0.21 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 124.016 3.144 . . . . 0.65 113.322 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 51' ' ' ASP . . . -86.93 -41.38 14.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.926 -1.139 . . . . 1.47 107.926 168.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -103.64 -50.04 3.52 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.502 1.521 . . . . 2.76 110.433 176.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 m -127.29 131.84 50.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 128.506 2.722 . . . . 1.38 117.978 -160.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.65 -161.46 12.26 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 108.998 -1.641 . . . . 0.76 108.998 154.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 t -31.5 -44.97 0.08 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.888 2.875 . . . . 1.62 113.34 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.37 -56.84 6.09 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.857 0.753 . . . . 1.69 112.674 174.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.78 -36.38 65.06 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 122.535 1.16 . . . . 1.59 109.261 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mt -64.36 -54.88 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.165 -1.38 . . . . 1.84 110.72 -172.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -51.01 37.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.144 1.338 . . . . 0.73 110.756 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -42.93 -56.36 3.32 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.09 0.956 . . . . 2.36 112.44 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -41.89 74.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.901 -0.719 . . . . 2.71 111.189 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.9 mm -53.18 -44.92 53.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.368 0.667 . . . . 1.8 110.357 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -50.8 -52.93 36.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.247 0.619 . . . . 1.61 110.077 174.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -37.54 87.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.662 0.785 . . . . 6.63 112.511 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.44 -19.92 6.57 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.554 0.742 . . . . 3.54 111.862 168.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.65 28.69 6.92 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.343 0.973 . . . . 0.36 110.844 170.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -142.98 171.51 13.96 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.975 -1.12 . . . . 2.96 107.975 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.07 128.81 47.96 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.679 -1.6 . . . . 5.56 106.679 173.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.42 142.25 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 119.021 -0.514 . . . . 1.89 109.629 170.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.23 161.65 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.222 -0.658 . . . . 2.22 109.222 173.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.1 mm -125.28 90.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.676 1.191 . . . . 2.08 107.976 171.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -145.7 117.08 7.96 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 104.981 -2.229 . . . . 4.51 104.981 169.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.86 -49.32 0.49 Allowed Glycine 0 CA--C 1.524 0.631 0 CA-C-N 119.668 1.122 . . . . 4.55 113.406 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.23 0 N-CA-C 105.456 -2.053 . . . . 8.9 105.456 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.0 mtp . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 107.167 -1.42 . . . . 8.94 107.167 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.29 73.65 0.16 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.897 1.279 . . . . 7.09 111.71 175.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 m -130.71 134.87 47.28 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.607 -1.257 . . . . 3.91 107.607 -177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.17 154.48 30.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.458 -1.312 . . . . 2.88 107.458 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -95.27 169.02 10.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.009 0.924 . . . . 0.81 110.758 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -149.6 160.89 43.12 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.24 0.543 . . . . 2.91 111.466 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -84.61 144.82 28.37 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.399 1.48 . . . . 2.21 109.133 168.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 tp -124.47 154.32 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.234 -1.765 . . . . 2.17 106.234 165.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.0 129.56 21.41 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.498 1.119 . . . . 1.7 109.088 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -156.86 173.5 16.89 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.511 0.725 . . . . 2.19 110.756 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -100.67 148.52 24.77 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.045 1.338 . . . . 3.37 109.781 -174.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -118.46 161.99 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.19 0.996 . . . . 1.44 109.346 -176.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -127.32 128.52 46.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.245 1.018 . . . . 1.24 108.901 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.57 -10.72 21.56 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.438 1.018 . . . . 1.44 113.087 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.31 115.66 3.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.919 1.359 . . . . 3.73 109.5 174.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.2 t -57.3 -41.28 79.54 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.531 -0.747 . . . . 5.07 110.556 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.8 t 148.17 -40.76 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.387 2.275 . . . . 4.94 111.359 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.4 -160.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.416 0.686 . . . . 3.77 110.735 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.62 39.26 0.1 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.816 -1.177 . . . . 2.36 113.063 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -72.07 -60.3 2.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.47 1.908 . . . . 2.07 109.657 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.35 69.31 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.234 0.54 . . . . 1.8 111.643 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.77 -47.08 67.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.633 0.373 . . . . 1.7 111.508 169.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -64.1 -47.19 81.0 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.21 0.604 . . . . 5.39 110.043 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.0 mt -48.11 -60.09 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.283 -1.006 . . . . 1.86 108.283 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -70.3 -35.63 73.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.168 -0.613 . . . . 2.34 110.689 -171.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -58.01 -33.22 68.71 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 120.664 -1.272 . . . . 2.21 111.308 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.3 -47.26 83.61 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 110.366 -1.093 . . . . 0.37 110.366 167.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.21 -29.22 70.34 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 118.625 1.212 . . . . 1.69 112.428 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -59.89 -17.38 36.69 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.513 1.052 . . . . 2.98 111.243 173.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.75 -16.24 57.44 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.067 1.136 . . . . 4.68 114.067 169.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.77 136.82 66.74 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 120.809 1.641 . . . . 3.7 112.425 -171.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.71 99.32 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.867 3.045 . . . . 0.57 110.995 -173.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.66 -15.79 4.08 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.304 -1.119 . . . . 0.25 110.304 177.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.81 150.93 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 O-C-N 122.047 -0.678 . . . . 1.59 110.943 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.78 -65.3 1.19 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.812 -1.181 . . . . 1.57 107.812 165.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -147.03 132.66 18.8 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 112.702 0.63 . . . . 3.36 112.702 -163.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.8 136.77 50.63 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.902 1.681 . . . . 1.59 108.55 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -139.73 112.96 8.25 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.591 1.156 . . . . 1.5 108.325 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -84.5 141.07 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.183 0.993 . . . . 1.67 110.444 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -137.03 65.32 1.51 Allowed 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.544 -1.28 . . . . 3.6 107.544 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 47.6 mt -63.23 -17.38 62.39 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 121.671 -0.643 . . . . 1.77 112.281 174.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.28 -16.28 8.16 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.482 0.713 . . . . 1.76 111.551 169.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.4 m -136.07 19.16 3.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.626 1.171 . . . . 1.52 109.325 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 48.27 40.86 15.12 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.114 0.966 . . . . 3.4 111.46 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.8 m -137.85 155.55 48.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.275 -1.38 . . . . 1.55 107.275 -171.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.8 p -134.37 148.85 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 107.635 -1.246 . . . . 1.62 107.635 170.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.73 150.23 43.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.973 0.796 . . . . 2.68 109.273 171.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.99 142.73 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.841 -0.8 . . . . 1.64 108.841 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.2 mt -104.01 127.57 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 126.675 1.99 . . . . 2.26 106.781 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -152.14 170.23 20.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.311 0.645 . . . . 3.05 110.143 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -104.21 113.09 65.53 Favored Pre-proline 0 N--CA 1.44 -0.961 0 CA-C-N 115.01 -0.996 . . . . 1.31 110.145 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -68.8 10.35 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.799 3.0 . . . . 0.53 113.634 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.57 -43.05 21.25 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 108.353 -0.98 . . . . 1.47 108.353 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -98.53 -44.97 6.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.319 1.447 . . . . 2.85 110.0 176.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 m -138.04 130.91 29.87 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 118.915 2.931 . . . . 1.59 118.915 -155.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.6 -157.82 9.27 Favored Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 108.385 -1.886 . . . . 0.78 108.385 155.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.272 0.0 OUTLIER -32.17 -46.09 0.12 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.285 2.634 . . . . 1.91 113.504 175.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.81 -57.43 4.9 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.001 0.741 . . . . 1.4 113.001 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.02 -38.33 64.09 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 122.091 0.948 . . . . 1.5 109.225 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mt -63.11 -58.87 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 114.347 -1.297 . . . . 1.91 109.601 -172.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.6 -51.74 15.06 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.753 1.16 . . . . 0.81 110.971 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -42.81 -55.49 3.64 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.15 0.98 . . . . 2.17 112.066 174.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.56 -40.5 73.3 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.146 -0.622 . . . . 2.92 110.82 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.5 mm -54.56 -45.99 71.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 118.863 0.756 . . . . 1.81 110.007 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -50.49 -51.9 43.15 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.232 0.539 . . . . 2.23 109.792 172.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -42.3 98.91 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.559 0.577 . . . . 4.9 112.559 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mp -52.45 -19.69 2.37 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.917 1.287 . . . . 3.67 111.875 169.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.21 29.26 9.08 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.327 -1.109 . . . . 0.38 110.327 173.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -137.98 162.88 32.95 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.098 -1.445 . . . . 2.9 107.098 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.84 134.6 54.83 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.122 -1.807 . . . . 5.16 106.122 171.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.63 150.04 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.604 0.762 . . . . 1.77 110.444 168.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.29 169.11 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.672 0.789 . . . . 1.78 109.532 171.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.7 mm -121.82 82.49 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 125.259 1.424 . . . . 2.02 108.17 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -135.45 85.75 2.19 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 107.197 -1.409 . . . . 4.88 107.197 176.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.52 -120.6 0.55 Allowed Glycine 0 CA--C 1.521 0.453 0 N-CA-C 107.551 -2.219 . . . . 4.39 107.551 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.101 0 C-N-CA 126.255 1.822 . . . . 8.04 113.663 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ptt? . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 107.374 -1.343 . . . . 10.75 107.374 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.63 145.43 52.2 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 123.868 0.73 . . . . 6.65 110.291 173.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p -88.81 142.23 27.84 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.62 1.168 . . . . 3.99 108.648 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -127.78 106.02 8.84 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.207 1.003 . . . . 3.35 109.247 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -83.19 160.13 21.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.036 -0.529 . . . . 0.83 111.357 -175.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -149.08 158.55 44.27 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.109 -0.7 . . . . 3.38 109.109 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -91.03 141.0 29.31 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.685 -1.143 . . . . 2.89 109.51 168.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.95 138.08 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 105.407 -2.072 . . . . 4.28 105.407 170.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.55 125.65 48.35 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.421 1.488 . . . . 1.71 108.036 176.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -154.88 164.69 38.48 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.485 0.584 . . . . 1.76 110.697 -175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.47 151.59 19.42 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.09 0.956 . . . . 1.76 109.575 -173.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 t -116.1 161.21 15.01 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 C-N-CA 123.139 0.575 . . . . 1.7 109.904 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -127.72 123.28 35.04 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.963 1.305 . . . . 1.34 108.711 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.6 -20.03 8.92 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.861 1.22 . . . . 1.43 113.057 170.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.47 148.82 1.82 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.98 1.312 . . . . 4.43 112.477 175.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.9 p -135.26 40.4 2.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.556 0.742 . . . . 3.85 110.582 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.5 t 58.68 -140.05 0.75 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.654 -1.165 . . . . 4.57 110.934 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 37.89 48.06 0.97 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.207 1.803 . . . . 2.46 114.818 172.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 57.19 24.34 9.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.549 1.14 . . . . 2.52 113.663 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.1 m -72.04 -60.66 2.12 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 123.914 0.886 . . . . 1.98 109.153 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.43 -23.79 67.56 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.497 -0.752 . . . . 1.8 112.218 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.51 -45.24 81.16 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 121.64 -0.663 . . . . 1.54 110.798 167.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.3 mmp_? -58.91 -47.91 83.32 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.449 1.022 . . . . 5.65 110.321 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.0 mt -47.21 -60.8 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.809 -0.811 . . . . 1.57 108.809 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -72.11 -34.15 68.38 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 119.968 -0.693 . . . . 2.55 111.707 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm -55.69 -36.65 67.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 120.858 -1.151 . . . . 3.7 111.028 175.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.46 -54.64 12.55 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.187 -1.165 . . . . 0.34 110.187 166.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.74 -32.73 74.32 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 112.885 0.698 . . . . 1.42 112.885 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -57.62 -17.54 15.04 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.229 0.922 . . . . 2.06 111.796 172.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.7 -11.3 48.68 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.694 1.368 . . . . 5.16 114.694 170.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.24 138.62 86.96 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 121.278 1.854 . . . . 4.42 111.856 -177.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.52 90.69 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.605 2.87 . . . . 0.49 111.079 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.82 -7.67 3.57 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.756 1.17 . . . . 0.3 111.341 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -67.4 160.29 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 118.271 1.035 . . . . 1.58 110.806 164.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.73 -59.55 1.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.767 1.227 . . . . 1.74 108.659 168.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -145.13 162.91 35.9 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 112.477 0.547 . . . . 2.31 112.477 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.54 123.51 12.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.086 1.754 . . . . 1.7 109.625 -173.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -135.64 119.62 17.48 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.423 1.489 . . . . 1.56 109.284 -172.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -91.93 139.13 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.127 0.971 . . . . 1.64 110.545 -176.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -131.08 66.69 1.53 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.833 1.653 . . . . 1.69 111.143 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.4 mt -67.01 -15.92 64.03 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 113.113 0.782 . . . . 1.89 113.113 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.81 -24.84 9.74 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.66 0.384 . . . . 1.88 110.622 167.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.0 m -128.55 19.99 6.18 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.213 1.405 . . . . 1.63 110.044 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 47.58 35.01 3.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.188 0.995 . . . . 2.8 112.145 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.4 m -132.52 152.03 51.71 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.118 -1.068 . . . . 1.61 108.118 -168.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.2 p -133.96 147.47 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.367 0.667 . . . . 1.79 109.389 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -121.34 129.13 52.91 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.1 1.36 . . . . 2.6 108.464 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.92 137.1 51.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.021 -0.733 . . . . 1.96 109.021 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.4 mp -108.55 120.77 60.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.012 1.325 . . . . 2.61 108.134 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -144.36 171.37 14.42 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.186 0.994 . . . . 3.04 110.877 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -108.39 111.73 61.36 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 124.979 1.312 . . . . 1.79 111.15 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -76.83 30.13 0.41 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.747 2.964 . . . . 0.71 112.711 -172.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.96 -50.16 5.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.77 -1.567 . . . . 1.63 106.77 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.16 -43.52 7.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.16 1.784 . . . . 2.87 110.495 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.6 m -133.93 127.3 32.17 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 116.45 2.019 . . . . 1.62 116.45 -159.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.89 -164.23 13.32 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 108.898 -1.681 . . . . 0.65 108.898 153.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.2 t -34.78 -40.39 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.706 2.802 . . . . 1.63 112.831 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.0 -54.46 8.34 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.907 0.883 . . . . 1.78 113.233 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.63 -36.83 65.49 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.924 1.345 . . . . 1.72 109.642 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.82 -50.16 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 113.309 -1.768 . . . . 1.72 110.903 -164.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.75 -52.34 49.46 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.388 1.449 . . . . 0.76 109.034 172.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.46 -45.66 46.98 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.708 1.203 . . . . 5.04 112.294 -177.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -44.59 60.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.247 -1.533 . . . . 4.04 112.823 172.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 mm -51.43 -44.93 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.986 1.315 . . . . 1.73 110.707 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -49.73 -47.53 50.64 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.453 0.644 . . . . 1.56 110.361 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -32.65 67.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.249 1.02 . . . . 6.36 112.292 -177.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.45 -25.62 37.47 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 119.385 -0.34 . . . . 1.87 110.239 166.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.31 29.22 5.78 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.542 1.068 . . . . 0.37 110.823 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -142.86 165.73 26.57 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.273 -1.01 . . . . 2.94 108.273 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.95 125.68 48.02 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.267 -1.753 . . . . 5.64 106.267 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -96.78 143.06 13.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 O-C-N 123.751 0.657 . . . . 1.63 109.894 172.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.3 m -97.21 161.82 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.425 -0.583 . . . . 2.35 109.425 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.4 mm -125.74 74.35 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 108.083 -1.08 . . . . 2.04 108.083 172.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -125.36 90.19 3.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.798 -1.927 . . . . 4.49 105.798 168.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.82 89.24 0.07 OUTLIER Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.058 -2.017 . . . . 4.85 108.058 -174.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 C--O 1.253 1.274 0 CA-C-O 116.246 -1.835 . . . . 10.23 107.159 168.043 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 106.175 -1.787 . . . . 10.11 106.175 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.1 tp 75.25 70.81 0.09 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.657 1.223 . . . . 7.93 111.876 170.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.2 m -139.56 150.21 44.78 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 106.644 -1.613 . . . . 3.75 106.644 170.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -157.27 148.4 21.75 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.003 -1.11 . . . . 4.13 108.003 169.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -85.77 162.55 18.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.952 0.901 . . . . 0.97 111.437 -177.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -154.68 158.49 39.7 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 122.011 0.91 . . . . 4.33 111.177 178.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -84.03 114.13 21.51 Favored 'General case' 0 N--CA 1.452 -0.332 1 C-N-CA 131.984 4.113 . . . . 2.3 107.363 174.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.48 149.3 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 105.803 -1.925 . . . . 3.85 105.803 164.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.73 123.73 18.94 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.602 1.561 . . . . 1.59 108.261 176.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -157.49 166.71 32.23 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.941 0.496 . . . . 2.13 111.78 -171.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -101.44 140.09 36.2 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.069 1.748 . . . . 3.28 108.855 -169.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.92 142.12 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 123.487 0.715 . . . . 1.73 110.166 -177.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -86.76 116.46 24.87 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.136 -1.061 . . . . 1.52 108.136 173.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.05 73.24 1.24 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.965 -0.854 . . . . 2.74 110.965 179.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -129.82 -174.86 3.43 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.366 1.866 . . . . 4.23 107.244 175.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 t 47.25 43.28 14.68 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.59 1.156 . . . . 7.74 112.849 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.43 51.54 2.0 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.755 0.788 . . . . 7.06 109.794 -175.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 77.79 74.02 0.06 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.75 2.02 . . . . 3.65 110.996 -173.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.72 34.09 17.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.998 1.319 . . . . 2.06 112.67 171.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.2 m -70.74 -63.01 1.18 Allowed 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 121.602 -0.686 . . . . 3.17 110.8 -168.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.25 -35.14 69.36 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.373 0.533 . . . . 2.37 110.688 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.48 -55.94 27.5 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.452 -0.34 . . . . 1.69 111.22 173.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -59.08 -49.85 76.33 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.425 0.557 . . . . 4.52 110.74 177.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.7 mt -45.67 -59.88 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.767 1.227 . . . . 1.69 108.723 177.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -70.84 -35.74 72.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.383 -0.371 . . . . 2.31 110.715 -173.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -59.15 -30.44 68.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.06 -1.025 . . . . 2.09 110.872 174.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.56 -52.33 48.8 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 110.743 -0.943 . . . . 0.34 110.743 164.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.0 -29.93 71.2 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.268 -1.136 . . . . 1.7 113.13 177.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -54.74 -18.96 5.32 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.246 0.93 . . . . 3.14 111.924 170.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.29 -15.03 48.13 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.022 1.119 . . . . 3.5 114.022 171.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.2 mmm -76.89 137.8 65.94 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 120.252 1.387 . . . . 2.91 112.424 -172.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.71 101.08 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.513 2.808 . . . . 0.55 110.922 -173.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.39 -13.29 5.16 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 124.981 1.277 . . . . 0.27 110.151 175.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.01 147.51 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 117.806 0.803 . . . . 1.59 110.676 169.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.67 -60.44 1.82 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.986 1.315 . . . . 1.66 110.407 168.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -154.43 148.88 26.2 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 115.401 1.63 . . . . 2.53 115.401 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.3 142.23 42.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.265 1.426 . . . . 1.73 110.825 -176.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -145.38 102.3 3.7 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.171 -1.048 . . . . 3.78 108.171 -170.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.5 p -83.79 134.32 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.296 0.638 . . . . 1.99 110.889 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -131.12 70.12 1.47 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.075 -1.083 . . . . 3.62 108.075 -177.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.4 mt -64.02 -24.65 67.79 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.502 -0.749 . . . . 2.39 111.954 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.38 -24.25 28.79 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.08 0.552 . . . . 1.87 111.03 171.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.6 m -118.97 11.44 12.5 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.372 1.469 . . . . 2.11 110.309 -179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 46.4 47.96 13.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.053 0.842 . . . . 2.23 111.673 -178.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.47 159.02 39.47 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.12 -1.067 . . . . 2.23 108.12 -174.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.2 p -125.68 146.92 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 108.558 -0.905 . . . . 1.86 108.558 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -117.44 141.5 48.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.711 1.205 . . . . 2.43 108.351 176.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.05 132.24 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.695 -0.483 . . . . 1.76 109.695 173.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.5 mt -91.86 126.2 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.387 1.875 . . . . 1.77 106.871 176.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -147.5 173.86 12.26 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.428 0.691 . . . . 3.36 111.114 176.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -110.44 120.03 45.14 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 124.366 1.066 . . . . 1.43 110.965 -178.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -69.33 7.28 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 124.596 3.531 . . . . 0.67 113.575 -178.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.49 -37.22 37.27 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 108.644 -0.873 . . . . 1.63 108.644 176.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -114.88 -53.82 2.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.571 1.549 . . . . 2.77 110.041 -179.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 m -104.34 129.99 52.2 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 128.233 2.613 . . . . 2.21 117.343 -172.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.25 -173.36 22.44 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 109.779 -1.328 . . . . 0.71 109.779 151.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.3 t -35.24 -41.14 0.15 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.556 2.742 . . . . 1.43 112.414 174.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.77 -57.19 5.9 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.981 0.734 . . . . 1.47 112.981 173.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.47 66.43 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 122.338 1.066 . . . . 1.54 108.835 -176.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.02 -58.04 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 114.012 -1.449 . . . . 1.8 110.082 -174.4 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.47 -51.1 15.93 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.681 1.128 . . . . 0.78 110.823 175.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.517 ' CD ' ' HZ1' ' A' ' 66' ' ' LYS . 1.9 tm-20 -45.31 -51.85 10.48 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.406 0.683 . . . . 2.34 112.342 177.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -43.68 67.37 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 118.17 -0.919 . . . . 3.05 111.667 177.338 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 mm -52.4 -45.71 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 119.698 1.135 . . . . 1.54 110.196 -179.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -49.46 -47.04 48.62 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.26 0.624 . . . . 1.63 110.11 172.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.517 ' HZ1' ' CD ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -70.38 -36.57 74.2 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.674 0.79 . . . . 5.27 112.318 -178.452 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -54.46 -22.76 13.62 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.837 0.455 . . . . 1.72 110.41 169.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.13 28.51 5.81 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 110.444 -1.063 . . . . 0.39 110.444 170.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -144.61 169.17 18.49 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.638 -1.245 . . . . 3.46 107.638 -177.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.08 135.53 54.59 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.358 -1.719 . . . . 5.16 106.358 172.038 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -98.36 147.67 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.056 0.942 . . . . 1.74 109.549 167.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.59 160.92 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.032 -0.729 . . . . 1.94 109.032 169.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.6 mm -121.32 79.85 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.232 -1.395 . . . . 1.81 107.232 172.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -102.19 120.19 40.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 105.433 -2.062 . . . . 4.32 105.433 168.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.48 -50.34 0.2 Allowed Glycine 0 C--N 1.338 0.689 0 CA-C-N 118.817 0.735 . . . . 3.65 112.507 -176.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.0 tpp85 . . . . . 0 C--O 1.253 1.257 0 CA-C-O 116.785 -1.579 . . . . 8.84 107.795 167.893 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.485 -0.561 . . . . 8.76 109.485 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mp -65.74 166.36 11.06 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.341 -0.615 . . . . 7.64 109.341 171.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.0 m -109.12 158.49 17.73 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.957 1.303 . . . . 3.26 107.863 170.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -146.33 148.83 32.79 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.105 -1.443 . . . . 4.13 107.105 174.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -107.02 171.78 7.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.329 1.051 . . . . 0.81 110.738 -172.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.76 159.88 40.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.764 0.792 . . . . 4.68 111.854 -179.341 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.12 135.77 34.26 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.496 -1.684 . . . . 2.49 108.232 169.248 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 tp -109.44 151.04 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 105.843 -1.91 . . . . 1.96 105.843 161.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.62 123.65 16.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.997 1.319 . . . . 1.86 107.85 176.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.6 ptt? -157.7 172.16 19.01 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.713 0.405 . . . . 1.88 110.292 -170.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -102.74 150.08 23.82 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.401 1.08 . . . . 3.2 110.123 -171.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.71 167.89 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 C-N-CA 123.684 0.794 . . . . 1.68 109.706 -178.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t -136.14 129.89 32.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.287 1.035 . . . . 1.74 108.829 176.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.77 -17.89 20.04 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.647 1.117 . . . . 1.41 113.628 171.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.4 123.56 12.34 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.457 1.128 . . . . 3.98 112.213 178.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 p -96.58 30.47 2.58 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.247 0.619 . . . . 4.28 110.747 175.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 t 70.73 -159.99 0.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.899 1.28 . . . . 4.43 111.461 174.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 47.02 -136.93 0.79 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.06 0.944 . . . . 3.71 110.567 -173.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.18 7.95 6.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.112 0.782 . . . . 2.31 113.112 -175.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.3 m -69.01 -60.08 2.6 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.759 1.163 . . . . 2.62 110.301 -164.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.69 -27.79 69.45 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.88 -0.512 . . . . 1.85 112.28 176.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.91 -50.81 67.88 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.686 -0.487 . . . . 1.57 109.686 168.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -59.4 -45.1 92.43 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 118.481 -0.771 . . . . 4.3 111.99 174.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.7 mt -46.96 -59.95 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.359 -0.608 . . . . 1.61 109.359 176.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -70.13 -41.18 74.26 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 119.634 -0.826 . . . . 3.58 109.993 -173.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -52.15 -35.6 48.99 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 120.423 -1.423 . . . . 2.81 112.089 179.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.26 -52.12 33.42 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 110.921 -0.872 . . . . 0.38 110.921 167.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.1 mt -66.94 -27.76 67.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 118.51 -0.757 . . . . 1.69 112.587 177.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.445 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 20.9 ttmt -59.87 -16.99 33.43 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 119.614 1.097 . . . . 2.23 110.566 171.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.36 -8.83 58.25 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.013 1.116 . . . . 3.97 114.013 171.297 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.5 mmt -71.75 138.67 82.91 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 120.304 1.411 . . . . 3.15 111.722 -175.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.28 90.82 0.57 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.263 2.642 . . . . 0.52 110.793 -175.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.27 -16.33 2.1 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.483 1.04 . . . . 0.25 111.495 -179.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 p -70.82 156.02 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 O-C-N 121.674 -0.897 . . . . 1.59 111.409 171.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.22 -62.58 1.57 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.424 1.09 . . . . 1.73 109.126 166.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.445 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 2.5 m-20 -147.76 142.25 26.45 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 112.502 0.556 . . . . 3.02 112.502 -169.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.86 157.09 17.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.237 1.815 . . . . 1.89 109.333 178.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.54 95.82 1.83 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.042 -1.095 . . . . 2.05 108.042 177.046 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.12 140.24 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 121.917 -0.49 . . . . 1.95 111.449 -178.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -137.02 69.94 1.41 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.148 1.379 . . . . 3.54 109.092 -174.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 68.7 mt -65.69 -16.56 63.87 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 115.565 -0.743 . . . . 1.85 112.932 177.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.6 -22.5 8.72 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.543 0.737 . . . . 1.61 110.741 169.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.9 m -133.05 21.22 4.1 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.938 0.895 . . . . 2.18 109.854 179.064 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 50.37 34.7 9.46 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.058 0.844 . . . . 3.05 112.069 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.6 m -128.53 152.57 48.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.644 1.178 . . . . 1.5 107.876 -168.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 p -135.14 143.57 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.844 -0.798 . . . . 1.89 108.844 173.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -119.24 145.27 46.21 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.848 1.259 . . . . 2.47 107.969 176.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.86 139.03 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.629 -0.508 . . . . 1.6 109.629 174.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.9 mt -101.05 119.2 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 126.96 2.104 . . . . 2.11 107.196 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -146.35 168.87 20.06 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.398 1.079 . . . . 3.34 109.593 -178.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -101.65 115.63 64.63 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 118.385 -0.817 . . . . 2.07 109.278 177.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -68.63 7.6 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.747 2.965 . . . . 0.79 113.646 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.21 -55.54 5.18 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 107.441 -1.318 . . . . 1.89 107.441 172.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -88.18 -30.75 19.53 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.435 1.094 . . . . 3.93 112.109 176.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.9 m -148.47 121.4 8.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 117.677 2.473 . . . . 1.81 117.677 -157.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.69 -166.79 23.14 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.588 -1.005 . . . . 0.75 110.588 159.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 t -29.61 -46.68 0.06 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.499 3.119 . . . . 1.76 112.841 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.42 -58.42 3.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.048 0.939 . . . . 1.86 113.155 173.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.18 -34.19 65.86 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 122.511 1.148 . . . . 1.52 109.554 -178.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -52.86 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 117.199 -1.381 . . . . 2.08 110.928 -171.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -50.16 40.44 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 121.04 1.746 . . . . 0.84 110.922 175.229 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -39.73 -60.27 1.01 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.904 0.882 . . . . 2.68 112.634 172.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -70.73 -40.43 72.76 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.202 -0.999 . . . . 2.84 110.82 -177.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.8 mm -53.31 -44.68 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 119.034 0.834 . . . . 1.69 110.046 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -53.81 -45.66 70.85 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.129 0.49 . . . . 1.82 109.772 174.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.62 -39.74 91.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.485 -0.76 . . . . 3.74 111.354 -179.19 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.4 -23.58 16.32 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.443 0.697 . . . . 1.76 110.786 171.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.95 26.93 7.25 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 124.466 1.031 . . . . 0.37 110.9 173.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -144.8 176.34 9.52 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 122.025 0.916 . . . . 2.9 109.617 -175.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.68 117.24 23.06 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 106.035 -1.839 . . . . 5.03 106.035 -171.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.9 p -96.13 142.45 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.868 -0.79 . . . . 1.67 108.868 165.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.23 157.6 10.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 108.764 -0.828 . . . . 2.65 108.764 173.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 33.7 mm -118.71 74.66 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.852 -1.166 . . . . 2.13 107.852 -177.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -116.78 130.54 56.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.231 -2.137 . . . . 4.13 105.231 168.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.94 -104.0 0.37 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 108.059 -2.016 . . . . 3.6 108.059 -169.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 . . . . . 0 C--O 1.251 1.132 0 CA-C-O 117.546 -1.216 . . . . 10.66 110.119 -166.529 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ptt? . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 111.844 0.313 . . . . 13.1 111.844 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 29.5 mt -121.17 172.83 7.69 Favored 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 107.29 -1.374 . . . . 7.12 107.29 168.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 p -139.97 70.82 1.36 Allowed 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 125.265 1.426 . . . . 3.59 107.449 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -134.38 121.76 21.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.628 1.171 . . . . 3.29 107.933 -175.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -84.6 167.25 16.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.092 -0.504 . . . . 0.99 111.515 -173.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -139.67 152.83 47.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.521 0.677 . . . . 3.4 109.822 179.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -90.34 125.92 35.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 127.036 2.134 . . . . 2.25 106.762 168.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 tp -109.21 151.29 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.167 -1.42 . . . . 1.98 107.167 167.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.52 133.93 36.99 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.731 -1.211 . . . . 1.42 107.731 170.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.75 170.92 21.34 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.439 0.462 . . . . 1.64 111.195 175.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.65 152.81 19.35 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.854 0.861 . . . . 1.98 110.362 -176.498 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.57 171.56 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 123.7 0.8 . . . . 1.78 110.034 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -130.48 131.82 45.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.782 0.833 . . . . 1.54 110.603 176.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.15 31.51 10.74 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.667 1.127 . . . . 1.38 113.311 169.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.24 91.44 4.74 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.92 0.86 . . . . 3.89 110.811 -171.581 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 m -79.53 45.37 0.67 Allowed 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.27 -0.894 . . . . 4.42 112.011 -177.248 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 t 47.27 -130.01 1.52 Allowed 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 126.078 1.751 . . . . 4.61 110.14 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 39.4 46.81 1.43 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 121.756 2.071 . . . . 2.75 113.676 178.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.36 18.08 8.94 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.202 1.401 . . . . 1.59 114.157 179.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.4 m -71.1 -60.75 2.06 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.279 -1.008 . . . . 2.08 108.279 -176.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.13 -43.73 61.23 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.918 0.866 . . . . 1.77 111.284 177.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.15 -50.66 68.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.086 -0.961 . . . . 1.66 110.664 174.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -54.63 -45.24 73.7 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.574 -0.726 . . . . 5.07 111.444 173.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.4 mt -52.46 -60.89 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.391 -0.966 . . . . 2.06 108.391 177.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.62 -33.96 73.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.4 -0.92 . . . . 2.36 110.615 -168.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -56.24 -36.76 68.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.092 -1.005 . . . . 2.3 111.263 171.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.5 -44.51 90.45 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.054 -0.818 . . . . 0.36 111.054 168.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.3 mt -65.6 -30.66 71.41 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 119.407 1.603 . . . . 1.69 112.514 175.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -56.62 -18.41 11.97 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.13 0.877 . . . . 2.16 112.03 170.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 mtp85 -87.88 -5.29 58.65 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.891 -1.13 . . . . 5.49 112.694 174.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 95.1 mmm -82.74 136.62 44.69 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 120.389 1.45 . . . . 2.91 111.748 179.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.8 100.73 0.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.506 2.804 . . . . 0.36 111.262 -173.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.37 -13.03 3.77 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.58 1.086 . . . . 0.21 111.173 176.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.9 152.97 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.836 0.854 . . . . 1.61 111.182 169.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.1 -60.5 1.87 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.582 1.153 . . . . 1.59 109.356 166.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -148.66 141.59 24.76 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.239 0.459 . . . . 3.14 112.239 -169.138 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.61 136.71 53.11 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.779 1.632 . . . . 1.63 108.632 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -142.05 108.9 5.41 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.577 1.151 . . . . 1.64 108.5 -177.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.4 p -89.92 142.7 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.742 0.817 . . . . 1.64 111.772 -175.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -137.71 68.99 1.4 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.364 1.465 . . . . 1.68 111.011 -175.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.4 mt -66.71 -14.91 63.1 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 112.948 0.721 . . . . 1.82 112.948 177.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.5 -13.34 5.35 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.983 0.356 . . . . 1.62 111.221 167.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.5 m -138.38 18.46 2.75 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.387 1.075 . . . . 1.75 109.572 177.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 51.76 30.75 7.22 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.14 0.882 . . . . 3.14 112.035 -179.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.4 m -129.66 153.42 48.14 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.069 -1.086 . . . . 1.49 108.069 -167.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.4 144.47 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 108.802 -0.814 . . . . 1.61 108.802 173.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -112.78 139.99 47.94 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.744 1.218 . . . . 2.46 108.055 176.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.44 141.2 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.249 -0.649 . . . . 1.52 109.249 171.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 mt -104.74 127.37 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.971 1.708 . . . . 2.23 106.533 -179.054 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -152.3 171.78 17.45 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.946 0.498 . . . . 3.28 110.098 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -111.07 120.51 43.1 Favored Pre-proline 0 N--CA 1.448 -0.563 0 O-C-N 123.944 0.777 . . . . 2.09 111.187 -177.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.14 19.39 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.072 3.181 . . . . 0.64 113.681 -178.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.63 -50.74 7.91 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.256 -1.387 . . . . 1.77 107.256 169.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -96.33 -39.81 9.44 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.099 1.36 . . . . 3.55 111.4 176.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.5 m -132.41 129.89 39.9 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 117.748 2.499 . . . . 1.76 117.748 -155.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.76 -172.09 22.91 Favored Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 110.043 -1.223 . . . . 0.72 110.043 157.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.272 0.1 OUTLIER -29.31 -43.09 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 128.633 2.773 . . . . 1.74 113.902 169.241 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.64 -55.35 16.79 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.868 0.758 . . . . 1.5 112.671 175.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.08 -36.24 66.78 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 122.557 1.17 . . . . 1.48 108.966 -176.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.257 0.9 OUTLIER -65.47 -56.56 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 113.852 -1.522 . . . . 1.69 110.351 -172.617 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -49.61 47.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.171 1.35 . . . . 0.74 110.913 177.255 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -42.48 -58.4 2.26 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.74 0.816 . . . . 2.28 112.094 173.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -42.36 73.39 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 119.548 -0.861 . . . . 3.26 111.421 -177.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.3 mm -51.21 -47.6 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.67 0.788 . . . . 1.76 109.832 177.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -50.6 -53.47 30.38 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 121.426 0.632 . . . . 1.61 109.678 175.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -29.3 70.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.028 0.531 . . . . 6.16 112.412 -178.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -63.85 -20.02 65.49 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.23 0.612 . . . . 3.21 109.783 173.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.26 28.76 6.65 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 125.075 1.321 . . . . 0.36 110.618 173.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -143.85 168.47 19.88 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.122 -1.436 . . . . 2.85 107.122 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.83 135.97 54.66 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.428 -1.693 . . . . 5.52 106.428 169.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -100.63 142.92 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.331 1.052 . . . . 1.99 109.722 166.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.65 168.76 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.692 -0.855 . . . . 2.31 108.692 173.457 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 23.5 mm -127.74 94.92 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.768 -1.567 . . . . 1.97 106.768 170.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -47.64 102.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.965 1.306 . . . . 7.68 112.232 174.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.87 -105.09 1.53 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.799 -0.92 . . . . 6.13 110.799 177.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.026 0 N-CA-C 104.376 -2.453 . . . . 10.2 104.376 166.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 mtt . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 108.078 -1.082 . . . . 11.49 108.078 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.74 173.58 11.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 106.997 -1.483 . . . . 6.36 106.997 179.473 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 p -119.71 149.86 41.31 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.647 -1.612 . . . . 2.81 106.647 166.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -157.52 146.18 19.49 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.331 -1.359 . . . . 4.07 107.331 173.027 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -84.88 168.96 14.58 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.994 0.918 . . . . 0.65 111.518 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -148.8 161.75 41.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.687 -0.857 . . . . 3.63 108.687 173.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -82.91 138.46 33.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.522 -1.288 . . . . 2.63 107.522 162.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 tp -107.14 153.48 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 2.21 105.713 157.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.53 128.21 17.18 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.917 -1.142 . . . . 1.68 107.917 173.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.48 175.86 13.41 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.189 0.45 . . . . 2.09 110.866 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -94.19 149.37 21.3 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.287 1.035 . . . . 3.07 109.279 -174.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.21 165.59 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.854 -0.795 . . . . 1.62 108.854 177.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.42 145.46 50.3 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.643 -1.243 . . . . 1.4 107.643 171.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.22 -21.47 35.37 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.204 0.907 . . . . 1.41 113.441 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.8 146.17 42.74 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.461 1.13 . . . . 4.0 112.463 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.8 p -133.32 41.14 3.12 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.628 1.171 . . . . 3.89 110.15 177.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.0 t 50.28 -140.8 0.78 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 117.538 -1.22 . . . . 4.54 111.616 -177.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 36.17 57.77 1.01 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 120.564 1.529 . . . . 2.55 113.302 177.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.66 16.72 5.65 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.218 1.407 . . . . 1.68 114.369 176.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 91.2 m -72.54 -60.79 2.06 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 121.293 -0.88 . . . . 2.48 109.433 -177.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.18 70.04 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 121.652 0.739 . . . . 1.77 111.665 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.4 -42.57 70.6 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 118.757 -0.64 . . . . 1.6 111.04 171.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -61.07 -45.42 94.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.279 0.945 . . . . 4.53 110.598 176.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.9 mt -48.35 -60.94 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.319 -0.993 . . . . 1.77 108.319 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.28 -34.1 67.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 119.945 -0.702 . . . . 2.58 111.838 -173.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -55.94 -37.73 69.37 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.121 -0.987 . . . . 2.73 110.736 176.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.5 -52.75 27.49 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.458 -1.057 . . . . 0.38 110.458 167.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.0 mt -64.62 -31.1 72.17 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.591 -0.946 . . . . 1.65 112.503 179.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.25 23.3 ttmt -59.03 -13.73 7.52 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 119.209 0.913 . . . . 2.56 111.69 170.514 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 -1.63 40.23 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.553 -1.342 . . . . 6.11 114.001 170.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.91 139.3 61.67 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 120.815 1.643 . . . . 4.19 111.489 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.78 92.78 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.588 2.858 . . . . 0.45 110.429 -174.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.33 -9.65 3.79 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.562 1.077 . . . . 0.26 111.633 177.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -66.73 157.42 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 118.054 0.927 . . . . 1.6 110.884 167.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.74 -56.41 2.12 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.989 1.316 . . . . 1.54 110.229 168.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -143.17 157.35 44.59 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 123.081 0.553 . . . . 3.14 109.917 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.63 134.84 39.67 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.936 1.694 . . . . 1.69 108.165 174.413 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -142.07 116.86 9.82 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.499 1.119 . . . . 1.42 108.833 -173.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.73 139.54 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.429 1.092 . . . . 1.88 111.541 -175.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -132.37 67.77 1.52 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.628 1.571 . . . . 1.7 111.913 179.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.3 mt -65.86 -16.01 63.44 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 113.281 0.845 . . . . 1.78 113.281 178.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.16 -19.66 8.31 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.073 0.397 . . . . 1.84 110.997 168.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.3 m -130.48 14.9 5.51 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.907 1.283 . . . . 1.61 110.373 178.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 51.44 35.28 13.81 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.037 0.835 . . . . 2.75 112.048 -177.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 m -134.01 153.59 51.69 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 107.88 -1.156 . . . . 1.62 107.88 -170.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.16 151.38 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.374 -0.973 . . . . 1.51 108.374 174.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.17 150.29 42.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 124.178 0.924 . . . . 2.75 109.895 172.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.61 134.0 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.346 -0.983 . . . . 1.68 108.346 177.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.5 127.84 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.923 -1.51 . . . . 2.13 106.923 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -150.29 170.09 19.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.024 0.529 . . . . 3.45 110.348 -178.142 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.8 120.47 47.06 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 124.311 1.044 . . . . 1.39 111.002 -179.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -69.93 8.4 0.82 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.48 3.453 . . . . 0.81 113.914 -177.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.8 -44.61 26.97 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 108.162 -1.051 . . . . 1.66 108.162 175.303 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -102.68 -42.67 5.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.293 1.837 . . . . 3.03 110.249 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.6 m -129.53 127.45 40.79 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 117.57 2.433 . . . . 1.71 117.57 -158.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.42 -173.24 22.42 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 109.607 -1.397 . . . . 0.77 109.607 158.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 t -41.64 -34.03 0.55 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.282 2.633 . . . . 1.46 112.195 178.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.8 -57.59 7.04 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.915 0.709 . . . . 1.37 112.915 171.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.61 -35.88 67.95 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 122.581 1.182 . . . . 1.64 108.759 -176.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -58.3 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 113.896 -1.502 . . . . 1.75 109.551 -173.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -50.67 24.6 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.412 1.46 . . . . 0.78 111.065 177.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -41.41 -58.45 1.87 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.667 0.787 . . . . 2.46 112.693 173.31 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -41.32 77.63 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 119.31 -0.956 . . . . 2.74 111.417 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.0 mm -52.56 -47.0 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.056 0.844 . . . . 1.75 110.319 -179.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -51.25 -46.59 62.42 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.217 0.532 . . . . 1.82 109.854 173.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -34.6 71.73 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.349 -0.844 . . . . 5.36 112.88 -176.454 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.98 -22.5 5.73 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.563 0.745 . . . . 2.09 110.486 167.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.56 26.99 8.8 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.315 -1.114 . . . . 0.29 110.315 174.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -139.34 160.83 38.9 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.278 -1.008 . . . . 3.47 108.278 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 122.94 43.05 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.008 -1.479 . . . . 5.84 107.008 178.144 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.57 151.67 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 124.534 1.134 . . . . 1.61 109.793 173.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.27 140.07 46.5 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 N-CA-C 108.815 -0.809 . . . . 1.96 108.815 179.126 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.7 mm -104.59 93.84 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 108.055 -1.091 . . . . 1.98 108.055 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -152.36 149.58 28.78 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.156 -1.794 . . . . 5.2 106.156 174.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.5 -54.71 0.43 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.83 -0.908 . . . . 5.04 110.83 176.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 117.019 -1.467 . . . . 8.37 107.6 162.421 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 mtp . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 107.562 -1.273 . . . . 9.48 107.562 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -170.31 152.43 4.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.437 -1.69 . . . . 7.65 106.437 166.26 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 p 179.2 116.65 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.353 -1.721 . . . . 3.74 106.353 -176.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.57 155.27 40.03 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.744 -1.576 . . . . 4.25 106.744 175.491 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -99.04 161.85 13.4 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.231 1.012 . . . . 0.72 109.584 -177.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -142.37 154.49 44.68 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.848 0.832 . . . . 3.79 112.189 176.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -89.78 108.13 19.51 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 128.186 2.594 . . . . 2.53 107.322 171.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.64 154.53 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.86 -1.163 . . . . 2.69 107.86 165.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.8 132.9 37.31 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.502 -1.666 . . . . 1.48 106.502 173.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -155.67 166.44 33.5 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 123.273 0.629 . . . . 1.64 109.781 -173.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -93.56 156.18 16.88 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.026 -0.731 . . . . 2.96 109.026 -172.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.28 161.57 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 120.952 0.406 . . . . 1.6 110.656 177.012 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 t -130.5 137.95 50.0 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.946 2.098 . . . . 1.5 107.731 172.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.45 -28.03 11.51 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.594 1.093 . . . . 1.35 113.183 174.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.03 145.15 1.05 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.398 1.479 . . . . 4.6 113.133 175.093 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.3 p -133.23 23.44 4.12 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.381 0.672 . . . . 3.77 111.885 173.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HA ' ' CD1' ' A' ' 41' ' ' LEU . 3.8 t 63.25 -150.15 0.33 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 117.744 -1.122 . . . . 4.58 111.185 -176.445 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 40.1 51.99 2.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 120.297 1.408 . . . . 2.61 113.535 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 65.61 14.35 9.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.086 1.355 . . . . 1.75 114.029 177.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.4 m -72.85 -60.18 2.36 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.353 -0.98 . . . . 2.23 108.353 179.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.68 -39.03 70.43 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.828 0.823 . . . . 2.0 110.95 -177.197 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.69 -37.72 42.85 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 118.913 -0.565 . . . . 1.57 112.442 173.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -59.22 -40.79 86.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.197 0.908 . . . . 4.05 110.894 176.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.41 HG12 ' CD1' ' A' ' 69' ' ' TYR . 57.2 mt -54.13 -60.6 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.207 -1.405 . . . . 1.96 107.207 -177.016 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -32.9 65.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.022 -0.99 . . . . 2.52 112.11 -175.34 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -55.16 -38.79 68.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.083 -1.011 . . . . 2.86 110.478 172.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.1 -51.74 39.43 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.791 -0.923 . . . . 0.59 110.791 168.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.33 -33.97 76.69 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.553 -0.969 . . . . 1.71 112.232 178.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.425 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP 0.259 0.9 OUTLIER -59.99 -18.11 43.39 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 118.986 0.812 . . . . 2.32 110.81 172.609 . . . . . . . . 4 4 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.22 -14.71 43.07 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.463 -1.398 . . . . 4.89 114.384 167.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.3 mtp -74.97 134.85 74.35 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 121.102 1.773 . . . . 3.11 111.26 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.06 114.19 2.34 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.06 2.507 . . . . 0.73 109.589 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.84 -16.02 6.19 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 124.852 1.215 . . . . 0.26 110.09 174.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.9 p -67.75 154.2 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 O-C-N 122.401 -0.47 . . . . 1.62 110.481 169.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.32 -54.24 2.48 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.735 1.214 . . . . 1.48 109.571 166.387 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.425 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 44.0 t0 -145.91 157.56 43.89 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.556 0.162 . . . . 2.58 110.909 -177.612 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.76 127.27 16.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.531 1.533 . . . . 2.03 108.82 -175.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -143.14 115.69 8.6 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.811 0.844 . . . . 2.03 109.537 -168.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -92.1 139.14 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 112.86 0.689 . . . . 2.06 112.86 -176.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -128.7 68.79 1.38 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.906 2.083 . . . . 1.65 111.246 -176.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 17' ' ' CYS . 58.3 mt -64.62 -16.81 63.33 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 113.038 0.755 . . . . 1.86 113.038 178.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.76 -19.92 4.92 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.967 0.507 . . . . 1.64 111.121 169.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.1 m -136.33 18.0 3.16 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.834 1.253 . . . . 1.53 109.976 -178.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 48.46 32.93 3.59 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.19 0.996 . . . . 2.75 112.181 -176.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.9 m -124.73 153.1 42.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.239 -1.393 . . . . 1.68 107.239 -169.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 p -134.79 144.58 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.593 -0.892 . . . . 1.71 108.593 173.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -108.19 140.34 41.54 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.066 1.347 . . . . 2.87 107.822 175.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.83 134.71 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.825 -0.806 . . . . 1.63 108.825 167.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.8 mt -103.93 117.73 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 126.2 1.8 . . . . 1.97 106.331 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -145.19 173.24 12.11 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.164 0.586 . . . . 3.23 110.115 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -110.59 123.16 36.37 Favored Pre-proline 0 N--CA 1.443 -0.778 0 C-N-CA 124.618 1.167 . . . . 1.49 111.154 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -66.45 3.54 1.36 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.758 3.638 . . . . 0.96 114.384 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.07 -44.74 45.81 Favored 'General case' 0 C--N 1.335 -0.057 0 N-CA-C 108.483 -0.932 . . . . 2.06 108.483 176.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -101.37 -37.0 8.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.779 1.631 . . . . 3.26 110.366 178.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.3 m -138.64 131.52 29.48 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 118.71 2.855 . . . . 1.98 118.71 -150.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.81 -171.76 30.45 Favored Glycine 0 N--CA 1.435 -1.42 0 N-CA-C 109.417 -1.473 . . . . 0.74 109.417 164.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -35.04 -43.82 0.21 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.927 2.491 . . . . 1.69 112.088 176.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.55 -58.73 3.17 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.249 0.833 . . . . 1.46 113.249 173.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.35 -38.14 65.83 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.914 -0.772 . . . . 1.54 108.914 -176.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -61.14 -59.69 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.719 -1.128 . . . . 2.7 108.424 -173.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.92 -52.23 14.99 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.151 0.887 . . . . 0.87 110.644 -178.32 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -43.36 -55.0 4.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.621 1.168 . . . . 2.55 112.632 174.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -43.42 72.67 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 118.434 -0.793 . . . . 2.71 111.338 178.283 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.9 mm -52.32 -46.17 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 119.051 0.841 . . . . 1.63 109.725 -177.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -51.17 -50.24 59.37 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.014 0.435 . . . . 1.61 110.335 174.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -71.07 -31.37 67.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.42 -0.8 . . . . 4.2 112.444 -174.464 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.98 -21.77 12.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 122.967 0.507 . . . . 1.86 110.68 167.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.24 26.91 9.71 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 124.532 1.063 . . . . 0.46 110.488 174.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.41 ' CD1' HG12 ' A' ' 24' ' ' ILE . 71.2 m-85 -138.88 164.77 28.81 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 117.324 0.562 . . . . 2.88 109.588 -178.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 120.17 37.96 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.576 -1.268 . . . . 5.99 107.576 -179.156 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.65 150.5 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 109.305 -0.628 . . . . 1.74 109.305 170.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.69 116.74 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 124.37 1.068 . . . . 2.74 108.854 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt -110.34 66.39 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.857 1.263 . . . . 2.91 109.488 -177.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -94.15 125.64 38.9 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.155 0.982 . . . . 5.27 108.751 176.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.11 124.71 0.54 Allowed Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.143 -1.183 . . . . 3.77 110.143 -177.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.268 0 CA-C-O 116.196 -1.859 . . . . 8.86 107.012 -175.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 106.63 -1.618 . . . . 8.96 106.63 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.27 142.65 39.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.829 -1.175 . . . . 7.01 107.829 164.609 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.4 m -149.34 146.84 27.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.034 -1.839 . . . . 3.22 106.034 173.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -157.66 148.26 20.97 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.431 -1.322 . . . . 3.72 107.431 176.572 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -86.8 172.3 10.23 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.711 -0.677 . . . . 0.63 110.84 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -150.45 162.93 39.63 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.835 -0.432 . . . . 3.19 109.835 174.29 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -83.75 153.28 24.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.521 -1.218 . . . . 2.95 109.112 164.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 tp -131.48 155.07 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 106.416 -1.698 . . . . 2.0 106.416 161.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.09 131.88 31.23 Favored 'General case' 0 N--CA 1.458 -0.036 0 C-N-CA 125.139 1.376 . . . . 1.76 108.359 175.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.9 ptp -156.5 169.54 24.4 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.899 0.772 . . . . 3.18 111.144 -176.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.74 146.04 32.67 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.974 0.91 . . . . 2.1 109.477 -171.709 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.09 160.66 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 124.212 1.005 . . . . 1.88 111.228 -172.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -88.95 167.25 13.35 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.109 0.48 . . . . 2.11 111.381 166.446 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 50.29 33.38 23.53 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.095 1.807 . . . . 1.98 114.501 176.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 16.1 ptm -108.31 -160.94 0.75 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.866 1.267 . . . . 4.97 109.383 -179.124 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.6 t 52.79 20.0 1.46 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.781 2.032 . . . . 7.97 113.706 177.003 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.5 t -104.95 -48.33 3.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.838 0.855 . . . . 7.32 109.689 -167.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -159.37 -98.98 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.403 1.081 . . . . 3.5 108.426 166.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -107.81 30.16 6.58 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.15 0.98 . . . . 2.23 111.495 -175.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.1 m -70.27 -62.87 1.22 Allowed 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.176 -0.676 . . . . 3.17 109.176 -171.015 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.96 -36.01 64.87 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 122.763 0.425 . . . . 2.32 111.308 178.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.73 -55.34 36.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 119.358 -0.353 . . . . 1.51 111.091 175.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -56.0 -52.52 63.92 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.412 0.551 . . . . 4.22 110.885 175.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.9 mt -45.19 -60.64 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.893 1.277 . . . . 1.76 109.12 178.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -71.47 -36.46 71.17 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 120.83 0.348 . . . . 2.34 111.153 -172.102 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -56.12 -35.79 67.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.117 -0.989 . . . . 2.3 110.448 173.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.64 -49.6 46.08 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 111.471 -0.651 . . . . 0.33 111.471 166.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.83 -30.76 71.43 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 121.107 -1.231 . . . . 1.55 112.615 176.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -57.57 -17.72 15.65 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.21 0.913 . . . . 2.51 111.811 170.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -88.28 -3.72 58.81 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.164 1.172 . . . . 4.88 114.164 171.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 95.2 mmm -84.25 135.78 41.3 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 120.45 1.477 . . . . 3.11 111.408 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.95 99.43 0.56 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.769 2.98 . . . . 0.45 111.135 -172.03 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.2 -12.93 3.82 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.785 -0.926 . . . . 0.23 110.785 177.102 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.33 153.68 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 123.523 0.729 . . . . 1.58 111.206 171.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.95 -60.16 1.92 Allowed 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.457 1.103 . . . . 1.6 109.027 167.184 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -147.32 142.97 27.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 112.187 0.439 . . . . 3.23 112.187 -169.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.21 136.1 53.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.165 1.786 . . . . 1.59 108.27 179.163 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -137.71 111.97 8.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.46 1.104 . . . . 1.75 108.652 -178.443 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.2 141.67 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.438 1.095 . . . . 2.2 111.118 -178.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -136.57 65.46 1.52 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.903 1.281 . . . . 1.65 111.445 178.156 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -59.63 -23.71 63.24 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.946 -0.471 . . . . 2.02 112.115 177.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.39 -22.59 43.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.385 0.539 . . . . 1.69 111.207 174.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 m -121.75 16.01 11.02 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.802 1.241 . . . . 1.54 110.294 179.092 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 44.02 46.24 6.92 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.124 0.969 . . . . 2.83 110.876 -174.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.9 m -145.77 154.3 41.89 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.027 -1.472 . . . . 1.78 107.027 -171.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -132.69 151.9 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.306 -0.998 . . . . 1.78 108.306 170.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.54 150.77 47.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.296 -0.631 . . . . 2.71 109.296 175.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.87 146.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.512 -0.922 . . . . 1.58 108.512 -176.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.2 mt -114.75 125.95 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.523 1.929 . . . . 2.01 106.58 -173.373 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -152.37 170.1 20.93 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.223 0.609 . . . . 3.25 110.363 -175.671 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -109.21 115.77 56.13 Favored Pre-proline 0 N--CA 1.44 -0.943 0 O-C-N 124.276 0.985 . . . . 1.48 110.469 -177.064 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.37 8.55 0.5 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.172 3.248 . . . . 0.62 113.752 -178.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.99 -44.73 38.2 Favored 'General case' 0 N--CA 1.458 -0.026 0 N-CA-C 108.087 -1.079 . . . . 1.77 108.087 172.36 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -102.05 -38.32 7.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.291 1.436 . . . . 3.02 111.074 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 m -143.56 133.95 24.7 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 119.284 3.068 . . . . 1.86 119.284 -156.431 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.31 -149.74 6.28 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 108.88 -1.688 . . . . 0.81 108.88 154.34 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -44.82 -35.37 2.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.955 2.102 . . . . 1.61 112.833 -175.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.18 -55.1 26.86 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.658 -0.651 . . . . 1.74 111.821 174.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.41 -41.78 60.34 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.686 1.231 . . . . 1.65 109.323 -175.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mt -62.85 -52.57 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 113.967 -1.469 . . . . 1.68 111.502 -169.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -55.92 -47.04 78.21 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.471 1.032 . . . . 3.03 110.429 179.135 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -42.59 -60.06 1.68 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.113 0.965 . . . . 2.23 112.781 171.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -37.54 81.24 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 119.217 -0.993 . . . . 3.69 110.726 -177.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.1 mm -56.23 -44.09 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 118.154 0.434 . . . . 1.69 110.301 -178.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -48.06 -49.16 32.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.158 0.504 . . . . 1.53 110.279 172.08 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -71.88 -31.28 66.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.941 0.896 . . . . 4.21 113.128 -175.411 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -53.48 -24.35 12.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 119.441 -0.314 . . . . 2.13 110.616 165.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.36 29.23 4.58 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.37 0.986 . . . . 0.37 110.778 167.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -148.12 159.55 43.81 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.739 -1.578 . . . . 3.51 106.739 -177.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.79 147.27 27.07 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 105.819 -1.919 . . . . 4.84 105.819 170.283 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.9 p -110.9 157.56 11.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 125.494 1.518 . . . . 2.2 109.804 169.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.1 137.16 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.355 1.062 . . . . 2.27 111.359 178.333 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.2 mm -102.38 93.47 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 125.368 1.467 . . . . 2.44 107.248 175.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -72.02 127.35 32.27 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.842 -1.17 . . . . 5.2 107.842 174.067 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.21 68.58 1.71 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.626 -0.99 . . . . 5.23 110.626 176.12 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 117.938 -1.029 . . . . 12.04 111.176 175.373 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 mtt . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 107.661 -1.237 . . . . 10.34 107.661 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.6 mp -118.54 147.62 43.5 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 106.831 -1.544 . . . . 7.43 106.831 174.341 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 m -67.55 159.34 29.97 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.483 0.713 . . . . 4.41 110.115 171.036 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 4.6 tt0 -137.46 132.33 33.2 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.844 1.258 . . . . 3.51 107.869 177.037 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -84.39 157.64 21.36 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.608 0.763 . . . . 0.87 111.056 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 28.3 mttp -155.54 168.04 28.42 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.954 0.407 . . . . 5.24 110.73 178.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -84.37 133.08 34.53 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.444 2.298 . . . . 2.09 109.188 175.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.28 148.73 16.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.067 0 N-CA-C 106.286 -1.746 . . . . 2.61 106.286 162.462 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.78 133.04 44.3 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.256 1.422 . . . . 1.69 108.245 176.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.6 168.84 25.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 122.028 0.918 . . . . 2.77 112.887 -176.168 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.433 ' N ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -104.06 96.68 6.82 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 104.293 -2.484 . . . . 2.06 104.293 -164.201 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.81 141.11 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 108.294 -1.002 . . . . 2.7 108.294 175.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -84.65 156.2 21.63 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.678 -0.489 . . . . 1.66 109.678 178.337 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.04 67.49 1.95 Allowed Glycine 0 CA--C 1.532 1.112 0 N-CA-C 111.987 -0.445 . . . . 2.48 111.987 175.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 8.1 ptp -141.13 178.57 7.3 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.875 1.27 . . . . 4.81 108.653 -179.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 m 56.28 37.08 28.5 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.999 -0.741 . . . . 8.59 108.999 -175.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.7 t -121.43 -65.28 1.15 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.48 1.112 . . . . 8.4 108.959 -168.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.97 80.04 0.77 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.079 0.552 . . . . 4.57 110.501 171.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.06 28.6 11.05 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.633 1.173 . . . . 1.93 111.966 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.7 m -72.56 -62.74 1.34 Allowed 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.453 -0.573 . . . . 2.88 109.453 -165.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.13 -41.52 36.35 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 123.832 0.853 . . . . 1.95 111.807 178.186 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.4 -55.31 36.4 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.547 -0.751 . . . . 1.59 111.191 175.334 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -60.94 -47.99 83.86 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.576 0.625 . . . . 5.18 111.567 177.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.3 mt -43.36 -60.86 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 125.089 1.356 . . . . 1.74 108.324 175.198 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -71.37 -37.43 71.62 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.139 -0.482 . . . . 2.4 111.213 -172.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -57.54 -32.61 67.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.261 -0.9 . . . . 2.26 110.857 175.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.56 -51.15 54.02 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.663 -0.975 . . . . 0.33 110.663 165.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.6 -28.63 70.05 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 118.967 1.384 . . . . 1.7 112.597 176.17 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.29 21.2 ttmt -61.66 -15.2 37.76 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 119.854 1.206 . . . . 1.92 111.859 171.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -18.18 42.52 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.367 -1.458 . . . . 5.55 114.657 165.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.27 128.19 90.52 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 120.332 1.423 . . . . 3.66 110.936 -170.722 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -60.87 104.37 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.981 2.454 . . . . 0.6 111.032 -176.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.74 -3.45 8.63 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.715 2.103 . . . . 0.34 110.555 172.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.88 158.22 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 121.576 -0.955 . . . . 1.73 111.361 164.06 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.33 -58.15 1.72 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.251 1.42 . . . . 1.75 110.448 169.094 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -139.37 154.25 47.82 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 112.102 0.408 . . . . 3.13 112.102 -176.388 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.3 129.72 46.76 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.483 1.913 . . . . 1.69 108.731 174.393 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.65 113.14 7.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.881 1.272 . . . . 1.37 109.518 -174.625 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.78 148.76 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.975 0.91 . . . . 2.28 111.689 -174.304 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -140.74 67.55 1.36 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-O 122.789 1.28 . . . . 3.86 108.059 178.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.4 mt -62.14 -16.01 49.71 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.502 -0.772 . . . . 2.47 112.366 175.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.64 -12.55 4.27 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.477 1.111 . . . . 2.08 111.467 170.027 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.3 m -144.17 27.25 1.44 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.49 0.716 . . . . 1.64 109.201 178.026 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 36.93 59.64 1.04 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 125.213 1.405 . . . . 3.27 111.218 -176.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -156.52 157.51 35.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.021 -1.474 . . . . 1.8 107.021 -172.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.89 154.56 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 109.245 -0.65 . . . . 2.59 109.245 171.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -119.38 145.85 45.85 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.167 1.387 . . . . 2.58 109.247 -178.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.15 134.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.911 0.885 . . . . 1.5 109.055 179.036 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 78.5 mt -95.2 128.09 46.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.047 -1.464 . . . . 2.42 107.047 174.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -149.84 171.96 15.92 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.352 0.661 . . . . 3.07 110.491 177.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -108.02 121.99 42.12 Favored Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 124.002 0.921 . . . . 1.94 111.655 -176.358 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.93 23.0 0.35 Allowed 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 124.718 3.612 . . . . 0.81 113.489 -176.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.56 -48.93 6.13 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 107.714 -1.217 . . . . 1.69 107.714 171.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -99.43 -48.95 4.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.317 1.447 . . . . 2.71 110.687 178.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.2 m -111.11 133.03 53.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.07 1.748 . . . . 1.45 114.759 -164.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.1 177.28 32.42 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 108.638 -1.785 . . . . 1.08 108.638 163.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -34.15 -47.95 0.3 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.587 1.955 . . . . 2.09 111.082 172.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -41.26 -58.35 1.85 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.594 1.158 . . . . 1.75 113.402 173.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.05 -38.52 66.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.854 -0.795 . . . . 1.65 108.854 -176.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.78 -61.21 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-N 114.696 -1.138 . . . . 2.38 109.84 179.2 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -45.36 -52.58 9.71 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.003 1.274 . . . . 1.47 110.373 178.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.65 -51.46 12.23 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.573 0.749 . . . . 2.54 112.603 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -48.03 57.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.764 -0.774 . . . . 2.64 111.495 174.647 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.5 mm -49.6 -44.07 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.855 0.862 . . . . 1.53 110.662 -176.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -50.86 -52.57 40.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.446 0.698 . . . . 1.59 110.027 175.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -71.58 -29.12 64.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 114.048 1.129 . . . . 4.29 114.048 -178.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -53.9 -25.03 18.19 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.426 0.557 . . . . 1.76 110.388 165.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.68 27.82 3.94 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 124.507 1.051 . . . . 0.4 111.067 166.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -151.16 174.51 13.15 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.806 -1.183 . . . . 3.04 107.806 -173.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.33 141.05 48.79 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.066 -1.087 . . . . 4.65 108.066 171.64 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.94 142.3 15.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 113.542 -1.663 . . . . 2.02 107.969 162.085 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.7 m -117.52 139.37 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.117 -0.697 . . . . 2.26 109.117 173.612 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.3 mm -120.45 86.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.938 1.295 . . . . 2.39 107.519 -164.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -123.96 147.97 47.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.272 -1.381 . . . . 4.57 107.272 168.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.24 63.57 3.07 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 119.72 -0.489 . . . . 4.4 112.594 173.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.1 ttt85 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.497 1.919 . . . . 9.33 110.961 169.385 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mtt . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 106.335 -1.728 . . . . 8.51 106.335 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 66.07 54.62 0.97 Allowed 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.419 1.075 . . . . 9.45 109.533 175.726 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.2 p -171.97 78.24 0.06 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.199 1.4 . . . . 3.78 107.238 -176.231 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.25 121.74 6.31 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.1 0.96 . . . . 4.99 108.445 -175.515 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -89.46 172.08 9.26 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.957 0.903 . . . . 0.77 112.423 -171.051 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.09 165.87 31.48 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.99 0.9 . . . . 4.0 111.803 169.35 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -82.15 141.12 33.35 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.062 2.145 . . . . 2.28 107.721 167.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.68 150.92 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 106.022 -1.844 . . . . 2.61 106.022 164.016 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.61 128.3 23.19 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.292 1.437 . . . . 1.67 107.955 176.286 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -155.91 173.17 17.17 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.994 0.518 . . . . 1.78 110.251 -172.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.22 152.25 21.26 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.951 0.9 . . . . 1.83 109.371 -176.426 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 t -115.02 162.89 12.78 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.06 0 C-N-CA 123.432 0.693 . . . . 1.74 109.834 178.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 t -129.26 125.31 36.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.303 1.441 . . . . 1.52 108.565 175.503 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.84 -11.98 20.55 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.835 1.207 . . . . 1.38 113.454 173.148 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.62 146.23 17.1 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.134 0.967 . . . . 4.06 111.519 178.103 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.1 p -130.32 26.55 5.12 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.65 0.78 . . . . 3.98 110.962 175.418 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.5 t 57.92 -140.01 0.8 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.42 -0.8 . . . . 4.41 110.941 -176.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 54.99 -82.25 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.939 1.695 . . . . 3.19 111.816 -172.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.0 16.09 0.75 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.606 1.162 . . . . 2.74 111.61 175.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.7 m -71.89 -61.17 1.88 Allowed 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 121.415 -0.803 . . . . 1.78 109.49 -169.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.45 -33.54 71.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.767 0.794 . . . . 1.78 111.24 -179.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.65 -50.53 73.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.946 -0.471 . . . . 1.6 110.369 171.32 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -53.93 -45.58 71.26 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 118.817 -0.611 . . . . 4.3 111.36 174.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -49.24 -61.96 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.15 -0.685 . . . . 1.78 109.15 177.547 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -72.18 -33.12 67.43 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.015 -0.674 . . . . 2.46 111.017 -170.193 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.5 mmtt -54.42 -39.51 67.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 121.029 -1.045 . . . . 2.66 110.703 170.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.51 -53.04 34.06 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.889 -1.284 . . . . 0.42 109.889 168.757 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.66 -33.15 72.39 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 117.811 -1.09 . . . . 1.8 112.543 178.252 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.285 13.8 ttpt -56.43 -19.33 14.57 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 120.08 1.309 . . . . 3.18 111.678 175.499 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.46 -14.94 54.23 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.094 1.516 . . . . 4.06 115.094 170.284 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.6 mmt -73.54 134.59 79.16 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 120.165 1.348 . . . . 3.72 111.88 -175.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.85 94.35 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.291 2.661 . . . . 0.48 111.549 -176.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.84 -13.7 2.88 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.719 1.152 . . . . 0.44 111.092 171.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.23 152.84 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 121.678 -0.896 . . . . 2.39 109.121 162.623 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.19 -57.03 2.09 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.668 1.187 . . . . 1.55 110.374 169.064 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -154.67 158.07 39.08 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 117.903 0.319 . . . . 2.69 111.61 -177.047 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.36 132.43 47.07 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 127.494 2.317 . . . . 1.56 109.986 -171.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -138.35 104.34 5.15 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.819 1.248 . . . . 1.46 108.798 -176.539 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.9 p -83.67 141.55 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.74 0.816 . . . . 1.96 111.371 -178.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -136.83 67.84 1.44 Allowed 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.715 1.606 . . . . 1.61 111.535 -175.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.81 -16.98 62.63 Favored 'General case' 0 C--O 1.228 -0.045 0 N-CA-C 113.146 0.795 . . . . 1.9 113.146 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.45 -26.09 11.84 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.17 0.441 . . . . 1.75 110.612 169.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.6 m -125.45 18.56 8.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.319 1.448 . . . . 1.87 110.315 -179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 46.46 39.66 6.95 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.202 1.001 . . . . 2.66 111.973 -177.352 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.37 156.82 46.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.596 -0.89 . . . . 2.58 108.596 -169.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.59 145.66 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.349 -0.841 . . . . 1.62 108.809 174.335 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -116.06 139.01 50.72 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.022 -1.473 . . . . 2.48 107.022 176.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.59 138.34 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.489 -0.93 . . . . 1.81 108.489 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 79.9 mt -105.11 125.3 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.196 -1.409 . . . . 2.11 107.196 -177.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -146.12 166.36 26.38 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 122.945 0.498 . . . . 3.18 111.227 -179.418 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -103.68 115.62 63.22 Favored Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 114.31 -1.313 . . . . 1.34 110.245 176.324 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -68.46 6.73 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.674 2.916 . . . . 0.56 113.706 -179.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.62 -43.24 48.98 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 119.381 0.991 . . . . 1.7 108.438 174.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -100.86 -40.82 7.11 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.27 1.828 . . . . 2.99 109.906 178.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.6 m -138.82 127.3 23.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 118.568 2.803 . . . . 1.31 118.568 -154.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -159.0 -164.68 14.74 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 109.752 -1.339 . . . . 0.64 109.752 156.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.273 0.1 OUTLIER -29.28 -44.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 129.357 3.063 . . . . 1.69 114.13 173.245 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.48 -57.09 8.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.195 0.907 . . . . 1.66 112.546 175.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.26 -39.36 63.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 122.181 0.991 . . . . 1.59 108.933 -176.12 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mt -60.87 -59.24 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-N 114.149 -1.387 . . . . 1.79 109.279 -174.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.65 -51.48 12.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.914 1.234 . . . . 0.75 111.279 177.728 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -42.48 -56.07 3.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.893 0.701 . . . . 2.44 112.893 174.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -44.27 71.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 119.056 -1.058 . . . . 2.78 111.347 178.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.8 mm -51.01 -46.33 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.65 0.78 . . . . 1.67 110.456 -178.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -50.11 -50.56 48.1 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.328 0.585 . . . . 1.42 110.07 174.092 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -72.35 -30.79 65.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.904 0.705 . . . . 3.85 112.904 -175.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.51 -25.34 24.97 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.68 0.392 . . . . 1.74 110.383 165.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.25 28.78 5.38 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 124.656 1.122 . . . . 0.39 110.859 172.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -145.52 163.52 34.47 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 107.943 -1.132 . . . . 3.45 107.943 -176.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.01 126.58 50.28 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.977 -1.49 . . . . 5.65 106.977 177.781 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.0 p -94.74 141.58 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 122.92 0.488 . . . . 1.7 109.771 172.22 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 m -96.88 158.14 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.987 -0.746 . . . . 2.09 108.987 173.393 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.8 mm -125.03 82.2 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 107.421 -1.326 . . . . 1.8 107.421 174.218 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -132.26 132.47 43.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.582 -2.377 . . . . 5.01 104.582 172.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.93 -64.91 0.24 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-N 119.378 0.99 . . . . 4.14 113.389 -177.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.276 0 N-CA-C 105.636 -1.987 . . . . 11.78 105.636 -177.792 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 119.123 -0.465 . . . . 11.77 110.056 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 mp 65.84 -174.86 0.18 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.249 0.619 . . . . 11.58 109.973 -172.477 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 m 65.24 -165.22 0.24 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.749 0.82 . . . . 5.88 109.484 -168.407 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 68.93 133.7 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.649 1.98 . . . . 3.21 113.002 177.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -83.05 155.67 23.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.976 -0.556 . . . . 0.83 110.962 -175.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -147.9 156.56 42.83 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.982 0.896 . . . . 4.57 110.763 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.28 111.14 18.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.848 2.459 . . . . 2.19 108.991 173.251 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.02 151.89 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 107.203 -1.406 . . . . 2.71 107.203 162.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.02 127.82 19.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.431 1.492 . . . . 1.47 107.899 175.317 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -157.03 164.5 37.9 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.163 0.438 . . . . 1.87 110.727 -171.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.34 145.89 27.61 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.074 0.95 . . . . 1.83 109.066 -172.089 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.71 159.25 19.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 C-N-CA 123.127 0.571 . . . . 1.75 110.053 -176.087 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 t -121.34 125.03 46.0 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.909 1.284 . . . . 1.26 108.096 177.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.98 -12.25 11.6 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.14 0.876 . . . . 1.38 113.486 172.745 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.97 136.25 52.0 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.238 1.519 . . . . 4.38 110.886 176.454 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.7 p -110.77 26.83 10.28 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.606 0.763 . . . . 4.22 110.87 175.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.1 t 79.1 -175.92 0.08 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.362 1.465 . . . . 4.55 110.348 175.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 53.8 -146.18 0.56 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.784 0.834 . . . . 3.92 110.761 179.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.53 15.52 1.64 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.513 -0.742 . . . . 1.97 112.66 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.0 m -72.61 -60.19 2.35 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 119.296 0.953 . . . . 2.32 108.762 -177.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.87 -42.2 47.18 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-O 121.583 0.706 . . . . 2.03 111.503 175.309 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.19 -40.16 46.14 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.812 -0.613 . . . . 1.59 111.581 177.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -57.98 -43.4 86.53 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.848 0.749 . . . . 4.08 110.696 177.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.5 mt -53.47 -59.45 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 107.96 -1.126 . . . . 1.84 107.96 -176.799 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -70.58 -41.17 72.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.818 -0.628 . . . . 3.36 109.811 -176.03 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -49.66 -38.49 32.79 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.39 -1.444 . . . . 2.4 112.005 179.084 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.42 -51.79 40.78 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 111.548 -0.621 . . . . 0.4 111.548 169.064 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.6 mt -67.1 -27.7 67.56 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.639 -0.918 . . . . 2.0 112.666 177.476 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -62.09 -15.82 47.81 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.758 1.163 . . . . 3.57 110.004 172.146 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -96.89 4.97 51.35 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.162 1.171 . . . . 4.97 114.162 170.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 81.5 mmm -83.12 138.81 42.35 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 120.498 1.499 . . . . 3.12 111.529 176.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.68 94.26 0.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.387 2.724 . . . . 0.41 111.228 -172.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.87 -13.81 2.87 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.514 1.054 . . . . 0.22 111.327 178.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.3 p -69.22 160.59 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 117.735 0.767 . . . . 1.61 110.889 168.076 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.25 -56.37 1.82 Allowed 'General case' 0 C--N 1.335 -0.058 0 C-N-CA 124.055 0.942 . . . . 1.68 109.967 168.793 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -145.01 157.54 44.09 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.968 -0.382 . . . . 2.85 109.968 -179.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.22 136.12 39.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.504 2.322 . . . . 1.67 107.854 176.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.57 115.19 9.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.658 1.583 . . . . 1.42 108.193 -174.155 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.57 143.6 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.859 0.863 . . . . 1.83 112.062 -177.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -133.14 67.72 1.52 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.335 1.854 . . . . 1.7 111.86 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.5 mt -67.37 -16.89 64.5 Favored 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 113.085 0.772 . . . . 1.81 113.085 -179.046 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.83 -22.06 13.29 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.654 0.382 . . . . 1.58 110.875 168.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.1 m -127.82 17.79 6.78 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.741 1.216 . . . . 1.66 110.032 178.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 44.68 40.52 4.19 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.558 1.143 . . . . 2.75 111.632 -175.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.8 m -134.72 155.66 50.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.22 -1.4 . . . . 1.58 107.22 -169.132 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.8 148.9 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.773 -0.825 . . . . 1.46 108.773 173.012 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.25 153.11 36.81 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 124.047 0.842 . . . . 2.83 110.168 174.374 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.98 133.64 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 123.617 0.767 . . . . 1.64 109.382 -177.139 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.5 mt -100.01 112.04 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.755 1.622 . . . . 2.06 106.794 179.375 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -135.84 167.41 21.23 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.276 1.03 . . . . 3.16 110.998 178.335 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.91 119.85 54.28 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 124.726 1.21 . . . . 1.34 110.998 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.14 8.83 1.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.72 2.947 . . . . 0.56 113.586 -175.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.4 -53.25 6.78 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 107.585 -1.265 . . . . 1.63 107.585 175.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -85.48 -41.87 14.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.273 1.429 . . . . 2.87 110.429 175.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.0 m -138.14 126.61 23.34 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 117.925 2.565 . . . . 1.67 117.925 -151.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.83 -165.35 19.76 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.909 -1.041 . . . . 0.64 110.731 155.458 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.5 t -31.5 -43.22 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 129.386 3.075 . . . . 1.62 112.987 176.776 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.0 -56.87 7.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.785 0.72 . . . . 1.47 112.831 174.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.57 -37.05 65.65 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 122.29 1.043 . . . . 1.69 109.198 -179.517 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mt -64.79 -54.64 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 114.348 -1.296 . . . . 1.76 110.338 -171.516 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.74 -51.47 22.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.011 1.278 . . . . 0.77 110.882 174.711 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -43.42 -53.84 5.13 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 113.025 0.75 . . . . 2.26 113.025 173.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.14 -45.56 66.57 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 118.419 -0.8 . . . . 3.09 110.862 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.2 mm -50.1 -47.5 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.641 1.176 . . . . 1.58 110.384 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -51.22 -47.53 62.31 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.427 0.632 . . . . 1.53 110.053 174.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -33.06 67.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.75 0.82 . . . . 4.39 112.42 -177.001 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.64 -22.62 23.65 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.883 0.473 . . . . 2.09 110.395 166.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.19 30.88 7.55 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.225 -1.15 . . . . 0.45 110.225 175.325 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -137.32 163.62 30.55 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.615 -1.254 . . . . 3.6 107.615 178.511 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.24 130.88 56.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.104 -1.443 . . . . 5.23 107.104 174.119 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -99.4 146.72 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.629 0.771 . . . . 1.68 111.111 171.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.77 149.91 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.987 0.915 . . . . 2.28 109.738 171.077 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.1 mm -118.63 97.89 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 106.557 -1.646 . . . . 2.21 106.557 168.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.1 157.47 25.84 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.478 1.511 . . . . 4.5 108.624 176.461 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.52 -47.8 0.26 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.486 1.041 . . . . 4.68 112.281 177.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.194 0 CA-C-O 115.792 -2.051 . . . . 12.14 106.47 -176.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.1 mtt . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 108.646 -0.872 . . . . 9.03 108.646 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 36.4 tp 176.77 -85.44 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.913 2.085 . . . . 8.84 105.542 174.294 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 p -169.57 147.13 3.48 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 104.741 -2.318 . . . . 3.47 104.741 175.537 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.434 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 4.8 pt-20 -135.66 154.47 51.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.817 -1.92 . . . . 3.72 105.817 165.093 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -115.85 165.74 12.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.916 0.886 . . . . 0.68 109.671 178.095 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.434 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 28.1 mttp -149.72 162.98 39.17 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.357 0.599 . . . . 5.25 110.56 178.576 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -84.11 133.62 34.62 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.779 1.632 . . . . 2.04 107.768 166.849 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 tp -106.29 154.14 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.104 -1.813 . . . . 1.92 106.104 160.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.9 131.45 30.98 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.894 -1.521 . . . . 1.55 106.894 171.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -156.46 165.85 35.12 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.278 0.631 . . . . 1.81 110.428 -174.005 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -93.92 148.56 22.03 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.04 1.336 . . . . 2.99 107.785 -171.294 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.13 141.07 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 118.956 0.798 . . . . 1.87 110.522 178.705 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t -106.2 124.87 50.25 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.893 -1.521 . . . . 1.69 106.893 173.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.22 -74.26 0.35 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.376 -1.09 . . . . 2.45 110.376 -179.751 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 28.08 82.52 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.285 2.234 . . . . 6.84 114.404 179.634 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -95.08 11.45 32.07 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.925 1.69 . . . . 5.09 111.396 175.065 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.5 t 62.15 -154.49 0.35 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.928 1.291 . . . . 4.35 111.691 179.095 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 41.68 59.09 2.58 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.386 1.448 . . . . 3.14 113.338 177.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.48 19.46 7.88 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.931 1.292 . . . . 2.37 113.462 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.0 m -72.22 -56.94 4.69 Favored 'General case' 0 CA--C 1.514 -0.437 0 O-C-N 121.068 -1.02 . . . . 2.01 109.148 -173.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.02 -26.13 67.4 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.291 0.567 . . . . 2.08 112.111 177.383 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.24 -47.59 73.29 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 118.587 -0.72 . . . . 1.5 110.208 169.026 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -52.41 -48.76 65.52 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.389 0.995 . . . . 4.85 111.381 173.168 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.444 HG12 ' CD1' ' A' ' 69' ' ' TYR . 80.1 mt -43.68 -61.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.284 0 N-CA-C 108.856 -0.794 . . . . 1.97 108.856 179.78 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -36.08 66.3 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.773 -0.649 . . . . 2.43 112.427 -174.473 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -54.72 -37.63 66.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.941 -1.099 . . . . 3.63 111.009 176.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.51 -45.09 77.81 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.983 -0.847 . . . . 0.46 110.983 169.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.9 mt -67.25 -31.18 71.35 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.128 -1.219 . . . . 1.55 111.517 176.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -60.47 -17.5 45.32 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.221 0.918 . . . . 2.08 111.215 172.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -81.38 -16.22 52.91 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.928 -1.107 . . . . 4.41 113.674 169.378 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 14.8 mmt -73.71 137.73 77.05 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 120.785 1.63 . . . . 3.23 112.744 -173.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.74 87.82 0.8 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.903 3.069 . . . . 0.79 111.284 -172.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.05 -22.82 0.99 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.994 -0.843 . . . . 0.48 110.994 -174.302 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.09 159.65 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 O-C-N 121.845 -0.797 . . . . 1.71 111.939 175.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.54 -57.36 1.47 Allowed 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.652 1.181 . . . . 1.74 109.344 169.49 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -138.97 154.84 48.34 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 113.884 1.068 . . . . 3.07 113.884 178.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.13 124.06 18.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.071 1.748 . . . . 1.74 108.025 -175.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -143.44 119.97 11.04 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.584 0.754 . . . . 1.64 109.166 -166.111 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -96.63 128.17 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.466 0.707 . . . . 2.2 111.529 -173.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -113.91 69.51 0.71 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.032 -1.47 . . . . 3.68 107.032 177.158 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 72.9 mt -61.57 -21.79 64.62 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.893 -0.594 . . . . 1.89 111.641 175.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.71 -25.05 16.67 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.872 0.869 . . . . 1.61 111.405 170.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 m -124.96 15.39 8.54 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.123 1.369 . . . . 2.12 109.886 -179.308 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 47.02 37.04 4.6 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.407 1.083 . . . . 2.46 111.632 -176.348 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.0 m -133.78 150.59 51.45 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.807 -1.553 . . . . 1.61 106.807 -170.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.3 p -128.96 146.9 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 107.684 -1.228 . . . . 1.6 107.684 174.492 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.32 149.08 44.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 123.895 0.747 . . . . 2.75 109.114 173.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.26 133.78 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.393 -0.965 . . . . 1.85 108.393 -179.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.2 mt -101.69 120.25 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 127.231 2.212 . . . . 1.8 106.501 -176.462 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -149.68 166.15 30.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.656 0.782 . . . . 3.08 110.548 -177.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -95.22 108.08 36.45 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 125.228 1.411 . . . . 2.26 110.611 175.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -70.34 12.82 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.229 3.286 . . . . 0.95 114.117 -179.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.97 -49.66 6.92 Favored 'General case' 0 N--CA 1.459 0.023 0 N-CA-C 107.105 -1.443 . . . . 1.73 107.105 171.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -85.6 -34.09 21.51 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.18 1.392 . . . . 2.47 111.037 178.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.9 m -154.39 122.15 5.87 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 117.112 2.264 . . . . 1.59 117.112 -156.601 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.97 -171.68 24.2 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 121.69 -0.631 . . . . 0.66 112.222 165.383 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.96 -44.66 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.942 2.897 . . . . 1.52 112.531 176.499 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.4 -55.78 9.91 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.062 0.764 . . . . 1.6 113.062 175.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.18 -38.7 63.59 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 122.644 1.211 . . . . 1.65 109.127 178.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.95 -48.61 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 114.407 -1.27 . . . . 1.62 110.619 -169.063 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -50.53 60.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.164 1.347 . . . . 0.9 110.355 173.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -43.32 -57.95 2.78 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.852 0.834 . . . . 2.4 112.879 171.846 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -42.27 83.66 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 118.595 -0.717 . . . . 2.8 111.418 -178.228 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.47 -47.8 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 119.355 0.98 . . . . 1.76 110.047 177.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -51.72 -46.29 63.91 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.103 0.478 . . . . 1.66 110.026 173.083 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -37.7 84.27 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.482 -0.761 . . . . 4.47 112.01 -178.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.97 -21.95 34.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.75 0.82 . . . . 2.09 110.517 170.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.83 28.5 7.8 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 124.409 1.004 . . . . 0.51 110.97 173.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.444 ' CD1' HG12 ' A' ' 24' ' ' ILE . 47.5 m-85 -141.23 175.11 9.91 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.042 -1.095 . . . . 3.64 108.042 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 111.43 7.39 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.232 -1.025 . . . . 6.11 108.232 -171.525 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.49 147.21 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.466 -0.788 . . . . 1.7 109.74 -179.007 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.12 131.57 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.449 1.499 . . . . 2.82 110.15 -174.424 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.8 mt -119.84 91.85 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.437 1.495 . . . . 2.82 108.142 -177.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -72.41 71.19 0.91 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 122.185 0.993 . . . . 5.28 112.167 -177.356 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.01 -47.0 3.73 Favored Glycine 0 CA--C 1.528 0.848 0 O-C-N 121.343 -0.848 . . . . 5.15 112.685 168.658 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 116.996 -1.478 . . . . 10.08 108.105 169.87 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 110.601 -0.148 . . . . 0.93000000000000005 110.601 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -152.38 162.32 41.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.597 0.713 . . . . 2.7799999999999998 111.642 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 0.8 OUTLIER -84.4 150.2 25.5 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.492 1.517 . . . . 3.75 109.006 166.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 tp -129.48 156.47 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.352 -1.721 . . . . 1.2 106.352 162.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.88 130.78 24.46 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.711 1.204 . . . . 0.31 108.442 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.84 171.63 19.94 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.238 0.472 . . . . 1.1599999999999999 111.956 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.22 153.7 19.12 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.516 0.726 . . . . 1.97 110.009 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -118.51 158.06 19.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 123.903 0.881 . . . . 0.57999999999999996 109.402 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.45 -0.472 0 C-N-CA 124.319 1.048 . . . . 0.79000000000000004 108.178 176.618 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 112.051 0.389 . . . . 0.45000000000000001 112.051 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.91 -41.73 99.55 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.444 0.566 . . . . 4.0700000000000003 111.221 177.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.427 ' CG2' HD12 ' A' ' 64' ' ' ILE . 60.4 mt -51.71 -60.16 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.612 -1.255 . . . . 0.54000000000000004 107.612 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.409 ' CD ' HG21 ' A' ' 46' ' ' VAL . 1.0 OUTLIER -71.73 -34.49 69.61 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.372 -0.831 . . . . 2.6000000000000001 111.516 -173.006 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -56.39 -36.84 69.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.116 -0.99 . . . . 1.45 110.963 174.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.28 -49.18 60.98 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.765 -0.934 . . . . 0.29999999999999999 110.765 168.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.825 HD11 HD11 ' A' ' 64' ' ' ILE . 96.8 mt -65.14 -30.9 71.87 Favored 'General case' 0 C--O 1.225 -0.207 0 O-C-N 121.544 -0.974 . . . . 0.33000000000000002 112.882 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt -58.85 -17.55 24.88 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.145 0.884 . . . . 1.26 111.257 171.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -93.77 4.35 54.06 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.962 1.097 . . . . 5.5800000000000001 113.962 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.0 mmt -82.03 136.4 47.22 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 120.702 1.592 . . . . 2.79 112.605 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.17 98.25 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.8 3.0 . . . . 0.38 110.111 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.74 -14.96 4.12 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.588 -1.005 . . . . 0.22 110.588 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 p -69.45 152.74 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 117.524 0.662 . . . . 0.28999999999999998 110.434 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.53 -57.48 2.21 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.159 1.384 . . . . 0.73999999999999999 109.48 170.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -144.51 158.09 43.92 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 122.973 0.509 . . . . 3.1800000000000002 110.39 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.65 127.6 33.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.272 1.829 . . . . 0.79000000000000004 107.926 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.09 113.31 8.37 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.854 0.861 . . . . 1.48 109.164 -174.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -89.73 140.34 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.098 0.959 . . . . 0.68000000000000005 111.72 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -131.72 67.22 1.52 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.169 1.788 . . . . 1.22 111.581 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.74 -16.68 64.01 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 113.131 0.789 . . . . 0.69999999999999996 113.131 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.03 -23.94 15.31 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.637 0.375 . . . . 0.58999999999999997 110.748 168.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.5 m -126.62 18.31 7.42 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.073 1.349 . . . . 0.47999999999999998 110.008 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 45.35 38.96 3.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.616 1.166 . . . . 2.48 111.869 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.9 m -136.17 154.63 50.9 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.28 -1.378 . . . . 0.48999999999999999 107.28 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.409 HG21 ' CD ' ' A' ' 25' ' ' GLU . 7.1 p -133.55 150.02 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.588 -0.893 . . . . 0.42999999999999999 108.588 173.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.41 150.08 41.35 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.739 -0.837 . . . . 2.8300000000000001 108.739 171.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.94 139.63 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 107.146 -1.427 . . . . 0.38 107.146 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.1 mt -108.09 131.63 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.019 -1.474 . . . . 0.88 107.019 -175.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -154.2 167.78 28.74 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 123.257 0.348 . . . . 1.8300000000000001 111.767 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -102.75 110.85 64.15 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 124.508 1.123 . . . . 1.6200000000000001 109.856 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -74.74 30.12 0.35 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.94 3.093 . . . . 0.81999999999999995 112.752 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.13 -50.21 5.17 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.044 -1.465 . . . . 0.44 107.044 167.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -87.24 -46.71 9.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.689 1.196 . . . . 2.6499999999999999 110.269 173.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.6 m -140.88 136.42 32.31 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 117.591 2.441 . . . . 0.68000000000000005 117.591 -148.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.85 -161.31 23.05 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 109.102 -1.599 . . . . 0.47999999999999998 109.102 164.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 t -38.15 -43.53 0.77 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.833 2.453 . . . . 0.54000000000000004 112.427 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.32 -57.43 4.62 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.809 0.844 . . . . 0.28999999999999998 112.72 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.56 -37.56 65.49 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.873 0.844 . . . . 0.19 109.328 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.556 HG12 HD22 ' A' ' 28' ' ' LEU . 1.2 mt -61.56 -59.46 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-N 114.466 -1.243 . . . . 0.76000000000000001 109.341 -171.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -47.94 -50.36 27.33 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.099 1.318 . . . . 0.80000000000000004 110.846 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.28 -52.58 9.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.205 1.002 . . . . 2.3900000000000001 111.988 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -43.84 69.07 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.984 -0.686 . . . . 2.02 111.373 177.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.825 HD11 HD11 ' A' ' 28' ' ' LEU . 35.7 mm -52.53 -45.28 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 118.985 0.811 . . . . 0.56999999999999995 110.284 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -49.3 -47.35 47.06 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.895 0.379 . . . . 1.6200000000000001 110.646 173.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -71.96 -33.23 68.03 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.954 1.094 . . . . 2.9700000000000002 113.954 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.49 -24.59 21.09 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.268 0.486 . . . . 0.89000000000000001 110.205 166.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.66 29.29 6.64 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.114 -1.194 . . . . 0.27000000000000002 110.114 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -140.73 162.08 36.27 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.01 -1.478 . . . . 1.6599999999999999 107.01 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.61 ' HE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -113.79 133.72 55.21 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.118 -1.808 . . . . 4.0499999999999998 106.118 170.438 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.443 ' HB ' HG21 ' A' ' 64' ' ' ILE . 4.5 p -100.73 148.53 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.39 0.676 . . . . 0.46999999999999997 109.948 170.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.61 HG13 ' HE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.569 0 CA-C-N 118.594 0.634 . . . . 1.45 109.738 167.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.288 0.089 . . . . 1.22 110.939 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.98 154.77 41.64 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.68 0.752 . . . . 3.4399999999999999 110.878 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -86.97 137.06 32.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.837 -1.529 . . . . 2.1800000000000002 108.993 166.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.0 tp -112.07 155.64 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 105.917 -1.883 . . . . 1.1799999999999999 105.917 162.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.55 130.55 21.84 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 108.072 -1.085 . . . . 0.41999999999999998 108.072 172.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.62 173.47 16.89 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.177 0.899 . . . . 1.2 111.4 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.93 149.47 22.37 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.434 0.694 . . . . 1.8200000000000001 109.599 -172.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.596 HG11 HD13 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -125.34 143.78 37.69 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.059 0 C-N-CA 122.708 0.403 . . . . 0.83999999999999997 110.883 -176.664 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.45 -0.428 0 C-N-CA 124.343 1.057 . . . . 1.03 109.31 175.613 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 109.469 -0.567 . . . . 0.44 109.469 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -49.99 -49.66 49.81 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.707 0.685 . . . . 6.9199999999999999 111.652 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.596 HD13 HG11 ' A' ' 12' ' ' VAL . 90.5 mt -44.02 -62.62 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 123.432 0.693 . . . . 0.98999999999999999 109.324 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.42 -35.37 65.82 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.303 0.573 . . . . 2.3599999999999999 112.394 -172.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -58.2 -36.43 73.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.955 -1.091 . . . . 1.22 110.722 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.59 -51.01 51.13 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.564 -1.014 . . . . 0.34000000000000002 110.564 166.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.766 HD11 HD11 ' A' ' 64' ' ' ILE . 94.2 mt -63.71 -33.6 76.0 Favored 'General case' 0 C--O 1.221 -0.417 0 O-C-N 121.579 -0.954 . . . . 0.40999999999999998 112.444 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -57.79 -18.61 22.81 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.28 0.946 . . . . 1.5600000000000001 112.058 172.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -85.33 -11.78 53.83 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.822 1.415 . . . . 4.2300000000000004 114.822 169.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.561 ' O ' HG12 ' A' ' 34' ' ' VAL . 4.8 mmt -69.63 143.51 92.8 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 120.85 1.659 . . . . 1.8500000000000001 112.074 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.74 106.63 1.51 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.39 2.06 . . . . 0.56999999999999995 109.537 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.09 -13.41 5.75 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.079 1.323 . . . . 0.25 110.784 171.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 31' ' ' MET . 8.1 p -70.27 160.56 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 O-C-N 121.939 -0.742 . . . . 0.32000000000000001 111.517 171.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.49 -65.7 1.15 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.84 1.256 . . . . 0.56999999999999995 108.212 165.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -144.43 147.43 33.34 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.349 -0.387 . . . . 3.25 111.793 -162.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.27 138.29 50.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.24 1.416 . . . . 0.63 108.587 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -140.0 118.45 12.18 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.975 0.91 . . . . 1.4199999999999999 109.408 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -86.4 136.35 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.99 0.916 . . . . 0.65000000000000002 111.054 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -129.23 69.68 1.41 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.318 1.847 . . . . 1.21 110.994 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.2 mt -64.09 -18.63 64.57 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.848 0.685 . . . . 0.95999999999999996 112.848 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.84 -18.21 8.15 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.124 0.42 . . . . 0.84999999999999998 110.977 170.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.7 m -131.87 18.06 4.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.823 1.249 . . . . 0.68999999999999995 109.872 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 41.12 39.24 0.86 Allowed 'General case' 0 C--N 1.346 0.419 0 C-N-CA 124.895 1.278 . . . . 2.6000000000000001 112.128 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.4 m -129.59 152.46 49.09 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.16 -1.422 . . . . 0.64000000000000001 107.16 -171.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 p -133.85 146.85 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 107.143 -1.429 . . . . 0.52000000000000002 107.143 173.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.75 145.8 46.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 123.93 0.769 . . . . 2.6000000000000001 109.39 173.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -144.0 136.66 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.615 -0.883 . . . . 0.25 108.615 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.0 mt -103.61 118.87 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.704 2.002 . . . . 0.94999999999999996 107.145 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -146.17 169.0 19.63 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.74 0.781 . . . . 1.8999999999999999 110.415 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -96.71 125.3 47.32 Favored Pre-proline 0 N--CA 1.439 -1.003 0 CA-C-N 114.316 -1.311 . . . . 1.3500000000000001 109.502 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.41 6.69 2.56 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.778 2.318 . . . . 0.71999999999999997 113.315 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.19 -54.47 4.59 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 119.358 0.981 . . . . 0.46999999999999997 108.95 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -85.43 -55.86 3.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.312 1.445 . . . . 3.1299999999999999 109.297 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.8 m -86.93 160.16 18.78 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 126.366 1.867 . . . . 2.1000000000000001 112.984 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.24 161.25 35.07 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 104.859 -3.296 . . . . 1.4099999999999999 104.859 168.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 t -51.29 -32.24 24.24 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 117.192 0.496 . . . . 1.1399999999999999 110.288 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -36.26 -61.32 0.51 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.97 1.708 . . . . 0.68999999999999995 114.449 164.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.89 -37.97 73.03 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.938 -1.134 . . . . 0.38 107.938 -172.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.531 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -55.62 -62.29 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-N 114.315 -1.311 . . . . 0.92000000000000004 109.214 177.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -46.9 -54.1 10.75 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.354 1.434 . . . . 1.1899999999999999 110.676 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -41.05 -57.0 2.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.663 0.785 . . . . 2.52 112.767 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.64 -40.46 69.7 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 119.917 -0.713 . . . . 1.8799999999999999 110.046 -176.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.766 HD11 HD11 ' A' ' 28' ' ' LEU . 27.5 mm -52.61 -47.18 49.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 119.188 0.903 . . . . 0.41999999999999998 109.994 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -53.28 -42.54 66.66 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.637 0.375 . . . . 1.6899999999999999 110.754 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -71.04 -38.96 72.56 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.422 -0.799 . . . . 2.9399999999999999 110.915 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -54.96 -25.09 27.24 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.715 0.806 . . . . 1.0800000000000001 110.263 171.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.17 29.66 6.3 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.331 -1.108 . . . . 0.46999999999999997 110.331 172.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.533 ' CD2' HD11 ' A' ' 24' ' ' ILE . 44.0 m-85 -140.76 166.25 25.27 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.968 -1.123 . . . . 1.9399999999999999 107.968 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -122.17 122.0 38.18 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 104.679 -2.341 . . . . 3.3300000000000001 104.679 -173.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.411 ' HB ' HG21 ' A' ' 64' ' ' ILE . 7.2 p -100.54 142.51 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.182 -0.673 . . . . 0.42999999999999999 109.182 173.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--O 1.226 -0.17 0 N-CA-C 108.545 -0.909 . . . . 1.03 108.545 173.472 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 110.697 -0.112 . . . . 0.60999999999999999 110.697 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -146.14 157.17 43.83 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.013 -0.736 . . . . 3.71 109.013 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.68 127.94 35.59 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.625 1.57 . . . . 3.71 109.5 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 tp -106.73 152.17 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.767 -1.568 . . . . 1.0900000000000001 106.767 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.81 132.65 27.51 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.258 -1.386 . . . . 0.34999999999999998 107.258 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -156.41 163.16 39.8 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.072 0.549 . . . . 1.25 110.68 -170.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.77 154.56 18.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.343 -1.355 . . . . 2.2599999999999998 107.343 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.4 163.43 14.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.064 -1.087 . . . . 0.56000000000000005 108.064 173.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 107.555 -1.276 . . . . 1.0700000000000001 107.555 173.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 110.529 -0.174 . . . . 0.56999999999999995 110.529 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -62.79 -48.1 80.58 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 122.89 0.476 . . . . 4.0499999999999998 110.752 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.1 mt -49.62 -56.74 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.437 -0.579 . . . . 0.57999999999999996 109.437 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.78 -42.89 76.78 Favored 'General case' 0 C--O 1.219 -0.522 0 C-N-CA 120.208 -0.597 . . . . 3.48 109.567 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -49.51 -36.77 24.23 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.406 -1.434 . . . . 2.04 111.691 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.17 -51.71 39.93 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 112.191 -0.364 . . . . 0.44 112.191 167.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.805 HD11 HD11 ' A' ' 64' ' ' ILE . 90.2 mt -68.4 -28.34 67.01 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 121.401 -1.058 . . . . 0.55000000000000004 113.043 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.281 21.5 ttmt -62.7 -15.04 50.84 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.965 1.257 . . . . 2.29 110.238 175.003 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -25.63 60.12 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.217 1.192 . . . . 3.8900000000000001 114.217 166.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.549 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -67.18 134.83 93.55 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 120.14 1.336 . . . . 2.52 111.939 -169.687 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -65.58 100.79 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.303 2.669 . . . . 0.38 109.52 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.6 -17.68 3.48 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.405 -1.078 . . . . 0.23000000000000001 110.405 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 31' ' ' MET . 6.2 p -72.17 154.65 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 121.965 -0.727 . . . . 0.28000000000000003 110.385 169.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.18 -57.22 2.23 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 123.009 0.524 . . . . 0.45000000000000001 109.666 171.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -148.49 157.45 43.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.516 -0.55 . . . . 2.5600000000000001 109.516 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.72 136.11 33.85 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 127.232 2.213 . . . . 0.65000000000000002 108.325 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -137.87 117.71 13.23 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 125.222 1.576 . . . . 1.7 107.931 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -84.32 144.15 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.159 0.984 . . . . 0.73999999999999999 110.847 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -137.73 64.36 1.52 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.321 1.449 . . . . 1.25 112.124 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 41' ' ' LEU . 91.4 mt -65.55 -16.97 64.21 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 112.523 0.564 . . . . 0.96999999999999997 112.523 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.05 59.42 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.227 0.467 . . . . 0.82999999999999996 110.82 168.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.9 m -118.63 16.45 13.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.231 1.412 . . . . 0.75 109.962 176.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 48.28 36.37 6.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.601 1.161 . . . . 2.3300000000000001 111.769 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.4 m -138.04 155.3 48.95 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.747 -1.205 . . . . 0.56000000000000005 107.747 -168.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 p -136.48 150.36 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 108.825 -0.805 . . . . 0.52000000000000002 108.825 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.98 153.01 44.94 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 123.852 0.72 . . . . 2.7200000000000002 110.224 175.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.78 136.8 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.998 -0.742 . . . . 0.37 108.998 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.8 114.14 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.065 -1.457 . . . . 1.01 107.065 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -137.67 167.24 22.09 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.515 0.726 . . . . 1.9299999999999999 111.118 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -102.73 113.91 65.61 Favored Pre-proline 0 N--CA 1.443 -0.805 0 C-N-CA 124.475 1.11 . . . . 1.3100000000000001 110.612 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.8 17.89 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.529 2.819 . . . . 0.56000000000000005 113.724 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.47 -51.76 7.08 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 107.646 -1.242 . . . . 0.52000000000000002 107.646 168.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -81.47 -46.23 14.85 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.257 1.023 . . . . 2.9500000000000002 110.265 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.9 m -142.37 129.61 21.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 118.295 2.702 . . . . 0.67000000000000004 118.295 -143.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.08 -160.55 20.88 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.024 -1.23 . . . . 0.55000000000000004 110.024 162.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 t -29.43 -48.73 0.08 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 129.544 3.137 . . . . 0.56000000000000005 112.9 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.2 -55.9 7.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.719 0.808 . . . . 0.31 112.39 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.53 -38.0 65.42 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 122.149 0.976 . . . . 0.26000000000000001 109.432 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.528 HG12 HD22 ' A' ' 28' ' ' LEU . 1.4 mt -63.55 -56.63 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 114.408 -1.269 . . . . 0.67000000000000004 110.017 -169.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.51 -53.49 14.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.81 1.186 . . . . 0.77000000000000002 110.41 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -41.81 -54.05 3.51 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.245 1.018 . . . . 2.4399999999999999 112.266 175.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -41.39 68.06 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 118.179 -0.915 . . . . 1.8400000000000001 110.791 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.805 HD11 HD11 ' A' ' 28' ' ' LEU . 41.4 mm -53.75 -46.54 62.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.871 1.214 . . . . 0.40000000000000002 110.216 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -51.83 -42.9 62.89 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.333 0.587 . . . . 1.54 109.946 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -37.19 73.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.594 0.758 . . . . 4.5499999999999998 112.174 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -56.05 -19.95 14.91 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.149 0.579 . . . . 0.89000000000000001 110.731 168.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.51 27.76 12.56 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 110.405 -1.078 . . . . 0.42999999999999999 110.405 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -136.07 169.55 17.42 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 108.256 -1.016 . . . . 2.0 108.256 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.5 123.85 43.02 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.036 -1.098 . . . . 4.5199999999999996 108.036 176.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 p -91.61 153.29 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.969 1.308 . . . . 0.55000000000000004 109.712 173.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.173 0 C-N-CA 122.929 0.492 . . . . 1.26 110.222 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.215 0.055 . . . . 0.79000000000000004 111.05 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -153.46 159.44 42.32 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.356 0.598 . . . . 2.54 111.697 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -84.87 124.92 32.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.665 2.386 . . . . 2.1600000000000001 108.31 169.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 tp -104.06 147.92 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 106.878 -1.526 . . . . 1.2 106.878 161.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.47 129.35 37.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.651 -1.24 . . . . 0.34000000000000002 107.651 173.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -155.41 170.19 22.51 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.799 -0.445 . . . . 1.6599999999999999 109.799 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -97.1 148.69 22.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.272 1.029 . . . . 3.0899999999999999 108.879 -174.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.431 HG11 HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -122.03 160.57 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 C-N-CA 123.783 0.833 . . . . 0.60999999999999999 109.573 179.122 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 109.0 -0.741 . . . . 1.3799999999999999 109.0 165.313 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.737 0 CA-C-O 118.861 -0.59 . . . . 0.52000000000000002 110.615 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -61.8 -48.7 79.45 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.243 0.929 . . . . 3.71 111.415 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.482 HG22 ' OE1' ' A' ' 25' ' ' GLU . 47.3 mt -42.34 -62.82 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 124.716 1.206 . . . . 1.1399999999999999 108.388 173.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.482 ' OE1' HG22 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -73.45 -32.71 64.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 119.458 -0.897 . . . . 2.5600000000000001 112.664 -174.18 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -57.16 -37.7 72.46 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.95 -1.094 . . . . 2.1000000000000001 110.434 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.69 -50.7 56.74 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 110.476 -1.05 . . . . 0.46999999999999997 110.476 169.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.555 HD22 HG12 ' A' ' 60' ' ' ILE . 88.7 mt -62.29 -31.57 72.18 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 121.896 -0.767 . . . . 0.47999999999999998 112.12 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -62.51 -15.59 51.24 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 119.155 0.889 . . . . 2.6200000000000001 110.722 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.27 -3.17 44.56 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.043 1.127 . . . . 4.5 114.043 169.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.442 ' O ' HG12 ' A' ' 34' ' ' VAL . 75.1 mmm -74.07 138.91 75.82 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 120.786 1.63 . . . . 2.1000000000000001 111.768 -177.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.64 90.39 0.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.31 2.673 . . . . 0.52000000000000002 110.971 -173.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.99 -9.04 4.19 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.122 1.344 . . . . 0.31 111.347 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 31' ' ' MET . 4.4 p -64.69 161.87 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.399 1.099 . . . . 0.33000000000000002 110.251 164.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.21 -53.61 2.13 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.738 1.215 . . . . 0.42999999999999999 110.373 166.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -148.25 163.77 36.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.467 -0.568 . . . . 3.0499999999999998 109.467 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.24 141.99 26.75 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.979 1.712 . . . . 0.72999999999999998 108.627 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -152.19 119.63 6.0 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.887 0.875 . . . . 1.4299999999999999 108.754 -165.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.541 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.2 p -84.98 145.72 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.318 1.047 . . . . 0.93000000000000005 112.376 -175.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -134.32 69.95 1.45 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.968 1.707 . . . . 1.3 112.345 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.4 mt -61.57 -22.26 65.04 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 112.295 0.48 . . . . 1.46 112.295 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.61 -16.44 25.79 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.406 0.548 . . . . 0.95999999999999996 111.174 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.9 m -132.66 18.24 4.28 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.918 0.887 . . . . 0.75 109.529 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 43.95 45.5 6.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.902 0.881 . . . . 2.4100000000000001 111.505 -175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.8 m -136.37 159.92 40.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.95 1.3 . . . . 0.47999999999999998 108.145 -170.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.541 HG23 ' HA ' ' A' ' 39' ' ' VAL . 12.0 p -139.61 149.65 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.378 -0.971 . . . . 0.60999999999999999 108.378 172.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -117.58 139.45 50.95 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.922 1.289 . . . . 2.5 109.301 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.29 132.85 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.274 0.63 . . . . 0.53000000000000003 109.841 174.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.72 125.12 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.295 1.438 . . . . 0.93000000000000005 107.542 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -146.24 169.72 18.2 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.314 0.646 . . . . 1.95 110.983 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -107.73 121.4 44.24 Favored Pre-proline 0 N--CA 1.447 -0.619 0 C-N-CA 124.726 1.21 . . . . 2.0899999999999999 110.982 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -71.94 10.85 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.349 3.366 . . . . 0.85999999999999999 113.684 -176.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.74 -50.32 12.63 Favored 'General case' 0 N--CA 1.458 -0.037 0 N-CA-C 107.409 -1.33 . . . . 0.84999999999999998 107.409 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -96.03 -40.16 9.39 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.019 1.728 . . . . 3.0 110.557 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.4 m -136.08 131.15 34.46 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 117.929 2.566 . . . . 0.56000000000000005 117.929 -153.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.99 -168.62 24.16 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.866 -1.293 . . . . 0.5 109.866 160.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.1 t -38.69 -40.35 0.59 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.947 2.499 . . . . 0.65000000000000002 112.243 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.17 -56.43 6.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.569 0.748 . . . . 0.28000000000000003 112.593 173.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.25 -34.48 68.3 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 122.562 1.172 . . . . 0.22 109.323 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.555 HG12 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -69.26 -52.51 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 113.943 -1.481 . . . . 0.56000000000000005 111.161 -169.605 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.49 -50.69 59.39 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.322 1.419 . . . . 0.79000000000000004 109.641 173.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.47 -53.88 16.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.32 1.048 . . . . 4.9199999999999999 111.193 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -67.22 -41.93 84.9 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 121.703 -0.623 . . . . 2.2000000000000002 111.531 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.499 HD11 HD11 ' A' ' 28' ' ' LEU . 4.0 mm -55.19 -45.27 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.054 0.942 . . . . 0.37 110.191 -176.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -48.96 -47.01 44.31 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.305 0.574 . . . . 1.5800000000000001 110.596 171.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -32.71 69.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.378 0.881 . . . . 2.9900000000000002 113.378 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.63 -25.54 18.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.321 0.509 . . . . 0.93999999999999995 110.118 166.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.13 29.67 5.67 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.256 -1.138 . . . . 0.46000000000000002 110.256 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.431 ' CD2' HD11 ' A' ' 24' ' ' ILE . 26.8 m-85 -146.23 159.55 43.18 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 106.84 -1.541 . . . . 1.9299999999999999 106.84 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.79 135.37 54.03 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.776 0.798 . . . . 3.9399999999999999 109.324 171.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.9 p -99.34 152.54 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.478 1.511 . . . . 0.55000000000000004 109.751 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 C--O 1.226 -0.174 0 N-CA-C 109.4 -0.593 . . . . 0.88 109.4 175.208 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 119.662 -0.209 . . . . 0.68000000000000005 111.076 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -146.84 151.53 37.25 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 122.689 1.233 . . . . 3.3399999999999999 112.724 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -84.83 106.08 16.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 131.21 3.804 . . . . 2.4300000000000002 107.858 171.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.09 148.3 4.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 N-CA-C 107.199 -1.408 . . . . 1.21 107.199 165.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.54 126.28 29.01 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 124.775 1.23 . . . . 0.35999999999999999 107.73 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -156.52 165.48 36.17 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.525 -0.546 . . . . 1.0600000000000001 109.525 -170.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.72 155.2 16.87 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 108.827 -0.805 . . . . 2.02 108.827 -174.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.11 163.06 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 108.218 -1.03 . . . . 0.59999999999999998 108.218 175.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 107.085 -1.45 . . . . 1.0900000000000001 107.085 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.564 0 CA-C-O 119.369 -0.348 . . . . 0.40999999999999998 111.633 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -58.79 -41.49 86.82 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.592 0.633 . . . . 5.6299999999999999 111.145 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.2 mt -54.51 -59.74 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.592 -1.262 . . . . 0.80000000000000004 107.592 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.37 -36.14 73.97 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.431 -0.804 . . . . 2.54 110.501 -171.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -56.12 -36.47 68.25 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.199 -0.938 . . . . 1.77 110.961 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.2 -48.04 48.12 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.007 -0.837 . . . . 0.47999999999999998 111.007 166.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.712 HD11 HD11 ' A' ' 64' ' ' ILE . 44.2 mt -68.01 -30.55 69.83 Favored 'General case' 0 C--O 1.224 -0.241 0 O-C-N 121.351 -1.088 . . . . 0.51000000000000001 111.842 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.531 ' HA ' HG11 ' A' ' 34' ' ' VAL . 9.2 ttmt -60.33 -19.1 54.03 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.712 1.142 . . . . 1.21 111.468 172.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -25.21 62.02 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.95 -1.094 . . . . 4.04 113.349 168.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.502 ' O ' HG12 ' A' ' 34' ' ' VAL . 92.1 mmm -72.6 134.02 82.23 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 119.784 1.174 . . . . 2.0099999999999998 112.448 -167.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.03 101.44 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.902 3.068 . . . . 0.38 110.653 -172.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.22 -15.35 3.97 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.667 -0.973 . . . . 0.23000000000000001 110.667 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.3 p -72.48 154.71 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 O-C-N 122.081 -0.658 . . . . 0.29999999999999999 111.158 171.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.65 -53.78 2.08 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.784 1.234 . . . . 0.46999999999999997 109.801 171.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -142.44 153.46 43.73 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 113.606 0.965 . . . . 2.9300000000000002 113.606 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.65 125.4 38.02 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.596 1.958 . . . . 0.80000000000000004 107.971 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.13 109.39 6.88 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.043 1.337 . . . . 1.4199999999999999 108.857 -168.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.3 145.26 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.928 0.891 . . . . 0.60999999999999999 112.372 -172.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -135.6 67.73 1.47 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.121 1.768 . . . . 1.3200000000000001 111.622 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.5 mt -68.0 -14.6 63.09 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 113.159 0.8 . . . . 0.65000000000000002 113.159 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.15 -14.1 3.7 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.822 0.449 . . . . 0.60999999999999999 111.355 166.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 m -137.27 19.34 2.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.477 1.111 . . . . 0.55000000000000004 109.422 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 47.44 36.98 5.57 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.262 1.025 . . . . 2.71 111.232 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.9 m -132.22 156.27 46.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.781 -1.192 . . . . 0.46000000000000002 107.781 -168.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.81 148.2 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 108.828 -0.804 . . . . 0.41999999999999998 108.828 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -116.55 138.2 51.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.796 -1.187 . . . . 2.48 107.796 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.87 131.09 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.275 -1.009 . . . . 0.28000000000000003 108.275 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.91 115.76 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.803 -1.554 . . . . 1.28 106.803 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -141.49 170.59 15.43 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.177 0.991 . . . . 2.1499999999999999 110.323 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -104.56 111.47 65.21 Favored Pre-proline 0 N--CA 1.443 -0.814 0 C-N-CA 124.36 1.064 . . . . 1.3700000000000001 110.012 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.06 11.65 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.738 2.959 . . . . 0.68000000000000005 113.852 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.55 -48.0 12.37 Favored 'General case' 0 C--N 1.337 0.051 0 N-CA-C 107.416 -1.327 . . . . 0.60999999999999999 107.416 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -84.28 -47.35 10.87 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.999 1.32 . . . . 2.48 109.471 171.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.6 m -144.22 127.22 16.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 118.509 2.781 . . . . 0.69999999999999996 118.509 -146.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.44 -152.78 7.64 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.687 -0.965 . . . . 0.53000000000000003 110.687 158.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -28.76 -48.78 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 129.08 2.952 . . . . 1.1200000000000001 113.804 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.23 -55.37 18.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.705 0.684 . . . . 0.46000000000000002 112.527 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -40.24 63.78 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 122.425 1.107 . . . . 0.28000000000000003 108.418 -176.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.644 HG13 HD22 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -67.57 -49.98 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-N 114.131 -1.395 . . . . 1.2 111.312 -169.742 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.08 -51.1 56.62 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.592 1.542 . . . . 0.85999999999999999 110.279 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -45.38 -53.55 8.47 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.057 0.943 . . . . 2.3799999999999999 111.94 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -43.47 71.13 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 118.2 -0.905 . . . . 1.97 111.222 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.712 HD11 HD11 ' A' ' 28' ' ' LEU . 10.7 mm -50.88 -47.35 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.53 1.059 . . . . 0.58999999999999997 109.156 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -51.86 -48.02 64.2 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.978 0.418 . . . . 1.48 110.43 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -69.1 -34.56 75.29 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.437 -0.789 . . . . 3.3199999999999998 112.575 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.95 -21.96 13.46 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 122.97 0.508 . . . . 0.88 110.605 168.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.78 29.93 8.34 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.169 -1.172 . . . . 0.35999999999999999 110.169 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -137.67 170.88 15.3 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.372 -1.344 . . . . 2.0899999999999999 107.372 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.83 127.68 45.36 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.882 0.873 . . . . 4.0899999999999999 108.964 172.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.43 149.38 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 125.911 1.684 . . . . 0.52000000000000002 109.541 172.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.527 0.088 0 C-N-CA 123.797 0.839 . . . . 0.93000000000000005 109.828 176.554 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.548 0.213 . . . . 0.66000000000000003 111.101 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -147.53 162.55 38.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.186 0.517 . . . . 2.4199999999999999 110.752 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -83.07 143.44 30.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 113.596 -1.638 . . . . 2.5899999999999999 107.359 163.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -125.33 148.2 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 105.609 -1.997 . . . . 1.24 105.609 161.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.89 124.34 20.73 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.772 1.229 . . . . 0.40000000000000002 108.543 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -156.33 161.63 40.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.425 0.29 . . . . 1.25 111.62 -170.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.11 146.71 24.43 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.56 1.144 . . . . 1.74 109.934 -169.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.75 141.35 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.094 0.558 . . . . 0.77000000000000002 110.273 -176.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 107.372 -1.344 . . . . 1.05 107.372 170.993 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 119.566 -0.254 . . . . 0.44 110.924 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -58.28 -49.55 76.74 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.339 0.655 . . . . 4.1299999999999999 111.609 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.6 mt -47.38 -59.24 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.094 1.358 . . . . 0.68000000000000005 109.056 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.401 ' OE2' HD12 ' A' ' 28' ' ' LEU . 1.1 tm-20 -68.0 -44.31 76.88 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 119.868 -0.733 . . . . 3.71 109.038 -175.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -50.64 -36.66 36.55 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.701 -1.249 . . . . 1.4299999999999999 112.289 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.22 -48.07 82.89 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 112.011 -0.435 . . . . 0.39000000000000001 112.011 168.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.785 HD11 HD11 ' A' ' 64' ' ' ILE . 39.0 mt -64.38 -30.04 71.09 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 120.846 -1.385 . . . . 0.64000000000000001 112.154 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.554 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.27 16.6 ttmt -59.27 -18.6 38.85 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.821 1.191 . . . . 1.1899999999999999 111.666 171.099 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -17.89 59.95 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.9 -1.125 . . . . 3.3999999999999999 114.022 168.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.493 ' O ' HG12 ' A' ' 34' ' ' VAL . 92.9 mmm -74.65 135.07 75.17 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 120.419 1.463 . . . . 2.04 112.901 -172.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.73 95.21 0.63 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.934 3.089 . . . . 0.46000000000000002 111.737 -171.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.53 -18.95 2.24 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.55 -1.02 . . . . 0.20000000000000001 110.55 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 29' ' ' LYS . 4.2 p -66.88 155.25 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 O-C-N 121.939 -0.741 . . . . 0.28999999999999998 110.817 168.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.7 -59.99 1.76 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.065 0.946 . . . . 0.47999999999999998 109.776 168.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -146.25 142.1 28.02 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 114.309 1.226 . . . . 2.2799999999999998 114.309 -171.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.53 139.44 48.97 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.233 1.813 . . . . 0.79000000000000004 109.888 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -143.77 113.48 7.1 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.864 -0.791 . . . . 1.3100000000000001 108.864 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -81.57 142.25 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.295 0.638 . . . . 0.88 110.414 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -129.79 68.8 1.43 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.582 1.553 . . . . 1.3600000000000001 111.333 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.5 mt -62.09 -21.42 64.96 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 121.896 -0.503 . . . . 1.22 112.353 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.17 -20.21 16.84 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.806 0.442 . . . . 0.94999999999999996 111.179 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 m -130.71 18.5 5.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.316 1.046 . . . . 0.71999999999999997 110.041 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 35.23 55.85 0.81 Allowed 'General case' 0 C--N 1.345 0.382 0 C-N-CA 124.404 1.082 . . . . 3.8399999999999999 111.659 -170.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.5 m -143.89 154.36 43.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.423 -1.695 . . . . 0.5 106.423 -175.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.56 146.97 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.167 -0.679 . . . . 0.52000000000000002 109.167 171.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -115.96 143.87 44.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.999 1.32 . . . . 2.48 108.525 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.39 141.1 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 109.699 -0.482 . . . . 0.39000000000000001 109.699 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.4 mt -100.64 122.26 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.53 1.932 . . . . 0.68999999999999995 106.99 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -146.7 167.52 23.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.681 0.792 . . . . 1.76 110.337 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -100.54 113.02 65.44 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 114.786 -1.097 . . . . 2.1200000000000001 110.432 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -69.26 10.24 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.246 3.297 . . . . 0.66000000000000003 114.107 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.43 -50.76 8.52 Favored 'General case' 0 N--CA 1.458 -0.073 0 N-CA-C 107.436 -1.32 . . . . 0.63 107.436 173.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -92.19 -35.08 14.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.635 1.574 . . . . 3.3199999999999998 111.076 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.9 m -146.4 130.25 17.17 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 117.742 2.497 . . . . 0.54000000000000004 117.742 -157.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.94 -156.66 10.75 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.983 -1.247 . . . . 0.57999999999999996 109.983 155.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -29.21 -51.4 0.1 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.867 2.867 . . . . 0.64000000000000001 112.744 175.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.9 -55.69 9.29 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.074 0.768 . . . . 0.26000000000000001 113.074 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -38.58 64.83 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 122.047 0.927 . . . . 0.20999999999999999 108.726 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.454 HG12 HD22 ' A' ' 28' ' ' LEU . 2.5 mt -65.25 -54.0 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 114.37 -1.286 . . . . 0.68999999999999995 110.894 -169.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.53 -51.86 25.4 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.101 1.319 . . . . 0.73999999999999999 110.158 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -48.53 -47.78 38.87 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.916 1.286 . . . . 4.7300000000000004 112.195 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.66 -42.85 63.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 118.774 -0.631 . . . . 2.6699999999999999 112.479 174.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.785 HD11 HD11 ' A' ' 28' ' ' LEU . 11.1 mm -52.24 -45.13 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 119.544 1.065 . . . . 0.45000000000000001 109.974 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -49.06 -44.38 41.78 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.31 0.576 . . . . 1.5800000000000001 110.71 173.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -38.61 75.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.79 0.836 . . . . 3.6899999999999999 111.799 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.42 -25.71 26.4 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 119.431 -0.318 . . . . 0.96999999999999997 110.636 170.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.1 25.87 5.69 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 124.469 1.033 . . . . 0.40000000000000002 111.264 169.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -145.58 164.81 30.52 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 106.748 -1.575 . . . . 2.1600000000000001 106.748 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 129.12 54.99 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 103.747 -2.686 . . . . 3.1899999999999999 103.747 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.62 139.14 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.106 -0.701 . . . . 0.53000000000000003 109.106 171.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.226 -0.154 0 N-CA-C 109.212 -0.662 . . . . 1.3700000000000001 109.212 176.032 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 111.677 0.251 . . . . 0.68000000000000005 111.677 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.97 162.5 39.2 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.411 1.1 . . . . 2.6899999999999999 111.685 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -84.24 143.96 29.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 130.252 3.421 . . . . 2.8199999999999998 106.727 170.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 tp -130.1 151.66 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.309 -1.737 . . . . 1.1399999999999999 106.309 162.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.78 129.12 24.03 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.461 1.104 . . . . 0.38 108.981 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.69 173.58 16.75 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 119.384 -0.341 . . . . 1.1299999999999999 111.87 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.64 155.91 18.5 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 109.077 -0.712 . . . . 2.1200000000000001 109.077 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.01 157.35 16.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 N-CA-C 108.124 -1.065 . . . . 0.65000000000000002 108.124 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 108.31 -0.996 . . . . 0.92000000000000004 108.31 175.513 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.475 0 CA-C-O 119.432 -0.318 . . . . 0.44 111.023 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.7 mtp-105 -63.14 -45.66 90.91 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.583 0.629 . . . . 5.0700000000000003 110.58 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -49.64 -59.63 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 108.192 -1.04 . . . . 0.65000000000000002 108.192 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.94 -35.53 72.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.72 -0.673 . . . . 2.6099999999999999 110.665 -171.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -56.2 -36.1 68.03 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 120.894 -1.129 . . . . 1.24 111.155 171.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.52 -47.34 57.43 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.658 -0.977 . . . . 0.33000000000000002 110.658 167.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.684 HD11 HD11 ' A' ' 64' ' ' ILE . 94.8 mt -67.68 -28.73 67.94 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.384 -1.068 . . . . 0.33000000000000002 112.747 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.558 ' HA ' HG11 ' A' ' 34' ' ' VAL . 2.3 ttmt -58.49 -17.71 23.22 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.403 1.002 . . . . 1.5700000000000001 111.398 169.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -91.42 6.27 46.12 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.97 1.1 . . . . 3.2400000000000002 113.97 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.496 ' O ' HG12 ' A' ' 34' ' ' VAL . 34.4 mmt -85.57 135.28 38.56 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 120.499 1.5 . . . . 2.4500000000000002 112.45 171.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.03 84.11 1.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.666 2.911 . . . . 0.78000000000000003 112.301 -168.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.01 -16.43 0.91 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.486 1.041 . . . . 0.31 111.832 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.558 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.8 p -59.22 154.23 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.647 -0.914 . . . . 0.28999999999999998 111.501 168.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.69 -61.32 1.76 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.787 1.235 . . . . 0.53000000000000003 108.926 169.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -149.77 149.53 30.68 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 114.329 1.233 . . . . 2.5600000000000001 114.329 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.65 119.91 25.57 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.025 1.73 . . . . 0.96999999999999997 109.334 -170.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -134.28 111.72 10.46 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.151 0.98 . . . . 1.3899999999999999 108.431 -172.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -84.28 139.02 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 123.072 0.549 . . . . 0.81999999999999995 110.824 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -125.74 64.6 1.19 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.839 2.056 . . . . 1.25 110.636 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.8 mt -65.9 -16.96 64.32 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 112.67 0.618 . . . . 0.77000000000000002 112.67 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.1 -22.77 11.78 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.69 0.396 . . . . 0.63 110.712 168.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.4 m -127.14 17.78 7.15 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.268 1.427 . . . . 0.48999999999999999 110.163 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 47.66 35.8 4.88 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.138 0.975 . . . . 2.4199999999999999 112.374 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.7 m -131.79 153.29 50.26 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.434 -1.321 . . . . 0.55000000000000004 107.434 -169.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.95 146.48 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.013 -0.736 . . . . 0.48999999999999999 109.013 173.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -115.91 137.44 52.1 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.687 -1.227 . . . . 2.4900000000000002 107.687 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.95 140.69 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 108.683 -0.858 . . . . 0.29999999999999999 108.683 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.6 mt -105.2 132.07 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.814 1.645 . . . . 0.90000000000000002 106.836 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -152.59 163.93 38.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.62 0.768 . . . . 1.8300000000000001 110.774 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -92.82 110.57 46.43 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 124.158 0.983 . . . . 1.45 109.517 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.6 15.56 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.638 2.892 . . . . 0.62 113.501 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.8 -52.72 5.84 Favored 'General case' 0 CA--C 1.526 0.049 0 N-CA-C 107.57 -1.27 . . . . 0.59999999999999998 107.57 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -88.96 -45.75 9.43 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.538 1.535 . . . . 2.9700000000000002 110.406 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.6 m -131.59 129.24 40.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 116.886 2.18 . . . . 0.59999999999999998 116.886 -158.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.83 -162.6 16.2 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 110.181 -1.168 . . . . 0.47999999999999998 110.181 159.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.9 t -35.93 -41.67 0.24 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.523 2.729 . . . . 0.63 112.732 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.19 -56.22 9.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.305 0.642 . . . . 0.28000000000000003 112.46 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.22 -39.03 65.83 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 122.201 1.001 . . . . 0.23999999999999999 108.99 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.536 HG12 HD22 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -61.45 -56.66 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.275 -1.33 . . . . 0.72999999999999998 109.872 -171.292 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.84 -54.21 8.46 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.557 1.071 . . . . 0.83999999999999997 110.428 174.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 1.4 tm-20 -44.59 -52.1 8.4 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.628 0.728 . . . . 2.1899999999999999 111.547 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -45.06 64.18 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 117.958 -1.02 . . . . 1.9299999999999999 110.735 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.684 HD11 HD11 ' A' ' 28' ' ' LEU . 23.3 mm -51.29 -46.89 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 120.024 1.284 . . . . 0.48999999999999999 110.173 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -52.0 -47.06 65.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.492 0.717 . . . . 1.8 109.753 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.401 ' NZ ' ' OE2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -68.99 -37.61 78.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.275 0.63 . . . . 4.6399999999999997 111.522 -176.387 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -55.97 -22.38 26.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.068 0.947 . . . . 0.92000000000000004 110.665 170.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.41 29.79 6.52 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 124.289 0.947 . . . . 0.33000000000000002 110.868 173.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -141.4 174.22 10.75 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 108.619 -0.882 . . . . 1.7 108.619 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.13 117.54 18.43 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.815 -1.179 . . . . 4.29 107.815 -175.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 p -84.2 145.29 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.247 -0.888 . . . . 0.62 108.731 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.399 0 C-N-CA 124.649 1.18 . . . . 1.47 110.237 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.897 -0.409 . . . . 0.71999999999999997 109.897 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -146.24 157.66 43.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.573 0.701 . . . . 2.6899999999999999 111.367 -173.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -83.89 144.82 28.96 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 125.469 1.508 . . . . 2.4900000000000002 108.318 167.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 tp -122.13 153.31 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.056 -1.831 . . . . 1.1000000000000001 106.056 160.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.0 126.17 19.89 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.998 1.319 . . . . 0.34000000000000002 107.85 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.26 165.9 35.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.453 0.701 . . . . 2.3199999999999998 112.16 -174.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.66 147.58 23.75 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.608 1.163 . . . . 1.7 109.044 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -115.63 164.11 12.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 123.438 0.695 . . . . 0.64000000000000001 109.776 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.454 -0.242 0 C-N-CA 123.538 0.735 . . . . 0.76000000000000001 109.36 176.234 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.609 0 CA-C-O 119.569 -0.253 . . . . 0.34000000000000002 111.046 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 mtm105 -65.06 -41.45 95.09 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 118.258 0.481 . . . . 6.8300000000000001 111.175 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.0 mt -51.72 -59.13 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.127 -1.064 . . . . 0.56000000000000005 108.127 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.94 -36.77 72.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 120.046 -0.662 . . . . 2.2799999999999998 111.147 -171.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -50.99 -40.33 57.78 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.318 -0.864 . . . . 1.6299999999999999 110.558 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.79 -48.09 57.55 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.127 -0.789 . . . . 0.38 111.127 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 64' ' ' ILE . 96.9 mt -67.93 -32.4 72.83 Favored 'General case' 0 CA--C 1.519 -0.25 0 O-C-N 121.244 -1.15 . . . . 0.34999999999999998 112.693 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.511 ' HA ' HG11 ' A' ' 34' ' ' VAL . 11.5 ttpt -59.54 -17.1 29.45 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.949 0.795 . . . . 1.6599999999999999 110.63 171.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 mtt-85 -91.86 -0.05 57.5 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.747 -1.221 . . . . 3.2200000000000002 113.622 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.511 ' O ' HG12 ' A' ' 34' ' ' VAL . 5.9 mmt -78.67 142.68 61.79 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 120.804 1.638 . . . . 1.97 111.959 174.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.92 102.92 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.942 2.428 . . . . 0.41999999999999998 110.381 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.11 -4.34 6.37 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.326 1.441 . . . . 0.23999999999999999 110.941 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.511 HG11 ' HA ' ' A' ' 29' ' ' LYS . 6.6 p -70.88 157.21 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.848 -0.795 . . . . 0.28999999999999998 110.658 164.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.91 -63.91 1.38 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 107.623 -1.251 . . . . 0.41999999999999998 107.623 165.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -141.85 157.35 45.1 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 112.004 0.372 . . . . 2.8399999999999999 112.004 -170.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.46 137.07 40.02 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.26 1.824 . . . . 0.58999999999999997 107.414 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -139.55 114.89 9.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.902 1.281 . . . . 1.4199999999999999 108.63 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -83.93 138.2 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.96 0.904 . . . . 0.65000000000000002 110.339 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -132.88 63.71 1.63 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.607 1.563 . . . . 1.1699999999999999 111.376 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.1 mt -67.42 -15.56 63.74 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 113.062 0.764 . . . . 0.90000000000000002 113.062 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.66 -25.63 18.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 117.947 0.34 . . . . 0.70999999999999996 110.529 166.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.5 m -122.65 17.33 10.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.303 1.441 . . . . 0.55000000000000004 110.216 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 47.2 38.32 6.74 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.361 0.982 . . . . 2.7400000000000002 111.836 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.1 m -137.34 154.43 50.05 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.432 -1.322 . . . . 0.5 107.432 -171.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.52 152.58 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.238 -1.023 . . . . 0.44 108.238 170.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.44 150.63 48.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 123.58 0.55 . . . . 2.7400000000000002 109.701 174.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.19 138.07 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.398 -0.964 . . . . 0.25 108.398 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.43 119.99 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 126.05 1.74 . . . . 1.22 108.166 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -145.84 172.79 12.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.635 1.174 . . . . 1.8999999999999999 110.631 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -111.87 118.94 45.59 Favored Pre-proline 0 N--CA 1.447 -0.609 0 C-N-CA 124.186 0.994 . . . . 1.3999999999999999 110.815 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.27 9.73 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.91 3.74 . . . . 0.58999999999999997 114.248 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.21 -40.48 37.36 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 108.437 -0.949 . . . . 0.71999999999999997 108.437 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -112.09 -49.54 2.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.716 1.606 . . . . 3.04 110.25 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.6 m -111.04 128.33 55.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.593 2.757 . . . . 0.91000000000000003 117.145 -168.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.21 -175.48 25.48 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.952 -0.859 . . . . 0.56000000000000005 110.952 156.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -29.17 -45.2 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 128.302 2.641 . . . . 0.85999999999999999 112.958 167.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.23 -55.11 13.64 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.756 0.65 . . . . 0.34000000000000002 112.756 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.23 -40.06 65.0 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 122.256 1.026 . . . . 0.20999999999999999 108.91 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.57 HG12 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -62.27 -57.12 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-N 113.918 -1.492 . . . . 0.57999999999999996 110.241 -171.221 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.45 -51.09 28.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.621 1.1 . . . . 0.78000000000000003 110.595 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -48.51 -50.19 32.9 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.737 0.815 . . . . 2.5099999999999998 111.287 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -46.15 64.96 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 118.638 -0.696 . . . . 2.1699999999999999 110.888 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 28' ' ' LEU . 18.7 mm -49.79 -47.61 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 119.069 0.85 . . . . 0.44 109.875 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -48.3 -50.4 30.2 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.449 0.642 . . . . 1.48 110.03 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.03 -33.22 70.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 121.671 -0.643 . . . . 3.4100000000000001 112.278 -176.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.83 -25.22 10.83 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 119.337 -0.364 . . . . 0.87 110.285 168.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.84 30.58 4.5 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.527 1.06 . . . . 0.29999999999999999 110.675 170.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -148.4 165.75 30.17 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 105.61 -1.996 . . . . 1.6899999999999999 105.61 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -120.63 140.38 51.64 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 119.1 0.864 . . . . 3.2999999999999998 109.113 166.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.6 p -94.94 141.37 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.803 1.641 . . . . 0.46000000000000002 108.581 172.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.225 -0.21 0 N-CA-C 108.891 -0.781 . . . . 1.5 108.891 173.86 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 120.361 0.125 . . . . 1.23 111.068 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -150.47 164.29 36.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.386 0.612 . . . . 3.0299999999999998 111.095 172.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -83.47 144.94 29.22 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.94 -1.482 . . . . 2.4300000000000002 108.019 163.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -124.05 148.85 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 105.145 -2.169 . . . . 1.24 105.145 162.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.53 120.45 15.46 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 125.302 1.441 . . . . 0.46000000000000002 108.097 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.1 ptt? -156.7 165.14 37.08 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.202 0.455 . . . . 1.02 111.117 -169.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.84 151.96 19.16 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.859 0.864 . . . . 1.76 109.239 -171.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.36 164.59 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 123.519 0.728 . . . . 0.68999999999999995 109.582 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.454 -0.23 0 C-N-CA 124.866 1.266 . . . . 0.78000000000000003 109.05 175.682 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 119.117 -0.468 . . . . 0.44 111.18 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -63.42 -46.24 87.27 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.22 0.918 . . . . 3.6099999999999999 110.455 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.8 mt -48.47 -58.53 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.172 -0.677 . . . . 0.83999999999999997 109.172 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.408 ' HG3' HG21 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -70.6 -37.37 73.87 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.206 -0.452 . . . . 3.8100000000000001 110.579 -172.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -55.7 -33.92 64.61 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 120.727 -1.233 . . . . 1.24 111.404 174.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.45 -48.91 53.83 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 111.301 -0.719 . . . . 0.31 111.301 166.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.62 HD11 HD11 ' A' ' 64' ' ' ILE . 86.1 mt -64.38 -32.75 74.5 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 118.247 1.023 . . . . 0.38 113.202 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.26 8.9 ttmt -56.15 -17.73 8.04 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.105 0.866 . . . . 1.22 111.575 170.311 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 8.73 44.05 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.506 1.299 . . . . 4.6900000000000004 114.506 172.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.463 ' O ' HG12 ' A' ' 34' ' ' VAL . 4.4 mtp -85.43 140.58 36.27 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 121.085 1.766 . . . . 2.0299999999999998 110.971 167.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.6 106.28 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.701 2.934 . . . . 0.47999999999999998 111.206 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.44 -18.95 3.63 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.48 -1.048 . . . . 0.27000000000000002 110.48 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 29' ' ' LYS . 8.5 p -69.42 152.22 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.595 0.758 . . . . 0.26000000000000001 110.87 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -58.29 2.16 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.679 1.192 . . . . 0.46999999999999997 109.516 171.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -145.25 150.48 36.76 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 113.01 0.745 . . . . 2.7000000000000002 113.01 -175.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.65 148.45 25.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.907 2.083 . . . . 1.21 109.408 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.38 90.23 1.32 Allowed 'General case' 0 CA--C 1.527 0.074 0 CA-C-O 121.965 0.888 . . . . 2.2999999999999998 110.176 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.24 135.5 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.744 0.818 . . . . 0.81000000000000005 110.445 -173.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -136.74 65.96 1.49 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.0 1.32 . . . . 1.26 111.305 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.93 -18.69 65.44 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 115.917 -0.583 . . . . 1.04 112.512 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.58 -27.85 58.92 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.242 0.474 . . . . 0.92000000000000004 110.668 169.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 m -115.94 18.23 15.64 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.347 1.459 . . . . 0.79000000000000004 110.109 177.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 48.6 35.56 6.31 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.515 1.126 . . . . 2.0699999999999998 112.066 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -143.04 151.97 41.38 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.053 -1.091 . . . . 0.51000000000000001 108.053 -165.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.408 HG21 ' HG3' ' A' ' 25' ' ' GLU . 5.5 p -133.18 148.95 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 109.416 -0.587 . . . . 0.5 109.416 173.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.18 126.38 46.88 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.036 1.334 . . . . 2.4900000000000002 108.148 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.35 138.66 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.938 -0.764 . . . . 0.25 108.938 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.4 mt -99.85 126.9 53.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 107.818 -1.179 . . . . 1.02 107.818 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -150.3 170.15 19.69 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.914 0.486 . . . . 1.9099999999999999 111.096 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -108.49 116.22 56.65 Favored Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 124.34 1.056 . . . . 1.3400000000000001 111.13 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -67.58 5.12 1.06 Allowed 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.916 3.077 . . . . 0.56000000000000005 113.875 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.32 -46.9 25.55 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 107.971 -1.122 . . . . 0.41999999999999998 107.971 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -95.41 -33.21 12.57 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.161 1.384 . . . . 3.46 111.027 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.7 m -155.82 129.97 8.76 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 119.447 3.129 . . . . 0.81999999999999995 119.447 -152.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.78 -163.14 12.59 Favored Glycine 0 N--CA 1.438 -1.217 0 N-CA-C 108.78 -1.728 . . . . 0.46000000000000002 108.78 154.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 t -34.04 -40.21 0.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.976 2.91 . . . . 0.82999999999999996 113.332 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.83 -56.23 7.93 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.081 0.855 . . . . 0.32000000000000001 113.083 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.83 -34.48 66.84 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 123.022 1.392 . . . . 0.20999999999999999 109.261 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.527 ' CG1' HD22 ' A' ' 28' ' ' LEU 0.252 0.9 OUTLIER -70.03 -51.44 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 CA-C-N 113.506 -1.679 . . . . 0.57999999999999996 111.007 -170.5 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -50.53 -49.66 55.24 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.982 1.719 . . . . 0.82999999999999996 110.348 173.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -42.88 -58.37 2.41 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 121.775 0.798 . . . . 2.3300000000000001 111.971 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.29 -40.93 73.99 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 119.889 -0.724 . . . . 2.3599999999999999 110.974 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.62 HD11 HD11 ' A' ' 28' ' ' LEU . 15.1 mm -52.59 -46.0 48.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.315 1.046 . . . . 0.40999999999999998 110.283 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -51.38 -47.39 62.87 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.52 -0.548 . . . . 1.8700000000000001 109.52 174.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -70.09 -34.44 73.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 121.416 -0.802 . . . . 3.79 112.789 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.96 -22.0 13.68 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.066 0.394 . . . . 0.92000000000000004 110.751 167.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.91 24.5 8.55 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 124.778 1.18 . . . . 0.40000000000000002 110.739 173.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -140.95 167.72 21.51 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.59 -0.893 . . . . 1.79 108.59 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -120.95 122.44 40.17 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 103.84 -2.652 . . . . 3.6200000000000001 103.84 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.1 p -100.43 141.39 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 109.663 -0.495 . . . . 0.56999999999999995 109.663 170.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 C--O 1.225 -0.194 0 N-CA-C 109.199 -0.667 . . . . 1.1699999999999999 109.199 175.158 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 109.452 -0.574 . . . . 0.59999999999999998 109.452 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -145.83 157.0 43.94 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.686 0.755 . . . . 2.3100000000000001 111.077 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.68 145.73 31.46 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.452 1.901 . . . . 2.2999999999999998 108.054 165.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 tp -127.84 157.11 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.138 -1.801 . . . . 1.1200000000000001 106.138 165.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.05 121.33 9.57 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.884 0.874 . . . . 0.46999999999999997 108.952 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -156.74 167.85 29.22 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.264 0.484 . . . . 1.27 111.396 -174.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.59 156.98 16.75 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.807 0.843 . . . . 1.8100000000000001 111.156 -172.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.79 132.66 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 C-N-CA 123.468 0.707 . . . . 0.67000000000000004 110.517 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 108.91 -0.774 . . . . 1.0800000000000001 108.91 173.372 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.604 0 CA-C-O 119.591 -0.242 . . . . 0.40000000000000002 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -56.8 -49.36 75.59 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 118.926 -0.559 . . . . 5.2400000000000002 111.705 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -48.33 -59.29 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 108.252 -1.018 . . . . 0.79000000000000004 108.252 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -70.06 -35.57 74.33 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.864 -0.734 . . . . 2.5499999999999998 110.39 -171.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp -61.02 -27.35 68.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.908 -1.12 . . . . 1.28 111.44 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.19 -52.56 48.65 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.248 -1.141 . . . . 0.46000000000000002 110.248 162.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.779 HD11 HD11 ' A' ' 64' ' ' ILE . 98.8 mt -63.43 -31.8 73.06 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 113.673 0.99 . . . . 0.40000000000000002 113.673 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -51.1 -19.23 1.04 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.98 0.912 . . . . 1.9299999999999999 111.705 169.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -91.25 -7.23 51.78 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.372 0.878 . . . . 4.1399999999999997 113.372 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.507 ' O ' HG12 ' A' ' 34' ' ' VAL . 26.3 mtp -76.07 139.6 69.22 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 120.212 1.369 . . . . 2.1899999999999999 112.43 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.81 88.99 0.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.603 2.869 . . . . 0.46000000000000002 111.363 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.68 -15.36 2.0 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.745 1.164 . . . . 0.23000000000000001 111.125 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 31' ' ' MET . 6.3 p -65.46 154.51 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 O-C-N 121.422 -1.046 . . . . 0.26000000000000001 110.934 169.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.24 -63.93 1.38 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.564 1.146 . . . . 0.5 108.084 167.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -150.55 137.39 19.12 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 112.368 0.507 . . . . 3.1800000000000002 112.368 -168.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.16 150.66 23.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.806 1.642 . . . . 0.94999999999999996 109.664 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.74 105.66 3.45 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.654 1.182 . . . . 1.9199999999999999 108.684 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.37 137.79 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.212 0.605 . . . . 0.56999999999999995 110.698 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -131.76 66.57 1.54 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.701 1.601 . . . . 1.21 111.083 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.1 mt -67.0 -19.09 65.66 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 115.918 -0.583 . . . . 0.72999999999999998 112.17 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.76 -11.66 8.29 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.629 0.772 . . . . 0.65000000000000002 111.665 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 m -135.31 17.82 3.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.37 1.068 . . . . 0.46000000000000002 109.525 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 44.85 39.53 3.64 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.058 1.343 . . . . 3.3100000000000001 111.957 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.1 m -134.37 155.28 50.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.542 -1.281 . . . . 0.48999999999999999 107.542 -170.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 p -131.96 143.13 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 109.136 -0.69 . . . . 0.47999999999999998 109.136 172.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.36 141.68 43.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.651 1.58 . . . . 2.4900000000000002 106.836 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.44 144.19 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 108.501 -0.926 . . . . 0.33000000000000002 108.501 171.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.7 mt -112.13 121.21 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 125.996 1.718 . . . . 0.72999999999999998 107.069 -174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -144.39 166.1 26.05 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.892 0.877 . . . . 1.98 110.818 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -95.38 109.71 46.7 Favored Pre-proline 0 N--CA 1.445 -0.701 0 C-N-CA 124.727 1.211 . . . . 1.45 109.564 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -71.18 12.89 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.688 2.925 . . . . 0.69999999999999996 113.659 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.75 -48.47 10.08 Favored 'General case' 0 C--N 1.337 0.025 0 N-CA-C 107.647 -1.242 . . . . 0.73999999999999999 107.647 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -89.5 -40.33 12.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.886 1.275 . . . . 2.6200000000000001 111.026 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.1 m -143.79 126.85 16.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 117.5 2.407 . . . . 0.56000000000000005 117.5 -152.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.72 -159.55 10.23 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 109.207 -1.557 . . . . 0.55000000000000004 109.207 156.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.4 t -33.71 -42.93 0.12 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.248 2.619 . . . . 0.75 113.134 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.49 -56.25 8.79 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.977 0.808 . . . . 0.33000000000000002 112.683 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.76 -35.89 62.58 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 122.113 0.959 . . . . 0.26000000000000001 109.369 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.642 HG12 HD22 ' A' ' 28' ' ' LEU 0.254 0.8 OUTLIER -64.93 -55.52 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 114.358 -1.292 . . . . 0.57999999999999996 110.245 -174.496 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -49.68 -49.88 45.83 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 120.553 1.524 . . . . 0.83999999999999997 111.315 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -38.82 -57.35 1.23 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.051 0.929 . . . . 2.7200000000000002 112.902 171.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -71.77 -41.53 68.25 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.606 -0.725 . . . . 2.1299999999999999 109.827 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.779 HD11 HD11 ' A' ' 28' ' ' LEU . 37.8 mm -55.13 -45.09 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 119.413 1.006 . . . . 0.44 110.436 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -52.35 -54.18 34.99 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.547 1.139 . . . . 1.6399999999999999 109.241 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -45.94 85.15 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.479 0.548 . . . . 4.1299999999999999 112.479 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mp -55.07 -19.32 6.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.815 1.646 . . . . 2.3700000000000001 111.789 172.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.72 24.91 7.9 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.343 0.973 . . . . 0.44 111.346 169.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -139.22 175.44 9.56 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 108.879 -0.786 . . . . 2.1699999999999999 108.879 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 123.05 27.51 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.51 -1.663 . . . . 4.29 106.51 175.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -87.96 145.42 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.19 -0.67 . . . . 0.72999999999999998 109.19 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 108.904 -0.776 . . . . 1.46 108.904 168.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 120.42 0.152 . . . . 1.0 110.609 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -150.54 156.64 41.79 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.372 0.606 . . . . 2.9900000000000002 110.093 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -84.07 114.15 21.55 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.867 2.067 . . . . 2.2999999999999998 106.683 169.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -96.96 155.37 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 106.416 -1.698 . . . . 1.1299999999999999 106.416 167.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.93 137.69 34.99 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.855 -0.794 . . . . 0.5 108.855 170.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.18 169.25 25.2 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.638 0.586 . . . . 1.25 111.995 175.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.56 153.46 19.74 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.498 1.119 . . . . 1.9099999999999999 110.723 -175.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.85 134.99 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 123.098 0.559 . . . . 0.90000000000000002 111.656 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.452 -0.331 0 C-N-CA 124.112 0.965 . . . . 0.83999999999999997 109.293 175.024 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 111.598 0.221 . . . . 0.68000000000000005 111.598 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -69.9 -45.86 66.69 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.488 0.715 . . . . 4.75 110.099 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -50.75 -54.14 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.367 -0.605 . . . . 0.83999999999999997 109.367 177.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -69.62 -42.92 73.69 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.505 -0.554 . . . . 3.79 109.505 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -51.61 -36.93 47.78 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.175 -1.578 . . . . 1.6000000000000001 111.809 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.28 -52.96 37.25 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 111.543 -0.623 . . . . 0.52000000000000002 111.543 166.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 64' ' ' ILE . 87.3 mt -61.3 -29.46 69.89 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.1 -1.236 . . . . 0.63 113.289 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.56 ' HA ' HG11 ' A' ' 34' ' ' VAL . 4.2 ttmm -59.9 -18.75 47.21 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.151 1.342 . . . . 1.49 111.715 172.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -16.55 57.83 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.885 1.068 . . . . 4.5999999999999996 113.885 169.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.496 ' O ' HG12 ' A' ' 34' ' ' VAL . 83.8 mmm -72.12 135.79 82.3 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 120.031 1.287 . . . . 2.0499999999999998 111.431 -174.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.58 101.32 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.042 2.494 . . . . 0.35999999999999999 110.711 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.31 -15.12 3.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 119.459 1.027 . . . . 0.25 110.809 176.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 29' ' ' LYS . 5.2 p -69.17 153.31 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 O-C-N 122.312 -0.523 . . . . 0.26000000000000001 109.941 166.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.65 -61.04 1.76 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.126 -1.064 . . . . 0.45000000000000001 108.126 162.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -141.42 145.98 35.98 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 113.527 0.936 . . . . 3.3900000000000001 113.527 -168.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.64 150.9 26.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.758 1.623 . . . . 1.1699999999999999 108.551 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.86 101.54 2.91 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.77 0.828 . . . . 1.96 108.785 175.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.95 141.54 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.828 0.851 . . . . 1.0700000000000001 110.997 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -139.11 66.04 1.43 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.137 1.375 . . . . 1.27 111.429 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 41' ' ' LEU . 56.2 mt -67.04 -13.82 62.29 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 113.342 0.867 . . . . 1.05 113.342 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.36 -25.52 9.98 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.578 0.351 . . . . 0.96999999999999997 110.886 165.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.8 m -125.17 17.92 8.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.343 1.457 . . . . 0.69999999999999996 110.157 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 48.18 33.39 3.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.414 1.086 . . . . 2.48 112.156 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -131.66 149.24 52.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.29 -1.004 . . . . 0.60999999999999999 108.29 -168.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -134.02 144.45 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 109.399 -0.593 . . . . 0.55000000000000004 109.399 174.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -112.11 145.08 40.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.052 1.741 . . . . 2.3799999999999999 108.096 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.52 136.44 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.011 -0.737 . . . . 0.32000000000000001 109.011 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.36 119.17 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.694 1.597 . . . . 0.98999999999999999 107.535 178.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -144.49 167.81 21.61 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.009 0.923 . . . . 1.79 110.712 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -108.26 122.88 39.16 Favored Pre-proline 0 N--CA 1.451 -0.416 0 O-C-N 124.211 0.944 . . . . 1.47 110.888 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.79 5.05 1.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.931 3.088 . . . . 0.58999999999999997 113.544 -177.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.74 -55.28 6.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.419 -1.326 . . . . 0.40000000000000002 107.419 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -84.04 -42.57 16.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.526 1.13 . . . . 3.6800000000000002 110.54 172.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.8 m -143.27 131.6 22.11 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 119.175 3.028 . . . . 0.64000000000000001 119.175 -143.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.06 -159.55 18.67 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.13 -1.188 . . . . 0.51000000000000001 110.13 159.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -30.66 -47.63 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.839 2.855 . . . . 0.56000000000000005 112.845 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.86 -56.27 7.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.396 0.678 . . . . 0.26000000000000001 112.488 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.65 -38.49 64.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.197 0.999 . . . . 0.17999999999999999 109.393 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.492 HG12 HD13 ' A' ' 28' ' ' LEU . 1.7 mt -64.75 -55.36 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.465 -1.243 . . . . 0.62 110.377 -170.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -50.98 -50.02 59.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.923 1.238 . . . . 0.77000000000000002 110.695 177.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -43.7 -56.14 3.96 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.712 0.805 . . . . 2.1299999999999999 112.023 175.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -41.48 72.57 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.559 -0.856 . . . . 1.6899999999999999 110.586 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.603 HD11 HD11 ' A' ' 28' ' ' LEU . 14.6 mm -52.42 -46.05 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 119.489 1.04 . . . . 0.34999999999999998 110.019 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -50.82 -46.69 59.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.041 0.448 . . . . 1.8600000000000001 110.098 174.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -32.89 70.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 114.015 1.117 . . . . 3.1299999999999999 114.015 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.65 -21.23 25.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.548 0.613 . . . . 0.88 110.571 166.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.93 27.3 8.4 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.768 -0.933 . . . . 0.32000000000000001 110.768 173.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -140.39 173.67 11.28 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.181 -1.044 . . . . 1.72 108.181 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 122.88 31.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.702 -1.592 . . . . 4.1600000000000001 106.702 176.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 p -89.92 145.78 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.906 -0.776 . . . . 0.55000000000000004 108.906 171.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 109.289 -0.634 . . . . 1.27 109.289 170.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 120.42 0.152 . . . . 1.0 110.609 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -150.54 156.64 41.79 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.372 0.606 . . . . 2.9900000000000002 110.093 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -84.07 114.15 21.55 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.867 2.067 . . . . 2.2999999999999998 106.683 169.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -96.96 155.37 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 106.416 -1.698 . . . . 1.1299999999999999 106.416 167.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.93 137.69 34.99 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.855 -0.794 . . . . 0.5 108.855 170.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.18 169.25 25.2 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.638 0.586 . . . . 1.25 111.995 175.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.56 153.46 19.74 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.498 1.119 . . . . 1.9099999999999999 110.723 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.85 134.99 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 123.098 0.559 . . . . 0.90000000000000002 111.656 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.452 -0.331 0 C-N-CA 124.112 0.965 . . . . 0.83999999999999997 109.293 175.024 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 111.598 0.221 . . . . 0.68000000000000005 111.598 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -69.9 -45.86 66.69 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.488 0.715 . . . . 4.75 110.099 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -50.75 -54.14 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.367 -0.605 . . . . 0.83999999999999997 109.367 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -69.62 -42.92 73.69 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.505 -0.554 . . . . 3.79 109.505 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -51.61 -36.93 47.78 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.175 -1.578 . . . . 1.6000000000000001 111.809 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.28 -52.96 37.25 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 111.543 -0.623 . . . . 0.52000000000000002 111.543 166.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 64' ' ' ILE . 87.3 mt -61.3 -29.46 69.89 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.1 -1.236 . . . . 0.63 113.289 174.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.56 ' HA ' HG11 ' A' ' 34' ' ' VAL . 4.2 ttmm -59.9 -18.75 47.21 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.151 1.342 . . . . 1.49 111.715 172.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -16.55 57.83 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.885 1.068 . . . . 4.5999999999999996 113.885 169.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.496 ' O ' HG12 ' A' ' 34' ' ' VAL . 83.8 mmm -72.12 135.79 82.3 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 120.031 1.287 . . . . 2.0499999999999998 111.431 -174.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.58 101.32 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.042 2.494 . . . . 0.35999999999999999 110.711 -174.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.31 -15.12 3.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 119.459 1.027 . . . . 0.25 110.809 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 29' ' ' LYS . 5.2 p -69.17 153.31 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 O-C-N 122.312 -0.523 . . . . 0.26000000000000001 109.941 166.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.65 -61.04 1.76 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.126 -1.064 . . . . 0.45000000000000001 108.126 162.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -141.42 145.98 35.98 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 113.527 0.936 . . . . 3.3900000000000001 113.527 -168.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.64 150.9 26.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.758 1.623 . . . . 1.1699999999999999 108.551 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.86 101.54 2.91 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.77 0.828 . . . . 1.96 108.785 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.95 141.54 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.828 0.851 . . . . 1.0700000000000001 110.997 -175.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -139.11 66.04 1.43 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.137 1.375 . . . . 1.27 111.429 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 41' ' ' LEU . 56.2 mt -67.04 -13.82 62.29 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 113.342 0.867 . . . . 1.05 113.342 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.36 -25.52 9.98 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.578 0.351 . . . . 0.96999999999999997 110.886 165.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.8 m -125.17 17.92 8.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.343 1.457 . . . . 0.69999999999999996 110.157 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 48.18 33.39 3.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.414 1.086 . . . . 2.48 112.156 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -131.66 149.24 52.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.29 -1.004 . . . . 0.60999999999999999 108.29 -168.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -134.02 144.45 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 109.399 -0.593 . . . . 0.55000000000000004 109.399 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -112.11 145.08 40.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.052 1.741 . . . . 2.3799999999999999 108.096 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.52 136.44 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.011 -0.737 . . . . 0.32000000000000001 109.011 174.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.36 119.17 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.694 1.597 . . . . 0.98999999999999999 107.535 178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -144.49 167.81 21.61 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.009 0.923 . . . . 1.79 110.712 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -108.26 122.88 39.16 Favored Pre-proline 0 N--CA 1.451 -0.416 0 O-C-N 124.211 0.944 . . . . 1.47 110.888 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.79 5.05 1.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.931 3.088 . . . . 0.58999999999999997 113.544 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.74 -55.28 6.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.419 -1.326 . . . . 0.40000000000000002 107.419 175.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -84.04 -42.57 16.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.526 1.13 . . . . 3.6800000000000002 110.54 172.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.8 m -143.27 131.6 22.11 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 119.175 3.028 . . . . 0.64000000000000001 119.175 -143.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.06 -159.55 18.67 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.13 -1.188 . . . . 0.51000000000000001 110.13 159.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -30.66 -47.63 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.839 2.855 . . . . 0.56000000000000005 112.845 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.86 -56.27 7.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.396 0.678 . . . . 0.26000000000000001 112.488 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.65 -38.49 64.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.197 0.999 . . . . 0.17999999999999999 109.393 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.492 HG12 HD13 ' A' ' 28' ' ' LEU . 1.7 mt -64.75 -55.36 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.465 -1.243 . . . . 0.62 110.377 -170.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -50.98 -50.02 59.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.923 1.238 . . . . 0.77000000000000002 110.695 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -43.7 -56.14 3.96 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.712 0.805 . . . . 2.1299999999999999 112.023 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -41.48 72.57 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.559 -0.856 . . . . 1.6899999999999999 110.586 -178.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.603 HD11 HD11 ' A' ' 28' ' ' LEU . 14.6 mm -52.42 -46.05 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 119.489 1.04 . . . . 0.34999999999999998 110.019 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -50.82 -46.69 59.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.041 0.448 . . . . 1.8600000000000001 110.098 174.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -32.89 70.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 114.015 1.117 . . . . 3.1299999999999999 114.015 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.65 -21.23 25.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.548 0.613 . . . . 0.88 110.571 166.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.93 27.3 8.4 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.768 -0.933 . . . . 0.32000000000000001 110.768 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -140.39 173.67 11.28 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.181 -1.044 . . . . 1.72 108.181 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 122.88 31.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.702 -1.592 . . . . 4.1600000000000001 106.702 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 p -89.92 145.78 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.906 -0.776 . . . . 0.55000000000000004 108.906 171.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 109.289 -0.634 . . . . 1.27 109.289 170.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 . . . . . 0 N--CA 1.45 -0.434 0 CA-C-O 120.56 0.219 . . . . 0.93999999999999995 111.289 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.32 161.55 40.07 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.998 -0.371 . . . . 3.6000000000000001 109.998 172.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.41 136.29 33.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.627 -1.17 . . . . 3.3900000000000001 107.935 161.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 tp -107.4 153.91 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.051 -1.833 . . . . 1.1699999999999999 106.051 162.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.58 128.56 17.49 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.589 1.156 . . . . 0.35999999999999999 108.44 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.78 172.33 18.81 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.506 0.594 . . . . 1.3700000000000001 111.939 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.62 157.38 17.51 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.278 -0.638 . . . . 2.2799999999999998 109.278 -176.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 24' ' ' ILE . 2.1 t -123.34 132.12 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 O-C-N 123.492 0.495 . . . . 0.70999999999999996 110.315 177.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 107.922 -1.14 . . . . 0.90000000000000002 107.922 172.464 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 CA-C-O 118.579 -0.724 . . . . 0.5 110.609 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -52.98 -44.38 67.14 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 119.347 0.976 . . . . 5.5999999999999996 111.451 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.568 HD11 ' CD2' ' A' ' 69' ' ' TYR . 71.4 mt -44.66 -61.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 123.494 0.717 . . . . 0.82999999999999996 109.15 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.01 -37.99 66.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.809 -0.632 . . . . 2.3999999999999999 112.177 -175.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -57.5 -34.63 69.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.328 -0.858 . . . . 1.52 110.691 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.81 -49.82 64.23 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 110.781 -0.928 . . . . 0.40000000000000002 110.781 167.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.663 HD22 HG13 ' A' ' 60' ' ' ILE . 92.9 mt -64.41 -32.72 74.45 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 118.302 1.051 . . . . 0.40999999999999998 112.311 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.458 ' HA ' HG11 ' A' ' 34' ' ' VAL . 12.8 ttmm -57.83 -16.43 11.62 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.151 0.887 . . . . 1.51 112.094 171.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -97.85 -0.47 45.03 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.178 0.899 . . . . 3.23 112.744 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.426 ' O ' HG12 ' A' ' 34' ' ' VAL . 53.7 mmm -79.99 135.56 55.03 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 119.895 1.225 . . . . 2.3799999999999999 110.629 174.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.09 116.94 3.89 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.421 2.08 . . . . 0.81999999999999995 109.448 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.35 -17.18 6.61 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.929 1.252 . . . . 0.19 110.146 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' A' ' 29' ' ' LYS . 4.7 p -75.7 158.69 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.305 0.642 . . . . 0.29999999999999999 111.366 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.38 -63.05 1.4 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.581 1.152 . . . . 0.44 108.099 165.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -135.36 151.86 50.89 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 112.441 0.534 . . . . 3.1099999999999999 112.441 -169.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.32 140.09 41.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.928 1.291 . . . . 0.60999999999999999 107.558 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -147.63 129.98 15.7 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.201 -0.666 . . . . 1.74 109.201 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.89 134.87 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 123.98 0.912 . . . . 0.66000000000000003 110.593 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -124.82 65.2 1.11 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.008 1.723 . . . . 1.22 110.201 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.97 -20.36 63.77 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 116.071 -0.513 . . . . 0.91000000000000003 112.334 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.52 -24.69 21.75 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.997 0.519 . . . . 0.78000000000000003 110.996 171.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.4 m -125.61 16.24 8.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.96 1.304 . . . . 0.68000000000000005 109.935 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 45.93 38.39 4.5 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.339 1.056 . . . . 2.0099999999999998 111.44 -175.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.4 m -131.86 153.05 50.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.11 -1.441 . . . . 0.55000000000000004 107.11 -171.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 p -133.2 149.86 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.721 -1.214 . . . . 0.40999999999999998 107.721 174.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.22 148.45 48.64 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 123.967 0.792 . . . . 2.8999999999999999 109.565 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.3 131.26 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 121.576 0.703 . . . . 0.32000000000000001 109.266 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mt -95.38 120.12 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.508 1.923 . . . . 0.94999999999999996 107.361 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -149.33 170.15 19.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.455 0.702 . . . . 1.8200000000000001 110.188 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -104.44 121.29 47.78 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 114.36 -1.291 . . . . 2.0299999999999998 111.22 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.18 2.69 1.67 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.683 3.589 . . . . 0.5 114.203 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.92 -51.16 10.85 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 119.268 0.94 . . . . 0.46999999999999997 108.864 176.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -90.7 -44.27 9.59 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.545 1.538 . . . . 3.04 109.633 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.2 m -127.07 121.83 32.62 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 116.865 2.172 . . . . 0.58999999999999997 116.865 -157.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.09 169.63 27.41 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 106.223 -2.751 . . . . 0.96999999999999997 106.223 173.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.304 0.0 OUTLIER -39.52 -40.05 0.8 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.324 1.849 . . . . 0.70999999999999996 113.248 177.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -38.3 -59.76 0.85 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.331 1.052 . . . . 0.52000000000000002 113.245 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.51 -35.61 65.64 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 122.012 0.911 . . . . 0.28999999999999998 109.246 -173.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.663 HG13 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -60.75 -60.09 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-N 114.189 -1.368 . . . . 1.0600000000000001 108.237 -176.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.72 -51.88 26.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.162 0.892 . . . . 1.1299999999999999 110.436 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.68 -51.31 12.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.929 0.892 . . . . 2.3799999999999999 112.01 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -46.01 65.31 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.911 -0.716 . . . . 1.8999999999999999 110.938 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.651 HD11 HD11 ' A' ' 28' ' ' LEU . 8.3 mm -52.41 -44.53 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 118.94 0.791 . . . . 0.87 110.73 -175.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -48.85 -51.3 30.43 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.327 0.585 . . . . 1.5900000000000001 109.939 173.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -73.31 -28.75 62.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.602 0.761 . . . . 4.0499999999999998 112.85 -175.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.46 -25.45 25.29 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.155 0.434 . . . . 0.93999999999999995 110.254 165.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.02 29.93 5.61 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 124.891 1.234 . . . . 0.56999999999999995 110.566 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.568 ' CD2' HD11 ' A' ' 24' ' ' ILE . 58.5 m-85 -144.12 169.26 18.19 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 108.198 -1.038 . . . . 2.0 108.198 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.95 120.47 30.44 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.103 -1.073 . . . . 4.3600000000000003 108.103 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.8 p -87.49 149.64 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.835 -0.432 . . . . 0.42999999999999999 109.835 172.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.26 0 C-N-CA 124.181 0.992 . . . . 1.28 110.217 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 109.846 -0.427 . . . . 0.68999999999999995 109.846 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -147.98 162.1 40.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.248 1.023 . . . . 3.2200000000000002 111.395 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.16 146.93 30.28 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 112.647 -2.069 . . . . 3.3399999999999999 107.807 164.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -132.25 158.06 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.401 -2.074 . . . . 1.4299999999999999 105.401 165.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.73 144.1 32.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.062 0.945 . . . . 0.57999999999999996 109.129 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.9 169.82 23.73 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.252 0.621 . . . . 1.3100000000000001 110.609 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.1 155.01 19.72 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.367 -0.975 . . . . 2.3199999999999998 108.367 176.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -116.54 160.85 15.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.283 -1.006 . . . . 0.67000000000000004 108.283 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.445 -0.701 0 N-CA-C 107.452 -1.314 . . . . 0.79000000000000004 107.452 175.148 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.547 0 CA-C-O 118.586 -0.721 . . . . 0.35999999999999999 110.937 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.69 -48.33 66.64 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.176 0.898 . . . . 4.0 110.543 172.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.425 HD11 ' CD2' ' A' ' 69' ' ' TYR . 66.0 mt -49.03 -61.13 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.24 0 N-CA-C 109.054 -0.721 . . . . 0.57999999999999996 109.054 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -71.2 -35.1 71.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.077 -0.649 . . . . 2.3700000000000001 110.895 -171.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -54.57 -37.99 66.15 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 121.02 -1.05 . . . . 1.52 110.688 171.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.37 -51.52 36.57 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.584 -1.006 . . . . 0.47999999999999998 110.584 168.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.796 HD11 HD11 ' A' ' 64' ' ' ILE . 96.1 mt -64.79 -29.91 70.9 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 121.702 -0.881 . . . . 0.42999999999999999 112.367 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.652 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -63.1 -18.07 63.01 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 118.984 0.811 . . . . 1.48 109.809 176.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.83 -23.08 63.25 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.219 -1.551 . . . . 3.1800000000000002 113.934 168.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.57 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -69.03 133.19 89.99 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 120.214 1.37 . . . . 1.8500000000000001 110.463 -172.23 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.24 100.12 0.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.822 2.348 . . . . 0.44 110.19 -176.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.57 -21.82 2.37 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.588 -1.005 . . . . 0.29999999999999999 110.588 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.652 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.8 p -67.37 153.7 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 122.293 -0.533 . . . . 0.28000000000000003 110.675 170.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.25 -61.07 1.77 Allowed 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.467 -0.938 . . . . 0.46000000000000002 108.467 167.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.26 152.93 39.12 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.645 0.259 . . . . 2.7599999999999998 111.315 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.13 135.28 46.29 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.901 2.08 . . . . 0.68000000000000005 107.77 -173.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -144.7 121.67 11.36 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.408 0.683 . . . . 1.5700000000000001 109.73 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -97.8 137.59 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 112.937 0.717 . . . . 0.97999999999999998 112.937 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -126.33 69.79 1.23 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.401 2.281 . . . . 1.3 111.181 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.9 mt -65.08 -17.98 64.92 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 112.692 0.627 . . . . 0.73999999999999999 112.692 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.89 -10.0 5.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.154 0.434 . . . . 0.63 111.44 169.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 m -138.17 17.18 2.8 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.23 1.012 . . . . 0.45000000000000001 109.758 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mp0 51.2 30.6 5.89 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.048 0.84 . . . . 2.8900000000000001 111.935 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.7 m -128.98 153.66 47.34 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.804 -1.184 . . . . 0.53000000000000003 107.804 -168.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.02 147.46 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.951 -1.129 . . . . 0.46000000000000002 107.951 174.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.46 151.73 41.0 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 124.209 0.943 . . . . 2.8399999999999999 109.154 175.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.5 140.2 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.142 -1.059 . . . . 0.27000000000000002 108.142 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.46 124.89 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.531 1.532 . . . . 0.87 107.438 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -148.46 165.99 29.49 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.387 0.675 . . . . 1.8200000000000001 110.622 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -97.98 110.84 57.42 Favored Pre-proline 0 N--CA 1.447 -0.611 0 C-N-CA 124.673 1.189 . . . . 2.0499999999999998 110.247 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -72.25 13.25 0.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.963 3.108 . . . . 0.60999999999999999 113.716 -177.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.41 -51.26 8.02 Favored 'General case' 0 C--N 1.337 0.059 0 N-CA-C 107.257 -1.386 . . . . 0.59999999999999998 107.257 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -80.83 -47.98 13.06 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.273 1.429 . . . . 2.7400000000000002 109.637 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.5 m -143.04 125.7 15.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 117.252 2.316 . . . . 0.70999999999999996 117.252 -145.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.51 -159.74 13.65 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 109.857 -1.297 . . . . 0.5 109.857 165.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.4 t -29.47 -50.04 0.1 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 129.138 2.975 . . . . 0.72999999999999998 112.632 177.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.05 -56.33 6.68 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.025 0.93 . . . . 0.32000000000000001 112.654 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -38.47 64.88 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 122.248 1.023 . . . . 0.20000000000000001 109.403 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.596 HG12 HD22 ' A' ' 28' ' ' LEU . 1.3 mt -63.29 -56.26 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.242 -1.345 . . . . 0.59999999999999998 110.216 -170.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.21 -52.69 19.87 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.174 1.352 . . . . 0.76000000000000001 110.611 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -44.09 -51.95 7.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.683 1.193 . . . . 2.5099999999999998 111.968 176.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -43.44 68.61 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 118.248 -0.882 . . . . 2.0800000000000001 111.464 177.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.796 HD11 HD11 ' A' ' 28' ' ' LEU . 37.7 mm -52.58 -45.55 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 119.77 1.168 . . . . 0.38 110.075 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -50.38 -49.2 55.05 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.763 0.316 . . . . 1.8200000000000001 110.183 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -70.77 -30.67 67.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 114.279 1.214 . . . . 3.25 114.279 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.27 -21.0 12.75 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.532 0.606 . . . . 0.91000000000000003 110.635 166.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.24 28.74 9.52 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.998 -1.241 . . . . 0.29999999999999999 109.998 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.425 ' CD2' HD11 ' A' ' 24' ' ' ILE . 71.2 m-85 -137.44 168.3 19.91 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.735 -0.839 . . . . 1.71 108.735 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.33 123.1 42.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.746 -1.576 . . . . 4.4900000000000002 106.746 175.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.442 ' HB ' HG21 ' A' ' 64' ' ' ILE . 8.7 p -91.65 152.99 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.46 -0.57 . . . . 0.54000000000000004 109.46 172.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.103 0 CA-C-O 121.305 0.574 . . . . 1.4299999999999999 110.305 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 109.546 -0.539 . . . . 0.69999999999999996 109.546 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.45 162.22 41.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.238 0.542 . . . . 4.79 110.878 176.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -82.83 155.03 24.38 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.222 1.809 . . . . 3.71 109.765 168.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.7 142.84 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 104.847 -2.279 . . . . 3.2599999999999998 104.847 162.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.52 130.72 51.14 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.689 1.196 . . . . 0.40999999999999998 107.869 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -155.53 174.78 14.77 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.876 0.47 . . . . 1.2 110.381 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.419 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -104.87 150.31 24.96 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.753 -1.203 . . . . 1.8999999999999999 107.753 -176.379 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.42 161.52 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 107.502 -1.296 . . . . 0.64000000000000001 107.502 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 107.609 -1.256 . . . . 1.29 107.609 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 119.489 -0.291 . . . . 0.40000000000000002 110.24 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -58.4 -45.14 88.95 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 118.778 -0.629 . . . . 3.6800000000000002 111.997 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.2 mt -49.06 -60.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.041 -0.725 . . . . 0.62 109.041 176.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' CD ' HG21 ' A' ' 46' ' ' VAL . 3.4 tp10 -70.86 -33.98 71.17 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.16 0.505 . . . . 2.6400000000000001 110.336 -170.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -60.15 -31.29 69.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.864 -1.147 . . . . 2.29 111.234 171.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.67 -51.82 31.74 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.515 -1.034 . . . . 0.34000000000000002 110.515 162.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 64' ' ' ILE . 93.3 mt -65.2 -32.66 74.45 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 121.253 -1.145 . . . . 0.39000000000000001 113.023 177.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HA ' HG11 ' A' ' 34' ' ' VAL . 13.5 tppt? -54.97 -21.22 11.08 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.373 0.988 . . . . 1.79 111.458 171.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -76.02 -24.32 55.25 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.788 1.033 . . . . 3.0800000000000001 113.788 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.48 ' O ' HG12 ' A' ' 34' ' ' VAL . 1.5 mtp -69.7 132.83 88.82 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 120.375 1.443 . . . . 2.2400000000000002 112.478 -172.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.6 95.38 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.644 2.896 . . . . 0.46000000000000002 110.716 -172.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.44 -20.8 2.23 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.696 -0.962 . . . . 0.26000000000000001 110.696 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 31' ' ' MET . 9.8 p -62.62 144.54 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 121.966 -0.726 . . . . 0.39000000000000001 110.954 171.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.12 -61.79 1.34 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.629 1.172 . . . . 0.81000000000000005 109.269 167.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -149.41 147.98 28.92 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 114.315 1.228 . . . . 2.8700000000000001 114.315 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.415 ' HB1' ' CG ' ' A' ' 25' ' ' GLU . . . -116.46 121.3 41.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.84 2.056 . . . . 0.91000000000000003 108.331 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.99 107.42 6.15 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.921 0.889 . . . . 1.3899999999999999 108.986 -170.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 p -85.4 143.6 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.91 0.884 . . . . 0.60999999999999999 112.058 -172.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -133.49 65.78 1.57 Allowed 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.226 1.811 . . . . 1.29 111.163 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.6 mt -65.61 -16.35 63.63 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 121.685 -0.634 . . . . 0.71999999999999997 112.704 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.4 -19.65 15.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.645 0.378 . . . . 0.52000000000000002 110.902 168.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.4 m -129.19 19.33 5.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.088 1.355 . . . . 0.45000000000000001 109.685 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 50.24 35.14 9.84 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.138 0.975 . . . . 2.4399999999999999 111.846 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.89 158.08 44.86 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 108.847 -0.797 . . . . 0.97999999999999998 108.847 -169.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.439 HG21 ' CD ' ' A' ' 25' ' ' GLU . 7.2 p -134.96 148.85 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.081 -0.711 . . . . 0.45000000000000001 109.081 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -115.81 134.41 55.04 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.95 -1.5 . . . . 2.5 106.95 176.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.43 140.07 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.284 -0.635 . . . . 0.37 109.284 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.0 mt -105.58 132.67 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 126.201 1.8 . . . . 0.90000000000000002 106.945 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.01 167.42 28.48 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.959 0.409 . . . . 2.0299999999999998 111.498 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -98.25 114.16 64.86 Favored Pre-proline 0 N--CA 1.442 -0.829 0 C-N-CA 124.752 1.221 . . . . 1.46 109.839 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -69.48 9.87 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 124.289 3.326 . . . . 0.53000000000000003 113.971 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.39 -51.59 8.18 Favored 'General case' 0 N--CA 1.458 -0.058 0 N-CA-C 107.411 -1.329 . . . . 0.46999999999999997 107.411 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -93.67 -29.75 15.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.579 1.552 . . . . 3.1200000000000001 111.289 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.7 m -150.2 130.25 13.5 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 118.031 2.604 . . . . 0.47999999999999998 118.031 -156.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.33 -165.25 17.79 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 110.453 -1.059 . . . . 0.42999999999999999 110.453 156.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.4 t -39.88 -38.31 0.67 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.291 2.636 . . . . 1.04 112.138 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.65 -56.0 9.71 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.181 0.808 . . . . 0.32000000000000001 113.181 174.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.56 -37.82 65.41 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.838 1.304 . . . . 0.19 108.904 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.597 ' CG1' HD22 ' A' ' 28' ' ' LEU 0.269 0.8 OUTLIER -64.04 -53.6 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 113.708 -1.587 . . . . 0.57999999999999996 111.013 -173.749 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.87 -53.07 12.91 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.766 1.621 . . . . 0.96999999999999997 111.048 173.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -39.75 -58.12 1.4 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.829 0.823 . . . . 2.52 113.106 172.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -70.34 -40.28 74.2 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 119.465 -0.894 . . . . 2.9900000000000002 110.224 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.696 HD11 HD11 ' A' ' 28' ' ' LEU . 31.3 mm -54.12 -46.74 67.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.506 1.048 . . . . 0.35999999999999999 110.114 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -53.13 -45.53 68.4 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.289 0.636 . . . . 1.5700000000000001 109.927 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -38.99 86.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.456 -0.778 . . . . 3.9199999999999999 111.23 -177.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.6 -19.85 18.11 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.656 1.182 . . . . 0.96999999999999997 110.898 170.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.01 28.54 9.25 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 124.187 0.899 . . . . 0.34999999999999998 110.938 173.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -138.06 165.31 26.91 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.041 -1.096 . . . . 1.79 108.041 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.69 129.3 55.2 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.752 0.821 . . . . 3.9199999999999999 108.943 173.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.3 p -96.14 148.52 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 125.276 1.431 . . . . 0.41999999999999998 110.22 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 11' ' ' GLN . 2.9 m . . . . . 0 N--CA 1.463 0.177 0 C-N-CA 123.594 0.758 . . . . 1.0 110.376 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 119.92 -0.085 . . . . 0.57999999999999996 111.182 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -143.67 157.0 44.72 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.599 0.714 . . . . 2.4199999999999999 111.399 174.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -84.28 125.68 32.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.244 1.818 . . . . 2.3300000000000001 107.035 163.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 tp -103.64 149.18 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.278 -1.749 . . . . 1.1200000000000001 106.278 163.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.82 129.11 40.06 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.674 -1.232 . . . . 0.40999999999999998 107.674 172.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -155.75 168.63 26.58 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.841 0.456 . . . . 1.02 110.553 -172.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -91.57 151.51 20.69 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.811 -0.811 . . . . 2.8999999999999999 108.811 -173.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -117.96 160.84 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 108.922 -0.769 . . . . 0.67000000000000004 108.922 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.445 -0.685 0 N-CA-C 107.839 -1.171 . . . . 0.79000000000000004 107.839 174.194 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.676 0 CA-C-O 118.68 -0.676 . . . . 0.54000000000000004 111.935 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -57.48 -47.11 82.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.357 0.98 . . . . 3.3999999999999999 110.753 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.595 HD12 ' H ' ' A' ' 24' ' ' ILE . 3.5 mp -48.7 -61.62 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.413 -0.958 . . . . 1.6100000000000001 108.413 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.56 -33.57 66.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.433 -0.507 . . . . 2.5699999999999998 112.003 -172.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -56.29 -39.8 73.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.149 -0.969 . . . . 1.9399999999999999 110.026 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.01 -55.5 11.61 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.937 -1.265 . . . . 0.33000000000000002 109.937 167.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.88 HD11 HD11 ' A' ' 64' ' ' ILE . 96.5 mt -63.5 -31.39 72.54 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 113.439 0.903 . . . . 0.34000000000000002 113.439 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.447 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.26 14.0 ttpt -61.62 -17.14 53.99 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.656 1.116 . . . . 2.0899999999999999 111.116 172.831 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.92 -12.8 52.6 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.154 1.168 . . . . 3.6000000000000001 114.154 168.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.471 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -71.44 137.58 83.68 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 120.827 1.649 . . . . 3.3799999999999999 111.241 -173.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.48 94.48 0.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.113 2.542 . . . . 0.37 110.433 -175.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.42 -12.78 3.5 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.74 1.162 . . . . 0.23000000000000001 111.193 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 31' ' ' MET . 4.7 p -67.38 160.57 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 117.791 0.795 . . . . 0.26000000000000001 110.526 167.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.77 -55.44 1.9 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.358 1.063 . . . . 0.51000000000000001 110.152 165.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -143.99 162.26 36.64 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.068 0.395 . . . . 2.2599999999999998 111.815 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.44 135.73 28.77 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 126.072 1.749 . . . . 0.62 109.607 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -142.47 110.25 5.83 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 125.439 1.496 . . . . 1.55 108.746 -173.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.0 p -84.14 140.93 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.555 0.742 . . . . 0.62 111.728 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -132.48 69.06 1.48 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.991 1.717 . . . . 1.23 112.328 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.9 mt -63.38 -18.97 64.25 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 113.087 0.773 . . . . 0.79000000000000004 113.087 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.83 -21.93 12.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.264 0.484 . . . . 0.58999999999999997 110.933 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 m -125.65 10.19 7.77 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.919 1.288 . . . . 0.51000000000000001 110.605 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 45.52 44.68 10.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.176 0.991 . . . . 3.29 112.266 -169.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.9 m -134.31 155.29 50.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.411 -1.329 . . . . 0.54000000000000004 107.411 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.3 p -134.12 146.92 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.559 -0.904 . . . . 0.5 108.559 172.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -115.3 134.65 54.93 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 124.498 1.124 . . . . 2.3799999999999999 108.244 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -138.56 135.48 43.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.11 -0.7 . . . . 0.29999999999999999 109.11 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.9 mp -102.02 120.88 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.765 1.626 . . . . 1.1000000000000001 107.178 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -147.28 167.29 24.63 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.484 0.714 . . . . 1.8500000000000001 110.619 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -105.54 119.2 53.5 Favored Pre-proline 0 N--CA 1.443 -0.799 0 O-C-N 124.135 0.897 . . . . 1.3700000000000001 109.677 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -67.95 7.72 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 124.464 3.443 . . . . 0.46999999999999997 113.83 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.44 -57.0 4.12 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.201 -1.407 . . . . 0.46000000000000002 107.201 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.0 mp0 -87.84 -37.14 16.79 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.303 1.041 . . . . 3.7799999999999998 112.161 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.3 m -138.08 129.38 27.6 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 118.649 2.833 . . . . 0.54000000000000004 118.649 -155.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.41 -163.62 17.86 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.475 -1.05 . . . . 0.42999999999999999 110.475 155.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -29.29 -47.91 0.07 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.512 2.725 . . . . 0.88 112.863 172.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.15 -54.41 16.47 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.114 0.565 . . . . 0.40000000000000002 112.487 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.3 -41.62 60.86 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 122.201 1.0 . . . . 0.26000000000000001 109.182 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.708 HG12 HD22 ' A' ' 28' ' ' LEU . 1.6 mt -61.36 -60.25 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 114.137 -1.392 . . . . 0.56000000000000005 109.266 -170.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.98 -53.81 7.28 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.506 1.048 . . . . 0.79000000000000004 110.397 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -44.47 -54.44 5.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.624 1.17 . . . . 2.5899999999999999 111.363 176.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -40.7 76.04 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.987 -0.685 . . . . 2.3900000000000001 111.355 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 28' ' ' LEU . 37.7 mm -55.41 -44.27 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 119.233 0.924 . . . . 0.66000000000000003 109.947 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -52.67 -42.85 65.12 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.109 0.48 . . . . 1.8200000000000001 110.721 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -37.08 73.9 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.008 -1.057 . . . . 3.5899999999999999 111.016 -177.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.83 -21.0 17.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.538 0.735 . . . . 0.89000000000000001 110.911 169.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.08 27.39 16.23 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.588 -1.005 . . . . 0.35999999999999999 110.588 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.547 ' CE2' HD11 ' A' ' 24' ' ' ILE . 41.8 m-85 -135.51 169.51 17.4 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 107.942 -1.133 . . . . 2.02 107.942 176.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.4 114.79 16.0 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 107.84 -1.17 . . . . 4.5199999999999996 107.84 -174.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.41 144.11 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 123.795 0.838 . . . . 0.52000000000000002 108.803 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.431 0 C-N-CA 124.461 1.104 . . . . 1.5700000000000001 109.373 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 120.256 0.074 . . . . 1.1100000000000001 111.087 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.47 160.52 43.25 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.318 0.58 . . . . 4.0999999999999996 111.725 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -84.4 127.01 33.75 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.445 1.498 . . . . 2.4900000000000002 108.303 166.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tp -108.8 155.88 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.313 -1.736 . . . . 1.22 106.313 162.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.86 140.27 23.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.091 0.557 . . . . 0.72999999999999998 109.816 175.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.441 ' HG3' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -157.75 169.41 24.68 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 123.647 0.592 . . . . 1.6200000000000001 111.189 -177.88 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.5 152.85 23.67 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 108.105 -1.072 . . . . 2.4399999999999999 108.105 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.424 HG11 HD13 ' A' ' 24' ' ' ILE . 2.2 t -131.17 139.0 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.867 0.365 . . . . 1.0 110.289 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.446 -0.657 0 C-N-CA 124.512 1.125 . . . . 0.76000000000000001 108.188 -178.278 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 119.108 -0.473 . . . . 0.32000000000000001 110.563 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -57.24 -44.65 84.02 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.965 0.802 . . . . 6.6900000000000004 111.527 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.562 HD11 ' CD2' ' A' ' 69' ' ' TYR . 67.7 mt -46.74 -61.19 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 108.882 -0.784 . . . . 0.81999999999999995 108.882 177.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.14 -35.48 69.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.968 -0.56 . . . . 2.6000000000000001 111.787 -172.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -57.34 -35.68 70.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.094 -1.004 . . . . 1.46 110.786 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.26 -53.57 15.14 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.821 -0.911 . . . . 0.45000000000000001 110.821 165.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.71 HD22 HG12 ' A' ' 60' ' ' ILE . 89.4 mt -65.05 -31.06 72.1 Favored 'General case' 0 C--O 1.223 -0.314 0 O-C-N 121.778 -0.837 . . . . 0.53000000000000003 112.151 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.275 14.1 ttmt -58.87 -17.76 26.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.405 1.002 . . . . 1.21 112.104 171.792 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -20.24 47.66 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.66 1.118 . . . . 3.3599999999999999 113.726 168.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.474 ' O ' HG12 ' A' ' 34' ' ' VAL . 94.4 mmm -74.33 137.54 75.02 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 119.99 1.268 . . . . 2.0499999999999998 111.924 -169.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.49 91.17 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.671 2.914 . . . . 0.44 111.403 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.59 -13.65 2.23 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.941 1.257 . . . . 0.25 111.522 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 29' ' ' LYS . 6.8 p -66.18 159.68 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 121.709 -0.877 . . . . 0.31 111.635 168.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.22 -56.39 1.63 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.135 1.374 . . . . 0.60999999999999999 110.76 168.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -143.73 157.1 44.63 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 122.299 -0.251 . . . . 2.52 111.62 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.34 131.22 31.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.885 1.274 . . . . 0.69999999999999996 109.389 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -136.98 117.74 14.04 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.639 0.776 . . . . 1.5900000000000001 110.009 -176.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -84.32 140.62 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.448 1.099 . . . . 0.65000000000000002 110.732 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -130.36 65.0 1.53 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.591 1.557 . . . . 1.21 110.777 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.5 mt -64.37 -15.3 60.17 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 113.201 0.815 . . . . 0.66000000000000003 113.201 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.27 -20.07 3.84 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.274 0.63 . . . . 0.59999999999999998 111.514 167.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.6 m -134.45 18.66 3.64 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.421 1.488 . . . . 0.56000000000000005 109.957 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.8 mp0 47.28 34.84 3.37 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.299 1.04 . . . . 2.8100000000000001 111.815 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -132.5 153.17 51.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.744 -1.576 . . . . 0.5 106.744 -170.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -139.3 153.24 24.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.382 -0.97 . . . . 1.0700000000000001 108.382 173.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.12 151.73 36.98 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 124.342 1.026 . . . . 2.7400000000000002 109.815 176.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.16 136.04 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 108.598 -0.89 . . . . 0.31 108.598 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 mt -101.01 116.64 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.767 2.027 . . . . 0.81999999999999995 106.08 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -144.44 167.48 22.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.682 0.793 . . . . 1.8500000000000001 109.971 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -103.26 115.76 63.36 Favored Pre-proline 0 N--CA 1.443 -0.78 0 CA-C-N 114.726 -1.124 . . . . 1.4099999999999999 110.618 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -69.92 8.86 0.71 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 124.258 3.305 . . . . 0.5 113.953 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.38 -49.06 12.96 Favored 'General case' 0 CA--C 1.526 0.046 0 N-CA-C 107.943 -1.132 . . . . 0.42999999999999999 107.943 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -96.05 -36.22 11.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.979 1.712 . . . . 2.6600000000000001 110.693 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 m -142.19 129.07 20.62 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 117.708 2.484 . . . . 0.5 117.708 -159.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.11 -161.37 13.12 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.885 -0.886 . . . . 0.41999999999999998 110.885 157.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -32.92 -43.68 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 128.379 2.672 . . . . 0.91000000000000003 113.394 176.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.83 -57.19 7.87 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.041 0.536 . . . . 0.40999999999999998 112.145 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.85 -39.79 63.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 122.337 1.065 . . . . 0.26000000000000001 108.88 -177.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.71 HG12 HD22 ' A' ' 28' ' ' LEU . 1.8 mt -63.75 -53.44 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 114.359 -1.292 . . . . 0.55000000000000004 110.551 -169.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -51.67 58.19 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.623 1.101 . . . . 0.80000000000000004 110.454 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -46.29 -54.43 8.92 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.222 1.009 . . . . 2.1800000000000002 111.121 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -43.16 78.9 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 119.475 -0.89 . . . . 2.9300000000000002 111.263 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.432 HD11 HD11 ' A' ' 28' ' ' LEU . 4.9 mm -53.91 -45.17 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 123.822 0.849 . . . . 0.37 110.429 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -48.79 -47.64 41.86 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.915 -0.402 . . . . 1.6200000000000001 109.915 173.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -71.91 -30.04 64.95 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.642 0.979 . . . . 3.4500000000000002 113.642 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.97 -23.11 12.03 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.493 0.588 . . . . 0.84999999999999998 110.56 165.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.67 28.82 8.13 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 109.888 -1.285 . . . . 0.37 109.888 175.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.562 ' CD2' HD11 ' A' ' 24' ' ' ILE . 51.0 m-85 -139.96 164.2 30.64 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 108.122 -1.066 . . . . 1.77 108.122 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.48 121.21 36.04 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.367 -1.346 . . . . 4.5499999999999998 107.367 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.441 HG22 ' HG3' ' A' ' 10' ' ' MET . 1.4 p -86.77 159.35 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 124.838 1.255 . . . . 0.82999999999999996 108.951 174.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 121.412 0.625 . . . . 1.6100000000000001 111.322 176.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 110.248 -0.279 . . . . 0.64000000000000001 110.248 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -149.22 162.63 39.63 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.198 0.523 . . . . 3.0600000000000001 111.518 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.09 139.4 32.5 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.527 1.931 . . . . 2.2599999999999998 108.269 170.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 tp -118.32 151.7 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.202 -1.777 . . . . 1.1000000000000001 106.202 163.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.57 120.19 11.79 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.249 1.419 . . . . 0.58999999999999997 107.944 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.5 ptt? -156.51 167.71 29.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.296 0.498 . . . . 1.1000000000000001 110.105 -171.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.08 156.95 16.41 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.422 0.689 . . . . 1.79 110.282 -173.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -115.26 160.6 14.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 C-N-CA 123.043 0.537 . . . . 0.73999999999999999 109.919 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 124.933 1.293 . . . . 0.85999999999999999 108.316 174.882 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 119.15 -0.452 . . . . 0.48999999999999999 110.791 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.2 mmt-85 -54.81 -49.79 70.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.683 0.674 . . . . 4.0899999999999999 111.048 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.495 HD11 ' CD2' ' A' ' 69' ' ' TYR . 83.0 mt -48.45 -60.68 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.944 -0.762 . . . . 0.55000000000000004 108.944 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.461 ' HG2' HG21 ' A' ' 46' ' ' VAL . 1.9 tm-20 -69.19 -38.79 78.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 118.8 -1.16 . . . . 3.4199999999999999 109.801 -173.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -58.3 -28.37 64.93 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.086 -1.633 . . . . 1.26 112.365 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.53 -52.08 52.48 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 110.732 -0.947 . . . . 0.37 110.732 165.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.564 HD22 HG12 ' A' ' 60' ' ' ILE . 89.9 mt -64.03 -29.93 71.04 Favored 'General case' 0 C--O 1.223 -0.29 0 O-C-N 121.551 -0.97 . . . . 0.35999999999999999 112.966 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -55.08 -18.7 5.82 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.596 1.089 . . . . 1.9299999999999999 111.957 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -86.18 -14.82 42.85 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.753 1.16 . . . . 2.96 114.042 171.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.446 ' O ' HG12 ' A' ' 34' ' ' VAL . 82.2 mmm -73.12 138.43 79.0 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 120.01 1.277 . . . . 2.1400000000000001 112.313 -170.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.06 91.88 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.801 3.001 . . . . 0.5 111.268 -171.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.57 -11.0 4.03 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.606 -0.998 . . . . 0.22 110.606 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 31' ' ' MET . 6.5 p -61.92 145.97 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 118.286 1.043 . . . . 0.31 110.507 168.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.07 -67.79 0.89 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.09 -1.078 . . . . 0.5 108.09 162.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -149.86 126.83 11.17 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 113.628 0.973 . . . . 3.5299999999999998 113.628 -163.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.14 150.76 21.25 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.367 1.867 . . . . 1.1000000000000001 110.4 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.78 100.06 2.19 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.46 0.704 . . . . 1.8600000000000001 109.266 174.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.83 140.73 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.535 0.734 . . . . 0.81999999999999995 111.476 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -136.79 69.52 1.41 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.701 1.6 . . . . 1.26 111.566 -174.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.6 mt -65.61 -15.58 62.88 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 113.32 0.859 . . . . 0.78000000000000003 113.32 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.93 -17.08 5.68 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.715 0.406 . . . . 0.56999999999999995 111.292 168.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.1 m -136.59 18.91 3.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.923 1.289 . . . . 0.57999999999999996 109.735 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 47.67 32.36 2.51 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.716 1.206 . . . . 3.0299999999999998 112.164 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 m -127.97 151.53 49.01 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.806 -1.183 . . . . 0.53000000000000003 107.806 -168.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.461 HG21 ' HG2' ' A' ' 25' ' ' GLU . 8.9 p -134.0 142.41 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 109.003 -0.74 . . . . 0.65000000000000002 109.003 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -116.59 142.53 46.76 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.294 -1.372 . . . . 2.5699999999999998 107.294 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.38 140.38 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.945 -0.391 . . . . 0.52000000000000002 109.945 172.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.4 mt -100.68 127.47 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.725 -1.583 . . . . 1.01 106.725 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -149.82 171.42 16.77 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.914 0.886 . . . . 1.73 110.565 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -105.11 106.4 55.49 Favored Pre-proline 0 N--CA 1.446 -0.649 0 C-N-CA 124.951 1.3 . . . . 1.79 110.606 -177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -70.79 20.98 0.21 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 124.016 3.144 . . . . 0.53000000000000003 113.322 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.93 -41.38 14.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.926 -1.139 . . . . 0.42999999999999999 107.926 168.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -103.64 -50.04 3.52 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.502 1.521 . . . . 2.7599999999999998 110.433 176.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 m -127.29 131.84 50.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 128.506 2.722 . . . . 0.73999999999999999 117.978 -160.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.65 -161.46 12.26 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 108.998 -1.641 . . . . 0.54000000000000004 108.998 154.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 t -31.5 -44.97 0.08 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.888 2.875 . . . . 0.56000000000000005 113.34 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.37 -56.84 6.09 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.857 0.753 . . . . 0.32000000000000001 112.674 174.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.78 -36.38 65.06 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 122.535 1.16 . . . . 0.23999999999999999 109.261 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.564 HG12 HD22 ' A' ' 28' ' ' LEU . 1.5 mt -64.36 -54.88 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.165 -1.38 . . . . 0.67000000000000004 110.72 -172.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -49.35 -51.01 37.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.144 1.338 . . . . 0.72999999999999998 110.756 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -42.93 -56.36 3.32 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.09 0.956 . . . . 2.3599999999999999 112.44 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -41.89 74.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.901 -0.719 . . . . 1.8100000000000001 111.189 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.554 HD11 HD11 ' A' ' 28' ' ' LEU . 6.9 mm -53.18 -44.92 53.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.368 0.667 . . . . 0.40999999999999998 110.357 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -50.8 -52.93 36.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.247 0.619 . . . . 1.6100000000000001 110.077 174.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -37.54 87.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.662 0.785 . . . . 5.6399999999999997 112.511 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.44 -19.92 6.57 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.554 0.742 . . . . 2.2000000000000002 111.862 168.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.65 28.69 6.92 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.343 0.973 . . . . 0.33000000000000002 110.844 170.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.495 ' CD2' HD11 ' A' ' 24' ' ' ILE . 72.6 m-85 -142.98 171.51 13.96 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.975 -1.12 . . . . 1.75 107.975 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.07 128.81 47.96 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.679 -1.6 . . . . 4.2300000000000004 106.679 173.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.42 142.25 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 119.021 -0.514 . . . . 0.54000000000000004 109.629 170.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 109.222 -0.658 . . . . 1.1399999999999999 109.222 173.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 110.758 -0.09 . . . . 0.68999999999999995 110.758 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -149.6 160.89 43.12 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.24 0.543 . . . . 2.3100000000000001 111.466 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -84.61 144.82 28.37 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.399 1.48 . . . . 2.21 109.133 168.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 tp -124.47 154.32 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.234 -1.765 . . . . 1.24 106.234 165.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.0 129.56 21.41 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.498 1.119 . . . . 0.29999999999999999 109.088 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -156.86 173.5 16.89 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.511 0.725 . . . . 1.5 110.756 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -100.67 148.52 24.77 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.045 1.338 . . . . 3.3700000000000001 109.781 -174.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -118.46 161.99 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.19 0.996 . . . . 0.56000000000000005 109.346 -176.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.451 -0.389 0 C-N-CA 124.245 1.018 . . . . 0.75 108.901 179.413 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 119.639 -0.22 . . . . 0.42999999999999999 111.508 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -64.1 -47.19 81.0 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.21 0.604 . . . . 4.7000000000000002 110.043 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.438 HD11 ' CD2' ' A' ' 69' ' ' TYR . 62.0 mt -48.11 -60.09 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.283 -1.006 . . . . 0.58999999999999997 108.283 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -70.3 -35.63 73.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.168 -0.613 . . . . 2.3399999999999999 110.689 -171.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -58.01 -33.22 68.71 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 120.664 -1.272 . . . . 1.23 111.308 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.3 -47.26 83.61 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 110.366 -1.093 . . . . 0.28999999999999998 110.366 167.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 64' ' ' ILE . 91.7 mt -64.21 -29.22 70.34 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 118.625 1.212 . . . . 0.33000000000000002 112.428 175.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HA ' HG11 ' A' ' 34' ' ' VAL . 6.1 ttmm -59.89 -17.38 36.69 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.513 1.052 . . . . 1.72 111.243 173.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.75 -16.24 57.44 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.067 1.136 . . . . 3.5299999999999998 114.067 169.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.506 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -76.77 136.82 66.74 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 120.809 1.641 . . . . 2.5699999999999998 112.425 -171.889 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.71 99.32 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.867 3.045 . . . . 0.47999999999999998 110.995 -173.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.66 -15.79 4.08 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.304 -1.119 . . . . 0.22 110.304 177.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 31' ' ' MET . 8.5 p -67.81 150.93 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 O-C-N 122.047 -0.678 . . . . 0.28999999999999998 110.943 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.78 -65.3 1.19 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.812 -1.181 . . . . 0.41999999999999998 107.812 165.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -147.03 132.66 18.8 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 112.702 0.63 . . . . 3.3599999999999999 112.702 -163.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.8 136.77 50.63 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.902 1.681 . . . . 0.58999999999999997 108.55 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -139.73 112.96 8.25 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.591 1.156 . . . . 1.3400000000000001 108.325 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -84.5 141.07 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.183 0.993 . . . . 0.59999999999999998 110.444 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -137.03 65.32 1.51 Allowed 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.544 -1.28 . . . . 2.52 107.544 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 47.6 mt -63.23 -17.38 62.39 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 121.671 -0.643 . . . . 0.68999999999999995 112.281 174.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.28 -16.28 8.16 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.482 0.713 . . . . 0.65000000000000002 111.551 169.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.4 m -136.07 19.16 3.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.626 1.171 . . . . 0.54000000000000004 109.325 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 48.27 40.86 15.12 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.114 0.966 . . . . 3.3999999999999999 111.46 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.8 m -137.85 155.55 48.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.275 -1.38 . . . . 0.56000000000000005 107.275 -171.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.8 p -134.37 148.85 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 107.635 -1.246 . . . . 0.41999999999999998 107.635 170.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.73 150.23 43.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.973 0.796 . . . . 2.6800000000000002 109.273 171.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.99 142.73 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.841 -0.8 . . . . 0.35999999999999999 108.841 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.2 mt -104.01 127.57 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 126.675 1.99 . . . . 1.0 106.781 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -152.14 170.23 20.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.311 0.645 . . . . 1.74 110.143 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -104.21 113.09 65.53 Favored Pre-proline 0 N--CA 1.44 -0.961 0 CA-C-N 115.01 -0.996 . . . . 1.3100000000000001 110.145 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -68.8 10.35 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.799 3.0 . . . . 0.48999999999999999 113.634 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.57 -43.05 21.25 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 108.353 -0.98 . . . . 0.44 108.353 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -98.53 -44.97 6.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.319 1.447 . . . . 2.8500000000000001 110.0 176.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 m -138.04 130.91 29.87 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 118.915 2.931 . . . . 0.77000000000000002 118.915 -155.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.6 -157.82 9.27 Favored Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 108.385 -1.886 . . . . 0.54000000000000004 108.385 155.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.272 0.0 OUTLIER -32.17 -46.09 0.12 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.285 2.634 . . . . 0.53000000000000003 113.504 175.745 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.81 -57.43 4.9 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.001 0.741 . . . . 0.28999999999999998 113.001 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.02 -38.33 64.09 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 122.091 0.948 . . . . 0.19 109.225 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.616 HG12 HD22 ' A' ' 28' ' ' LEU . 1.3 mt -63.11 -58.87 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 114.347 -1.297 . . . . 0.63 109.601 -172.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.6 -51.74 15.06 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.753 1.16 . . . . 0.81000000000000005 110.971 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -42.81 -55.49 3.64 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.15 0.98 . . . . 2.1699999999999999 112.066 174.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.56 -40.5 73.3 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.146 -0.622 . . . . 2.0699999999999998 110.82 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.813 HD11 HD11 ' A' ' 28' ' ' LEU . 36.5 mm -54.56 -45.99 71.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 118.863 0.756 . . . . 0.42999999999999999 110.007 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -50.49 -51.9 43.15 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.232 0.539 . . . . 2.23 109.792 172.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -42.3 98.91 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.559 0.577 . . . . 3.7000000000000002 112.559 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mp -52.45 -19.69 2.37 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.917 1.287 . . . . 2.3999999999999999 111.875 169.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.21 29.26 9.08 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.327 -1.109 . . . . 0.34999999999999998 110.327 173.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.438 ' CD2' HD11 ' A' ' 24' ' ' ILE . 72.6 m-85 -137.98 162.88 32.95 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.098 -1.445 . . . . 1.7 107.098 177.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.782 ' HE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -115.84 134.6 54.83 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.122 -1.807 . . . . 3.8100000000000001 106.122 171.461 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.63 150.04 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.604 0.762 . . . . 0.41999999999999998 110.444 168.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.782 HG13 ' HE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.758 0 C-N-CA 123.672 0.789 . . . . 1.1499999999999999 109.532 171.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 120.67 0.271 . . . . 0.82999999999999996 111.357 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -149.08 158.55 44.27 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.109 -0.7 . . . . 2.73 109.109 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -91.03 141.0 29.31 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.685 -1.143 . . . . 2.8900000000000001 109.51 168.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.95 138.08 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 105.407 -2.072 . . . . 3.1899999999999999 105.407 170.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.55 125.65 48.35 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.421 1.488 . . . . 0.42999999999999999 108.036 176.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -154.88 164.69 38.48 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.485 0.584 . . . . 1.1899999999999999 110.697 -175.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.47 151.59 19.42 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.09 0.956 . . . . 1.76 109.575 -173.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 t -116.1 161.21 15.01 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 C-N-CA 123.139 0.575 . . . . 0.68999999999999995 109.904 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.451 -0.4 0 C-N-CA 124.963 1.305 . . . . 0.83999999999999997 108.711 175.581 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.688 0 CA-C-O 118.717 -0.659 . . . . 0.34999999999999998 110.798 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.3 mmp_? -58.91 -47.91 83.32 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.449 1.022 . . . . 4.8300000000000001 110.321 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.0 mt -47.21 -60.8 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.809 -0.811 . . . . 0.53000000000000003 108.809 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -72.11 -34.15 68.38 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 119.968 -0.693 . . . . 2.5499999999999998 111.707 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm -55.69 -36.65 67.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 120.858 -1.151 . . . . 2.6200000000000001 111.028 175.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.46 -54.64 12.55 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.187 -1.165 . . . . 0.34000000000000002 110.187 166.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.606 HD22 HG12 ' A' ' 60' ' ' ILE . 89.0 mt -63.74 -32.73 74.32 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 112.885 0.698 . . . . 0.31 112.885 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -57.62 -17.54 15.04 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.229 0.922 . . . . 1.29 111.796 172.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.7 -11.3 48.68 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.694 1.368 . . . . 4.4400000000000004 114.694 170.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.469 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -70.24 138.62 86.96 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 121.278 1.854 . . . . 3.23 111.856 -177.536 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.52 90.69 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.605 2.87 . . . . 0.48999999999999999 111.079 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.82 -7.67 3.57 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.756 1.17 . . . . 0.28000000000000003 111.341 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 31' ' ' MET . 5.2 p -67.4 160.29 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 118.271 1.035 . . . . 0.28999999999999998 110.806 164.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.73 -59.55 1.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.767 1.227 . . . . 0.40000000000000002 108.659 168.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -145.13 162.91 35.9 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 112.477 0.547 . . . . 2.3100000000000001 112.477 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.54 123.51 12.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.086 1.754 . . . . 0.88 109.625 -173.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -135.64 119.62 17.48 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.423 1.489 . . . . 1.5600000000000001 109.284 -172.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -91.93 139.13 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.127 0.971 . . . . 0.66000000000000003 110.545 -176.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -131.08 66.69 1.53 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.833 1.653 . . . . 1.23 111.143 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.4 mt -67.01 -15.92 64.03 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 113.113 0.782 . . . . 0.81000000000000005 113.113 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.81 -24.84 9.74 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.66 0.384 . . . . 0.76000000000000001 110.622 167.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.0 m -128.55 19.99 6.18 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.213 1.405 . . . . 0.60999999999999999 110.044 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 47.58 35.01 3.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.188 0.995 . . . . 2.7999999999999998 112.145 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.4 m -132.52 152.03 51.71 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.118 -1.068 . . . . 0.46999999999999997 108.118 -168.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.2 p -133.96 147.47 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.367 0.667 . . . . 0.45000000000000001 109.389 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -121.34 129.13 52.91 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.1 1.36 . . . . 2.6000000000000001 108.464 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.92 137.1 51.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.021 -0.733 . . . . 0.39000000000000001 109.021 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.4 mp -108.55 120.77 60.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.012 1.325 . . . . 1.26 108.134 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -144.36 171.37 14.42 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.186 0.994 . . . . 1.73 110.877 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -108.39 111.73 61.36 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 124.979 1.312 . . . . 1.79 111.15 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -76.83 30.13 0.41 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.747 2.964 . . . . 0.70999999999999996 112.711 -172.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.96 -50.16 5.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.77 -1.567 . . . . 0.40999999999999998 106.77 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.16 -43.52 7.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.16 1.784 . . . . 2.8700000000000001 110.495 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.6 m -133.93 127.3 32.17 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 116.45 2.019 . . . . 0.53000000000000003 116.45 -159.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.89 -164.23 13.32 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 108.898 -1.681 . . . . 0.46999999999999997 108.898 153.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.2 t -34.78 -40.39 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.706 2.802 . . . . 0.67000000000000004 112.831 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.0 -54.46 8.34 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.907 0.883 . . . . 0.42999999999999999 113.233 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.63 -36.83 65.49 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.924 1.345 . . . . 0.34000000000000002 109.642 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.606 HG12 HD22 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -70.82 -50.16 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 113.309 -1.768 . . . . 0.54000000000000004 110.903 -164.294 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.75 -52.34 49.46 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.388 1.449 . . . . 0.76000000000000001 109.034 172.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.46 -45.66 46.98 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.708 1.203 . . . . 5.04 112.294 -177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -44.59 60.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.247 -1.533 . . . . 2.9900000000000002 112.823 172.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.473 HD11 HD11 ' A' ' 28' ' ' LEU . 4.1 mm -51.43 -44.93 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.986 1.315 . . . . 0.42999999999999999 110.707 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -49.73 -47.53 50.64 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.453 0.644 . . . . 1.5600000000000001 110.361 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -32.65 67.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.249 1.02 . . . . 5.5199999999999996 112.292 -177.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.45 -25.62 37.47 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 119.385 -0.34 . . . . 0.93000000000000005 110.239 166.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.31 29.22 5.78 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.542 1.068 . . . . 0.37 110.823 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -142.86 165.73 26.57 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.273 -1.01 . . . . 1.74 108.273 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.95 125.68 48.02 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.267 -1.753 . . . . 4.2999999999999998 106.267 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -96.78 143.06 13.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 O-C-N 123.751 0.657 . . . . 0.46000000000000002 109.894 172.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.466 0.338 0 N-CA-C 109.425 -0.583 . . . . 1.1799999999999999 109.425 175.187 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 120.726 0.298 . . . . 0.96999999999999997 111.437 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -154.68 158.49 39.7 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 122.011 0.91 . . . . 3.3199999999999998 111.177 178.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -84.03 114.13 21.51 Favored 'General case' 0 N--CA 1.452 -0.332 1 C-N-CA 131.984 4.113 . . . . 2.2999999999999998 107.363 174.064 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.48 149.3 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 105.803 -1.925 . . . . 2.46 105.803 164.388 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.73 123.73 18.94 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.602 1.561 . . . . 0.38 108.261 176.492 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -157.49 166.71 32.23 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.941 0.496 . . . . 1.1499999999999999 111.78 -171.277 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -101.44 140.09 36.2 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.069 1.748 . . . . 3.2799999999999998 108.855 -169.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.92 142.12 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 123.487 0.715 . . . . 0.85999999999999999 110.166 -177.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 108.136 -1.061 . . . . 1.01 108.136 173.514 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 119.546 -0.264 . . . . 0.55000000000000004 111.22 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -59.08 -49.85 76.33 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.425 0.557 . . . . 3.9500000000000002 110.74 177.316 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.7 mt -45.67 -59.88 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.767 1.227 . . . . 0.57999999999999996 108.723 177.392 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -70.84 -35.74 72.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.383 -0.371 . . . . 2.3100000000000001 110.715 -173.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -59.15 -30.44 68.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.06 -1.025 . . . . 1.26 110.872 174.322 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.56 -52.33 48.8 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 110.743 -0.943 . . . . 0.32000000000000001 110.743 164.666 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.664 HD11 HD11 ' A' ' 64' ' ' ILE . 95.6 mt -63.0 -29.93 71.2 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.268 -1.136 . . . . 0.32000000000000001 113.13 177.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -54.74 -18.96 5.32 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.246 0.93 . . . . 1.8899999999999999 111.924 170.283 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.29 -15.03 48.13 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.022 1.119 . . . . 2.98 114.022 171.783 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.462 ' O ' HG12 ' A' ' 34' ' ' VAL . 93.2 mmm -76.89 137.8 65.94 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 120.252 1.387 . . . . 1.97 112.424 -172.68 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.71 101.08 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.513 2.808 . . . . 0.55000000000000004 110.922 -173.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.39 -13.29 5.16 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 124.981 1.277 . . . . 0.25 110.151 175.483 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 31' ' ' MET . 5.8 p -64.01 147.51 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 117.806 0.803 . . . . 0.31 110.676 169.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.67 -60.44 1.82 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.986 1.315 . . . . 0.53000000000000003 110.407 168.563 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -154.43 148.88 26.2 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 115.401 1.63 . . . . 2.5299999999999998 115.401 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.3 142.23 42.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.265 1.426 . . . . 0.69999999999999996 110.825 -176.533 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -145.38 102.3 3.7 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.171 -1.048 . . . . 3.7799999999999998 108.171 -170.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.5 p -83.79 134.32 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.296 0.638 . . . . 0.80000000000000004 110.889 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -131.12 70.12 1.47 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.075 -1.083 . . . . 2.4900000000000002 108.075 -177.099 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.4 mt -64.02 -24.65 67.79 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.502 -0.749 . . . . 1.2 111.954 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.38 -24.25 28.79 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.08 0.552 . . . . 0.82999999999999996 111.03 171.37 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.6 m -118.97 11.44 12.5 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.372 1.469 . . . . 1.0600000000000001 110.309 -179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 46.4 47.96 13.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.053 0.842 . . . . 2.23 111.673 -178.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.47 159.02 39.47 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.12 -1.067 . . . . 1.3200000000000001 108.12 -174.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.2 p -125.68 146.92 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 108.558 -0.905 . . . . 0.46000000000000002 108.558 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -117.44 141.5 48.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.711 1.205 . . . . 2.4300000000000002 108.351 176.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.05 132.24 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.695 -0.483 . . . . 0.35999999999999999 109.695 173.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.5 mt -91.86 126.2 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.387 1.875 . . . . 0.71999999999999997 106.871 176.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -147.5 173.86 12.26 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.428 0.691 . . . . 1.95 111.114 176.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -110.44 120.03 45.14 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 124.366 1.066 . . . . 1.4299999999999999 110.965 -178.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -69.33 7.28 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 124.596 3.531 . . . . 0.55000000000000004 113.575 -178.022 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.49 -37.22 37.27 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 108.644 -0.873 . . . . 0.69999999999999996 108.644 176.133 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -114.88 -53.82 2.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.571 1.549 . . . . 2.77 110.041 -179.631 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 m -104.34 129.99 52.2 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 128.233 2.613 . . . . 0.90000000000000002 117.343 -172.161 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.25 -173.36 22.44 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 109.779 -1.328 . . . . 0.48999999999999999 109.779 151.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.3 t -35.24 -41.14 0.15 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.556 2.742 . . . . 0.57999999999999996 112.414 174.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.77 -57.19 5.9 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.981 0.734 . . . . 0.29999999999999999 112.981 173.388 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.47 66.43 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 122.338 1.066 . . . . 0.22 108.835 -176.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.589 HG12 HD22 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -62.02 -58.04 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 114.012 -1.449 . . . . 0.62 110.082 -174.4 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.47 -51.1 15.93 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.681 1.128 . . . . 0.78000000000000003 110.823 175.669 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -45.31 -51.85 10.48 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.406 0.683 . . . . 2.3399999999999999 112.342 177.336 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -43.68 67.37 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 118.17 -0.919 . . . . 2.0800000000000001 111.667 177.338 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.664 HD11 HD11 ' A' ' 28' ' ' LEU . 24.7 mm -52.4 -45.71 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 119.698 1.135 . . . . 0.32000000000000001 110.196 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -49.46 -47.04 48.62 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.26 0.624 . . . . 1.6299999999999999 110.11 172.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -36.57 74.2 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.674 0.79 . . . . 4.4400000000000004 112.318 -178.452 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -54.46 -22.76 13.62 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.837 0.455 . . . . 0.92000000000000004 110.41 169.372 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.13 28.51 5.81 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 110.444 -1.063 . . . . 0.39000000000000001 110.444 170.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -144.61 169.17 18.49 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.638 -1.245 . . . . 2.0 107.638 -177.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.713 ' HE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -119.08 135.53 54.59 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.358 -1.719 . . . . 3.8300000000000001 106.358 172.038 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -98.36 147.67 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.056 0.942 . . . . 0.46999999999999997 109.549 167.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.713 HG13 ' HE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 109.032 -0.729 . . . . 1.0700000000000001 109.032 169.539 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 119.876 -0.107 . . . . 0.69999999999999996 110.738 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.76 159.88 40.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.764 0.792 . . . . 3.73 111.854 -179.341 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.12 135.77 34.26 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.496 -1.684 . . . . 2.4900000000000002 108.232 169.248 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 tp -109.44 151.04 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 105.843 -1.91 . . . . 1.0900000000000001 105.843 161.792 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.62 123.65 16.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.997 1.319 . . . . 0.40999999999999998 107.85 176.381 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.6 ptt? -157.7 172.16 19.01 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.713 0.405 . . . . 1.0800000000000001 110.292 -170.437 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -102.74 150.08 23.82 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.401 1.08 . . . . 3.2000000000000002 110.123 -171.147 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.71 167.89 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 C-N-CA 123.684 0.794 . . . . 0.78000000000000003 109.706 -178.499 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.451 -0.401 0 C-N-CA 124.287 1.035 . . . . 0.77000000000000002 108.829 176.569 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 109.686 -0.487 . . . . 0.38 109.686 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -59.4 -45.1 92.43 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 118.481 -0.771 . . . . 3.6400000000000001 111.99 174.329 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.7 mt -46.96 -59.95 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.359 -0.608 . . . . 0.55000000000000004 109.359 176.446 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -70.13 -41.18 74.26 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 119.634 -0.826 . . . . 3.5800000000000001 109.993 -173.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -52.15 -35.6 48.99 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 120.423 -1.423 . . . . 1.77 112.089 179.21 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.26 -52.12 33.42 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 110.921 -0.872 . . . . 0.38 110.921 167.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 64' ' ' ILE . 73.1 mt -66.94 -27.76 67.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 118.51 -0.757 . . . . 0.60999999999999999 112.587 177.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -59.87 -16.99 33.43 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 119.614 1.097 . . . . 1.4199999999999999 110.566 171.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.36 -8.83 58.25 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.013 1.116 . . . . 3.3999999999999999 114.013 171.297 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.507 ' O ' HG12 ' A' ' 34' ' ' VAL . 9.5 mmt -71.75 138.67 82.91 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 120.304 1.411 . . . . 2.0699999999999998 111.722 -175.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.28 90.82 0.57 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.263 2.642 . . . . 0.52000000000000002 110.793 -175.188 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.27 -16.33 2.1 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.483 1.04 . . . . 0.25 111.495 -179.078 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 31' ' ' MET . 5.5 p -70.82 156.02 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 O-C-N 121.674 -0.897 . . . . 0.28000000000000003 111.409 171.512 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.22 -62.58 1.57 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.424 1.09 . . . . 0.54000000000000004 109.126 166.77 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -147.76 142.25 26.45 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 112.502 0.556 . . . . 3.02 112.502 -169.433 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.86 157.09 17.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.237 1.815 . . . . 1.1299999999999999 109.333 178.36 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.54 95.82 1.83 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.042 -1.095 . . . . 2.0499999999999998 108.042 177.046 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.12 140.24 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 121.917 -0.49 . . . . 0.73999999999999999 111.449 -178.231 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -137.02 69.94 1.41 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.148 1.379 . . . . 2.48 109.092 -174.627 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 68.7 mt -65.69 -16.56 63.87 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 115.565 -0.743 . . . . 0.76000000000000001 112.932 177.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.6 -22.5 8.72 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.543 0.737 . . . . 0.70999999999999996 110.741 169.237 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.9 m -133.05 21.22 4.1 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.938 0.895 . . . . 0.75 109.854 179.064 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 50.37 34.7 9.46 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.058 0.844 . . . . 3.0499999999999998 112.069 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.6 m -128.53 152.57 48.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.644 1.178 . . . . 0.55000000000000004 107.876 -168.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 p -135.14 143.57 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.844 -0.798 . . . . 0.64000000000000001 108.844 173.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -119.24 145.27 46.21 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.848 1.259 . . . . 2.4700000000000002 107.969 176.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.86 139.03 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.629 -0.508 . . . . 0.39000000000000001 109.629 174.566 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.9 mt -101.05 119.2 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 126.96 2.104 . . . . 0.88 107.196 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.448 ' CE2' HD13 ' A' ' 60' ' ' ILE . 2.1 p90 -146.35 168.87 20.06 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.398 1.079 . . . . 2.02 109.593 -178.572 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -101.65 115.63 64.63 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 118.385 -0.817 . . . . 2.0699999999999998 109.278 177.221 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -68.63 7.6 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.747 2.965 . . . . 0.77000000000000002 113.646 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.21 -55.54 5.18 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 107.441 -1.318 . . . . 0.75 107.441 172.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -88.18 -30.75 19.53 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.435 1.094 . . . . 3.9300000000000002 112.109 176.854 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.9 m -148.47 121.4 8.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 117.677 2.473 . . . . 0.72999999999999998 117.677 -157.128 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.69 -166.79 23.14 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.588 -1.005 . . . . 0.53000000000000003 110.588 159.685 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 t -29.61 -46.68 0.06 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.499 3.119 . . . . 0.57999999999999996 112.841 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.42 -58.42 3.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.048 0.939 . . . . 0.37 113.155 173.826 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.18 -34.19 65.86 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 122.511 1.148 . . . . 0.23999999999999999 109.554 -178.735 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.477 HG12 HD13 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -66.57 -52.86 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 117.199 -1.381 . . . . 0.73999999999999999 110.928 -171.887 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -49.29 -50.16 40.44 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 121.04 1.746 . . . . 0.83999999999999997 110.922 175.229 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -39.73 -60.27 1.01 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.904 0.882 . . . . 2.6800000000000002 112.634 172.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -70.73 -40.43 72.76 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.202 -0.999 . . . . 1.8799999999999999 110.82 -177.182 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.604 HD11 HD11 ' A' ' 28' ' ' LEU . 16.8 mm -53.31 -44.68 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 119.034 0.834 . . . . 0.46000000000000002 110.046 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -53.81 -45.66 70.85 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.129 0.49 . . . . 1.8200000000000001 109.772 174.405 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.62 -39.74 91.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.485 -0.76 . . . . 3.0699999999999998 111.354 -179.19 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.4 -23.58 16.32 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.443 0.697 . . . . 0.93000000000000005 110.786 171.56 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.95 26.93 7.25 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 124.466 1.031 . . . . 0.37 110.9 173.784 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -144.8 176.34 9.52 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 122.025 0.916 . . . . 1.7 109.617 -175.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.68 117.24 23.06 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 106.035 -1.839 . . . . 3.77 106.035 -171.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.9 p -96.13 142.45 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.868 -0.79 . . . . 0.47999999999999998 108.868 165.022 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.287 0 N-CA-C 108.764 -0.828 . . . . 1.0900000000000001 108.764 173.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 120.787 0.327 . . . . 0.98999999999999999 111.515 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -139.67 152.83 47.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.521 0.677 . . . . 2.5099999999999998 109.822 179.433 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -90.34 125.92 35.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 127.036 2.134 . . . . 2.25 106.762 168.028 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 tp -109.21 151.29 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.167 -1.42 . . . . 1.1000000000000001 107.167 167.249 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.52 133.93 36.99 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.731 -1.211 . . . . 0.34999999999999998 107.731 170.247 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.75 170.92 21.34 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.439 0.462 . . . . 1.4099999999999999 111.195 175.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.65 152.81 19.35 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.854 0.861 . . . . 1.98 110.362 -176.498 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.57 171.56 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 123.7 0.8 . . . . 0.81000000000000005 110.034 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 CA--C 1.53 0.194 0 C-N-CA 123.782 0.833 . . . . 0.71999999999999997 110.603 176.934 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 119.389 -0.339 . . . . 0.31 110.664 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -54.63 -45.24 73.7 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.574 -0.726 . . . . 4.3200000000000003 111.444 173.647 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.4 mt -52.46 -60.89 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.391 -0.966 . . . . 0.76000000000000001 108.391 177.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.62 -33.96 73.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.4 -0.92 . . . . 2.3599999999999999 110.615 -168.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -56.24 -36.76 68.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.092 -1.005 . . . . 1.3899999999999999 111.263 171.547 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.5 -44.51 90.45 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.054 -0.818 . . . . 0.29999999999999999 111.054 168.371 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.709 HD11 HD11 ' A' ' 64' ' ' ILE . 97.3 mt -65.6 -30.66 71.41 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 119.407 1.603 . . . . 0.33000000000000002 112.514 175.342 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.537 ' HA ' HG11 ' A' ' 34' ' ' VAL . 12.9 ttmt -56.62 -18.41 11.97 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.13 0.877 . . . . 1.4399999999999999 112.03 170.621 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 mtp85 -87.88 -5.29 58.65 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.891 -1.13 . . . . 4.3799999999999999 112.694 174.308 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.471 ' O ' HG12 ' A' ' 34' ' ' VAL . 95.1 mmm -82.74 136.62 44.69 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 120.389 1.45 . . . . 1.98 111.748 179.203 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.8 100.73 0.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.506 2.804 . . . . 0.35999999999999999 111.262 -173.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.37 -13.03 3.77 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.58 1.086 . . . . 0.20000000000000001 111.173 176.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.0 p -67.9 152.97 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.836 0.854 . . . . 0.27000000000000002 111.182 169.408 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.1 -60.5 1.87 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.582 1.153 . . . . 0.40999999999999998 109.356 166.516 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -148.66 141.59 24.76 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.239 0.459 . . . . 3.1400000000000001 112.239 -169.138 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.61 136.71 53.11 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.779 1.632 . . . . 0.59999999999999998 108.632 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -142.05 108.9 5.41 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.577 1.151 . . . . 1.3600000000000001 108.5 -177.274 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.4 p -89.92 142.7 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.742 0.817 . . . . 0.60999999999999999 111.772 -175.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -137.71 68.99 1.4 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.364 1.465 . . . . 1.22 111.011 -175.472 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.4 mt -66.71 -14.91 63.1 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 112.948 0.721 . . . . 0.75 112.948 177.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.5 -13.34 5.35 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.983 0.356 . . . . 0.53000000000000003 111.221 167.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.5 m -138.38 18.46 2.75 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.387 1.075 . . . . 0.51000000000000001 109.572 177.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 51.76 30.75 7.22 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.14 0.882 . . . . 3.1400000000000001 112.035 -179.546 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.4 m -129.66 153.42 48.14 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.069 -1.086 . . . . 0.51000000000000001 108.069 -167.588 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.4 144.47 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 108.802 -0.814 . . . . 0.45000000000000001 108.802 173.614 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -112.78 139.99 47.94 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.744 1.218 . . . . 2.46 108.055 176.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.44 141.2 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.249 -0.649 . . . . 0.25 109.249 171.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 mt -104.74 127.37 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.971 1.708 . . . . 0.92000000000000004 106.533 -179.054 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -152.3 171.78 17.45 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.946 0.498 . . . . 1.8799999999999999 110.098 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -111.07 120.51 43.1 Favored Pre-proline 0 N--CA 1.448 -0.563 0 O-C-N 123.944 0.777 . . . . 2.0899999999999999 111.187 -177.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.14 19.39 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.072 3.181 . . . . 0.64000000000000001 113.681 -178.646 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.63 -50.74 7.91 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.256 -1.387 . . . . 0.54000000000000004 107.256 169.514 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -96.33 -39.81 9.44 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.099 1.36 . . . . 3.5499999999999998 111.4 176.802 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.5 m -132.41 129.89 39.9 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 117.748 2.499 . . . . 0.54000000000000004 117.748 -155.513 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.76 -172.09 22.91 Favored Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 110.043 -1.223 . . . . 0.5 110.043 157.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.272 0.1 OUTLIER -29.31 -43.09 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 128.633 2.773 . . . . 0.63 113.902 169.241 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.64 -55.35 16.79 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.868 0.758 . . . . 0.34000000000000002 112.671 175.203 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.08 -36.24 66.78 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 122.557 1.17 . . . . 0.17999999999999999 108.966 -176.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.541 HG12 HD22 ' A' ' 28' ' ' LEU 0.257 0.9 OUTLIER -65.47 -56.56 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 113.852 -1.522 . . . . 0.55000000000000004 110.351 -172.617 . . . . . . . . 4 4 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -49.61 47.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.171 1.35 . . . . 0.73999999999999999 110.913 177.255 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -42.48 -58.4 2.26 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.74 0.816 . . . . 2.2799999999999998 112.094 173.844 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -42.36 73.39 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 119.548 -0.861 . . . . 2.3199999999999998 111.421 -177.326 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.709 HD11 HD11 ' A' ' 28' ' ' LEU . 17.3 mm -51.21 -47.6 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.67 0.788 . . . . 0.39000000000000001 109.832 177.594 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -50.6 -53.47 30.38 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 121.426 0.632 . . . . 1.6100000000000001 109.678 175.12 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -29.3 70.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.028 0.531 . . . . 5.3399999999999999 112.412 -178.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -63.85 -20.02 65.49 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.23 0.612 . . . . 2.0899999999999999 109.783 173.173 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.26 28.76 6.65 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 125.075 1.321 . . . . 0.35999999999999999 110.618 173.285 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -143.85 168.47 19.88 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.122 -1.436 . . . . 1.6499999999999999 107.122 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.732 ' HE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -119.83 135.97 54.66 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.428 -1.693 . . . . 4.1500000000000004 106.428 169.435 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -100.63 142.92 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.331 1.052 . . . . 0.64000000000000001 109.722 166.742 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.732 HG13 ' HE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 108.692 -0.855 . . . . 1.27 108.692 173.457 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 120.854 0.359 . . . . 0.65000000000000002 111.518 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -148.8 161.75 41.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.687 -0.857 . . . . 2.8100000000000001 108.687 173.356 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -82.91 138.46 33.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.522 -1.288 . . . . 2.6299999999999999 107.522 162.18 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 tp -107.14 153.48 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 1.1100000000000001 105.713 157.188 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.53 128.21 17.18 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.917 -1.142 . . . . 0.35999999999999999 107.917 173.347 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.48 175.86 13.41 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.189 0.45 . . . . 1.2 110.866 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.0 mp0 -94.19 149.37 21.3 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.287 1.035 . . . . 3.0699999999999998 109.279 -174.468 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.21 165.59 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.854 -0.795 . . . . 0.69999999999999996 108.854 177.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 107.643 -1.243 . . . . 1.1000000000000001 107.643 171.566 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.627 0 CA-C-O 118.757 -0.64 . . . . 0.34999999999999998 111.04 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -61.07 -45.42 94.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.279 0.945 . . . . 3.4700000000000002 110.598 176.079 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.488 HD11 ' CD2' ' A' ' 69' ' ' TYR . 63.9 mt -48.35 -60.94 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.319 -0.993 . . . . 0.67000000000000004 108.319 179.098 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.28 -34.1 67.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 119.945 -0.702 . . . . 2.5800000000000001 111.838 -173.844 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -55.94 -37.73 69.37 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.121 -0.987 . . . . 1.73 110.736 176.175 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.5 -52.75 27.49 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.458 -1.057 . . . . 0.38 110.458 167.677 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 64' ' ' ILE . 87.0 mt -64.62 -31.1 72.17 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.591 -0.946 . . . . 0.38 112.503 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.25 23.3 ttmt -59.03 -13.73 7.52 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 119.209 0.913 . . . . 1.74 111.69 170.514 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 -1.63 40.23 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.553 -1.342 . . . . 5.4100000000000001 114.001 170.395 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.418 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.91 139.3 61.67 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 120.815 1.643 . . . . 3.0299999999999998 111.489 179.578 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.78 92.78 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.588 2.858 . . . . 0.37 110.429 -174.66 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.33 -9.65 3.79 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.562 1.077 . . . . 0.20000000000000001 111.633 177.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 31' ' ' MET . 5.8 p -66.73 157.42 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 118.054 0.927 . . . . 0.31 110.884 167.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.74 -56.41 2.12 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.989 1.316 . . . . 0.45000000000000001 110.229 168.862 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -143.17 157.35 44.59 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 123.081 0.553 . . . . 3.1400000000000001 109.917 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.63 134.84 39.67 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.936 1.694 . . . . 0.67000000000000004 108.165 174.413 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -142.07 116.86 9.82 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.499 1.119 . . . . 1.4199999999999999 108.833 -173.378 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.73 139.54 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.429 1.092 . . . . 0.57999999999999996 111.541 -175.459 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -132.37 67.77 1.52 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.628 1.571 . . . . 1.23 111.913 179.921 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.3 mt -65.86 -16.01 63.44 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 113.281 0.845 . . . . 0.73999999999999999 113.281 178.33 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.16 -19.66 8.31 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.073 0.397 . . . . 0.54000000000000004 110.997 168.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.3 m -130.48 14.9 5.51 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.907 1.283 . . . . 0.48999999999999999 110.373 178.592 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 51.44 35.28 13.81 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.037 0.835 . . . . 2.75 112.048 -177.618 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 m -134.01 153.59 51.69 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 107.88 -1.156 . . . . 0.47999999999999998 107.88 -170.319 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.16 151.38 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.374 -0.973 . . . . 0.42999999999999999 108.374 174.518 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.17 150.29 42.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 124.178 0.924 . . . . 2.75 109.895 172.717 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.61 134.0 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.346 -0.983 . . . . 0.32000000000000001 108.346 177.556 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.5 127.84 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.923 -1.51 . . . . 0.84999999999999998 106.923 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -150.29 170.09 19.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.024 0.529 . . . . 2.04 110.348 -178.142 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.8 120.47 47.06 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 124.311 1.044 . . . . 1.3899999999999999 111.002 -179.493 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -69.93 8.4 0.82 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.48 3.453 . . . . 0.70999999999999996 113.914 -177.899 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.8 -44.61 26.97 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 108.162 -1.051 . . . . 0.69999999999999996 108.162 175.303 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -102.68 -42.67 5.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.293 1.837 . . . . 3.0299999999999998 110.249 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.6 m -129.53 127.45 40.79 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 117.57 2.433 . . . . 0.52000000000000002 117.57 -158.333 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.42 -173.24 22.42 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 109.607 -1.397 . . . . 0.56000000000000005 109.607 158.32 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 t -41.64 -34.03 0.55 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.282 2.633 . . . . 0.84999999999999998 112.195 178.761 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.8 -57.59 7.04 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.915 0.709 . . . . 0.26000000000000001 112.915 171.393 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.61 -35.88 67.95 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 122.581 1.182 . . . . 0.23000000000000001 108.759 -176.671 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.598 HG12 HD22 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -63.68 -58.3 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 113.896 -1.502 . . . . 0.53000000000000003 109.551 -173.983 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.73 -50.67 24.6 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.412 1.46 . . . . 0.78000000000000003 111.065 177.559 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -41.41 -58.45 1.87 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.667 0.787 . . . . 2.46 112.693 173.31 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -41.32 77.63 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 119.31 -0.956 . . . . 1.8400000000000001 111.417 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.783 HD11 HD11 ' A' ' 28' ' ' LEU . 31.0 mm -52.56 -47.0 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.056 0.844 . . . . 0.40000000000000002 110.319 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -51.25 -46.59 62.42 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.217 0.532 . . . . 1.8200000000000001 109.854 173.688 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -34.6 71.73 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.349 -0.844 . . . . 4.5300000000000002 112.88 -176.454 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.98 -22.5 5.73 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.563 0.745 . . . . 0.85999999999999999 110.486 167.847 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.56 26.99 8.8 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.315 -1.114 . . . . 0.28999999999999998 110.315 174.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.488 ' CD2' HD11 ' A' ' 24' ' ' ILE . 61.5 m-85 -139.34 160.83 38.9 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.278 -1.008 . . . . 2.0 108.278 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 122.94 43.05 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.008 -1.479 . . . . 4.4900000000000002 107.008 178.144 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.57 151.67 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 124.534 1.134 . . . . 0.47999999999999998 109.793 173.823 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.224 -0.263 0 N-CA-C 108.815 -0.809 . . . . 0.92000000000000004 108.815 179.126 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.584 -0.524 . . . . 0.71999999999999997 109.584 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -142.37 154.49 44.68 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.848 0.832 . . . . 2.9100000000000001 112.189 176.349 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -89.78 108.13 19.51 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 128.186 2.594 . . . . 2.5299999999999998 107.322 171.205 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.64 154.53 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.86 -1.163 . . . . 1.3500000000000001 107.86 165.729 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.8 132.9 37.31 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.502 -1.666 . . . . 0.40000000000000002 106.502 173.617 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -155.67 166.44 33.5 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 123.273 0.629 . . . . 1.04 109.781 -173.111 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -93.56 156.18 16.88 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.026 -0.731 . . . . 2.96 109.026 -172.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.28 161.57 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 120.952 0.406 . . . . 0.73999999999999999 110.656 177.012 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 126.946 2.098 . . . . 0.71999999999999997 107.731 172.449 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 CA-C-O 118.913 -0.565 . . . . 0.40999999999999998 112.442 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -59.22 -40.79 86.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.197 0.908 . . . . 3.3799999999999999 110.894 176.539 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.446 HD11 ' CD2' ' A' ' 69' ' ' TYR . 57.2 mt -54.13 -60.6 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.207 -1.405 . . . . 0.80000000000000004 107.207 -177.016 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -32.9 65.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.022 -0.99 . . . . 2.52 112.11 -175.34 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -55.16 -38.79 68.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.083 -1.011 . . . . 1.97 110.478 172.113 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.1 -51.74 39.43 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.791 -0.923 . . . . 0.48999999999999999 110.791 168.597 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.725 HD22 HG13 ' A' ' 60' ' ' ILE . 85.5 mt -63.33 -33.97 76.69 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.553 -0.969 . . . . 0.63 112.232 178.573 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.569 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.259 0.9 OUTLIER -59.99 -18.11 43.39 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 118.986 0.812 . . . . 1.3300000000000001 110.81 172.609 . . . . . . . . 4 4 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.22 -14.71 43.07 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.463 -1.398 . . . . 3.5899999999999999 114.384 167.789 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.3 mtp -74.97 134.85 74.35 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 121.102 1.773 . . . . 2.1299999999999999 111.26 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.06 114.19 2.34 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.06 2.507 . . . . 0.72999999999999998 109.589 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.84 -16.02 6.19 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 124.852 1.215 . . . . 0.20000000000000001 110.09 174.324 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 29' ' ' LYS . 4.9 p -67.75 154.2 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 O-C-N 122.401 -0.47 . . . . 0.28000000000000003 110.481 169.758 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.32 -54.24 2.48 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.735 1.214 . . . . 0.35999999999999999 109.571 166.387 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -145.91 157.56 43.89 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.556 0.162 . . . . 2.5800000000000001 110.909 -177.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.76 127.27 16.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.531 1.533 . . . . 0.98999999999999999 108.82 -175.797 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -143.14 115.69 8.6 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.811 0.844 . . . . 2.0299999999999998 109.537 -168.238 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -92.1 139.14 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 112.86 0.689 . . . . 1.0600000000000001 112.86 -176.065 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -128.7 68.79 1.38 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.906 2.083 . . . . 1.2 111.246 -176.583 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.3 mt -64.62 -16.81 63.33 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 113.038 0.755 . . . . 0.75 113.038 178.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.76 -19.92 4.92 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.967 0.507 . . . . 0.56000000000000005 111.121 169.334 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.1 m -136.33 18.0 3.16 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.834 1.253 . . . . 0.54000000000000004 109.976 -178.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 48.46 32.93 3.59 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.19 0.996 . . . . 2.75 112.181 -176.926 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.9 m -124.73 153.1 42.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.239 -1.393 . . . . 0.60999999999999999 107.239 -169.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 p -134.79 144.58 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.593 -0.892 . . . . 0.58999999999999997 108.593 173.63 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -108.19 140.34 41.54 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.066 1.347 . . . . 2.8700000000000001 107.822 175.547 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.83 134.71 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.825 -0.806 . . . . 0.46000000000000002 108.825 167.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.8 mt -103.93 117.73 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 126.2 1.8 . . . . 0.75 106.331 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -145.19 173.24 12.11 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.164 0.586 . . . . 1.8999999999999999 110.115 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -110.59 123.16 36.37 Favored Pre-proline 0 N--CA 1.443 -0.778 0 C-N-CA 124.618 1.167 . . . . 1.49 111.154 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -66.45 3.54 1.36 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.758 3.638 . . . . 0.80000000000000004 114.384 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.07 -44.74 45.81 Favored 'General case' 0 C--N 1.335 -0.057 0 N-CA-C 108.483 -0.932 . . . . 0.87 108.483 176.784 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -101.37 -37.0 8.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.779 1.631 . . . . 3.2599999999999998 110.366 178.544 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.3 m -138.64 131.52 29.48 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 118.71 2.855 . . . . 0.56000000000000005 118.71 -150.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.81 -171.76 30.45 Favored Glycine 0 N--CA 1.435 -1.42 0 N-CA-C 109.417 -1.473 . . . . 0.53000000000000003 109.417 164.436 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -35.04 -43.82 0.21 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.927 2.491 . . . . 0.60999999999999999 112.088 176.971 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.55 -58.73 3.17 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.249 0.833 . . . . 0.32000000000000001 113.249 173.023 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.35 -38.14 65.83 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.914 -0.772 . . . . 0.26000000000000001 108.914 -176.304 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.725 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -61.14 -59.69 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.719 -1.128 . . . . 1.24 108.424 -173.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.92 -52.23 14.99 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.151 0.887 . . . . 0.87 110.644 -178.32 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -43.36 -55.0 4.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.621 1.168 . . . . 2.5499999999999998 112.632 174.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -43.42 72.67 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 118.434 -0.793 . . . . 1.76 111.338 178.283 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.663 HD11 HD11 ' A' ' 28' ' ' LEU . 37.9 mm -52.32 -46.17 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 119.051 0.841 . . . . 0.46000000000000002 109.725 -177.818 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -51.17 -50.24 59.37 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.014 0.435 . . . . 1.6100000000000001 110.335 174.792 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -71.07 -31.37 67.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.42 -0.8 . . . . 3.5499999999999998 112.444 -174.464 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.98 -21.77 12.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 122.967 0.507 . . . . 0.90000000000000002 110.68 167.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.24 26.91 9.71 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 124.532 1.063 . . . . 0.46000000000000002 110.488 174.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.446 ' CD2' HD11 ' A' ' 24' ' ' ILE . 71.2 m-85 -138.88 164.77 28.81 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 117.324 0.562 . . . . 1.71 109.588 -178.631 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 120.17 37.96 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.576 -1.268 . . . . 4.6799999999999997 107.576 -179.156 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.521 ' HB ' HG21 ' A' ' 64' ' ' ILE . 8.4 p -85.65 150.5 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 109.305 -0.628 . . . . 0.59999999999999998 109.305 170.36 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.237 0 C-N-CA 124.37 1.068 . . . . 1.5800000000000001 108.854 179.325 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 120.568 0.223 . . . . 0.63 110.84 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -150.45 162.93 39.63 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.835 -0.432 . . . . 2.3700000000000001 109.835 174.29 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -83.75 153.28 24.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.521 -1.218 . . . . 2.9500000000000002 109.112 164.315 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 tp -131.48 155.07 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 106.416 -1.698 . . . . 1.0900000000000001 106.416 161.749 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.09 131.88 31.23 Favored 'General case' 0 N--CA 1.458 -0.036 0 C-N-CA 125.139 1.376 . . . . 0.57999999999999996 108.359 175.862 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.9 ptp -156.5 169.54 24.4 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.899 0.772 . . . . 1.8899999999999999 111.144 -176.739 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.74 146.04 32.67 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.974 0.91 . . . . 2.1000000000000001 109.477 -171.709 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.09 160.66 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 124.212 1.005 . . . . 0.82999999999999996 111.228 -172.918 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 121.109 0.48 . . . . 2.1099999999999999 111.381 166.446 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 119.358 -0.353 . . . . 0.41999999999999998 111.091 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -56.0 -52.52 63.92 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.412 0.551 . . . . 3.6299999999999999 110.885 175.673 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.9 mt -45.19 -60.64 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.893 1.277 . . . . 0.59999999999999998 109.12 178.243 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -71.47 -36.46 71.17 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 120.83 0.348 . . . . 2.3399999999999999 111.153 -172.102 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -56.12 -35.79 67.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.117 -0.989 . . . . 1.28 110.448 173.285 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.64 -49.6 46.08 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 111.471 -0.651 . . . . 0.33000000000000002 111.471 166.419 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.671 HD22 HG12 ' A' ' 60' ' ' ILE . 94.4 mt -65.83 -30.76 71.43 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 121.107 -1.231 . . . . 0.40000000000000002 112.615 176.809 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.513 ' HA ' HG11 ' A' ' 34' ' ' VAL . 10.0 ttmt -57.57 -17.72 15.65 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.21 0.913 . . . . 1.53 111.811 170.796 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -88.28 -3.72 58.81 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.164 1.172 . . . . 3.9399999999999999 114.164 171.576 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.445 ' O ' HG12 ' A' ' 34' ' ' VAL . 95.2 mmm -84.25 135.78 41.3 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 120.45 1.477 . . . . 2.1000000000000001 111.408 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.95 99.43 0.56 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.769 2.98 . . . . 0.39000000000000001 111.135 -172.03 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.2 -12.93 3.82 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.785 -0.926 . . . . 0.22 110.785 177.102 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.513 HG11 ' HA ' ' A' ' 29' ' ' LYS . 8.9 p -68.33 153.68 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 123.523 0.729 . . . . 0.31 111.206 171.393 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.95 -60.16 1.92 Allowed 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.457 1.103 . . . . 0.37 109.027 167.184 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -147.32 142.97 27.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 112.187 0.439 . . . . 3.23 112.187 -169.322 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.21 136.1 53.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.165 1.786 . . . . 0.59999999999999998 108.27 179.163 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -137.71 111.97 8.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.46 1.104 . . . . 1.45 108.652 -178.443 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.2 141.67 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.438 1.095 . . . . 1.03 111.118 -178.086 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -136.57 65.46 1.52 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.903 1.281 . . . . 1.1499999999999999 111.445 178.156 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -59.63 -23.71 63.24 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.946 -0.471 . . . . 0.93999999999999995 112.115 177.584 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.39 -22.59 43.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.385 0.539 . . . . 0.65000000000000002 111.207 174.608 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 m -121.75 16.01 11.02 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.802 1.241 . . . . 0.58999999999999997 110.294 179.092 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 44.02 46.24 6.92 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.124 0.969 . . . . 2.8300000000000001 110.876 -174.929 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.9 m -145.77 154.3 41.89 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.027 -1.472 . . . . 0.64000000000000001 107.027 -171.911 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -132.69 151.9 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.306 -0.998 . . . . 0.69999999999999996 108.306 170.679 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.54 150.77 47.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.296 -0.631 . . . . 2.71 109.296 175.698 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.87 146.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.512 -0.922 . . . . 0.31 108.512 -176.722 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.2 mt -114.75 125.95 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.523 1.929 . . . . 0.78000000000000003 106.58 -173.373 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -152.37 170.1 20.93 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.223 0.609 . . . . 1.8500000000000001 110.363 -175.671 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -109.21 115.77 56.13 Favored Pre-proline 0 N--CA 1.44 -0.943 0 O-C-N 124.276 0.985 . . . . 1.48 110.469 -177.064 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.37 8.55 0.5 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.172 3.248 . . . . 0.62 113.752 -178.756 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.99 -44.73 38.2 Favored 'General case' 0 N--CA 1.458 -0.026 0 N-CA-C 108.087 -1.079 . . . . 0.72999999999999998 108.087 172.36 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -102.05 -38.32 7.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.291 1.436 . . . . 3.02 111.074 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 m -143.56 133.95 24.7 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 119.284 3.068 . . . . 0.59999999999999998 119.284 -156.431 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.31 -149.74 6.28 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 108.88 -1.688 . . . . 0.54000000000000004 108.88 154.34 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -44.82 -35.37 2.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.955 2.102 . . . . 0.68999999999999995 112.833 -175.833 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.18 -55.1 26.86 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.658 -0.651 . . . . 0.52000000000000002 111.821 174.692 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.41 -41.78 60.34 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.686 1.231 . . . . 0.32000000000000001 109.323 -175.369 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.671 HG12 HD22 ' A' ' 28' ' ' LEU . 1.9 mt -62.85 -52.57 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 113.967 -1.469 . . . . 0.59999999999999998 111.502 -169.42 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -55.92 -47.04 78.21 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.471 1.032 . . . . 3.0299999999999998 110.429 179.135 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -42.59 -60.06 1.68 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.113 0.965 . . . . 2.23 112.781 171.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -37.54 81.24 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 119.217 -0.993 . . . . 2.5899999999999999 110.726 -177.714 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.435 HD11 HD11 ' A' ' 28' ' ' LEU . 6.1 mm -56.23 -44.09 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 118.154 0.434 . . . . 0.37 110.301 -178.803 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -48.06 -49.16 32.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.158 0.504 . . . . 1.53 110.279 172.08 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -71.88 -31.28 66.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.941 0.896 . . . . 3.3599999999999999 113.128 -175.411 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -53.48 -24.35 12.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 119.441 -0.314 . . . . 0.89000000000000001 110.616 165.495 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.36 29.23 4.58 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.37 0.986 . . . . 0.37 110.778 167.613 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -148.12 159.55 43.81 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.739 -1.578 . . . . 2.0099999999999998 106.739 -177.499 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.455 ' CE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -102.79 147.27 27.07 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 105.819 -1.919 . . . . 3.54 105.819 170.283 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.9 p -110.9 157.56 11.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 125.494 1.518 . . . . 0.90000000000000002 109.804 169.965 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.455 HG13 ' CE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.409 0 C-N-CA 124.355 1.062 . . . . 1.0600000000000001 111.359 178.333 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 119.63 -0.224 . . . . 0.75 111.056 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -155.54 168.04 28.42 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.954 0.407 . . . . 4.2999999999999998 110.73 178.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -84.37 133.08 34.53 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.444 2.298 . . . . 2.0899999999999999 109.188 175.558 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.28 148.73 16.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.067 0 N-CA-C 106.286 -1.746 . . . . 1.47 106.286 162.462 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.78 133.04 44.3 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.256 1.422 . . . . 0.75 108.245 176.897 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.6 168.84 25.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 122.028 0.918 . . . . 2.77 112.887 -176.168 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -104.06 96.68 6.82 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 104.293 -2.484 . . . . 2.0600000000000001 104.293 -164.201 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.81 141.11 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 108.294 -1.002 . . . . 1.5900000000000001 108.294 175.711 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.678 -0.489 . . . . 1.6599999999999999 109.678 178.337 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.771 0 CA-C-O 119.454 -0.308 . . . . 0.34000000000000002 111.191 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -60.94 -47.99 83.86 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.576 0.625 . . . . 4.3600000000000003 111.567 177.828 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.3 mt -43.36 -60.86 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 125.089 1.356 . . . . 0.56999999999999995 108.324 175.198 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -71.37 -37.43 71.62 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.139 -0.482 . . . . 2.3999999999999999 111.213 -172.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -57.54 -32.61 67.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.261 -0.9 . . . . 1.28 110.857 175.175 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.56 -51.15 54.02 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.663 -0.975 . . . . 0.33000000000000002 110.663 165.314 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.742 HD11 HD11 ' A' ' 64' ' ' ILE . 96.2 mt -63.6 -28.63 70.05 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 118.967 1.384 . . . . 0.37 112.597 176.17 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.29 21.2 ttmt -61.66 -15.2 37.76 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 119.854 1.206 . . . . 1.23 111.859 171.666 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -18.18 42.52 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.367 -1.458 . . . . 4.7800000000000002 114.657 165.651 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.436 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -71.27 128.19 90.52 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 120.332 1.423 . . . . 2.6000000000000001 110.936 -170.722 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -60.87 104.37 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.981 2.454 . . . . 0.59999999999999998 111.032 -176.425 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.74 -3.45 8.63 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.715 2.103 . . . . 0.27000000000000002 110.555 172.807 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 31' ' ' MET . 7.3 p -65.88 158.22 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 121.576 -0.955 . . . . 0.28999999999999998 111.361 164.06 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.33 -58.15 1.72 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.251 1.42 . . . . 0.41999999999999998 110.448 169.094 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -139.37 154.25 47.82 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 112.102 0.408 . . . . 3.1299999999999999 112.102 -176.388 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.3 129.72 46.76 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.483 1.913 . . . . 0.63 108.731 174.393 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.65 113.14 7.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.881 1.272 . . . . 1.3700000000000001 109.518 -174.625 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.78 148.76 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.975 0.91 . . . . 1.1000000000000001 111.689 -174.304 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -140.74 67.55 1.36 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-O 122.789 1.28 . . . . 2.79 108.059 178.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.4 mt -62.14 -16.01 49.71 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.502 -0.772 . . . . 1.26 112.366 175.272 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.64 -12.55 4.27 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.477 1.111 . . . . 1.0600000000000001 111.467 170.027 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.3 m -144.17 27.25 1.44 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.49 0.716 . . . . 0.78000000000000003 109.201 178.026 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 36.93 59.64 1.04 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 125.213 1.405 . . . . 3.27 111.218 -176.717 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -156.52 157.51 35.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.021 -1.474 . . . . 1.02 107.021 -172.225 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.89 154.56 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 109.245 -0.65 . . . . 1.1699999999999999 109.245 171.616 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -119.38 145.85 45.85 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.167 1.387 . . . . 2.5800000000000001 109.247 -178.423 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.15 134.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.911 0.885 . . . . 0.27000000000000002 109.055 179.036 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 78.5 mt -95.2 128.09 46.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.047 -1.464 . . . . 1.1100000000000001 107.047 174.694 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -149.84 171.96 15.92 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.352 0.661 . . . . 1.77 110.491 177.377 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -108.02 121.99 42.12 Favored Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 124.002 0.921 . . . . 1.9399999999999999 111.655 -176.358 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.93 23.0 0.35 Allowed 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 124.718 3.612 . . . . 0.81000000000000005 113.489 -176.712 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.56 -48.93 6.13 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 107.714 -1.217 . . . . 0.41999999999999998 107.714 171.165 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -99.43 -48.95 4.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.317 1.447 . . . . 2.71 110.687 178.678 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.2 m -111.11 133.03 53.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.07 1.748 . . . . 0.96999999999999997 114.759 -164.772 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.1 177.28 32.42 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 108.638 -1.785 . . . . 0.69999999999999996 108.638 163.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -34.15 -47.95 0.3 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.587 1.955 . . . . 0.72999999999999998 111.082 172.622 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -41.26 -58.35 1.85 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.594 1.158 . . . . 0.46999999999999997 113.402 173.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.05 -38.52 66.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.854 -0.795 . . . . 0.39000000000000001 108.854 -176.505 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.594 HG13 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -54.78 -61.21 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-N 114.696 -1.138 . . . . 0.87 109.84 179.2 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.36 -52.58 9.71 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.003 1.274 . . . . 1.47 110.373 178.794 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.65 -51.46 12.23 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.573 0.749 . . . . 2.54 112.603 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -48.03 57.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.764 -0.774 . . . . 1.6799999999999999 111.495 174.647 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.742 HD11 HD11 ' A' ' 28' ' ' LEU . 33.5 mm -49.6 -44.07 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.855 0.862 . . . . 0.38 110.662 -176.364 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -50.86 -52.57 40.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.446 0.698 . . . . 1.5900000000000001 110.027 175.146 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -71.58 -29.12 64.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 114.048 1.129 . . . . 3.3399999999999999 114.048 -178.836 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -53.9 -25.03 18.19 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.426 0.557 . . . . 0.93999999999999995 110.388 165.455 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.68 27.82 3.94 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 124.507 1.051 . . . . 0.38 111.067 166.003 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -151.16 174.51 13.15 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.806 -1.183 . . . . 1.8200000000000001 107.806 -173.814 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.33 141.05 48.79 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.066 -1.087 . . . . 3.3799999999999999 108.066 171.64 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.94 142.3 15.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 113.542 -1.663 . . . . 0.81999999999999995 107.969 162.085 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.117 -0.697 . . . . 1.45 109.117 173.612 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 112.423 0.527 . . . . 0.77000000000000002 112.423 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.09 165.87 31.48 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.99 0.9 . . . . 3.21 111.803 169.35 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -82.15 141.12 33.35 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.062 2.145 . . . . 2.2799999999999998 107.721 167.13 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.68 150.92 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 106.022 -1.844 . . . . 1.5700000000000001 106.022 164.016 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.61 128.3 23.19 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.292 1.437 . . . . 0.46000000000000002 107.955 176.286 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -155.91 173.17 17.17 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.994 0.518 . . . . 1.02 110.251 -172.247 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.405 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -102.22 152.25 21.26 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.951 0.9 . . . . 1.8300000000000001 109.371 -176.426 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 t -115.02 162.89 12.78 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.06 0 C-N-CA 123.432 0.693 . . . . 0.75 109.834 178.832 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.45 -0.453 0 C-N-CA 125.303 1.441 . . . . 0.81999999999999995 108.565 175.503 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 119.232 -0.413 . . . . 0.40000000000000002 110.369 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -53.93 -45.58 71.26 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 118.817 -0.611 . . . . 3.6499999999999999 111.36 174.147 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.463 HD11 ' CD2' ' A' ' 69' ' ' TYR . 72.9 mt -49.24 -61.96 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.15 -0.685 . . . . 0.66000000000000003 109.15 177.547 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.466 ' CD ' HG21 ' A' ' 46' ' ' VAL . 1.1 tp10 -72.18 -33.12 67.43 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.015 -0.674 . . . . 2.46 111.017 -170.193 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.5 mmtt -54.42 -39.51 67.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 121.029 -1.045 . . . . 1.74 110.703 170.715 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.51 -53.04 34.06 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.889 -1.284 . . . . 0.41999999999999998 109.889 168.757 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 64' ' ' ILE . 94.1 mt -60.66 -33.15 72.39 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 117.811 -1.09 . . . . 0.46999999999999997 112.543 178.252 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.422 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.285 13.8 ttpt -56.43 -19.33 14.57 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 120.08 1.309 . . . . 2.0699999999999998 111.678 175.499 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.46 -14.94 54.23 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.094 1.516 . . . . 3.21 115.094 170.284 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.6 mmt -73.54 134.59 79.16 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 120.165 1.348 . . . . 2.6400000000000001 111.88 -175.935 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.85 94.35 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.291 2.661 . . . . 0.40000000000000002 111.549 -176.31 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.84 -13.7 2.88 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.719 1.152 . . . . 0.44 111.092 171.968 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -71.23 152.84 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 121.678 -0.896 . . . . 1.1699999999999999 109.121 162.623 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.19 -57.03 2.09 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.668 1.187 . . . . 0.46999999999999997 110.374 169.064 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -154.67 158.07 39.08 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 117.903 0.319 . . . . 2.6899999999999999 111.61 -177.047 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.42 ' HB1' ' CG ' ' A' ' 25' ' ' GLU . . . -129.36 132.43 47.07 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 127.494 2.317 . . . . 0.65000000000000002 109.986 -171.694 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -138.35 104.34 5.15 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.819 1.248 . . . . 1.3100000000000001 108.798 -176.539 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.9 p -83.67 141.55 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.74 0.816 . . . . 0.82999999999999996 111.371 -178.693 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -136.83 67.84 1.44 Allowed 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.715 1.606 . . . . 1.1499999999999999 111.535 -175.429 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.81 -16.98 62.63 Favored 'General case' 0 C--O 1.228 -0.045 0 N-CA-C 113.146 0.795 . . . . 0.78000000000000003 113.146 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.45 -26.09 11.84 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.17 0.441 . . . . 0.53000000000000003 110.612 169.624 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.6 m -125.45 18.56 8.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.319 1.448 . . . . 0.45000000000000001 110.315 -179.778 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 46.46 39.66 6.95 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.202 1.001 . . . . 2.6600000000000001 111.973 -177.352 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.37 156.82 46.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.596 -0.89 . . . . 0.96999999999999997 108.596 -169.828 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.466 HG21 ' CD ' ' A' ' 25' ' ' GLU . 7.7 p -131.59 145.66 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.349 -0.841 . . . . 0.53000000000000003 108.809 174.335 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -116.06 139.01 50.72 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.022 -1.473 . . . . 2.48 107.022 176.458 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.59 138.34 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.489 -0.93 . . . . 0.44 108.489 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 79.9 mt -105.11 125.3 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.196 -1.409 . . . . 0.94999999999999996 107.196 -177.269 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -146.12 166.36 26.38 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 122.945 0.498 . . . . 1.8899999999999999 111.227 -179.418 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -103.68 115.62 63.22 Favored Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 114.31 -1.313 . . . . 1.3400000000000001 110.245 176.324 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -68.46 6.73 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.674 2.916 . . . . 0.47999999999999998 113.706 -179.484 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.62 -43.24 48.98 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 119.381 0.991 . . . . 0.42999999999999999 108.438 174.816 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -100.86 -40.82 7.11 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.27 1.828 . . . . 2.9900000000000002 109.906 178.792 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.6 m -138.82 127.3 23.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 118.568 2.803 . . . . 0.52000000000000002 118.568 -154.256 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -159.0 -164.68 14.74 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 109.752 -1.339 . . . . 0.45000000000000001 109.752 156.533 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.273 0.1 OUTLIER -29.28 -44.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 129.357 3.063 . . . . 0.71999999999999997 114.13 173.245 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.48 -57.09 8.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.195 0.907 . . . . 0.34999999999999998 112.546 175.487 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.26 -39.36 63.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 122.181 0.991 . . . . 0.20999999999999999 108.933 -176.12 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.566 HG12 HD22 ' A' ' 28' ' ' LEU . 1.1 mt -60.87 -59.24 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-N 114.149 -1.387 . . . . 0.55000000000000004 109.279 -174.583 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.65 -51.48 12.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.914 1.234 . . . . 0.75 111.279 177.728 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -42.48 -56.07 3.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.893 0.701 . . . . 2.4399999999999999 112.893 174.157 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -44.27 71.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 119.056 -1.058 . . . . 1.9099999999999999 111.347 178.922 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 28' ' ' LEU . 38.8 mm -51.01 -46.33 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.65 0.78 . . . . 0.47999999999999998 110.456 -178.557 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -50.11 -50.56 48.1 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.328 0.585 . . . . 1.4199999999999999 110.07 174.092 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -72.35 -30.79 65.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.904 0.705 . . . . 3.0699999999999998 112.904 -175.214 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.51 -25.34 24.97 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.68 0.392 . . . . 0.94999999999999996 110.383 165.482 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.25 28.78 5.38 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 124.656 1.122 . . . . 0.37 110.859 172.827 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.463 ' CD2' HD11 ' A' ' 24' ' ' ILE . 64.2 m-85 -145.52 163.52 34.47 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 107.943 -1.132 . . . . 1.97 107.943 -176.228 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.01 126.58 50.28 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.977 -1.49 . . . . 4.3099999999999996 106.977 177.781 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.0 p -94.74 141.58 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 122.92 0.488 . . . . 0.53000000000000003 109.771 172.22 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 11' ' ' GLN . 13.4 m . . . . . 0 N--CA 1.466 0.357 0 N-CA-C 108.987 -0.746 . . . . 1.1000000000000001 108.987 173.393 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 120.664 0.268 . . . . 0.82999999999999996 110.962 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -147.9 156.56 42.83 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.982 0.896 . . . . 3.6600000000000001 110.763 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.28 111.14 18.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.848 2.459 . . . . 2.1899999999999999 108.991 173.251 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.02 151.89 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 107.203 -1.406 . . . . 1.6200000000000001 107.203 162.783 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.02 127.82 19.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.431 1.492 . . . . 0.33000000000000002 107.899 175.317 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -157.03 164.5 37.9 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.163 0.438 . . . . 1.1499999999999999 110.727 -171.293 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.34 145.89 27.61 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.074 0.95 . . . . 1.8300000000000001 109.066 -172.089 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.71 159.25 19.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 C-N-CA 123.127 0.571 . . . . 0.54000000000000004 110.053 -176.087 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.448 -0.563 0 C-N-CA 124.909 1.284 . . . . 0.72999999999999998 108.096 177.081 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 118.812 -0.613 . . . . 0.44 111.581 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -57.98 -43.4 86.53 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.848 0.749 . . . . 3.5 110.696 177.126 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.5 mt -53.47 -59.45 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 107.96 -1.126 . . . . 0.62 107.96 -176.799 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' CG ' HG21 ' A' ' 46' ' ' VAL . 1.5 tm-20 -70.58 -41.17 72.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.818 -0.628 . . . . 3.3599999999999999 109.811 -176.03 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -49.66 -38.49 32.79 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.39 -1.444 . . . . 1.46 112.005 179.084 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.42 -51.79 40.78 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 111.548 -0.621 . . . . 0.37 111.548 169.064 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 64' ' ' ILE . 74.6 mt -67.1 -27.7 67.56 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.639 -0.918 . . . . 0.60999999999999999 112.666 177.476 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -62.09 -15.82 47.81 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.758 1.163 . . . . 2.5099999999999998 110.004 172.146 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -96.89 4.97 51.35 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.162 1.171 . . . . 3.77 114.162 170.47 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 34' ' ' VAL . 81.5 mmm -83.12 138.81 42.35 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 120.498 1.499 . . . . 2.0699999999999998 111.529 176.024 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.68 94.26 0.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.387 2.724 . . . . 0.40999999999999998 111.228 -172.655 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.87 -13.81 2.87 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.514 1.054 . . . . 0.19 111.327 178.846 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 31' ' ' MET . 5.3 p -69.22 160.59 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 117.735 0.767 . . . . 0.26000000000000001 110.889 168.076 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.25 -56.37 1.82 Allowed 'General case' 0 C--N 1.335 -0.058 0 C-N-CA 124.055 0.942 . . . . 0.44 109.967 168.793 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -145.01 157.54 44.09 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.968 -0.382 . . . . 2.8500000000000001 109.968 -179.155 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.22 136.12 39.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.504 2.322 . . . . 0.67000000000000004 107.854 176.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.57 115.19 9.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.658 1.583 . . . . 1.4199999999999999 108.193 -174.155 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.57 143.6 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.859 0.863 . . . . 0.57999999999999996 112.062 -177.103 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -133.14 67.72 1.52 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.335 1.854 . . . . 1.21 111.86 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.5 mt -67.37 -16.89 64.5 Favored 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 113.085 0.772 . . . . 0.65000000000000002 113.085 -179.046 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.83 -22.06 13.29 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.654 0.382 . . . . 0.58999999999999997 110.875 168.742 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.1 m -127.82 17.79 6.78 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.741 1.216 . . . . 0.54000000000000004 110.032 178.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 44.68 40.52 4.19 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.558 1.143 . . . . 2.75 111.632 -175.515 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.8 m -134.72 155.66 50.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.22 -1.4 . . . . 0.46000000000000002 107.22 -169.132 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.4 HG21 ' CG ' ' A' ' 25' ' ' GLU . 7.4 p -134.8 148.9 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.773 -0.825 . . . . 0.41999999999999998 108.773 173.012 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.25 153.11 36.81 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 124.047 0.842 . . . . 2.8300000000000001 110.168 174.374 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.98 133.64 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 123.617 0.767 . . . . 0.33000000000000002 109.382 -177.139 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.5 mt -100.01 112.04 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.755 1.622 . . . . 0.91000000000000003 106.794 179.375 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -135.84 167.41 21.23 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.276 1.03 . . . . 1.8500000000000001 110.998 178.335 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.91 119.85 54.28 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 124.726 1.21 . . . . 1.3400000000000001 110.998 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.14 8.83 1.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.72 2.947 . . . . 0.46000000000000002 113.586 -175.29 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.4 -53.25 6.78 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 107.585 -1.265 . . . . 0.45000000000000001 107.585 175.869 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -85.48 -41.87 14.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.273 1.429 . . . . 2.8700000000000001 110.429 175.383 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.0 m -138.14 126.61 23.34 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 117.925 2.565 . . . . 0.52000000000000002 117.925 -151.857 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.83 -165.35 19.76 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.909 -1.041 . . . . 0.42999999999999999 110.731 155.458 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.5 t -31.5 -43.22 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 129.386 3.075 . . . . 0.54000000000000004 112.987 176.776 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.0 -56.87 7.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.785 0.72 . . . . 0.34000000000000002 112.831 174.512 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.57 -37.05 65.65 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 122.29 1.043 . . . . 0.29999999999999999 109.198 -179.517 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.513 HG12 HD22 ' A' ' 28' ' ' LEU . 1.2 mt -64.79 -54.64 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 114.348 -1.296 . . . . 0.51000000000000001 110.338 -171.516 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.74 -51.47 22.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.011 1.278 . . . . 0.77000000000000002 110.882 174.711 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -43.42 -53.84 5.13 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 113.025 0.75 . . . . 2.2599999999999998 113.025 173.989 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.14 -45.56 66.57 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 118.419 -0.8 . . . . 2.1600000000000001 110.862 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.593 HD11 HD11 ' A' ' 28' ' ' LEU . 17.2 mm -50.1 -47.5 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.641 1.176 . . . . 0.41999999999999998 110.384 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -51.22 -47.53 62.31 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.427 0.632 . . . . 1.53 110.053 174.512 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -33.06 67.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.75 0.82 . . . . 3.4399999999999999 112.42 -177.001 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.64 -22.62 23.65 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.883 0.473 . . . . 0.85999999999999999 110.395 166.348 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.19 30.88 7.55 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.225 -1.15 . . . . 0.39000000000000001 110.225 175.325 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -137.32 163.62 30.55 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.615 -1.254 . . . . 2.1200000000000001 107.615 178.511 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.24 130.88 56.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.104 -1.443 . . . . 3.9100000000000001 107.104 174.119 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -99.4 146.72 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.629 0.771 . . . . 0.47999999999999998 111.111 171.513 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 C-N-CA 123.987 0.915 . . . . 0.94999999999999996 109.738 171.077 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.671 -0.492 . . . . 0.68000000000000005 109.671 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.1 mttp -149.72 162.98 39.17 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.357 0.599 . . . . 4.4000000000000004 110.56 178.576 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -84.11 133.62 34.62 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.779 1.632 . . . . 2.04 107.768 166.849 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 tp -106.29 154.14 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.104 -1.813 . . . . 1.0900000000000001 106.104 160.611 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.9 131.45 30.98 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.894 -1.521 . . . . 0.47999999999999998 106.894 171.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -156.46 165.85 35.12 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.278 0.631 . . . . 1.1899999999999999 110.428 -174.005 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -93.92 148.56 22.03 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.04 1.336 . . . . 2.9900000000000002 107.785 -171.294 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.443 HG11 HD13 ' A' ' 24' ' ' ILE . 2.2 t -116.13 141.07 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 118.956 0.798 . . . . 0.72999999999999998 110.522 178.705 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 106.893 -1.521 . . . . 0.90000000000000002 106.893 173.239 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 118.587 -0.72 . . . . 0.41999999999999998 110.208 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -52.41 -48.76 65.52 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.389 0.995 . . . . 4.0999999999999996 111.381 173.168 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.577 HD11 ' CD2' ' A' ' 69' ' ' TYR . 80.1 mt -43.68 -61.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.284 0 N-CA-C 108.856 -0.794 . . . . 0.81999999999999995 108.856 179.78 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -36.08 66.3 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.773 -0.649 . . . . 2.4300000000000002 112.427 -174.473 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -54.72 -37.63 66.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.941 -1.099 . . . . 2.4100000000000001 111.009 176.523 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.51 -45.09 77.81 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.983 -0.847 . . . . 0.46000000000000002 110.983 169.556 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.706 HD22 HG12 ' A' ' 60' ' ' ILE . 75.9 mt -67.25 -31.18 71.35 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.128 -1.219 . . . . 0.5 111.517 176.461 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HA ' HG11 ' A' ' 34' ' ' VAL . 6.4 ttmm -60.47 -17.5 45.32 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.221 0.918 . . . . 1.29 111.215 172.257 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -81.38 -16.22 52.91 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.928 -1.107 . . . . 3.3399999999999999 113.674 169.378 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 34' ' ' VAL . 14.8 mmt -73.71 137.73 77.05 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 120.785 1.63 . . . . 2.2599999999999998 112.744 -173.483 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.74 87.82 0.8 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.903 3.069 . . . . 0.79000000000000004 111.284 -172.196 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.05 -22.82 0.99 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.994 -0.843 . . . . 0.47999999999999998 110.994 -174.302 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 29' ' ' LYS . 5.8 p -68.09 159.65 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 O-C-N 121.845 -0.797 . . . . 0.39000000000000001 111.939 175.265 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.54 -57.36 1.47 Allowed 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.652 1.181 . . . . 0.54000000000000004 109.344 169.49 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -138.97 154.84 48.34 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 113.884 1.068 . . . . 3.0699999999999998 113.884 178.464 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.13 124.06 18.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.071 1.748 . . . . 0.97999999999999998 108.025 -175.969 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -143.44 119.97 11.04 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.584 0.754 . . . . 1.6399999999999999 109.166 -166.111 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -96.63 128.17 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.466 0.707 . . . . 0.89000000000000001 111.529 -173.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -113.91 69.51 0.71 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.032 -1.47 . . . . 2.5800000000000001 107.032 177.158 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 72.9 mt -61.57 -21.79 64.62 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.893 -0.594 . . . . 0.76000000000000001 111.641 175.803 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.71 -25.05 16.67 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.872 0.869 . . . . 0.60999999999999999 111.405 170.461 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 m -124.96 15.39 8.54 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.123 1.369 . . . . 0.69999999999999996 109.886 -179.308 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 47.02 37.04 4.6 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.407 1.083 . . . . 2.46 111.632 -176.348 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.0 m -133.78 150.59 51.45 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.807 -1.553 . . . . 0.70999999999999996 106.807 -170.904 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.3 p -128.96 146.9 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 107.684 -1.228 . . . . 0.58999999999999997 107.684 174.492 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.32 149.08 44.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 123.895 0.747 . . . . 2.75 109.114 173.849 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.26 133.78 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.393 -0.965 . . . . 0.28000000000000003 108.393 -179.135 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.2 mt -101.69 120.25 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 127.231 2.212 . . . . 0.69999999999999996 106.501 -176.462 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -149.68 166.15 30.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.656 0.782 . . . . 1.77 110.548 -177.53 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -95.22 108.08 36.45 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 125.228 1.411 . . . . 2.2599999999999998 110.611 175.752 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -70.34 12.82 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.229 3.286 . . . . 0.81999999999999995 114.117 -179.434 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.97 -49.66 6.92 Favored 'General case' 0 N--CA 1.459 0.023 0 N-CA-C 107.105 -1.443 . . . . 0.73999999999999999 107.105 171.469 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -85.6 -34.09 21.51 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.18 1.392 . . . . 2.4700000000000002 111.037 178.267 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.9 m -154.39 122.15 5.87 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 117.112 2.264 . . . . 0.76000000000000001 117.112 -156.601 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.97 -171.68 24.2 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 121.69 -0.631 . . . . 0.5 112.222 165.383 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.96 -44.66 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.942 2.897 . . . . 0.55000000000000004 112.531 176.499 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.4 -55.78 9.91 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.062 0.764 . . . . 0.35999999999999999 113.062 175.965 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.18 -38.7 63.59 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 122.644 1.211 . . . . 0.37 109.127 178.69 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.706 HG12 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -64.95 -48.61 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 114.407 -1.27 . . . . 0.54000000000000004 110.619 -169.063 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -50.53 60.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.164 1.347 . . . . 0.90000000000000002 110.355 173.862 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -43.32 -57.95 2.78 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.852 0.834 . . . . 2.3999999999999999 112.879 171.846 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -42.27 83.66 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 118.595 -0.717 . . . . 1.79 111.418 -178.228 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.403 HD11 HD11 ' A' ' 28' ' ' LEU . 5.7 mm -52.47 -47.8 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 119.355 0.98 . . . . 0.56000000000000005 110.047 177.654 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -51.72 -46.29 63.91 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.103 0.478 . . . . 1.6599999999999999 110.026 173.083 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -37.7 84.27 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.482 -0.761 . . . . 3.6200000000000001 112.01 -178.835 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.97 -21.95 34.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.75 0.82 . . . . 0.94999999999999996 110.517 170.73 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.83 28.5 7.8 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 124.409 1.004 . . . . 0.51000000000000001 110.97 173.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.577 ' CD2' HD11 ' A' ' 24' ' ' ILE . 47.5 m-85 -141.23 175.11 9.91 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.042 -1.095 . . . . 2.1699999999999999 108.042 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 111.43 7.39 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.232 -1.025 . . . . 4.5899999999999999 108.232 -171.525 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.49 147.21 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.466 -0.788 . . . . 0.46000000000000002 109.74 -179.007 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 C-N-CA 125.449 1.499 . . . . 1.55 110.15 -174.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 118.662 -0.685 . . . . 15.289999999999999 109.162 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.43 -76.75 0.1 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.003 -0.74 . . . . 8.0500000000000007 109.003 171.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 m -66.29 159.88 25.68 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 122.044 -0.41 . . . . 3.0800000000000001 110.603 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -133.74 113.92 12.85 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.929 -1.878 . . . . 2.6499999999999999 105.929 172.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -91.74 172.09 8.71 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.995 0.918 . . . . 0.93000000000000005 110.601 -175.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -152.38 162.32 41.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.597 0.713 . . . . 2.7799999999999998 111.642 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 0.8 OUTLIER -84.4 150.2 25.5 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.492 1.517 . . . . 3.75 109.006 166.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 tp -129.48 156.47 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.352 -1.721 . . . . 1.2 106.352 162.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.88 130.78 24.46 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.711 1.204 . . . . 0.31 108.442 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.84 171.63 19.94 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.238 0.472 . . . . 1.1599999999999999 111.956 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.22 153.7 19.12 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.516 0.726 . . . . 1.97 110.009 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -118.51 158.06 19.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 123.903 0.881 . . . . 0.57999999999999996 109.402 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -121.62 125.38 46.56 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.319 1.048 . . . . 0.79000000000000004 108.178 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.73 -11.8 13.65 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.233 0.92 . . . . 1.3799999999999999 113.202 172.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.36 151.17 16.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.752 1.276 . . . . 3.23 111.669 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 p -134.23 32.86 3.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.802 1.241 . . . . 3.4399999999999999 110.006 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.0 t 60.54 -142.09 0.54 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.248 1.019 . . . . 3.96 110.573 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 34.03 53.6 0.53 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.878 2.071 . . . . 2.5600000000000001 115.108 171.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.09 19.89 9.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.775 1.23 . . . . 1.28 113.949 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.4 m -73.32 -61.51 1.8 Allowed 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 123.515 0.726 . . . . 1.5900000000000001 109.315 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.23 -34.66 68.8 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 121.693 0.759 . . . . 0.84999999999999998 111.842 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.35 -41.52 19.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 122.951 0.5 . . . . 0.45000000000000001 112.051 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.91 -41.73 99.55 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.444 0.566 . . . . 4.0700000000000003 111.221 177.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.427 ' CG2' HD12 ' A' ' 64' ' ' ILE . 60.4 mt -51.71 -60.16 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.612 -1.255 . . . . 0.54000000000000004 107.612 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.409 ' CD ' HG21 ' A' ' 46' ' ' VAL . 1.0 OUTLIER -71.73 -34.49 69.61 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.372 -0.831 . . . . 2.6000000000000001 111.516 -173.006 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -56.39 -36.84 69.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.116 -0.99 . . . . 1.45 110.963 174.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.28 -49.18 60.98 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.765 -0.934 . . . . 0.29999999999999999 110.765 168.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.825 HD11 HD11 ' A' ' 64' ' ' ILE . 96.8 mt -65.14 -30.9 71.87 Favored 'General case' 0 C--O 1.225 -0.207 0 O-C-N 121.544 -0.974 . . . . 0.33000000000000002 112.882 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt -58.85 -17.55 24.88 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.145 0.884 . . . . 1.26 111.257 171.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -93.77 4.35 54.06 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.962 1.097 . . . . 5.5800000000000001 113.962 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.0 mmt -82.03 136.4 47.22 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 120.702 1.592 . . . . 2.79 112.605 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.17 98.25 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.8 3.0 . . . . 0.38 110.111 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.74 -14.96 4.12 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.588 -1.005 . . . . 0.22 110.588 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 p -69.45 152.74 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 117.524 0.662 . . . . 0.28999999999999998 110.434 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.53 -57.48 2.21 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.159 1.384 . . . . 0.73999999999999999 109.48 170.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -144.51 158.09 43.92 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 122.973 0.509 . . . . 3.1800000000000002 110.39 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.65 127.6 33.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.272 1.829 . . . . 0.79000000000000004 107.926 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.09 113.31 8.37 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.854 0.861 . . . . 1.48 109.164 -174.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -89.73 140.34 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.098 0.959 . . . . 0.68000000000000005 111.72 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -131.72 67.22 1.52 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.169 1.788 . . . . 1.22 111.581 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.74 -16.68 64.01 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 113.131 0.789 . . . . 0.69999999999999996 113.131 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.03 -23.94 15.31 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.637 0.375 . . . . 0.58999999999999997 110.748 168.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.5 m -126.62 18.31 7.42 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.073 1.349 . . . . 0.47999999999999998 110.008 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 45.35 38.96 3.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.616 1.166 . . . . 2.48 111.869 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.9 m -136.17 154.63 50.9 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.28 -1.378 . . . . 0.48999999999999999 107.28 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.409 HG21 ' CD ' ' A' ' 25' ' ' GLU . 7.1 p -133.55 150.02 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.588 -0.893 . . . . 0.42999999999999999 108.588 173.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.41 150.08 41.35 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.739 -0.837 . . . . 2.8300000000000001 108.739 171.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.94 139.63 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 107.146 -1.427 . . . . 0.38 107.146 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.1 mt -108.09 131.63 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.019 -1.474 . . . . 0.88 107.019 -175.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -154.2 167.78 28.74 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 123.257 0.348 . . . . 1.8300000000000001 111.767 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -102.75 110.85 64.15 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 124.508 1.123 . . . . 1.6200000000000001 109.856 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -74.74 30.12 0.35 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.94 3.093 . . . . 0.81999999999999995 112.752 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.13 -50.21 5.17 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.044 -1.465 . . . . 0.44 107.044 167.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -87.24 -46.71 9.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.689 1.196 . . . . 2.6499999999999999 110.269 173.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.6 m -140.88 136.42 32.31 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 117.591 2.441 . . . . 0.68000000000000005 117.591 -148.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.85 -161.31 23.05 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 109.102 -1.599 . . . . 0.47999999999999998 109.102 164.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 t -38.15 -43.53 0.77 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.833 2.453 . . . . 0.54000000000000004 112.427 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.32 -57.43 4.62 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.809 0.844 . . . . 0.28999999999999998 112.72 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.56 -37.56 65.49 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.873 0.844 . . . . 0.19 109.328 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.556 HG12 HD22 ' A' ' 28' ' ' LEU . 1.2 mt -61.56 -59.46 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-N 114.466 -1.243 . . . . 0.76000000000000001 109.341 -171.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -47.94 -50.36 27.33 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.099 1.318 . . . . 0.80000000000000004 110.846 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.28 -52.58 9.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.205 1.002 . . . . 2.3900000000000001 111.988 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -43.84 69.07 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.984 -0.686 . . . . 2.02 111.373 177.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.825 HD11 HD11 ' A' ' 28' ' ' LEU . 35.7 mm -52.53 -45.28 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 118.985 0.811 . . . . 0.56999999999999995 110.284 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -49.3 -47.35 47.06 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.895 0.379 . . . . 1.6200000000000001 110.646 173.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -71.96 -33.23 68.03 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.954 1.094 . . . . 2.9700000000000002 113.954 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.49 -24.59 21.09 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.268 0.486 . . . . 0.89000000000000001 110.205 166.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.66 29.29 6.64 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.114 -1.194 . . . . 0.27000000000000002 110.114 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -140.73 162.08 36.27 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.01 -1.478 . . . . 1.6599999999999999 107.01 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.61 ' HE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -113.79 133.72 55.21 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.118 -1.808 . . . . 4.0499999999999998 106.118 170.438 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.443 ' HB ' HG21 ' A' ' 64' ' ' ILE . 4.5 p -100.73 148.53 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.39 0.676 . . . . 0.46999999999999997 109.948 170.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.61 HG13 ' HE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -96.58 166.43 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.594 0.634 . . . . 1.45 109.738 167.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 35.3 mm -118.7 108.19 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 105.209 -2.145 . . . . 1.1299999999999999 105.209 165.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -52.99 99.43 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.622 0.769 . . . . 7.3799999999999999 111.319 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.69 -172.75 38.82 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 121.37 0.428 . . . . 5.3899999999999997 112.082 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.174 0 CA-C-O 117.205 -1.379 . . . . 9.1199999999999992 110.586 -172.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttm . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 119.138 -0.458 . . . . 9.4800000000000004 111.503 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.2 tp -133.04 67.58 1.53 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.375 -1.342 . . . . 9.2799999999999994 107.375 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.7 p 60.21 171.95 0.09 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.348 1.459 . . . . 4.3499999999999996 110.155 -153.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -179.12 117.26 0.07 Allowed 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.9 2.08 . . . . 3.25 106.021 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -95.23 174.35 7.09 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 123.442 0.697 . . . . 1.22 110.939 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.98 154.77 41.64 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.68 0.752 . . . . 3.4399999999999999 110.878 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -86.97 137.06 32.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.837 -1.529 . . . . 2.1800000000000002 108.993 166.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.0 tp -112.07 155.64 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 105.917 -1.883 . . . . 1.1799999999999999 105.917 162.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.55 130.55 21.84 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 108.072 -1.085 . . . . 0.41999999999999998 108.072 172.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.62 173.47 16.89 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.177 0.899 . . . . 1.2 111.4 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.93 149.47 22.37 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.434 0.694 . . . . 1.8200000000000001 109.599 -172.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.596 HG11 HD13 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -125.34 143.78 37.69 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.059 0 C-N-CA 122.708 0.403 . . . . 0.83999999999999997 110.883 -176.664 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t -101.4 149.68 23.8 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.343 1.057 . . . . 1.03 109.31 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.4 30.78 9.52 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.726 0.679 . . . . 1.47 112.894 174.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.97 77.66 0.32 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 118.506 1.153 . . . . 6.1100000000000003 110.624 173.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 p -76.47 -1.89 29.43 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.048 0.939 . . . . 4.1200000000000001 112.762 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t 78.08 175.54 0.17 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.855 1.662 . . . . 3.7799999999999998 110.481 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.77 63.97 0.58 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.848 1.259 . . . . 3.2400000000000002 112.396 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.34 23.21 11.66 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.992 1.317 . . . . 1.1499999999999999 113.081 172.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -73.09 -52.28 14.89 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 121.744 -0.597 . . . . 1.3500000000000001 110.214 -173.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.632 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -68.02 -27.3 66.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.641 0.734 . . . . 0.73999999999999999 110.968 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.96 -49.85 70.92 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.743 -0.598 . . . . 0.44 109.469 169.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -49.99 -49.66 49.81 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.707 0.685 . . . . 6.9199999999999999 111.652 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.632 HD12 ' HA ' ' A' ' 21' ' ' ALA . 90.5 mt -44.02 -62.62 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 123.432 0.693 . . . . 0.98999999999999999 109.324 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.42 -35.37 65.82 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.303 0.573 . . . . 2.3599999999999999 112.394 -172.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -58.2 -36.43 73.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.955 -1.091 . . . . 1.22 110.722 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.59 -51.01 51.13 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.564 -1.014 . . . . 0.34000000000000002 110.564 166.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.766 HD11 HD11 ' A' ' 64' ' ' ILE . 94.2 mt -63.71 -33.6 76.0 Favored 'General case' 0 C--O 1.221 -0.417 0 O-C-N 121.579 -0.954 . . . . 0.40999999999999998 112.444 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -57.79 -18.61 22.81 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.28 0.946 . . . . 1.5600000000000001 112.058 172.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -85.33 -11.78 53.83 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.822 1.415 . . . . 4.2300000000000004 114.822 169.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.561 ' O ' HG12 ' A' ' 34' ' ' VAL . 4.8 mmt -69.63 143.51 92.8 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 120.85 1.659 . . . . 1.8500000000000001 112.074 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.74 106.63 1.51 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.39 2.06 . . . . 0.56999999999999995 109.537 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.09 -13.41 5.75 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.079 1.323 . . . . 0.25 110.784 171.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 31' ' ' MET . 8.1 p -70.27 160.56 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 O-C-N 121.939 -0.742 . . . . 0.32000000000000001 111.517 171.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.49 -65.7 1.15 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.84 1.256 . . . . 0.56999999999999995 108.212 165.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -144.43 147.43 33.34 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.349 -0.387 . . . . 3.25 111.793 -162.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.27 138.29 50.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.24 1.416 . . . . 0.63 108.587 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -140.0 118.45 12.18 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.975 0.91 . . . . 1.4199999999999999 109.408 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -86.4 136.35 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.99 0.916 . . . . 0.65000000000000002 111.054 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -129.23 69.68 1.41 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.318 1.847 . . . . 1.21 110.994 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.2 mt -64.09 -18.63 64.57 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.848 0.685 . . . . 0.95999999999999996 112.848 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.84 -18.21 8.15 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.124 0.42 . . . . 0.84999999999999998 110.977 170.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.7 m -131.87 18.06 4.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.823 1.249 . . . . 0.68999999999999995 109.872 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 41.12 39.24 0.86 Allowed 'General case' 0 C--N 1.346 0.419 0 C-N-CA 124.895 1.278 . . . . 2.6000000000000001 112.128 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.4 m -129.59 152.46 49.09 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.16 -1.422 . . . . 0.64000000000000001 107.16 -171.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 p -133.85 146.85 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 107.143 -1.429 . . . . 0.52000000000000002 107.143 173.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.75 145.8 46.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 123.93 0.769 . . . . 2.6000000000000001 109.39 173.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -144.0 136.66 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.615 -0.883 . . . . 0.25 108.615 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.0 mt -103.61 118.87 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.704 2.002 . . . . 0.94999999999999996 107.145 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -146.17 169.0 19.63 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.74 0.781 . . . . 1.8999999999999999 110.415 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -96.71 125.3 47.32 Favored Pre-proline 0 N--CA 1.439 -1.003 0 CA-C-N 114.316 -1.311 . . . . 1.3500000000000001 109.502 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.41 6.69 2.56 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.778 2.318 . . . . 0.71999999999999997 113.315 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.19 -54.47 4.59 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 119.358 0.981 . . . . 0.46999999999999997 108.95 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -85.43 -55.86 3.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.312 1.445 . . . . 3.1299999999999999 109.297 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.8 m -86.93 160.16 18.78 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 126.366 1.867 . . . . 2.1000000000000001 112.984 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.24 161.25 35.07 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 104.859 -3.296 . . . . 1.4099999999999999 104.859 168.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 t -51.29 -32.24 24.24 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 117.192 0.496 . . . . 1.1399999999999999 110.288 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -36.26 -61.32 0.51 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.97 1.708 . . . . 0.68999999999999995 114.449 164.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.89 -37.97 73.03 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.938 -1.134 . . . . 0.38 107.938 -172.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.531 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -55.62 -62.29 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-N 114.315 -1.311 . . . . 0.92000000000000004 109.214 177.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -46.9 -54.1 10.75 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.354 1.434 . . . . 1.1899999999999999 110.676 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -41.05 -57.0 2.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.663 0.785 . . . . 2.52 112.767 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.64 -40.46 69.7 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 119.917 -0.713 . . . . 1.8799999999999999 110.046 -176.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.766 HD11 HD11 ' A' ' 28' ' ' LEU . 27.5 mm -52.61 -47.18 49.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 119.188 0.903 . . . . 0.41999999999999998 109.994 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -53.28 -42.54 66.66 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.637 0.375 . . . . 1.6899999999999999 110.754 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -71.04 -38.96 72.56 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.422 -0.799 . . . . 2.9399999999999999 110.915 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -54.96 -25.09 27.24 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.715 0.806 . . . . 1.0800000000000001 110.263 171.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.17 29.66 6.3 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.331 -1.108 . . . . 0.46999999999999997 110.331 172.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.533 ' CD2' HD11 ' A' ' 24' ' ' ILE . 44.0 m-85 -140.76 166.25 25.27 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.968 -1.123 . . . . 1.9399999999999999 107.968 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -122.17 122.0 38.18 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 104.679 -2.341 . . . . 3.3300000000000001 104.679 -173.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.411 ' HB ' HG21 ' A' ' 64' ' ' ILE . 7.2 p -100.54 142.51 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.182 -0.673 . . . . 0.42999999999999999 109.182 173.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -104.26 151.87 6.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 N-CA-C 108.545 -0.909 . . . . 1.03 108.545 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.0 mm -124.84 67.68 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.388 -1.338 . . . . 0.98999999999999999 107.388 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -87.61 100.81 13.07 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 106.937 -1.505 . . . . 4.6200000000000001 106.937 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 23.77 66.63 0.03 OUTLIER Glycine 0 CA--C 1.53 0.983 0 C-N-CA 127.774 2.607 . . . . 3.5699999999999998 115.509 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.342 0 CA-C-O 115.507 -2.187 . . . . 10.98 109.544 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 mtt . . . . . 0 N--CA 1.472 0.675 0 N-CA-C 106.392 -1.707 . . . . 10.119999999999999 106.392 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 tp -169.61 89.44 0.18 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.534 -0.913 . . . . 7.2300000000000004 108.534 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 p -170.42 81.52 0.1 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.308 -0.997 . . . . 3.1899999999999999 108.308 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -122.47 133.47 54.6 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.816 -1.92 . . . . 3.9700000000000002 105.816 170.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -93.18 163.05 13.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.473 1.109 . . . . 0.60999999999999999 110.697 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -146.14 157.17 43.83 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.013 -0.736 . . . . 3.71 109.013 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.68 127.94 35.59 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.625 1.57 . . . . 3.71 109.5 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 tp -106.73 152.17 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.767 -1.568 . . . . 1.0900000000000001 106.767 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.81 132.65 27.51 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.258 -1.386 . . . . 0.34999999999999998 107.258 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -156.41 163.16 39.8 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.072 0.549 . . . . 1.25 110.68 -170.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.77 154.56 18.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.343 -1.355 . . . . 2.2599999999999998 107.343 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.4 163.43 14.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.064 -1.087 . . . . 0.56000000000000005 108.064 173.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.99 142.65 51.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.555 -1.276 . . . . 1.0700000000000001 107.555 173.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.33 -10.96 56.78 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.89 0.757 . . . . 1.4199999999999999 113.722 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.6 157.37 11.78 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.282 1.541 . . . . 3.1800000000000002 110.635 172.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -131.21 33.81 4.08 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.523 0.729 . . . . 4.3200000000000003 109.223 169.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.516 ' HA ' HD13 ' A' ' 41' ' ' LEU . 14.5 t 69.91 -49.39 0.63 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.298 1.839 . . . . 4.2300000000000004 113.633 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.4 86.14 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.358 1.463 . . . . 2.8100000000000001 111.765 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.53 13.56 4.26 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.36 1.864 . . . . 1.1100000000000001 113.63 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.7 m -72.13 -63.9 1.05 Allowed 'General case' 0 CA--C 1.519 -0.236 0 O-C-N 121.78 -0.575 . . . . 1.6599999999999999 110.522 -167.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.65 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -64.85 -27.52 68.93 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.79 -0.364 . . . . 1.1299999999999999 111.064 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.61 -54.94 34.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.725 0.41 . . . . 0.56999999999999995 110.529 169.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -62.79 -48.1 80.58 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 122.89 0.476 . . . . 4.0499999999999998 110.752 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.65 HD12 ' HA ' ' A' ' 21' ' ' ALA . 66.1 mt -49.62 -56.74 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.437 -0.579 . . . . 0.57999999999999996 109.437 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.78 -42.89 76.78 Favored 'General case' 0 C--O 1.219 -0.522 0 C-N-CA 120.208 -0.597 . . . . 3.48 109.567 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -49.51 -36.77 24.23 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.406 -1.434 . . . . 2.04 111.691 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.17 -51.71 39.93 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 112.191 -0.364 . . . . 0.44 112.191 167.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.805 HD11 HD11 ' A' ' 64' ' ' ILE . 90.2 mt -68.4 -28.34 67.01 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 121.401 -1.058 . . . . 0.55000000000000004 113.043 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.281 21.5 ttmt -62.7 -15.04 50.84 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.965 1.257 . . . . 2.29 110.238 175.003 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -25.63 60.12 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.217 1.192 . . . . 3.8900000000000001 114.217 166.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.549 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -67.18 134.83 93.55 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 120.14 1.336 . . . . 2.52 111.939 -169.687 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -65.58 100.79 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.303 2.669 . . . . 0.38 109.52 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.6 -17.68 3.48 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.405 -1.078 . . . . 0.23000000000000001 110.405 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 31' ' ' MET . 6.2 p -72.17 154.65 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 121.965 -0.727 . . . . 0.28000000000000003 110.385 169.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.18 -57.22 2.23 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 123.009 0.524 . . . . 0.45000000000000001 109.666 171.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -148.49 157.45 43.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.516 -0.55 . . . . 2.5600000000000001 109.516 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.72 136.11 33.85 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 127.232 2.213 . . . . 0.65000000000000002 108.325 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -137.87 117.71 13.23 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 125.222 1.576 . . . . 1.7 107.931 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -84.32 144.15 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.159 0.984 . . . . 0.73999999999999999 110.847 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -137.73 64.36 1.52 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.321 1.449 . . . . 1.25 112.124 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.516 HD13 ' HA ' ' A' ' 17' ' ' CYS . 91.4 mt -65.55 -16.97 64.21 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 112.523 0.564 . . . . 0.96999999999999997 112.523 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.05 59.42 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.227 0.467 . . . . 0.82999999999999996 110.82 168.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.9 m -118.63 16.45 13.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.231 1.412 . . . . 0.75 109.962 176.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 48.28 36.37 6.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.601 1.161 . . . . 2.3300000000000001 111.769 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.4 m -138.04 155.3 48.95 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.747 -1.205 . . . . 0.56000000000000005 107.747 -168.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 p -136.48 150.36 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 108.825 -0.805 . . . . 0.52000000000000002 108.825 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.98 153.01 44.94 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 123.852 0.72 . . . . 2.7200000000000002 110.224 175.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.78 136.8 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.998 -0.742 . . . . 0.37 108.998 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.8 114.14 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.065 -1.457 . . . . 1.01 107.065 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -137.67 167.24 22.09 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.515 0.726 . . . . 1.9299999999999999 111.118 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -102.73 113.91 65.61 Favored Pre-proline 0 N--CA 1.443 -0.805 0 C-N-CA 124.475 1.11 . . . . 1.3100000000000001 110.612 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.8 17.89 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.529 2.819 . . . . 0.56000000000000005 113.724 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.47 -51.76 7.08 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 107.646 -1.242 . . . . 0.52000000000000002 107.646 168.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -81.47 -46.23 14.85 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.257 1.023 . . . . 2.9500000000000002 110.265 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.9 m -142.37 129.61 21.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 118.295 2.702 . . . . 0.67000000000000004 118.295 -143.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.08 -160.55 20.88 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.024 -1.23 . . . . 0.55000000000000004 110.024 162.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 t -29.43 -48.73 0.08 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 129.544 3.137 . . . . 0.56000000000000005 112.9 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.2 -55.9 7.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.719 0.808 . . . . 0.31 112.39 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.53 -38.0 65.42 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 122.149 0.976 . . . . 0.26000000000000001 109.432 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.528 HG12 HD22 ' A' ' 28' ' ' LEU . 1.4 mt -63.55 -56.63 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 114.408 -1.269 . . . . 0.67000000000000004 110.017 -169.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.51 -53.49 14.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.81 1.186 . . . . 0.77000000000000002 110.41 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -41.81 -54.05 3.51 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.245 1.018 . . . . 2.4399999999999999 112.266 175.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -41.39 68.06 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 118.179 -0.915 . . . . 1.8400000000000001 110.791 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.805 HD11 HD11 ' A' ' 28' ' ' LEU . 41.4 mm -53.75 -46.54 62.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.871 1.214 . . . . 0.40000000000000002 110.216 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -51.83 -42.9 62.89 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.333 0.587 . . . . 1.54 109.946 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -37.19 73.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.594 0.758 . . . . 4.5499999999999998 112.174 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -56.05 -19.95 14.91 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.149 0.579 . . . . 0.89000000000000001 110.731 168.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.51 27.76 12.56 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 110.405 -1.078 . . . . 0.42999999999999999 110.405 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -136.07 169.55 17.42 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 108.256 -1.016 . . . . 2.0 108.256 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.5 123.85 43.02 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.036 -1.098 . . . . 4.5199999999999996 108.036 176.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 p -91.61 153.29 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.969 1.308 . . . . 0.55000000000000004 109.712 173.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.78 104.15 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 122.929 0.492 . . . . 1.26 110.222 178.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mt -107.31 91.2 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 124.02 0.928 . . . . 1.9099999999999999 108.566 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -149.48 115.62 5.74 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.204 -2.146 . . . . 6.8600000000000003 105.204 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.58 -88.53 0.1 OUTLIER Glycine 0 CA--C 1.528 0.875 0 CA-C-N 118.935 0.788 . . . . 3.52 113.005 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.191 -1.385 . . . . 9.9299999999999997 110.255 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.4 mtt . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 107.54 -1.281 . . . . 9.2100000000000009 107.54 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.3 pp -62.36 165.72 5.76 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.14 -0.319 . . . . 5.8099999999999996 110.14 165.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.5 t -124.84 159.62 30.64 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.079 -1.822 . . . . 3.6899999999999999 106.079 167.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -157.47 144.51 18.33 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.507 -1.294 . . . . 3.8599999999999999 107.507 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -84.26 166.02 17.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.569 0.747 . . . . 0.79000000000000004 111.05 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -153.46 159.44 42.32 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.356 0.598 . . . . 2.54 111.697 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -84.87 124.92 32.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.665 2.386 . . . . 2.1600000000000001 108.31 169.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 tp -104.06 147.92 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 106.878 -1.526 . . . . 1.2 106.878 161.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.47 129.35 37.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.651 -1.24 . . . . 0.34000000000000002 107.651 173.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -155.41 170.19 22.51 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.799 -0.445 . . . . 1.6599999999999999 109.799 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -97.1 148.69 22.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.272 1.029 . . . . 3.0899999999999999 108.879 -174.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.431 HG11 HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -122.03 160.57 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 C-N-CA 123.783 0.833 . . . . 0.60999999999999999 109.573 179.122 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -94.84 149.63 21.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.0 -0.741 . . . . 1.3799999999999999 109.0 165.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.17 82.19 0.26 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.701 -0.56 . . . . 2.71 111.701 173.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.8 ptp -144.57 178.26 8.09 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.906 1.282 . . . . 3.4100000000000001 108.876 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 m 57.92 35.34 25.26 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.346 0.593 . . . . 7.2400000000000002 110.391 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.28 59.47 1.7 Allowed 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 107.904 -1.147 . . . . 7.0 107.904 -174.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 63.31 82.24 0.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.056 1.342 . . . . 3.4700000000000002 111.593 -175.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 57.85 31.59 20.73 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.488 1.115 . . . . 1.3100000000000001 113.232 170.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -70.14 -61.26 1.85 Allowed 'General case' 0 C--O 1.226 -0.159 0 O-C-N 121.677 -0.639 . . . . 1.76 110.474 -173.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -58.26 -36.1 72.72 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 122.255 1.026 . . . . 0.87 110.913 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.4 -49.44 77.79 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.53 -0.759 . . . . 0.52000000000000002 110.615 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -61.8 -48.7 79.45 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.243 0.929 . . . . 3.71 111.415 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 21' ' ' ALA . 47.3 mt -42.34 -62.82 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 124.716 1.206 . . . . 1.1399999999999999 108.388 173.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.482 ' OE1' HG22 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -73.45 -32.71 64.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 119.458 -0.897 . . . . 2.5600000000000001 112.664 -174.18 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -57.16 -37.7 72.46 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.95 -1.094 . . . . 2.1000000000000001 110.434 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.69 -50.7 56.74 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 110.476 -1.05 . . . . 0.46999999999999997 110.476 169.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.555 HD22 HG12 ' A' ' 60' ' ' ILE . 88.7 mt -62.29 -31.57 72.18 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 121.896 -0.767 . . . . 0.47999999999999998 112.12 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -62.51 -15.59 51.24 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 119.155 0.889 . . . . 2.6200000000000001 110.722 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.27 -3.17 44.56 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.043 1.127 . . . . 4.5 114.043 169.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.442 ' O ' HG12 ' A' ' 34' ' ' VAL . 75.1 mmm -74.07 138.91 75.82 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 120.786 1.63 . . . . 2.1000000000000001 111.768 -177.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.64 90.39 0.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.31 2.673 . . . . 0.52000000000000002 110.971 -173.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.99 -9.04 4.19 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.122 1.344 . . . . 0.31 111.347 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 31' ' ' MET . 4.4 p -64.69 161.87 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.399 1.099 . . . . 0.33000000000000002 110.251 164.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.21 -53.61 2.13 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.738 1.215 . . . . 0.42999999999999999 110.373 166.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -148.25 163.77 36.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.467 -0.568 . . . . 3.0499999999999998 109.467 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.24 141.99 26.75 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.979 1.712 . . . . 0.72999999999999998 108.627 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -152.19 119.63 6.0 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.887 0.875 . . . . 1.4299999999999999 108.754 -165.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.541 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.2 p -84.98 145.72 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.318 1.047 . . . . 0.93000000000000005 112.376 -175.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -134.32 69.95 1.45 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.968 1.707 . . . . 1.3 112.345 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.4 mt -61.57 -22.26 65.04 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 112.295 0.48 . . . . 1.46 112.295 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.61 -16.44 25.79 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.406 0.548 . . . . 0.95999999999999996 111.174 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.9 m -132.66 18.24 4.28 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.918 0.887 . . . . 0.75 109.529 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 43.95 45.5 6.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.902 0.881 . . . . 2.4100000000000001 111.505 -175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.8 m -136.37 159.92 40.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.95 1.3 . . . . 0.47999999999999998 108.145 -170.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.541 HG23 ' HA ' ' A' ' 39' ' ' VAL . 12.0 p -139.61 149.65 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.378 -0.971 . . . . 0.60999999999999999 108.378 172.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -117.58 139.45 50.95 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.922 1.289 . . . . 2.5 109.301 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.29 132.85 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.274 0.63 . . . . 0.53000000000000003 109.841 174.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.72 125.12 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.295 1.438 . . . . 0.93000000000000005 107.542 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -146.24 169.72 18.2 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.314 0.646 . . . . 1.95 110.983 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -107.73 121.4 44.24 Favored Pre-proline 0 N--CA 1.447 -0.619 0 C-N-CA 124.726 1.21 . . . . 2.0899999999999999 110.982 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -71.94 10.85 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.349 3.366 . . . . 0.85999999999999999 113.684 -176.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.74 -50.32 12.63 Favored 'General case' 0 N--CA 1.458 -0.037 0 N-CA-C 107.409 -1.33 . . . . 0.84999999999999998 107.409 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -96.03 -40.16 9.39 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.019 1.728 . . . . 3.0 110.557 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.4 m -136.08 131.15 34.46 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 117.929 2.566 . . . . 0.56000000000000005 117.929 -153.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.99 -168.62 24.16 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.866 -1.293 . . . . 0.5 109.866 160.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.1 t -38.69 -40.35 0.59 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.947 2.499 . . . . 0.65000000000000002 112.243 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.17 -56.43 6.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.569 0.748 . . . . 0.28000000000000003 112.593 173.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.25 -34.48 68.3 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 122.562 1.172 . . . . 0.22 109.323 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.555 HG12 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -69.26 -52.51 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 113.943 -1.481 . . . . 0.56000000000000005 111.161 -169.605 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.49 -50.69 59.39 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.322 1.419 . . . . 0.79000000000000004 109.641 173.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.47 -53.88 16.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.32 1.048 . . . . 4.9199999999999999 111.193 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -67.22 -41.93 84.9 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 121.703 -0.623 . . . . 2.2000000000000002 111.531 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.499 HD11 HD11 ' A' ' 28' ' ' LEU . 4.0 mm -55.19 -45.27 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.054 0.942 . . . . 0.37 110.191 -176.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -48.96 -47.01 44.31 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.305 0.574 . . . . 1.5800000000000001 110.596 171.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -32.71 69.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.378 0.881 . . . . 2.9900000000000002 113.378 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.63 -25.54 18.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.321 0.509 . . . . 0.93999999999999995 110.118 166.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.13 29.67 5.67 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.256 -1.138 . . . . 0.46000000000000002 110.256 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.431 ' CD2' HD11 ' A' ' 24' ' ' ILE . 26.8 m-85 -146.23 159.55 43.18 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 106.84 -1.541 . . . . 1.9299999999999999 106.84 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.79 135.37 54.03 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.776 0.798 . . . . 3.9399999999999999 109.324 171.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.9 p -99.34 152.54 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.478 1.511 . . . . 0.55000000000000004 109.751 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m -115.42 153.62 16.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 N-CA-C 109.4 -0.593 . . . . 0.88 109.4 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.3 mm -109.04 93.5 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 106.425 -1.694 . . . . 1.4099999999999999 106.425 173.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -133.96 138.29 45.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.899 -2.26 . . . . 4.2199999999999998 104.899 168.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.78 52.84 3.73 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 123.819 0.699 . . . . 5.04 113.041 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 . . . . . 0 C--O 1.251 1.136 0 C-N-CA 126.316 1.847 . . . . 8.4399999999999995 110.556 176.365 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.4 mtt . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 109.388 -0.597 . . . . 8.7200000000000006 109.388 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.51 170.18 3.01 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 105.979 -1.86 . . . . 6.1600000000000001 105.979 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.5 m -100.92 148.83 24.54 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.692 -1.225 . . . . 2.5499999999999998 107.692 171.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -153.57 139.67 18.34 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.163 -1.421 . . . . 3.2799999999999998 107.163 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -101.17 164.52 11.75 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.525 0.73 . . . . 0.68000000000000005 111.076 -170.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -146.84 151.53 37.25 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 122.689 1.233 . . . . 3.3399999999999999 112.724 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -84.83 106.08 16.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 131.21 3.804 . . . . 2.4300000000000002 107.858 171.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.09 148.3 4.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 N-CA-C 107.199 -1.408 . . . . 1.21 107.199 165.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.54 126.28 29.01 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 124.775 1.23 . . . . 0.35999999999999999 107.73 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -156.52 165.48 36.17 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.525 -0.546 . . . . 1.0600000000000001 109.525 -170.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.72 155.2 16.87 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 108.827 -0.805 . . . . 2.02 108.827 -174.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.11 163.06 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 108.218 -1.03 . . . . 0.59999999999999998 108.218 175.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.23 135.82 48.54 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.085 -1.45 . . . . 1.0900000000000001 107.085 176.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.33 -12.6 30.97 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.346 0.974 . . . . 1.3400000000000001 113.62 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.4 153.15 16.26 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.051 1.425 . . . . 3.3999999999999999 111.682 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 p -138.17 33.64 2.34 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.255 1.022 . . . . 3.3999999999999999 110.097 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.0 t 53.74 -146.1 0.56 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 117.447 -1.263 . . . . 4.21 111.655 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 37.41 51.72 1.19 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.578 1.551 . . . . 2.5 114.218 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 65.06 14.21 9.21 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.208 1.403 . . . . 1.25 114.262 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.0 m -72.16 -60.79 2.05 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.383 -0.823 . . . . 1.6899999999999999 109.019 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.79 -42.21 62.27 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 122.139 0.971 . . . . 0.93000000000000005 111.448 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.74 -43.02 47.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.064 0.946 . . . . 0.40999999999999998 111.633 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -58.79 -41.49 86.82 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.592 0.633 . . . . 5.6299999999999999 111.145 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.2 mt -54.51 -59.74 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.592 -1.262 . . . . 0.80000000000000004 107.592 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.37 -36.14 73.97 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.431 -0.804 . . . . 2.54 110.501 -171.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -56.12 -36.47 68.25 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.199 -0.938 . . . . 1.77 110.961 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.2 -48.04 48.12 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.007 -0.837 . . . . 0.47999999999999998 111.007 166.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.712 HD11 HD11 ' A' ' 64' ' ' ILE . 44.2 mt -68.01 -30.55 69.83 Favored 'General case' 0 C--O 1.224 -0.241 0 O-C-N 121.351 -1.088 . . . . 0.51000000000000001 111.842 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.531 ' HA ' HG11 ' A' ' 34' ' ' VAL . 9.2 ttmt -60.33 -19.1 54.03 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.712 1.142 . . . . 1.21 111.468 172.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -25.21 62.02 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.95 -1.094 . . . . 4.04 113.349 168.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.502 ' O ' HG12 ' A' ' 34' ' ' VAL . 92.1 mmm -72.6 134.02 82.23 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 119.784 1.174 . . . . 2.0099999999999998 112.448 -167.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.03 101.44 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.902 3.068 . . . . 0.38 110.653 -172.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.22 -15.35 3.97 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.667 -0.973 . . . . 0.23000000000000001 110.667 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.3 p -72.48 154.71 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 O-C-N 122.081 -0.658 . . . . 0.29999999999999999 111.158 171.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.65 -53.78 2.08 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.784 1.234 . . . . 0.46999999999999997 109.801 171.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -142.44 153.46 43.73 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 113.606 0.965 . . . . 2.9300000000000002 113.606 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.65 125.4 38.02 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.596 1.958 . . . . 0.80000000000000004 107.971 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.13 109.39 6.88 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.043 1.337 . . . . 1.4199999999999999 108.857 -168.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.3 145.26 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.928 0.891 . . . . 0.60999999999999999 112.372 -172.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -135.6 67.73 1.47 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.121 1.768 . . . . 1.3200000000000001 111.622 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.5 mt -68.0 -14.6 63.09 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 113.159 0.8 . . . . 0.65000000000000002 113.159 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.15 -14.1 3.7 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.822 0.449 . . . . 0.60999999999999999 111.355 166.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 m -137.27 19.34 2.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.477 1.111 . . . . 0.55000000000000004 109.422 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 47.44 36.98 5.57 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.262 1.025 . . . . 2.71 111.232 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.9 m -132.22 156.27 46.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.781 -1.192 . . . . 0.46000000000000002 107.781 -168.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.81 148.2 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 108.828 -0.804 . . . . 0.41999999999999998 108.828 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -116.55 138.2 51.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.796 -1.187 . . . . 2.48 107.796 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.87 131.09 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.275 -1.009 . . . . 0.28000000000000003 108.275 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.91 115.76 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.803 -1.554 . . . . 1.28 106.803 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -141.49 170.59 15.43 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.177 0.991 . . . . 2.1499999999999999 110.323 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -104.56 111.47 65.21 Favored Pre-proline 0 N--CA 1.443 -0.814 0 C-N-CA 124.36 1.064 . . . . 1.3700000000000001 110.012 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.06 11.65 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.738 2.959 . . . . 0.68000000000000005 113.852 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.55 -48.0 12.37 Favored 'General case' 0 C--N 1.337 0.051 0 N-CA-C 107.416 -1.327 . . . . 0.60999999999999999 107.416 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -84.28 -47.35 10.87 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.999 1.32 . . . . 2.48 109.471 171.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.6 m -144.22 127.22 16.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 118.509 2.781 . . . . 0.69999999999999996 118.509 -146.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.44 -152.78 7.64 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.687 -0.965 . . . . 0.53000000000000003 110.687 158.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -28.76 -48.78 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 129.08 2.952 . . . . 1.1200000000000001 113.804 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.23 -55.37 18.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.705 0.684 . . . . 0.46000000000000002 112.527 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -40.24 63.78 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 122.425 1.107 . . . . 0.28000000000000003 108.418 -176.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.644 HG13 HD22 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -67.57 -49.98 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-N 114.131 -1.395 . . . . 1.2 111.312 -169.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.08 -51.1 56.62 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.592 1.542 . . . . 0.85999999999999999 110.279 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -45.38 -53.55 8.47 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.057 0.943 . . . . 2.3799999999999999 111.94 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -43.47 71.13 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 118.2 -0.905 . . . . 1.97 111.222 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.712 HD11 HD11 ' A' ' 28' ' ' LEU . 10.7 mm -50.88 -47.35 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.53 1.059 . . . . 0.58999999999999997 109.156 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -51.86 -48.02 64.2 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.978 0.418 . . . . 1.48 110.43 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -69.1 -34.56 75.29 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.437 -0.789 . . . . 3.3199999999999998 112.575 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.95 -21.96 13.46 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 122.97 0.508 . . . . 0.88 110.605 168.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.78 29.93 8.34 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.169 -1.172 . . . . 0.35999999999999999 110.169 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -137.67 170.88 15.3 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.372 -1.344 . . . . 2.0899999999999999 107.372 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.83 127.68 45.36 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.882 0.873 . . . . 4.0899999999999999 108.964 172.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.43 149.38 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 125.911 1.684 . . . . 0.52000000000000002 109.541 172.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.2 m -118.44 134.18 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 C-N-CA 123.797 0.839 . . . . 0.93000000000000005 109.828 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.1 mm -107.17 91.39 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.207 -1.405 . . . . 1.0800000000000001 107.207 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -140.12 149.24 42.8 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.845 -2.28 . . . . 4.6200000000000001 104.845 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 143.68 -65.31 0.47 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.815 -1.314 . . . . 4.0099999999999998 109.815 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 . . . . . 0 C--O 1.25 1.089 0 C-N-CA 126.784 2.034 . . . . 9.0999999999999996 105.565 176.06 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 106.722 -1.585 . . . . 10.890000000000001 106.722 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mp -149.2 171.21 16.84 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 105.658 -1.978 . . . . 5.4800000000000004 105.658 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 p -151.13 153.06 34.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.102 -1.814 . . . . 3.0699999999999998 106.102 172.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -162.96 138.88 7.05 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.76 -1.571 . . . . 3.6400000000000001 106.76 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -106.8 172.69 6.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.465 0.706 . . . . 0.66000000000000003 111.101 -172.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -147.53 162.55 38.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.186 0.517 . . . . 2.4199999999999999 110.752 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -83.07 143.44 30.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 113.596 -1.638 . . . . 2.5899999999999999 107.359 163.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -125.33 148.2 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 105.609 -1.997 . . . . 1.24 105.609 161.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.89 124.34 20.73 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.772 1.229 . . . . 0.40000000000000002 108.543 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -156.33 161.63 40.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.425 0.29 . . . . 1.25 111.62 -170.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.11 146.71 24.43 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.56 1.144 . . . . 1.74 109.934 -169.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.75 141.35 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.094 0.558 . . . . 0.77000000000000002 110.273 -176.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -84.4 117.82 23.86 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.372 -1.344 . . . . 1.05 107.372 170.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.79 77.16 1.25 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.029 -0.828 . . . . 2.6600000000000001 111.029 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.7 ptm -135.42 -171.96 2.96 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.59 1.556 . . . . 4.0800000000000001 107.744 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.0 t 49.12 29.55 2.57 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.955 1.302 . . . . 7.0 114.388 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.1 t -125.65 48.25 2.09 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.28 0.562 . . . . 7.04 110.036 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 84.14 79.52 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.534 2.334 . . . . 3.29 111.794 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 57.34 29.28 16.6 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.956 1.302 . . . . 1.2 112.853 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.5 m -71.27 -62.13 1.51 Allowed 'General case' 0 C--O 1.222 -0.361 0 O-C-N 122.064 -0.398 . . . . 1.5 110.017 -170.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.2 -39.92 67.11 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.089 0.404 . . . . 0.95999999999999996 111.063 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.69 -58.73 6.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 122.929 0.492 . . . . 0.44 110.924 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -58.28 -49.55 76.74 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.339 0.655 . . . . 4.1299999999999999 111.609 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.6 mt -47.38 -59.24 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.094 1.358 . . . . 0.68000000000000005 109.056 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.401 ' OE2' HD12 ' A' ' 28' ' ' LEU . 1.1 tm-20 -68.0 -44.31 76.88 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 119.868 -0.733 . . . . 3.71 109.038 -175.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -50.64 -36.66 36.55 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.701 -1.249 . . . . 1.4299999999999999 112.289 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.22 -48.07 82.89 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 112.011 -0.435 . . . . 0.39000000000000001 112.011 168.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.785 HD11 HD11 ' A' ' 64' ' ' ILE . 39.0 mt -64.38 -30.04 71.09 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 120.846 -1.385 . . . . 0.64000000000000001 112.154 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.554 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.27 16.6 ttmt -59.27 -18.6 38.85 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.821 1.191 . . . . 1.1899999999999999 111.666 171.099 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -17.89 59.95 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.9 -1.125 . . . . 3.3999999999999999 114.022 168.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.493 ' O ' HG12 ' A' ' 34' ' ' VAL . 92.9 mmm -74.65 135.07 75.17 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 120.419 1.463 . . . . 2.04 112.901 -172.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.73 95.21 0.63 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.934 3.089 . . . . 0.46000000000000002 111.737 -171.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.53 -18.95 2.24 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.55 -1.02 . . . . 0.20000000000000001 110.55 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 29' ' ' LYS . 4.2 p -66.88 155.25 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 O-C-N 121.939 -0.741 . . . . 0.28999999999999998 110.817 168.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.7 -59.99 1.76 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.065 0.946 . . . . 0.47999999999999998 109.776 168.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -146.25 142.1 28.02 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 114.309 1.226 . . . . 2.2799999999999998 114.309 -171.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.53 139.44 48.97 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.233 1.813 . . . . 0.79000000000000004 109.888 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -143.77 113.48 7.1 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.864 -0.791 . . . . 1.3100000000000001 108.864 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -81.57 142.25 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.295 0.638 . . . . 0.88 110.414 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -129.79 68.8 1.43 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.582 1.553 . . . . 1.3600000000000001 111.333 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.5 mt -62.09 -21.42 64.96 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 121.896 -0.503 . . . . 1.22 112.353 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.17 -20.21 16.84 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.806 0.442 . . . . 0.94999999999999996 111.179 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 m -130.71 18.5 5.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.316 1.046 . . . . 0.71999999999999997 110.041 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 35.23 55.85 0.81 Allowed 'General case' 0 C--N 1.345 0.382 0 C-N-CA 124.404 1.082 . . . . 3.8399999999999999 111.659 -170.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.5 m -143.89 154.36 43.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.423 -1.695 . . . . 0.5 106.423 -175.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.56 146.97 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.167 -0.679 . . . . 0.52000000000000002 109.167 171.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -115.96 143.87 44.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.999 1.32 . . . . 2.48 108.525 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.39 141.1 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 109.699 -0.482 . . . . 0.39000000000000001 109.699 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.4 mt -100.64 122.26 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.53 1.932 . . . . 0.68999999999999995 106.99 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -146.7 167.52 23.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.681 0.792 . . . . 1.76 110.337 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -100.54 113.02 65.44 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 114.786 -1.097 . . . . 2.1200000000000001 110.432 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -69.26 10.24 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.246 3.297 . . . . 0.66000000000000003 114.107 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.43 -50.76 8.52 Favored 'General case' 0 N--CA 1.458 -0.073 0 N-CA-C 107.436 -1.32 . . . . 0.63 107.436 173.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -92.19 -35.08 14.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.635 1.574 . . . . 3.3199999999999998 111.076 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.9 m -146.4 130.25 17.17 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 117.742 2.497 . . . . 0.54000000000000004 117.742 -157.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.94 -156.66 10.75 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.983 -1.247 . . . . 0.57999999999999996 109.983 155.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -29.21 -51.4 0.1 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.867 2.867 . . . . 0.64000000000000001 112.744 175.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.9 -55.69 9.29 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.074 0.768 . . . . 0.26000000000000001 113.074 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -38.58 64.83 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 122.047 0.927 . . . . 0.20999999999999999 108.726 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.454 HG12 HD22 ' A' ' 28' ' ' LEU . 2.5 mt -65.25 -54.0 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 114.37 -1.286 . . . . 0.68999999999999995 110.894 -169.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.53 -51.86 25.4 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.101 1.319 . . . . 0.73999999999999999 110.158 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -48.53 -47.78 38.87 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.916 1.286 . . . . 4.7300000000000004 112.195 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.66 -42.85 63.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 118.774 -0.631 . . . . 2.6699999999999999 112.479 174.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.785 HD11 HD11 ' A' ' 28' ' ' LEU . 11.1 mm -52.24 -45.13 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 119.544 1.065 . . . . 0.45000000000000001 109.974 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -49.06 -44.38 41.78 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.31 0.576 . . . . 1.5800000000000001 110.71 173.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -38.61 75.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.79 0.836 . . . . 3.6899999999999999 111.799 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.42 -25.71 26.4 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 119.431 -0.318 . . . . 0.96999999999999997 110.636 170.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.1 25.87 5.69 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 124.469 1.033 . . . . 0.40000000000000002 111.264 169.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -145.58 164.81 30.52 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 106.748 -1.575 . . . . 2.1600000000000001 106.748 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 129.12 54.99 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 103.747 -2.686 . . . . 3.1899999999999999 103.747 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.62 139.14 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.106 -0.701 . . . . 0.53000000000000003 109.106 171.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -93.92 164.06 2.15 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 109.212 -0.662 . . . . 1.3700000000000001 109.212 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.6 mm -128.24 77.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.025 -1.102 . . . . 1.1599999999999999 108.025 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -129.44 146.82 51.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.86 1.264 . . . . 4.9900000000000002 108.156 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.46 -69.63 0.07 OUTLIER Glycine 0 CA--C 1.527 0.813 0 N-CA-C 107.447 -2.261 . . . . 4.6900000000000004 107.447 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 116.821 -1.561 . . . . 10.81 110.776 178.552 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.4 mtt . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 118.113 -0.946 . . . . 11.970000000000001 113.492 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 tt -164.56 -49.03 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.978 1.263 . . . . 6.1600000000000001 109.972 -164.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.9 p -140.32 127.48 21.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.333 -1.729 . . . . 2.7599999999999998 106.333 170.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -153.11 141.56 20.73 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.278 -1.008 . . . . 4.2800000000000002 108.278 -175.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -87.97 171.69 10.13 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.252 1.021 . . . . 0.68000000000000005 111.677 -170.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.97 162.5 39.2 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.411 1.1 . . . . 2.6899999999999999 111.685 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -84.24 143.96 29.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 130.252 3.421 . . . . 2.8199999999999998 106.727 170.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 tp -130.1 151.66 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.309 -1.737 . . . . 1.1399999999999999 106.309 162.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.78 129.12 24.03 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.461 1.104 . . . . 0.38 108.981 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.69 173.58 16.75 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 119.384 -0.341 . . . . 1.1299999999999999 111.87 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.64 155.91 18.5 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 109.077 -0.712 . . . . 2.1200000000000001 109.077 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.01 157.35 16.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 N-CA-C 108.124 -1.065 . . . . 0.65000000000000002 108.124 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t -129.07 126.08 38.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.31 -0.996 . . . . 0.92000000000000004 108.31 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.1 -18.05 12.48 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.088 1.328 . . . . 1.4299999999999999 113.205 174.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.82 146.63 10.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.161 0.984 . . . . 3.29 112.384 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.7 p -125.03 29.78 6.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.747 1.219 . . . . 3.5800000000000001 110.769 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.6 t 49.89 -137.63 1.04 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.477 -1.249 . . . . 4.0199999999999996 111.535 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 37.31 55.13 1.36 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.658 1.572 . . . . 2.48 113.051 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.38 20.35 4.65 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.2 1.4 . . . . 1.3400000000000001 114.062 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.6 m -73.67 -60.21 2.36 Favored 'General case' 0 CA--C 1.521 -0.166 0 O-C-N 121.292 -0.88 . . . . 1.6699999999999999 109.81 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.33 -30.89 67.06 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 121.344 0.592 . . . . 0.85999999999999999 111.856 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.28 -42.87 64.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 122.014 -0.429 . . . . 0.44 111.023 170.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.7 mtp-105 -63.14 -45.66 90.91 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.583 0.629 . . . . 5.0700000000000003 110.58 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -49.64 -59.63 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 108.192 -1.04 . . . . 0.65000000000000002 108.192 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.94 -35.53 72.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.72 -0.673 . . . . 2.6099999999999999 110.665 -171.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -56.2 -36.1 68.03 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 120.894 -1.129 . . . . 1.24 111.155 171.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.52 -47.34 57.43 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.658 -0.977 . . . . 0.33000000000000002 110.658 167.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.684 HD11 HD11 ' A' ' 64' ' ' ILE . 94.8 mt -67.68 -28.73 67.94 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.384 -1.068 . . . . 0.33000000000000002 112.747 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.558 ' HA ' HG11 ' A' ' 34' ' ' VAL . 2.3 ttmt -58.49 -17.71 23.22 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.403 1.002 . . . . 1.5700000000000001 111.398 169.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -91.42 6.27 46.12 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.97 1.1 . . . . 3.2400000000000002 113.97 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.496 ' O ' HG12 ' A' ' 34' ' ' VAL . 34.4 mmt -85.57 135.28 38.56 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 120.499 1.5 . . . . 2.4500000000000002 112.45 171.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.03 84.11 1.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.666 2.911 . . . . 0.78000000000000003 112.301 -168.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.01 -16.43 0.91 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.486 1.041 . . . . 0.31 111.832 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.558 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.8 p -59.22 154.23 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.647 -0.914 . . . . 0.28999999999999998 111.501 168.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.69 -61.32 1.76 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.787 1.235 . . . . 0.53000000000000003 108.926 169.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -149.77 149.53 30.68 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 114.329 1.233 . . . . 2.5600000000000001 114.329 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.65 119.91 25.57 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.025 1.73 . . . . 0.96999999999999997 109.334 -170.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -134.28 111.72 10.46 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.151 0.98 . . . . 1.3899999999999999 108.431 -172.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -84.28 139.02 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 123.072 0.549 . . . . 0.81999999999999995 110.824 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -125.74 64.6 1.19 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.839 2.056 . . . . 1.25 110.636 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.8 mt -65.9 -16.96 64.32 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 112.67 0.618 . . . . 0.77000000000000002 112.67 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.1 -22.77 11.78 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.69 0.396 . . . . 0.63 110.712 168.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.4 m -127.14 17.78 7.15 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.268 1.427 . . . . 0.48999999999999999 110.163 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 47.66 35.8 4.88 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.138 0.975 . . . . 2.4199999999999999 112.374 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.7 m -131.79 153.29 50.26 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.434 -1.321 . . . . 0.55000000000000004 107.434 -169.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.95 146.48 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.013 -0.736 . . . . 0.48999999999999999 109.013 173.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -115.91 137.44 52.1 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.687 -1.227 . . . . 2.4900000000000002 107.687 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.95 140.69 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 108.683 -0.858 . . . . 0.29999999999999999 108.683 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.6 mt -105.2 132.07 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.814 1.645 . . . . 0.90000000000000002 106.836 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -152.59 163.93 38.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.62 0.768 . . . . 1.8300000000000001 110.774 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -92.82 110.57 46.43 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 124.158 0.983 . . . . 1.45 109.517 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.6 15.56 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.638 2.892 . . . . 0.62 113.501 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.8 -52.72 5.84 Favored 'General case' 0 CA--C 1.526 0.049 0 N-CA-C 107.57 -1.27 . . . . 0.59999999999999998 107.57 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -88.96 -45.75 9.43 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.538 1.535 . . . . 2.9700000000000002 110.406 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.6 m -131.59 129.24 40.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 116.886 2.18 . . . . 0.59999999999999998 116.886 -158.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.83 -162.6 16.2 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 110.181 -1.168 . . . . 0.47999999999999998 110.181 159.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.9 t -35.93 -41.67 0.24 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.523 2.729 . . . . 0.63 112.732 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.19 -56.22 9.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.305 0.642 . . . . 0.28000000000000003 112.46 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.22 -39.03 65.83 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 122.201 1.001 . . . . 0.23999999999999999 108.99 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.536 HG12 HD22 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -61.45 -56.66 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.275 -1.33 . . . . 0.72999999999999998 109.872 -171.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.84 -54.21 8.46 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.557 1.071 . . . . 0.83999999999999997 110.428 174.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 1.4 tm-20 -44.59 -52.1 8.4 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.628 0.728 . . . . 2.1899999999999999 111.547 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -45.06 64.18 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 117.958 -1.02 . . . . 1.9299999999999999 110.735 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.684 HD11 HD11 ' A' ' 28' ' ' LEU . 23.3 mm -51.29 -46.89 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 120.024 1.284 . . . . 0.48999999999999999 110.173 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -52.0 -47.06 65.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.492 0.717 . . . . 1.8 109.753 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.401 ' NZ ' ' OE2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -68.99 -37.61 78.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.275 0.63 . . . . 4.6399999999999997 111.522 -176.387 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -55.97 -22.38 26.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.068 0.947 . . . . 0.92000000000000004 110.665 170.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.41 29.79 6.52 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 124.289 0.947 . . . . 0.33000000000000002 110.868 173.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -141.4 174.22 10.75 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 108.619 -0.882 . . . . 1.7 108.619 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.13 117.54 18.43 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.815 -1.179 . . . . 4.29 107.815 -175.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 p -84.2 145.29 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.247 -0.888 . . . . 0.62 108.731 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.78 112.37 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 124.649 1.18 . . . . 1.47 110.237 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.8 mt -120.34 96.4 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 126.481 1.913 . . . . 1.73 106.698 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -112.92 117.0 30.88 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.467 -1.308 . . . . 5.1299999999999999 107.467 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.72 -145.29 16.81 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.22 0.914 . . . . 5.3300000000000001 110.949 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.168 0 CA-C-O 116.072 -1.918 . . . . 8.75 106.188 172.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mtt . . . . . 0 N--CA 1.474 0.775 0 CA-C-O 118.655 -0.688 . . . . 9.0 109.659 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 tp -108.58 -79.55 0.58 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.461 -0.94 . . . . 6.4699999999999998 108.461 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 p -166.19 153.04 9.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 105.427 -2.064 . . . . 3.2000000000000002 105.427 171.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -170.2 139.0 1.7 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.195 -2.15 . . . . 3.98 105.195 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -117.95 160.88 20.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.33 0.652 . . . . 0.71999999999999997 109.897 -171.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -146.24 157.66 43.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.573 0.701 . . . . 2.6899999999999999 111.367 -173.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -83.89 144.82 28.96 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 125.469 1.508 . . . . 2.4900000000000002 108.318 167.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 tp -122.13 153.31 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.056 -1.831 . . . . 1.1000000000000001 106.056 160.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.0 126.17 19.89 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.998 1.319 . . . . 0.34000000000000002 107.85 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.26 165.9 35.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.453 0.701 . . . . 2.3199999999999998 112.16 -174.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.66 147.58 23.75 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.608 1.163 . . . . 1.7 109.044 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -115.63 164.11 12.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 123.438 0.695 . . . . 0.64000000000000001 109.776 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -128.27 130.83 48.48 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.538 0.735 . . . . 0.76000000000000001 109.36 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.24 -16.57 24.74 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.538 1.066 . . . . 1.49 113.164 173.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.55 150.89 14.54 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.097 0.948 . . . . 2.9900000000000002 111.724 176.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.8 p -130.0 33.63 4.36 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.761 0.791 . . . . 3.48 110.556 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.5 t 58.47 -130.57 1.29 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 117.776 -1.107 . . . . 4.1500000000000004 110.05 -172.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 29.21 59.16 0.15 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.286 1.834 . . . . 2.4500000000000002 114.441 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.58 24.09 2.93 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.32 1.448 . . . . 1.26 114.19 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.9 m -73.51 -61.81 1.7 Allowed 'General case' 0 CA--C 1.521 -0.137 0 O-C-N 121.311 -0.868 . . . . 1.46 110.009 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.05 -28.16 69.9 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 121.586 0.708 . . . . 0.82999999999999996 111.608 -175.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.03 -44.08 41.18 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.09 -0.504 . . . . 0.34000000000000002 111.046 169.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 mtm105 -65.06 -41.45 95.09 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 118.258 0.481 . . . . 6.8300000000000001 111.175 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.0 mt -51.72 -59.13 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.127 -1.064 . . . . 0.56000000000000005 108.127 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.94 -36.77 72.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 120.046 -0.662 . . . . 2.2799999999999998 111.147 -171.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -50.99 -40.33 57.78 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.318 -0.864 . . . . 1.6299999999999999 110.558 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.79 -48.09 57.55 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.127 -0.789 . . . . 0.38 111.127 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 64' ' ' ILE . 96.9 mt -67.93 -32.4 72.83 Favored 'General case' 0 CA--C 1.519 -0.25 0 O-C-N 121.244 -1.15 . . . . 0.34999999999999998 112.693 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.511 ' HA ' HG11 ' A' ' 34' ' ' VAL . 11.5 ttpt -59.54 -17.1 29.45 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.949 0.795 . . . . 1.6599999999999999 110.63 171.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 mtt-85 -91.86 -0.05 57.5 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.747 -1.221 . . . . 3.2200000000000002 113.622 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.511 ' O ' HG12 ' A' ' 34' ' ' VAL . 5.9 mmt -78.67 142.68 61.79 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 120.804 1.638 . . . . 1.97 111.959 174.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.92 102.92 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.942 2.428 . . . . 0.41999999999999998 110.381 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.11 -4.34 6.37 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.326 1.441 . . . . 0.23999999999999999 110.941 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.511 HG11 ' HA ' ' A' ' 29' ' ' LYS . 6.6 p -70.88 157.21 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.848 -0.795 . . . . 0.28999999999999998 110.658 164.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.91 -63.91 1.38 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 107.623 -1.251 . . . . 0.41999999999999998 107.623 165.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -141.85 157.35 45.1 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 112.004 0.372 . . . . 2.8399999999999999 112.004 -170.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.46 137.07 40.02 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.26 1.824 . . . . 0.58999999999999997 107.414 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -139.55 114.89 9.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.902 1.281 . . . . 1.4199999999999999 108.63 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -83.93 138.2 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.96 0.904 . . . . 0.65000000000000002 110.339 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -132.88 63.71 1.63 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.607 1.563 . . . . 1.1699999999999999 111.376 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.1 mt -67.42 -15.56 63.74 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 113.062 0.764 . . . . 0.90000000000000002 113.062 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.66 -25.63 18.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 117.947 0.34 . . . . 0.70999999999999996 110.529 166.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.5 m -122.65 17.33 10.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.303 1.441 . . . . 0.55000000000000004 110.216 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 47.2 38.32 6.74 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.361 0.982 . . . . 2.7400000000000002 111.836 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.1 m -137.34 154.43 50.05 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.432 -1.322 . . . . 0.5 107.432 -171.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.52 152.58 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.238 -1.023 . . . . 0.44 108.238 170.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.44 150.63 48.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 123.58 0.55 . . . . 2.7400000000000002 109.701 174.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.19 138.07 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.398 -0.964 . . . . 0.25 108.398 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.43 119.99 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 126.05 1.74 . . . . 1.22 108.166 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -145.84 172.79 12.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.635 1.174 . . . . 1.8999999999999999 110.631 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -111.87 118.94 45.59 Favored Pre-proline 0 N--CA 1.447 -0.609 0 C-N-CA 124.186 0.994 . . . . 1.3999999999999999 110.815 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.27 9.73 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.91 3.74 . . . . 0.58999999999999997 114.248 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.21 -40.48 37.36 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 108.437 -0.949 . . . . 0.71999999999999997 108.437 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -112.09 -49.54 2.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.716 1.606 . . . . 3.04 110.25 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.6 m -111.04 128.33 55.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.593 2.757 . . . . 0.91000000000000003 117.145 -168.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.21 -175.48 25.48 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.952 -0.859 . . . . 0.56000000000000005 110.952 156.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -29.17 -45.2 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 128.302 2.641 . . . . 0.85999999999999999 112.958 167.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.23 -55.11 13.64 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.756 0.65 . . . . 0.34000000000000002 112.756 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.23 -40.06 65.0 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 122.256 1.026 . . . . 0.20999999999999999 108.91 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.57 HG12 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -62.27 -57.12 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-N 113.918 -1.492 . . . . 0.57999999999999996 110.241 -171.221 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.45 -51.09 28.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.621 1.1 . . . . 0.78000000000000003 110.595 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -48.51 -50.19 32.9 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.737 0.815 . . . . 2.5099999999999998 111.287 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -46.15 64.96 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 118.638 -0.696 . . . . 2.1699999999999999 110.888 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 28' ' ' LEU . 18.7 mm -49.79 -47.61 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 119.069 0.85 . . . . 0.44 109.875 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -48.3 -50.4 30.2 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.449 0.642 . . . . 1.48 110.03 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.03 -33.22 70.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 121.671 -0.643 . . . . 3.4100000000000001 112.278 -176.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.83 -25.22 10.83 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 119.337 -0.364 . . . . 0.87 110.285 168.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.84 30.58 4.5 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.527 1.06 . . . . 0.29999999999999999 110.675 170.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -148.4 165.75 30.17 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 105.61 -1.996 . . . . 1.6899999999999999 105.61 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -120.63 140.38 51.64 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 119.1 0.864 . . . . 3.2999999999999998 109.113 166.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.6 p -94.94 141.37 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.803 1.641 . . . . 0.46000000000000002 108.581 172.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 m -97.34 165.64 2.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 108.891 -0.781 . . . . 1.5 108.891 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.7 mm -128.42 77.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.353 -0.98 . . . . 1.1299999999999999 108.353 175.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -111.06 129.63 55.85 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 105.401 -2.074 . . . . 4.2999999999999998 105.401 156.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.14 -125.85 1.15 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 108.994 -1.642 . . . . 3.4900000000000002 108.994 -171.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 . . . . . 0 C--O 1.249 1.042 0 N-CA-C 105.036 -2.209 . . . . 10.19 105.036 175.606 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 117.995 -1.002 . . . . 11.869999999999999 108.497 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 mt 168.37 163.84 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 129.24 3.016 . . . . 6.2000000000000002 105.175 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.5 m 63.65 92.2 0.07 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.673 1.189 . . . . 3.0099999999999998 111.363 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -142.5 150.83 41.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.707 -1.22 . . . . 2.9199999999999999 107.707 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -95.61 175.23 6.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.536 1.134 . . . . 1.23 111.068 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -150.47 164.29 36.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.386 0.612 . . . . 3.0299999999999998 111.095 172.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -83.47 144.94 29.22 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.94 -1.482 . . . . 2.4300000000000002 108.019 163.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -124.05 148.85 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 105.145 -2.169 . . . . 1.24 105.145 162.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.53 120.45 15.46 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 125.302 1.441 . . . . 0.46000000000000002 108.097 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.1 ptt? -156.7 165.14 37.08 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.202 0.455 . . . . 1.02 111.117 -169.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.84 151.96 19.16 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.859 0.864 . . . . 1.76 109.239 -171.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.36 164.59 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 123.519 0.728 . . . . 0.68999999999999995 109.582 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -124.88 124.02 41.17 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.866 1.266 . . . . 0.78000000000000003 109.05 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.66 -16.53 14.02 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.724 1.154 . . . . 1.4299999999999999 113.466 170.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.439 ' HG3' HD22 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -55.14 143.15 28.28 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.145 0.973 . . . . 3.0899999999999999 111.916 177.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.0 p -114.0 21.88 14.43 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.804 0.842 . . . . 3.4199999999999999 111.324 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.542 ' HA ' HD13 ' A' ' 41' ' ' LEU . 37.3 t 71.2 -49.13 0.68 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.561 1.545 . . . . 4.1799999999999997 112.794 -175.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.83 81.32 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.979 1.712 . . . . 2.8300000000000001 112.42 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.67 11.43 3.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.995 2.118 . . . . 1.1100000000000001 113.89 171.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.65 -64.11 0.99 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.542 -0.724 . . . . 1.51 110.832 -164.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.681 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -61.3 -28.8 69.46 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.019 -0.537 . . . . 1.05 110.35 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.14 -54.36 47.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 119.117 -0.468 . . . . 0.44 111.18 173.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -63.42 -46.24 87.27 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.22 0.918 . . . . 3.6099999999999999 110.455 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' A' ' 21' ' ' ALA . 54.8 mt -48.47 -58.53 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.172 -0.677 . . . . 0.83999999999999997 109.172 177.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.408 ' HG3' HG21 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -70.6 -37.37 73.87 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.206 -0.452 . . . . 3.8100000000000001 110.579 -172.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -55.7 -33.92 64.61 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 120.727 -1.233 . . . . 1.24 111.404 174.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.45 -48.91 53.83 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 111.301 -0.719 . . . . 0.31 111.301 166.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.62 HD11 HD11 ' A' ' 64' ' ' ILE . 86.1 mt -64.38 -32.75 74.5 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 118.247 1.023 . . . . 0.38 113.202 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.26 8.9 ttmt -56.15 -17.73 8.04 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.105 0.866 . . . . 1.22 111.575 170.311 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 8.73 44.05 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.506 1.299 . . . . 4.6900000000000004 114.506 172.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.463 ' O ' HG12 ' A' ' 34' ' ' VAL . 4.4 mtp -85.43 140.58 36.27 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 121.085 1.766 . . . . 2.0299999999999998 110.971 167.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.6 106.28 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.701 2.934 . . . . 0.47999999999999998 111.206 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.44 -18.95 3.63 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.48 -1.048 . . . . 0.27000000000000002 110.48 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 29' ' ' LYS . 8.5 p -69.42 152.22 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.595 0.758 . . . . 0.26000000000000001 110.87 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -58.29 2.16 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.679 1.192 . . . . 0.46999999999999997 109.516 171.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -145.25 150.48 36.76 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 113.01 0.745 . . . . 2.7000000000000002 113.01 -175.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.65 148.45 25.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.907 2.083 . . . . 1.21 109.408 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.38 90.23 1.32 Allowed 'General case' 0 CA--C 1.527 0.074 0 CA-C-O 121.965 0.888 . . . . 2.2999999999999998 110.176 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.24 135.5 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.744 0.818 . . . . 0.81000000000000005 110.445 -173.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -136.74 65.96 1.49 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.0 1.32 . . . . 1.26 111.305 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.542 HD13 ' HA ' ' A' ' 17' ' ' CYS . 86.4 mt -64.93 -18.69 65.44 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 115.917 -0.583 . . . . 1.04 112.512 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.58 -27.85 58.92 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.242 0.474 . . . . 0.92000000000000004 110.668 169.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 m -115.94 18.23 15.64 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.347 1.459 . . . . 0.79000000000000004 110.109 177.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 48.6 35.56 6.31 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.515 1.126 . . . . 2.0699999999999998 112.066 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -143.04 151.97 41.38 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.053 -1.091 . . . . 0.51000000000000001 108.053 -165.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.408 HG21 ' HG3' ' A' ' 25' ' ' GLU . 5.5 p -133.18 148.95 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 109.416 -0.587 . . . . 0.5 109.416 173.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.18 126.38 46.88 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.036 1.334 . . . . 2.4900000000000002 108.148 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.35 138.66 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.938 -0.764 . . . . 0.25 108.938 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.4 mt -99.85 126.9 53.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 107.818 -1.179 . . . . 1.02 107.818 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -150.3 170.15 19.69 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.914 0.486 . . . . 1.9099999999999999 111.096 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -108.49 116.22 56.65 Favored Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 124.34 1.056 . . . . 1.3400000000000001 111.13 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -67.58 5.12 1.06 Allowed 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.916 3.077 . . . . 0.56000000000000005 113.875 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.32 -46.9 25.55 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 107.971 -1.122 . . . . 0.41999999999999998 107.971 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -95.41 -33.21 12.57 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.161 1.384 . . . . 3.46 111.027 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.7 m -155.82 129.97 8.76 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 119.447 3.129 . . . . 0.81999999999999995 119.447 -152.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.78 -163.14 12.59 Favored Glycine 0 N--CA 1.438 -1.217 0 N-CA-C 108.78 -1.728 . . . . 0.46000000000000002 108.78 154.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 t -34.04 -40.21 0.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.976 2.91 . . . . 0.82999999999999996 113.332 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.83 -56.23 7.93 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.081 0.855 . . . . 0.32000000000000001 113.083 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.83 -34.48 66.84 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 123.022 1.392 . . . . 0.20999999999999999 109.261 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.527 ' CG1' HD22 ' A' ' 28' ' ' LEU 0.252 0.9 OUTLIER -70.03 -51.44 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 CA-C-N 113.506 -1.679 . . . . 0.57999999999999996 111.007 -170.5 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -50.53 -49.66 55.24 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.982 1.719 . . . . 0.82999999999999996 110.348 173.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -42.88 -58.37 2.41 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 121.775 0.798 . . . . 2.3300000000000001 111.971 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.29 -40.93 73.99 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 119.889 -0.724 . . . . 2.3599999999999999 110.974 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.62 HD11 HD11 ' A' ' 28' ' ' LEU . 15.1 mm -52.59 -46.0 48.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.315 1.046 . . . . 0.40999999999999998 110.283 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -51.38 -47.39 62.87 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.52 -0.548 . . . . 1.8700000000000001 109.52 174.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -70.09 -34.44 73.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 121.416 -0.802 . . . . 3.79 112.789 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.96 -22.0 13.68 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.066 0.394 . . . . 0.92000000000000004 110.751 167.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.91 24.5 8.55 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 124.778 1.18 . . . . 0.40000000000000002 110.739 173.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -140.95 167.72 21.51 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.59 -0.893 . . . . 1.79 108.59 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -120.95 122.44 40.17 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 103.84 -2.652 . . . . 3.6200000000000001 103.84 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.1 p -100.43 141.39 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 109.663 -0.495 . . . . 0.56999999999999995 109.663 170.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.4 m -98.79 161.65 3.0 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 109.199 -0.667 . . . . 1.1699999999999999 109.199 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.1 mm -128.24 77.56 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 107.455 -1.313 . . . . 1.01 107.455 176.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -120.07 118.39 30.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.615 -1.624 . . . . 4.1799999999999997 106.615 174.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.49 141.56 2.82 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.741 1.162 . . . . 4.8499999999999996 111.051 -171.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.122 0 C-N-CA 127.17 2.188 . . . . 8.2699999999999996 106.056 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 106.606 -1.627 . . . . 11.289999999999999 106.606 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.5 174.0 11.79 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.946 0.794 . . . . 7.21 109.149 171.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -55.57 147.34 18.24 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.852 0.461 . . . . 2.5899999999999999 110.667 174.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -139.94 160.41 39.98 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.602 -1.629 . . . . 3.25 106.602 170.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -112.98 169.74 8.7 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.851 1.26 . . . . 0.59999999999999998 109.452 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -145.83 157.0 43.94 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.686 0.755 . . . . 2.3100000000000001 111.077 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.68 145.73 31.46 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.452 1.901 . . . . 2.2999999999999998 108.054 165.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 tp -127.84 157.11 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.138 -1.801 . . . . 1.1200000000000001 106.138 165.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.05 121.33 9.57 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.884 0.874 . . . . 0.46999999999999997 108.952 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -156.74 167.85 29.22 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.264 0.484 . . . . 1.27 111.396 -174.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.59 156.98 16.75 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.807 0.843 . . . . 1.8100000000000001 111.156 -172.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.79 132.66 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 C-N-CA 123.468 0.707 . . . . 0.67000000000000004 110.517 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -84.44 124.19 31.06 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.91 -0.774 . . . . 1.0800000000000001 108.91 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.07 -76.2 0.41 Allowed Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.822 -1.311 . . . . 2.8100000000000001 109.822 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 8.2 tmm? 38.71 70.09 0.23 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.819 1.648 . . . . 4.2199999999999998 112.703 173.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 p -81.68 18.25 1.28 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.509 1.123 . . . . 3.9199999999999999 111.364 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.3 t 54.86 -138.98 1.04 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.422 1.489 . . . . 3.5600000000000001 111.719 175.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 56.07 -83.13 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.472 1.909 . . . . 3.0899999999999999 112.149 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.19 16.61 0.74 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.956 1.302 . . . . 1.24 110.969 176.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.5 m -72.65 -60.56 2.17 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.478 -0.764 . . . . 1.47 110.039 -166.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.75 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -54.24 -40.25 67.55 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.643 0.735 . . . . 0.68000000000000005 111.364 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.93 -53.0 62.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.841 -0.618 . . . . 0.40000000000000002 110.875 173.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -56.8 -49.36 75.59 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 118.926 -0.559 . . . . 5.2400000000000002 111.705 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 21' ' ' ALA . 72.4 mt -48.33 -59.29 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 108.252 -1.018 . . . . 0.79000000000000004 108.252 177.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -70.06 -35.57 74.33 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.864 -0.734 . . . . 2.5499999999999998 110.39 -171.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp -61.02 -27.35 68.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.908 -1.12 . . . . 1.28 111.44 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.19 -52.56 48.65 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.248 -1.141 . . . . 0.46000000000000002 110.248 162.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.779 HD11 HD11 ' A' ' 64' ' ' ILE . 98.8 mt -63.43 -31.8 73.06 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 113.673 0.99 . . . . 0.40000000000000002 113.673 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -51.1 -19.23 1.04 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.98 0.912 . . . . 1.9299999999999999 111.705 169.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -91.25 -7.23 51.78 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.372 0.878 . . . . 4.1399999999999997 113.372 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.507 ' O ' HG12 ' A' ' 34' ' ' VAL . 26.3 mtp -76.07 139.6 69.22 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 120.212 1.369 . . . . 2.1899999999999999 112.43 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.81 88.99 0.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.603 2.869 . . . . 0.46000000000000002 111.363 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.68 -15.36 2.0 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.745 1.164 . . . . 0.23000000000000001 111.125 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 31' ' ' MET . 6.3 p -65.46 154.51 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 O-C-N 121.422 -1.046 . . . . 0.26000000000000001 110.934 169.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.24 -63.93 1.38 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.564 1.146 . . . . 0.5 108.084 167.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -150.55 137.39 19.12 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 112.368 0.507 . . . . 3.1800000000000002 112.368 -168.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.16 150.66 23.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.806 1.642 . . . . 0.94999999999999996 109.664 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.74 105.66 3.45 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.654 1.182 . . . . 1.9199999999999999 108.684 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.37 137.79 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.212 0.605 . . . . 0.56999999999999995 110.698 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -131.76 66.57 1.54 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.701 1.601 . . . . 1.21 111.083 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.1 mt -67.0 -19.09 65.66 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 115.918 -0.583 . . . . 0.72999999999999998 112.17 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.76 -11.66 8.29 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.629 0.772 . . . . 0.65000000000000002 111.665 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 m -135.31 17.82 3.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.37 1.068 . . . . 0.46000000000000002 109.525 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 44.85 39.53 3.64 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.058 1.343 . . . . 3.3100000000000001 111.957 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.1 m -134.37 155.28 50.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.542 -1.281 . . . . 0.48999999999999999 107.542 -170.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 p -131.96 143.13 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 109.136 -0.69 . . . . 0.47999999999999998 109.136 172.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.36 141.68 43.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.651 1.58 . . . . 2.4900000000000002 106.836 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.44 144.19 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 108.501 -0.926 . . . . 0.33000000000000002 108.501 171.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.7 mt -112.13 121.21 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 125.996 1.718 . . . . 0.72999999999999998 107.069 -174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -144.39 166.1 26.05 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.892 0.877 . . . . 1.98 110.818 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -95.38 109.71 46.7 Favored Pre-proline 0 N--CA 1.445 -0.701 0 C-N-CA 124.727 1.211 . . . . 1.45 109.564 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -71.18 12.89 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.688 2.925 . . . . 0.69999999999999996 113.659 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.75 -48.47 10.08 Favored 'General case' 0 C--N 1.337 0.025 0 N-CA-C 107.647 -1.242 . . . . 0.73999999999999999 107.647 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -89.5 -40.33 12.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.886 1.275 . . . . 2.6200000000000001 111.026 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.1 m -143.79 126.85 16.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 117.5 2.407 . . . . 0.56000000000000005 117.5 -152.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.72 -159.55 10.23 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 109.207 -1.557 . . . . 0.55000000000000004 109.207 156.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.4 t -33.71 -42.93 0.12 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.248 2.619 . . . . 0.75 113.134 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.49 -56.25 8.79 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.977 0.808 . . . . 0.33000000000000002 112.683 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.76 -35.89 62.58 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 122.113 0.959 . . . . 0.26000000000000001 109.369 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.642 HG12 HD22 ' A' ' 28' ' ' LEU 0.254 0.8 OUTLIER -64.93 -55.52 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 114.358 -1.292 . . . . 0.57999999999999996 110.245 -174.496 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -49.68 -49.88 45.83 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 120.553 1.524 . . . . 0.83999999999999997 111.315 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -38.82 -57.35 1.23 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.051 0.929 . . . . 2.7200000000000002 112.902 171.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -71.77 -41.53 68.25 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.606 -0.725 . . . . 2.1299999999999999 109.827 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.779 HD11 HD11 ' A' ' 28' ' ' LEU . 37.8 mm -55.13 -45.09 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 119.413 1.006 . . . . 0.44 110.436 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -52.35 -54.18 34.99 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.547 1.139 . . . . 1.6399999999999999 109.241 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -45.94 85.15 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.479 0.548 . . . . 4.1299999999999999 112.479 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mp -55.07 -19.32 6.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.815 1.646 . . . . 2.3700000000000001 111.789 172.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.72 24.91 7.9 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.343 0.973 . . . . 0.44 111.346 169.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -139.22 175.44 9.56 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 108.879 -0.786 . . . . 2.1699999999999999 108.879 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 123.05 27.51 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.51 -1.663 . . . . 4.29 106.51 175.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -87.96 145.42 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.19 -0.67 . . . . 0.72999999999999998 109.19 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.33 166.95 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.904 -0.776 . . . . 1.46 108.904 168.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.1 mm -127.03 89.1 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 107.442 -1.318 . . . . 1.1000000000000001 107.442 168.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -147.39 88.89 1.74 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.341 -1.726 . . . . 4.2000000000000002 106.341 176.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.77 50.58 0.04 OUTLIER Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.612 -0.595 . . . . 5.6100000000000003 111.612 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 . . . . . 0 C--O 1.251 1.168 0 CA-C-O 117.904 -1.046 . . . . 9.9399999999999995 109.728 -169.633 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtm . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 105.893 -1.892 . . . . 9.8699999999999992 105.893 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 mp -95.72 118.27 32.07 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 120.115 1.325 . . . . 6.9500000000000002 109.041 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.5 t -145.27 152.67 40.3 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 104.476 -2.416 . . . . 4.5899999999999999 104.476 161.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -157.4 147.58 20.81 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.114 -1.439 . . . . 4.0899999999999999 107.114 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -84.1 162.45 20.29 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 123.541 0.526 . . . . 1.0 110.609 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -150.54 156.64 41.79 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.372 0.606 . . . . 2.9900000000000002 110.093 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -84.07 114.15 21.55 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.867 2.067 . . . . 2.2999999999999998 106.683 169.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -96.96 155.37 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 106.416 -1.698 . . . . 1.1299999999999999 106.416 167.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.93 137.69 34.99 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.855 -0.794 . . . . 0.5 108.855 170.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.18 169.25 25.2 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.638 0.586 . . . . 1.25 111.995 175.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.56 153.46 19.74 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.498 1.119 . . . . 1.9099999999999999 110.723 -175.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.85 134.99 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 123.098 0.559 . . . . 0.90000000000000002 111.656 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.3 t -92.06 130.96 37.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.112 0.965 . . . . 0.83999999999999997 109.293 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.77 -13.22 24.82 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.324 0.964 . . . . 1.45 113.336 172.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.619 ' HG3' HD22 ' A' ' 41' ' ' LEU . 10.1 tmm? -48.77 114.47 0.99 Allowed 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.225 1.01 . . . . 4.4500000000000002 110.65 172.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -139.98 24.8 2.35 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.797 0.839 . . . . 4.29 110.676 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.4 m -138.98 -154.25 0.51 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.124 1.37 . . . . 6.5099999999999998 108.087 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.65 -3.1 14.37 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.982 0.913 . . . . 4.7699999999999996 112.281 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.79 38.47 0.42 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.873 0.761 . . . . 2.0499999999999998 111.827 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -71.58 -61.99 1.58 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.152 0.581 . . . . 1.8999999999999999 109.549 172.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.486 ' CB ' HD21 ' A' ' 41' ' ' LEU . . . -51.82 -36.49 48.16 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 123.473 0.709 . . . . 1.3600000000000001 111.3 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.02 -54.16 22.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.009 0.523 . . . . 0.68000000000000005 111.598 173.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -69.9 -45.86 66.69 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.488 0.715 . . . . 4.75 110.099 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -50.75 -54.14 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.367 -0.605 . . . . 0.83999999999999997 109.367 177.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -69.62 -42.92 73.69 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.505 -0.554 . . . . 3.79 109.505 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -51.61 -36.93 47.78 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.175 -1.578 . . . . 1.6000000000000001 111.809 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.28 -52.96 37.25 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 111.543 -0.623 . . . . 0.52000000000000002 111.543 166.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 64' ' ' ILE . 87.3 mt -61.3 -29.46 69.89 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.1 -1.236 . . . . 0.63 113.289 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.56 ' HA ' HG11 ' A' ' 34' ' ' VAL . 4.2 ttmm -59.9 -18.75 47.21 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.151 1.342 . . . . 1.49 111.715 172.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -16.55 57.83 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.885 1.068 . . . . 4.5999999999999996 113.885 169.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.496 ' O ' HG12 ' A' ' 34' ' ' VAL . 83.8 mmm -72.12 135.79 82.3 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 120.031 1.287 . . . . 2.0499999999999998 111.431 -174.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.58 101.32 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.042 2.494 . . . . 0.35999999999999999 110.711 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.31 -15.12 3.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 119.459 1.027 . . . . 0.25 110.809 176.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 29' ' ' LYS . 5.2 p -69.17 153.31 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 O-C-N 122.312 -0.523 . . . . 0.26000000000000001 109.941 166.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.65 -61.04 1.76 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.126 -1.064 . . . . 0.45000000000000001 108.126 162.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -141.42 145.98 35.98 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 113.527 0.936 . . . . 3.3900000000000001 113.527 -168.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.64 150.9 26.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.758 1.623 . . . . 1.1699999999999999 108.551 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.86 101.54 2.91 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.77 0.828 . . . . 1.96 108.785 175.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.95 141.54 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.828 0.851 . . . . 1.0700000000000001 110.997 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -139.11 66.04 1.43 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.137 1.375 . . . . 1.27 111.429 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.619 HD22 ' HG3' ' A' ' 15' ' ' MET . 56.2 mt -67.04 -13.82 62.29 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 113.342 0.867 . . . . 1.05 113.342 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.36 -25.52 9.98 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.578 0.351 . . . . 0.96999999999999997 110.886 165.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.8 m -125.17 17.92 8.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.343 1.457 . . . . 0.69999999999999996 110.157 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 48.18 33.39 3.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.414 1.086 . . . . 2.48 112.156 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -131.66 149.24 52.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.29 -1.004 . . . . 0.60999999999999999 108.29 -168.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -134.02 144.45 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 109.399 -0.593 . . . . 0.55000000000000004 109.399 174.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -112.11 145.08 40.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.052 1.741 . . . . 2.3799999999999999 108.096 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.52 136.44 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.011 -0.737 . . . . 0.32000000000000001 109.011 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.36 119.17 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.694 1.597 . . . . 0.98999999999999999 107.535 178.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -144.49 167.81 21.61 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.009 0.923 . . . . 1.79 110.712 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -108.26 122.88 39.16 Favored Pre-proline 0 N--CA 1.451 -0.416 0 O-C-N 124.211 0.944 . . . . 1.47 110.888 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.79 5.05 1.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.931 3.088 . . . . 0.58999999999999997 113.544 -177.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.74 -55.28 6.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.419 -1.326 . . . . 0.40000000000000002 107.419 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -84.04 -42.57 16.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.526 1.13 . . . . 3.6800000000000002 110.54 172.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.8 m -143.27 131.6 22.11 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 119.175 3.028 . . . . 0.64000000000000001 119.175 -143.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.06 -159.55 18.67 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.13 -1.188 . . . . 0.51000000000000001 110.13 159.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -30.66 -47.63 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.839 2.855 . . . . 0.56000000000000005 112.845 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.86 -56.27 7.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.396 0.678 . . . . 0.26000000000000001 112.488 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.65 -38.49 64.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.197 0.999 . . . . 0.17999999999999999 109.393 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.492 HG12 HD13 ' A' ' 28' ' ' LEU . 1.7 mt -64.75 -55.36 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.465 -1.243 . . . . 0.62 110.377 -170.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.98 -50.02 59.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.923 1.238 . . . . 0.77000000000000002 110.695 177.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -43.7 -56.14 3.96 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.712 0.805 . . . . 2.1299999999999999 112.023 175.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -41.48 72.57 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.559 -0.856 . . . . 1.6899999999999999 110.586 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.603 HD11 HD11 ' A' ' 28' ' ' LEU . 14.6 mm -52.42 -46.05 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 119.489 1.04 . . . . 0.34999999999999998 110.019 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -50.82 -46.69 59.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.041 0.448 . . . . 1.8600000000000001 110.098 174.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -32.89 70.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 114.015 1.117 . . . . 3.1299999999999999 114.015 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.65 -21.23 25.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.548 0.613 . . . . 0.88 110.571 166.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.93 27.3 8.4 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.768 -0.933 . . . . 0.32000000000000001 110.768 173.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -140.39 173.67 11.28 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.181 -1.044 . . . . 1.72 108.181 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 122.88 31.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.702 -1.592 . . . . 4.1600000000000001 106.702 176.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 p -89.92 145.78 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.906 -0.776 . . . . 0.55000000000000004 108.906 171.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.81 164.16 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.289 -0.634 . . . . 1.27 109.289 170.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.4 mm -123.17 104.16 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.023 -1.843 . . . . 1.0 106.023 165.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.12 71.16 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.047 1.339 . . . . 7.9900000000000002 112.614 173.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.37 -58.53 0.2 Allowed Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.22 -0.925 . . . . 6.2000000000000002 113.856 169.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.0 ttp85 . . . . . 0 C--O 1.251 1.177 0 CA-C-O 117.249 -1.358 . . . . 12.69 108.531 -168.097 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtm . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 105.893 -1.892 . . . . 9.8699999999999992 105.893 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 mp -95.72 118.27 32.07 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 120.115 1.325 . . . . 6.9500000000000002 109.041 174.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.5 t -145.27 152.67 40.3 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 104.476 -2.416 . . . . 4.5899999999999999 104.476 161.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -157.4 147.58 20.81 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.114 -1.439 . . . . 4.0899999999999999 107.114 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -84.1 162.45 20.29 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 123.541 0.526 . . . . 1.0 110.609 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -150.54 156.64 41.79 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.372 0.606 . . . . 2.9900000000000002 110.093 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -84.07 114.15 21.55 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.867 2.067 . . . . 2.2999999999999998 106.683 169.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -96.96 155.37 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 106.416 -1.698 . . . . 1.1299999999999999 106.416 167.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.93 137.69 34.99 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.855 -0.794 . . . . 0.5 108.855 170.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.18 169.25 25.2 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.638 0.586 . . . . 1.25 111.995 175.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.56 153.46 19.74 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.498 1.119 . . . . 1.9099999999999999 110.723 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.85 134.99 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 123.098 0.559 . . . . 0.90000000000000002 111.656 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.3 t -92.06 130.96 37.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.112 0.965 . . . . 0.83999999999999997 109.293 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.77 -13.22 24.82 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.324 0.964 . . . . 1.45 113.336 172.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.619 ' HG3' HD22 ' A' ' 41' ' ' LEU . 10.1 tmm? -48.77 114.47 0.99 Allowed 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.225 1.01 . . . . 4.4500000000000002 110.65 172.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -139.98 24.8 2.35 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.797 0.839 . . . . 4.29 110.676 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.4 m -138.98 -154.25 0.51 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.124 1.37 . . . . 6.5099999999999998 108.087 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.65 -3.1 14.37 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.982 0.913 . . . . 4.7699999999999996 112.281 171.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.79 38.47 0.42 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.873 0.761 . . . . 2.0499999999999998 111.827 -174.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -71.58 -61.99 1.58 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.152 0.581 . . . . 1.8999999999999999 109.549 172.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.486 ' CB ' HD21 ' A' ' 41' ' ' LEU . . . -51.82 -36.49 48.16 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 123.473 0.709 . . . . 1.3600000000000001 111.3 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.02 -54.16 22.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.009 0.523 . . . . 0.68000000000000005 111.598 173.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -69.9 -45.86 66.69 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.488 0.715 . . . . 4.75 110.099 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -50.75 -54.14 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.367 -0.605 . . . . 0.83999999999999997 109.367 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -69.62 -42.92 73.69 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.505 -0.554 . . . . 3.79 109.505 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -51.61 -36.93 47.78 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.175 -1.578 . . . . 1.6000000000000001 111.809 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.28 -52.96 37.25 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 111.543 -0.623 . . . . 0.52000000000000002 111.543 166.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 64' ' ' ILE . 87.3 mt -61.3 -29.46 69.89 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.1 -1.236 . . . . 0.63 113.289 174.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.56 ' HA ' HG11 ' A' ' 34' ' ' VAL . 4.2 ttmm -59.9 -18.75 47.21 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.151 1.342 . . . . 1.49 111.715 172.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -16.55 57.83 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.885 1.068 . . . . 4.5999999999999996 113.885 169.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.496 ' O ' HG12 ' A' ' 34' ' ' VAL . 83.8 mmm -72.12 135.79 82.3 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 120.031 1.287 . . . . 2.0499999999999998 111.431 -174.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.58 101.32 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.042 2.494 . . . . 0.35999999999999999 110.711 -174.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.31 -15.12 3.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 119.459 1.027 . . . . 0.25 110.809 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 29' ' ' LYS . 5.2 p -69.17 153.31 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 O-C-N 122.312 -0.523 . . . . 0.26000000000000001 109.941 166.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.65 -61.04 1.76 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.126 -1.064 . . . . 0.45000000000000001 108.126 162.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -141.42 145.98 35.98 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 113.527 0.936 . . . . 3.3900000000000001 113.527 -168.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.64 150.9 26.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.758 1.623 . . . . 1.1699999999999999 108.551 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.86 101.54 2.91 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.77 0.828 . . . . 1.96 108.785 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.95 141.54 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.828 0.851 . . . . 1.0700000000000001 110.997 -175.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -139.11 66.04 1.43 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.137 1.375 . . . . 1.27 111.429 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.619 HD22 ' HG3' ' A' ' 15' ' ' MET . 56.2 mt -67.04 -13.82 62.29 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 113.342 0.867 . . . . 1.05 113.342 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.36 -25.52 9.98 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.578 0.351 . . . . 0.96999999999999997 110.886 165.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.8 m -125.17 17.92 8.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.343 1.457 . . . . 0.69999999999999996 110.157 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 48.18 33.39 3.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.414 1.086 . . . . 2.48 112.156 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -131.66 149.24 52.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.29 -1.004 . . . . 0.60999999999999999 108.29 -168.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -134.02 144.45 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 109.399 -0.593 . . . . 0.55000000000000004 109.399 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -112.11 145.08 40.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.052 1.741 . . . . 2.3799999999999999 108.096 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.52 136.44 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.011 -0.737 . . . . 0.32000000000000001 109.011 174.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.36 119.17 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.694 1.597 . . . . 0.98999999999999999 107.535 178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -144.49 167.81 21.61 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.009 0.923 . . . . 1.79 110.712 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -108.26 122.88 39.16 Favored Pre-proline 0 N--CA 1.451 -0.416 0 O-C-N 124.211 0.944 . . . . 1.47 110.888 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.79 5.05 1.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.931 3.088 . . . . 0.58999999999999997 113.544 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.74 -55.28 6.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.419 -1.326 . . . . 0.40000000000000002 107.419 175.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -84.04 -42.57 16.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.526 1.13 . . . . 3.6800000000000002 110.54 172.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.8 m -143.27 131.6 22.11 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 119.175 3.028 . . . . 0.64000000000000001 119.175 -143.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.06 -159.55 18.67 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.13 -1.188 . . . . 0.51000000000000001 110.13 159.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -30.66 -47.63 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.839 2.855 . . . . 0.56000000000000005 112.845 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.86 -56.27 7.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.396 0.678 . . . . 0.26000000000000001 112.488 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.65 -38.49 64.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.197 0.999 . . . . 0.17999999999999999 109.393 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.492 HG12 HD13 ' A' ' 28' ' ' LEU . 1.7 mt -64.75 -55.36 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.465 -1.243 . . . . 0.62 110.377 -170.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.98 -50.02 59.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.923 1.238 . . . . 0.77000000000000002 110.695 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -43.7 -56.14 3.96 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.712 0.805 . . . . 2.1299999999999999 112.023 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -41.48 72.57 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.559 -0.856 . . . . 1.6899999999999999 110.586 -178.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.603 HD11 HD11 ' A' ' 28' ' ' LEU . 14.6 mm -52.42 -46.05 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 119.489 1.04 . . . . 0.34999999999999998 110.019 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -50.82 -46.69 59.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.041 0.448 . . . . 1.8600000000000001 110.098 174.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -32.89 70.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 114.015 1.117 . . . . 3.1299999999999999 114.015 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.65 -21.23 25.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.548 0.613 . . . . 0.88 110.571 166.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.93 27.3 8.4 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.768 -0.933 . . . . 0.32000000000000001 110.768 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -140.39 173.67 11.28 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.181 -1.044 . . . . 1.72 108.181 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 122.88 31.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.702 -1.592 . . . . 4.1600000000000001 106.702 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 p -89.92 145.78 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.906 -0.776 . . . . 0.55000000000000004 108.906 171.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.81 164.16 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.289 -0.634 . . . . 1.27 109.289 170.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.4 mm -123.17 104.16 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.023 -1.843 . . . . 1.0 106.023 165.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.12 71.16 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.047 1.339 . . . . 7.9900000000000002 112.614 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.37 -58.53 0.2 Allowed Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.22 -0.925 . . . . 6.2000000000000002 113.856 169.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.0 ttp85 . . . . . 0 C--O 1.251 1.177 0 CA-C-O 117.249 -1.358 . . . . 12.69 108.531 -168.097 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 mtt . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 108.481 -0.933 . . . . 8.5700000000000003 108.481 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 tp -66.53 174.43 2.79 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.155 -0.683 . . . . 6.2400000000000002 109.155 166.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 t -139.27 163.32 32.79 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 105.946 -1.872 . . . . 3.3599999999999999 105.946 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -159.55 152.37 21.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.88 -1.156 . . . . 3.4199999999999999 107.88 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -88.34 174.7 8.01 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.51 -0.768 . . . . 0.93999999999999995 111.289 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.32 161.55 40.07 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.998 -0.371 . . . . 3.6000000000000001 109.998 172.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.41 136.29 33.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.627 -1.17 . . . . 3.3900000000000001 107.935 161.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 tp -107.4 153.91 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.051 -1.833 . . . . 1.1699999999999999 106.051 162.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.58 128.56 17.49 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.589 1.156 . . . . 0.35999999999999999 108.44 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.78 172.33 18.81 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.506 0.594 . . . . 1.3700000000000001 111.939 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.62 157.38 17.51 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.278 -0.638 . . . . 2.2799999999999998 109.278 -176.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 24' ' ' ILE . 2.1 t -123.34 132.12 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 O-C-N 123.492 0.495 . . . . 0.70999999999999996 110.315 177.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 t -88.22 118.72 28.0 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.922 -1.14 . . . . 0.90000000000000002 107.922 172.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.81 -83.48 0.19 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.252 1.406 . . . . 2.7400000000000002 110.152 175.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 50.61 58.26 5.72 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 122.822 1.296 . . . . 5.5599999999999996 110.82 173.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 m -70.26 -16.14 63.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.476 -1.238 . . . . 4.5300000000000002 111.583 175.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.2 t 74.1 178.77 0.21 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.326 1.451 . . . . 3.5299999999999998 110.073 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 60.3 59.26 2.35 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.681 1.128 . . . . 3.1299999999999999 111.115 -174.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 65.92 15.29 10.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.457 1.503 . . . . 1.1200000000000001 113.408 175.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.66 -58.88 3.09 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.606 -0.887 . . . . 1.4299999999999999 108.606 -173.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -56.69 -28.83 61.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.756 -1.111 . . . . 0.98999999999999999 111.709 176.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.14 -47.0 69.29 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.579 -0.724 . . . . 0.5 110.609 173.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -52.98 -44.38 67.14 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 119.347 0.976 . . . . 5.5999999999999996 111.451 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.568 HD11 ' CD2' ' A' ' 69' ' ' TYR . 71.4 mt -44.66 -61.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 123.494 0.717 . . . . 0.82999999999999996 109.15 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.01 -37.99 66.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.809 -0.632 . . . . 2.3999999999999999 112.177 -175.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -57.5 -34.63 69.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.328 -0.858 . . . . 1.52 110.691 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.81 -49.82 64.23 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 110.781 -0.928 . . . . 0.40000000000000002 110.781 167.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.663 HD22 HG13 ' A' ' 60' ' ' ILE . 92.9 mt -64.41 -32.72 74.45 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 118.302 1.051 . . . . 0.40999999999999998 112.311 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.458 ' HA ' HG11 ' A' ' 34' ' ' VAL . 12.8 ttmm -57.83 -16.43 11.62 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.151 0.887 . . . . 1.51 112.094 171.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -97.85 -0.47 45.03 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.178 0.899 . . . . 3.23 112.744 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.426 ' O ' HG12 ' A' ' 34' ' ' VAL . 53.7 mmm -79.99 135.56 55.03 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 119.895 1.225 . . . . 2.3799999999999999 110.629 174.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.09 116.94 3.89 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.421 2.08 . . . . 0.81999999999999995 109.448 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.35 -17.18 6.61 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.929 1.252 . . . . 0.19 110.146 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' A' ' 29' ' ' LYS . 4.7 p -75.7 158.69 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.305 0.642 . . . . 0.29999999999999999 111.366 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.38 -63.05 1.4 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.581 1.152 . . . . 0.44 108.099 165.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -135.36 151.86 50.89 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 112.441 0.534 . . . . 3.1099999999999999 112.441 -169.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.32 140.09 41.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.928 1.291 . . . . 0.60999999999999999 107.558 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -147.63 129.98 15.7 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.201 -0.666 . . . . 1.74 109.201 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.89 134.87 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 123.98 0.912 . . . . 0.66000000000000003 110.593 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -124.82 65.2 1.11 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.008 1.723 . . . . 1.22 110.201 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.97 -20.36 63.77 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 116.071 -0.513 . . . . 0.91000000000000003 112.334 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.52 -24.69 21.75 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.997 0.519 . . . . 0.78000000000000003 110.996 171.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.4 m -125.61 16.24 8.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.96 1.304 . . . . 0.68000000000000005 109.935 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 45.93 38.39 4.5 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.339 1.056 . . . . 2.0099999999999998 111.44 -175.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.4 m -131.86 153.05 50.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.11 -1.441 . . . . 0.55000000000000004 107.11 -171.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 p -133.2 149.86 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.721 -1.214 . . . . 0.40999999999999998 107.721 174.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.22 148.45 48.64 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 123.967 0.792 . . . . 2.8999999999999999 109.565 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.3 131.26 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 121.576 0.703 . . . . 0.32000000000000001 109.266 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mt -95.38 120.12 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.508 1.923 . . . . 0.94999999999999996 107.361 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -149.33 170.15 19.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.455 0.702 . . . . 1.8200000000000001 110.188 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -104.44 121.29 47.78 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 114.36 -1.291 . . . . 2.0299999999999998 111.22 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.18 2.69 1.67 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.683 3.589 . . . . 0.5 114.203 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.92 -51.16 10.85 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 119.268 0.94 . . . . 0.46999999999999997 108.864 176.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -90.7 -44.27 9.59 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.545 1.538 . . . . 3.04 109.633 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.2 m -127.07 121.83 32.62 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 116.865 2.172 . . . . 0.58999999999999997 116.865 -157.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.09 169.63 27.41 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 106.223 -2.751 . . . . 0.96999999999999997 106.223 173.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.304 0.0 OUTLIER -39.52 -40.05 0.8 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.324 1.849 . . . . 0.70999999999999996 113.248 177.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -38.3 -59.76 0.85 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.331 1.052 . . . . 0.52000000000000002 113.245 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.51 -35.61 65.64 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 122.012 0.911 . . . . 0.28999999999999998 109.246 -173.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.663 HG13 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -60.75 -60.09 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-N 114.189 -1.368 . . . . 1.0600000000000001 108.237 -176.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.72 -51.88 26.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.162 0.892 . . . . 1.1299999999999999 110.436 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.68 -51.31 12.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.929 0.892 . . . . 2.3799999999999999 112.01 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -46.01 65.31 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.911 -0.716 . . . . 1.8999999999999999 110.938 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.651 HD11 HD11 ' A' ' 28' ' ' LEU . 8.3 mm -52.41 -44.53 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 118.94 0.791 . . . . 0.87 110.73 -175.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -48.85 -51.3 30.43 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.327 0.585 . . . . 1.5900000000000001 109.939 173.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -73.31 -28.75 62.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.602 0.761 . . . . 4.0499999999999998 112.85 -175.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.46 -25.45 25.29 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.155 0.434 . . . . 0.93999999999999995 110.254 165.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.02 29.93 5.61 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 124.891 1.234 . . . . 0.56999999999999995 110.566 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.568 ' CD2' HD11 ' A' ' 24' ' ' ILE . 58.5 m-85 -144.12 169.26 18.19 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 108.198 -1.038 . . . . 2.0 108.198 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.95 120.47 30.44 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.103 -1.073 . . . . 4.3600000000000003 108.103 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.8 p -87.49 149.64 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.835 -0.432 . . . . 0.42999999999999999 109.835 172.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.48 109.06 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.181 0.992 . . . . 1.28 110.217 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.6 mt -112.53 79.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 124.67 1.188 . . . . 1.9099999999999999 108.299 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -127.75 150.67 49.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.748 -1.945 . . . . 7.3700000000000001 105.748 172.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.44 -49.57 0.14 Allowed Glycine 0 CA--C 1.524 0.618 0 CA-C-N 119.226 0.921 . . . . 4.6600000000000001 112.884 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.315 0 CA-C-O 115.794 -2.05 . . . . 7.5800000000000001 106.312 163.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 109.103 -0.703 . . . . 10.56 109.103 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 39.5 tp -166.63 120.1 1.05 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.697 -1.594 . . . . 6.0599999999999996 106.697 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 p -85.43 149.07 25.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.159 -1.052 . . . . 3.4399999999999999 108.159 169.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -145.55 140.0 27.13 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 104.583 -2.377 . . . . 2.9199999999999999 104.583 168.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -109.96 169.69 8.56 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.702 0.801 . . . . 0.68999999999999995 109.846 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -147.98 162.1 40.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.248 1.023 . . . . 3.2200000000000002 111.395 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.16 146.93 30.28 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 112.647 -2.069 . . . . 3.3399999999999999 107.807 164.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -132.25 158.06 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.401 -2.074 . . . . 1.4299999999999999 105.401 165.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.73 144.1 32.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.062 0.945 . . . . 0.57999999999999996 109.129 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.9 169.82 23.73 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.252 0.621 . . . . 1.3100000000000001 110.609 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.1 155.01 19.72 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.367 -0.975 . . . . 2.3199999999999998 108.367 176.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -116.54 160.85 15.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.283 -1.006 . . . . 0.67000000000000004 108.283 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.1 t -126.79 133.44 50.8 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.452 -1.314 . . . . 0.79000000000000004 107.452 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.84 -25.32 14.81 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.435 1.017 . . . . 1.3600000000000001 113.687 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.21 142.78 6.75 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.402 1.101 . . . . 3.1099999999999999 113.29 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.9 p -134.81 39.05 3.01 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.309 1.043 . . . . 3.4300000000000002 110.511 176.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t 52.16 -141.93 0.79 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.171 -1.395 . . . . 4.1200000000000001 110.916 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 38.55 56.01 1.85 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 121.147 1.794 . . . . 2.7200000000000002 112.886 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.67 11.01 3.67 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.456 1.502 . . . . 1.0900000000000001 114.389 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 91.5 m -72.05 -60.24 2.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.737 -1.209 . . . . 1.28 107.737 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.608 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.72 -37.1 70.49 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.432 -0.804 . . . . 0.82999999999999996 110.997 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.78 -47.73 84.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.586 -0.721 . . . . 0.35999999999999999 110.937 172.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.69 -48.33 66.64 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.176 0.898 . . . . 4.0 110.543 172.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.425 HD11 ' CD2' ' A' ' 69' ' ' TYR . 66.0 mt -49.03 -61.13 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.24 0 N-CA-C 109.054 -0.721 . . . . 0.57999999999999996 109.054 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -71.2 -35.1 71.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.077 -0.649 . . . . 2.3700000000000001 110.895 -171.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -54.57 -37.99 66.15 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 121.02 -1.05 . . . . 1.52 110.688 171.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.37 -51.52 36.57 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.584 -1.006 . . . . 0.47999999999999998 110.584 168.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.796 HD11 HD11 ' A' ' 64' ' ' ILE . 96.1 mt -64.79 -29.91 70.9 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 121.702 -0.881 . . . . 0.42999999999999999 112.367 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.652 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -63.1 -18.07 63.01 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 118.984 0.811 . . . . 1.48 109.809 176.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.83 -23.08 63.25 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.219 -1.551 . . . . 3.1800000000000002 113.934 168.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.57 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -69.03 133.19 89.99 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 120.214 1.37 . . . . 1.8500000000000001 110.463 -172.23 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.24 100.12 0.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.822 2.348 . . . . 0.44 110.19 -176.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.57 -21.82 2.37 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.588 -1.005 . . . . 0.29999999999999999 110.588 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.652 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.8 p -67.37 153.7 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 122.293 -0.533 . . . . 0.28000000000000003 110.675 170.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.25 -61.07 1.77 Allowed 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.467 -0.938 . . . . 0.46000000000000002 108.467 167.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.26 152.93 39.12 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.645 0.259 . . . . 2.7599999999999998 111.315 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.13 135.28 46.29 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.901 2.08 . . . . 0.68000000000000005 107.77 -173.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -144.7 121.67 11.36 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.408 0.683 . . . . 1.5700000000000001 109.73 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.608 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.3 p -97.8 137.59 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 112.937 0.717 . . . . 0.97999999999999998 112.937 -176.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -126.33 69.79 1.23 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.401 2.281 . . . . 1.3 111.181 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.9 mt -65.08 -17.98 64.92 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 112.692 0.627 . . . . 0.73999999999999999 112.692 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.89 -10.0 5.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.154 0.434 . . . . 0.63 111.44 169.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 m -138.17 17.18 2.8 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.23 1.012 . . . . 0.45000000000000001 109.758 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mp0 51.2 30.6 5.89 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.048 0.84 . . . . 2.8900000000000001 111.935 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.7 m -128.98 153.66 47.34 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.804 -1.184 . . . . 0.53000000000000003 107.804 -168.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.02 147.46 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.951 -1.129 . . . . 0.46000000000000002 107.951 174.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.46 151.73 41.0 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 124.209 0.943 . . . . 2.8399999999999999 109.154 175.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.5 140.2 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.142 -1.059 . . . . 0.27000000000000002 108.142 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.46 124.89 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.531 1.532 . . . . 0.87 107.438 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -148.46 165.99 29.49 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.387 0.675 . . . . 1.8200000000000001 110.622 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -97.98 110.84 57.42 Favored Pre-proline 0 N--CA 1.447 -0.611 0 C-N-CA 124.673 1.189 . . . . 2.0499999999999998 110.247 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -72.25 13.25 0.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.963 3.108 . . . . 0.60999999999999999 113.716 -177.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.41 -51.26 8.02 Favored 'General case' 0 C--N 1.337 0.059 0 N-CA-C 107.257 -1.386 . . . . 0.59999999999999998 107.257 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -80.83 -47.98 13.06 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.273 1.429 . . . . 2.7400000000000002 109.637 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.5 m -143.04 125.7 15.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 117.252 2.316 . . . . 0.70999999999999996 117.252 -145.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.51 -159.74 13.65 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 109.857 -1.297 . . . . 0.5 109.857 165.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.4 t -29.47 -50.04 0.1 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 129.138 2.975 . . . . 0.72999999999999998 112.632 177.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.05 -56.33 6.68 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.025 0.93 . . . . 0.32000000000000001 112.654 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -38.47 64.88 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 122.248 1.023 . . . . 0.20000000000000001 109.403 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.596 HG12 HD22 ' A' ' 28' ' ' LEU . 1.3 mt -63.29 -56.26 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.242 -1.345 . . . . 0.59999999999999998 110.216 -170.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.21 -52.69 19.87 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.174 1.352 . . . . 0.76000000000000001 110.611 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -44.09 -51.95 7.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.683 1.193 . . . . 2.5099999999999998 111.968 176.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -43.44 68.61 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 118.248 -0.882 . . . . 2.0800000000000001 111.464 177.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.796 HD11 HD11 ' A' ' 28' ' ' LEU . 37.7 mm -52.58 -45.55 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 119.77 1.168 . . . . 0.38 110.075 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -50.38 -49.2 55.05 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.763 0.316 . . . . 1.8200000000000001 110.183 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -70.77 -30.67 67.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 114.279 1.214 . . . . 3.25 114.279 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.27 -21.0 12.75 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.532 0.606 . . . . 0.91000000000000003 110.635 166.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.24 28.74 9.52 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.998 -1.241 . . . . 0.29999999999999999 109.998 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.425 ' CD2' HD11 ' A' ' 24' ' ' ILE . 71.2 m-85 -137.44 168.3 19.91 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.735 -0.839 . . . . 1.71 108.735 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.33 123.1 42.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.746 -1.576 . . . . 4.4900000000000002 106.746 175.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.442 ' HB ' HG21 ' A' ' 64' ' ' ILE . 8.7 p -91.65 152.99 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.46 -0.57 . . . . 0.54000000000000004 109.46 172.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.01 96.61 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-O 121.305 0.574 . . . . 1.4299999999999999 110.305 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.8 mt -95.8 94.35 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.249 -1.019 . . . . 1.74 108.249 172.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.42 166.78 29.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.481 -1.303 . . . . 5.0199999999999996 107.481 167.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.69 -88.06 1.52 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.877 -0.889 . . . . 3.5800000000000001 110.877 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 116.725 -1.607 . . . . 9.3200000000000003 107.122 -172.683 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptt? . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 107.348 -1.353 . . . . 8.3399999999999999 107.348 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.98 147.64 0.59 Allowed 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 105.899 -1.889 . . . . 6.71 105.899 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 p -81.85 145.17 30.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.37 -0.974 . . . . 3.25 108.37 171.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -149.15 154.93 39.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.049 -1.463 . . . . 2.79 107.049 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -113.02 170.93 7.85 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.444 1.498 . . . . 0.69999999999999996 109.546 -176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.45 162.22 41.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.238 0.542 . . . . 4.79 110.878 176.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -82.83 155.03 24.38 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.222 1.809 . . . . 3.71 109.765 168.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.7 142.84 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 104.847 -2.279 . . . . 3.2599999999999998 104.847 162.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.52 130.72 51.14 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.689 1.196 . . . . 0.40999999999999998 107.869 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -155.53 174.78 14.77 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.876 0.47 . . . . 1.2 110.381 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.419 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -104.87 150.31 24.96 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.753 -1.203 . . . . 1.8999999999999999 107.753 -176.379 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.42 161.52 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 107.502 -1.296 . . . . 0.64000000000000001 107.502 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.67 131.07 46.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.609 -1.256 . . . . 1.29 107.609 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.0 -15.95 25.64 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.375 0.988 . . . . 1.3999999999999999 113.785 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.38 145.21 18.6 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.575 1.188 . . . . 3.1099999999999999 111.75 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.5 p -125.8 36.36 4.55 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.791 0.836 . . . . 3.5099999999999998 110.28 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.9 t 50.58 -137.62 1.1 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.98 0.912 . . . . 4.0700000000000003 111.914 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 54.95 -80.18 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.607 1.963 . . . . 3.3799999999999999 112.334 -176.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.01 13.57 0.7 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.56 1.144 . . . . 1.22 112.039 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.33 -62.09 1.53 Allowed 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 121.299 -0.876 . . . . 1.23 109.502 -167.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -60.83 -32.87 72.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.891 0.377 . . . . 0.69999999999999996 111.168 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.11 -53.4 57.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 119.489 -0.291 . . . . 0.40000000000000002 110.24 170.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -58.4 -45.14 88.95 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 118.778 -0.629 . . . . 3.6800000000000002 111.997 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 21' ' ' ALA . 82.2 mt -49.06 -60.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.041 -0.725 . . . . 0.62 109.041 176.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.439 ' CD ' HG21 ' A' ' 46' ' ' VAL . 3.4 tp10 -70.86 -33.98 71.17 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.16 0.505 . . . . 2.6400000000000001 110.336 -170.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -60.15 -31.29 69.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.864 -1.147 . . . . 2.29 111.234 171.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.67 -51.82 31.74 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.515 -1.034 . . . . 0.34000000000000002 110.515 162.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 64' ' ' ILE . 93.3 mt -65.2 -32.66 74.45 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 121.253 -1.145 . . . . 0.39000000000000001 113.023 177.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HA ' HG11 ' A' ' 34' ' ' VAL . 13.5 tppt? -54.97 -21.22 11.08 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.373 0.988 . . . . 1.79 111.458 171.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -76.02 -24.32 55.25 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.788 1.033 . . . . 3.0800000000000001 113.788 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.48 ' O ' HG12 ' A' ' 34' ' ' VAL . 1.5 mtp -69.7 132.83 88.82 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 120.375 1.443 . . . . 2.2400000000000002 112.478 -172.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.6 95.38 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.644 2.896 . . . . 0.46000000000000002 110.716 -172.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.44 -20.8 2.23 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.696 -0.962 . . . . 0.26000000000000001 110.696 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 31' ' ' MET . 9.8 p -62.62 144.54 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 121.966 -0.726 . . . . 0.39000000000000001 110.954 171.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.12 -61.79 1.34 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.629 1.172 . . . . 0.81000000000000005 109.269 167.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -149.41 147.98 28.92 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 114.315 1.228 . . . . 2.8700000000000001 114.315 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.415 ' HB1' ' CG ' ' A' ' 25' ' ' GLU . . . -116.46 121.3 41.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.84 2.056 . . . . 0.91000000000000003 108.331 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.99 107.42 6.15 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.921 0.889 . . . . 1.3899999999999999 108.986 -170.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 p -85.4 143.6 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.91 0.884 . . . . 0.60999999999999999 112.058 -172.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -133.49 65.78 1.57 Allowed 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.226 1.811 . . . . 1.29 111.163 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.6 mt -65.61 -16.35 63.63 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 121.685 -0.634 . . . . 0.71999999999999997 112.704 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.4 -19.65 15.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.645 0.378 . . . . 0.52000000000000002 110.902 168.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.4 m -129.19 19.33 5.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.088 1.355 . . . . 0.45000000000000001 109.685 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 50.24 35.14 9.84 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.138 0.975 . . . . 2.4399999999999999 111.846 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.89 158.08 44.86 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 108.847 -0.797 . . . . 0.97999999999999998 108.847 -169.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.439 HG21 ' CD ' ' A' ' 25' ' ' GLU . 7.2 p -134.96 148.85 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.081 -0.711 . . . . 0.45000000000000001 109.081 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -115.81 134.41 55.04 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.95 -1.5 . . . . 2.5 106.95 176.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.43 140.07 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.284 -0.635 . . . . 0.37 109.284 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.0 mt -105.58 132.67 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 126.201 1.8 . . . . 0.90000000000000002 106.945 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.01 167.42 28.48 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.959 0.409 . . . . 2.0299999999999998 111.498 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -98.25 114.16 64.86 Favored Pre-proline 0 N--CA 1.442 -0.829 0 C-N-CA 124.752 1.221 . . . . 1.46 109.839 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -69.48 9.87 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 124.289 3.326 . . . . 0.53000000000000003 113.971 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.39 -51.59 8.18 Favored 'General case' 0 N--CA 1.458 -0.058 0 N-CA-C 107.411 -1.329 . . . . 0.46999999999999997 107.411 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -93.67 -29.75 15.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.579 1.552 . . . . 3.1200000000000001 111.289 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.7 m -150.2 130.25 13.5 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 118.031 2.604 . . . . 0.47999999999999998 118.031 -156.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.33 -165.25 17.79 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 110.453 -1.059 . . . . 0.42999999999999999 110.453 156.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.4 t -39.88 -38.31 0.67 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.291 2.636 . . . . 1.04 112.138 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.65 -56.0 9.71 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.181 0.808 . . . . 0.32000000000000001 113.181 174.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.56 -37.82 65.41 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.838 1.304 . . . . 0.19 108.904 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.597 ' CG1' HD22 ' A' ' 28' ' ' LEU 0.269 0.8 OUTLIER -64.04 -53.6 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 113.708 -1.587 . . . . 0.57999999999999996 111.013 -173.749 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.87 -53.07 12.91 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.766 1.621 . . . . 0.96999999999999997 111.048 173.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -39.75 -58.12 1.4 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.829 0.823 . . . . 2.52 113.106 172.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -70.34 -40.28 74.2 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 119.465 -0.894 . . . . 2.9900000000000002 110.224 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.696 HD11 HD11 ' A' ' 28' ' ' LEU . 31.3 mm -54.12 -46.74 67.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.506 1.048 . . . . 0.35999999999999999 110.114 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -53.13 -45.53 68.4 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.289 0.636 . . . . 1.5700000000000001 109.927 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -38.99 86.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.456 -0.778 . . . . 3.9199999999999999 111.23 -177.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.6 -19.85 18.11 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.656 1.182 . . . . 0.96999999999999997 110.898 170.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.01 28.54 9.25 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 124.187 0.899 . . . . 0.34999999999999998 110.938 173.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -138.06 165.31 26.91 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.041 -1.096 . . . . 1.79 108.041 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.69 129.3 55.2 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.752 0.821 . . . . 3.9199999999999999 108.943 173.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.3 p -96.14 148.52 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 125.276 1.431 . . . . 0.41999999999999998 110.22 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 11' ' ' GLN . 2.9 m -116.41 132.76 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 123.594 0.758 . . . . 1.0 110.376 -178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.0 mm -102.91 82.84 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.862 -1.162 . . . . 1.1000000000000001 107.862 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -135.67 151.8 50.57 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 105.945 -1.872 . . . . 4.5 105.945 166.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.18 -113.1 0.72 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 107.763 -2.135 . . . . 3.8300000000000001 107.763 -169.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 . . . . . 0 C--O 1.251 1.175 0 CA-C-O 116.993 -1.479 . . . . 7.8200000000000003 109.952 -172.045 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.0 mtp . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 105.945 -1.872 . . . . 10.789999999999999 105.945 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.05 55.71 9.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.165 0.983 . . . . 5.5099999999999998 110.058 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 p -148.26 118.98 7.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.927 1.691 . . . . 3.23 106.705 -165.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -136.54 147.91 47.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.308 -1.367 . . . . 3.0699999999999998 107.308 176.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -110.68 167.89 9.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.598 1.159 . . . . 0.57999999999999996 111.182 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -143.67 157.0 44.72 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.599 0.714 . . . . 2.4199999999999999 111.399 174.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -84.28 125.68 32.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.244 1.818 . . . . 2.3300000000000001 107.035 163.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 tp -103.64 149.18 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.278 -1.749 . . . . 1.1200000000000001 106.278 163.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.82 129.11 40.06 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.674 -1.232 . . . . 0.40999999999999998 107.674 172.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -155.75 168.63 26.58 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.841 0.456 . . . . 1.02 110.553 -172.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -91.57 151.51 20.69 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.811 -0.811 . . . . 2.8999999999999999 108.811 -173.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -117.96 160.84 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 108.922 -0.769 . . . . 0.67000000000000004 108.922 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -133.49 125.31 28.67 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.839 -1.171 . . . . 0.79000000000000004 107.839 174.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.89 -21.23 6.63 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.035 1.302 . . . . 1.3400000000000001 113.228 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.33 154.48 3.3 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.348 1.074 . . . . 3.1499999999999999 112.809 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.1 p -142.52 39.39 1.55 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.554 0.742 . . . . 3.46 110.728 174.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.3 t 56.03 -147.56 0.52 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 117.404 -1.284 . . . . 4.1299999999999999 110.464 -177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 41.77 47.63 3.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.741 1.61 . . . . 2.6400000000000001 114.138 173.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.95 15.88 6.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.872 1.269 . . . . 1.0600000000000001 113.788 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.1 m -73.11 -60.61 2.16 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.23 -1.396 . . . . 1.5 107.23 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.674 ' HA ' HD13 ' A' ' 24' ' ' ILE . . . -46.75 -39.5 11.8 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.067 1.347 . . . . 1.24 112.031 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.29 -38.51 87.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.385 -0.825 . . . . 0.54000000000000004 111.935 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -57.48 -47.11 82.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.357 0.98 . . . . 3.3999999999999999 110.753 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.674 HD13 ' HA ' ' A' ' 21' ' ' ALA . 3.5 mp -48.7 -61.62 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.413 -0.958 . . . . 1.6100000000000001 108.413 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.56 -33.57 66.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.433 -0.507 . . . . 2.5699999999999998 112.003 -172.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -56.29 -39.8 73.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.149 -0.969 . . . . 1.9399999999999999 110.026 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.01 -55.5 11.61 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.937 -1.265 . . . . 0.33000000000000002 109.937 167.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.88 HD11 HD11 ' A' ' 64' ' ' ILE . 96.5 mt -63.5 -31.39 72.54 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 113.439 0.903 . . . . 0.34000000000000002 113.439 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.447 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.26 14.0 ttpt -61.62 -17.14 53.99 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.656 1.116 . . . . 2.0899999999999999 111.116 172.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.92 -12.8 52.6 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.154 1.168 . . . . 3.6000000000000001 114.154 168.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.471 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -71.44 137.58 83.68 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 120.827 1.649 . . . . 3.3799999999999999 111.241 -173.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.48 94.48 0.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.113 2.542 . . . . 0.37 110.433 -175.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.42 -12.78 3.5 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.74 1.162 . . . . 0.23000000000000001 111.193 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 31' ' ' MET . 4.7 p -67.38 160.57 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 117.791 0.795 . . . . 0.26000000000000001 110.526 167.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.77 -55.44 1.9 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.358 1.063 . . . . 0.51000000000000001 110.152 165.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -143.99 162.26 36.64 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.068 0.395 . . . . 2.2599999999999998 111.815 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.44 135.73 28.77 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 126.072 1.749 . . . . 0.62 109.607 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -142.47 110.25 5.83 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 125.439 1.496 . . . . 1.55 108.746 -173.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.0 p -84.14 140.93 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.555 0.742 . . . . 0.62 111.728 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -132.48 69.06 1.48 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.991 1.717 . . . . 1.23 112.328 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.9 mt -63.38 -18.97 64.25 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 113.087 0.773 . . . . 0.79000000000000004 113.087 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.83 -21.93 12.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.264 0.484 . . . . 0.58999999999999997 110.933 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 m -125.65 10.19 7.77 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.919 1.288 . . . . 0.51000000000000001 110.605 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 45.52 44.68 10.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.176 0.991 . . . . 3.29 112.266 -169.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.9 m -134.31 155.29 50.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.411 -1.329 . . . . 0.54000000000000004 107.411 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.3 p -134.12 146.92 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.559 -0.904 . . . . 0.5 108.559 172.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -115.3 134.65 54.93 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 124.498 1.124 . . . . 2.3799999999999999 108.244 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -138.56 135.48 43.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.11 -0.7 . . . . 0.29999999999999999 109.11 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.9 mp -102.02 120.88 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.765 1.626 . . . . 1.1000000000000001 107.178 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -147.28 167.29 24.63 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.484 0.714 . . . . 1.8500000000000001 110.619 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -105.54 119.2 53.5 Favored Pre-proline 0 N--CA 1.443 -0.799 0 O-C-N 124.135 0.897 . . . . 1.3700000000000001 109.677 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -67.95 7.72 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 124.464 3.443 . . . . 0.46999999999999997 113.83 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.44 -57.0 4.12 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.201 -1.407 . . . . 0.46000000000000002 107.201 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.0 mp0 -87.84 -37.14 16.79 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.303 1.041 . . . . 3.7799999999999998 112.161 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.3 m -138.08 129.38 27.6 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 118.649 2.833 . . . . 0.54000000000000004 118.649 -155.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.41 -163.62 17.86 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.475 -1.05 . . . . 0.42999999999999999 110.475 155.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -29.29 -47.91 0.07 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.512 2.725 . . . . 0.88 112.863 172.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.15 -54.41 16.47 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.114 0.565 . . . . 0.40000000000000002 112.487 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.3 -41.62 60.86 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 122.201 1.0 . . . . 0.26000000000000001 109.182 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.708 HG12 HD22 ' A' ' 28' ' ' LEU . 1.6 mt -61.36 -60.25 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 114.137 -1.392 . . . . 0.56000000000000005 109.266 -170.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.98 -53.81 7.28 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.506 1.048 . . . . 0.79000000000000004 110.397 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -44.47 -54.44 5.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.624 1.17 . . . . 2.5899999999999999 111.363 176.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -40.7 76.04 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.987 -0.685 . . . . 2.3900000000000001 111.355 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 28' ' ' LEU . 37.7 mm -55.41 -44.27 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 119.233 0.924 . . . . 0.66000000000000003 109.947 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -52.67 -42.85 65.12 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.109 0.48 . . . . 1.8200000000000001 110.721 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -37.08 73.9 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.008 -1.057 . . . . 3.5899999999999999 111.016 -177.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.83 -21.0 17.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.538 0.735 . . . . 0.89000000000000001 110.911 169.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.08 27.39 16.23 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.588 -1.005 . . . . 0.35999999999999999 110.588 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.547 ' CE2' HD11 ' A' ' 24' ' ' ILE . 41.8 m-85 -135.51 169.51 17.4 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 107.942 -1.133 . . . . 2.02 107.942 176.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.4 114.79 16.0 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 107.84 -1.17 . . . . 4.5199999999999996 107.84 -174.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.41 144.11 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 123.795 0.838 . . . . 0.52000000000000002 108.803 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.18 108.23 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.461 1.104 . . . . 1.5700000000000001 109.373 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.2 mt -106.21 72.69 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.212 1.405 . . . . 1.5600000000000001 108.645 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -90.68 120.33 31.65 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.547 -1.649 . . . . 4.7300000000000004 106.547 163.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.04 161.13 35.04 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.546 0.593 . . . . 4.0800000000000001 112.619 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 . . . . . 0 C--O 1.254 1.304 0 C-N-CA 128.44 2.696 . . . . 9.4600000000000009 104.494 167.488 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 mtp . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 116.977 -1.487 . . . . 9.0 107.082 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mt 29.86 76.19 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.824 1.65 . . . . 5.8200000000000003 112.403 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 t -133.4 143.88 49.19 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.372 -1.714 . . . . 2.9300000000000002 106.372 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -157.51 145.81 19.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.768 -1.568 . . . . 3.3199999999999998 106.768 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -84.73 177.23 8.1 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.909 -0.587 . . . . 1.1100000000000001 111.087 -176.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.47 160.52 43.25 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.318 0.58 . . . . 4.0999999999999996 111.725 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -84.4 127.01 33.75 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.445 1.498 . . . . 2.4900000000000002 108.303 166.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tp -108.8 155.88 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.313 -1.736 . . . . 1.22 106.313 162.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.86 140.27 23.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.091 0.557 . . . . 0.72999999999999998 109.816 175.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.441 ' HG3' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -157.75 169.41 24.68 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 123.647 0.592 . . . . 1.6200000000000001 111.189 -177.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.5 152.85 23.67 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 108.105 -1.072 . . . . 2.4399999999999999 108.105 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.424 HG11 HD13 ' A' ' 24' ' ' ILE . 2.2 t -131.17 139.0 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.867 0.365 . . . . 1.0 110.289 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t -101.23 136.77 40.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.512 1.125 . . . . 0.76000000000000001 108.188 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.45 2.76 40.95 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.856 1.217 . . . . 1.4399999999999999 112.741 -173.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.513 ' SD ' HD13 ' A' ' 41' ' ' LEU . 11.0 tmm? -46.11 104.05 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.444 1.898 . . . . 4.7999999999999998 111.507 172.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.89 13.56 17.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.808 1.643 . . . . 3.7799999999999998 110.669 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.8 t 55.68 -145.52 0.62 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.367 1.467 . . . . 3.8500000000000001 111.386 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 54.66 -80.83 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.257 1.823 . . . . 3.46 112.162 -174.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -152.74 18.48 0.6 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.54 1.136 . . . . 1.0600000000000001 111.445 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.62 -59.61 2.66 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 120.864 -1.147 . . . . 1.23 109.304 -168.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -56.52 -34.18 66.76 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.478 -0.783 . . . . 0.71999999999999997 111.312 177.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.85 -47.0 87.51 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 121.88 -0.512 . . . . 0.32000000000000001 110.563 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -57.24 -44.65 84.02 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.965 0.802 . . . . 6.6900000000000004 111.527 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.562 HD11 ' CD2' ' A' ' 69' ' ' TYR . 67.7 mt -46.74 -61.19 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 108.882 -0.784 . . . . 0.81999999999999995 108.882 177.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.14 -35.48 69.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.968 -0.56 . . . . 2.6000000000000001 111.787 -172.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -57.34 -35.68 70.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.094 -1.004 . . . . 1.46 110.786 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.26 -53.57 15.14 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.821 -0.911 . . . . 0.45000000000000001 110.821 165.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.71 HD22 HG12 ' A' ' 60' ' ' ILE . 89.4 mt -65.05 -31.06 72.1 Favored 'General case' 0 C--O 1.223 -0.314 0 O-C-N 121.778 -0.837 . . . . 0.53000000000000003 112.151 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.275 14.1 ttmt -58.87 -17.76 26.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.405 1.002 . . . . 1.21 112.104 171.792 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -20.24 47.66 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.66 1.118 . . . . 3.3599999999999999 113.726 168.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.474 ' O ' HG12 ' A' ' 34' ' ' VAL . 94.4 mmm -74.33 137.54 75.02 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 119.99 1.268 . . . . 2.0499999999999998 111.924 -169.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.49 91.17 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.671 2.914 . . . . 0.44 111.403 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.59 -13.65 2.23 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.941 1.257 . . . . 0.25 111.522 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 29' ' ' LYS . 6.8 p -66.18 159.68 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 121.709 -0.877 . . . . 0.31 111.635 168.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.22 -56.39 1.63 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.135 1.374 . . . . 0.60999999999999999 110.76 168.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -143.73 157.1 44.63 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 122.299 -0.251 . . . . 2.52 111.62 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.34 131.22 31.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.885 1.274 . . . . 0.69999999999999996 109.389 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -136.98 117.74 14.04 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.639 0.776 . . . . 1.5900000000000001 110.009 -176.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -84.32 140.62 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.448 1.099 . . . . 0.65000000000000002 110.732 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -130.36 65.0 1.53 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.591 1.557 . . . . 1.21 110.777 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.513 HD13 ' SD ' ' A' ' 15' ' ' MET . 20.5 mt -64.37 -15.3 60.17 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 113.201 0.815 . . . . 0.66000000000000003 113.201 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.27 -20.07 3.84 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.274 0.63 . . . . 0.59999999999999998 111.514 167.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.6 m -134.45 18.66 3.64 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.421 1.488 . . . . 0.56000000000000005 109.957 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.8 mp0 47.28 34.84 3.37 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.299 1.04 . . . . 2.8100000000000001 111.815 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -132.5 153.17 51.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.744 -1.576 . . . . 0.5 106.744 -170.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -139.3 153.24 24.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.382 -0.97 . . . . 1.0700000000000001 108.382 173.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.12 151.73 36.98 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 124.342 1.026 . . . . 2.7400000000000002 109.815 176.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.16 136.04 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 108.598 -0.89 . . . . 0.31 108.598 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 mt -101.01 116.64 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.767 2.027 . . . . 0.81999999999999995 106.08 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -144.44 167.48 22.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.682 0.793 . . . . 1.8500000000000001 109.971 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -103.26 115.76 63.36 Favored Pre-proline 0 N--CA 1.443 -0.78 0 CA-C-N 114.726 -1.124 . . . . 1.4099999999999999 110.618 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -69.92 8.86 0.71 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 124.258 3.305 . . . . 0.5 113.953 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.38 -49.06 12.96 Favored 'General case' 0 CA--C 1.526 0.046 0 N-CA-C 107.943 -1.132 . . . . 0.42999999999999999 107.943 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -96.05 -36.22 11.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.979 1.712 . . . . 2.6600000000000001 110.693 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 m -142.19 129.07 20.62 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 117.708 2.484 . . . . 0.5 117.708 -159.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.11 -161.37 13.12 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.885 -0.886 . . . . 0.41999999999999998 110.885 157.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -32.92 -43.68 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 128.379 2.672 . . . . 0.91000000000000003 113.394 176.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.83 -57.19 7.87 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.041 0.536 . . . . 0.40999999999999998 112.145 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.85 -39.79 63.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 122.337 1.065 . . . . 0.26000000000000001 108.88 -177.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.71 HG12 HD22 ' A' ' 28' ' ' LEU . 1.8 mt -63.75 -53.44 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 114.359 -1.292 . . . . 0.55000000000000004 110.551 -169.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -51.67 58.19 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.623 1.101 . . . . 0.80000000000000004 110.454 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -46.29 -54.43 8.92 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.222 1.009 . . . . 2.1800000000000002 111.121 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -43.16 78.9 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 119.475 -0.89 . . . . 2.9300000000000002 111.263 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.432 HD11 HD11 ' A' ' 28' ' ' LEU . 4.9 mm -53.91 -45.17 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 123.822 0.849 . . . . 0.37 110.429 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -48.79 -47.64 41.86 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.915 -0.402 . . . . 1.6200000000000001 109.915 173.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -71.91 -30.04 64.95 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.642 0.979 . . . . 3.4500000000000002 113.642 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.97 -23.11 12.03 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.493 0.588 . . . . 0.84999999999999998 110.56 165.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.67 28.82 8.13 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 109.888 -1.285 . . . . 0.37 109.888 175.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.562 ' CD2' HD11 ' A' ' 24' ' ' ILE . 51.0 m-85 -139.96 164.2 30.64 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 108.122 -1.066 . . . . 1.77 108.122 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.48 121.21 36.04 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.367 -1.346 . . . . 4.5499999999999998 107.367 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.441 HG22 ' HG3' ' A' ' 10' ' ' MET . 1.4 p -86.77 159.35 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 124.838 1.255 . . . . 0.82999999999999996 108.951 174.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.97 95.08 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.412 0.625 . . . . 1.6100000000000001 111.322 176.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 37.9 mt -95.38 97.68 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 124.484 1.114 . . . . 1.6799999999999999 108.296 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -144.23 131.82 21.12 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.431 -2.063 . . . . 5.5999999999999996 105.431 168.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.68 -45.03 0.8 Allowed Glycine 0 CA--C 1.529 0.964 0 CA-C-N 118.639 0.654 . . . . 3.8999999999999999 113.831 175.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.205 0 N-CA-C 104.914 -2.254 . . . . 7.1699999999999999 104.914 -172.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mtm . . . . . 0 N--CA 1.474 0.752 0 CA-C-O 118.618 -0.706 . . . . 10.869999999999999 109.481 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.24 165.72 26.62 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.308 0.643 . . . . 5.96 109.401 174.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 75.64 130.89 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.98 2.112 . . . . 2.79 109.604 -172.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.83 148.57 27.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.311 -1.366 . . . . 2.79 107.311 174.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -90.33 168.67 11.71 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.0 0.92 . . . . 0.64000000000000001 110.248 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -149.22 162.63 39.63 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.198 0.523 . . . . 3.0600000000000001 111.518 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.09 139.4 32.5 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.527 1.931 . . . . 2.2599999999999998 108.269 170.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 tp -118.32 151.7 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.202 -1.777 . . . . 1.1000000000000001 106.202 163.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.57 120.19 11.79 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.249 1.419 . . . . 0.58999999999999997 107.944 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.5 ptt? -156.51 167.71 29.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.296 0.498 . . . . 1.1000000000000001 110.105 -171.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.08 156.95 16.41 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.422 0.689 . . . . 1.79 110.282 -173.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -115.26 160.6 14.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 C-N-CA 123.043 0.537 . . . . 0.73999999999999999 109.919 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 t -126.74 123.24 36.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.933 1.293 . . . . 0.85999999999999999 108.316 174.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.72 -18.58 11.65 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.531 1.062 . . . . 1.4099999999999999 113.221 170.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.81 141.93 3.67 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.944 1.298 . . . . 3.6200000000000001 112.443 175.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.2 p -127.12 23.01 6.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.57 1.148 . . . . 3.4500000000000002 110.718 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.6 t 58.46 -136.42 0.91 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.613 0.765 . . . . 3.9900000000000002 111.049 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 52.91 -81.19 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.829 1.652 . . . . 3.0800000000000001 112.317 -171.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.61 13.78 0.94 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.662 1.185 . . . . 1.54 111.727 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.3 m -71.6 -61.36 1.81 Allowed 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 121.255 -0.903 . . . . 1.27 109.393 -167.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -60.1 -33.26 71.86 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.278 0.561 . . . . 0.66000000000000003 111.552 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.26 -53.41 57.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 119.15 -0.452 . . . . 0.48999999999999999 110.791 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.2 mmt-85 -54.81 -49.79 70.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.683 0.674 . . . . 4.0899999999999999 111.048 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.495 HD11 ' CD2' ' A' ' 69' ' ' TYR . 83.0 mt -48.45 -60.68 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.944 -0.762 . . . . 0.55000000000000004 108.944 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.461 ' HG2' HG21 ' A' ' 46' ' ' VAL . 1.9 tm-20 -69.19 -38.79 78.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 118.8 -1.16 . . . . 3.4199999999999999 109.801 -173.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -58.3 -28.37 64.93 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.086 -1.633 . . . . 1.26 112.365 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.53 -52.08 52.48 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 110.732 -0.947 . . . . 0.37 110.732 165.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.564 HD22 HG12 ' A' ' 60' ' ' ILE . 89.9 mt -64.03 -29.93 71.04 Favored 'General case' 0 C--O 1.223 -0.29 0 O-C-N 121.551 -0.97 . . . . 0.35999999999999999 112.966 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -55.08 -18.7 5.82 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.596 1.089 . . . . 1.9299999999999999 111.957 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -86.18 -14.82 42.85 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.753 1.16 . . . . 2.96 114.042 171.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.446 ' O ' HG12 ' A' ' 34' ' ' VAL . 82.2 mmm -73.12 138.43 79.0 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 120.01 1.277 . . . . 2.1400000000000001 112.313 -170.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.06 91.88 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.801 3.001 . . . . 0.5 111.268 -171.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.57 -11.0 4.03 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.606 -0.998 . . . . 0.22 110.606 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 31' ' ' MET . 6.5 p -61.92 145.97 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 118.286 1.043 . . . . 0.31 110.507 168.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.07 -67.79 0.89 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.09 -1.078 . . . . 0.5 108.09 162.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -149.86 126.83 11.17 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 113.628 0.973 . . . . 3.5299999999999998 113.628 -163.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.14 150.76 21.25 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.367 1.867 . . . . 1.1000000000000001 110.4 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.78 100.06 2.19 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.46 0.704 . . . . 1.8600000000000001 109.266 174.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.83 140.73 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.535 0.734 . . . . 0.81999999999999995 111.476 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -136.79 69.52 1.41 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.701 1.6 . . . . 1.26 111.566 -174.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.6 mt -65.61 -15.58 62.88 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 113.32 0.859 . . . . 0.78000000000000003 113.32 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.93 -17.08 5.68 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.715 0.406 . . . . 0.56999999999999995 111.292 168.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.1 m -136.59 18.91 3.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.923 1.289 . . . . 0.57999999999999996 109.735 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 47.67 32.36 2.51 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.716 1.206 . . . . 3.0299999999999998 112.164 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 m -127.97 151.53 49.01 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.806 -1.183 . . . . 0.53000000000000003 107.806 -168.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.461 HG21 ' HG2' ' A' ' 25' ' ' GLU . 8.9 p -134.0 142.41 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 109.003 -0.74 . . . . 0.65000000000000002 109.003 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -116.59 142.53 46.76 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.294 -1.372 . . . . 2.5699999999999998 107.294 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.38 140.38 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.945 -0.391 . . . . 0.52000000000000002 109.945 172.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.4 mt -100.68 127.47 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.725 -1.583 . . . . 1.01 106.725 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -149.82 171.42 16.77 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.914 0.886 . . . . 1.73 110.565 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -105.11 106.4 55.49 Favored Pre-proline 0 N--CA 1.446 -0.649 0 C-N-CA 124.951 1.3 . . . . 1.79 110.606 -177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -70.79 20.98 0.21 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 124.016 3.144 . . . . 0.53000000000000003 113.322 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.93 -41.38 14.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.926 -1.139 . . . . 0.42999999999999999 107.926 168.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -103.64 -50.04 3.52 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.502 1.521 . . . . 2.7599999999999998 110.433 176.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 m -127.29 131.84 50.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 128.506 2.722 . . . . 0.73999999999999999 117.978 -160.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.65 -161.46 12.26 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 108.998 -1.641 . . . . 0.54000000000000004 108.998 154.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 t -31.5 -44.97 0.08 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.888 2.875 . . . . 0.56000000000000005 113.34 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.37 -56.84 6.09 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.857 0.753 . . . . 0.32000000000000001 112.674 174.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.78 -36.38 65.06 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 122.535 1.16 . . . . 0.23999999999999999 109.261 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.564 HG12 HD22 ' A' ' 28' ' ' LEU . 1.5 mt -64.36 -54.88 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.165 -1.38 . . . . 0.67000000000000004 110.72 -172.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -49.35 -51.01 37.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.144 1.338 . . . . 0.72999999999999998 110.756 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -42.93 -56.36 3.32 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.09 0.956 . . . . 2.3599999999999999 112.44 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -41.89 74.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.901 -0.719 . . . . 1.8100000000000001 111.189 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.554 HD11 HD11 ' A' ' 28' ' ' LEU . 6.9 mm -53.18 -44.92 53.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.368 0.667 . . . . 0.40999999999999998 110.357 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -50.8 -52.93 36.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.247 0.619 . . . . 1.6100000000000001 110.077 174.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -37.54 87.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.662 0.785 . . . . 5.6399999999999997 112.511 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.44 -19.92 6.57 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.554 0.742 . . . . 2.2000000000000002 111.862 168.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.65 28.69 6.92 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.343 0.973 . . . . 0.33000000000000002 110.844 170.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.495 ' CD2' HD11 ' A' ' 24' ' ' ILE . 72.6 m-85 -142.98 171.51 13.96 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.975 -1.12 . . . . 1.75 107.975 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.07 128.81 47.96 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.679 -1.6 . . . . 4.2300000000000004 106.679 173.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.42 142.25 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 119.021 -0.514 . . . . 0.54000000000000004 109.629 170.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.23 161.65 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.222 -0.658 . . . . 1.1399999999999999 109.222 173.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.1 mm -125.28 90.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.676 1.191 . . . . 1.05 107.976 171.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -145.7 117.08 7.96 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 104.981 -2.229 . . . . 4.5099999999999998 104.981 169.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.86 -49.32 0.49 Allowed Glycine 0 CA--C 1.524 0.631 0 CA-C-N 119.668 1.122 . . . . 4.5499999999999998 113.406 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.23 0 N-CA-C 105.456 -2.053 . . . . 8.0399999999999991 105.456 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.0 mtp . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 107.167 -1.42 . . . . 8.2300000000000004 107.167 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.29 73.65 0.16 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.897 1.279 . . . . 6.4299999999999997 111.71 175.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 m -130.71 134.87 47.28 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.607 -1.257 . . . . 3.0099999999999998 107.607 -177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.17 154.48 30.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.458 -1.312 . . . . 2.8799999999999999 107.458 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -95.27 169.02 10.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.009 0.924 . . . . 0.68999999999999995 110.758 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -149.6 160.89 43.12 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.24 0.543 . . . . 2.3100000000000001 111.466 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -84.61 144.82 28.37 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.399 1.48 . . . . 2.21 109.133 168.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 tp -124.47 154.32 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.234 -1.765 . . . . 1.24 106.234 165.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.0 129.56 21.41 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.498 1.119 . . . . 0.29999999999999999 109.088 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -156.86 173.5 16.89 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.511 0.725 . . . . 1.5 110.756 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -100.67 148.52 24.77 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.045 1.338 . . . . 3.3700000000000001 109.781 -174.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -118.46 161.99 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.19 0.996 . . . . 0.56000000000000005 109.346 -176.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -127.32 128.52 46.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.245 1.018 . . . . 0.75 108.901 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.57 -10.72 21.56 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.438 1.018 . . . . 1.4399999999999999 113.087 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.31 115.66 3.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.919 1.359 . . . . 2.9900000000000002 109.5 174.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.2 t -57.3 -41.28 79.54 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.531 -0.747 . . . . 4.2400000000000002 110.556 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.8 t 148.17 -40.76 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.387 2.275 . . . . 4.0899999999999999 111.359 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.4 -160.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.416 0.686 . . . . 3.77 110.735 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.62 39.26 0.1 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.816 -1.177 . . . . 1.52 113.063 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -72.07 -60.3 2.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.47 1.908 . . . . 1.1299999999999999 109.657 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.416 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -58.27 -33.35 69.31 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.234 0.54 . . . . 0.68999999999999995 111.643 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.77 -47.08 67.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.633 0.373 . . . . 0.42999999999999999 111.508 169.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -64.1 -47.19 81.0 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.21 0.604 . . . . 4.7000000000000002 110.043 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.438 HD11 ' CD2' ' A' ' 69' ' ' TYR . 62.0 mt -48.11 -60.09 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.283 -1.006 . . . . 0.58999999999999997 108.283 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -70.3 -35.63 73.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.168 -0.613 . . . . 2.3399999999999999 110.689 -171.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -58.01 -33.22 68.71 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 120.664 -1.272 . . . . 1.23 111.308 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.3 -47.26 83.61 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 110.366 -1.093 . . . . 0.28999999999999998 110.366 167.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 64' ' ' ILE . 91.7 mt -64.21 -29.22 70.34 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 118.625 1.212 . . . . 0.33000000000000002 112.428 175.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HA ' HG11 ' A' ' 34' ' ' VAL . 6.1 ttmm -59.89 -17.38 36.69 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.513 1.052 . . . . 1.72 111.243 173.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.75 -16.24 57.44 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.067 1.136 . . . . 3.5299999999999998 114.067 169.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.506 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -76.77 136.82 66.74 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 120.809 1.641 . . . . 2.5699999999999998 112.425 -171.889 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.71 99.32 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.867 3.045 . . . . 0.47999999999999998 110.995 -173.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.66 -15.79 4.08 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.304 -1.119 . . . . 0.22 110.304 177.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 31' ' ' MET . 8.5 p -67.81 150.93 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 O-C-N 122.047 -0.678 . . . . 0.28999999999999998 110.943 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.78 -65.3 1.19 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.812 -1.181 . . . . 0.41999999999999998 107.812 165.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -147.03 132.66 18.8 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 112.702 0.63 . . . . 3.3599999999999999 112.702 -163.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.8 136.77 50.63 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.902 1.681 . . . . 0.58999999999999997 108.55 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -139.73 112.96 8.25 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.591 1.156 . . . . 1.3400000000000001 108.325 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -84.5 141.07 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.183 0.993 . . . . 0.59999999999999998 110.444 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -137.03 65.32 1.51 Allowed 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.544 -1.28 . . . . 2.52 107.544 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 47.6 mt -63.23 -17.38 62.39 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 121.671 -0.643 . . . . 0.68999999999999995 112.281 174.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.28 -16.28 8.16 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.482 0.713 . . . . 0.65000000000000002 111.551 169.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.4 m -136.07 19.16 3.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.626 1.171 . . . . 0.54000000000000004 109.325 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 48.27 40.86 15.12 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.114 0.966 . . . . 3.3999999999999999 111.46 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.8 m -137.85 155.55 48.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.275 -1.38 . . . . 0.56000000000000005 107.275 -171.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.8 p -134.37 148.85 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 107.635 -1.246 . . . . 0.41999999999999998 107.635 170.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.73 150.23 43.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.973 0.796 . . . . 2.6800000000000002 109.273 171.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.99 142.73 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.841 -0.8 . . . . 0.35999999999999999 108.841 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.2 mt -104.01 127.57 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 126.675 1.99 . . . . 1.0 106.781 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -152.14 170.23 20.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.311 0.645 . . . . 1.74 110.143 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -104.21 113.09 65.53 Favored Pre-proline 0 N--CA 1.44 -0.961 0 CA-C-N 115.01 -0.996 . . . . 1.3100000000000001 110.145 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -68.8 10.35 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.799 3.0 . . . . 0.48999999999999999 113.634 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.57 -43.05 21.25 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 108.353 -0.98 . . . . 0.44 108.353 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -98.53 -44.97 6.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.319 1.447 . . . . 2.8500000000000001 110.0 176.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 m -138.04 130.91 29.87 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 118.915 2.931 . . . . 0.77000000000000002 118.915 -155.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.6 -157.82 9.27 Favored Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 108.385 -1.886 . . . . 0.54000000000000004 108.385 155.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.272 0.0 OUTLIER -32.17 -46.09 0.12 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.285 2.634 . . . . 0.53000000000000003 113.504 175.745 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.81 -57.43 4.9 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.001 0.741 . . . . 0.28999999999999998 113.001 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.02 -38.33 64.09 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 122.091 0.948 . . . . 0.19 109.225 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.616 HG12 HD22 ' A' ' 28' ' ' LEU . 1.3 mt -63.11 -58.87 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 114.347 -1.297 . . . . 0.63 109.601 -172.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.6 -51.74 15.06 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.753 1.16 . . . . 0.81000000000000005 110.971 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -42.81 -55.49 3.64 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.15 0.98 . . . . 2.1699999999999999 112.066 174.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.56 -40.5 73.3 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.146 -0.622 . . . . 2.0699999999999998 110.82 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.813 HD11 HD11 ' A' ' 28' ' ' LEU . 36.5 mm -54.56 -45.99 71.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 118.863 0.756 . . . . 0.42999999999999999 110.007 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -50.49 -51.9 43.15 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.232 0.539 . . . . 2.23 109.792 172.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -42.3 98.91 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.559 0.577 . . . . 3.7000000000000002 112.559 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mp -52.45 -19.69 2.37 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.917 1.287 . . . . 2.3999999999999999 111.875 169.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.21 29.26 9.08 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.327 -1.109 . . . . 0.34999999999999998 110.327 173.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.438 ' CD2' HD11 ' A' ' 24' ' ' ILE . 72.6 m-85 -137.98 162.88 32.95 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.098 -1.445 . . . . 1.7 107.098 177.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.782 ' HE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -115.84 134.6 54.83 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.122 -1.807 . . . . 3.8100000000000001 106.122 171.461 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.63 150.04 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.604 0.762 . . . . 0.41999999999999998 110.444 168.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.782 HG13 ' HE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -105.29 169.11 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.672 0.789 . . . . 1.1499999999999999 109.532 171.054 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.7 mm -121.82 82.49 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 125.259 1.424 . . . . 1.1299999999999999 108.17 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -135.45 85.75 2.19 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 107.197 -1.409 . . . . 4.8799999999999999 107.197 176.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.52 -120.6 0.55 Allowed Glycine 0 CA--C 1.521 0.453 0 N-CA-C 107.551 -2.219 . . . . 3.7599999999999998 107.551 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.101 0 C-N-CA 126.255 1.822 . . . . 7.3099999999999996 113.663 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ptt? . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 107.374 -1.343 . . . . 10.050000000000001 107.374 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.63 145.43 52.2 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 123.868 0.73 . . . . 5.7999999999999998 110.291 173.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p -88.81 142.23 27.84 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.62 1.168 . . . . 3.27 108.648 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -127.78 106.02 8.84 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.207 1.003 . . . . 3.2999999999999998 109.247 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -83.19 160.13 21.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.036 -0.529 . . . . 0.82999999999999996 111.357 -175.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -149.08 158.55 44.27 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.109 -0.7 . . . . 2.73 109.109 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -91.03 141.0 29.31 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.685 -1.143 . . . . 2.8900000000000001 109.51 168.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.95 138.08 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 105.407 -2.072 . . . . 3.1899999999999999 105.407 170.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.55 125.65 48.35 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.421 1.488 . . . . 0.42999999999999999 108.036 176.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -154.88 164.69 38.48 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.485 0.584 . . . . 1.1899999999999999 110.697 -175.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.47 151.59 19.42 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.09 0.956 . . . . 1.76 109.575 -173.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 t -116.1 161.21 15.01 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 C-N-CA 123.139 0.575 . . . . 0.68999999999999995 109.904 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -127.72 123.28 35.04 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.963 1.305 . . . . 0.83999999999999997 108.711 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.6 -20.03 8.92 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.861 1.22 . . . . 1.4299999999999999 113.057 170.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.47 148.82 1.82 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.98 1.312 . . . . 3.5299999999999998 112.477 175.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.9 p -135.26 40.4 2.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.556 0.742 . . . . 3.4500000000000002 110.582 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.5 t 58.68 -140.05 0.75 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.654 -1.165 . . . . 3.9700000000000002 110.934 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 37.89 48.06 0.97 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.207 1.803 . . . . 2.46 114.818 172.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 57.19 24.34 9.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.549 1.14 . . . . 1.3100000000000001 113.663 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.1 m -72.04 -60.66 2.12 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 123.914 0.886 . . . . 1.3600000000000001 109.153 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -63.43 -23.79 67.56 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.497 -0.752 . . . . 0.80000000000000004 112.218 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.51 -45.24 81.16 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 121.64 -0.663 . . . . 0.34999999999999998 110.798 167.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.3 mmp_? -58.91 -47.91 83.32 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.449 1.022 . . . . 4.8300000000000001 110.321 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 21' ' ' ALA . 77.0 mt -47.21 -60.8 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.809 -0.811 . . . . 0.53000000000000003 108.809 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -72.11 -34.15 68.38 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 119.968 -0.693 . . . . 2.5499999999999998 111.707 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm -55.69 -36.65 67.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 120.858 -1.151 . . . . 2.6200000000000001 111.028 175.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.46 -54.64 12.55 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.187 -1.165 . . . . 0.34000000000000002 110.187 166.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.606 HD22 HG12 ' A' ' 60' ' ' ILE . 89.0 mt -63.74 -32.73 74.32 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 112.885 0.698 . . . . 0.31 112.885 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -57.62 -17.54 15.04 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.229 0.922 . . . . 1.29 111.796 172.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.7 -11.3 48.68 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.694 1.368 . . . . 4.4400000000000004 114.694 170.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.469 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -70.24 138.62 86.96 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 121.278 1.854 . . . . 3.23 111.856 -177.536 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.52 90.69 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.605 2.87 . . . . 0.48999999999999999 111.079 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.82 -7.67 3.57 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.756 1.17 . . . . 0.28000000000000003 111.341 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 31' ' ' MET . 5.2 p -67.4 160.29 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 118.271 1.035 . . . . 0.28999999999999998 110.806 164.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.73 -59.55 1.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.767 1.227 . . . . 0.40000000000000002 108.659 168.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -145.13 162.91 35.9 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 112.477 0.547 . . . . 2.3100000000000001 112.477 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.54 123.51 12.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.086 1.754 . . . . 0.88 109.625 -173.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -135.64 119.62 17.48 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.423 1.489 . . . . 1.5600000000000001 109.284 -172.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -91.93 139.13 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.127 0.971 . . . . 0.66000000000000003 110.545 -176.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -131.08 66.69 1.53 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.833 1.653 . . . . 1.23 111.143 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.4 mt -67.01 -15.92 64.03 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 113.113 0.782 . . . . 0.81000000000000005 113.113 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.81 -24.84 9.74 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.66 0.384 . . . . 0.76000000000000001 110.622 167.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.0 m -128.55 19.99 6.18 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.213 1.405 . . . . 0.60999999999999999 110.044 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 47.58 35.01 3.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.188 0.995 . . . . 2.7999999999999998 112.145 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.4 m -132.52 152.03 51.71 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.118 -1.068 . . . . 0.46999999999999997 108.118 -168.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.2 p -133.96 147.47 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.367 0.667 . . . . 0.45000000000000001 109.389 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -121.34 129.13 52.91 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.1 1.36 . . . . 2.6000000000000001 108.464 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.92 137.1 51.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.021 -0.733 . . . . 0.39000000000000001 109.021 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.4 mp -108.55 120.77 60.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.012 1.325 . . . . 1.26 108.134 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -144.36 171.37 14.42 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.186 0.994 . . . . 1.73 110.877 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -108.39 111.73 61.36 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 124.979 1.312 . . . . 1.79 111.15 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -76.83 30.13 0.41 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.747 2.964 . . . . 0.70999999999999996 112.711 -172.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.96 -50.16 5.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.77 -1.567 . . . . 0.40999999999999998 106.77 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.16 -43.52 7.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.16 1.784 . . . . 2.8700000000000001 110.495 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.6 m -133.93 127.3 32.17 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 116.45 2.019 . . . . 0.53000000000000003 116.45 -159.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.89 -164.23 13.32 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 108.898 -1.681 . . . . 0.46999999999999997 108.898 153.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.2 t -34.78 -40.39 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.706 2.802 . . . . 0.67000000000000004 112.831 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.0 -54.46 8.34 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.907 0.883 . . . . 0.42999999999999999 113.233 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.63 -36.83 65.49 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.924 1.345 . . . . 0.34000000000000002 109.642 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.606 HG12 HD22 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -70.82 -50.16 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 113.309 -1.768 . . . . 0.54000000000000004 110.903 -164.294 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.75 -52.34 49.46 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.388 1.449 . . . . 0.76000000000000001 109.034 172.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.46 -45.66 46.98 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.708 1.203 . . . . 5.04 112.294 -177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -44.59 60.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.247 -1.533 . . . . 2.9900000000000002 112.823 172.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.473 HD11 HD11 ' A' ' 28' ' ' LEU . 4.1 mm -51.43 -44.93 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.986 1.315 . . . . 0.42999999999999999 110.707 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -49.73 -47.53 50.64 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.453 0.644 . . . . 1.5600000000000001 110.361 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -32.65 67.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.249 1.02 . . . . 5.5199999999999996 112.292 -177.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.45 -25.62 37.47 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 119.385 -0.34 . . . . 0.93000000000000005 110.239 166.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.31 29.22 5.78 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.542 1.068 . . . . 0.37 110.823 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -142.86 165.73 26.57 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.273 -1.01 . . . . 1.74 108.273 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.95 125.68 48.02 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.267 -1.753 . . . . 4.2999999999999998 106.267 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -96.78 143.06 13.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 O-C-N 123.751 0.657 . . . . 0.46000000000000002 109.894 172.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.3 m -97.21 161.82 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.425 -0.583 . . . . 1.1799999999999999 109.425 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.4 mm -125.74 74.35 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 108.083 -1.08 . . . . 1.0700000000000001 108.083 172.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -125.36 90.19 3.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.798 -1.927 . . . . 4.4900000000000002 105.798 168.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.82 89.24 0.07 OUTLIER Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.058 -2.017 . . . . 4.8499999999999996 108.058 -174.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 C--O 1.253 1.274 0 CA-C-O 116.246 -1.835 . . . . 9.25 107.159 168.043 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 106.175 -1.787 . . . . 9.25 106.175 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.1 tp 75.25 70.81 0.09 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.657 1.223 . . . . 7.2400000000000002 111.876 170.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.2 m -139.56 150.21 44.78 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 106.644 -1.613 . . . . 3.3199999999999998 106.644 170.142 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -157.27 148.4 21.75 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.003 -1.11 . . . . 4.1299999999999999 108.003 169.196 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -85.77 162.55 18.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.952 0.901 . . . . 0.96999999999999997 111.437 -177.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -154.68 158.49 39.7 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 122.011 0.91 . . . . 3.3199999999999998 111.177 178.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -84.03 114.13 21.51 Favored 'General case' 0 N--CA 1.452 -0.332 1 C-N-CA 131.984 4.113 . . . . 2.2999999999999998 107.363 174.064 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.48 149.3 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 105.803 -1.925 . . . . 2.46 105.803 164.388 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.73 123.73 18.94 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.602 1.561 . . . . 0.38 108.261 176.492 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -157.49 166.71 32.23 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.941 0.496 . . . . 1.1499999999999999 111.78 -171.277 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -101.44 140.09 36.2 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.069 1.748 . . . . 3.2799999999999998 108.855 -169.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.92 142.12 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 123.487 0.715 . . . . 0.85999999999999999 110.166 -177.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -86.76 116.46 24.87 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.136 -1.061 . . . . 1.01 108.136 173.514 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.05 73.24 1.24 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.965 -0.854 . . . . 2.7400000000000002 110.965 179.083 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -129.82 -174.86 3.43 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.366 1.866 . . . . 3.4199999999999999 107.244 175.127 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 t 47.25 43.28 14.68 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.59 1.156 . . . . 6.8799999999999999 112.849 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.43 51.54 2.0 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.755 0.788 . . . . 7.0599999999999996 109.794 -175.721 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 77.79 74.02 0.06 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.75 2.02 . . . . 3.23 110.996 -173.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.72 34.09 17.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.998 1.319 . . . . 1.23 112.67 171.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.2 m -70.74 -63.01 1.18 Allowed 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 121.602 -0.686 . . . . 1.6499999999999999 110.8 -168.745 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -57.25 -35.14 69.36 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.373 0.533 . . . . 1.0700000000000001 110.688 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.48 -55.94 27.5 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.452 -0.34 . . . . 0.55000000000000004 111.22 173.158 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -59.08 -49.85 76.33 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.425 0.557 . . . . 3.9500000000000002 110.74 177.316 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 21' ' ' ALA . 66.7 mt -45.67 -59.88 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.767 1.227 . . . . 0.57999999999999996 108.723 177.392 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -70.84 -35.74 72.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.383 -0.371 . . . . 2.3100000000000001 110.715 -173.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -59.15 -30.44 68.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.06 -1.025 . . . . 1.26 110.872 174.322 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.56 -52.33 48.8 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 110.743 -0.943 . . . . 0.32000000000000001 110.743 164.666 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.664 HD11 HD11 ' A' ' 64' ' ' ILE . 95.6 mt -63.0 -29.93 71.2 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.268 -1.136 . . . . 0.32000000000000001 113.13 177.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -54.74 -18.96 5.32 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.246 0.93 . . . . 1.8899999999999999 111.924 170.283 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.29 -15.03 48.13 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.022 1.119 . . . . 2.98 114.022 171.783 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.462 ' O ' HG12 ' A' ' 34' ' ' VAL . 93.2 mmm -76.89 137.8 65.94 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 120.252 1.387 . . . . 1.97 112.424 -172.68 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.71 101.08 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.513 2.808 . . . . 0.55000000000000004 110.922 -173.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.39 -13.29 5.16 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 124.981 1.277 . . . . 0.25 110.151 175.483 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 31' ' ' MET . 5.8 p -64.01 147.51 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 117.806 0.803 . . . . 0.31 110.676 169.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.67 -60.44 1.82 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.986 1.315 . . . . 0.53000000000000003 110.407 168.563 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -154.43 148.88 26.2 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 115.401 1.63 . . . . 2.5299999999999998 115.401 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.3 142.23 42.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.265 1.426 . . . . 0.69999999999999996 110.825 -176.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -145.38 102.3 3.7 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.171 -1.048 . . . . 3.7799999999999998 108.171 -170.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.5 p -83.79 134.32 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.296 0.638 . . . . 0.80000000000000004 110.889 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -131.12 70.12 1.47 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.075 -1.083 . . . . 2.4900000000000002 108.075 -177.099 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.4 mt -64.02 -24.65 67.79 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.502 -0.749 . . . . 1.2 111.954 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.38 -24.25 28.79 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.08 0.552 . . . . 0.82999999999999996 111.03 171.37 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.6 m -118.97 11.44 12.5 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.372 1.469 . . . . 1.0600000000000001 110.309 -179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 46.4 47.96 13.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.053 0.842 . . . . 2.23 111.673 -178.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.47 159.02 39.47 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.12 -1.067 . . . . 1.3200000000000001 108.12 -174.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.2 p -125.68 146.92 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 108.558 -0.905 . . . . 0.46000000000000002 108.558 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -117.44 141.5 48.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.711 1.205 . . . . 2.4300000000000002 108.351 176.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.05 132.24 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.695 -0.483 . . . . 0.35999999999999999 109.695 173.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.5 mt -91.86 126.2 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.387 1.875 . . . . 0.71999999999999997 106.871 176.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -147.5 173.86 12.26 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.428 0.691 . . . . 1.95 111.114 176.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -110.44 120.03 45.14 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 124.366 1.066 . . . . 1.4299999999999999 110.965 -178.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -69.33 7.28 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 124.596 3.531 . . . . 0.55000000000000004 113.575 -178.022 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.49 -37.22 37.27 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 108.644 -0.873 . . . . 0.69999999999999996 108.644 176.133 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -114.88 -53.82 2.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.571 1.549 . . . . 2.77 110.041 -179.631 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 m -104.34 129.99 52.2 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 128.233 2.613 . . . . 0.90000000000000002 117.343 -172.161 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.25 -173.36 22.44 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 109.779 -1.328 . . . . 0.48999999999999999 109.779 151.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.3 t -35.24 -41.14 0.15 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.556 2.742 . . . . 0.57999999999999996 112.414 174.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.77 -57.19 5.9 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.981 0.734 . . . . 0.29999999999999999 112.981 173.388 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.47 66.43 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 122.338 1.066 . . . . 0.22 108.835 -176.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.589 HG12 HD22 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -62.02 -58.04 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 114.012 -1.449 . . . . 0.62 110.082 -174.4 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.47 -51.1 15.93 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.681 1.128 . . . . 0.78000000000000003 110.823 175.669 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -45.31 -51.85 10.48 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.406 0.683 . . . . 2.3399999999999999 112.342 177.336 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -43.68 67.37 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 118.17 -0.919 . . . . 2.0800000000000001 111.667 177.338 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.664 HD11 HD11 ' A' ' 28' ' ' LEU . 24.7 mm -52.4 -45.71 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 119.698 1.135 . . . . 0.32000000000000001 110.196 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -49.46 -47.04 48.62 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.26 0.624 . . . . 1.6299999999999999 110.11 172.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -36.57 74.2 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.674 0.79 . . . . 4.4400000000000004 112.318 -178.452 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -54.46 -22.76 13.62 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.837 0.455 . . . . 0.92000000000000004 110.41 169.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.13 28.51 5.81 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 110.444 -1.063 . . . . 0.39000000000000001 110.444 170.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -144.61 169.17 18.49 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.638 -1.245 . . . . 2.0 107.638 -177.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.713 ' HE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -119.08 135.53 54.59 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.358 -1.719 . . . . 3.8300000000000001 106.358 172.038 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -98.36 147.67 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.056 0.942 . . . . 0.46999999999999997 109.549 167.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.713 HG13 ' HE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -101.59 160.92 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.032 -0.729 . . . . 1.0700000000000001 109.032 169.539 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.6 mm -121.32 79.85 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.232 -1.395 . . . . 1.0800000000000001 107.232 172.118 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -102.19 120.19 40.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 105.433 -2.062 . . . . 4.3200000000000003 105.433 168.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.48 -50.34 0.2 Allowed Glycine 0 C--N 1.338 0.689 0 CA-C-N 118.817 0.735 . . . . 3.6499999999999999 112.507 -176.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.0 tpp85 . . . . . 0 C--O 1.253 1.257 0 CA-C-O 116.785 -1.579 . . . . 7.9100000000000001 107.795 167.893 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.485 -0.561 . . . . 8.0899999999999999 109.485 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mp -65.74 166.36 11.06 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.341 -0.615 . . . . 6.8700000000000001 109.341 171.631 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.0 m -109.12 158.49 17.73 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.957 1.303 . . . . 2.5899999999999999 107.863 170.544 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -146.33 148.83 32.79 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.105 -1.443 . . . . 4.1299999999999999 107.105 174.247 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -107.02 171.78 7.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.329 1.051 . . . . 0.69999999999999996 110.738 -172.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.76 159.88 40.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.764 0.792 . . . . 3.73 111.854 -179.341 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.12 135.77 34.26 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.496 -1.684 . . . . 2.4900000000000002 108.232 169.248 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 tp -109.44 151.04 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 105.843 -1.91 . . . . 1.0900000000000001 105.843 161.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.62 123.65 16.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.997 1.319 . . . . 0.40999999999999998 107.85 176.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.6 ptt? -157.7 172.16 19.01 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.713 0.405 . . . . 1.0800000000000001 110.292 -170.437 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -102.74 150.08 23.82 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.401 1.08 . . . . 3.2000000000000002 110.123 -171.147 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.71 167.89 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 C-N-CA 123.684 0.794 . . . . 0.78000000000000003 109.706 -178.499 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t -136.14 129.89 32.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.287 1.035 . . . . 0.77000000000000002 108.829 176.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.77 -17.89 20.04 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.647 1.117 . . . . 1.4099999999999999 113.628 171.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.4 123.56 12.34 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.457 1.128 . . . . 3.0899999999999999 112.213 178.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 p -96.58 30.47 2.58 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.247 0.619 . . . . 3.6499999999999999 110.747 175.229 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.473 ' HA ' HD13 ' A' ' 41' ' ' LEU . 1.8 t 70.73 -159.99 0.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.899 1.28 . . . . 3.9199999999999999 111.461 174.345 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 47.02 -136.93 0.79 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.06 0.944 . . . . 3.71 110.567 -173.071 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.18 7.95 6.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.112 0.782 . . . . 1.1399999999999999 113.112 -175.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.3 m -69.01 -60.08 2.6 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.759 1.163 . . . . 1.45 110.301 -164.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.69 -27.79 69.45 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.88 -0.512 . . . . 0.68999999999999995 112.28 176.6 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.91 -50.81 67.88 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.686 -0.487 . . . . 0.38 109.686 168.151 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -59.4 -45.1 92.43 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 118.481 -0.771 . . . . 3.6400000000000001 111.99 174.329 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.7 mt -46.96 -59.95 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.359 -0.608 . . . . 0.55000000000000004 109.359 176.446 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -70.13 -41.18 74.26 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 119.634 -0.826 . . . . 3.5800000000000001 109.993 -173.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -52.15 -35.6 48.99 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 120.423 -1.423 . . . . 1.77 112.089 179.21 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.26 -52.12 33.42 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 110.921 -0.872 . . . . 0.38 110.921 167.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 64' ' ' ILE . 73.1 mt -66.94 -27.76 67.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 118.51 -0.757 . . . . 0.60999999999999999 112.587 177.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -59.87 -16.99 33.43 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 119.614 1.097 . . . . 1.4199999999999999 110.566 171.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.36 -8.83 58.25 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.013 1.116 . . . . 3.3999999999999999 114.013 171.297 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.507 ' O ' HG12 ' A' ' 34' ' ' VAL . 9.5 mmt -71.75 138.67 82.91 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 120.304 1.411 . . . . 2.0699999999999998 111.722 -175.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.28 90.82 0.57 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.263 2.642 . . . . 0.52000000000000002 110.793 -175.188 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.27 -16.33 2.1 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.483 1.04 . . . . 0.25 111.495 -179.078 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 31' ' ' MET . 5.5 p -70.82 156.02 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 O-C-N 121.674 -0.897 . . . . 0.28000000000000003 111.409 171.512 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.22 -62.58 1.57 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.424 1.09 . . . . 0.54000000000000004 109.126 166.77 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -147.76 142.25 26.45 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 112.502 0.556 . . . . 3.02 112.502 -169.433 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.86 157.09 17.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.237 1.815 . . . . 1.1299999999999999 109.333 178.36 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.54 95.82 1.83 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.042 -1.095 . . . . 2.0499999999999998 108.042 177.046 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.12 140.24 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 121.917 -0.49 . . . . 0.73999999999999999 111.449 -178.231 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -137.02 69.94 1.41 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.148 1.379 . . . . 2.48 109.092 -174.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 17' ' ' CYS . 68.7 mt -65.69 -16.56 63.87 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 115.565 -0.743 . . . . 0.76000000000000001 112.932 177.93 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.6 -22.5 8.72 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.543 0.737 . . . . 0.70999999999999996 110.741 169.237 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.9 m -133.05 21.22 4.1 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.938 0.895 . . . . 0.75 109.854 179.064 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 50.37 34.7 9.46 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.058 0.844 . . . . 3.0499999999999998 112.069 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.6 m -128.53 152.57 48.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.644 1.178 . . . . 0.55000000000000004 107.876 -168.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 p -135.14 143.57 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.844 -0.798 . . . . 0.64000000000000001 108.844 173.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -119.24 145.27 46.21 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.848 1.259 . . . . 2.4700000000000002 107.969 176.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.86 139.03 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.629 -0.508 . . . . 0.39000000000000001 109.629 174.566 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.9 mt -101.05 119.2 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 126.96 2.104 . . . . 0.88 107.196 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.448 ' CE2' HD13 ' A' ' 60' ' ' ILE . 2.1 p90 -146.35 168.87 20.06 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.398 1.079 . . . . 2.02 109.593 -178.572 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -101.65 115.63 64.63 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 118.385 -0.817 . . . . 2.0699999999999998 109.278 177.221 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -68.63 7.6 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.747 2.965 . . . . 0.77000000000000002 113.646 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.21 -55.54 5.18 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 107.441 -1.318 . . . . 0.75 107.441 172.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -88.18 -30.75 19.53 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.435 1.094 . . . . 3.9300000000000002 112.109 176.854 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.9 m -148.47 121.4 8.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 117.677 2.473 . . . . 0.72999999999999998 117.677 -157.128 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.69 -166.79 23.14 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.588 -1.005 . . . . 0.53000000000000003 110.588 159.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 t -29.61 -46.68 0.06 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.499 3.119 . . . . 0.57999999999999996 112.841 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.42 -58.42 3.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.048 0.939 . . . . 0.37 113.155 173.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.18 -34.19 65.86 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 122.511 1.148 . . . . 0.23999999999999999 109.554 -178.735 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.477 HG12 HD13 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -66.57 -52.86 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 117.199 -1.381 . . . . 0.73999999999999999 110.928 -171.887 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -49.29 -50.16 40.44 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 121.04 1.746 . . . . 0.83999999999999997 110.922 175.229 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -39.73 -60.27 1.01 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.904 0.882 . . . . 2.6800000000000002 112.634 172.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -70.73 -40.43 72.76 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.202 -0.999 . . . . 1.8799999999999999 110.82 -177.182 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.604 HD11 HD11 ' A' ' 28' ' ' LEU . 16.8 mm -53.31 -44.68 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 119.034 0.834 . . . . 0.46000000000000002 110.046 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -53.81 -45.66 70.85 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.129 0.49 . . . . 1.8200000000000001 109.772 174.405 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.62 -39.74 91.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.485 -0.76 . . . . 3.0699999999999998 111.354 -179.19 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.4 -23.58 16.32 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.443 0.697 . . . . 0.93000000000000005 110.786 171.56 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.95 26.93 7.25 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 124.466 1.031 . . . . 0.37 110.9 173.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -144.8 176.34 9.52 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 122.025 0.916 . . . . 1.7 109.617 -175.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.68 117.24 23.06 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 106.035 -1.839 . . . . 3.77 106.035 -171.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.9 p -96.13 142.45 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.868 -0.79 . . . . 0.47999999999999998 108.868 165.022 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.23 157.6 10.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 108.764 -0.828 . . . . 1.0900000000000001 108.764 173.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 33.7 mm -118.71 74.66 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.852 -1.166 . . . . 1.1100000000000001 107.852 -177.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -116.78 130.54 56.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.231 -2.137 . . . . 4.1299999999999999 105.231 168.067 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.94 -104.0 0.37 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 108.059 -2.016 . . . . 3.46 108.059 -169.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 . . . . . 0 C--O 1.251 1.132 0 CA-C-O 117.546 -1.216 . . . . 9.5899999999999999 110.119 -166.529 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ptt? . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 111.844 0.313 . . . . 12.16 111.844 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 29.5 mt -121.17 172.83 7.69 Favored 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 107.29 -1.374 . . . . 6.4000000000000004 107.29 168.047 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 p -139.97 70.82 1.36 Allowed 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 125.265 1.426 . . . . 3.1299999999999999 107.449 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -134.38 121.76 21.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.628 1.171 . . . . 3.29 107.933 -175.234 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -84.6 167.25 16.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.092 -0.504 . . . . 0.98999999999999999 111.515 -173.333 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -139.67 152.83 47.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.521 0.677 . . . . 2.5099999999999998 109.822 179.433 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -90.34 125.92 35.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 127.036 2.134 . . . . 2.25 106.762 168.028 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 tp -109.21 151.29 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.167 -1.42 . . . . 1.1000000000000001 107.167 167.249 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.52 133.93 36.99 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.731 -1.211 . . . . 0.34999999999999998 107.731 170.247 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.75 170.92 21.34 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.439 0.462 . . . . 1.4099999999999999 111.195 175.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.65 152.81 19.35 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.854 0.861 . . . . 1.98 110.362 -176.498 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.57 171.56 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 123.7 0.8 . . . . 0.81000000000000005 110.034 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -130.48 131.82 45.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.782 0.833 . . . . 0.71999999999999997 110.603 176.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.15 31.51 10.74 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.667 1.127 . . . . 1.3799999999999999 113.311 169.405 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.24 91.44 4.74 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.92 0.86 . . . . 3.0899999999999999 110.811 -171.581 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 m -79.53 45.37 0.67 Allowed 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.27 -0.894 . . . . 4.0 112.011 -177.248 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 t 47.27 -130.01 1.52 Allowed 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 126.078 1.751 . . . . 3.8900000000000001 110.14 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 39.4 46.81 1.43 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 121.756 2.071 . . . . 2.75 113.676 178.786 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.36 18.08 8.94 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.202 1.401 . . . . 0.93999999999999995 114.157 179.119 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.4 m -71.1 -60.75 2.06 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.279 -1.008 . . . . 1.1799999999999999 108.279 -176.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.13 -43.73 61.23 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.918 0.866 . . . . 0.70999999999999996 111.284 177.527 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.15 -50.66 68.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.086 -0.961 . . . . 0.31 110.664 174.26 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -54.63 -45.24 73.7 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.574 -0.726 . . . . 4.3200000000000003 111.444 173.647 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.4 mt -52.46 -60.89 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.391 -0.966 . . . . 0.76000000000000001 108.391 177.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.62 -33.96 73.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.4 -0.92 . . . . 2.3599999999999999 110.615 -168.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -56.24 -36.76 68.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.092 -1.005 . . . . 1.3899999999999999 111.263 171.547 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.5 -44.51 90.45 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.054 -0.818 . . . . 0.29999999999999999 111.054 168.371 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.709 HD11 HD11 ' A' ' 64' ' ' ILE . 97.3 mt -65.6 -30.66 71.41 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 119.407 1.603 . . . . 0.33000000000000002 112.514 175.342 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.537 ' HA ' HG11 ' A' ' 34' ' ' VAL . 12.9 ttmt -56.62 -18.41 11.97 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.13 0.877 . . . . 1.4399999999999999 112.03 170.621 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 mtp85 -87.88 -5.29 58.65 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.891 -1.13 . . . . 4.3799999999999999 112.694 174.308 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.471 ' O ' HG12 ' A' ' 34' ' ' VAL . 95.1 mmm -82.74 136.62 44.69 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 120.389 1.45 . . . . 1.98 111.748 179.203 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.8 100.73 0.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.506 2.804 . . . . 0.35999999999999999 111.262 -173.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.37 -13.03 3.77 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.58 1.086 . . . . 0.20000000000000001 111.173 176.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.0 p -67.9 152.97 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.836 0.854 . . . . 0.27000000000000002 111.182 169.408 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.1 -60.5 1.87 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.582 1.153 . . . . 0.40999999999999998 109.356 166.516 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -148.66 141.59 24.76 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.239 0.459 . . . . 3.1400000000000001 112.239 -169.138 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.61 136.71 53.11 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.779 1.632 . . . . 0.59999999999999998 108.632 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -142.05 108.9 5.41 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.577 1.151 . . . . 1.3600000000000001 108.5 -177.274 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.4 p -89.92 142.7 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.742 0.817 . . . . 0.60999999999999999 111.772 -175.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -137.71 68.99 1.4 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.364 1.465 . . . . 1.22 111.011 -175.472 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.4 mt -66.71 -14.91 63.1 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 112.948 0.721 . . . . 0.75 112.948 177.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.5 -13.34 5.35 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.983 0.356 . . . . 0.53000000000000003 111.221 167.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.5 m -138.38 18.46 2.75 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.387 1.075 . . . . 0.51000000000000001 109.572 177.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 51.76 30.75 7.22 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.14 0.882 . . . . 3.1400000000000001 112.035 -179.546 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.4 m -129.66 153.42 48.14 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.069 -1.086 . . . . 0.51000000000000001 108.069 -167.588 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.4 144.47 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 108.802 -0.814 . . . . 0.45000000000000001 108.802 173.614 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -112.78 139.99 47.94 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.744 1.218 . . . . 2.46 108.055 176.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.44 141.2 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.249 -0.649 . . . . 0.25 109.249 171.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 mt -104.74 127.37 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.971 1.708 . . . . 0.92000000000000004 106.533 -179.054 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -152.3 171.78 17.45 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.946 0.498 . . . . 1.8799999999999999 110.098 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -111.07 120.51 43.1 Favored Pre-proline 0 N--CA 1.448 -0.563 0 O-C-N 123.944 0.777 . . . . 2.0899999999999999 111.187 -177.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.14 19.39 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.072 3.181 . . . . 0.64000000000000001 113.681 -178.646 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.63 -50.74 7.91 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.256 -1.387 . . . . 0.54000000000000004 107.256 169.514 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -96.33 -39.81 9.44 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.099 1.36 . . . . 3.5499999999999998 111.4 176.802 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.5 m -132.41 129.89 39.9 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 117.748 2.499 . . . . 0.54000000000000004 117.748 -155.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.76 -172.09 22.91 Favored Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 110.043 -1.223 . . . . 0.5 110.043 157.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.272 0.1 OUTLIER -29.31 -43.09 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 128.633 2.773 . . . . 0.63 113.902 169.241 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.64 -55.35 16.79 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.868 0.758 . . . . 0.34000000000000002 112.671 175.203 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.08 -36.24 66.78 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 122.557 1.17 . . . . 0.17999999999999999 108.966 -176.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.541 HG12 HD22 ' A' ' 28' ' ' LEU 0.257 0.9 OUTLIER -65.47 -56.56 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 113.852 -1.522 . . . . 0.55000000000000004 110.351 -172.617 . . . . . . . . 4 4 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -49.61 47.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.171 1.35 . . . . 0.73999999999999999 110.913 177.255 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -42.48 -58.4 2.26 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.74 0.816 . . . . 2.2799999999999998 112.094 173.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -42.36 73.39 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 119.548 -0.861 . . . . 2.3199999999999998 111.421 -177.326 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.709 HD11 HD11 ' A' ' 28' ' ' LEU . 17.3 mm -51.21 -47.6 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.67 0.788 . . . . 0.39000000000000001 109.832 177.594 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -50.6 -53.47 30.38 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 121.426 0.632 . . . . 1.6100000000000001 109.678 175.12 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -29.3 70.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.028 0.531 . . . . 5.3399999999999999 112.412 -178.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -63.85 -20.02 65.49 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.23 0.612 . . . . 2.0899999999999999 109.783 173.173 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.26 28.76 6.65 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 125.075 1.321 . . . . 0.35999999999999999 110.618 173.285 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -143.85 168.47 19.88 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.122 -1.436 . . . . 1.6499999999999999 107.122 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.732 ' HE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -119.83 135.97 54.66 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.428 -1.693 . . . . 4.1500000000000004 106.428 169.435 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -100.63 142.92 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.331 1.052 . . . . 0.64000000000000001 109.722 166.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.732 HG13 ' HE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -94.65 168.76 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.692 -0.855 . . . . 1.27 108.692 173.457 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 23.5 mm -127.74 94.92 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.768 -1.567 . . . . 1.0600000000000001 106.768 170.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -47.64 102.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.965 1.306 . . . . 7.6799999999999997 112.232 174.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.87 -105.09 1.53 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.799 -0.92 . . . . 6.1299999999999999 110.799 177.305 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.026 0 N-CA-C 104.376 -2.453 . . . . 9.5199999999999996 104.376 166.56 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 mtt . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 108.078 -1.082 . . . . 10.529999999999999 108.078 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.74 173.58 11.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 106.997 -1.483 . . . . 5.5 106.997 179.473 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 p -119.71 149.86 41.31 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.647 -1.612 . . . . 2.3500000000000001 106.647 166.311 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -157.52 146.18 19.49 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.331 -1.359 . . . . 4.0700000000000003 107.331 173.027 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -84.88 168.96 14.58 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.994 0.918 . . . . 0.65000000000000002 111.518 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -148.8 161.75 41.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.687 -0.857 . . . . 2.8100000000000001 108.687 173.356 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -82.91 138.46 33.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.522 -1.288 . . . . 2.6299999999999999 107.522 162.18 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 tp -107.14 153.48 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 1.1100000000000001 105.713 157.188 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.53 128.21 17.18 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.917 -1.142 . . . . 0.35999999999999999 107.917 173.347 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.48 175.86 13.41 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.189 0.45 . . . . 1.2 110.866 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.0 mp0 -94.19 149.37 21.3 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.287 1.035 . . . . 3.0699999999999998 109.279 -174.468 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.21 165.59 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.854 -0.795 . . . . 0.69999999999999996 108.854 177.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.42 145.46 50.3 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.643 -1.243 . . . . 1.1000000000000001 107.643 171.566 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.22 -21.47 35.37 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.204 0.907 . . . . 1.4099999999999999 113.441 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.8 146.17 42.74 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.461 1.13 . . . . 2.98 112.463 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.8 p -133.32 41.14 3.12 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.628 1.171 . . . . 3.4500000000000002 110.15 177.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.0 t 50.28 -140.8 0.78 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 117.538 -1.22 . . . . 4.0099999999999998 111.616 -177.265 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 36.17 57.77 1.01 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 120.564 1.529 . . . . 2.5499999999999998 113.302 177.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.66 16.72 5.65 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.218 1.407 . . . . 0.98999999999999999 114.369 176.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 91.2 m -72.54 -60.79 2.06 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 121.293 -0.88 . . . . 1.3600000000000001 109.433 -177.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.407 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -59.5 -32.18 70.04 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 121.652 0.739 . . . . 0.69999999999999996 111.665 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.4 -42.57 70.6 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 118.757 -0.64 . . . . 0.34999999999999998 111.04 171.782 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -61.07 -45.42 94.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.279 0.945 . . . . 3.4700000000000002 110.598 176.079 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.488 HD11 ' CD2' ' A' ' 69' ' ' TYR . 63.9 mt -48.35 -60.94 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.319 -0.993 . . . . 0.67000000000000004 108.319 179.098 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.28 -34.1 67.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 119.945 -0.702 . . . . 2.5800000000000001 111.838 -173.844 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -55.94 -37.73 69.37 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.121 -0.987 . . . . 1.73 110.736 176.175 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.5 -52.75 27.49 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.458 -1.057 . . . . 0.38 110.458 167.677 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 64' ' ' ILE . 87.0 mt -64.62 -31.1 72.17 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.591 -0.946 . . . . 0.38 112.503 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.25 23.3 ttmt -59.03 -13.73 7.52 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 119.209 0.913 . . . . 1.74 111.69 170.514 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 -1.63 40.23 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.553 -1.342 . . . . 5.4100000000000001 114.001 170.395 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.418 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.91 139.3 61.67 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 120.815 1.643 . . . . 3.0299999999999998 111.489 179.578 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.78 92.78 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.588 2.858 . . . . 0.37 110.429 -174.66 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.33 -9.65 3.79 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.562 1.077 . . . . 0.20000000000000001 111.633 177.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 31' ' ' MET . 5.8 p -66.73 157.42 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 118.054 0.927 . . . . 0.31 110.884 167.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.74 -56.41 2.12 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.989 1.316 . . . . 0.45000000000000001 110.229 168.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -143.17 157.35 44.59 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 123.081 0.553 . . . . 3.1400000000000001 109.917 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.63 134.84 39.67 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.936 1.694 . . . . 0.67000000000000004 108.165 174.413 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -142.07 116.86 9.82 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.499 1.119 . . . . 1.4199999999999999 108.833 -173.378 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.73 139.54 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.429 1.092 . . . . 0.57999999999999996 111.541 -175.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -132.37 67.77 1.52 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.628 1.571 . . . . 1.23 111.913 179.921 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.3 mt -65.86 -16.01 63.44 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 113.281 0.845 . . . . 0.73999999999999999 113.281 178.33 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.16 -19.66 8.31 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.073 0.397 . . . . 0.54000000000000004 110.997 168.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.3 m -130.48 14.9 5.51 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.907 1.283 . . . . 0.48999999999999999 110.373 178.592 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 51.44 35.28 13.81 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.037 0.835 . . . . 2.75 112.048 -177.618 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 m -134.01 153.59 51.69 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 107.88 -1.156 . . . . 0.47999999999999998 107.88 -170.319 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.16 151.38 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.374 -0.973 . . . . 0.42999999999999999 108.374 174.518 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.17 150.29 42.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 124.178 0.924 . . . . 2.75 109.895 172.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.61 134.0 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.346 -0.983 . . . . 0.32000000000000001 108.346 177.556 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.5 127.84 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.923 -1.51 . . . . 0.84999999999999998 106.923 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -150.29 170.09 19.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.024 0.529 . . . . 2.04 110.348 -178.142 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.8 120.47 47.06 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 124.311 1.044 . . . . 1.3899999999999999 111.002 -179.493 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -69.93 8.4 0.82 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.48 3.453 . . . . 0.70999999999999996 113.914 -177.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.8 -44.61 26.97 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 108.162 -1.051 . . . . 0.69999999999999996 108.162 175.303 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -102.68 -42.67 5.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.293 1.837 . . . . 3.0299999999999998 110.249 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.6 m -129.53 127.45 40.79 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 117.57 2.433 . . . . 0.52000000000000002 117.57 -158.333 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.42 -173.24 22.42 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 109.607 -1.397 . . . . 0.56000000000000005 109.607 158.32 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 t -41.64 -34.03 0.55 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.282 2.633 . . . . 0.84999999999999998 112.195 178.761 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.8 -57.59 7.04 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.915 0.709 . . . . 0.26000000000000001 112.915 171.393 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.61 -35.88 67.95 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 122.581 1.182 . . . . 0.23000000000000001 108.759 -176.671 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.598 HG12 HD22 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -63.68 -58.3 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 113.896 -1.502 . . . . 0.53000000000000003 109.551 -173.983 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.73 -50.67 24.6 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.412 1.46 . . . . 0.78000000000000003 111.065 177.559 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -41.41 -58.45 1.87 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.667 0.787 . . . . 2.46 112.693 173.31 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -41.32 77.63 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 119.31 -0.956 . . . . 1.8400000000000001 111.417 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.783 HD11 HD11 ' A' ' 28' ' ' LEU . 31.0 mm -52.56 -47.0 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.056 0.844 . . . . 0.40000000000000002 110.319 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -51.25 -46.59 62.42 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.217 0.532 . . . . 1.8200000000000001 109.854 173.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -34.6 71.73 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.349 -0.844 . . . . 4.5300000000000002 112.88 -176.454 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.98 -22.5 5.73 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.563 0.745 . . . . 0.85999999999999999 110.486 167.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.56 26.99 8.8 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.315 -1.114 . . . . 0.28999999999999998 110.315 174.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.488 ' CD2' HD11 ' A' ' 24' ' ' ILE . 61.5 m-85 -139.34 160.83 38.9 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.278 -1.008 . . . . 2.0 108.278 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 122.94 43.05 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.008 -1.479 . . . . 4.4900000000000002 107.008 178.144 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.57 151.67 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 124.534 1.134 . . . . 0.47999999999999998 109.793 173.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.27 140.07 46.5 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 N-CA-C 108.815 -0.809 . . . . 0.92000000000000004 108.815 179.126 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.7 mm -104.59 93.84 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 108.055 -1.091 . . . . 1.01 108.055 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -152.36 149.58 28.78 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.156 -1.794 . . . . 5.2000000000000002 106.156 174.278 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.5 -54.71 0.43 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.83 -0.908 . . . . 5.04 110.83 176.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 117.019 -1.467 . . . . 7.4900000000000002 107.6 162.421 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 mtp . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 107.562 -1.273 . . . . 8.6699999999999999 107.562 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -170.31 152.43 4.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.437 -1.69 . . . . 6.7999999999999998 106.437 166.26 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 p 179.2 116.65 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.353 -1.721 . . . . 3.0099999999999998 106.353 -176.164 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.57 155.27 40.03 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.744 -1.576 . . . . 4.25 106.744 175.491 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -99.04 161.85 13.4 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.231 1.012 . . . . 0.71999999999999997 109.584 -177.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -142.37 154.49 44.68 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.848 0.832 . . . . 2.9100000000000001 112.189 176.349 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -89.78 108.13 19.51 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 128.186 2.594 . . . . 2.5299999999999998 107.322 171.205 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.64 154.53 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.86 -1.163 . . . . 1.3500000000000001 107.86 165.729 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.8 132.9 37.31 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.502 -1.666 . . . . 0.40000000000000002 106.502 173.617 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -155.67 166.44 33.5 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 123.273 0.629 . . . . 1.04 109.781 -173.111 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -93.56 156.18 16.88 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.026 -0.731 . . . . 2.96 109.026 -172.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.28 161.57 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 120.952 0.406 . . . . 0.73999999999999999 110.656 177.012 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 t -130.5 137.95 50.0 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.946 2.098 . . . . 0.71999999999999997 107.731 172.449 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.45 -28.03 11.51 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.594 1.093 . . . . 1.3500000000000001 113.183 174.42 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.03 145.15 1.05 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.398 1.479 . . . . 3.5 113.133 175.093 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.3 p -133.23 23.44 4.12 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.381 0.672 . . . . 3.4700000000000002 111.885 173.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.426 ' HA ' ' CD1' ' A' ' 41' ' ' LEU . 3.8 t 63.25 -150.15 0.33 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 117.744 -1.122 . . . . 4.1200000000000001 111.185 -176.445 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 40.1 51.99 2.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 120.297 1.408 . . . . 2.6000000000000001 113.535 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 65.61 14.35 9.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.086 1.355 . . . . 1.0800000000000001 114.029 177.441 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.4 m -72.85 -60.18 2.36 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.353 -0.98 . . . . 1.3899999999999999 108.353 179.056 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.68 -39.03 70.43 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.828 0.823 . . . . 0.91000000000000003 110.95 -177.197 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.69 -37.72 42.85 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 118.913 -0.565 . . . . 0.40999999999999998 112.442 173.723 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -59.22 -40.79 86.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.197 0.908 . . . . 3.3799999999999999 110.894 176.539 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.446 HD11 ' CD2' ' A' ' 69' ' ' TYR . 57.2 mt -54.13 -60.6 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.207 -1.405 . . . . 0.80000000000000004 107.207 -177.016 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -32.9 65.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.022 -0.99 . . . . 2.52 112.11 -175.34 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -55.16 -38.79 68.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.083 -1.011 . . . . 1.97 110.478 172.113 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.1 -51.74 39.43 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.791 -0.923 . . . . 0.48999999999999999 110.791 168.597 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.725 HD22 HG13 ' A' ' 60' ' ' ILE . 85.5 mt -63.33 -33.97 76.69 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.553 -0.969 . . . . 0.63 112.232 178.573 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.569 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.259 0.9 OUTLIER -59.99 -18.11 43.39 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 118.986 0.812 . . . . 1.3300000000000001 110.81 172.609 . . . . . . . . 4 4 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.22 -14.71 43.07 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.463 -1.398 . . . . 3.5899999999999999 114.384 167.789 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.3 mtp -74.97 134.85 74.35 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 121.102 1.773 . . . . 2.1299999999999999 111.26 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.06 114.19 2.34 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.06 2.507 . . . . 0.72999999999999998 109.589 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.84 -16.02 6.19 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 124.852 1.215 . . . . 0.20000000000000001 110.09 174.324 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 29' ' ' LYS . 4.9 p -67.75 154.2 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 O-C-N 122.401 -0.47 . . . . 0.28000000000000003 110.481 169.758 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.32 -54.24 2.48 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.735 1.214 . . . . 0.35999999999999999 109.571 166.387 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -145.91 157.56 43.89 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.556 0.162 . . . . 2.5800000000000001 110.909 -177.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.76 127.27 16.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.531 1.533 . . . . 0.98999999999999999 108.82 -175.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -143.14 115.69 8.6 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.811 0.844 . . . . 2.0299999999999998 109.537 -168.238 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -92.1 139.14 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 112.86 0.689 . . . . 1.0600000000000001 112.86 -176.065 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -128.7 68.79 1.38 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.906 2.083 . . . . 1.2 111.246 -176.583 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.426 ' CD1' ' HA ' ' A' ' 17' ' ' CYS . 58.3 mt -64.62 -16.81 63.33 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 113.038 0.755 . . . . 0.75 113.038 178.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.76 -19.92 4.92 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.967 0.507 . . . . 0.56000000000000005 111.121 169.334 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.1 m -136.33 18.0 3.16 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.834 1.253 . . . . 0.54000000000000004 109.976 -178.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 48.46 32.93 3.59 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.19 0.996 . . . . 2.75 112.181 -176.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.9 m -124.73 153.1 42.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.239 -1.393 . . . . 0.60999999999999999 107.239 -169.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 p -134.79 144.58 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.593 -0.892 . . . . 0.58999999999999997 108.593 173.63 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -108.19 140.34 41.54 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.066 1.347 . . . . 2.8700000000000001 107.822 175.547 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.83 134.71 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.825 -0.806 . . . . 0.46000000000000002 108.825 167.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.8 mt -103.93 117.73 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 126.2 1.8 . . . . 0.75 106.331 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -145.19 173.24 12.11 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.164 0.586 . . . . 1.8999999999999999 110.115 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -110.59 123.16 36.37 Favored Pre-proline 0 N--CA 1.443 -0.778 0 C-N-CA 124.618 1.167 . . . . 1.49 111.154 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -66.45 3.54 1.36 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.758 3.638 . . . . 0.80000000000000004 114.384 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.07 -44.74 45.81 Favored 'General case' 0 C--N 1.335 -0.057 0 N-CA-C 108.483 -0.932 . . . . 0.87 108.483 176.784 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -101.37 -37.0 8.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.779 1.631 . . . . 3.2599999999999998 110.366 178.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.3 m -138.64 131.52 29.48 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 118.71 2.855 . . . . 0.56000000000000005 118.71 -150.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.81 -171.76 30.45 Favored Glycine 0 N--CA 1.435 -1.42 0 N-CA-C 109.417 -1.473 . . . . 0.53000000000000003 109.417 164.436 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -35.04 -43.82 0.21 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.927 2.491 . . . . 0.60999999999999999 112.088 176.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.55 -58.73 3.17 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.249 0.833 . . . . 0.32000000000000001 113.249 173.023 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.35 -38.14 65.83 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.914 -0.772 . . . . 0.26000000000000001 108.914 -176.304 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.725 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -61.14 -59.69 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.719 -1.128 . . . . 1.24 108.424 -173.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.92 -52.23 14.99 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.151 0.887 . . . . 0.87 110.644 -178.32 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -43.36 -55.0 4.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.621 1.168 . . . . 2.5499999999999998 112.632 174.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -43.42 72.67 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 118.434 -0.793 . . . . 1.76 111.338 178.283 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.663 HD11 HD11 ' A' ' 28' ' ' LEU . 37.9 mm -52.32 -46.17 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 119.051 0.841 . . . . 0.46000000000000002 109.725 -177.818 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -51.17 -50.24 59.37 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.014 0.435 . . . . 1.6100000000000001 110.335 174.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -71.07 -31.37 67.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.42 -0.8 . . . . 3.5499999999999998 112.444 -174.464 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.98 -21.77 12.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 122.967 0.507 . . . . 0.90000000000000002 110.68 167.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.24 26.91 9.71 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 124.532 1.063 . . . . 0.46000000000000002 110.488 174.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.446 ' CD2' HD11 ' A' ' 24' ' ' ILE . 71.2 m-85 -138.88 164.77 28.81 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 117.324 0.562 . . . . 1.71 109.588 -178.631 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 120.17 37.96 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.576 -1.268 . . . . 4.6799999999999997 107.576 -179.156 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.521 ' HB ' HG21 ' A' ' 64' ' ' ILE . 8.4 p -85.65 150.5 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 109.305 -0.628 . . . . 0.59999999999999998 109.305 170.36 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.69 116.74 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 124.37 1.068 . . . . 1.5800000000000001 108.854 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt -110.34 66.39 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.857 1.263 . . . . 1.72 109.488 -177.064 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -94.15 125.64 38.9 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.155 0.982 . . . . 5.2699999999999996 108.751 176.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.11 124.71 0.54 Allowed Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.143 -1.183 . . . . 3.77 110.143 -177.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.268 0 CA-C-O 116.196 -1.859 . . . . 7.8600000000000003 107.012 -175.309 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 106.63 -1.618 . . . . 8.3800000000000008 106.63 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.27 142.65 39.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.829 -1.175 . . . . 6.1500000000000004 107.829 164.609 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.4 m -149.34 146.84 27.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.034 -1.839 . . . . 2.8500000000000001 106.034 173.506 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -157.66 148.26 20.97 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.431 -1.322 . . . . 3.7200000000000002 107.431 176.572 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -86.8 172.3 10.23 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.711 -0.677 . . . . 0.63 110.84 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -150.45 162.93 39.63 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.835 -0.432 . . . . 2.3700000000000001 109.835 174.29 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -83.75 153.28 24.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.521 -1.218 . . . . 2.9500000000000002 109.112 164.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 tp -131.48 155.07 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 106.416 -1.698 . . . . 1.0900000000000001 106.416 161.749 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.09 131.88 31.23 Favored 'General case' 0 N--CA 1.458 -0.036 0 C-N-CA 125.139 1.376 . . . . 0.57999999999999996 108.359 175.862 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.9 ptp -156.5 169.54 24.4 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.899 0.772 . . . . 1.8899999999999999 111.144 -176.739 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.74 146.04 32.67 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.974 0.91 . . . . 2.1000000000000001 109.477 -171.709 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.09 160.66 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 124.212 1.005 . . . . 0.82999999999999996 111.228 -172.918 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -88.95 167.25 13.35 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.109 0.48 . . . . 2.1099999999999999 111.381 166.446 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 50.29 33.38 23.53 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.095 1.807 . . . . 1.98 114.501 176.09 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 16.1 ptm -108.31 -160.94 0.75 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.866 1.267 . . . . 4.0199999999999996 109.383 -179.124 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.592 ' HA ' HD13 ' A' ' 41' ' ' LEU . 6.6 t 52.79 20.0 1.46 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.781 2.032 . . . . 7.9699999999999998 113.706 177.003 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.5 t -104.95 -48.33 3.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.838 0.855 . . . . 6.0 109.689 -167.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -159.37 -98.98 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.403 1.081 . . . . 3.5 108.426 166.633 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -107.81 30.16 6.58 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.15 0.98 . . . . 1.1599999999999999 111.495 -175.153 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.1 m -70.27 -62.87 1.22 Allowed 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.176 -0.676 . . . . 1.7 109.176 -171.015 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.467 ' CB ' HD21 ' A' ' 41' ' ' LEU . . . -54.96 -36.01 64.87 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 122.763 0.425 . . . . 1.01 111.308 178.417 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.73 -55.34 36.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 119.358 -0.353 . . . . 0.41999999999999998 111.091 175.114 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -56.0 -52.52 63.92 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.412 0.551 . . . . 3.6299999999999999 110.885 175.673 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.9 mt -45.19 -60.64 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.893 1.277 . . . . 0.59999999999999998 109.12 178.243 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -71.47 -36.46 71.17 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 120.83 0.348 . . . . 2.3399999999999999 111.153 -172.102 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -56.12 -35.79 67.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.117 -0.989 . . . . 1.28 110.448 173.285 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.64 -49.6 46.08 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 111.471 -0.651 . . . . 0.33000000000000002 111.471 166.419 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.671 HD22 HG12 ' A' ' 60' ' ' ILE . 94.4 mt -65.83 -30.76 71.43 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 121.107 -1.231 . . . . 0.40000000000000002 112.615 176.809 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.513 ' HA ' HG11 ' A' ' 34' ' ' VAL . 10.0 ttmt -57.57 -17.72 15.65 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.21 0.913 . . . . 1.53 111.811 170.796 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -88.28 -3.72 58.81 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.164 1.172 . . . . 3.9399999999999999 114.164 171.576 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.445 ' O ' HG12 ' A' ' 34' ' ' VAL . 95.2 mmm -84.25 135.78 41.3 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 120.45 1.477 . . . . 2.1000000000000001 111.408 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.95 99.43 0.56 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.769 2.98 . . . . 0.39000000000000001 111.135 -172.03 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.2 -12.93 3.82 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.785 -0.926 . . . . 0.22 110.785 177.102 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.513 HG11 ' HA ' ' A' ' 29' ' ' LYS . 8.9 p -68.33 153.68 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 123.523 0.729 . . . . 0.31 111.206 171.393 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.95 -60.16 1.92 Allowed 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.457 1.103 . . . . 0.37 109.027 167.184 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -147.32 142.97 27.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 112.187 0.439 . . . . 3.23 112.187 -169.322 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.21 136.1 53.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.165 1.786 . . . . 0.59999999999999998 108.27 179.163 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -137.71 111.97 8.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.46 1.104 . . . . 1.45 108.652 -178.443 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.2 141.67 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.438 1.095 . . . . 1.03 111.118 -178.086 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -136.57 65.46 1.52 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.903 1.281 . . . . 1.1499999999999999 111.445 178.156 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.592 HD13 ' HA ' ' A' ' 16' ' ' THR . 36.3 mt -59.63 -23.71 63.24 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.946 -0.471 . . . . 0.93999999999999995 112.115 177.584 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.39 -22.59 43.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.385 0.539 . . . . 0.65000000000000002 111.207 174.608 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 m -121.75 16.01 11.02 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.802 1.241 . . . . 0.58999999999999997 110.294 179.092 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 44.02 46.24 6.92 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.124 0.969 . . . . 2.8300000000000001 110.876 -174.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.9 m -145.77 154.3 41.89 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.027 -1.472 . . . . 0.64000000000000001 107.027 -171.911 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -132.69 151.9 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.306 -0.998 . . . . 0.69999999999999996 108.306 170.679 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.54 150.77 47.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.296 -0.631 . . . . 2.71 109.296 175.698 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.87 146.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.512 -0.922 . . . . 0.31 108.512 -176.722 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.2 mt -114.75 125.95 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.523 1.929 . . . . 0.78000000000000003 106.58 -173.373 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -152.37 170.1 20.93 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.223 0.609 . . . . 1.8500000000000001 110.363 -175.671 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -109.21 115.77 56.13 Favored Pre-proline 0 N--CA 1.44 -0.943 0 O-C-N 124.276 0.985 . . . . 1.48 110.469 -177.064 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.37 8.55 0.5 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.172 3.248 . . . . 0.62 113.752 -178.756 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.99 -44.73 38.2 Favored 'General case' 0 N--CA 1.458 -0.026 0 N-CA-C 108.087 -1.079 . . . . 0.72999999999999998 108.087 172.36 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -102.05 -38.32 7.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.291 1.436 . . . . 3.02 111.074 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 m -143.56 133.95 24.7 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 119.284 3.068 . . . . 0.59999999999999998 119.284 -156.431 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.31 -149.74 6.28 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 108.88 -1.688 . . . . 0.54000000000000004 108.88 154.34 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -44.82 -35.37 2.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.955 2.102 . . . . 0.68999999999999995 112.833 -175.833 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.18 -55.1 26.86 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.658 -0.651 . . . . 0.52000000000000002 111.821 174.692 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.41 -41.78 60.34 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.686 1.231 . . . . 0.32000000000000001 109.323 -175.369 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.671 HG12 HD22 ' A' ' 28' ' ' LEU . 1.9 mt -62.85 -52.57 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 113.967 -1.469 . . . . 0.59999999999999998 111.502 -169.42 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -55.92 -47.04 78.21 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.471 1.032 . . . . 3.0299999999999998 110.429 179.135 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -42.59 -60.06 1.68 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.113 0.965 . . . . 2.23 112.781 171.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -37.54 81.24 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 119.217 -0.993 . . . . 2.5899999999999999 110.726 -177.714 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.435 HD11 HD11 ' A' ' 28' ' ' LEU . 6.1 mm -56.23 -44.09 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 118.154 0.434 . . . . 0.37 110.301 -178.803 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -48.06 -49.16 32.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.158 0.504 . . . . 1.53 110.279 172.08 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -71.88 -31.28 66.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.941 0.896 . . . . 3.3599999999999999 113.128 -175.411 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -53.48 -24.35 12.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 119.441 -0.314 . . . . 0.89000000000000001 110.616 165.495 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.36 29.23 4.58 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.37 0.986 . . . . 0.37 110.778 167.613 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -148.12 159.55 43.81 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.739 -1.578 . . . . 2.0099999999999998 106.739 -177.499 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.455 ' CE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -102.79 147.27 27.07 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 105.819 -1.919 . . . . 3.54 105.819 170.283 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.9 p -110.9 157.56 11.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 125.494 1.518 . . . . 0.90000000000000002 109.804 169.965 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.455 HG13 ' CE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -126.1 137.16 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.355 1.062 . . . . 1.0600000000000001 111.359 178.333 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.2 mm -102.38 93.47 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 125.368 1.467 . . . . 1.27 107.248 175.53 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -72.02 127.35 32.27 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.842 -1.17 . . . . 5.2000000000000002 107.842 174.067 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.21 68.58 1.71 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.626 -0.99 . . . . 4.8700000000000001 110.626 176.12 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 117.938 -1.029 . . . . 11.039999999999999 111.176 175.373 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 mtt . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 107.661 -1.237 . . . . 9.4100000000000001 107.661 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.6 mp -118.54 147.62 43.5 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 106.831 -1.544 . . . . 6.6100000000000003 106.831 174.341 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 m -67.55 159.34 29.97 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.483 0.713 . . . . 3.4399999999999999 110.115 171.036 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 4.6 tt0 -137.46 132.33 33.2 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.844 1.258 . . . . 3.5099999999999998 107.869 177.037 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -84.39 157.64 21.36 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.608 0.763 . . . . 0.75 111.056 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 28.3 mttp -155.54 168.04 28.42 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.954 0.407 . . . . 4.2999999999999998 110.73 178.904 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -84.37 133.08 34.53 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.444 2.298 . . . . 2.0899999999999999 109.188 175.558 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.28 148.73 16.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.067 0 N-CA-C 106.286 -1.746 . . . . 1.47 106.286 162.462 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.78 133.04 44.3 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.256 1.422 . . . . 0.75 108.245 176.897 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.6 168.84 25.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 122.028 0.918 . . . . 2.77 112.887 -176.168 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -104.06 96.68 6.82 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 104.293 -2.484 . . . . 2.0600000000000001 104.293 -164.201 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.81 141.11 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 108.294 -1.002 . . . . 1.5900000000000001 108.294 175.711 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -84.65 156.2 21.63 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.678 -0.489 . . . . 1.6599999999999999 109.678 178.337 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.04 67.49 1.95 Allowed Glycine 0 CA--C 1.532 1.112 0 N-CA-C 111.987 -0.445 . . . . 2.48 111.987 175.598 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 8.1 ptp -141.13 178.57 7.3 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.875 1.27 . . . . 4.0499999999999998 108.653 -179.042 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 m 56.28 37.08 28.5 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.999 -0.741 . . . . 7.6600000000000001 108.999 -175.682 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.7 t -121.43 -65.28 1.15 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.48 1.112 . . . . 7.1900000000000004 108.959 -168.553 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.97 80.04 0.77 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.079 0.552 . . . . 3.6899999999999999 110.501 171.684 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.06 28.6 11.05 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.633 1.173 . . . . 1.5900000000000001 111.966 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.7 m -72.56 -62.74 1.34 Allowed 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.453 -0.573 . . . . 1.3999999999999999 109.453 -165.75 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.13 -41.52 36.35 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 123.832 0.853 . . . . 0.79000000000000004 111.807 178.186 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.4 -55.31 36.4 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.547 -0.751 . . . . 0.34000000000000002 111.191 175.334 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -60.94 -47.99 83.86 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.576 0.625 . . . . 4.3600000000000003 111.567 177.828 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.3 mt -43.36 -60.86 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 125.089 1.356 . . . . 0.56999999999999995 108.324 175.198 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -71.37 -37.43 71.62 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.139 -0.482 . . . . 2.3999999999999999 111.213 -172.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -57.54 -32.61 67.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.261 -0.9 . . . . 1.28 110.857 175.175 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.56 -51.15 54.02 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.663 -0.975 . . . . 0.33000000000000002 110.663 165.314 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.742 HD11 HD11 ' A' ' 64' ' ' ILE . 96.2 mt -63.6 -28.63 70.05 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 118.967 1.384 . . . . 0.37 112.597 176.17 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.29 21.2 ttmt -61.66 -15.2 37.76 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 119.854 1.206 . . . . 1.23 111.859 171.666 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -18.18 42.52 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.367 -1.458 . . . . 4.7800000000000002 114.657 165.651 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.436 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -71.27 128.19 90.52 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 120.332 1.423 . . . . 2.6000000000000001 110.936 -170.722 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -60.87 104.37 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.981 2.454 . . . . 0.59999999999999998 111.032 -176.425 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.74 -3.45 8.63 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.715 2.103 . . . . 0.27000000000000002 110.555 172.807 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 31' ' ' MET . 7.3 p -65.88 158.22 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 121.576 -0.955 . . . . 0.28999999999999998 111.361 164.06 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.33 -58.15 1.72 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.251 1.42 . . . . 0.41999999999999998 110.448 169.094 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -139.37 154.25 47.82 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 112.102 0.408 . . . . 3.1299999999999999 112.102 -176.388 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.3 129.72 46.76 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.483 1.913 . . . . 0.63 108.731 174.393 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.65 113.14 7.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.881 1.272 . . . . 1.3700000000000001 109.518 -174.625 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.78 148.76 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.975 0.91 . . . . 1.1000000000000001 111.689 -174.304 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -140.74 67.55 1.36 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-O 122.789 1.28 . . . . 2.79 108.059 178.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.4 mt -62.14 -16.01 49.71 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.502 -0.772 . . . . 1.26 112.366 175.272 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.64 -12.55 4.27 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.477 1.111 . . . . 1.0600000000000001 111.467 170.027 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.3 m -144.17 27.25 1.44 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.49 0.716 . . . . 0.78000000000000003 109.201 178.026 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 36.93 59.64 1.04 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 125.213 1.405 . . . . 3.27 111.218 -176.717 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -156.52 157.51 35.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.021 -1.474 . . . . 1.02 107.021 -172.225 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.89 154.56 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 109.245 -0.65 . . . . 1.1699999999999999 109.245 171.616 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -119.38 145.85 45.85 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.167 1.387 . . . . 2.5800000000000001 109.247 -178.423 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.15 134.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.911 0.885 . . . . 0.27000000000000002 109.055 179.036 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 78.5 mt -95.2 128.09 46.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.047 -1.464 . . . . 1.1100000000000001 107.047 174.694 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -149.84 171.96 15.92 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.352 0.661 . . . . 1.77 110.491 177.377 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -108.02 121.99 42.12 Favored Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 124.002 0.921 . . . . 1.9399999999999999 111.655 -176.358 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.93 23.0 0.35 Allowed 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 124.718 3.612 . . . . 0.81000000000000005 113.489 -176.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.56 -48.93 6.13 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 107.714 -1.217 . . . . 0.41999999999999998 107.714 171.165 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -99.43 -48.95 4.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.317 1.447 . . . . 2.71 110.687 178.678 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.2 m -111.11 133.03 53.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.07 1.748 . . . . 0.96999999999999997 114.759 -164.772 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.1 177.28 32.42 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 108.638 -1.785 . . . . 0.69999999999999996 108.638 163.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -34.15 -47.95 0.3 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.587 1.955 . . . . 0.72999999999999998 111.082 172.622 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -41.26 -58.35 1.85 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.594 1.158 . . . . 0.46999999999999997 113.402 173.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.05 -38.52 66.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.854 -0.795 . . . . 0.39000000000000001 108.854 -176.505 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.594 HG13 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -54.78 -61.21 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-N 114.696 -1.138 . . . . 0.87 109.84 179.2 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.36 -52.58 9.71 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.003 1.274 . . . . 1.47 110.373 178.794 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.65 -51.46 12.23 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.573 0.749 . . . . 2.54 112.603 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -48.03 57.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.764 -0.774 . . . . 1.6799999999999999 111.495 174.647 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.742 HD11 HD11 ' A' ' 28' ' ' LEU . 33.5 mm -49.6 -44.07 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.855 0.862 . . . . 0.38 110.662 -176.364 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -50.86 -52.57 40.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.446 0.698 . . . . 1.5900000000000001 110.027 175.146 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -71.58 -29.12 64.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 114.048 1.129 . . . . 3.3399999999999999 114.048 -178.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -53.9 -25.03 18.19 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.426 0.557 . . . . 0.93999999999999995 110.388 165.455 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.68 27.82 3.94 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 124.507 1.051 . . . . 0.38 111.067 166.003 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -151.16 174.51 13.15 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.806 -1.183 . . . . 1.8200000000000001 107.806 -173.814 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.33 141.05 48.79 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.066 -1.087 . . . . 3.3799999999999999 108.066 171.64 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.94 142.3 15.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 113.542 -1.663 . . . . 0.81999999999999995 107.969 162.085 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.7 m -117.52 139.37 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.117 -0.697 . . . . 1.45 109.117 173.612 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.3 mm -120.45 86.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.938 1.295 . . . . 1.3400000000000001 107.519 -164.866 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -123.96 147.97 47.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.272 -1.381 . . . . 4.5700000000000003 107.272 168.886 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.24 63.57 3.07 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 119.72 -0.489 . . . . 4.4000000000000004 112.594 173.645 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.1 ttt85 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.497 1.919 . . . . 8.6699999999999999 110.961 169.385 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mtt . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 106.335 -1.728 . . . . 7.9299999999999997 106.335 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 66.07 54.62 0.97 Allowed 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.419 1.075 . . . . 8.5099999999999998 109.533 175.726 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.2 p -171.97 78.24 0.06 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.199 1.4 . . . . 3.2000000000000002 107.238 -176.231 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.25 121.74 6.31 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.1 0.96 . . . . 4.9900000000000002 108.445 -175.515 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -89.46 172.08 9.26 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.957 0.903 . . . . 0.77000000000000002 112.423 -171.051 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.09 165.87 31.48 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.99 0.9 . . . . 3.21 111.803 169.35 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -82.15 141.12 33.35 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.062 2.145 . . . . 2.2799999999999998 107.721 167.13 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.68 150.92 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 106.022 -1.844 . . . . 1.5700000000000001 106.022 164.016 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.61 128.3 23.19 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.292 1.437 . . . . 0.46000000000000002 107.955 176.286 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -155.91 173.17 17.17 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.994 0.518 . . . . 1.02 110.251 -172.247 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.405 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -102.22 152.25 21.26 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.951 0.9 . . . . 1.8300000000000001 109.371 -176.426 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 t -115.02 162.89 12.78 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.06 0 C-N-CA 123.432 0.693 . . . . 0.75 109.834 178.832 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 t -129.26 125.31 36.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.303 1.441 . . . . 0.81999999999999995 108.565 175.503 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.84 -11.98 20.55 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.835 1.207 . . . . 1.3799999999999999 113.454 173.148 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.62 146.23 17.1 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.134 0.967 . . . . 3.3399999999999999 111.519 178.103 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.1 p -130.32 26.55 5.12 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.65 0.78 . . . . 3.5 110.962 175.418 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.5 t 57.92 -140.01 0.8 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.42 -0.8 . . . . 3.9399999999999999 110.941 -176.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 54.99 -82.25 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.939 1.695 . . . . 3.1899999999999999 111.816 -172.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.0 16.09 0.75 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.606 1.162 . . . . 1.3 111.61 175.55 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.7 m -71.89 -61.17 1.88 Allowed 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 121.415 -0.803 . . . . 1.25 109.49 -169.446 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.442 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -59.45 -33.54 71.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.767 0.794 . . . . 0.70999999999999996 111.24 -179.599 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.65 -50.53 73.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.946 -0.471 . . . . 0.40000000000000002 110.369 171.32 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -53.93 -45.58 71.26 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 118.817 -0.611 . . . . 3.6499999999999999 111.36 174.147 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.463 HD11 ' CD2' ' A' ' 69' ' ' TYR . 72.9 mt -49.24 -61.96 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.15 -0.685 . . . . 0.66000000000000003 109.15 177.547 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.466 ' CD ' HG21 ' A' ' 46' ' ' VAL . 1.1 tp10 -72.18 -33.12 67.43 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.015 -0.674 . . . . 2.46 111.017 -170.193 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.5 mmtt -54.42 -39.51 67.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 121.029 -1.045 . . . . 1.74 110.703 170.715 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.51 -53.04 34.06 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.889 -1.284 . . . . 0.41999999999999998 109.889 168.757 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 64' ' ' ILE . 94.1 mt -60.66 -33.15 72.39 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 117.811 -1.09 . . . . 0.46999999999999997 112.543 178.252 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.285 13.8 ttpt -56.43 -19.33 14.57 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 120.08 1.309 . . . . 2.0699999999999998 111.678 175.499 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.46 -14.94 54.23 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.094 1.516 . . . . 3.21 115.094 170.284 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.6 mmt -73.54 134.59 79.16 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 120.165 1.348 . . . . 2.6400000000000001 111.88 -175.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.85 94.35 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.291 2.661 . . . . 0.40000000000000002 111.549 -176.31 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.84 -13.7 2.88 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.719 1.152 . . . . 0.44 111.092 171.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -71.23 152.84 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 121.678 -0.896 . . . . 1.1699999999999999 109.121 162.623 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.19 -57.03 2.09 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.668 1.187 . . . . 0.46999999999999997 110.374 169.064 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -154.67 158.07 39.08 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 117.903 0.319 . . . . 2.6899999999999999 111.61 -177.047 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.42 ' HB1' ' CG ' ' A' ' 25' ' ' GLU . . . -129.36 132.43 47.07 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 127.494 2.317 . . . . 0.65000000000000002 109.986 -171.694 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -138.35 104.34 5.15 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.819 1.248 . . . . 1.3100000000000001 108.798 -176.539 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.9 p -83.67 141.55 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.74 0.816 . . . . 0.82999999999999996 111.371 -178.693 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -136.83 67.84 1.44 Allowed 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.715 1.606 . . . . 1.1499999999999999 111.535 -175.429 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.81 -16.98 62.63 Favored 'General case' 0 C--O 1.228 -0.045 0 N-CA-C 113.146 0.795 . . . . 0.78000000000000003 113.146 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.45 -26.09 11.84 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.17 0.441 . . . . 0.53000000000000003 110.612 169.624 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.6 m -125.45 18.56 8.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.319 1.448 . . . . 0.45000000000000001 110.315 -179.778 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 46.46 39.66 6.95 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.202 1.001 . . . . 2.6600000000000001 111.973 -177.352 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.37 156.82 46.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.596 -0.89 . . . . 0.96999999999999997 108.596 -169.828 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.466 HG21 ' CD ' ' A' ' 25' ' ' GLU . 7.7 p -131.59 145.66 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.349 -0.841 . . . . 0.53000000000000003 108.809 174.335 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -116.06 139.01 50.72 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.022 -1.473 . . . . 2.48 107.022 176.458 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.59 138.34 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.489 -0.93 . . . . 0.44 108.489 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 79.9 mt -105.11 125.3 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.196 -1.409 . . . . 0.94999999999999996 107.196 -177.269 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -146.12 166.36 26.38 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 122.945 0.498 . . . . 1.8899999999999999 111.227 -179.418 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -103.68 115.62 63.22 Favored Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 114.31 -1.313 . . . . 1.3400000000000001 110.245 176.324 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -68.46 6.73 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.674 2.916 . . . . 0.47999999999999998 113.706 -179.484 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.62 -43.24 48.98 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 119.381 0.991 . . . . 0.42999999999999999 108.438 174.816 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -100.86 -40.82 7.11 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.27 1.828 . . . . 2.9900000000000002 109.906 178.792 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.6 m -138.82 127.3 23.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 118.568 2.803 . . . . 0.52000000000000002 118.568 -154.256 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -159.0 -164.68 14.74 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 109.752 -1.339 . . . . 0.45000000000000001 109.752 156.533 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.273 0.1 OUTLIER -29.28 -44.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 129.357 3.063 . . . . 0.71999999999999997 114.13 173.245 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.48 -57.09 8.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.195 0.907 . . . . 0.34999999999999998 112.546 175.487 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.26 -39.36 63.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 122.181 0.991 . . . . 0.20999999999999999 108.933 -176.12 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.566 HG12 HD22 ' A' ' 28' ' ' LEU . 1.1 mt -60.87 -59.24 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-N 114.149 -1.387 . . . . 0.55000000000000004 109.279 -174.583 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.65 -51.48 12.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.914 1.234 . . . . 0.75 111.279 177.728 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -42.48 -56.07 3.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.893 0.701 . . . . 2.4399999999999999 112.893 174.157 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -44.27 71.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 119.056 -1.058 . . . . 1.9099999999999999 111.347 178.922 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 28' ' ' LEU . 38.8 mm -51.01 -46.33 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.65 0.78 . . . . 0.47999999999999998 110.456 -178.557 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -50.11 -50.56 48.1 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.328 0.585 . . . . 1.4199999999999999 110.07 174.092 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -72.35 -30.79 65.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.904 0.705 . . . . 3.0699999999999998 112.904 -175.214 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.51 -25.34 24.97 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.68 0.392 . . . . 0.94999999999999996 110.383 165.482 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.25 28.78 5.38 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 124.656 1.122 . . . . 0.37 110.859 172.827 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.463 ' CD2' HD11 ' A' ' 24' ' ' ILE . 64.2 m-85 -145.52 163.52 34.47 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 107.943 -1.132 . . . . 1.97 107.943 -176.228 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.01 126.58 50.28 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.977 -1.49 . . . . 4.3099999999999996 106.977 177.781 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.0 p -94.74 141.58 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 122.92 0.488 . . . . 0.53000000000000003 109.771 172.22 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 11' ' ' GLN . 13.4 m -96.88 158.14 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.987 -0.746 . . . . 1.1000000000000001 108.987 173.393 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.8 mm -125.03 82.2 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 107.421 -1.326 . . . . 1.02 107.421 174.218 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -132.26 132.47 43.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.582 -2.377 . . . . 5.0099999999999998 104.582 172.19 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.93 -64.91 0.24 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-N 119.378 0.99 . . . . 4.1399999999999997 113.389 -177.74 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.276 0 N-CA-C 105.636 -1.987 . . . . 10.619999999999999 105.636 -177.792 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 119.123 -0.465 . . . . 11.0 110.056 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 mp 65.84 -174.86 0.18 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.249 0.619 . . . . 10.460000000000001 109.973 -172.477 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 m 65.24 -165.22 0.24 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.749 0.82 . . . . 4.8499999999999996 109.484 -168.407 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 68.93 133.7 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.649 1.98 . . . . 3.21 113.002 177.789 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -83.05 155.67 23.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.976 -0.556 . . . . 0.82999999999999996 110.962 -175.323 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -147.9 156.56 42.83 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.982 0.896 . . . . 3.6600000000000001 110.763 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.28 111.14 18.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.848 2.459 . . . . 2.1899999999999999 108.991 173.251 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.02 151.89 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 107.203 -1.406 . . . . 1.6200000000000001 107.203 162.783 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.02 127.82 19.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.431 1.492 . . . . 0.33000000000000002 107.899 175.317 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -157.03 164.5 37.9 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.163 0.438 . . . . 1.1499999999999999 110.727 -171.293 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.34 145.89 27.61 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.074 0.95 . . . . 1.8300000000000001 109.066 -172.089 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.71 159.25 19.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 C-N-CA 123.127 0.571 . . . . 0.54000000000000004 110.053 -176.087 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 t -121.34 125.03 46.0 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.909 1.284 . . . . 0.72999999999999998 108.096 177.081 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.98 -12.25 11.6 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.14 0.876 . . . . 1.3799999999999999 113.486 172.745 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.97 136.25 52.0 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.238 1.519 . . . . 3.46 110.886 176.454 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.7 p -110.77 26.83 10.28 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.606 0.763 . . . . 3.5800000000000001 110.87 175.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.1 t 79.1 -175.92 0.08 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.362 1.465 . . . . 4.0099999999999998 110.348 175.497 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 53.8 -146.18 0.56 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.784 0.834 . . . . 3.9199999999999999 110.761 179.902 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.53 15.52 1.64 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.513 -0.742 . . . . 1.3400000000000001 112.66 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.0 m -72.61 -60.19 2.35 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 119.296 0.953 . . . . 2.0 108.762 -177.445 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.87 -42.2 47.18 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-O 121.583 0.706 . . . . 0.92000000000000004 111.503 175.309 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.19 -40.16 46.14 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.812 -0.613 . . . . 0.44 111.581 177.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -57.98 -43.4 86.53 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.848 0.749 . . . . 3.5 110.696 177.126 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.5 mt -53.47 -59.45 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 107.96 -1.126 . . . . 0.62 107.96 -176.799 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' CG ' HG21 ' A' ' 46' ' ' VAL . 1.5 tm-20 -70.58 -41.17 72.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.818 -0.628 . . . . 3.3599999999999999 109.811 -176.03 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -49.66 -38.49 32.79 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.39 -1.444 . . . . 1.46 112.005 179.084 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.42 -51.79 40.78 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 111.548 -0.621 . . . . 0.37 111.548 169.064 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 64' ' ' ILE . 74.6 mt -67.1 -27.7 67.56 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.639 -0.918 . . . . 0.60999999999999999 112.666 177.476 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -62.09 -15.82 47.81 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.758 1.163 . . . . 2.5099999999999998 110.004 172.146 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -96.89 4.97 51.35 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.162 1.171 . . . . 3.77 114.162 170.47 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 34' ' ' VAL . 81.5 mmm -83.12 138.81 42.35 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 120.498 1.499 . . . . 2.0699999999999998 111.529 176.024 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.68 94.26 0.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.387 2.724 . . . . 0.40999999999999998 111.228 -172.655 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.87 -13.81 2.87 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.514 1.054 . . . . 0.19 111.327 178.846 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 31' ' ' MET . 5.3 p -69.22 160.59 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 117.735 0.767 . . . . 0.26000000000000001 110.889 168.076 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.25 -56.37 1.82 Allowed 'General case' 0 C--N 1.335 -0.058 0 C-N-CA 124.055 0.942 . . . . 0.44 109.967 168.793 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -145.01 157.54 44.09 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.968 -0.382 . . . . 2.8500000000000001 109.968 -179.155 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.22 136.12 39.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.504 2.322 . . . . 0.67000000000000004 107.854 176.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.57 115.19 9.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.658 1.583 . . . . 1.4199999999999999 108.193 -174.155 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.57 143.6 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.859 0.863 . . . . 0.57999999999999996 112.062 -177.103 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -133.14 67.72 1.52 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.335 1.854 . . . . 1.21 111.86 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.5 mt -67.37 -16.89 64.5 Favored 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 113.085 0.772 . . . . 0.65000000000000002 113.085 -179.046 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.83 -22.06 13.29 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.654 0.382 . . . . 0.58999999999999997 110.875 168.742 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.1 m -127.82 17.79 6.78 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.741 1.216 . . . . 0.54000000000000004 110.032 178.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 44.68 40.52 4.19 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.558 1.143 . . . . 2.75 111.632 -175.515 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.8 m -134.72 155.66 50.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.22 -1.4 . . . . 0.46000000000000002 107.22 -169.132 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.4 HG21 ' CG ' ' A' ' 25' ' ' GLU . 7.4 p -134.8 148.9 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.773 -0.825 . . . . 0.41999999999999998 108.773 173.012 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.25 153.11 36.81 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 124.047 0.842 . . . . 2.8300000000000001 110.168 174.374 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.98 133.64 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 123.617 0.767 . . . . 0.33000000000000002 109.382 -177.139 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.5 mt -100.01 112.04 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.755 1.622 . . . . 0.91000000000000003 106.794 179.375 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -135.84 167.41 21.23 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.276 1.03 . . . . 1.8500000000000001 110.998 178.335 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.91 119.85 54.28 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 124.726 1.21 . . . . 1.3400000000000001 110.998 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.14 8.83 1.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.72 2.947 . . . . 0.46000000000000002 113.586 -175.29 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.4 -53.25 6.78 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 107.585 -1.265 . . . . 0.45000000000000001 107.585 175.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -85.48 -41.87 14.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.273 1.429 . . . . 2.8700000000000001 110.429 175.383 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.0 m -138.14 126.61 23.34 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 117.925 2.565 . . . . 0.52000000000000002 117.925 -151.857 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.83 -165.35 19.76 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.909 -1.041 . . . . 0.42999999999999999 110.731 155.458 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.5 t -31.5 -43.22 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 129.386 3.075 . . . . 0.54000000000000004 112.987 176.776 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.0 -56.87 7.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.785 0.72 . . . . 0.34000000000000002 112.831 174.512 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.57 -37.05 65.65 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 122.29 1.043 . . . . 0.29999999999999999 109.198 -179.517 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.513 HG12 HD22 ' A' ' 28' ' ' LEU . 1.2 mt -64.79 -54.64 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 114.348 -1.296 . . . . 0.51000000000000001 110.338 -171.516 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.74 -51.47 22.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.011 1.278 . . . . 0.77000000000000002 110.882 174.711 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -43.42 -53.84 5.13 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 113.025 0.75 . . . . 2.2599999999999998 113.025 173.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.14 -45.56 66.57 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 118.419 -0.8 . . . . 2.1600000000000001 110.862 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.593 HD11 HD11 ' A' ' 28' ' ' LEU . 17.2 mm -50.1 -47.5 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.641 1.176 . . . . 0.41999999999999998 110.384 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -51.22 -47.53 62.31 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.427 0.632 . . . . 1.53 110.053 174.512 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -33.06 67.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.75 0.82 . . . . 3.4399999999999999 112.42 -177.001 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.64 -22.62 23.65 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.883 0.473 . . . . 0.85999999999999999 110.395 166.348 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.19 30.88 7.55 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.225 -1.15 . . . . 0.39000000000000001 110.225 175.325 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -137.32 163.62 30.55 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.615 -1.254 . . . . 2.1200000000000001 107.615 178.511 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.24 130.88 56.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.104 -1.443 . . . . 3.9100000000000001 107.104 174.119 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -99.4 146.72 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.629 0.771 . . . . 0.47999999999999998 111.111 171.513 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.77 149.91 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.987 0.915 . . . . 0.94999999999999996 109.738 171.077 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.1 mm -118.63 97.89 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 106.557 -1.646 . . . . 1.0900000000000001 106.557 168.884 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.1 157.47 25.84 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.478 1.511 . . . . 4.5 108.624 176.461 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.52 -47.8 0.26 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.486 1.041 . . . . 4.6799999999999997 112.281 177.385 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.194 0 CA-C-O 115.792 -2.051 . . . . 10.949999999999999 106.47 -176.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.1 mtt . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 108.646 -0.872 . . . . 8.4199999999999999 108.646 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 36.4 tp 176.77 -85.44 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.913 2.085 . . . . 7.6200000000000001 105.542 174.294 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 p -169.57 147.13 3.48 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 104.741 -2.318 . . . . 2.98 104.741 175.537 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.462 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 4.8 pt-20 -135.66 154.47 51.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.817 -1.92 . . . . 3.7200000000000002 105.817 165.093 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -115.85 165.74 12.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.916 0.886 . . . . 0.68000000000000005 109.671 178.095 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 28.1 mttp -149.72 162.98 39.17 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.357 0.599 . . . . 4.4000000000000004 110.56 178.576 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -84.11 133.62 34.62 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.779 1.632 . . . . 2.04 107.768 166.849 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 tp -106.29 154.14 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.104 -1.813 . . . . 1.0900000000000001 106.104 160.611 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.9 131.45 30.98 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.894 -1.521 . . . . 0.47999999999999998 106.894 171.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -156.46 165.85 35.12 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.278 0.631 . . . . 1.1899999999999999 110.428 -174.005 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -93.92 148.56 22.03 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.04 1.336 . . . . 2.9900000000000002 107.785 -171.294 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.443 HG11 HD13 ' A' ' 24' ' ' ILE . 2.2 t -116.13 141.07 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 118.956 0.798 . . . . 0.72999999999999998 110.522 178.705 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t -106.2 124.87 50.25 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.893 -1.521 . . . . 0.90000000000000002 106.893 173.239 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.22 -74.26 0.35 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.376 -1.09 . . . . 2.4500000000000002 110.376 -179.751 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.408 ' CE ' HD13 ' A' ' 41' ' ' LEU . 0.5 OUTLIER 28.08 82.52 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.285 2.234 . . . . 5.8300000000000001 114.404 179.634 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -95.08 11.45 32.07 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.925 1.69 . . . . 4.1699999999999999 111.396 175.065 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.5 t 62.15 -154.49 0.35 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.928 1.291 . . . . 3.5499999999999998 111.691 179.095 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 41.68 59.09 2.58 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.386 1.448 . . . . 3.1000000000000001 113.338 177.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.48 19.46 7.88 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.931 1.292 . . . . 1.0900000000000001 113.462 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.0 m -72.22 -56.94 4.69 Favored 'General case' 0 CA--C 1.514 -0.437 0 O-C-N 121.068 -1.02 . . . . 1.3799999999999999 109.148 -173.653 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.614 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -61.02 -26.13 67.4 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.291 0.567 . . . . 0.79000000000000004 112.111 177.383 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.24 -47.59 73.29 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 118.587 -0.72 . . . . 0.41999999999999998 110.208 169.026 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -52.41 -48.76 65.52 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.389 0.995 . . . . 4.0999999999999996 111.381 173.168 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.614 HD12 ' HA ' ' A' ' 21' ' ' ALA . 80.1 mt -43.68 -61.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.284 0 N-CA-C 108.856 -0.794 . . . . 0.81999999999999995 108.856 179.78 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -36.08 66.3 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.773 -0.649 . . . . 2.4300000000000002 112.427 -174.473 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -54.72 -37.63 66.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.941 -1.099 . . . . 2.4100000000000001 111.009 176.523 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.51 -45.09 77.81 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.983 -0.847 . . . . 0.46000000000000002 110.983 169.556 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.706 HD22 HG12 ' A' ' 60' ' ' ILE . 75.9 mt -67.25 -31.18 71.35 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.128 -1.219 . . . . 0.5 111.517 176.461 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HA ' HG11 ' A' ' 34' ' ' VAL . 6.4 ttmm -60.47 -17.5 45.32 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.221 0.918 . . . . 1.29 111.215 172.257 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -81.38 -16.22 52.91 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.928 -1.107 . . . . 3.3399999999999999 113.674 169.378 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 34' ' ' VAL . 14.8 mmt -73.71 137.73 77.05 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 120.785 1.63 . . . . 2.2599999999999998 112.744 -173.483 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.74 87.82 0.8 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.903 3.069 . . . . 0.79000000000000004 111.284 -172.196 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.05 -22.82 0.99 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.994 -0.843 . . . . 0.47999999999999998 110.994 -174.302 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 29' ' ' LYS . 5.8 p -68.09 159.65 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 O-C-N 121.845 -0.797 . . . . 0.39000000000000001 111.939 175.265 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.54 -57.36 1.47 Allowed 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.652 1.181 . . . . 0.54000000000000004 109.344 169.49 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -138.97 154.84 48.34 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 113.884 1.068 . . . . 3.0699999999999998 113.884 178.464 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.13 124.06 18.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.071 1.748 . . . . 0.97999999999999998 108.025 -175.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -143.44 119.97 11.04 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.584 0.754 . . . . 1.6399999999999999 109.166 -166.111 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -96.63 128.17 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.466 0.707 . . . . 0.89000000000000001 111.529 -173.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -113.91 69.51 0.71 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.032 -1.47 . . . . 2.5800000000000001 107.032 177.158 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.408 HD13 ' CE ' ' A' ' 15' ' ' MET . 72.9 mt -61.57 -21.79 64.62 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.893 -0.594 . . . . 0.76000000000000001 111.641 175.803 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.71 -25.05 16.67 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.872 0.869 . . . . 0.60999999999999999 111.405 170.461 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 m -124.96 15.39 8.54 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.123 1.369 . . . . 0.69999999999999996 109.886 -179.308 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 47.02 37.04 4.6 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.407 1.083 . . . . 2.46 111.632 -176.348 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.0 m -133.78 150.59 51.45 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.807 -1.553 . . . . 0.70999999999999996 106.807 -170.904 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.3 p -128.96 146.9 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 107.684 -1.228 . . . . 0.58999999999999997 107.684 174.492 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.32 149.08 44.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 123.895 0.747 . . . . 2.75 109.114 173.849 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.26 133.78 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.393 -0.965 . . . . 0.28000000000000003 108.393 -179.135 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.2 mt -101.69 120.25 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 127.231 2.212 . . . . 0.69999999999999996 106.501 -176.462 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -149.68 166.15 30.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.656 0.782 . . . . 1.77 110.548 -177.53 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -95.22 108.08 36.45 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 125.228 1.411 . . . . 2.2599999999999998 110.611 175.752 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -70.34 12.82 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.229 3.286 . . . . 0.81999999999999995 114.117 -179.434 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.97 -49.66 6.92 Favored 'General case' 0 N--CA 1.459 0.023 0 N-CA-C 107.105 -1.443 . . . . 0.73999999999999999 107.105 171.469 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -85.6 -34.09 21.51 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.18 1.392 . . . . 2.4700000000000002 111.037 178.267 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.9 m -154.39 122.15 5.87 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 117.112 2.264 . . . . 0.76000000000000001 117.112 -156.601 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.97 -171.68 24.2 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 121.69 -0.631 . . . . 0.5 112.222 165.383 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.96 -44.66 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.942 2.897 . . . . 0.55000000000000004 112.531 176.499 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.4 -55.78 9.91 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.062 0.764 . . . . 0.35999999999999999 113.062 175.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.18 -38.7 63.59 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 122.644 1.211 . . . . 0.37 109.127 178.69 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.706 HG12 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -64.95 -48.61 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 114.407 -1.27 . . . . 0.54000000000000004 110.619 -169.063 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -50.53 60.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.164 1.347 . . . . 0.90000000000000002 110.355 173.862 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -43.32 -57.95 2.78 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.852 0.834 . . . . 2.3999999999999999 112.879 171.846 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -42.27 83.66 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 118.595 -0.717 . . . . 1.79 111.418 -178.228 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.403 HD11 HD11 ' A' ' 28' ' ' LEU . 5.7 mm -52.47 -47.8 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 119.355 0.98 . . . . 0.56000000000000005 110.047 177.654 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -51.72 -46.29 63.91 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.103 0.478 . . . . 1.6599999999999999 110.026 173.083 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -37.7 84.27 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.482 -0.761 . . . . 3.6200000000000001 112.01 -178.835 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.97 -21.95 34.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.75 0.82 . . . . 0.94999999999999996 110.517 170.73 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.83 28.5 7.8 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 124.409 1.004 . . . . 0.51000000000000001 110.97 173.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.577 ' CD2' HD11 ' A' ' 24' ' ' ILE . 47.5 m-85 -141.23 175.11 9.91 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.042 -1.095 . . . . 2.1699999999999999 108.042 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 111.43 7.39 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.232 -1.025 . . . . 4.5899999999999999 108.232 -171.525 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.49 147.21 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.466 -0.788 . . . . 0.46000000000000002 109.74 -179.007 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.12 131.57 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.449 1.499 . . . . 1.55 110.15 -174.424 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.8 mt -119.84 91.85 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.437 1.495 . . . . 1.72 108.142 -177.935 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -72.41 71.19 0.91 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 122.185 0.993 . . . . 5.2800000000000002 112.167 -177.356 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.01 -47.0 3.73 Favored Glycine 0 CA--C 1.528 0.848 0 O-C-N 121.343 -0.848 . . . . 4.4299999999999997 112.685 168.658 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 116.996 -1.478 . . . . 9.1600000000000001 108.105 169.87 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 110.601 -0.148 . . . . 0.93000000000000005 110.601 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -152.38 162.32 41.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.597 0.713 . . . . 2.7799999999999998 111.642 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 0.8 OUTLIER -84.4 150.2 25.5 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.492 1.517 . . . . 3.75 109.006 166.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 tp -129.48 156.47 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.352 -1.721 . . . . 1.2 106.352 162.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.88 130.78 24.46 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.711 1.204 . . . . 0.31 108.442 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.84 171.63 19.94 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.238 0.472 . . . . 1.1599999999999999 111.956 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.412 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -92.22 153.7 19.12 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.516 0.726 . . . . 1.97 110.009 -177.121 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -118.51 158.06 19.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 123.903 0.881 . . . . 0.57999999999999996 109.402 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.45 -0.472 0 C-N-CA 124.319 1.048 . . . . 0.79000000000000004 108.178 176.618 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 112.051 0.389 . . . . 0.45000000000000001 112.051 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.91 -41.73 99.55 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.444 0.566 . . . . 4.0700000000000003 111.221 177.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.427 ' CG2' HD12 ' A' ' 64' ' ' ILE . 60.4 mt -51.71 -60.16 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.612 -1.255 . . . . 0.54000000000000004 107.612 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.409 ' CD ' HG21 ' A' ' 46' ' ' VAL . 1.0 OUTLIER -71.73 -34.49 69.61 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.372 -0.831 . . . . 2.6000000000000001 111.516 -173.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -56.39 -36.84 69.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.116 -0.99 . . . . 1.45 110.963 174.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.28 -49.18 60.98 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.765 -0.934 . . . . 0.29999999999999999 110.765 168.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.825 HD11 HD11 ' A' ' 64' ' ' ILE . 96.8 mt -65.14 -30.9 71.87 Favored 'General case' 0 C--O 1.225 -0.207 0 O-C-N 121.544 -0.974 . . . . 0.33000000000000002 112.882 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt -58.85 -17.55 24.88 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.145 0.884 . . . . 1.26 111.257 171.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -93.77 4.35 54.06 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.962 1.097 . . . . 5.5800000000000001 113.962 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.0 mmt -82.03 136.4 47.22 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 120.702 1.592 . . . . 2.79 112.605 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.17 98.25 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.8 3.0 . . . . 0.38 110.111 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.74 -14.96 4.12 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.588 -1.005 . . . . 0.22 110.588 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 p -69.45 152.74 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 117.524 0.662 . . . . 0.28999999999999998 110.434 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.53 -57.48 2.21 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.159 1.384 . . . . 0.73999999999999999 109.48 170.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -144.51 158.09 43.92 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 122.973 0.509 . . . . 3.1800000000000002 110.39 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.65 127.6 33.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.272 1.829 . . . . 0.79000000000000004 107.926 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.09 113.31 8.37 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.854 0.861 . . . . 1.48 109.164 -174.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -89.73 140.34 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.098 0.959 . . . . 0.68000000000000005 111.72 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -131.72 67.22 1.52 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.169 1.788 . . . . 1.22 111.581 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.74 -16.68 64.01 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 113.131 0.789 . . . . 0.69999999999999996 113.131 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.03 -23.94 15.31 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.637 0.375 . . . . 0.58999999999999997 110.748 168.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.5 m -126.62 18.31 7.42 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.073 1.349 . . . . 0.47999999999999998 110.008 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 45.35 38.96 3.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.616 1.166 . . . . 2.48 111.869 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.9 m -136.17 154.63 50.9 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.28 -1.378 . . . . 0.48999999999999999 107.28 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.409 HG21 ' CD ' ' A' ' 25' ' ' GLU . 7.1 p -133.55 150.02 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.588 -0.893 . . . . 0.42999999999999999 108.588 173.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.41 150.08 41.35 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.739 -0.837 . . . . 2.8300000000000001 108.739 171.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.94 139.63 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 107.146 -1.427 . . . . 0.38 107.146 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.1 mt -108.09 131.63 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.019 -1.474 . . . . 0.88 107.019 -175.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -154.2 167.78 28.74 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 123.257 0.348 . . . . 1.8300000000000001 111.767 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -102.75 110.85 64.15 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 124.508 1.123 . . . . 1.6200000000000001 109.856 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -74.74 30.12 0.35 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.94 3.093 . . . . 0.81999999999999995 112.752 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.13 -50.21 5.17 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.044 -1.465 . . . . 0.44 107.044 167.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -87.24 -46.71 9.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.689 1.196 . . . . 2.6499999999999999 110.269 173.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.6 m -140.88 136.42 32.31 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 117.591 2.441 . . . . 0.68000000000000005 117.591 -148.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.85 -161.31 23.05 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 109.102 -1.599 . . . . 0.47999999999999998 109.102 164.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 t -38.15 -43.53 0.77 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.833 2.453 . . . . 0.54000000000000004 112.427 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.32 -57.43 4.62 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.809 0.844 . . . . 0.28999999999999998 112.72 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.56 -37.56 65.49 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.873 0.844 . . . . 0.19 109.328 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.556 HG12 HD22 ' A' ' 28' ' ' LEU . 1.2 mt -61.56 -59.46 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-N 114.466 -1.243 . . . . 0.76000000000000001 109.341 -171.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.94 -50.36 27.33 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.099 1.318 . . . . 0.80000000000000004 110.846 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.28 -52.58 9.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.205 1.002 . . . . 2.3900000000000001 111.988 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -43.84 69.07 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.984 -0.686 . . . . 2.02 111.373 177.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.825 HD11 HD11 ' A' ' 28' ' ' LEU . 35.7 mm -52.53 -45.28 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 118.985 0.811 . . . . 0.56999999999999995 110.284 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -49.3 -47.35 47.06 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.895 0.379 . . . . 1.6200000000000001 110.646 173.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -71.96 -33.23 68.03 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.954 1.094 . . . . 2.9700000000000002 113.954 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.49 -24.59 21.09 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.268 0.486 . . . . 0.89000000000000001 110.205 166.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.66 29.29 6.64 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.114 -1.194 . . . . 0.27000000000000002 110.114 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -140.73 162.08 36.27 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.01 -1.478 . . . . 1.6599999999999999 107.01 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.61 ' HE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -113.79 133.72 55.21 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.118 -1.808 . . . . 4.0499999999999998 106.118 170.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.443 ' HB ' HG21 ' A' ' 64' ' ' ILE . 4.5 p -100.73 148.53 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.39 0.676 . . . . 0.46999999999999997 109.948 170.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.61 HG13 ' HE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.569 0 CA-C-N 118.594 0.634 . . . . 1.45 109.738 167.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.288 0.089 . . . . 1.22 110.939 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.98 154.77 41.64 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.68 0.752 . . . . 3.4399999999999999 110.878 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -86.97 137.06 32.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.837 -1.529 . . . . 2.1800000000000002 108.993 166.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.0 tp -112.07 155.64 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 105.917 -1.883 . . . . 1.1799999999999999 105.917 162.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.55 130.55 21.84 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 108.072 -1.085 . . . . 0.41999999999999998 108.072 172.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.62 173.47 16.89 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.177 0.899 . . . . 1.2 111.4 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.93 149.47 22.37 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.434 0.694 . . . . 1.8200000000000001 109.599 -172.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.596 HG11 HD13 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -125.34 143.78 37.69 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.059 0 C-N-CA 122.708 0.403 . . . . 0.83999999999999997 110.883 -176.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.45 -0.428 0 C-N-CA 124.343 1.057 . . . . 1.03 109.31 175.613 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 109.469 -0.567 . . . . 0.44 109.469 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -49.99 -49.66 49.81 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.707 0.685 . . . . 6.9199999999999999 111.652 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.596 HD13 HG11 ' A' ' 12' ' ' VAL . 90.5 mt -44.02 -62.62 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 123.432 0.693 . . . . 0.98999999999999999 109.324 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.42 -35.37 65.82 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.303 0.573 . . . . 2.3599999999999999 112.394 -172.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -58.2 -36.43 73.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.955 -1.091 . . . . 1.22 110.722 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.59 -51.01 51.13 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.564 -1.014 . . . . 0.34000000000000002 110.564 166.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.766 HD11 HD11 ' A' ' 64' ' ' ILE . 94.2 mt -63.71 -33.6 76.0 Favored 'General case' 0 C--O 1.221 -0.417 0 O-C-N 121.579 -0.954 . . . . 0.40999999999999998 112.444 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -57.79 -18.61 22.81 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.28 0.946 . . . . 1.5600000000000001 112.058 172.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -85.33 -11.78 53.83 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.822 1.415 . . . . 4.2300000000000004 114.822 169.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.561 ' O ' HG12 ' A' ' 34' ' ' VAL . 4.8 mmt -69.63 143.51 92.8 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 120.85 1.659 . . . . 1.8500000000000001 112.074 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.74 106.63 1.51 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.39 2.06 . . . . 0.56999999999999995 109.537 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.09 -13.41 5.75 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.079 1.323 . . . . 0.25 110.784 171.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 31' ' ' MET . 8.1 p -70.27 160.56 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 O-C-N 121.939 -0.742 . . . . 0.32000000000000001 111.517 171.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.49 -65.7 1.15 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.84 1.256 . . . . 0.56999999999999995 108.212 165.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -144.43 147.43 33.34 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.349 -0.387 . . . . 3.25 111.793 -162.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.27 138.29 50.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.24 1.416 . . . . 0.63 108.587 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -140.0 118.45 12.18 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.975 0.91 . . . . 1.4199999999999999 109.408 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -86.4 136.35 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.99 0.916 . . . . 0.65000000000000002 111.054 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -129.23 69.68 1.41 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.318 1.847 . . . . 1.21 110.994 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.2 mt -64.09 -18.63 64.57 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.848 0.685 . . . . 0.95999999999999996 112.848 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.84 -18.21 8.15 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.124 0.42 . . . . 0.84999999999999998 110.977 170.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.7 m -131.87 18.06 4.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.823 1.249 . . . . 0.68999999999999995 109.872 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 41.12 39.24 0.86 Allowed 'General case' 0 C--N 1.346 0.419 0 C-N-CA 124.895 1.278 . . . . 2.6000000000000001 112.128 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.4 m -129.59 152.46 49.09 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.16 -1.422 . . . . 0.64000000000000001 107.16 -171.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 p -133.85 146.85 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 107.143 -1.429 . . . . 0.52000000000000002 107.143 173.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.75 145.8 46.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 123.93 0.769 . . . . 2.6000000000000001 109.39 173.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -144.0 136.66 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.615 -0.883 . . . . 0.25 108.615 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.0 mt -103.61 118.87 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.704 2.002 . . . . 0.94999999999999996 107.145 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -146.17 169.0 19.63 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.74 0.781 . . . . 1.8999999999999999 110.415 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -96.71 125.3 47.32 Favored Pre-proline 0 N--CA 1.439 -1.003 0 CA-C-N 114.316 -1.311 . . . . 1.3500000000000001 109.502 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.41 6.69 2.56 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.778 2.318 . . . . 0.71999999999999997 113.315 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.19 -54.47 4.59 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 119.358 0.981 . . . . 0.46999999999999997 108.95 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -85.43 -55.86 3.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.312 1.445 . . . . 3.1299999999999999 109.297 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.8 m -86.93 160.16 18.78 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 126.366 1.867 . . . . 2.1000000000000001 112.984 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.24 161.25 35.07 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 104.859 -3.296 . . . . 1.4099999999999999 104.859 168.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 t -51.29 -32.24 24.24 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 117.192 0.496 . . . . 1.1399999999999999 110.288 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -36.26 -61.32 0.51 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.97 1.708 . . . . 0.68999999999999995 114.449 164.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.89 -37.97 73.03 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.938 -1.134 . . . . 0.38 107.938 -172.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.531 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -55.62 -62.29 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-N 114.315 -1.311 . . . . 0.92000000000000004 109.214 177.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -46.9 -54.1 10.75 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.354 1.434 . . . . 1.1899999999999999 110.676 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -41.05 -57.0 2.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.663 0.785 . . . . 2.52 112.767 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.64 -40.46 69.7 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 119.917 -0.713 . . . . 1.8799999999999999 110.046 -176.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.766 HD11 HD11 ' A' ' 28' ' ' LEU . 27.5 mm -52.61 -47.18 49.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 119.188 0.903 . . . . 0.41999999999999998 109.994 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -53.28 -42.54 66.66 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.637 0.375 . . . . 1.6899999999999999 110.754 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -71.04 -38.96 72.56 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.422 -0.799 . . . . 2.9399999999999999 110.915 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -54.96 -25.09 27.24 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.715 0.806 . . . . 1.0800000000000001 110.263 171.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.17 29.66 6.3 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.331 -1.108 . . . . 0.46999999999999997 110.331 172.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.533 ' CD2' HD11 ' A' ' 24' ' ' ILE . 44.0 m-85 -140.76 166.25 25.27 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.968 -1.123 . . . . 1.9399999999999999 107.968 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.17 122.0 38.18 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 104.679 -2.341 . . . . 3.3300000000000001 104.679 -173.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.411 ' HB ' HG21 ' A' ' 64' ' ' ILE . 7.2 p -100.54 142.51 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.182 -0.673 . . . . 0.42999999999999999 109.182 173.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--O 1.226 -0.17 0 N-CA-C 108.545 -0.909 . . . . 1.03 108.545 173.472 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 110.697 -0.112 . . . . 0.60999999999999999 110.697 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -146.14 157.17 43.83 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.013 -0.736 . . . . 3.71 109.013 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.68 127.94 35.59 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.625 1.57 . . . . 3.71 109.5 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 tp -106.73 152.17 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.767 -1.568 . . . . 1.0900000000000001 106.767 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.81 132.65 27.51 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.258 -1.386 . . . . 0.34999999999999998 107.258 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -156.41 163.16 39.8 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.072 0.549 . . . . 1.25 110.68 -170.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.536 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -92.77 154.56 18.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.343 -1.355 . . . . 2.2599999999999998 107.343 178.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.4 163.43 14.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.064 -1.087 . . . . 0.56000000000000005 108.064 173.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 107.555 -1.276 . . . . 1.0700000000000001 107.555 173.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 110.529 -0.174 . . . . 0.56999999999999995 110.529 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -62.79 -48.1 80.58 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 122.89 0.476 . . . . 4.0499999999999998 110.752 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.1 mt -49.62 -56.74 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.437 -0.579 . . . . 0.57999999999999996 109.437 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.78 -42.89 76.78 Favored 'General case' 0 C--O 1.219 -0.522 0 C-N-CA 120.208 -0.597 . . . . 3.48 109.567 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -49.51 -36.77 24.23 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.406 -1.434 . . . . 2.04 111.691 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.17 -51.71 39.93 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 112.191 -0.364 . . . . 0.44 112.191 167.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.805 HD11 HD11 ' A' ' 64' ' ' ILE . 90.2 mt -68.4 -28.34 67.01 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 121.401 -1.058 . . . . 0.55000000000000004 113.043 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.281 21.5 ttmt -62.7 -15.04 50.84 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.965 1.257 . . . . 2.29 110.238 175.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -25.63 60.12 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.217 1.192 . . . . 3.8900000000000001 114.217 166.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.549 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -67.18 134.83 93.55 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 120.14 1.336 . . . . 2.52 111.939 -169.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -65.58 100.79 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.303 2.669 . . . . 0.38 109.52 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.6 -17.68 3.48 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.405 -1.078 . . . . 0.23000000000000001 110.405 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 31' ' ' MET . 6.2 p -72.17 154.65 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 121.965 -0.727 . . . . 0.28000000000000003 110.385 169.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.18 -57.22 2.23 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 123.009 0.524 . . . . 0.45000000000000001 109.666 171.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -148.49 157.45 43.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.516 -0.55 . . . . 2.5600000000000001 109.516 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.72 136.11 33.85 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 127.232 2.213 . . . . 0.65000000000000002 108.325 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -137.87 117.71 13.23 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 125.222 1.576 . . . . 1.7 107.931 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -84.32 144.15 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.159 0.984 . . . . 0.73999999999999999 110.847 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -137.73 64.36 1.52 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.321 1.449 . . . . 1.25 112.124 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 41' ' ' LEU . 91.4 mt -65.55 -16.97 64.21 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 112.523 0.564 . . . . 0.96999999999999997 112.523 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.05 59.42 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.227 0.467 . . . . 0.82999999999999996 110.82 168.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.9 m -118.63 16.45 13.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.231 1.412 . . . . 0.75 109.962 176.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 48.28 36.37 6.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.601 1.161 . . . . 2.3300000000000001 111.769 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.4 m -138.04 155.3 48.95 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.747 -1.205 . . . . 0.56000000000000005 107.747 -168.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 p -136.48 150.36 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 108.825 -0.805 . . . . 0.52000000000000002 108.825 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.98 153.01 44.94 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 123.852 0.72 . . . . 2.7200000000000002 110.224 175.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.78 136.8 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.998 -0.742 . . . . 0.37 108.998 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.8 114.14 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.065 -1.457 . . . . 1.01 107.065 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -137.67 167.24 22.09 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.515 0.726 . . . . 1.9299999999999999 111.118 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -102.73 113.91 65.61 Favored Pre-proline 0 N--CA 1.443 -0.805 0 C-N-CA 124.475 1.11 . . . . 1.3100000000000001 110.612 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.8 17.89 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.529 2.819 . . . . 0.56000000000000005 113.724 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.47 -51.76 7.08 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 107.646 -1.242 . . . . 0.52000000000000002 107.646 168.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -81.47 -46.23 14.85 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.257 1.023 . . . . 2.9500000000000002 110.265 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.9 m -142.37 129.61 21.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 118.295 2.702 . . . . 0.67000000000000004 118.295 -143.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.08 -160.55 20.88 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.024 -1.23 . . . . 0.55000000000000004 110.024 162.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 t -29.43 -48.73 0.08 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 129.544 3.137 . . . . 0.56000000000000005 112.9 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.2 -55.9 7.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.719 0.808 . . . . 0.31 112.39 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.53 -38.0 65.42 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 122.149 0.976 . . . . 0.26000000000000001 109.432 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.528 HG12 HD22 ' A' ' 28' ' ' LEU . 1.4 mt -63.55 -56.63 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 114.408 -1.269 . . . . 0.67000000000000004 110.017 -169.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.51 -53.49 14.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.81 1.186 . . . . 0.77000000000000002 110.41 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -41.81 -54.05 3.51 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.245 1.018 . . . . 2.4399999999999999 112.266 175.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -41.39 68.06 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 118.179 -0.915 . . . . 1.8400000000000001 110.791 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.805 HD11 HD11 ' A' ' 28' ' ' LEU . 41.4 mm -53.75 -46.54 62.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.871 1.214 . . . . 0.40000000000000002 110.216 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -51.83 -42.9 62.89 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.333 0.587 . . . . 1.54 109.946 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -37.19 73.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.594 0.758 . . . . 4.5499999999999998 112.174 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -56.05 -19.95 14.91 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.149 0.579 . . . . 0.89000000000000001 110.731 168.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.51 27.76 12.56 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 110.405 -1.078 . . . . 0.42999999999999999 110.405 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -136.07 169.55 17.42 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 108.256 -1.016 . . . . 2.0 108.256 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.5 123.85 43.02 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.036 -1.098 . . . . 4.5199999999999996 108.036 176.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 p -91.61 153.29 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.969 1.308 . . . . 0.55000000000000004 109.712 173.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.173 0 C-N-CA 122.929 0.492 . . . . 1.26 110.222 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.215 0.055 . . . . 0.79000000000000004 111.05 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -153.46 159.44 42.32 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.356 0.598 . . . . 2.54 111.697 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -84.87 124.92 32.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.665 2.386 . . . . 2.1600000000000001 108.31 169.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 tp -104.06 147.92 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 106.878 -1.526 . . . . 1.2 106.878 161.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.47 129.35 37.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.651 -1.24 . . . . 0.34000000000000002 107.651 173.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -155.41 170.19 22.51 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.799 -0.445 . . . . 1.6599999999999999 109.799 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -97.1 148.69 22.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.272 1.029 . . . . 3.0899999999999999 108.879 -174.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.431 HG11 HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -122.03 160.57 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 C-N-CA 123.783 0.833 . . . . 0.60999999999999999 109.573 179.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 109.0 -0.741 . . . . 1.3799999999999999 109.0 165.313 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.737 0 CA-C-O 118.861 -0.59 . . . . 0.52000000000000002 110.615 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -61.8 -48.7 79.45 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.243 0.929 . . . . 3.71 111.415 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.482 HG22 ' OE1' ' A' ' 25' ' ' GLU . 47.3 mt -42.34 -62.82 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 124.716 1.206 . . . . 1.1399999999999999 108.388 173.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.482 ' OE1' HG22 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -73.45 -32.71 64.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 119.458 -0.897 . . . . 2.5600000000000001 112.664 -174.18 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -57.16 -37.7 72.46 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.95 -1.094 . . . . 2.1000000000000001 110.434 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.69 -50.7 56.74 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 110.476 -1.05 . . . . 0.46999999999999997 110.476 169.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.555 HD22 HG12 ' A' ' 60' ' ' ILE . 88.7 mt -62.29 -31.57 72.18 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 121.896 -0.767 . . . . 0.47999999999999998 112.12 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -62.51 -15.59 51.24 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 119.155 0.889 . . . . 2.6200000000000001 110.722 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.27 -3.17 44.56 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.043 1.127 . . . . 4.5 114.043 169.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.442 ' O ' HG12 ' A' ' 34' ' ' VAL . 75.1 mmm -74.07 138.91 75.82 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 120.786 1.63 . . . . 2.1000000000000001 111.768 -177.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.64 90.39 0.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.31 2.673 . . . . 0.52000000000000002 110.971 -173.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.99 -9.04 4.19 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.122 1.344 . . . . 0.31 111.347 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 31' ' ' MET . 4.4 p -64.69 161.87 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.399 1.099 . . . . 0.33000000000000002 110.251 164.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.21 -53.61 2.13 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.738 1.215 . . . . 0.42999999999999999 110.373 166.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -148.25 163.77 36.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.467 -0.568 . . . . 3.0499999999999998 109.467 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.24 141.99 26.75 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.979 1.712 . . . . 0.72999999999999998 108.627 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -152.19 119.63 6.0 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.887 0.875 . . . . 1.4299999999999999 108.754 -165.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.541 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.2 p -84.98 145.72 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.318 1.047 . . . . 0.93000000000000005 112.376 -175.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -134.32 69.95 1.45 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.968 1.707 . . . . 1.3 112.345 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.4 mt -61.57 -22.26 65.04 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 112.295 0.48 . . . . 1.46 112.295 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.61 -16.44 25.79 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.406 0.548 . . . . 0.95999999999999996 111.174 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.9 m -132.66 18.24 4.28 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.918 0.887 . . . . 0.75 109.529 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 43.95 45.5 6.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.902 0.881 . . . . 2.4100000000000001 111.505 -175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.8 m -136.37 159.92 40.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.95 1.3 . . . . 0.47999999999999998 108.145 -170.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.541 HG23 ' HA ' ' A' ' 39' ' ' VAL . 12.0 p -139.61 149.65 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.378 -0.971 . . . . 0.60999999999999999 108.378 172.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -117.58 139.45 50.95 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.922 1.289 . . . . 2.5 109.301 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.29 132.85 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.274 0.63 . . . . 0.53000000000000003 109.841 174.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.72 125.12 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.295 1.438 . . . . 0.93000000000000005 107.542 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -146.24 169.72 18.2 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.314 0.646 . . . . 1.95 110.983 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -107.73 121.4 44.24 Favored Pre-proline 0 N--CA 1.447 -0.619 0 C-N-CA 124.726 1.21 . . . . 2.0899999999999999 110.982 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -71.94 10.85 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.349 3.366 . . . . 0.85999999999999999 113.684 -176.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.74 -50.32 12.63 Favored 'General case' 0 N--CA 1.458 -0.037 0 N-CA-C 107.409 -1.33 . . . . 0.84999999999999998 107.409 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -96.03 -40.16 9.39 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.019 1.728 . . . . 3.0 110.557 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.4 m -136.08 131.15 34.46 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 117.929 2.566 . . . . 0.56000000000000005 117.929 -153.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.99 -168.62 24.16 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.866 -1.293 . . . . 0.5 109.866 160.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.1 t -38.69 -40.35 0.59 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.947 2.499 . . . . 0.65000000000000002 112.243 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.17 -56.43 6.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.569 0.748 . . . . 0.28000000000000003 112.593 173.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.25 -34.48 68.3 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 122.562 1.172 . . . . 0.22 109.323 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.555 HG12 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -69.26 -52.51 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 113.943 -1.481 . . . . 0.56000000000000005 111.161 -169.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -50.69 59.39 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.322 1.419 . . . . 0.79000000000000004 109.641 173.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.47 -53.88 16.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.32 1.048 . . . . 4.9199999999999999 111.193 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -67.22 -41.93 84.9 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 121.703 -0.623 . . . . 2.2000000000000002 111.531 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.499 HD11 HD11 ' A' ' 28' ' ' LEU . 4.0 mm -55.19 -45.27 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.054 0.942 . . . . 0.37 110.191 -176.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -48.96 -47.01 44.31 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.305 0.574 . . . . 1.5800000000000001 110.596 171.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -32.71 69.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.378 0.881 . . . . 2.9900000000000002 113.378 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.63 -25.54 18.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.321 0.509 . . . . 0.93999999999999995 110.118 166.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.13 29.67 5.67 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.256 -1.138 . . . . 0.46000000000000002 110.256 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.431 ' CD2' HD11 ' A' ' 24' ' ' ILE . 26.8 m-85 -146.23 159.55 43.18 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 106.84 -1.541 . . . . 1.9299999999999999 106.84 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.79 135.37 54.03 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.776 0.798 . . . . 3.9399999999999999 109.324 171.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.9 p -99.34 152.54 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.478 1.511 . . . . 0.55000000000000004 109.751 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 C--O 1.226 -0.174 0 N-CA-C 109.4 -0.593 . . . . 0.88 109.4 175.208 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 119.662 -0.209 . . . . 0.68000000000000005 111.076 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -146.84 151.53 37.25 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 122.689 1.233 . . . . 3.3399999999999999 112.724 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -84.83 106.08 16.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 131.21 3.804 . . . . 2.4300000000000002 107.858 171.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.09 148.3 4.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 N-CA-C 107.199 -1.408 . . . . 1.21 107.199 165.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.54 126.28 29.01 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 124.775 1.23 . . . . 0.35999999999999999 107.73 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -156.52 165.48 36.17 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.525 -0.546 . . . . 1.0600000000000001 109.525 -170.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.5 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -96.72 155.2 16.87 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 108.827 -0.805 . . . . 2.02 108.827 -174.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.11 163.06 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 108.218 -1.03 . . . . 0.59999999999999998 108.218 175.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 107.085 -1.45 . . . . 1.0900000000000001 107.085 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.564 0 CA-C-O 119.369 -0.348 . . . . 0.40999999999999998 111.633 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -58.79 -41.49 86.82 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.592 0.633 . . . . 5.6299999999999999 111.145 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.2 mt -54.51 -59.74 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.592 -1.262 . . . . 0.80000000000000004 107.592 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.37 -36.14 73.97 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.431 -0.804 . . . . 2.54 110.501 -171.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -56.12 -36.47 68.25 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.199 -0.938 . . . . 1.77 110.961 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.2 -48.04 48.12 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.007 -0.837 . . . . 0.47999999999999998 111.007 166.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.712 HD11 HD11 ' A' ' 64' ' ' ILE . 44.2 mt -68.01 -30.55 69.83 Favored 'General case' 0 C--O 1.224 -0.241 0 O-C-N 121.351 -1.088 . . . . 0.51000000000000001 111.842 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.531 ' HA ' HG11 ' A' ' 34' ' ' VAL . 9.2 ttmt -60.33 -19.1 54.03 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.712 1.142 . . . . 1.21 111.468 172.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -25.21 62.02 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.95 -1.094 . . . . 4.04 113.349 168.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.502 ' O ' HG12 ' A' ' 34' ' ' VAL . 92.1 mmm -72.6 134.02 82.23 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 119.784 1.174 . . . . 2.0099999999999998 112.448 -167.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.03 101.44 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.902 3.068 . . . . 0.38 110.653 -172.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.22 -15.35 3.97 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.667 -0.973 . . . . 0.23000000000000001 110.667 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.3 p -72.48 154.71 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 O-C-N 122.081 -0.658 . . . . 0.29999999999999999 111.158 171.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.65 -53.78 2.08 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.784 1.234 . . . . 0.46999999999999997 109.801 171.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -142.44 153.46 43.73 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 113.606 0.965 . . . . 2.9300000000000002 113.606 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.65 125.4 38.02 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.596 1.958 . . . . 0.80000000000000004 107.971 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.13 109.39 6.88 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.043 1.337 . . . . 1.4199999999999999 108.857 -168.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.3 145.26 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.928 0.891 . . . . 0.60999999999999999 112.372 -172.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -135.6 67.73 1.47 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.121 1.768 . . . . 1.3200000000000001 111.622 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.5 mt -68.0 -14.6 63.09 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 113.159 0.8 . . . . 0.65000000000000002 113.159 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.15 -14.1 3.7 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.822 0.449 . . . . 0.60999999999999999 111.355 166.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 m -137.27 19.34 2.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.477 1.111 . . . . 0.55000000000000004 109.422 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 47.44 36.98 5.57 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.262 1.025 . . . . 2.71 111.232 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.9 m -132.22 156.27 46.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.781 -1.192 . . . . 0.46000000000000002 107.781 -168.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.81 148.2 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 108.828 -0.804 . . . . 0.41999999999999998 108.828 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -116.55 138.2 51.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.796 -1.187 . . . . 2.48 107.796 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.87 131.09 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.275 -1.009 . . . . 0.28000000000000003 108.275 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.91 115.76 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.803 -1.554 . . . . 1.28 106.803 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -141.49 170.59 15.43 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.177 0.991 . . . . 2.1499999999999999 110.323 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -104.56 111.47 65.21 Favored Pre-proline 0 N--CA 1.443 -0.814 0 C-N-CA 124.36 1.064 . . . . 1.3700000000000001 110.012 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.06 11.65 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.738 2.959 . . . . 0.68000000000000005 113.852 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.55 -48.0 12.37 Favored 'General case' 0 C--N 1.337 0.051 0 N-CA-C 107.416 -1.327 . . . . 0.60999999999999999 107.416 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -84.28 -47.35 10.87 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.999 1.32 . . . . 2.48 109.471 171.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.6 m -144.22 127.22 16.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 118.509 2.781 . . . . 0.69999999999999996 118.509 -146.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.44 -152.78 7.64 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.687 -0.965 . . . . 0.53000000000000003 110.687 158.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -28.76 -48.78 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 129.08 2.952 . . . . 1.1200000000000001 113.804 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.23 -55.37 18.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.705 0.684 . . . . 0.46000000000000002 112.527 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -40.24 63.78 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 122.425 1.107 . . . . 0.28000000000000003 108.418 -176.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.644 HG13 HD22 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -67.57 -49.98 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-N 114.131 -1.395 . . . . 1.2 111.312 -169.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.08 -51.1 56.62 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.592 1.542 . . . . 0.85999999999999999 110.279 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -45.38 -53.55 8.47 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.057 0.943 . . . . 2.3799999999999999 111.94 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -43.47 71.13 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 118.2 -0.905 . . . . 1.97 111.222 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.712 HD11 HD11 ' A' ' 28' ' ' LEU . 10.7 mm -50.88 -47.35 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.53 1.059 . . . . 0.58999999999999997 109.156 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -51.86 -48.02 64.2 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.978 0.418 . . . . 1.48 110.43 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -69.1 -34.56 75.29 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.437 -0.789 . . . . 3.3199999999999998 112.575 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.95 -21.96 13.46 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 122.97 0.508 . . . . 0.88 110.605 168.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.78 29.93 8.34 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.169 -1.172 . . . . 0.35999999999999999 110.169 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -137.67 170.88 15.3 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.372 -1.344 . . . . 2.0899999999999999 107.372 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.83 127.68 45.36 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.882 0.873 . . . . 4.0899999999999999 108.964 172.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.43 149.38 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 125.911 1.684 . . . . 0.52000000000000002 109.541 172.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.527 0.088 0 C-N-CA 123.797 0.839 . . . . 0.93000000000000005 109.828 176.554 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.548 0.213 . . . . 0.66000000000000003 111.101 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -147.53 162.55 38.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.186 0.517 . . . . 2.4199999999999999 110.752 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -83.07 143.44 30.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 113.596 -1.638 . . . . 2.5899999999999999 107.359 163.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -125.33 148.2 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 105.609 -1.997 . . . . 1.24 105.609 161.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.89 124.34 20.73 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.772 1.229 . . . . 0.40000000000000002 108.543 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -156.33 161.63 40.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.425 0.29 . . . . 1.25 111.62 -170.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.11 146.71 24.43 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.56 1.144 . . . . 1.74 109.934 -169.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.75 141.35 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.094 0.558 . . . . 0.77000000000000002 110.273 -176.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 107.372 -1.344 . . . . 1.05 107.372 170.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 119.566 -0.254 . . . . 0.44 110.924 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -58.28 -49.55 76.74 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.339 0.655 . . . . 4.1299999999999999 111.609 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.6 mt -47.38 -59.24 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.094 1.358 . . . . 0.68000000000000005 109.056 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.401 ' OE2' HD12 ' A' ' 28' ' ' LEU . 1.1 tm-20 -68.0 -44.31 76.88 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 119.868 -0.733 . . . . 3.71 109.038 -175.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -50.64 -36.66 36.55 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.701 -1.249 . . . . 1.4299999999999999 112.289 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.22 -48.07 82.89 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 112.011 -0.435 . . . . 0.39000000000000001 112.011 168.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.785 HD11 HD11 ' A' ' 64' ' ' ILE . 39.0 mt -64.38 -30.04 71.09 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 120.846 -1.385 . . . . 0.64000000000000001 112.154 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.554 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.27 16.6 ttmt -59.27 -18.6 38.85 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.821 1.191 . . . . 1.1899999999999999 111.666 171.099 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -17.89 59.95 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.9 -1.125 . . . . 3.3999999999999999 114.022 168.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.493 ' O ' HG12 ' A' ' 34' ' ' VAL . 92.9 mmm -74.65 135.07 75.17 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 120.419 1.463 . . . . 2.04 112.901 -172.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.73 95.21 0.63 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.934 3.089 . . . . 0.46000000000000002 111.737 -171.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.53 -18.95 2.24 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.55 -1.02 . . . . 0.20000000000000001 110.55 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 29' ' ' LYS . 4.2 p -66.88 155.25 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 O-C-N 121.939 -0.741 . . . . 0.28999999999999998 110.817 168.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.7 -59.99 1.76 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.065 0.946 . . . . 0.47999999999999998 109.776 168.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -146.25 142.1 28.02 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 114.309 1.226 . . . . 2.2799999999999998 114.309 -171.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.53 139.44 48.97 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.233 1.813 . . . . 0.79000000000000004 109.888 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -143.77 113.48 7.1 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.864 -0.791 . . . . 1.3100000000000001 108.864 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -81.57 142.25 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.295 0.638 . . . . 0.88 110.414 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -129.79 68.8 1.43 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.582 1.553 . . . . 1.3600000000000001 111.333 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.5 mt -62.09 -21.42 64.96 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 121.896 -0.503 . . . . 1.22 112.353 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.17 -20.21 16.84 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.806 0.442 . . . . 0.94999999999999996 111.179 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 m -130.71 18.5 5.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.316 1.046 . . . . 0.71999999999999997 110.041 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 35.23 55.85 0.81 Allowed 'General case' 0 C--N 1.345 0.382 0 C-N-CA 124.404 1.082 . . . . 3.8399999999999999 111.659 -170.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.5 m -143.89 154.36 43.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.423 -1.695 . . . . 0.5 106.423 -175.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.56 146.97 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.167 -0.679 . . . . 0.52000000000000002 109.167 171.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -115.96 143.87 44.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.999 1.32 . . . . 2.48 108.525 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.39 141.1 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 109.699 -0.482 . . . . 0.39000000000000001 109.699 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.4 mt -100.64 122.26 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.53 1.932 . . . . 0.68999999999999995 106.99 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -146.7 167.52 23.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.681 0.792 . . . . 1.76 110.337 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -100.54 113.02 65.44 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 114.786 -1.097 . . . . 2.1200000000000001 110.432 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -69.26 10.24 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.246 3.297 . . . . 0.66000000000000003 114.107 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.43 -50.76 8.52 Favored 'General case' 0 N--CA 1.458 -0.073 0 N-CA-C 107.436 -1.32 . . . . 0.63 107.436 173.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -92.19 -35.08 14.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.635 1.574 . . . . 3.3199999999999998 111.076 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.9 m -146.4 130.25 17.17 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 117.742 2.497 . . . . 0.54000000000000004 117.742 -157.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.94 -156.66 10.75 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.983 -1.247 . . . . 0.57999999999999996 109.983 155.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -29.21 -51.4 0.1 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.867 2.867 . . . . 0.64000000000000001 112.744 175.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.9 -55.69 9.29 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.074 0.768 . . . . 0.26000000000000001 113.074 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -38.58 64.83 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 122.047 0.927 . . . . 0.20999999999999999 108.726 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.454 HG12 HD22 ' A' ' 28' ' ' LEU . 2.5 mt -65.25 -54.0 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 114.37 -1.286 . . . . 0.68999999999999995 110.894 -169.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.53 -51.86 25.4 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.101 1.319 . . . . 0.73999999999999999 110.158 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -48.53 -47.78 38.87 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.916 1.286 . . . . 4.7300000000000004 112.195 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.66 -42.85 63.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 118.774 -0.631 . . . . 2.6699999999999999 112.479 174.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.785 HD11 HD11 ' A' ' 28' ' ' LEU . 11.1 mm -52.24 -45.13 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 119.544 1.065 . . . . 0.45000000000000001 109.974 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -49.06 -44.38 41.78 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.31 0.576 . . . . 1.5800000000000001 110.71 173.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -38.61 75.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.79 0.836 . . . . 3.6899999999999999 111.799 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.42 -25.71 26.4 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 119.431 -0.318 . . . . 0.96999999999999997 110.636 170.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.1 25.87 5.69 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 124.469 1.033 . . . . 0.40000000000000002 111.264 169.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -145.58 164.81 30.52 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 106.748 -1.575 . . . . 2.1600000000000001 106.748 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 129.12 54.99 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 103.747 -2.686 . . . . 3.1899999999999999 103.747 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.62 139.14 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.106 -0.701 . . . . 0.53000000000000003 109.106 171.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.226 -0.154 0 N-CA-C 109.212 -0.662 . . . . 1.3700000000000001 109.212 176.032 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 111.677 0.251 . . . . 0.68000000000000005 111.677 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.97 162.5 39.2 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.411 1.1 . . . . 2.6899999999999999 111.685 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -84.24 143.96 29.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 130.252 3.421 . . . . 2.8199999999999998 106.727 170.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 tp -130.1 151.66 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.309 -1.737 . . . . 1.1399999999999999 106.309 162.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.78 129.12 24.03 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.461 1.104 . . . . 0.38 108.981 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.69 173.58 16.75 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 119.384 -0.341 . . . . 1.1299999999999999 111.87 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.64 155.91 18.5 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 109.077 -0.712 . . . . 2.1200000000000001 109.077 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.01 157.35 16.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 N-CA-C 108.124 -1.065 . . . . 0.65000000000000002 108.124 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 108.31 -0.996 . . . . 0.92000000000000004 108.31 175.513 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.475 0 CA-C-O 119.432 -0.318 . . . . 0.44 111.023 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.7 mtp-105 -63.14 -45.66 90.91 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.583 0.629 . . . . 5.0700000000000003 110.58 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -49.64 -59.63 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 108.192 -1.04 . . . . 0.65000000000000002 108.192 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.94 -35.53 72.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.72 -0.673 . . . . 2.6099999999999999 110.665 -171.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -56.2 -36.1 68.03 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 120.894 -1.129 . . . . 1.24 111.155 171.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.52 -47.34 57.43 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.658 -0.977 . . . . 0.33000000000000002 110.658 167.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.684 HD11 HD11 ' A' ' 64' ' ' ILE . 94.8 mt -67.68 -28.73 67.94 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.384 -1.068 . . . . 0.33000000000000002 112.747 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.558 ' HA ' HG11 ' A' ' 34' ' ' VAL . 2.3 ttmt -58.49 -17.71 23.22 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.403 1.002 . . . . 1.5700000000000001 111.398 169.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -91.42 6.27 46.12 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.97 1.1 . . . . 3.2400000000000002 113.97 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.496 ' O ' HG12 ' A' ' 34' ' ' VAL . 34.4 mmt -85.57 135.28 38.56 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 120.499 1.5 . . . . 2.4500000000000002 112.45 171.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.03 84.11 1.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.666 2.911 . . . . 0.78000000000000003 112.301 -168.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.01 -16.43 0.91 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.486 1.041 . . . . 0.31 111.832 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.558 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.8 p -59.22 154.23 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.647 -0.914 . . . . 0.28999999999999998 111.501 168.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.69 -61.32 1.76 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.787 1.235 . . . . 0.53000000000000003 108.926 169.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -149.77 149.53 30.68 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 114.329 1.233 . . . . 2.5600000000000001 114.329 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.65 119.91 25.57 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.025 1.73 . . . . 0.96999999999999997 109.334 -170.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -134.28 111.72 10.46 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.151 0.98 . . . . 1.3899999999999999 108.431 -172.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -84.28 139.02 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 123.072 0.549 . . . . 0.81999999999999995 110.824 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -125.74 64.6 1.19 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.839 2.056 . . . . 1.25 110.636 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.8 mt -65.9 -16.96 64.32 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 112.67 0.618 . . . . 0.77000000000000002 112.67 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.1 -22.77 11.78 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.69 0.396 . . . . 0.63 110.712 168.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.4 m -127.14 17.78 7.15 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.268 1.427 . . . . 0.48999999999999999 110.163 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 47.66 35.8 4.88 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.138 0.975 . . . . 2.4199999999999999 112.374 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.7 m -131.79 153.29 50.26 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.434 -1.321 . . . . 0.55000000000000004 107.434 -169.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.95 146.48 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.013 -0.736 . . . . 0.48999999999999999 109.013 173.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -115.91 137.44 52.1 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.687 -1.227 . . . . 2.4900000000000002 107.687 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.95 140.69 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 108.683 -0.858 . . . . 0.29999999999999999 108.683 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.6 mt -105.2 132.07 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.814 1.645 . . . . 0.90000000000000002 106.836 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -152.59 163.93 38.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.62 0.768 . . . . 1.8300000000000001 110.774 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -92.82 110.57 46.43 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 124.158 0.983 . . . . 1.45 109.517 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.6 15.56 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.638 2.892 . . . . 0.62 113.501 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.8 -52.72 5.84 Favored 'General case' 0 CA--C 1.526 0.049 0 N-CA-C 107.57 -1.27 . . . . 0.59999999999999998 107.57 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -88.96 -45.75 9.43 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.538 1.535 . . . . 2.9700000000000002 110.406 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.6 m -131.59 129.24 40.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 116.886 2.18 . . . . 0.59999999999999998 116.886 -158.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.83 -162.6 16.2 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 110.181 -1.168 . . . . 0.47999999999999998 110.181 159.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.9 t -35.93 -41.67 0.24 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.523 2.729 . . . . 0.63 112.732 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.19 -56.22 9.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.305 0.642 . . . . 0.28000000000000003 112.46 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.22 -39.03 65.83 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 122.201 1.001 . . . . 0.23999999999999999 108.99 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.536 HG12 HD22 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -61.45 -56.66 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.275 -1.33 . . . . 0.72999999999999998 109.872 -171.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.84 -54.21 8.46 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.557 1.071 . . . . 0.83999999999999997 110.428 174.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 1.4 tm-20 -44.59 -52.1 8.4 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.628 0.728 . . . . 2.1899999999999999 111.547 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -45.06 64.18 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 117.958 -1.02 . . . . 1.9299999999999999 110.735 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.684 HD11 HD11 ' A' ' 28' ' ' LEU . 23.3 mm -51.29 -46.89 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 120.024 1.284 . . . . 0.48999999999999999 110.173 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -52.0 -47.06 65.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.492 0.717 . . . . 1.8 109.753 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.401 ' NZ ' ' OE2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -68.99 -37.61 78.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.275 0.63 . . . . 4.6399999999999997 111.522 -176.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -55.97 -22.38 26.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.068 0.947 . . . . 0.92000000000000004 110.665 170.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.41 29.79 6.52 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 124.289 0.947 . . . . 0.33000000000000002 110.868 173.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -141.4 174.22 10.75 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 108.619 -0.882 . . . . 1.7 108.619 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.13 117.54 18.43 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.815 -1.179 . . . . 4.29 107.815 -175.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 p -84.2 145.29 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.247 -0.888 . . . . 0.62 108.731 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.399 0 C-N-CA 124.649 1.18 . . . . 1.47 110.237 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.897 -0.409 . . . . 0.71999999999999997 109.897 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -146.24 157.66 43.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.573 0.701 . . . . 2.6899999999999999 111.367 -173.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -83.89 144.82 28.96 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 125.469 1.508 . . . . 2.4900000000000002 108.318 167.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 tp -122.13 153.31 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.056 -1.831 . . . . 1.1000000000000001 106.056 160.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.0 126.17 19.89 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.998 1.319 . . . . 0.34000000000000002 107.85 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.26 165.9 35.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.453 0.701 . . . . 2.3199999999999998 112.16 -174.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.66 147.58 23.75 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.608 1.163 . . . . 1.7 109.044 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -115.63 164.11 12.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 123.438 0.695 . . . . 0.64000000000000001 109.776 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.454 -0.242 0 C-N-CA 123.538 0.735 . . . . 0.76000000000000001 109.36 176.234 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.609 0 CA-C-O 119.569 -0.253 . . . . 0.34000000000000002 111.046 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 mtm105 -65.06 -41.45 95.09 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 118.258 0.481 . . . . 6.8300000000000001 111.175 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.0 mt -51.72 -59.13 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.127 -1.064 . . . . 0.56000000000000005 108.127 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.94 -36.77 72.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 120.046 -0.662 . . . . 2.2799999999999998 111.147 -171.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -50.99 -40.33 57.78 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.318 -0.864 . . . . 1.6299999999999999 110.558 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.79 -48.09 57.55 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.127 -0.789 . . . . 0.38 111.127 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 64' ' ' ILE . 96.9 mt -67.93 -32.4 72.83 Favored 'General case' 0 CA--C 1.519 -0.25 0 O-C-N 121.244 -1.15 . . . . 0.34999999999999998 112.693 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.511 ' HA ' HG11 ' A' ' 34' ' ' VAL . 11.5 ttpt -59.54 -17.1 29.45 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.949 0.795 . . . . 1.6599999999999999 110.63 171.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 mtt-85 -91.86 -0.05 57.5 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.747 -1.221 . . . . 3.2200000000000002 113.622 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.511 ' O ' HG12 ' A' ' 34' ' ' VAL . 5.9 mmt -78.67 142.68 61.79 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 120.804 1.638 . . . . 1.97 111.959 174.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.92 102.92 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.942 2.428 . . . . 0.41999999999999998 110.381 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.11 -4.34 6.37 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.326 1.441 . . . . 0.23999999999999999 110.941 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.511 HG11 ' HA ' ' A' ' 29' ' ' LYS . 6.6 p -70.88 157.21 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.848 -0.795 . . . . 0.28999999999999998 110.658 164.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.91 -63.91 1.38 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 107.623 -1.251 . . . . 0.41999999999999998 107.623 165.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -141.85 157.35 45.1 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 112.004 0.372 . . . . 2.8399999999999999 112.004 -170.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.46 137.07 40.02 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.26 1.824 . . . . 0.58999999999999997 107.414 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -139.55 114.89 9.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.902 1.281 . . . . 1.4199999999999999 108.63 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -83.93 138.2 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.96 0.904 . . . . 0.65000000000000002 110.339 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -132.88 63.71 1.63 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.607 1.563 . . . . 1.1699999999999999 111.376 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.1 mt -67.42 -15.56 63.74 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 113.062 0.764 . . . . 0.90000000000000002 113.062 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.66 -25.63 18.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 117.947 0.34 . . . . 0.70999999999999996 110.529 166.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.5 m -122.65 17.33 10.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.303 1.441 . . . . 0.55000000000000004 110.216 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 47.2 38.32 6.74 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.361 0.982 . . . . 2.7400000000000002 111.836 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.1 m -137.34 154.43 50.05 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.432 -1.322 . . . . 0.5 107.432 -171.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.52 152.58 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.238 -1.023 . . . . 0.44 108.238 170.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.44 150.63 48.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 123.58 0.55 . . . . 2.7400000000000002 109.701 174.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.19 138.07 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.398 -0.964 . . . . 0.25 108.398 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.43 119.99 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 126.05 1.74 . . . . 1.22 108.166 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -145.84 172.79 12.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.635 1.174 . . . . 1.8999999999999999 110.631 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -111.87 118.94 45.59 Favored Pre-proline 0 N--CA 1.447 -0.609 0 C-N-CA 124.186 0.994 . . . . 1.3999999999999999 110.815 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.27 9.73 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.91 3.74 . . . . 0.58999999999999997 114.248 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.21 -40.48 37.36 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 108.437 -0.949 . . . . 0.71999999999999997 108.437 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -112.09 -49.54 2.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.716 1.606 . . . . 3.04 110.25 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.6 m -111.04 128.33 55.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.593 2.757 . . . . 0.91000000000000003 117.145 -168.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.21 -175.48 25.48 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.952 -0.859 . . . . 0.56000000000000005 110.952 156.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -29.17 -45.2 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 128.302 2.641 . . . . 0.85999999999999999 112.958 167.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.23 -55.11 13.64 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.756 0.65 . . . . 0.34000000000000002 112.756 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.23 -40.06 65.0 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 122.256 1.026 . . . . 0.20999999999999999 108.91 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.57 HG12 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -62.27 -57.12 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-N 113.918 -1.492 . . . . 0.57999999999999996 110.241 -171.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.45 -51.09 28.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.621 1.1 . . . . 0.78000000000000003 110.595 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -48.51 -50.19 32.9 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.737 0.815 . . . . 2.5099999999999998 111.287 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -46.15 64.96 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 118.638 -0.696 . . . . 2.1699999999999999 110.888 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 28' ' ' LEU . 18.7 mm -49.79 -47.61 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 119.069 0.85 . . . . 0.44 109.875 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -48.3 -50.4 30.2 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.449 0.642 . . . . 1.48 110.03 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.03 -33.22 70.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 121.671 -0.643 . . . . 3.4100000000000001 112.278 -176.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.83 -25.22 10.83 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 119.337 -0.364 . . . . 0.87 110.285 168.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.84 30.58 4.5 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.527 1.06 . . . . 0.29999999999999999 110.675 170.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -148.4 165.75 30.17 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 105.61 -1.996 . . . . 1.6899999999999999 105.61 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -120.63 140.38 51.64 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 119.1 0.864 . . . . 3.2999999999999998 109.113 166.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.6 p -94.94 141.37 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.803 1.641 . . . . 0.46000000000000002 108.581 172.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.225 -0.21 0 N-CA-C 108.891 -0.781 . . . . 1.5 108.891 173.86 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 120.361 0.125 . . . . 1.23 111.068 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -150.47 164.29 36.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.386 0.612 . . . . 3.0299999999999998 111.095 172.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -83.47 144.94 29.22 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.94 -1.482 . . . . 2.4300000000000002 108.019 163.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -124.05 148.85 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 105.145 -2.169 . . . . 1.24 105.145 162.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.53 120.45 15.46 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 125.302 1.441 . . . . 0.46000000000000002 108.097 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.1 ptt? -156.7 165.14 37.08 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.202 0.455 . . . . 1.02 111.117 -169.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.84 151.96 19.16 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.859 0.864 . . . . 1.76 109.239 -171.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.36 164.59 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 123.519 0.728 . . . . 0.68999999999999995 109.582 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.454 -0.23 0 C-N-CA 124.866 1.266 . . . . 0.78000000000000003 109.05 175.682 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 119.117 -0.468 . . . . 0.44 111.18 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -63.42 -46.24 87.27 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.22 0.918 . . . . 3.6099999999999999 110.455 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.8 mt -48.47 -58.53 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.172 -0.677 . . . . 0.83999999999999997 109.172 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.408 ' HG3' HG21 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -70.6 -37.37 73.87 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.206 -0.452 . . . . 3.8100000000000001 110.579 -172.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -55.7 -33.92 64.61 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 120.727 -1.233 . . . . 1.24 111.404 174.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.45 -48.91 53.83 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 111.301 -0.719 . . . . 0.31 111.301 166.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.62 HD11 HD11 ' A' ' 64' ' ' ILE . 86.1 mt -64.38 -32.75 74.5 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 118.247 1.023 . . . . 0.38 113.202 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.26 8.9 ttmt -56.15 -17.73 8.04 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.105 0.866 . . . . 1.22 111.575 170.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 8.73 44.05 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.506 1.299 . . . . 4.6900000000000004 114.506 172.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.463 ' O ' HG12 ' A' ' 34' ' ' VAL . 4.4 mtp -85.43 140.58 36.27 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 121.085 1.766 . . . . 2.0299999999999998 110.971 167.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.6 106.28 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.701 2.934 . . . . 0.47999999999999998 111.206 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.44 -18.95 3.63 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.48 -1.048 . . . . 0.27000000000000002 110.48 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 29' ' ' LYS . 8.5 p -69.42 152.22 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.595 0.758 . . . . 0.26000000000000001 110.87 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -58.29 2.16 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.679 1.192 . . . . 0.46999999999999997 109.516 171.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -145.25 150.48 36.76 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 113.01 0.745 . . . . 2.7000000000000002 113.01 -175.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.65 148.45 25.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.907 2.083 . . . . 1.21 109.408 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.38 90.23 1.32 Allowed 'General case' 0 CA--C 1.527 0.074 0 CA-C-O 121.965 0.888 . . . . 2.2999999999999998 110.176 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.24 135.5 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.744 0.818 . . . . 0.81000000000000005 110.445 -173.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -136.74 65.96 1.49 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.0 1.32 . . . . 1.26 111.305 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.93 -18.69 65.44 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 115.917 -0.583 . . . . 1.04 112.512 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.58 -27.85 58.92 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.242 0.474 . . . . 0.92000000000000004 110.668 169.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 m -115.94 18.23 15.64 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.347 1.459 . . . . 0.79000000000000004 110.109 177.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 48.6 35.56 6.31 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.515 1.126 . . . . 2.0699999999999998 112.066 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -143.04 151.97 41.38 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.053 -1.091 . . . . 0.51000000000000001 108.053 -165.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.408 HG21 ' HG3' ' A' ' 25' ' ' GLU . 5.5 p -133.18 148.95 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 109.416 -0.587 . . . . 0.5 109.416 173.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.18 126.38 46.88 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.036 1.334 . . . . 2.4900000000000002 108.148 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.35 138.66 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.938 -0.764 . . . . 0.25 108.938 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.4 mt -99.85 126.9 53.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 107.818 -1.179 . . . . 1.02 107.818 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -150.3 170.15 19.69 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.914 0.486 . . . . 1.9099999999999999 111.096 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -108.49 116.22 56.65 Favored Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 124.34 1.056 . . . . 1.3400000000000001 111.13 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -67.58 5.12 1.06 Allowed 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.916 3.077 . . . . 0.56000000000000005 113.875 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.32 -46.9 25.55 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 107.971 -1.122 . . . . 0.41999999999999998 107.971 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -95.41 -33.21 12.57 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.161 1.384 . . . . 3.46 111.027 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.7 m -155.82 129.97 8.76 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 119.447 3.129 . . . . 0.81999999999999995 119.447 -152.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.78 -163.14 12.59 Favored Glycine 0 N--CA 1.438 -1.217 0 N-CA-C 108.78 -1.728 . . . . 0.46000000000000002 108.78 154.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 t -34.04 -40.21 0.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.976 2.91 . . . . 0.82999999999999996 113.332 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.83 -56.23 7.93 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.081 0.855 . . . . 0.32000000000000001 113.083 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.83 -34.48 66.84 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 123.022 1.392 . . . . 0.20999999999999999 109.261 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.527 ' CG1' HD22 ' A' ' 28' ' ' LEU 0.252 0.9 OUTLIER -70.03 -51.44 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 CA-C-N 113.506 -1.679 . . . . 0.57999999999999996 111.007 -170.5 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -49.66 55.24 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.982 1.719 . . . . 0.82999999999999996 110.348 173.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -42.88 -58.37 2.41 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 121.775 0.798 . . . . 2.3300000000000001 111.971 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.29 -40.93 73.99 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 119.889 -0.724 . . . . 2.3599999999999999 110.974 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.62 HD11 HD11 ' A' ' 28' ' ' LEU . 15.1 mm -52.59 -46.0 48.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.315 1.046 . . . . 0.40999999999999998 110.283 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -51.38 -47.39 62.87 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.52 -0.548 . . . . 1.8700000000000001 109.52 174.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -70.09 -34.44 73.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 121.416 -0.802 . . . . 3.79 112.789 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.96 -22.0 13.68 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.066 0.394 . . . . 0.92000000000000004 110.751 167.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.91 24.5 8.55 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 124.778 1.18 . . . . 0.40000000000000002 110.739 173.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -140.95 167.72 21.51 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.59 -0.893 . . . . 1.79 108.59 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.95 122.44 40.17 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 103.84 -2.652 . . . . 3.6200000000000001 103.84 -175.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.1 p -100.43 141.39 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 109.663 -0.495 . . . . 0.56999999999999995 109.663 170.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 C--O 1.225 -0.194 0 N-CA-C 109.199 -0.667 . . . . 1.1699999999999999 109.199 175.158 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 109.452 -0.574 . . . . 0.59999999999999998 109.452 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -145.83 157.0 43.94 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.686 0.755 . . . . 2.3100000000000001 111.077 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.68 145.73 31.46 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.452 1.901 . . . . 2.2999999999999998 108.054 165.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 tp -127.84 157.11 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.138 -1.801 . . . . 1.1200000000000001 106.138 165.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.05 121.33 9.57 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.884 0.874 . . . . 0.46999999999999997 108.952 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -156.74 167.85 29.22 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.264 0.484 . . . . 1.27 111.396 -174.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.59 156.98 16.75 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.807 0.843 . . . . 1.8100000000000001 111.156 -172.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.79 132.66 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 C-N-CA 123.468 0.707 . . . . 0.67000000000000004 110.517 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 108.91 -0.774 . . . . 1.0800000000000001 108.91 173.372 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.604 0 CA-C-O 119.591 -0.242 . . . . 0.40000000000000002 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -56.8 -49.36 75.59 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 118.926 -0.559 . . . . 5.2400000000000002 111.705 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -48.33 -59.29 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 108.252 -1.018 . . . . 0.79000000000000004 108.252 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -70.06 -35.57 74.33 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.864 -0.734 . . . . 2.5499999999999998 110.39 -171.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp -61.02 -27.35 68.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.908 -1.12 . . . . 1.28 111.44 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.19 -52.56 48.65 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.248 -1.141 . . . . 0.46000000000000002 110.248 162.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.779 HD11 HD11 ' A' ' 64' ' ' ILE . 98.8 mt -63.43 -31.8 73.06 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 113.673 0.99 . . . . 0.40000000000000002 113.673 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -51.1 -19.23 1.04 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.98 0.912 . . . . 1.9299999999999999 111.705 169.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -91.25 -7.23 51.78 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.372 0.878 . . . . 4.1399999999999997 113.372 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.507 ' O ' HG12 ' A' ' 34' ' ' VAL . 26.3 mtp -76.07 139.6 69.22 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 120.212 1.369 . . . . 2.1899999999999999 112.43 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.81 88.99 0.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.603 2.869 . . . . 0.46000000000000002 111.363 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.68 -15.36 2.0 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.745 1.164 . . . . 0.23000000000000001 111.125 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 31' ' ' MET . 6.3 p -65.46 154.51 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 O-C-N 121.422 -1.046 . . . . 0.26000000000000001 110.934 169.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.24 -63.93 1.38 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.564 1.146 . . . . 0.5 108.084 167.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -150.55 137.39 19.12 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 112.368 0.507 . . . . 3.1800000000000002 112.368 -168.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.16 150.66 23.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.806 1.642 . . . . 0.94999999999999996 109.664 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.74 105.66 3.45 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.654 1.182 . . . . 1.9199999999999999 108.684 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.37 137.79 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.212 0.605 . . . . 0.56999999999999995 110.698 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -131.76 66.57 1.54 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.701 1.601 . . . . 1.21 111.083 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.1 mt -67.0 -19.09 65.66 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 115.918 -0.583 . . . . 0.72999999999999998 112.17 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.76 -11.66 8.29 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.629 0.772 . . . . 0.65000000000000002 111.665 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 m -135.31 17.82 3.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.37 1.068 . . . . 0.46000000000000002 109.525 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 44.85 39.53 3.64 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.058 1.343 . . . . 3.3100000000000001 111.957 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.1 m -134.37 155.28 50.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.542 -1.281 . . . . 0.48999999999999999 107.542 -170.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 p -131.96 143.13 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 109.136 -0.69 . . . . 0.47999999999999998 109.136 172.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.36 141.68 43.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.651 1.58 . . . . 2.4900000000000002 106.836 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.44 144.19 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 108.501 -0.926 . . . . 0.33000000000000002 108.501 171.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.7 mt -112.13 121.21 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 125.996 1.718 . . . . 0.72999999999999998 107.069 -174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -144.39 166.1 26.05 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.892 0.877 . . . . 1.98 110.818 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -95.38 109.71 46.7 Favored Pre-proline 0 N--CA 1.445 -0.701 0 C-N-CA 124.727 1.211 . . . . 1.45 109.564 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -71.18 12.89 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.688 2.925 . . . . 0.69999999999999996 113.659 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.75 -48.47 10.08 Favored 'General case' 0 C--N 1.337 0.025 0 N-CA-C 107.647 -1.242 . . . . 0.73999999999999999 107.647 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -89.5 -40.33 12.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.886 1.275 . . . . 2.6200000000000001 111.026 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.1 m -143.79 126.85 16.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 117.5 2.407 . . . . 0.56000000000000005 117.5 -152.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.72 -159.55 10.23 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 109.207 -1.557 . . . . 0.55000000000000004 109.207 156.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.4 t -33.71 -42.93 0.12 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.248 2.619 . . . . 0.75 113.134 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.49 -56.25 8.79 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.977 0.808 . . . . 0.33000000000000002 112.683 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.76 -35.89 62.58 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 122.113 0.959 . . . . 0.26000000000000001 109.369 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.642 HG12 HD22 ' A' ' 28' ' ' LEU 0.254 0.8 OUTLIER -64.93 -55.52 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 114.358 -1.292 . . . . 0.57999999999999996 110.245 -174.496 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -49.88 45.83 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 120.553 1.524 . . . . 0.83999999999999997 111.315 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -38.82 -57.35 1.23 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.051 0.929 . . . . 2.7200000000000002 112.902 171.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -71.77 -41.53 68.25 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.606 -0.725 . . . . 2.1299999999999999 109.827 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.779 HD11 HD11 ' A' ' 28' ' ' LEU . 37.8 mm -55.13 -45.09 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 119.413 1.006 . . . . 0.44 110.436 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -52.35 -54.18 34.99 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.547 1.139 . . . . 1.6399999999999999 109.241 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -45.94 85.15 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.479 0.548 . . . . 4.1299999999999999 112.479 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mp -55.07 -19.32 6.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.815 1.646 . . . . 2.3700000000000001 111.789 172.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.72 24.91 7.9 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.343 0.973 . . . . 0.44 111.346 169.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -139.22 175.44 9.56 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 108.879 -0.786 . . . . 2.1699999999999999 108.879 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 123.05 27.51 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.51 -1.663 . . . . 4.29 106.51 175.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -87.96 145.42 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.19 -0.67 . . . . 0.72999999999999998 109.19 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 108.904 -0.776 . . . . 1.46 108.904 168.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 120.42 0.152 . . . . 1.0 110.609 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -150.54 156.64 41.79 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.372 0.606 . . . . 2.9900000000000002 110.093 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -84.07 114.15 21.55 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.867 2.067 . . . . 2.2999999999999998 106.683 169.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -96.96 155.37 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 106.416 -1.698 . . . . 1.1299999999999999 106.416 167.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.93 137.69 34.99 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.855 -0.794 . . . . 0.5 108.855 170.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.18 169.25 25.2 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.638 0.586 . . . . 1.25 111.995 175.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.429 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -91.56 153.46 19.74 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.498 1.119 . . . . 1.9099999999999999 110.723 -175.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.85 134.99 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 123.098 0.559 . . . . 0.90000000000000002 111.656 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.452 -0.331 0 C-N-CA 124.112 0.965 . . . . 0.83999999999999997 109.293 175.024 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 111.598 0.221 . . . . 0.68000000000000005 111.598 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -69.9 -45.86 66.69 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.488 0.715 . . . . 4.75 110.099 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -50.75 -54.14 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.367 -0.605 . . . . 0.83999999999999997 109.367 177.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -69.62 -42.92 73.69 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.505 -0.554 . . . . 3.79 109.505 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -51.61 -36.93 47.78 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.175 -1.578 . . . . 1.6000000000000001 111.809 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.28 -52.96 37.25 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 111.543 -0.623 . . . . 0.52000000000000002 111.543 166.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 64' ' ' ILE . 87.3 mt -61.3 -29.46 69.89 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.1 -1.236 . . . . 0.63 113.289 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.56 ' HA ' HG11 ' A' ' 34' ' ' VAL . 4.2 ttmm -59.9 -18.75 47.21 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.151 1.342 . . . . 1.49 111.715 172.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -16.55 57.83 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.885 1.068 . . . . 4.5999999999999996 113.885 169.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.496 ' O ' HG12 ' A' ' 34' ' ' VAL . 83.8 mmm -72.12 135.79 82.3 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 120.031 1.287 . . . . 2.0499999999999998 111.431 -174.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.58 101.32 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.042 2.494 . . . . 0.35999999999999999 110.711 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.31 -15.12 3.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 119.459 1.027 . . . . 0.25 110.809 176.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 29' ' ' LYS . 5.2 p -69.17 153.31 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 O-C-N 122.312 -0.523 . . . . 0.26000000000000001 109.941 166.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.65 -61.04 1.76 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.126 -1.064 . . . . 0.45000000000000001 108.126 162.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -141.42 145.98 35.98 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 113.527 0.936 . . . . 3.3900000000000001 113.527 -168.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.64 150.9 26.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.758 1.623 . . . . 1.1699999999999999 108.551 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.86 101.54 2.91 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.77 0.828 . . . . 1.96 108.785 175.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.95 141.54 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.828 0.851 . . . . 1.0700000000000001 110.997 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -139.11 66.04 1.43 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.137 1.375 . . . . 1.27 111.429 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 41' ' ' LEU . 56.2 mt -67.04 -13.82 62.29 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 113.342 0.867 . . . . 1.05 113.342 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.36 -25.52 9.98 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.578 0.351 . . . . 0.96999999999999997 110.886 165.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.8 m -125.17 17.92 8.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.343 1.457 . . . . 0.69999999999999996 110.157 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 48.18 33.39 3.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.414 1.086 . . . . 2.48 112.156 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -131.66 149.24 52.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.29 -1.004 . . . . 0.60999999999999999 108.29 -168.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -134.02 144.45 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 109.399 -0.593 . . . . 0.55000000000000004 109.399 174.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -112.11 145.08 40.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.052 1.741 . . . . 2.3799999999999999 108.096 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.52 136.44 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.011 -0.737 . . . . 0.32000000000000001 109.011 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.36 119.17 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.694 1.597 . . . . 0.98999999999999999 107.535 178.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -144.49 167.81 21.61 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.009 0.923 . . . . 1.79 110.712 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -108.26 122.88 39.16 Favored Pre-proline 0 N--CA 1.451 -0.416 0 O-C-N 124.211 0.944 . . . . 1.47 110.888 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.79 5.05 1.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.931 3.088 . . . . 0.58999999999999997 113.544 -177.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.74 -55.28 6.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.419 -1.326 . . . . 0.40000000000000002 107.419 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -84.04 -42.57 16.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.526 1.13 . . . . 3.6800000000000002 110.54 172.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.8 m -143.27 131.6 22.11 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 119.175 3.028 . . . . 0.64000000000000001 119.175 -143.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.06 -159.55 18.67 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.13 -1.188 . . . . 0.51000000000000001 110.13 159.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -30.66 -47.63 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.839 2.855 . . . . 0.56000000000000005 112.845 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.86 -56.27 7.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.396 0.678 . . . . 0.26000000000000001 112.488 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.65 -38.49 64.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.197 0.999 . . . . 0.17999999999999999 109.393 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.492 HG12 HD13 ' A' ' 28' ' ' LEU . 1.7 mt -64.75 -55.36 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.465 -1.243 . . . . 0.62 110.377 -170.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.98 -50.02 59.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.923 1.238 . . . . 0.77000000000000002 110.695 177.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -43.7 -56.14 3.96 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.712 0.805 . . . . 2.1299999999999999 112.023 175.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -41.48 72.57 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.559 -0.856 . . . . 1.6899999999999999 110.586 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.603 HD11 HD11 ' A' ' 28' ' ' LEU . 14.6 mm -52.42 -46.05 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 119.489 1.04 . . . . 0.34999999999999998 110.019 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -50.82 -46.69 59.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.041 0.448 . . . . 1.8600000000000001 110.098 174.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -32.89 70.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 114.015 1.117 . . . . 3.1299999999999999 114.015 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.65 -21.23 25.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.548 0.613 . . . . 0.88 110.571 166.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.93 27.3 8.4 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.768 -0.933 . . . . 0.32000000000000001 110.768 173.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -140.39 173.67 11.28 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.181 -1.044 . . . . 1.72 108.181 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 122.88 31.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.702 -1.592 . . . . 4.1600000000000001 106.702 176.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 p -89.92 145.78 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.906 -0.776 . . . . 0.55000000000000004 108.906 171.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 109.289 -0.634 . . . . 1.27 109.289 170.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 120.42 0.152 . . . . 1.0 110.609 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -150.54 156.64 41.79 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.372 0.606 . . . . 2.9900000000000002 110.093 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -84.07 114.15 21.55 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.867 2.067 . . . . 2.2999999999999998 106.683 169.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -96.96 155.37 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 106.416 -1.698 . . . . 1.1299999999999999 106.416 167.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.93 137.69 34.99 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.855 -0.794 . . . . 0.5 108.855 170.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.18 169.25 25.2 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.638 0.586 . . . . 1.25 111.995 175.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.429 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -91.56 153.46 19.74 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.498 1.119 . . . . 1.9099999999999999 110.723 -175.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.85 134.99 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 123.098 0.559 . . . . 0.90000000000000002 111.656 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.452 -0.331 0 C-N-CA 124.112 0.965 . . . . 0.83999999999999997 109.293 175.024 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 111.598 0.221 . . . . 0.68000000000000005 111.598 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -69.9 -45.86 66.69 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.488 0.715 . . . . 4.75 110.099 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -50.75 -54.14 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.367 -0.605 . . . . 0.83999999999999997 109.367 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -69.62 -42.92 73.69 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.505 -0.554 . . . . 3.79 109.505 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -51.61 -36.93 47.78 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.175 -1.578 . . . . 1.6000000000000001 111.809 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.28 -52.96 37.25 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 111.543 -0.623 . . . . 0.52000000000000002 111.543 166.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 64' ' ' ILE . 87.3 mt -61.3 -29.46 69.89 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.1 -1.236 . . . . 0.63 113.289 174.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.56 ' HA ' HG11 ' A' ' 34' ' ' VAL . 4.2 ttmm -59.9 -18.75 47.21 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.151 1.342 . . . . 1.49 111.715 172.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -16.55 57.83 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.885 1.068 . . . . 4.5999999999999996 113.885 169.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.496 ' O ' HG12 ' A' ' 34' ' ' VAL . 83.8 mmm -72.12 135.79 82.3 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 120.031 1.287 . . . . 2.0499999999999998 111.431 -174.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.58 101.32 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.042 2.494 . . . . 0.35999999999999999 110.711 -174.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.31 -15.12 3.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 119.459 1.027 . . . . 0.25 110.809 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 29' ' ' LYS . 5.2 p -69.17 153.31 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 O-C-N 122.312 -0.523 . . . . 0.26000000000000001 109.941 166.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.65 -61.04 1.76 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.126 -1.064 . . . . 0.45000000000000001 108.126 162.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -141.42 145.98 35.98 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 113.527 0.936 . . . . 3.3900000000000001 113.527 -168.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.64 150.9 26.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.758 1.623 . . . . 1.1699999999999999 108.551 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.86 101.54 2.91 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.77 0.828 . . . . 1.96 108.785 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.95 141.54 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.828 0.851 . . . . 1.0700000000000001 110.997 -175.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -139.11 66.04 1.43 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.137 1.375 . . . . 1.27 111.429 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 41' ' ' LEU . 56.2 mt -67.04 -13.82 62.29 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 113.342 0.867 . . . . 1.05 113.342 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.36 -25.52 9.98 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.578 0.351 . . . . 0.96999999999999997 110.886 165.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.8 m -125.17 17.92 8.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.343 1.457 . . . . 0.69999999999999996 110.157 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 48.18 33.39 3.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.414 1.086 . . . . 2.48 112.156 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -131.66 149.24 52.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.29 -1.004 . . . . 0.60999999999999999 108.29 -168.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -134.02 144.45 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 109.399 -0.593 . . . . 0.55000000000000004 109.399 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -112.11 145.08 40.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.052 1.741 . . . . 2.3799999999999999 108.096 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.52 136.44 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.011 -0.737 . . . . 0.32000000000000001 109.011 174.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.36 119.17 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.694 1.597 . . . . 0.98999999999999999 107.535 178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -144.49 167.81 21.61 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.009 0.923 . . . . 1.79 110.712 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -108.26 122.88 39.16 Favored Pre-proline 0 N--CA 1.451 -0.416 0 O-C-N 124.211 0.944 . . . . 1.47 110.888 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.79 5.05 1.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.931 3.088 . . . . 0.58999999999999997 113.544 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.74 -55.28 6.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.419 -1.326 . . . . 0.40000000000000002 107.419 175.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -84.04 -42.57 16.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.526 1.13 . . . . 3.6800000000000002 110.54 172.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.8 m -143.27 131.6 22.11 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 119.175 3.028 . . . . 0.64000000000000001 119.175 -143.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.06 -159.55 18.67 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.13 -1.188 . . . . 0.51000000000000001 110.13 159.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -30.66 -47.63 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.839 2.855 . . . . 0.56000000000000005 112.845 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.86 -56.27 7.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.396 0.678 . . . . 0.26000000000000001 112.488 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.65 -38.49 64.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.197 0.999 . . . . 0.17999999999999999 109.393 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.492 HG12 HD13 ' A' ' 28' ' ' LEU . 1.7 mt -64.75 -55.36 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.465 -1.243 . . . . 0.62 110.377 -170.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.98 -50.02 59.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.923 1.238 . . . . 0.77000000000000002 110.695 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -43.7 -56.14 3.96 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.712 0.805 . . . . 2.1299999999999999 112.023 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -41.48 72.57 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.559 -0.856 . . . . 1.6899999999999999 110.586 -178.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.603 HD11 HD11 ' A' ' 28' ' ' LEU . 14.6 mm -52.42 -46.05 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 119.489 1.04 . . . . 0.34999999999999998 110.019 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -50.82 -46.69 59.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.041 0.448 . . . . 1.8600000000000001 110.098 174.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -32.89 70.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 114.015 1.117 . . . . 3.1299999999999999 114.015 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.65 -21.23 25.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.548 0.613 . . . . 0.88 110.571 166.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.93 27.3 8.4 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.768 -0.933 . . . . 0.32000000000000001 110.768 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -140.39 173.67 11.28 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.181 -1.044 . . . . 1.72 108.181 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 122.88 31.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.702 -1.592 . . . . 4.1600000000000001 106.702 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 p -89.92 145.78 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.906 -0.776 . . . . 0.55000000000000004 108.906 171.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 109.289 -0.634 . . . . 1.27 109.289 170.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 N--CA 1.45 -0.434 0 CA-C-O 120.56 0.219 . . . . 0.93999999999999995 111.289 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.32 161.55 40.07 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.998 -0.371 . . . . 3.6000000000000001 109.998 172.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.41 136.29 33.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.627 -1.17 . . . . 3.3900000000000001 107.935 161.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 tp -107.4 153.91 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.051 -1.833 . . . . 1.1699999999999999 106.051 162.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.58 128.56 17.49 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.589 1.156 . . . . 0.35999999999999999 108.44 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.78 172.33 18.81 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.506 0.594 . . . . 1.3700000000000001 111.939 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.403 ' H ' ' NE2' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -90.62 157.38 17.51 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.278 -0.638 . . . . 2.2799999999999998 109.278 -176.562 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 24' ' ' ILE . 2.1 t -123.34 132.12 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 O-C-N 123.492 0.495 . . . . 0.70999999999999996 110.315 177.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 107.922 -1.14 . . . . 0.90000000000000002 107.922 172.464 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 CA-C-O 118.579 -0.724 . . . . 0.5 110.609 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -52.98 -44.38 67.14 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 119.347 0.976 . . . . 5.5999999999999996 111.451 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.568 HD11 ' CD2' ' A' ' 69' ' ' TYR . 71.4 mt -44.66 -61.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 123.494 0.717 . . . . 0.82999999999999996 109.15 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.01 -37.99 66.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.809 -0.632 . . . . 2.3999999999999999 112.177 -175.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -57.5 -34.63 69.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.328 -0.858 . . . . 1.52 110.691 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.81 -49.82 64.23 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 110.781 -0.928 . . . . 0.40000000000000002 110.781 167.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.663 HD22 HG13 ' A' ' 60' ' ' ILE . 92.9 mt -64.41 -32.72 74.45 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 118.302 1.051 . . . . 0.40999999999999998 112.311 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.458 ' HA ' HG11 ' A' ' 34' ' ' VAL . 12.8 ttmm -57.83 -16.43 11.62 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.151 0.887 . . . . 1.51 112.094 171.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -97.85 -0.47 45.03 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.178 0.899 . . . . 3.23 112.744 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.426 ' O ' HG12 ' A' ' 34' ' ' VAL . 53.7 mmm -79.99 135.56 55.03 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 119.895 1.225 . . . . 2.3799999999999999 110.629 174.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.09 116.94 3.89 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.421 2.08 . . . . 0.81999999999999995 109.448 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.35 -17.18 6.61 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.929 1.252 . . . . 0.19 110.146 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' A' ' 29' ' ' LYS . 4.7 p -75.7 158.69 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.305 0.642 . . . . 0.29999999999999999 111.366 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.38 -63.05 1.4 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.581 1.152 . . . . 0.44 108.099 165.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -135.36 151.86 50.89 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 112.441 0.534 . . . . 3.1099999999999999 112.441 -169.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.32 140.09 41.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.928 1.291 . . . . 0.60999999999999999 107.558 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -147.63 129.98 15.7 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.201 -0.666 . . . . 1.74 109.201 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.89 134.87 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 123.98 0.912 . . . . 0.66000000000000003 110.593 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -124.82 65.2 1.11 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.008 1.723 . . . . 1.22 110.201 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.97 -20.36 63.77 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 116.071 -0.513 . . . . 0.91000000000000003 112.334 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.52 -24.69 21.75 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.997 0.519 . . . . 0.78000000000000003 110.996 171.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.4 m -125.61 16.24 8.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.96 1.304 . . . . 0.68000000000000005 109.935 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 45.93 38.39 4.5 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.339 1.056 . . . . 2.0099999999999998 111.44 -175.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.4 m -131.86 153.05 50.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.11 -1.441 . . . . 0.55000000000000004 107.11 -171.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 p -133.2 149.86 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.721 -1.214 . . . . 0.40999999999999998 107.721 174.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.22 148.45 48.64 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 123.967 0.792 . . . . 2.8999999999999999 109.565 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.3 131.26 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 121.576 0.703 . . . . 0.32000000000000001 109.266 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mt -95.38 120.12 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.508 1.923 . . . . 0.94999999999999996 107.361 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -149.33 170.15 19.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.455 0.702 . . . . 1.8200000000000001 110.188 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -104.44 121.29 47.78 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 114.36 -1.291 . . . . 2.0299999999999998 111.22 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.18 2.69 1.67 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.683 3.589 . . . . 0.5 114.203 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.92 -51.16 10.85 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 119.268 0.94 . . . . 0.46999999999999997 108.864 176.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -90.7 -44.27 9.59 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.545 1.538 . . . . 3.04 109.633 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.2 m -127.07 121.83 32.62 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 116.865 2.172 . . . . 0.58999999999999997 116.865 -157.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.09 169.63 27.41 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 106.223 -2.751 . . . . 0.96999999999999997 106.223 173.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.304 0.0 OUTLIER -39.52 -40.05 0.8 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.324 1.849 . . . . 0.70999999999999996 113.248 177.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -38.3 -59.76 0.85 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.331 1.052 . . . . 0.52000000000000002 113.245 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.51 -35.61 65.64 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 122.012 0.911 . . . . 0.28999999999999998 109.246 -173.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.663 HG13 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -60.75 -60.09 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-N 114.189 -1.368 . . . . 1.0600000000000001 108.237 -176.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.72 -51.88 26.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.162 0.892 . . . . 1.1299999999999999 110.436 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.68 -51.31 12.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.929 0.892 . . . . 2.3799999999999999 112.01 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -46.01 65.31 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.911 -0.716 . . . . 1.8999999999999999 110.938 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.651 HD11 HD11 ' A' ' 28' ' ' LEU . 8.3 mm -52.41 -44.53 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 118.94 0.791 . . . . 0.87 110.73 -175.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -48.85 -51.3 30.43 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.327 0.585 . . . . 1.5900000000000001 109.939 173.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -73.31 -28.75 62.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.602 0.761 . . . . 4.0499999999999998 112.85 -175.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.46 -25.45 25.29 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.155 0.434 . . . . 0.93999999999999995 110.254 165.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.02 29.93 5.61 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 124.891 1.234 . . . . 0.56999999999999995 110.566 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.568 ' CD2' HD11 ' A' ' 24' ' ' ILE . 58.5 m-85 -144.12 169.26 18.19 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 108.198 -1.038 . . . . 2.0 108.198 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.95 120.47 30.44 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.103 -1.073 . . . . 4.3600000000000003 108.103 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.8 p -87.49 149.64 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.835 -0.432 . . . . 0.42999999999999999 109.835 172.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.26 0 C-N-CA 124.181 0.992 . . . . 1.28 110.217 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 109.846 -0.427 . . . . 0.68999999999999995 109.846 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -147.98 162.1 40.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.248 1.023 . . . . 3.2200000000000002 111.395 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.16 146.93 30.28 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 112.647 -2.069 . . . . 3.3399999999999999 107.807 164.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -132.25 158.06 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.401 -2.074 . . . . 1.4299999999999999 105.401 165.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.73 144.1 32.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.062 0.945 . . . . 0.57999999999999996 109.129 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.9 169.82 23.73 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.252 0.621 . . . . 1.3100000000000001 110.609 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.536 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -89.1 155.01 19.72 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.367 -0.975 . . . . 2.3199999999999998 108.367 176.475 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -116.54 160.85 15.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.283 -1.006 . . . . 0.67000000000000004 108.283 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.445 -0.701 0 N-CA-C 107.452 -1.314 . . . . 0.79000000000000004 107.452 175.148 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.547 0 CA-C-O 118.586 -0.721 . . . . 0.35999999999999999 110.937 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.69 -48.33 66.64 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.176 0.898 . . . . 4.0 110.543 172.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.425 HD11 ' CD2' ' A' ' 69' ' ' TYR . 66.0 mt -49.03 -61.13 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.24 0 N-CA-C 109.054 -0.721 . . . . 0.57999999999999996 109.054 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -71.2 -35.1 71.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.077 -0.649 . . . . 2.3700000000000001 110.895 -171.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -54.57 -37.99 66.15 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 121.02 -1.05 . . . . 1.52 110.688 171.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.37 -51.52 36.57 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.584 -1.006 . . . . 0.47999999999999998 110.584 168.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.796 HD11 HD11 ' A' ' 64' ' ' ILE . 96.1 mt -64.79 -29.91 70.9 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 121.702 -0.881 . . . . 0.42999999999999999 112.367 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.652 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -63.1 -18.07 63.01 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 118.984 0.811 . . . . 1.48 109.809 176.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.83 -23.08 63.25 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.219 -1.551 . . . . 3.1800000000000002 113.934 168.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.57 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -69.03 133.19 89.99 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 120.214 1.37 . . . . 1.8500000000000001 110.463 -172.23 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.24 100.12 0.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.822 2.348 . . . . 0.44 110.19 -176.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.57 -21.82 2.37 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.588 -1.005 . . . . 0.29999999999999999 110.588 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.652 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.8 p -67.37 153.7 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 122.293 -0.533 . . . . 0.28000000000000003 110.675 170.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.25 -61.07 1.77 Allowed 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.467 -0.938 . . . . 0.46000000000000002 108.467 167.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.26 152.93 39.12 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.645 0.259 . . . . 2.7599999999999998 111.315 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.13 135.28 46.29 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.901 2.08 . . . . 0.68000000000000005 107.77 -173.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -144.7 121.67 11.36 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.408 0.683 . . . . 1.5700000000000001 109.73 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -97.8 137.59 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 112.937 0.717 . . . . 0.97999999999999998 112.937 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -126.33 69.79 1.23 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.401 2.281 . . . . 1.3 111.181 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.9 mt -65.08 -17.98 64.92 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 112.692 0.627 . . . . 0.73999999999999999 112.692 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.89 -10.0 5.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.154 0.434 . . . . 0.63 111.44 169.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 m -138.17 17.18 2.8 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.23 1.012 . . . . 0.45000000000000001 109.758 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mp0 51.2 30.6 5.89 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.048 0.84 . . . . 2.8900000000000001 111.935 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.7 m -128.98 153.66 47.34 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.804 -1.184 . . . . 0.53000000000000003 107.804 -168.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.02 147.46 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.951 -1.129 . . . . 0.46000000000000002 107.951 174.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.46 151.73 41.0 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 124.209 0.943 . . . . 2.8399999999999999 109.154 175.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.5 140.2 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.142 -1.059 . . . . 0.27000000000000002 108.142 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.46 124.89 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.531 1.532 . . . . 0.87 107.438 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -148.46 165.99 29.49 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.387 0.675 . . . . 1.8200000000000001 110.622 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -97.98 110.84 57.42 Favored Pre-proline 0 N--CA 1.447 -0.611 0 C-N-CA 124.673 1.189 . . . . 2.0499999999999998 110.247 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -72.25 13.25 0.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.963 3.108 . . . . 0.60999999999999999 113.716 -177.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.41 -51.26 8.02 Favored 'General case' 0 C--N 1.337 0.059 0 N-CA-C 107.257 -1.386 . . . . 0.59999999999999998 107.257 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -80.83 -47.98 13.06 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.273 1.429 . . . . 2.7400000000000002 109.637 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.5 m -143.04 125.7 15.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 117.252 2.316 . . . . 0.70999999999999996 117.252 -145.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.51 -159.74 13.65 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 109.857 -1.297 . . . . 0.5 109.857 165.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.4 t -29.47 -50.04 0.1 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 129.138 2.975 . . . . 0.72999999999999998 112.632 177.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.05 -56.33 6.68 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.025 0.93 . . . . 0.32000000000000001 112.654 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -38.47 64.88 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 122.248 1.023 . . . . 0.20000000000000001 109.403 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.596 HG12 HD22 ' A' ' 28' ' ' LEU . 1.3 mt -63.29 -56.26 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.242 -1.345 . . . . 0.59999999999999998 110.216 -170.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.21 -52.69 19.87 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.174 1.352 . . . . 0.76000000000000001 110.611 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -44.09 -51.95 7.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.683 1.193 . . . . 2.5099999999999998 111.968 176.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -43.44 68.61 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 118.248 -0.882 . . . . 2.0800000000000001 111.464 177.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.796 HD11 HD11 ' A' ' 28' ' ' LEU . 37.7 mm -52.58 -45.55 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 119.77 1.168 . . . . 0.38 110.075 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -50.38 -49.2 55.05 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.763 0.316 . . . . 1.8200000000000001 110.183 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -70.77 -30.67 67.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 114.279 1.214 . . . . 3.25 114.279 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.27 -21.0 12.75 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.532 0.606 . . . . 0.91000000000000003 110.635 166.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.24 28.74 9.52 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.998 -1.241 . . . . 0.29999999999999999 109.998 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.425 ' CD2' HD11 ' A' ' 24' ' ' ILE . 71.2 m-85 -137.44 168.3 19.91 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.735 -0.839 . . . . 1.71 108.735 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.33 123.1 42.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.746 -1.576 . . . . 4.4900000000000002 106.746 175.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.442 ' HB ' HG21 ' A' ' 64' ' ' ILE . 8.7 p -91.65 152.99 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.46 -0.57 . . . . 0.54000000000000004 109.46 172.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.103 0 CA-C-O 121.305 0.574 . . . . 1.4299999999999999 110.305 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 109.546 -0.539 . . . . 0.69999999999999996 109.546 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.45 162.22 41.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.238 0.542 . . . . 4.79 110.878 176.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -82.83 155.03 24.38 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.222 1.809 . . . . 3.71 109.765 168.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.7 142.84 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 104.847 -2.279 . . . . 3.2599999999999998 104.847 162.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.52 130.72 51.14 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.689 1.196 . . . . 0.40999999999999998 107.869 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -155.53 174.78 14.77 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.876 0.47 . . . . 1.2 110.381 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.419 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -104.87 150.31 24.96 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.753 -1.203 . . . . 1.8999999999999999 107.753 -176.379 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.42 161.52 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 107.502 -1.296 . . . . 0.64000000000000001 107.502 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 107.609 -1.256 . . . . 1.29 107.609 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 119.489 -0.291 . . . . 0.40000000000000002 110.24 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -58.4 -45.14 88.95 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 118.778 -0.629 . . . . 3.6800000000000002 111.997 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.2 mt -49.06 -60.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.041 -0.725 . . . . 0.62 109.041 176.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' CD ' HG21 ' A' ' 46' ' ' VAL . 3.4 tp10 -70.86 -33.98 71.17 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.16 0.505 . . . . 2.6400000000000001 110.336 -170.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -60.15 -31.29 69.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.864 -1.147 . . . . 2.29 111.234 171.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.67 -51.82 31.74 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.515 -1.034 . . . . 0.34000000000000002 110.515 162.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 64' ' ' ILE . 93.3 mt -65.2 -32.66 74.45 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 121.253 -1.145 . . . . 0.39000000000000001 113.023 177.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HA ' HG11 ' A' ' 34' ' ' VAL . 13.5 tppt? -54.97 -21.22 11.08 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.373 0.988 . . . . 1.79 111.458 171.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -76.02 -24.32 55.25 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.788 1.033 . . . . 3.0800000000000001 113.788 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.48 ' O ' HG12 ' A' ' 34' ' ' VAL . 1.5 mtp -69.7 132.83 88.82 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 120.375 1.443 . . . . 2.2400000000000002 112.478 -172.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.6 95.38 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.644 2.896 . . . . 0.46000000000000002 110.716 -172.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.44 -20.8 2.23 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.696 -0.962 . . . . 0.26000000000000001 110.696 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 31' ' ' MET . 9.8 p -62.62 144.54 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 121.966 -0.726 . . . . 0.39000000000000001 110.954 171.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.12 -61.79 1.34 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.629 1.172 . . . . 0.81000000000000005 109.269 167.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -149.41 147.98 28.92 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 114.315 1.228 . . . . 2.8700000000000001 114.315 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.415 ' HB1' ' CG ' ' A' ' 25' ' ' GLU . . . -116.46 121.3 41.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.84 2.056 . . . . 0.91000000000000003 108.331 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.99 107.42 6.15 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.921 0.889 . . . . 1.3899999999999999 108.986 -170.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 p -85.4 143.6 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.91 0.884 . . . . 0.60999999999999999 112.058 -172.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -133.49 65.78 1.57 Allowed 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.226 1.811 . . . . 1.29 111.163 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.6 mt -65.61 -16.35 63.63 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 121.685 -0.634 . . . . 0.71999999999999997 112.704 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.4 -19.65 15.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.645 0.378 . . . . 0.52000000000000002 110.902 168.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.4 m -129.19 19.33 5.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.088 1.355 . . . . 0.45000000000000001 109.685 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 50.24 35.14 9.84 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.138 0.975 . . . . 2.4399999999999999 111.846 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.89 158.08 44.86 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 108.847 -0.797 . . . . 0.97999999999999998 108.847 -169.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.439 HG21 ' CD ' ' A' ' 25' ' ' GLU . 7.2 p -134.96 148.85 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.081 -0.711 . . . . 0.45000000000000001 109.081 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -115.81 134.41 55.04 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.95 -1.5 . . . . 2.5 106.95 176.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.43 140.07 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.284 -0.635 . . . . 0.37 109.284 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.0 mt -105.58 132.67 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 126.201 1.8 . . . . 0.90000000000000002 106.945 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.01 167.42 28.48 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.959 0.409 . . . . 2.0299999999999998 111.498 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -98.25 114.16 64.86 Favored Pre-proline 0 N--CA 1.442 -0.829 0 C-N-CA 124.752 1.221 . . . . 1.46 109.839 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -69.48 9.87 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 124.289 3.326 . . . . 0.53000000000000003 113.971 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.39 -51.59 8.18 Favored 'General case' 0 N--CA 1.458 -0.058 0 N-CA-C 107.411 -1.329 . . . . 0.46999999999999997 107.411 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -93.67 -29.75 15.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.579 1.552 . . . . 3.1200000000000001 111.289 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.7 m -150.2 130.25 13.5 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 118.031 2.604 . . . . 0.47999999999999998 118.031 -156.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.33 -165.25 17.79 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 110.453 -1.059 . . . . 0.42999999999999999 110.453 156.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.4 t -39.88 -38.31 0.67 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.291 2.636 . . . . 1.04 112.138 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.65 -56.0 9.71 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.181 0.808 . . . . 0.32000000000000001 113.181 174.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.56 -37.82 65.41 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.838 1.304 . . . . 0.19 108.904 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.597 ' CG1' HD22 ' A' ' 28' ' ' LEU 0.269 0.8 OUTLIER -64.04 -53.6 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 113.708 -1.587 . . . . 0.57999999999999996 111.013 -173.749 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.87 -53.07 12.91 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.766 1.621 . . . . 0.96999999999999997 111.048 173.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -39.75 -58.12 1.4 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.829 0.823 . . . . 2.52 113.106 172.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -70.34 -40.28 74.2 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 119.465 -0.894 . . . . 2.9900000000000002 110.224 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.696 HD11 HD11 ' A' ' 28' ' ' LEU . 31.3 mm -54.12 -46.74 67.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.506 1.048 . . . . 0.35999999999999999 110.114 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -53.13 -45.53 68.4 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.289 0.636 . . . . 1.5700000000000001 109.927 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -38.99 86.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.456 -0.778 . . . . 3.9199999999999999 111.23 -177.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.6 -19.85 18.11 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.656 1.182 . . . . 0.96999999999999997 110.898 170.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.01 28.54 9.25 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 124.187 0.899 . . . . 0.34999999999999998 110.938 173.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -138.06 165.31 26.91 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.041 -1.096 . . . . 1.79 108.041 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.69 129.3 55.2 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.752 0.821 . . . . 3.9199999999999999 108.943 173.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.3 p -96.14 148.52 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 125.276 1.431 . . . . 0.41999999999999998 110.22 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 11' ' ' GLN . 2.9 m . . . . . 0 N--CA 1.463 0.177 0 C-N-CA 123.594 0.758 . . . . 1.0 110.376 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 119.92 -0.085 . . . . 0.57999999999999996 111.182 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -143.67 157.0 44.72 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.599 0.714 . . . . 2.4199999999999999 111.399 174.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -84.28 125.68 32.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.244 1.818 . . . . 2.3300000000000001 107.035 163.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 tp -103.64 149.18 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.278 -1.749 . . . . 1.1200000000000001 106.278 163.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.82 129.11 40.06 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.674 -1.232 . . . . 0.40999999999999998 107.674 172.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -155.75 168.63 26.58 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.841 0.456 . . . . 1.02 110.553 -172.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -91.57 151.51 20.69 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.811 -0.811 . . . . 2.8999999999999999 108.811 -173.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -117.96 160.84 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 108.922 -0.769 . . . . 0.67000000000000004 108.922 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.445 -0.685 0 N-CA-C 107.839 -1.171 . . . . 0.79000000000000004 107.839 174.194 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.676 0 CA-C-O 118.68 -0.676 . . . . 0.54000000000000004 111.935 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -57.48 -47.11 82.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.357 0.98 . . . . 3.3999999999999999 110.753 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.595 HD12 ' H ' ' A' ' 24' ' ' ILE . 3.5 mp -48.7 -61.62 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.413 -0.958 . . . . 1.6100000000000001 108.413 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.56 -33.57 66.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.433 -0.507 . . . . 2.5699999999999998 112.003 -172.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -56.29 -39.8 73.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.149 -0.969 . . . . 1.9399999999999999 110.026 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.01 -55.5 11.61 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.937 -1.265 . . . . 0.33000000000000002 109.937 167.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.88 HD11 HD11 ' A' ' 64' ' ' ILE . 96.5 mt -63.5 -31.39 72.54 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 113.439 0.903 . . . . 0.34000000000000002 113.439 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.447 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.26 14.0 ttpt -61.62 -17.14 53.99 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.656 1.116 . . . . 2.0899999999999999 111.116 172.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.92 -12.8 52.6 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.154 1.168 . . . . 3.6000000000000001 114.154 168.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.471 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -71.44 137.58 83.68 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 120.827 1.649 . . . . 3.3799999999999999 111.241 -173.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.48 94.48 0.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.113 2.542 . . . . 0.37 110.433 -175.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.42 -12.78 3.5 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.74 1.162 . . . . 0.23000000000000001 111.193 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 31' ' ' MET . 4.7 p -67.38 160.57 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 117.791 0.795 . . . . 0.26000000000000001 110.526 167.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.77 -55.44 1.9 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.358 1.063 . . . . 0.51000000000000001 110.152 165.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -143.99 162.26 36.64 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.068 0.395 . . . . 2.2599999999999998 111.815 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.44 135.73 28.77 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 126.072 1.749 . . . . 0.62 109.607 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -142.47 110.25 5.83 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 125.439 1.496 . . . . 1.55 108.746 -173.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.0 p -84.14 140.93 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.555 0.742 . . . . 0.62 111.728 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -132.48 69.06 1.48 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.991 1.717 . . . . 1.23 112.328 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.9 mt -63.38 -18.97 64.25 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 113.087 0.773 . . . . 0.79000000000000004 113.087 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.83 -21.93 12.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.264 0.484 . . . . 0.58999999999999997 110.933 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 m -125.65 10.19 7.77 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.919 1.288 . . . . 0.51000000000000001 110.605 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 45.52 44.68 10.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.176 0.991 . . . . 3.29 112.266 -169.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.9 m -134.31 155.29 50.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.411 -1.329 . . . . 0.54000000000000004 107.411 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.3 p -134.12 146.92 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.559 -0.904 . . . . 0.5 108.559 172.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -115.3 134.65 54.93 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 124.498 1.124 . . . . 2.3799999999999999 108.244 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -138.56 135.48 43.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.11 -0.7 . . . . 0.29999999999999999 109.11 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.9 mp -102.02 120.88 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.765 1.626 . . . . 1.1000000000000001 107.178 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -147.28 167.29 24.63 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.484 0.714 . . . . 1.8500000000000001 110.619 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -105.54 119.2 53.5 Favored Pre-proline 0 N--CA 1.443 -0.799 0 O-C-N 124.135 0.897 . . . . 1.3700000000000001 109.677 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -67.95 7.72 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 124.464 3.443 . . . . 0.46999999999999997 113.83 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.44 -57.0 4.12 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.201 -1.407 . . . . 0.46000000000000002 107.201 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.0 mp0 -87.84 -37.14 16.79 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.303 1.041 . . . . 3.7799999999999998 112.161 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.3 m -138.08 129.38 27.6 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 118.649 2.833 . . . . 0.54000000000000004 118.649 -155.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.41 -163.62 17.86 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.475 -1.05 . . . . 0.42999999999999999 110.475 155.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -29.29 -47.91 0.07 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.512 2.725 . . . . 0.88 112.863 172.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.15 -54.41 16.47 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.114 0.565 . . . . 0.40000000000000002 112.487 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.3 -41.62 60.86 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 122.201 1.0 . . . . 0.26000000000000001 109.182 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.708 HG12 HD22 ' A' ' 28' ' ' LEU . 1.6 mt -61.36 -60.25 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 114.137 -1.392 . . . . 0.56000000000000005 109.266 -170.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.98 -53.81 7.28 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.506 1.048 . . . . 0.79000000000000004 110.397 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -44.47 -54.44 5.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.624 1.17 . . . . 2.5899999999999999 111.363 176.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -40.7 76.04 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.987 -0.685 . . . . 2.3900000000000001 111.355 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 28' ' ' LEU . 37.7 mm -55.41 -44.27 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 119.233 0.924 . . . . 0.66000000000000003 109.947 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -52.67 -42.85 65.12 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.109 0.48 . . . . 1.8200000000000001 110.721 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -37.08 73.9 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.008 -1.057 . . . . 3.5899999999999999 111.016 -177.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.83 -21.0 17.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.538 0.735 . . . . 0.89000000000000001 110.911 169.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.08 27.39 16.23 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.588 -1.005 . . . . 0.35999999999999999 110.588 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.547 ' CE2' HD11 ' A' ' 24' ' ' ILE . 41.8 m-85 -135.51 169.51 17.4 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 107.942 -1.133 . . . . 2.02 107.942 176.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.4 114.79 16.0 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 107.84 -1.17 . . . . 4.5199999999999996 107.84 -174.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.41 144.11 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 123.795 0.838 . . . . 0.52000000000000002 108.803 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.431 0 C-N-CA 124.461 1.104 . . . . 1.5700000000000001 109.373 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 120.256 0.074 . . . . 1.1100000000000001 111.087 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.47 160.52 43.25 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.318 0.58 . . . . 4.0999999999999996 111.725 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -84.4 127.01 33.75 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.445 1.498 . . . . 2.4900000000000002 108.303 166.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tp -108.8 155.88 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.313 -1.736 . . . . 1.22 106.313 162.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.86 140.27 23.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.091 0.557 . . . . 0.72999999999999998 109.816 175.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.441 ' HG3' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -157.75 169.41 24.68 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 123.647 0.592 . . . . 1.6200000000000001 111.189 -177.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.489 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -84.5 152.85 23.67 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 108.105 -1.072 . . . . 2.4399999999999999 108.105 178.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.424 HG11 HD13 ' A' ' 24' ' ' ILE . 2.2 t -131.17 139.0 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.867 0.365 . . . . 1.0 110.289 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.446 -0.657 0 C-N-CA 124.512 1.125 . . . . 0.76000000000000001 108.188 -178.278 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 119.108 -0.473 . . . . 0.32000000000000001 110.563 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -57.24 -44.65 84.02 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.965 0.802 . . . . 6.6900000000000004 111.527 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.562 HD11 ' CD2' ' A' ' 69' ' ' TYR . 67.7 mt -46.74 -61.19 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 108.882 -0.784 . . . . 0.81999999999999995 108.882 177.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.14 -35.48 69.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.968 -0.56 . . . . 2.6000000000000001 111.787 -172.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -57.34 -35.68 70.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.094 -1.004 . . . . 1.46 110.786 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.26 -53.57 15.14 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.821 -0.911 . . . . 0.45000000000000001 110.821 165.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.71 HD22 HG12 ' A' ' 60' ' ' ILE . 89.4 mt -65.05 -31.06 72.1 Favored 'General case' 0 C--O 1.223 -0.314 0 O-C-N 121.778 -0.837 . . . . 0.53000000000000003 112.151 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.275 14.1 ttmt -58.87 -17.76 26.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.405 1.002 . . . . 1.21 112.104 171.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -20.24 47.66 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.66 1.118 . . . . 3.3599999999999999 113.726 168.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.474 ' O ' HG12 ' A' ' 34' ' ' VAL . 94.4 mmm -74.33 137.54 75.02 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 119.99 1.268 . . . . 2.0499999999999998 111.924 -169.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.49 91.17 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.671 2.914 . . . . 0.44 111.403 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.59 -13.65 2.23 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.941 1.257 . . . . 0.25 111.522 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 29' ' ' LYS . 6.8 p -66.18 159.68 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 121.709 -0.877 . . . . 0.31 111.635 168.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.22 -56.39 1.63 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.135 1.374 . . . . 0.60999999999999999 110.76 168.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -143.73 157.1 44.63 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 122.299 -0.251 . . . . 2.52 111.62 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.34 131.22 31.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.885 1.274 . . . . 0.69999999999999996 109.389 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -136.98 117.74 14.04 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.639 0.776 . . . . 1.5900000000000001 110.009 -176.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -84.32 140.62 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.448 1.099 . . . . 0.65000000000000002 110.732 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -130.36 65.0 1.53 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.591 1.557 . . . . 1.21 110.777 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.5 mt -64.37 -15.3 60.17 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 113.201 0.815 . . . . 0.66000000000000003 113.201 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.27 -20.07 3.84 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.274 0.63 . . . . 0.59999999999999998 111.514 167.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.6 m -134.45 18.66 3.64 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.421 1.488 . . . . 0.56000000000000005 109.957 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.8 mp0 47.28 34.84 3.37 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.299 1.04 . . . . 2.8100000000000001 111.815 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -132.5 153.17 51.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.744 -1.576 . . . . 0.5 106.744 -170.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -139.3 153.24 24.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.382 -0.97 . . . . 1.0700000000000001 108.382 173.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.12 151.73 36.98 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 124.342 1.026 . . . . 2.7400000000000002 109.815 176.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.16 136.04 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 108.598 -0.89 . . . . 0.31 108.598 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 mt -101.01 116.64 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.767 2.027 . . . . 0.81999999999999995 106.08 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -144.44 167.48 22.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.682 0.793 . . . . 1.8500000000000001 109.971 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -103.26 115.76 63.36 Favored Pre-proline 0 N--CA 1.443 -0.78 0 CA-C-N 114.726 -1.124 . . . . 1.4099999999999999 110.618 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -69.92 8.86 0.71 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 124.258 3.305 . . . . 0.5 113.953 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.38 -49.06 12.96 Favored 'General case' 0 CA--C 1.526 0.046 0 N-CA-C 107.943 -1.132 . . . . 0.42999999999999999 107.943 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -96.05 -36.22 11.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.979 1.712 . . . . 2.6600000000000001 110.693 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 m -142.19 129.07 20.62 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 117.708 2.484 . . . . 0.5 117.708 -159.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.11 -161.37 13.12 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.885 -0.886 . . . . 0.41999999999999998 110.885 157.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -32.92 -43.68 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 128.379 2.672 . . . . 0.91000000000000003 113.394 176.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.83 -57.19 7.87 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.041 0.536 . . . . 0.40999999999999998 112.145 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.85 -39.79 63.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 122.337 1.065 . . . . 0.26000000000000001 108.88 -177.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.71 HG12 HD22 ' A' ' 28' ' ' LEU . 1.8 mt -63.75 -53.44 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 114.359 -1.292 . . . . 0.55000000000000004 110.551 -169.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -51.67 58.19 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.623 1.101 . . . . 0.80000000000000004 110.454 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -46.29 -54.43 8.92 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.222 1.009 . . . . 2.1800000000000002 111.121 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -43.16 78.9 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 119.475 -0.89 . . . . 2.9300000000000002 111.263 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.432 HD11 HD11 ' A' ' 28' ' ' LEU . 4.9 mm -53.91 -45.17 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 123.822 0.849 . . . . 0.37 110.429 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -48.79 -47.64 41.86 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.915 -0.402 . . . . 1.6200000000000001 109.915 173.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -71.91 -30.04 64.95 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.642 0.979 . . . . 3.4500000000000002 113.642 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.97 -23.11 12.03 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.493 0.588 . . . . 0.84999999999999998 110.56 165.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.67 28.82 8.13 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 109.888 -1.285 . . . . 0.37 109.888 175.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.562 ' CD2' HD11 ' A' ' 24' ' ' ILE . 51.0 m-85 -139.96 164.2 30.64 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 108.122 -1.066 . . . . 1.77 108.122 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.48 121.21 36.04 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.367 -1.346 . . . . 4.5499999999999998 107.367 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.441 HG22 ' HG3' ' A' ' 10' ' ' MET . 1.4 p -86.77 159.35 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 124.838 1.255 . . . . 0.82999999999999996 108.951 174.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 121.412 0.625 . . . . 1.6100000000000001 111.322 176.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 110.248 -0.279 . . . . 0.64000000000000001 110.248 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -149.22 162.63 39.63 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.198 0.523 . . . . 3.0600000000000001 111.518 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.09 139.4 32.5 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.527 1.931 . . . . 2.2599999999999998 108.269 170.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 tp -118.32 151.7 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.202 -1.777 . . . . 1.1000000000000001 106.202 163.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.57 120.19 11.79 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.249 1.419 . . . . 0.58999999999999997 107.944 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.5 ptt? -156.51 167.71 29.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.296 0.498 . . . . 1.1000000000000001 110.105 -171.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.401 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -98.08 156.95 16.41 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.422 0.689 . . . . 1.79 110.282 -173.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -115.26 160.6 14.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 C-N-CA 123.043 0.537 . . . . 0.73999999999999999 109.919 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 124.933 1.293 . . . . 0.85999999999999999 108.316 174.882 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 119.15 -0.452 . . . . 0.48999999999999999 110.791 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.2 mmt-85 -54.81 -49.79 70.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.683 0.674 . . . . 4.0899999999999999 111.048 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.495 HD11 ' CD2' ' A' ' 69' ' ' TYR . 83.0 mt -48.45 -60.68 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.944 -0.762 . . . . 0.55000000000000004 108.944 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.461 ' HG2' HG21 ' A' ' 46' ' ' VAL . 1.9 tm-20 -69.19 -38.79 78.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 118.8 -1.16 . . . . 3.4199999999999999 109.801 -173.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -58.3 -28.37 64.93 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.086 -1.633 . . . . 1.26 112.365 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.53 -52.08 52.48 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 110.732 -0.947 . . . . 0.37 110.732 165.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.564 HD22 HG12 ' A' ' 60' ' ' ILE . 89.9 mt -64.03 -29.93 71.04 Favored 'General case' 0 C--O 1.223 -0.29 0 O-C-N 121.551 -0.97 . . . . 0.35999999999999999 112.966 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -55.08 -18.7 5.82 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.596 1.089 . . . . 1.9299999999999999 111.957 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -86.18 -14.82 42.85 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.753 1.16 . . . . 2.96 114.042 171.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.446 ' O ' HG12 ' A' ' 34' ' ' VAL . 82.2 mmm -73.12 138.43 79.0 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 120.01 1.277 . . . . 2.1400000000000001 112.313 -170.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.06 91.88 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.801 3.001 . . . . 0.5 111.268 -171.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.57 -11.0 4.03 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.606 -0.998 . . . . 0.22 110.606 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 31' ' ' MET . 6.5 p -61.92 145.97 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 118.286 1.043 . . . . 0.31 110.507 168.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.07 -67.79 0.89 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.09 -1.078 . . . . 0.5 108.09 162.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -149.86 126.83 11.17 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 113.628 0.973 . . . . 3.5299999999999998 113.628 -163.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.14 150.76 21.25 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.367 1.867 . . . . 1.1000000000000001 110.4 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.78 100.06 2.19 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.46 0.704 . . . . 1.8600000000000001 109.266 174.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.83 140.73 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.535 0.734 . . . . 0.81999999999999995 111.476 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -136.79 69.52 1.41 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.701 1.6 . . . . 1.26 111.566 -174.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.6 mt -65.61 -15.58 62.88 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 113.32 0.859 . . . . 0.78000000000000003 113.32 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.93 -17.08 5.68 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.715 0.406 . . . . 0.56999999999999995 111.292 168.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.1 m -136.59 18.91 3.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.923 1.289 . . . . 0.57999999999999996 109.735 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 47.67 32.36 2.51 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.716 1.206 . . . . 3.0299999999999998 112.164 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 m -127.97 151.53 49.01 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.806 -1.183 . . . . 0.53000000000000003 107.806 -168.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.461 HG21 ' HG2' ' A' ' 25' ' ' GLU . 8.9 p -134.0 142.41 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 109.003 -0.74 . . . . 0.65000000000000002 109.003 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -116.59 142.53 46.76 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.294 -1.372 . . . . 2.5699999999999998 107.294 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.38 140.38 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.945 -0.391 . . . . 0.52000000000000002 109.945 172.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.4 mt -100.68 127.47 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.725 -1.583 . . . . 1.01 106.725 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -149.82 171.42 16.77 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.914 0.886 . . . . 1.73 110.565 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -105.11 106.4 55.49 Favored Pre-proline 0 N--CA 1.446 -0.649 0 C-N-CA 124.951 1.3 . . . . 1.79 110.606 -177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -70.79 20.98 0.21 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 124.016 3.144 . . . . 0.53000000000000003 113.322 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.93 -41.38 14.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.926 -1.139 . . . . 0.42999999999999999 107.926 168.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -103.64 -50.04 3.52 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.502 1.521 . . . . 2.7599999999999998 110.433 176.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 m -127.29 131.84 50.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 128.506 2.722 . . . . 0.73999999999999999 117.978 -160.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.65 -161.46 12.26 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 108.998 -1.641 . . . . 0.54000000000000004 108.998 154.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 t -31.5 -44.97 0.08 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.888 2.875 . . . . 0.56000000000000005 113.34 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.37 -56.84 6.09 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.857 0.753 . . . . 0.32000000000000001 112.674 174.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.78 -36.38 65.06 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 122.535 1.16 . . . . 0.23999999999999999 109.261 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.564 HG12 HD22 ' A' ' 28' ' ' LEU . 1.5 mt -64.36 -54.88 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.165 -1.38 . . . . 0.67000000000000004 110.72 -172.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -51.01 37.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.144 1.338 . . . . 0.72999999999999998 110.756 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -42.93 -56.36 3.32 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.09 0.956 . . . . 2.3599999999999999 112.44 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -41.89 74.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.901 -0.719 . . . . 1.8100000000000001 111.189 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.554 HD11 HD11 ' A' ' 28' ' ' LEU . 6.9 mm -53.18 -44.92 53.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.368 0.667 . . . . 0.40999999999999998 110.357 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -50.8 -52.93 36.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.247 0.619 . . . . 1.6100000000000001 110.077 174.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -37.54 87.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.662 0.785 . . . . 5.6399999999999997 112.511 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.44 -19.92 6.57 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.554 0.742 . . . . 2.2000000000000002 111.862 168.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.65 28.69 6.92 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.343 0.973 . . . . 0.33000000000000002 110.844 170.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.495 ' CD2' HD11 ' A' ' 24' ' ' ILE . 72.6 m-85 -142.98 171.51 13.96 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.975 -1.12 . . . . 1.75 107.975 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.07 128.81 47.96 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.679 -1.6 . . . . 4.2300000000000004 106.679 173.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.42 142.25 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 119.021 -0.514 . . . . 0.54000000000000004 109.629 170.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 109.222 -0.658 . . . . 1.1399999999999999 109.222 173.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 110.758 -0.09 . . . . 0.68999999999999995 110.758 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -149.6 160.89 43.12 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.24 0.543 . . . . 2.3100000000000001 111.466 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -84.61 144.82 28.37 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.399 1.48 . . . . 2.21 109.133 168.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 tp -124.47 154.32 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.234 -1.765 . . . . 1.24 106.234 165.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.0 129.56 21.41 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.498 1.119 . . . . 0.29999999999999999 109.088 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -156.86 173.5 16.89 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.511 0.725 . . . . 1.5 110.756 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -100.67 148.52 24.77 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.045 1.338 . . . . 3.3700000000000001 109.781 -174.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -118.46 161.99 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.19 0.996 . . . . 0.56000000000000005 109.346 -176.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.451 -0.389 0 C-N-CA 124.245 1.018 . . . . 0.75 108.901 179.413 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 119.639 -0.22 . . . . 0.42999999999999999 111.508 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -64.1 -47.19 81.0 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.21 0.604 . . . . 4.7000000000000002 110.043 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.438 HD11 ' CD2' ' A' ' 69' ' ' TYR . 62.0 mt -48.11 -60.09 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.283 -1.006 . . . . 0.58999999999999997 108.283 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -70.3 -35.63 73.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.168 -0.613 . . . . 2.3399999999999999 110.689 -171.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -58.01 -33.22 68.71 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 120.664 -1.272 . . . . 1.23 111.308 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.3 -47.26 83.61 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 110.366 -1.093 . . . . 0.28999999999999998 110.366 167.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 64' ' ' ILE . 91.7 mt -64.21 -29.22 70.34 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 118.625 1.212 . . . . 0.33000000000000002 112.428 175.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HA ' HG11 ' A' ' 34' ' ' VAL . 6.1 ttmm -59.89 -17.38 36.69 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.513 1.052 . . . . 1.72 111.243 173.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.75 -16.24 57.44 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.067 1.136 . . . . 3.5299999999999998 114.067 169.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.506 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -76.77 136.82 66.74 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 120.809 1.641 . . . . 2.5699999999999998 112.425 -171.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.71 99.32 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.867 3.045 . . . . 0.47999999999999998 110.995 -173.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.66 -15.79 4.08 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.304 -1.119 . . . . 0.22 110.304 177.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 31' ' ' MET . 8.5 p -67.81 150.93 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 O-C-N 122.047 -0.678 . . . . 0.28999999999999998 110.943 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.78 -65.3 1.19 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.812 -1.181 . . . . 0.41999999999999998 107.812 165.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -147.03 132.66 18.8 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 112.702 0.63 . . . . 3.3599999999999999 112.702 -163.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.8 136.77 50.63 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.902 1.681 . . . . 0.58999999999999997 108.55 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -139.73 112.96 8.25 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.591 1.156 . . . . 1.3400000000000001 108.325 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -84.5 141.07 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.183 0.993 . . . . 0.59999999999999998 110.444 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -137.03 65.32 1.51 Allowed 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.544 -1.28 . . . . 2.52 107.544 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 47.6 mt -63.23 -17.38 62.39 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 121.671 -0.643 . . . . 0.68999999999999995 112.281 174.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.28 -16.28 8.16 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.482 0.713 . . . . 0.65000000000000002 111.551 169.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.4 m -136.07 19.16 3.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.626 1.171 . . . . 0.54000000000000004 109.325 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 48.27 40.86 15.12 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.114 0.966 . . . . 3.3999999999999999 111.46 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.8 m -137.85 155.55 48.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.275 -1.38 . . . . 0.56000000000000005 107.275 -171.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.8 p -134.37 148.85 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 107.635 -1.246 . . . . 0.41999999999999998 107.635 170.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.73 150.23 43.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.973 0.796 . . . . 2.6800000000000002 109.273 171.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.99 142.73 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.841 -0.8 . . . . 0.35999999999999999 108.841 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.2 mt -104.01 127.57 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 126.675 1.99 . . . . 1.0 106.781 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -152.14 170.23 20.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.311 0.645 . . . . 1.74 110.143 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -104.21 113.09 65.53 Favored Pre-proline 0 N--CA 1.44 -0.961 0 CA-C-N 115.01 -0.996 . . . . 1.3100000000000001 110.145 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -68.8 10.35 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.799 3.0 . . . . 0.48999999999999999 113.634 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.57 -43.05 21.25 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 108.353 -0.98 . . . . 0.44 108.353 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -98.53 -44.97 6.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.319 1.447 . . . . 2.8500000000000001 110.0 176.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 m -138.04 130.91 29.87 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 118.915 2.931 . . . . 0.77000000000000002 118.915 -155.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.6 -157.82 9.27 Favored Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 108.385 -1.886 . . . . 0.54000000000000004 108.385 155.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.272 0.0 OUTLIER -32.17 -46.09 0.12 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.285 2.634 . . . . 0.53000000000000003 113.504 175.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.81 -57.43 4.9 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.001 0.741 . . . . 0.28999999999999998 113.001 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.02 -38.33 64.09 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 122.091 0.948 . . . . 0.19 109.225 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.616 HG12 HD22 ' A' ' 28' ' ' LEU . 1.3 mt -63.11 -58.87 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 114.347 -1.297 . . . . 0.63 109.601 -172.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.6 -51.74 15.06 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.753 1.16 . . . . 0.81000000000000005 110.971 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -42.81 -55.49 3.64 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.15 0.98 . . . . 2.1699999999999999 112.066 174.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.56 -40.5 73.3 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.146 -0.622 . . . . 2.0699999999999998 110.82 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.813 HD11 HD11 ' A' ' 28' ' ' LEU . 36.5 mm -54.56 -45.99 71.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 118.863 0.756 . . . . 0.42999999999999999 110.007 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -50.49 -51.9 43.15 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.232 0.539 . . . . 2.23 109.792 172.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -42.3 98.91 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.559 0.577 . . . . 3.7000000000000002 112.559 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mp -52.45 -19.69 2.37 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.917 1.287 . . . . 2.3999999999999999 111.875 169.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.21 29.26 9.08 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.327 -1.109 . . . . 0.34999999999999998 110.327 173.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.438 ' CD2' HD11 ' A' ' 24' ' ' ILE . 72.6 m-85 -137.98 162.88 32.95 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.098 -1.445 . . . . 1.7 107.098 177.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.782 ' HE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -115.84 134.6 54.83 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.122 -1.807 . . . . 3.8100000000000001 106.122 171.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.63 150.04 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.604 0.762 . . . . 0.41999999999999998 110.444 168.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.782 HG13 ' HE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.758 0 C-N-CA 123.672 0.789 . . . . 1.1499999999999999 109.532 171.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 120.67 0.271 . . . . 0.82999999999999996 111.357 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -149.08 158.55 44.27 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.109 -0.7 . . . . 2.73 109.109 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -91.03 141.0 29.31 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.685 -1.143 . . . . 2.8900000000000001 109.51 168.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.95 138.08 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 105.407 -2.072 . . . . 3.1899999999999999 105.407 170.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.55 125.65 48.35 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.421 1.488 . . . . 0.42999999999999999 108.036 176.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -154.88 164.69 38.48 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.485 0.584 . . . . 1.1899999999999999 110.697 -175.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.419 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -96.47 151.59 19.42 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.09 0.956 . . . . 1.76 109.575 -173.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 t -116.1 161.21 15.01 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 C-N-CA 123.139 0.575 . . . . 0.68999999999999995 109.904 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.451 -0.4 0 C-N-CA 124.963 1.305 . . . . 0.83999999999999997 108.711 175.581 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.688 0 CA-C-O 118.717 -0.659 . . . . 0.34999999999999998 110.798 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.3 mmp_? -58.91 -47.91 83.32 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.449 1.022 . . . . 4.8300000000000001 110.321 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.0 mt -47.21 -60.8 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.809 -0.811 . . . . 0.53000000000000003 108.809 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -72.11 -34.15 68.38 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 119.968 -0.693 . . . . 2.5499999999999998 111.707 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm -55.69 -36.65 67.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 120.858 -1.151 . . . . 2.6200000000000001 111.028 175.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.46 -54.64 12.55 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.187 -1.165 . . . . 0.34000000000000002 110.187 166.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.606 HD22 HG12 ' A' ' 60' ' ' ILE . 89.0 mt -63.74 -32.73 74.32 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 112.885 0.698 . . . . 0.31 112.885 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -57.62 -17.54 15.04 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.229 0.922 . . . . 1.29 111.796 172.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.7 -11.3 48.68 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.694 1.368 . . . . 4.4400000000000004 114.694 170.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.469 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -70.24 138.62 86.96 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 121.278 1.854 . . . . 3.23 111.856 -177.536 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.52 90.69 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.605 2.87 . . . . 0.48999999999999999 111.079 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.82 -7.67 3.57 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.756 1.17 . . . . 0.28000000000000003 111.341 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 31' ' ' MET . 5.2 p -67.4 160.29 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 118.271 1.035 . . . . 0.28999999999999998 110.806 164.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.73 -59.55 1.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.767 1.227 . . . . 0.40000000000000002 108.659 168.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -145.13 162.91 35.9 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 112.477 0.547 . . . . 2.3100000000000001 112.477 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.54 123.51 12.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.086 1.754 . . . . 0.88 109.625 -173.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -135.64 119.62 17.48 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.423 1.489 . . . . 1.5600000000000001 109.284 -172.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -91.93 139.13 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.127 0.971 . . . . 0.66000000000000003 110.545 -176.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -131.08 66.69 1.53 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.833 1.653 . . . . 1.23 111.143 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.4 mt -67.01 -15.92 64.03 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 113.113 0.782 . . . . 0.81000000000000005 113.113 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.81 -24.84 9.74 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.66 0.384 . . . . 0.76000000000000001 110.622 167.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.0 m -128.55 19.99 6.18 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.213 1.405 . . . . 0.60999999999999999 110.044 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 47.58 35.01 3.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.188 0.995 . . . . 2.7999999999999998 112.145 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.4 m -132.52 152.03 51.71 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.118 -1.068 . . . . 0.46999999999999997 108.118 -168.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.2 p -133.96 147.47 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.367 0.667 . . . . 0.45000000000000001 109.389 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -121.34 129.13 52.91 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.1 1.36 . . . . 2.6000000000000001 108.464 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.92 137.1 51.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.021 -0.733 . . . . 0.39000000000000001 109.021 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.4 mp -108.55 120.77 60.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.012 1.325 . . . . 1.26 108.134 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -144.36 171.37 14.42 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.186 0.994 . . . . 1.73 110.877 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -108.39 111.73 61.36 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 124.979 1.312 . . . . 1.79 111.15 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -76.83 30.13 0.41 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.747 2.964 . . . . 0.70999999999999996 112.711 -172.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.96 -50.16 5.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.77 -1.567 . . . . 0.40999999999999998 106.77 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.16 -43.52 7.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.16 1.784 . . . . 2.8700000000000001 110.495 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.6 m -133.93 127.3 32.17 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 116.45 2.019 . . . . 0.53000000000000003 116.45 -159.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.89 -164.23 13.32 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 108.898 -1.681 . . . . 0.46999999999999997 108.898 153.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.2 t -34.78 -40.39 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.706 2.802 . . . . 0.67000000000000004 112.831 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.0 -54.46 8.34 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.907 0.883 . . . . 0.42999999999999999 113.233 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.63 -36.83 65.49 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.924 1.345 . . . . 0.34000000000000002 109.642 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.606 HG12 HD22 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -70.82 -50.16 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 113.309 -1.768 . . . . 0.54000000000000004 110.903 -164.294 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.75 -52.34 49.46 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.388 1.449 . . . . 0.76000000000000001 109.034 172.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.46 -45.66 46.98 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.708 1.203 . . . . 5.04 112.294 -177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -44.59 60.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.247 -1.533 . . . . 2.9900000000000002 112.823 172.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.473 HD11 HD11 ' A' ' 28' ' ' LEU . 4.1 mm -51.43 -44.93 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.986 1.315 . . . . 0.42999999999999999 110.707 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -49.73 -47.53 50.64 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.453 0.644 . . . . 1.5600000000000001 110.361 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -32.65 67.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.249 1.02 . . . . 5.5199999999999996 112.292 -177.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.45 -25.62 37.47 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 119.385 -0.34 . . . . 0.93000000000000005 110.239 166.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.31 29.22 5.78 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.542 1.068 . . . . 0.37 110.823 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -142.86 165.73 26.57 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.273 -1.01 . . . . 1.74 108.273 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.95 125.68 48.02 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.267 -1.753 . . . . 4.2999999999999998 106.267 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -96.78 143.06 13.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 O-C-N 123.751 0.657 . . . . 0.46000000000000002 109.894 172.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.466 0.338 0 N-CA-C 109.425 -0.583 . . . . 1.1799999999999999 109.425 175.187 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.463 HE22 HG21 ' A' ' 35' ' ' THR . 7.0 pt20 . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 120.726 0.298 . . . . 0.96999999999999997 111.437 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -154.68 158.49 39.7 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 122.011 0.91 . . . . 3.3199999999999998 111.177 178.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -84.03 114.13 21.51 Favored 'General case' 0 N--CA 1.452 -0.332 1 C-N-CA 131.984 4.113 . . . . 2.2999999999999998 107.363 174.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.48 149.3 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 105.803 -1.925 . . . . 2.46 105.803 164.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.73 123.73 18.94 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.602 1.561 . . . . 0.38 108.261 176.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -157.49 166.71 32.23 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.941 0.496 . . . . 1.1499999999999999 111.78 -171.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -101.44 140.09 36.2 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.069 1.748 . . . . 3.2799999999999998 108.855 -169.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.92 142.12 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 123.487 0.715 . . . . 0.85999999999999999 110.166 -177.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 108.136 -1.061 . . . . 1.01 108.136 173.514 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 119.546 -0.264 . . . . 0.55000000000000004 111.22 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -59.08 -49.85 76.33 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.425 0.557 . . . . 3.9500000000000002 110.74 177.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.7 mt -45.67 -59.88 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.767 1.227 . . . . 0.57999999999999996 108.723 177.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -70.84 -35.74 72.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.383 -0.371 . . . . 2.3100000000000001 110.715 -173.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -59.15 -30.44 68.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.06 -1.025 . . . . 1.26 110.872 174.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.56 -52.33 48.8 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 110.743 -0.943 . . . . 0.32000000000000001 110.743 164.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.664 HD11 HD11 ' A' ' 64' ' ' ILE . 95.6 mt -63.0 -29.93 71.2 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.268 -1.136 . . . . 0.32000000000000001 113.13 177.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -54.74 -18.96 5.32 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.246 0.93 . . . . 1.8899999999999999 111.924 170.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.29 -15.03 48.13 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.022 1.119 . . . . 2.98 114.022 171.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.462 ' O ' HG12 ' A' ' 34' ' ' VAL . 93.2 mmm -76.89 137.8 65.94 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 120.252 1.387 . . . . 1.97 112.424 -172.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.71 101.08 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.513 2.808 . . . . 0.55000000000000004 110.922 -173.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.39 -13.29 5.16 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 124.981 1.277 . . . . 0.25 110.151 175.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 31' ' ' MET . 5.8 p -64.01 147.51 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 117.806 0.803 . . . . 0.31 110.676 169.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.463 HG21 HE22 ' A' ' 5' ' ' GLN . 0.1 OUTLIER -110.67 -60.44 1.82 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.986 1.315 . . . . 0.53000000000000003 110.407 168.563 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -154.43 148.88 26.2 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 115.401 1.63 . . . . 2.5299999999999998 115.401 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.3 142.23 42.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.265 1.426 . . . . 0.69999999999999996 110.825 -176.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -145.38 102.3 3.7 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.171 -1.048 . . . . 3.7799999999999998 108.171 -170.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.5 p -83.79 134.32 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.296 0.638 . . . . 0.80000000000000004 110.889 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -131.12 70.12 1.47 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.075 -1.083 . . . . 2.4900000000000002 108.075 -177.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.4 mt -64.02 -24.65 67.79 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.502 -0.749 . . . . 1.2 111.954 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.38 -24.25 28.79 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.08 0.552 . . . . 0.82999999999999996 111.03 171.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.6 m -118.97 11.44 12.5 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.372 1.469 . . . . 1.0600000000000001 110.309 -179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 46.4 47.96 13.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.053 0.842 . . . . 2.23 111.673 -178.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.47 159.02 39.47 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.12 -1.067 . . . . 1.3200000000000001 108.12 -174.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.2 p -125.68 146.92 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 108.558 -0.905 . . . . 0.46000000000000002 108.558 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -117.44 141.5 48.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.711 1.205 . . . . 2.4300000000000002 108.351 176.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.05 132.24 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.695 -0.483 . . . . 0.35999999999999999 109.695 173.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.5 mt -91.86 126.2 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.387 1.875 . . . . 0.71999999999999997 106.871 176.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -147.5 173.86 12.26 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.428 0.691 . . . . 1.95 111.114 176.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -110.44 120.03 45.14 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 124.366 1.066 . . . . 1.4299999999999999 110.965 -178.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -69.33 7.28 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 124.596 3.531 . . . . 0.55000000000000004 113.575 -178.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.49 -37.22 37.27 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 108.644 -0.873 . . . . 0.69999999999999996 108.644 176.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -114.88 -53.82 2.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.571 1.549 . . . . 2.77 110.041 -179.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 m -104.34 129.99 52.2 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 128.233 2.613 . . . . 0.90000000000000002 117.343 -172.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.25 -173.36 22.44 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 109.779 -1.328 . . . . 0.48999999999999999 109.779 151.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.3 t -35.24 -41.14 0.15 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.556 2.742 . . . . 0.57999999999999996 112.414 174.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.77 -57.19 5.9 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.981 0.734 . . . . 0.29999999999999999 112.981 173.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.47 66.43 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 122.338 1.066 . . . . 0.22 108.835 -176.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.589 HG12 HD22 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -62.02 -58.04 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 114.012 -1.449 . . . . 0.62 110.082 -174.4 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.47 -51.1 15.93 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.681 1.128 . . . . 0.78000000000000003 110.823 175.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -45.31 -51.85 10.48 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.406 0.683 . . . . 2.3399999999999999 112.342 177.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -43.68 67.37 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 118.17 -0.919 . . . . 2.0800000000000001 111.667 177.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.664 HD11 HD11 ' A' ' 28' ' ' LEU . 24.7 mm -52.4 -45.71 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 119.698 1.135 . . . . 0.32000000000000001 110.196 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -49.46 -47.04 48.62 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.26 0.624 . . . . 1.6299999999999999 110.11 172.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -36.57 74.2 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.674 0.79 . . . . 4.4400000000000004 112.318 -178.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -54.46 -22.76 13.62 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.837 0.455 . . . . 0.92000000000000004 110.41 169.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.13 28.51 5.81 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 110.444 -1.063 . . . . 0.39000000000000001 110.444 170.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -144.61 169.17 18.49 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.638 -1.245 . . . . 2.0 107.638 -177.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.713 ' HE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -119.08 135.53 54.59 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.358 -1.719 . . . . 3.8300000000000001 106.358 172.038 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -98.36 147.67 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.056 0.942 . . . . 0.46999999999999997 109.549 167.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.713 HG13 ' HE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 109.032 -0.729 . . . . 1.0700000000000001 109.032 169.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 119.876 -0.107 . . . . 0.69999999999999996 110.738 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.76 159.88 40.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.764 0.792 . . . . 3.73 111.854 -179.341 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.12 135.77 34.26 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.496 -1.684 . . . . 2.4900000000000002 108.232 169.248 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 tp -109.44 151.04 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 105.843 -1.91 . . . . 1.0900000000000001 105.843 161.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.62 123.65 16.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.997 1.319 . . . . 0.40999999999999998 107.85 176.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.6 ptt? -157.7 172.16 19.01 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.713 0.405 . . . . 1.0800000000000001 110.292 -170.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -102.74 150.08 23.82 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.401 1.08 . . . . 3.2000000000000002 110.123 -171.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.71 167.89 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 C-N-CA 123.684 0.794 . . . . 0.78000000000000003 109.706 -178.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.451 -0.401 0 C-N-CA 124.287 1.035 . . . . 0.77000000000000002 108.829 176.569 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 109.686 -0.487 . . . . 0.38 109.686 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -59.4 -45.1 92.43 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 118.481 -0.771 . . . . 3.6400000000000001 111.99 174.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.7 mt -46.96 -59.95 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.359 -0.608 . . . . 0.55000000000000004 109.359 176.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -70.13 -41.18 74.26 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 119.634 -0.826 . . . . 3.5800000000000001 109.993 -173.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -52.15 -35.6 48.99 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 120.423 -1.423 . . . . 1.77 112.089 179.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.26 -52.12 33.42 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 110.921 -0.872 . . . . 0.38 110.921 167.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 64' ' ' ILE . 73.1 mt -66.94 -27.76 67.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 118.51 -0.757 . . . . 0.60999999999999999 112.587 177.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -59.87 -16.99 33.43 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 119.614 1.097 . . . . 1.4199999999999999 110.566 171.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.36 -8.83 58.25 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.013 1.116 . . . . 3.3999999999999999 114.013 171.297 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.507 ' O ' HG12 ' A' ' 34' ' ' VAL . 9.5 mmt -71.75 138.67 82.91 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 120.304 1.411 . . . . 2.0699999999999998 111.722 -175.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.28 90.82 0.57 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.263 2.642 . . . . 0.52000000000000002 110.793 -175.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.27 -16.33 2.1 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.483 1.04 . . . . 0.25 111.495 -179.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 31' ' ' MET . 5.5 p -70.82 156.02 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 O-C-N 121.674 -0.897 . . . . 0.28000000000000003 111.409 171.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.22 -62.58 1.57 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.424 1.09 . . . . 0.54000000000000004 109.126 166.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -147.76 142.25 26.45 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 112.502 0.556 . . . . 3.02 112.502 -169.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.86 157.09 17.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.237 1.815 . . . . 1.1299999999999999 109.333 178.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.54 95.82 1.83 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.042 -1.095 . . . . 2.0499999999999998 108.042 177.046 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.12 140.24 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 121.917 -0.49 . . . . 0.73999999999999999 111.449 -178.231 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -137.02 69.94 1.41 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.148 1.379 . . . . 2.48 109.092 -174.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 68.7 mt -65.69 -16.56 63.87 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 115.565 -0.743 . . . . 0.76000000000000001 112.932 177.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.6 -22.5 8.72 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.543 0.737 . . . . 0.70999999999999996 110.741 169.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.9 m -133.05 21.22 4.1 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.938 0.895 . . . . 0.75 109.854 179.064 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 50.37 34.7 9.46 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.058 0.844 . . . . 3.0499999999999998 112.069 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.6 m -128.53 152.57 48.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.644 1.178 . . . . 0.55000000000000004 107.876 -168.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 p -135.14 143.57 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.844 -0.798 . . . . 0.64000000000000001 108.844 173.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -119.24 145.27 46.21 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.848 1.259 . . . . 2.4700000000000002 107.969 176.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.86 139.03 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.629 -0.508 . . . . 0.39000000000000001 109.629 174.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.9 mt -101.05 119.2 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 126.96 2.104 . . . . 0.88 107.196 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.448 ' CE2' HD13 ' A' ' 60' ' ' ILE . 2.1 p90 -146.35 168.87 20.06 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.398 1.079 . . . . 2.02 109.593 -178.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -101.65 115.63 64.63 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 118.385 -0.817 . . . . 2.0699999999999998 109.278 177.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -68.63 7.6 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.747 2.965 . . . . 0.77000000000000002 113.646 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.21 -55.54 5.18 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 107.441 -1.318 . . . . 0.75 107.441 172.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -88.18 -30.75 19.53 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.435 1.094 . . . . 3.9300000000000002 112.109 176.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.9 m -148.47 121.4 8.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 117.677 2.473 . . . . 0.72999999999999998 117.677 -157.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.69 -166.79 23.14 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.588 -1.005 . . . . 0.53000000000000003 110.588 159.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 t -29.61 -46.68 0.06 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.499 3.119 . . . . 0.57999999999999996 112.841 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.42 -58.42 3.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.048 0.939 . . . . 0.37 113.155 173.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.18 -34.19 65.86 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 122.511 1.148 . . . . 0.23999999999999999 109.554 -178.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.477 HG12 HD13 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -66.57 -52.86 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 117.199 -1.381 . . . . 0.73999999999999999 110.928 -171.887 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -50.16 40.44 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 121.04 1.746 . . . . 0.83999999999999997 110.922 175.229 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -39.73 -60.27 1.01 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.904 0.882 . . . . 2.6800000000000002 112.634 172.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -70.73 -40.43 72.76 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.202 -0.999 . . . . 1.8799999999999999 110.82 -177.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.604 HD11 HD11 ' A' ' 28' ' ' LEU . 16.8 mm -53.31 -44.68 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 119.034 0.834 . . . . 0.46000000000000002 110.046 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -53.81 -45.66 70.85 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.129 0.49 . . . . 1.8200000000000001 109.772 174.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.62 -39.74 91.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.485 -0.76 . . . . 3.0699999999999998 111.354 -179.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.4 -23.58 16.32 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.443 0.697 . . . . 0.93000000000000005 110.786 171.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.95 26.93 7.25 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 124.466 1.031 . . . . 0.37 110.9 173.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -144.8 176.34 9.52 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 122.025 0.916 . . . . 1.7 109.617 -175.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.68 117.24 23.06 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 106.035 -1.839 . . . . 3.77 106.035 -171.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.9 p -96.13 142.45 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.868 -0.79 . . . . 0.47999999999999998 108.868 165.022 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.287 0 N-CA-C 108.764 -0.828 . . . . 1.0900000000000001 108.764 173.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 120.787 0.327 . . . . 0.98999999999999999 111.515 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -139.67 152.83 47.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.521 0.677 . . . . 2.5099999999999998 109.822 179.433 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -90.34 125.92 35.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 127.036 2.134 . . . . 2.25 106.762 168.028 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 tp -109.21 151.29 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.167 -1.42 . . . . 1.1000000000000001 107.167 167.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.52 133.93 36.99 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.731 -1.211 . . . . 0.34999999999999998 107.731 170.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.75 170.92 21.34 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.439 0.462 . . . . 1.4099999999999999 111.195 175.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.443 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -92.65 152.81 19.35 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.854 0.861 . . . . 1.98 110.362 -176.498 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.57 171.56 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 123.7 0.8 . . . . 0.81000000000000005 110.034 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 CA--C 1.53 0.194 0 C-N-CA 123.782 0.833 . . . . 0.71999999999999997 110.603 176.934 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 119.389 -0.339 . . . . 0.31 110.664 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -54.63 -45.24 73.7 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.574 -0.726 . . . . 4.3200000000000003 111.444 173.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.4 mt -52.46 -60.89 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.391 -0.966 . . . . 0.76000000000000001 108.391 177.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.62 -33.96 73.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.4 -0.92 . . . . 2.3599999999999999 110.615 -168.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -56.24 -36.76 68.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.092 -1.005 . . . . 1.3899999999999999 111.263 171.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.5 -44.51 90.45 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.054 -0.818 . . . . 0.29999999999999999 111.054 168.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.709 HD11 HD11 ' A' ' 64' ' ' ILE . 97.3 mt -65.6 -30.66 71.41 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 119.407 1.603 . . . . 0.33000000000000002 112.514 175.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.537 ' HA ' HG11 ' A' ' 34' ' ' VAL . 12.9 ttmt -56.62 -18.41 11.97 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.13 0.877 . . . . 1.4399999999999999 112.03 170.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 mtp85 -87.88 -5.29 58.65 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.891 -1.13 . . . . 4.3799999999999999 112.694 174.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.471 ' O ' HG12 ' A' ' 34' ' ' VAL . 95.1 mmm -82.74 136.62 44.69 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 120.389 1.45 . . . . 1.98 111.748 179.203 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.8 100.73 0.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.506 2.804 . . . . 0.35999999999999999 111.262 -173.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.37 -13.03 3.77 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.58 1.086 . . . . 0.20000000000000001 111.173 176.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.0 p -67.9 152.97 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.836 0.854 . . . . 0.27000000000000002 111.182 169.408 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.1 -60.5 1.87 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.582 1.153 . . . . 0.40999999999999998 109.356 166.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -148.66 141.59 24.76 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.239 0.459 . . . . 3.1400000000000001 112.239 -169.138 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.61 136.71 53.11 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.779 1.632 . . . . 0.59999999999999998 108.632 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -142.05 108.9 5.41 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.577 1.151 . . . . 1.3600000000000001 108.5 -177.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.4 p -89.92 142.7 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.742 0.817 . . . . 0.60999999999999999 111.772 -175.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -137.71 68.99 1.4 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.364 1.465 . . . . 1.22 111.011 -175.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.4 mt -66.71 -14.91 63.1 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 112.948 0.721 . . . . 0.75 112.948 177.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.5 -13.34 5.35 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.983 0.356 . . . . 0.53000000000000003 111.221 167.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.5 m -138.38 18.46 2.75 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.387 1.075 . . . . 0.51000000000000001 109.572 177.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 51.76 30.75 7.22 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.14 0.882 . . . . 3.1400000000000001 112.035 -179.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.4 m -129.66 153.42 48.14 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.069 -1.086 . . . . 0.51000000000000001 108.069 -167.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.4 144.47 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 108.802 -0.814 . . . . 0.45000000000000001 108.802 173.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -112.78 139.99 47.94 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.744 1.218 . . . . 2.46 108.055 176.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.44 141.2 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.249 -0.649 . . . . 0.25 109.249 171.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 mt -104.74 127.37 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.971 1.708 . . . . 0.92000000000000004 106.533 -179.054 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -152.3 171.78 17.45 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.946 0.498 . . . . 1.8799999999999999 110.098 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -111.07 120.51 43.1 Favored Pre-proline 0 N--CA 1.448 -0.563 0 O-C-N 123.944 0.777 . . . . 2.0899999999999999 111.187 -177.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.14 19.39 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.072 3.181 . . . . 0.64000000000000001 113.681 -178.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.63 -50.74 7.91 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.256 -1.387 . . . . 0.54000000000000004 107.256 169.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -96.33 -39.81 9.44 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.099 1.36 . . . . 3.5499999999999998 111.4 176.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.5 m -132.41 129.89 39.9 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 117.748 2.499 . . . . 0.54000000000000004 117.748 -155.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.76 -172.09 22.91 Favored Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 110.043 -1.223 . . . . 0.5 110.043 157.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.272 0.1 OUTLIER -29.31 -43.09 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 128.633 2.773 . . . . 0.63 113.902 169.241 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.64 -55.35 16.79 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.868 0.758 . . . . 0.34000000000000002 112.671 175.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.08 -36.24 66.78 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 122.557 1.17 . . . . 0.17999999999999999 108.966 -176.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.541 HG12 HD22 ' A' ' 28' ' ' LEU 0.257 0.9 OUTLIER -65.47 -56.56 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 113.852 -1.522 . . . . 0.55000000000000004 110.351 -172.617 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -49.61 47.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.171 1.35 . . . . 0.73999999999999999 110.913 177.255 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -42.48 -58.4 2.26 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.74 0.816 . . . . 2.2799999999999998 112.094 173.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -42.36 73.39 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 119.548 -0.861 . . . . 2.3199999999999998 111.421 -177.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.709 HD11 HD11 ' A' ' 28' ' ' LEU . 17.3 mm -51.21 -47.6 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.67 0.788 . . . . 0.39000000000000001 109.832 177.594 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -50.6 -53.47 30.38 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 121.426 0.632 . . . . 1.6100000000000001 109.678 175.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -29.3 70.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.028 0.531 . . . . 5.3399999999999999 112.412 -178.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -63.85 -20.02 65.49 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.23 0.612 . . . . 2.0899999999999999 109.783 173.173 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.26 28.76 6.65 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 125.075 1.321 . . . . 0.35999999999999999 110.618 173.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -143.85 168.47 19.88 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.122 -1.436 . . . . 1.6499999999999999 107.122 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.732 ' HE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -119.83 135.97 54.66 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.428 -1.693 . . . . 4.1500000000000004 106.428 169.435 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -100.63 142.92 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.331 1.052 . . . . 0.64000000000000001 109.722 166.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.732 HG13 ' HE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 108.692 -0.855 . . . . 1.27 108.692 173.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 120.854 0.359 . . . . 0.65000000000000002 111.518 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -148.8 161.75 41.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.687 -0.857 . . . . 2.8100000000000001 108.687 173.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -82.91 138.46 33.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.522 -1.288 . . . . 2.6299999999999999 107.522 162.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 tp -107.14 153.48 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 1.1100000000000001 105.713 157.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.53 128.21 17.18 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.917 -1.142 . . . . 0.35999999999999999 107.917 173.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.48 175.86 13.41 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.189 0.45 . . . . 1.2 110.866 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -94.19 149.37 21.3 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.287 1.035 . . . . 3.0699999999999998 109.279 -174.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.21 165.59 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.854 -0.795 . . . . 0.69999999999999996 108.854 177.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 107.643 -1.243 . . . . 1.1000000000000001 107.643 171.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.627 0 CA-C-O 118.757 -0.64 . . . . 0.34999999999999998 111.04 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -61.07 -45.42 94.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.279 0.945 . . . . 3.4700000000000002 110.598 176.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.488 HD11 ' CD2' ' A' ' 69' ' ' TYR . 63.9 mt -48.35 -60.94 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.319 -0.993 . . . . 0.67000000000000004 108.319 179.098 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.28 -34.1 67.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 119.945 -0.702 . . . . 2.5800000000000001 111.838 -173.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -55.94 -37.73 69.37 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.121 -0.987 . . . . 1.73 110.736 176.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.5 -52.75 27.49 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.458 -1.057 . . . . 0.38 110.458 167.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 64' ' ' ILE . 87.0 mt -64.62 -31.1 72.17 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.591 -0.946 . . . . 0.38 112.503 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.25 23.3 ttmt -59.03 -13.73 7.52 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 119.209 0.913 . . . . 1.74 111.69 170.514 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 -1.63 40.23 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.553 -1.342 . . . . 5.4100000000000001 114.001 170.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.418 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.91 139.3 61.67 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 120.815 1.643 . . . . 3.0299999999999998 111.489 179.578 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.78 92.78 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.588 2.858 . . . . 0.37 110.429 -174.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.33 -9.65 3.79 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.562 1.077 . . . . 0.20000000000000001 111.633 177.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 31' ' ' MET . 5.8 p -66.73 157.42 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 118.054 0.927 . . . . 0.31 110.884 167.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.74 -56.41 2.12 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.989 1.316 . . . . 0.45000000000000001 110.229 168.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -143.17 157.35 44.59 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 123.081 0.553 . . . . 3.1400000000000001 109.917 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.63 134.84 39.67 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.936 1.694 . . . . 0.67000000000000004 108.165 174.413 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -142.07 116.86 9.82 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.499 1.119 . . . . 1.4199999999999999 108.833 -173.378 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.73 139.54 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.429 1.092 . . . . 0.57999999999999996 111.541 -175.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -132.37 67.77 1.52 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.628 1.571 . . . . 1.23 111.913 179.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.3 mt -65.86 -16.01 63.44 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 113.281 0.845 . . . . 0.73999999999999999 113.281 178.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.16 -19.66 8.31 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.073 0.397 . . . . 0.54000000000000004 110.997 168.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.3 m -130.48 14.9 5.51 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.907 1.283 . . . . 0.48999999999999999 110.373 178.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 51.44 35.28 13.81 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.037 0.835 . . . . 2.75 112.048 -177.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 m -134.01 153.59 51.69 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 107.88 -1.156 . . . . 0.47999999999999998 107.88 -170.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.16 151.38 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.374 -0.973 . . . . 0.42999999999999999 108.374 174.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.17 150.29 42.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 124.178 0.924 . . . . 2.75 109.895 172.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.61 134.0 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.346 -0.983 . . . . 0.32000000000000001 108.346 177.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.5 127.84 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.923 -1.51 . . . . 0.84999999999999998 106.923 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -150.29 170.09 19.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.024 0.529 . . . . 2.04 110.348 -178.142 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.8 120.47 47.06 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 124.311 1.044 . . . . 1.3899999999999999 111.002 -179.493 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -69.93 8.4 0.82 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.48 3.453 . . . . 0.70999999999999996 113.914 -177.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.8 -44.61 26.97 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 108.162 -1.051 . . . . 0.69999999999999996 108.162 175.303 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -102.68 -42.67 5.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.293 1.837 . . . . 3.0299999999999998 110.249 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.6 m -129.53 127.45 40.79 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 117.57 2.433 . . . . 0.52000000000000002 117.57 -158.333 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.42 -173.24 22.42 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 109.607 -1.397 . . . . 0.56000000000000005 109.607 158.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 t -41.64 -34.03 0.55 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.282 2.633 . . . . 0.84999999999999998 112.195 178.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.8 -57.59 7.04 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.915 0.709 . . . . 0.26000000000000001 112.915 171.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.61 -35.88 67.95 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 122.581 1.182 . . . . 0.23000000000000001 108.759 -176.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.598 HG12 HD22 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -63.68 -58.3 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 113.896 -1.502 . . . . 0.53000000000000003 109.551 -173.983 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -50.67 24.6 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.412 1.46 . . . . 0.78000000000000003 111.065 177.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -41.41 -58.45 1.87 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.667 0.787 . . . . 2.46 112.693 173.31 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -41.32 77.63 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 119.31 -0.956 . . . . 1.8400000000000001 111.417 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.783 HD11 HD11 ' A' ' 28' ' ' LEU . 31.0 mm -52.56 -47.0 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.056 0.844 . . . . 0.40000000000000002 110.319 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -51.25 -46.59 62.42 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.217 0.532 . . . . 1.8200000000000001 109.854 173.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -34.6 71.73 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.349 -0.844 . . . . 4.5300000000000002 112.88 -176.454 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.98 -22.5 5.73 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.563 0.745 . . . . 0.85999999999999999 110.486 167.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.56 26.99 8.8 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.315 -1.114 . . . . 0.28999999999999998 110.315 174.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.488 ' CD2' HD11 ' A' ' 24' ' ' ILE . 61.5 m-85 -139.34 160.83 38.9 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.278 -1.008 . . . . 2.0 108.278 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 122.94 43.05 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.008 -1.479 . . . . 4.4900000000000002 107.008 178.144 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.57 151.67 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 124.534 1.134 . . . . 0.47999999999999998 109.793 173.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.224 -0.263 0 N-CA-C 108.815 -0.809 . . . . 0.92000000000000004 108.815 179.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.584 -0.524 . . . . 0.71999999999999997 109.584 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -142.37 154.49 44.68 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.848 0.832 . . . . 2.9100000000000001 112.189 176.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -89.78 108.13 19.51 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 128.186 2.594 . . . . 2.5299999999999998 107.322 171.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.64 154.53 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.86 -1.163 . . . . 1.3500000000000001 107.86 165.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.8 132.9 37.31 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.502 -1.666 . . . . 0.40000000000000002 106.502 173.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -155.67 166.44 33.5 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 123.273 0.629 . . . . 1.04 109.781 -173.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -93.56 156.18 16.88 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.026 -0.731 . . . . 2.96 109.026 -172.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.28 161.57 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 120.952 0.406 . . . . 0.73999999999999999 110.656 177.012 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 126.946 2.098 . . . . 0.71999999999999997 107.731 172.449 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 CA-C-O 118.913 -0.565 . . . . 0.40999999999999998 112.442 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -59.22 -40.79 86.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.197 0.908 . . . . 3.3799999999999999 110.894 176.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.446 HD11 ' CD2' ' A' ' 69' ' ' TYR . 57.2 mt -54.13 -60.6 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.207 -1.405 . . . . 0.80000000000000004 107.207 -177.016 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -32.9 65.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.022 -0.99 . . . . 2.52 112.11 -175.34 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -55.16 -38.79 68.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.083 -1.011 . . . . 1.97 110.478 172.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.1 -51.74 39.43 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.791 -0.923 . . . . 0.48999999999999999 110.791 168.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.725 HD22 HG13 ' A' ' 60' ' ' ILE . 85.5 mt -63.33 -33.97 76.69 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.553 -0.969 . . . . 0.63 112.232 178.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.569 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.259 0.9 OUTLIER -59.99 -18.11 43.39 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 118.986 0.812 . . . . 1.3300000000000001 110.81 172.609 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.22 -14.71 43.07 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.463 -1.398 . . . . 3.5899999999999999 114.384 167.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.3 mtp -74.97 134.85 74.35 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 121.102 1.773 . . . . 2.1299999999999999 111.26 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.06 114.19 2.34 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.06 2.507 . . . . 0.72999999999999998 109.589 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.84 -16.02 6.19 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 124.852 1.215 . . . . 0.20000000000000001 110.09 174.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 29' ' ' LYS . 4.9 p -67.75 154.2 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 O-C-N 122.401 -0.47 . . . . 0.28000000000000003 110.481 169.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.32 -54.24 2.48 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.735 1.214 . . . . 0.35999999999999999 109.571 166.387 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -145.91 157.56 43.89 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.556 0.162 . . . . 2.5800000000000001 110.909 -177.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.76 127.27 16.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.531 1.533 . . . . 0.98999999999999999 108.82 -175.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -143.14 115.69 8.6 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.811 0.844 . . . . 2.0299999999999998 109.537 -168.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -92.1 139.14 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 112.86 0.689 . . . . 1.0600000000000001 112.86 -176.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -128.7 68.79 1.38 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.906 2.083 . . . . 1.2 111.246 -176.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.3 mt -64.62 -16.81 63.33 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 113.038 0.755 . . . . 0.75 113.038 178.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.76 -19.92 4.92 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.967 0.507 . . . . 0.56000000000000005 111.121 169.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.1 m -136.33 18.0 3.16 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.834 1.253 . . . . 0.54000000000000004 109.976 -178.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 48.46 32.93 3.59 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.19 0.996 . . . . 2.75 112.181 -176.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.9 m -124.73 153.1 42.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.239 -1.393 . . . . 0.60999999999999999 107.239 -169.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 p -134.79 144.58 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.593 -0.892 . . . . 0.58999999999999997 108.593 173.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -108.19 140.34 41.54 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.066 1.347 . . . . 2.8700000000000001 107.822 175.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.83 134.71 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.825 -0.806 . . . . 0.46000000000000002 108.825 167.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.8 mt -103.93 117.73 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 126.2 1.8 . . . . 0.75 106.331 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -145.19 173.24 12.11 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.164 0.586 . . . . 1.8999999999999999 110.115 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -110.59 123.16 36.37 Favored Pre-proline 0 N--CA 1.443 -0.778 0 C-N-CA 124.618 1.167 . . . . 1.49 111.154 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -66.45 3.54 1.36 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.758 3.638 . . . . 0.80000000000000004 114.384 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.07 -44.74 45.81 Favored 'General case' 0 C--N 1.335 -0.057 0 N-CA-C 108.483 -0.932 . . . . 0.87 108.483 176.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -101.37 -37.0 8.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.779 1.631 . . . . 3.2599999999999998 110.366 178.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.3 m -138.64 131.52 29.48 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 118.71 2.855 . . . . 0.56000000000000005 118.71 -150.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.81 -171.76 30.45 Favored Glycine 0 N--CA 1.435 -1.42 0 N-CA-C 109.417 -1.473 . . . . 0.53000000000000003 109.417 164.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -35.04 -43.82 0.21 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.927 2.491 . . . . 0.60999999999999999 112.088 176.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.55 -58.73 3.17 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.249 0.833 . . . . 0.32000000000000001 113.249 173.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.35 -38.14 65.83 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.914 -0.772 . . . . 0.26000000000000001 108.914 -176.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.725 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -61.14 -59.69 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.719 -1.128 . . . . 1.24 108.424 -173.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.92 -52.23 14.99 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.151 0.887 . . . . 0.87 110.644 -178.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -43.36 -55.0 4.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.621 1.168 . . . . 2.5499999999999998 112.632 174.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -43.42 72.67 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 118.434 -0.793 . . . . 1.76 111.338 178.283 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.663 HD11 HD11 ' A' ' 28' ' ' LEU . 37.9 mm -52.32 -46.17 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 119.051 0.841 . . . . 0.46000000000000002 109.725 -177.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -51.17 -50.24 59.37 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.014 0.435 . . . . 1.6100000000000001 110.335 174.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -71.07 -31.37 67.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.42 -0.8 . . . . 3.5499999999999998 112.444 -174.464 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.98 -21.77 12.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 122.967 0.507 . . . . 0.90000000000000002 110.68 167.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.24 26.91 9.71 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 124.532 1.063 . . . . 0.46000000000000002 110.488 174.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.446 ' CD2' HD11 ' A' ' 24' ' ' ILE . 71.2 m-85 -138.88 164.77 28.81 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 117.324 0.562 . . . . 1.71 109.588 -178.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 120.17 37.96 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.576 -1.268 . . . . 4.6799999999999997 107.576 -179.156 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.521 ' HB ' HG21 ' A' ' 64' ' ' ILE . 8.4 p -85.65 150.5 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 109.305 -0.628 . . . . 0.59999999999999998 109.305 170.36 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.237 0 C-N-CA 124.37 1.068 . . . . 1.5800000000000001 108.854 179.325 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 120.568 0.223 . . . . 0.63 110.84 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -150.45 162.93 39.63 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.835 -0.432 . . . . 2.3700000000000001 109.835 174.29 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -83.75 153.28 24.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.521 -1.218 . . . . 2.9500000000000002 109.112 164.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 tp -131.48 155.07 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 106.416 -1.698 . . . . 1.0900000000000001 106.416 161.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.09 131.88 31.23 Favored 'General case' 0 N--CA 1.458 -0.036 0 C-N-CA 125.139 1.376 . . . . 0.57999999999999996 108.359 175.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.9 ptp -156.5 169.54 24.4 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.899 0.772 . . . . 1.8899999999999999 111.144 -176.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.74 146.04 32.67 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.974 0.91 . . . . 2.1000000000000001 109.477 -171.709 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.09 160.66 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 124.212 1.005 . . . . 0.82999999999999996 111.228 -172.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 121.109 0.48 . . . . 2.1099999999999999 111.381 166.446 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 119.358 -0.353 . . . . 0.41999999999999998 111.091 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -56.0 -52.52 63.92 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.412 0.551 . . . . 3.6299999999999999 110.885 175.673 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.9 mt -45.19 -60.64 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.893 1.277 . . . . 0.59999999999999998 109.12 178.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -71.47 -36.46 71.17 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 120.83 0.348 . . . . 2.3399999999999999 111.153 -172.102 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -56.12 -35.79 67.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.117 -0.989 . . . . 1.28 110.448 173.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.64 -49.6 46.08 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 111.471 -0.651 . . . . 0.33000000000000002 111.471 166.419 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.671 HD22 HG12 ' A' ' 60' ' ' ILE . 94.4 mt -65.83 -30.76 71.43 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 121.107 -1.231 . . . . 0.40000000000000002 112.615 176.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.513 ' HA ' HG11 ' A' ' 34' ' ' VAL . 10.0 ttmt -57.57 -17.72 15.65 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.21 0.913 . . . . 1.53 111.811 170.796 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -88.28 -3.72 58.81 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.164 1.172 . . . . 3.9399999999999999 114.164 171.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.445 ' O ' HG12 ' A' ' 34' ' ' VAL . 95.2 mmm -84.25 135.78 41.3 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 120.45 1.477 . . . . 2.1000000000000001 111.408 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.95 99.43 0.56 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.769 2.98 . . . . 0.39000000000000001 111.135 -172.03 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.2 -12.93 3.82 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.785 -0.926 . . . . 0.22 110.785 177.102 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.513 HG11 ' HA ' ' A' ' 29' ' ' LYS . 8.9 p -68.33 153.68 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 123.523 0.729 . . . . 0.31 111.206 171.393 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.95 -60.16 1.92 Allowed 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.457 1.103 . . . . 0.37 109.027 167.184 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -147.32 142.97 27.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 112.187 0.439 . . . . 3.23 112.187 -169.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.21 136.1 53.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.165 1.786 . . . . 0.59999999999999998 108.27 179.163 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -137.71 111.97 8.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.46 1.104 . . . . 1.45 108.652 -178.443 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.2 141.67 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.438 1.095 . . . . 1.03 111.118 -178.086 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -136.57 65.46 1.52 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.903 1.281 . . . . 1.1499999999999999 111.445 178.156 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -59.63 -23.71 63.24 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.946 -0.471 . . . . 0.93999999999999995 112.115 177.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.39 -22.59 43.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.385 0.539 . . . . 0.65000000000000002 111.207 174.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 m -121.75 16.01 11.02 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.802 1.241 . . . . 0.58999999999999997 110.294 179.092 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 44.02 46.24 6.92 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.124 0.969 . . . . 2.8300000000000001 110.876 -174.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.9 m -145.77 154.3 41.89 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.027 -1.472 . . . . 0.64000000000000001 107.027 -171.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -132.69 151.9 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.306 -0.998 . . . . 0.69999999999999996 108.306 170.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.54 150.77 47.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.296 -0.631 . . . . 2.71 109.296 175.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.87 146.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.512 -0.922 . . . . 0.31 108.512 -176.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.2 mt -114.75 125.95 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.523 1.929 . . . . 0.78000000000000003 106.58 -173.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -152.37 170.1 20.93 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.223 0.609 . . . . 1.8500000000000001 110.363 -175.671 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -109.21 115.77 56.13 Favored Pre-proline 0 N--CA 1.44 -0.943 0 O-C-N 124.276 0.985 . . . . 1.48 110.469 -177.064 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.37 8.55 0.5 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.172 3.248 . . . . 0.62 113.752 -178.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.99 -44.73 38.2 Favored 'General case' 0 N--CA 1.458 -0.026 0 N-CA-C 108.087 -1.079 . . . . 0.72999999999999998 108.087 172.36 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -102.05 -38.32 7.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.291 1.436 . . . . 3.02 111.074 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 m -143.56 133.95 24.7 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 119.284 3.068 . . . . 0.59999999999999998 119.284 -156.431 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.31 -149.74 6.28 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 108.88 -1.688 . . . . 0.54000000000000004 108.88 154.34 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -44.82 -35.37 2.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.955 2.102 . . . . 0.68999999999999995 112.833 -175.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.18 -55.1 26.86 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.658 -0.651 . . . . 0.52000000000000002 111.821 174.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.41 -41.78 60.34 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.686 1.231 . . . . 0.32000000000000001 109.323 -175.369 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.671 HG12 HD22 ' A' ' 28' ' ' LEU . 1.9 mt -62.85 -52.57 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 113.967 -1.469 . . . . 0.59999999999999998 111.502 -169.42 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -55.92 -47.04 78.21 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.471 1.032 . . . . 3.0299999999999998 110.429 179.135 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -42.59 -60.06 1.68 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.113 0.965 . . . . 2.23 112.781 171.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -37.54 81.24 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 119.217 -0.993 . . . . 2.5899999999999999 110.726 -177.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.435 HD11 HD11 ' A' ' 28' ' ' LEU . 6.1 mm -56.23 -44.09 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 118.154 0.434 . . . . 0.37 110.301 -178.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -48.06 -49.16 32.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.158 0.504 . . . . 1.53 110.279 172.08 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -71.88 -31.28 66.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.941 0.896 . . . . 3.3599999999999999 113.128 -175.411 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -53.48 -24.35 12.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 119.441 -0.314 . . . . 0.89000000000000001 110.616 165.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.36 29.23 4.58 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.37 0.986 . . . . 0.37 110.778 167.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -148.12 159.55 43.81 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.739 -1.578 . . . . 2.0099999999999998 106.739 -177.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.455 ' CE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -102.79 147.27 27.07 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 105.819 -1.919 . . . . 3.54 105.819 170.283 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.9 p -110.9 157.56 11.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 125.494 1.518 . . . . 0.90000000000000002 109.804 169.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.455 HG13 ' CE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.409 0 C-N-CA 124.355 1.062 . . . . 1.0600000000000001 111.359 178.333 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 119.63 -0.224 . . . . 0.75 111.056 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -155.54 168.04 28.42 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.954 0.407 . . . . 4.2999999999999998 110.73 178.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -84.37 133.08 34.53 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.444 2.298 . . . . 2.0899999999999999 109.188 175.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.28 148.73 16.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.067 0 N-CA-C 106.286 -1.746 . . . . 1.47 106.286 162.462 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.78 133.04 44.3 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.256 1.422 . . . . 0.75 108.245 176.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.6 168.84 25.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 122.028 0.918 . . . . 2.77 112.887 -176.168 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.423 HE21 ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -104.06 96.68 6.82 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 104.293 -2.484 . . . . 2.0600000000000001 104.293 -164.201 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.81 141.11 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 108.294 -1.002 . . . . 1.5900000000000001 108.294 175.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.678 -0.489 . . . . 1.6599999999999999 109.678 178.337 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.771 0 CA-C-O 119.454 -0.308 . . . . 0.34000000000000002 111.191 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -60.94 -47.99 83.86 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.576 0.625 . . . . 4.3600000000000003 111.567 177.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.3 mt -43.36 -60.86 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 125.089 1.356 . . . . 0.56999999999999995 108.324 175.198 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -71.37 -37.43 71.62 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.139 -0.482 . . . . 2.3999999999999999 111.213 -172.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -57.54 -32.61 67.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.261 -0.9 . . . . 1.28 110.857 175.175 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.56 -51.15 54.02 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.663 -0.975 . . . . 0.33000000000000002 110.663 165.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.742 HD11 HD11 ' A' ' 64' ' ' ILE . 96.2 mt -63.6 -28.63 70.05 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 118.967 1.384 . . . . 0.37 112.597 176.17 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.29 21.2 ttmt -61.66 -15.2 37.76 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 119.854 1.206 . . . . 1.23 111.859 171.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -18.18 42.52 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.367 -1.458 . . . . 4.7800000000000002 114.657 165.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.436 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -71.27 128.19 90.52 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 120.332 1.423 . . . . 2.6000000000000001 110.936 -170.722 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -60.87 104.37 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.981 2.454 . . . . 0.59999999999999998 111.032 -176.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.74 -3.45 8.63 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.715 2.103 . . . . 0.27000000000000002 110.555 172.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 31' ' ' MET . 7.3 p -65.88 158.22 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 121.576 -0.955 . . . . 0.28999999999999998 111.361 164.06 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.33 -58.15 1.72 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.251 1.42 . . . . 0.41999999999999998 110.448 169.094 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -139.37 154.25 47.82 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 112.102 0.408 . . . . 3.1299999999999999 112.102 -176.388 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.3 129.72 46.76 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.483 1.913 . . . . 0.63 108.731 174.393 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.65 113.14 7.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.881 1.272 . . . . 1.3700000000000001 109.518 -174.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.78 148.76 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.975 0.91 . . . . 1.1000000000000001 111.689 -174.304 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -140.74 67.55 1.36 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-O 122.789 1.28 . . . . 2.79 108.059 178.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.4 mt -62.14 -16.01 49.71 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.502 -0.772 . . . . 1.26 112.366 175.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.64 -12.55 4.27 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.477 1.111 . . . . 1.0600000000000001 111.467 170.027 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.3 m -144.17 27.25 1.44 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.49 0.716 . . . . 0.78000000000000003 109.201 178.026 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 36.93 59.64 1.04 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 125.213 1.405 . . . . 3.27 111.218 -176.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -156.52 157.51 35.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.021 -1.474 . . . . 1.02 107.021 -172.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.89 154.56 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 109.245 -0.65 . . . . 1.1699999999999999 109.245 171.616 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -119.38 145.85 45.85 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.167 1.387 . . . . 2.5800000000000001 109.247 -178.423 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.15 134.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.911 0.885 . . . . 0.27000000000000002 109.055 179.036 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 78.5 mt -95.2 128.09 46.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.047 -1.464 . . . . 1.1100000000000001 107.047 174.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -149.84 171.96 15.92 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.352 0.661 . . . . 1.77 110.491 177.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -108.02 121.99 42.12 Favored Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 124.002 0.921 . . . . 1.9399999999999999 111.655 -176.358 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.93 23.0 0.35 Allowed 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 124.718 3.612 . . . . 0.81000000000000005 113.489 -176.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.56 -48.93 6.13 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 107.714 -1.217 . . . . 0.41999999999999998 107.714 171.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -99.43 -48.95 4.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.317 1.447 . . . . 2.71 110.687 178.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.2 m -111.11 133.03 53.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.07 1.748 . . . . 0.96999999999999997 114.759 -164.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.1 177.28 32.42 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 108.638 -1.785 . . . . 0.69999999999999996 108.638 163.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -34.15 -47.95 0.3 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.587 1.955 . . . . 0.72999999999999998 111.082 172.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -41.26 -58.35 1.85 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.594 1.158 . . . . 0.46999999999999997 113.402 173.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.05 -38.52 66.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.854 -0.795 . . . . 0.39000000000000001 108.854 -176.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.594 HG13 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -54.78 -61.21 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-N 114.696 -1.138 . . . . 0.87 109.84 179.2 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -45.36 -52.58 9.71 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.003 1.274 . . . . 1.47 110.373 178.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.65 -51.46 12.23 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.573 0.749 . . . . 2.54 112.603 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -48.03 57.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.764 -0.774 . . . . 1.6799999999999999 111.495 174.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.742 HD11 HD11 ' A' ' 28' ' ' LEU . 33.5 mm -49.6 -44.07 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.855 0.862 . . . . 0.38 110.662 -176.364 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -50.86 -52.57 40.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.446 0.698 . . . . 1.5900000000000001 110.027 175.146 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -71.58 -29.12 64.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 114.048 1.129 . . . . 3.3399999999999999 114.048 -178.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -53.9 -25.03 18.19 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.426 0.557 . . . . 0.93999999999999995 110.388 165.455 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.68 27.82 3.94 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 124.507 1.051 . . . . 0.38 111.067 166.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -151.16 174.51 13.15 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.806 -1.183 . . . . 1.8200000000000001 107.806 -173.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.33 141.05 48.79 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.066 -1.087 . . . . 3.3799999999999999 108.066 171.64 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.94 142.3 15.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 113.542 -1.663 . . . . 0.81999999999999995 107.969 162.085 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.117 -0.697 . . . . 1.45 109.117 173.612 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 112.423 0.527 . . . . 0.77000000000000002 112.423 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.09 165.87 31.48 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.99 0.9 . . . . 3.21 111.803 169.35 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -82.15 141.12 33.35 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.062 2.145 . . . . 2.2799999999999998 107.721 167.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.68 150.92 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 106.022 -1.844 . . . . 1.5700000000000001 106.022 164.016 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.61 128.3 23.19 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.292 1.437 . . . . 0.46000000000000002 107.955 176.286 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -155.91 173.17 17.17 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.994 0.518 . . . . 1.02 110.251 -172.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.405 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -102.22 152.25 21.26 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.951 0.9 . . . . 1.8300000000000001 109.371 -176.426 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 t -115.02 162.89 12.78 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.06 0 C-N-CA 123.432 0.693 . . . . 0.75 109.834 178.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.45 -0.453 0 C-N-CA 125.303 1.441 . . . . 0.81999999999999995 108.565 175.503 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 119.232 -0.413 . . . . 0.40000000000000002 110.369 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -53.93 -45.58 71.26 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 118.817 -0.611 . . . . 3.6499999999999999 111.36 174.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.463 HD11 ' CD2' ' A' ' 69' ' ' TYR . 72.9 mt -49.24 -61.96 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.15 -0.685 . . . . 0.66000000000000003 109.15 177.547 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.466 ' CD ' HG21 ' A' ' 46' ' ' VAL . 1.1 tp10 -72.18 -33.12 67.43 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.015 -0.674 . . . . 2.46 111.017 -170.193 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.5 mmtt -54.42 -39.51 67.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 121.029 -1.045 . . . . 1.74 110.703 170.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.51 -53.04 34.06 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.889 -1.284 . . . . 0.41999999999999998 109.889 168.757 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 64' ' ' ILE . 94.1 mt -60.66 -33.15 72.39 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 117.811 -1.09 . . . . 0.46999999999999997 112.543 178.252 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.422 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.285 13.8 ttpt -56.43 -19.33 14.57 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 120.08 1.309 . . . . 2.0699999999999998 111.678 175.499 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.46 -14.94 54.23 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.094 1.516 . . . . 3.21 115.094 170.284 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.6 mmt -73.54 134.59 79.16 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 120.165 1.348 . . . . 2.6400000000000001 111.88 -175.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.85 94.35 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.291 2.661 . . . . 0.40000000000000002 111.549 -176.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.84 -13.7 2.88 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.719 1.152 . . . . 0.44 111.092 171.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -71.23 152.84 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 121.678 -0.896 . . . . 1.1699999999999999 109.121 162.623 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.19 -57.03 2.09 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.668 1.187 . . . . 0.46999999999999997 110.374 169.064 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -154.67 158.07 39.08 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 117.903 0.319 . . . . 2.6899999999999999 111.61 -177.047 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.42 ' HB1' ' CG ' ' A' ' 25' ' ' GLU . . . -129.36 132.43 47.07 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 127.494 2.317 . . . . 0.65000000000000002 109.986 -171.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -138.35 104.34 5.15 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.819 1.248 . . . . 1.3100000000000001 108.798 -176.539 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.9 p -83.67 141.55 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.74 0.816 . . . . 0.82999999999999996 111.371 -178.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -136.83 67.84 1.44 Allowed 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.715 1.606 . . . . 1.1499999999999999 111.535 -175.429 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.81 -16.98 62.63 Favored 'General case' 0 C--O 1.228 -0.045 0 N-CA-C 113.146 0.795 . . . . 0.78000000000000003 113.146 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.45 -26.09 11.84 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.17 0.441 . . . . 0.53000000000000003 110.612 169.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.6 m -125.45 18.56 8.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.319 1.448 . . . . 0.45000000000000001 110.315 -179.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 46.46 39.66 6.95 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.202 1.001 . . . . 2.6600000000000001 111.973 -177.352 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.37 156.82 46.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.596 -0.89 . . . . 0.96999999999999997 108.596 -169.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.466 HG21 ' CD ' ' A' ' 25' ' ' GLU . 7.7 p -131.59 145.66 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.349 -0.841 . . . . 0.53000000000000003 108.809 174.335 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -116.06 139.01 50.72 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.022 -1.473 . . . . 2.48 107.022 176.458 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.59 138.34 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.489 -0.93 . . . . 0.44 108.489 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 79.9 mt -105.11 125.3 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.196 -1.409 . . . . 0.94999999999999996 107.196 -177.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -146.12 166.36 26.38 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 122.945 0.498 . . . . 1.8899999999999999 111.227 -179.418 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -103.68 115.62 63.22 Favored Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 114.31 -1.313 . . . . 1.3400000000000001 110.245 176.324 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -68.46 6.73 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.674 2.916 . . . . 0.47999999999999998 113.706 -179.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.62 -43.24 48.98 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 119.381 0.991 . . . . 0.42999999999999999 108.438 174.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -100.86 -40.82 7.11 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.27 1.828 . . . . 2.9900000000000002 109.906 178.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.6 m -138.82 127.3 23.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 118.568 2.803 . . . . 0.52000000000000002 118.568 -154.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -159.0 -164.68 14.74 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 109.752 -1.339 . . . . 0.45000000000000001 109.752 156.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.273 0.1 OUTLIER -29.28 -44.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 129.357 3.063 . . . . 0.71999999999999997 114.13 173.245 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.48 -57.09 8.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.195 0.907 . . . . 0.34999999999999998 112.546 175.487 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.26 -39.36 63.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 122.181 0.991 . . . . 0.20999999999999999 108.933 -176.12 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.566 HG12 HD22 ' A' ' 28' ' ' LEU . 1.1 mt -60.87 -59.24 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-N 114.149 -1.387 . . . . 0.55000000000000004 109.279 -174.583 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.65 -51.48 12.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.914 1.234 . . . . 0.75 111.279 177.728 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -42.48 -56.07 3.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.893 0.701 . . . . 2.4399999999999999 112.893 174.157 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -44.27 71.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 119.056 -1.058 . . . . 1.9099999999999999 111.347 178.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 28' ' ' LEU . 38.8 mm -51.01 -46.33 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.65 0.78 . . . . 0.47999999999999998 110.456 -178.557 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -50.11 -50.56 48.1 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.328 0.585 . . . . 1.4199999999999999 110.07 174.092 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -72.35 -30.79 65.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.904 0.705 . . . . 3.0699999999999998 112.904 -175.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.51 -25.34 24.97 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.68 0.392 . . . . 0.94999999999999996 110.383 165.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.25 28.78 5.38 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 124.656 1.122 . . . . 0.37 110.859 172.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.463 ' CD2' HD11 ' A' ' 24' ' ' ILE . 64.2 m-85 -145.52 163.52 34.47 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 107.943 -1.132 . . . . 1.97 107.943 -176.228 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.01 126.58 50.28 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.977 -1.49 . . . . 4.3099999999999996 106.977 177.781 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.0 p -94.74 141.58 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 122.92 0.488 . . . . 0.53000000000000003 109.771 172.22 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 11' ' ' GLN . 13.4 m . . . . . 0 N--CA 1.466 0.357 0 N-CA-C 108.987 -0.746 . . . . 1.1000000000000001 108.987 173.393 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 120.664 0.268 . . . . 0.82999999999999996 110.962 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -147.9 156.56 42.83 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.982 0.896 . . . . 3.6600000000000001 110.763 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.28 111.14 18.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.848 2.459 . . . . 2.1899999999999999 108.991 173.251 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.02 151.89 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 107.203 -1.406 . . . . 1.6200000000000001 107.203 162.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.02 127.82 19.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.431 1.492 . . . . 0.33000000000000002 107.899 175.317 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -157.03 164.5 37.9 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.163 0.438 . . . . 1.1499999999999999 110.727 -171.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.446 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -100.34 145.89 27.61 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.074 0.95 . . . . 1.8300000000000001 109.066 -172.089 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.71 159.25 19.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 C-N-CA 123.127 0.571 . . . . 0.54000000000000004 110.053 -176.087 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.448 -0.563 0 C-N-CA 124.909 1.284 . . . . 0.72999999999999998 108.096 177.081 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 118.812 -0.613 . . . . 0.44 111.581 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -57.98 -43.4 86.53 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.848 0.749 . . . . 3.5 110.696 177.126 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.5 mt -53.47 -59.45 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 107.96 -1.126 . . . . 0.62 107.96 -176.799 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' CG ' HG21 ' A' ' 46' ' ' VAL . 1.5 tm-20 -70.58 -41.17 72.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.818 -0.628 . . . . 3.3599999999999999 109.811 -176.03 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -49.66 -38.49 32.79 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.39 -1.444 . . . . 1.46 112.005 179.084 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.42 -51.79 40.78 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 111.548 -0.621 . . . . 0.37 111.548 169.064 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 64' ' ' ILE . 74.6 mt -67.1 -27.7 67.56 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.639 -0.918 . . . . 0.60999999999999999 112.666 177.476 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -62.09 -15.82 47.81 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.758 1.163 . . . . 2.5099999999999998 110.004 172.146 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -96.89 4.97 51.35 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.162 1.171 . . . . 3.77 114.162 170.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 34' ' ' VAL . 81.5 mmm -83.12 138.81 42.35 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 120.498 1.499 . . . . 2.0699999999999998 111.529 176.024 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.68 94.26 0.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.387 2.724 . . . . 0.40999999999999998 111.228 -172.655 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.87 -13.81 2.87 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.514 1.054 . . . . 0.19 111.327 178.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 31' ' ' MET . 5.3 p -69.22 160.59 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 117.735 0.767 . . . . 0.26000000000000001 110.889 168.076 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.25 -56.37 1.82 Allowed 'General case' 0 C--N 1.335 -0.058 0 C-N-CA 124.055 0.942 . . . . 0.44 109.967 168.793 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -145.01 157.54 44.09 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.968 -0.382 . . . . 2.8500000000000001 109.968 -179.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.22 136.12 39.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.504 2.322 . . . . 0.67000000000000004 107.854 176.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.57 115.19 9.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.658 1.583 . . . . 1.4199999999999999 108.193 -174.155 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.57 143.6 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.859 0.863 . . . . 0.57999999999999996 112.062 -177.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -133.14 67.72 1.52 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.335 1.854 . . . . 1.21 111.86 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.5 mt -67.37 -16.89 64.5 Favored 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 113.085 0.772 . . . . 0.65000000000000002 113.085 -179.046 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.83 -22.06 13.29 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.654 0.382 . . . . 0.58999999999999997 110.875 168.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.1 m -127.82 17.79 6.78 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.741 1.216 . . . . 0.54000000000000004 110.032 178.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 44.68 40.52 4.19 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.558 1.143 . . . . 2.75 111.632 -175.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.8 m -134.72 155.66 50.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.22 -1.4 . . . . 0.46000000000000002 107.22 -169.132 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.4 HG21 ' CG ' ' A' ' 25' ' ' GLU . 7.4 p -134.8 148.9 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.773 -0.825 . . . . 0.41999999999999998 108.773 173.012 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.25 153.11 36.81 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 124.047 0.842 . . . . 2.8300000000000001 110.168 174.374 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.98 133.64 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 123.617 0.767 . . . . 0.33000000000000002 109.382 -177.139 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.5 mt -100.01 112.04 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.755 1.622 . . . . 0.91000000000000003 106.794 179.375 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -135.84 167.41 21.23 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.276 1.03 . . . . 1.8500000000000001 110.998 178.335 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.91 119.85 54.28 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 124.726 1.21 . . . . 1.3400000000000001 110.998 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.14 8.83 1.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.72 2.947 . . . . 0.46000000000000002 113.586 -175.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.4 -53.25 6.78 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 107.585 -1.265 . . . . 0.45000000000000001 107.585 175.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -85.48 -41.87 14.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.273 1.429 . . . . 2.8700000000000001 110.429 175.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.0 m -138.14 126.61 23.34 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 117.925 2.565 . . . . 0.52000000000000002 117.925 -151.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.83 -165.35 19.76 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.909 -1.041 . . . . 0.42999999999999999 110.731 155.458 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.5 t -31.5 -43.22 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 129.386 3.075 . . . . 0.54000000000000004 112.987 176.776 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.0 -56.87 7.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.785 0.72 . . . . 0.34000000000000002 112.831 174.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.57 -37.05 65.65 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 122.29 1.043 . . . . 0.29999999999999999 109.198 -179.517 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.513 HG12 HD22 ' A' ' 28' ' ' LEU . 1.2 mt -64.79 -54.64 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 114.348 -1.296 . . . . 0.51000000000000001 110.338 -171.516 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.74 -51.47 22.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.011 1.278 . . . . 0.77000000000000002 110.882 174.711 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -43.42 -53.84 5.13 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 113.025 0.75 . . . . 2.2599999999999998 113.025 173.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.14 -45.56 66.57 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 118.419 -0.8 . . . . 2.1600000000000001 110.862 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.593 HD11 HD11 ' A' ' 28' ' ' LEU . 17.2 mm -50.1 -47.5 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.641 1.176 . . . . 0.41999999999999998 110.384 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -51.22 -47.53 62.31 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.427 0.632 . . . . 1.53 110.053 174.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -33.06 67.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.75 0.82 . . . . 3.4399999999999999 112.42 -177.001 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.64 -22.62 23.65 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.883 0.473 . . . . 0.85999999999999999 110.395 166.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.19 30.88 7.55 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.225 -1.15 . . . . 0.39000000000000001 110.225 175.325 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -137.32 163.62 30.55 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.615 -1.254 . . . . 2.1200000000000001 107.615 178.511 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.24 130.88 56.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.104 -1.443 . . . . 3.9100000000000001 107.104 174.119 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -99.4 146.72 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.629 0.771 . . . . 0.47999999999999998 111.111 171.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 C-N-CA 123.987 0.915 . . . . 0.94999999999999996 109.738 171.077 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.671 -0.492 . . . . 0.68000000000000005 109.671 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.1 mttp -149.72 162.98 39.17 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.357 0.599 . . . . 4.4000000000000004 110.56 178.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -84.11 133.62 34.62 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.779 1.632 . . . . 2.04 107.768 166.849 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 tp -106.29 154.14 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.104 -1.813 . . . . 1.0900000000000001 106.104 160.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.9 131.45 30.98 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.894 -1.521 . . . . 0.47999999999999998 106.894 171.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -156.46 165.85 35.12 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.278 0.631 . . . . 1.1899999999999999 110.428 -174.005 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.409 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 2.3 mp0 -93.92 148.56 22.03 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.04 1.336 . . . . 2.9900000000000002 107.785 -171.294 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.443 HG11 HD13 ' A' ' 24' ' ' ILE . 2.2 t -116.13 141.07 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 118.956 0.798 . . . . 0.72999999999999998 110.522 178.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 106.893 -1.521 . . . . 0.90000000000000002 106.893 173.239 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 118.587 -0.72 . . . . 0.41999999999999998 110.208 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -52.41 -48.76 65.52 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.389 0.995 . . . . 4.0999999999999996 111.381 173.168 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.577 HD11 ' CD2' ' A' ' 69' ' ' TYR . 80.1 mt -43.68 -61.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.284 0 N-CA-C 108.856 -0.794 . . . . 0.81999999999999995 108.856 179.78 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -36.08 66.3 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.773 -0.649 . . . . 2.4300000000000002 112.427 -174.473 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -54.72 -37.63 66.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.941 -1.099 . . . . 2.4100000000000001 111.009 176.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.51 -45.09 77.81 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.983 -0.847 . . . . 0.46000000000000002 110.983 169.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.706 HD22 HG12 ' A' ' 60' ' ' ILE . 75.9 mt -67.25 -31.18 71.35 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.128 -1.219 . . . . 0.5 111.517 176.461 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HA ' HG11 ' A' ' 34' ' ' VAL . 6.4 ttmm -60.47 -17.5 45.32 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.221 0.918 . . . . 1.29 111.215 172.257 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -81.38 -16.22 52.91 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.928 -1.107 . . . . 3.3399999999999999 113.674 169.378 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 34' ' ' VAL . 14.8 mmt -73.71 137.73 77.05 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 120.785 1.63 . . . . 2.2599999999999998 112.744 -173.483 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.74 87.82 0.8 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.903 3.069 . . . . 0.79000000000000004 111.284 -172.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.05 -22.82 0.99 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.994 -0.843 . . . . 0.47999999999999998 110.994 -174.302 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 29' ' ' LYS . 5.8 p -68.09 159.65 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 O-C-N 121.845 -0.797 . . . . 0.39000000000000001 111.939 175.265 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.54 -57.36 1.47 Allowed 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.652 1.181 . . . . 0.54000000000000004 109.344 169.49 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -138.97 154.84 48.34 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 113.884 1.068 . . . . 3.0699999999999998 113.884 178.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.13 124.06 18.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.071 1.748 . . . . 0.97999999999999998 108.025 -175.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -143.44 119.97 11.04 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.584 0.754 . . . . 1.6399999999999999 109.166 -166.111 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -96.63 128.17 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.466 0.707 . . . . 0.89000000000000001 111.529 -173.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -113.91 69.51 0.71 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.032 -1.47 . . . . 2.5800000000000001 107.032 177.158 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 72.9 mt -61.57 -21.79 64.62 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.893 -0.594 . . . . 0.76000000000000001 111.641 175.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.71 -25.05 16.67 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.872 0.869 . . . . 0.60999999999999999 111.405 170.461 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 m -124.96 15.39 8.54 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.123 1.369 . . . . 0.69999999999999996 109.886 -179.308 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 47.02 37.04 4.6 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.407 1.083 . . . . 2.46 111.632 -176.348 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.0 m -133.78 150.59 51.45 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.807 -1.553 . . . . 0.70999999999999996 106.807 -170.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.3 p -128.96 146.9 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 107.684 -1.228 . . . . 0.58999999999999997 107.684 174.492 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.32 149.08 44.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 123.895 0.747 . . . . 2.75 109.114 173.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.26 133.78 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.393 -0.965 . . . . 0.28000000000000003 108.393 -179.135 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.2 mt -101.69 120.25 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 127.231 2.212 . . . . 0.69999999999999996 106.501 -176.462 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -149.68 166.15 30.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.656 0.782 . . . . 1.77 110.548 -177.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -95.22 108.08 36.45 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 125.228 1.411 . . . . 2.2599999999999998 110.611 175.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -70.34 12.82 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.229 3.286 . . . . 0.81999999999999995 114.117 -179.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.97 -49.66 6.92 Favored 'General case' 0 N--CA 1.459 0.023 0 N-CA-C 107.105 -1.443 . . . . 0.73999999999999999 107.105 171.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -85.6 -34.09 21.51 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.18 1.392 . . . . 2.4700000000000002 111.037 178.267 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.9 m -154.39 122.15 5.87 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 117.112 2.264 . . . . 0.76000000000000001 117.112 -156.601 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.97 -171.68 24.2 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 121.69 -0.631 . . . . 0.5 112.222 165.383 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.96 -44.66 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.942 2.897 . . . . 0.55000000000000004 112.531 176.499 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.4 -55.78 9.91 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.062 0.764 . . . . 0.35999999999999999 113.062 175.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.18 -38.7 63.59 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 122.644 1.211 . . . . 0.37 109.127 178.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.706 HG12 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -64.95 -48.61 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 114.407 -1.27 . . . . 0.54000000000000004 110.619 -169.063 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -50.53 60.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.164 1.347 . . . . 0.90000000000000002 110.355 173.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -43.32 -57.95 2.78 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.852 0.834 . . . . 2.3999999999999999 112.879 171.846 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -42.27 83.66 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 118.595 -0.717 . . . . 1.79 111.418 -178.228 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.403 HD11 HD11 ' A' ' 28' ' ' LEU . 5.7 mm -52.47 -47.8 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 119.355 0.98 . . . . 0.56000000000000005 110.047 177.654 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -51.72 -46.29 63.91 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.103 0.478 . . . . 1.6599999999999999 110.026 173.083 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -37.7 84.27 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.482 -0.761 . . . . 3.6200000000000001 112.01 -178.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.97 -21.95 34.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.75 0.82 . . . . 0.94999999999999996 110.517 170.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.83 28.5 7.8 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 124.409 1.004 . . . . 0.51000000000000001 110.97 173.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.577 ' CD2' HD11 ' A' ' 24' ' ' ILE . 47.5 m-85 -141.23 175.11 9.91 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.042 -1.095 . . . . 2.1699999999999999 108.042 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 111.43 7.39 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.232 -1.025 . . . . 4.5899999999999999 108.232 -171.525 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.49 147.21 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.466 -0.788 . . . . 0.46000000000000002 109.74 -179.007 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 C-N-CA 125.449 1.499 . . . . 1.55 110.15 -174.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 118.662 -0.685 . . . . 15.289999999999999 109.162 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.43 -76.75 0.1 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.003 -0.74 . . . . 8.0500000000000007 109.003 171.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 m -66.29 159.88 25.68 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 122.044 -0.41 . . . . 3.0800000000000001 110.603 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -133.74 113.92 12.85 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.929 -1.878 . . . . 2.6499999999999999 105.929 172.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -91.74 172.09 8.71 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.995 0.918 . . . . 0.93000000000000005 110.601 -175.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -152.38 162.32 41.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.597 0.713 . . . . 2.7799999999999998 111.642 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 0.8 OUTLIER -84.4 150.2 25.5 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.492 1.517 . . . . 3.75 109.006 166.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 tp -129.48 156.47 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.352 -1.721 . . . . 1.2 106.352 162.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.88 130.78 24.46 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.711 1.204 . . . . 0.31 108.442 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.84 171.63 19.94 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.238 0.472 . . . . 1.1599999999999999 111.956 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.412 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -92.22 153.7 19.12 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.516 0.726 . . . . 1.97 110.009 -177.121 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -118.51 158.06 19.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 123.903 0.881 . . . . 0.57999999999999996 109.402 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -121.62 125.38 46.56 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.319 1.048 . . . . 0.79000000000000004 108.178 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.73 -11.8 13.65 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.233 0.92 . . . . 1.3799999999999999 113.202 172.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.36 151.17 16.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.752 1.276 . . . . 3.23 111.669 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 p -134.23 32.86 3.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.802 1.241 . . . . 3.4399999999999999 110.006 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.0 t 60.54 -142.09 0.54 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.248 1.019 . . . . 3.96 110.573 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 34.03 53.6 0.53 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.878 2.071 . . . . 2.5600000000000001 115.108 171.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.09 19.89 9.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.775 1.23 . . . . 1.28 113.949 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.4 m -73.32 -61.51 1.8 Allowed 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 123.515 0.726 . . . . 1.5900000000000001 109.315 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.23 -34.66 68.8 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 121.693 0.759 . . . . 0.84999999999999998 111.842 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.35 -41.52 19.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 122.951 0.5 . . . . 0.45000000000000001 112.051 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.91 -41.73 99.55 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.444 0.566 . . . . 4.0700000000000003 111.221 177.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.427 ' CG2' HD12 ' A' ' 64' ' ' ILE . 60.4 mt -51.71 -60.16 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.612 -1.255 . . . . 0.54000000000000004 107.612 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.409 ' CD ' HG21 ' A' ' 46' ' ' VAL . 1.0 OUTLIER -71.73 -34.49 69.61 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.372 -0.831 . . . . 2.6000000000000001 111.516 -173.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -56.39 -36.84 69.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.116 -0.99 . . . . 1.45 110.963 174.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.28 -49.18 60.98 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.765 -0.934 . . . . 0.29999999999999999 110.765 168.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.825 HD11 HD11 ' A' ' 64' ' ' ILE . 96.8 mt -65.14 -30.9 71.87 Favored 'General case' 0 C--O 1.225 -0.207 0 O-C-N 121.544 -0.974 . . . . 0.33000000000000002 112.882 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt -58.85 -17.55 24.88 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.145 0.884 . . . . 1.26 111.257 171.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -93.77 4.35 54.06 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.962 1.097 . . . . 5.5800000000000001 113.962 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.0 mmt -82.03 136.4 47.22 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 120.702 1.592 . . . . 2.79 112.605 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.17 98.25 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.8 3.0 . . . . 0.38 110.111 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.74 -14.96 4.12 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.588 -1.005 . . . . 0.22 110.588 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 p -69.45 152.74 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 117.524 0.662 . . . . 0.28999999999999998 110.434 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.53 -57.48 2.21 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.159 1.384 . . . . 0.73999999999999999 109.48 170.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -144.51 158.09 43.92 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 122.973 0.509 . . . . 3.1800000000000002 110.39 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.65 127.6 33.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.272 1.829 . . . . 0.79000000000000004 107.926 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.09 113.31 8.37 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.854 0.861 . . . . 1.48 109.164 -174.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -89.73 140.34 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.098 0.959 . . . . 0.68000000000000005 111.72 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -131.72 67.22 1.52 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.169 1.788 . . . . 1.22 111.581 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.74 -16.68 64.01 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 113.131 0.789 . . . . 0.69999999999999996 113.131 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.03 -23.94 15.31 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.637 0.375 . . . . 0.58999999999999997 110.748 168.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.5 m -126.62 18.31 7.42 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.073 1.349 . . . . 0.47999999999999998 110.008 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 45.35 38.96 3.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.616 1.166 . . . . 2.48 111.869 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.9 m -136.17 154.63 50.9 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.28 -1.378 . . . . 0.48999999999999999 107.28 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.409 HG21 ' CD ' ' A' ' 25' ' ' GLU . 7.1 p -133.55 150.02 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.588 -0.893 . . . . 0.42999999999999999 108.588 173.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.41 150.08 41.35 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.739 -0.837 . . . . 2.8300000000000001 108.739 171.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.94 139.63 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 107.146 -1.427 . . . . 0.38 107.146 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.1 mt -108.09 131.63 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.019 -1.474 . . . . 0.88 107.019 -175.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -154.2 167.78 28.74 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 123.257 0.348 . . . . 1.8300000000000001 111.767 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -102.75 110.85 64.15 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 124.508 1.123 . . . . 1.6200000000000001 109.856 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -74.74 30.12 0.35 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.94 3.093 . . . . 0.81999999999999995 112.752 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.13 -50.21 5.17 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.044 -1.465 . . . . 0.44 107.044 167.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -87.24 -46.71 9.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.689 1.196 . . . . 2.6499999999999999 110.269 173.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.6 m -140.88 136.42 32.31 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 117.591 2.441 . . . . 0.68000000000000005 117.591 -148.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.85 -161.31 23.05 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 109.102 -1.599 . . . . 0.47999999999999998 109.102 164.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 t -38.15 -43.53 0.77 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.833 2.453 . . . . 0.54000000000000004 112.427 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.32 -57.43 4.62 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.809 0.844 . . . . 0.28999999999999998 112.72 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.56 -37.56 65.49 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.873 0.844 . . . . 0.19 109.328 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.556 HG12 HD22 ' A' ' 28' ' ' LEU . 1.2 mt -61.56 -59.46 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-N 114.466 -1.243 . . . . 0.76000000000000001 109.341 -171.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.94 -50.36 27.33 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.099 1.318 . . . . 0.80000000000000004 110.846 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.28 -52.58 9.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.205 1.002 . . . . 2.3900000000000001 111.988 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -43.84 69.07 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.984 -0.686 . . . . 2.02 111.373 177.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.825 HD11 HD11 ' A' ' 28' ' ' LEU . 35.7 mm -52.53 -45.28 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 118.985 0.811 . . . . 0.56999999999999995 110.284 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -49.3 -47.35 47.06 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.895 0.379 . . . . 1.6200000000000001 110.646 173.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -71.96 -33.23 68.03 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.954 1.094 . . . . 2.9700000000000002 113.954 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.49 -24.59 21.09 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.268 0.486 . . . . 0.89000000000000001 110.205 166.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.66 29.29 6.64 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.114 -1.194 . . . . 0.27000000000000002 110.114 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -140.73 162.08 36.27 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.01 -1.478 . . . . 1.6599999999999999 107.01 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.61 ' HE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -113.79 133.72 55.21 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.118 -1.808 . . . . 4.0499999999999998 106.118 170.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.443 ' HB ' HG21 ' A' ' 64' ' ' ILE . 4.5 p -100.73 148.53 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.39 0.676 . . . . 0.46999999999999997 109.948 170.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.61 HG13 ' HE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -96.58 166.43 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.594 0.634 . . . . 1.45 109.738 167.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 35.3 mm -118.7 108.19 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 105.209 -2.145 . . . . 1.1299999999999999 105.209 165.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -52.99 99.43 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.622 0.769 . . . . 7.3799999999999999 111.319 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.69 -172.75 38.82 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 121.37 0.428 . . . . 5.3899999999999997 112.082 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.174 0 CA-C-O 117.205 -1.379 . . . . 9.1199999999999992 110.586 -172.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttm . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 119.138 -0.458 . . . . 9.4800000000000004 111.503 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.2 tp -133.04 67.58 1.53 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.375 -1.342 . . . . 9.2799999999999994 107.375 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.7 p 60.21 171.95 0.09 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.348 1.459 . . . . 4.3499999999999996 110.155 -153.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -179.12 117.26 0.07 Allowed 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.9 2.08 . . . . 3.25 106.021 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -95.23 174.35 7.09 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 123.442 0.697 . . . . 1.22 110.939 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.98 154.77 41.64 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.68 0.752 . . . . 3.4399999999999999 110.878 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -86.97 137.06 32.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.837 -1.529 . . . . 2.1800000000000002 108.993 166.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.0 tp -112.07 155.64 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 105.917 -1.883 . . . . 1.1799999999999999 105.917 162.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.55 130.55 21.84 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 108.072 -1.085 . . . . 0.41999999999999998 108.072 172.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.62 173.47 16.89 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.177 0.899 . . . . 1.2 111.4 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.93 149.47 22.37 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.434 0.694 . . . . 1.8200000000000001 109.599 -172.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.596 HG11 HD13 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -125.34 143.78 37.69 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.059 0 C-N-CA 122.708 0.403 . . . . 0.83999999999999997 110.883 -176.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t -101.4 149.68 23.8 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.343 1.057 . . . . 1.03 109.31 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.4 30.78 9.52 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.726 0.679 . . . . 1.47 112.894 174.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.97 77.66 0.32 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 118.506 1.153 . . . . 6.1100000000000003 110.624 173.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 p -76.47 -1.89 29.43 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.048 0.939 . . . . 4.1200000000000001 112.762 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t 78.08 175.54 0.17 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.855 1.662 . . . . 3.7799999999999998 110.481 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.77 63.97 0.58 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.848 1.259 . . . . 3.2400000000000002 112.396 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.34 23.21 11.66 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.992 1.317 . . . . 1.1499999999999999 113.081 172.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -73.09 -52.28 14.89 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 121.744 -0.597 . . . . 1.3500000000000001 110.214 -173.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.632 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -68.02 -27.3 66.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.641 0.734 . . . . 0.73999999999999999 110.968 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.96 -49.85 70.92 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.743 -0.598 . . . . 0.44 109.469 169.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -49.99 -49.66 49.81 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.707 0.685 . . . . 6.9199999999999999 111.652 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.632 HD12 ' HA ' ' A' ' 21' ' ' ALA . 90.5 mt -44.02 -62.62 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 123.432 0.693 . . . . 0.98999999999999999 109.324 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.42 -35.37 65.82 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.303 0.573 . . . . 2.3599999999999999 112.394 -172.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -58.2 -36.43 73.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.955 -1.091 . . . . 1.22 110.722 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.59 -51.01 51.13 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.564 -1.014 . . . . 0.34000000000000002 110.564 166.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.766 HD11 HD11 ' A' ' 64' ' ' ILE . 94.2 mt -63.71 -33.6 76.0 Favored 'General case' 0 C--O 1.221 -0.417 0 O-C-N 121.579 -0.954 . . . . 0.40999999999999998 112.444 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -57.79 -18.61 22.81 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.28 0.946 . . . . 1.5600000000000001 112.058 172.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -85.33 -11.78 53.83 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.822 1.415 . . . . 4.2300000000000004 114.822 169.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.561 ' O ' HG12 ' A' ' 34' ' ' VAL . 4.8 mmt -69.63 143.51 92.8 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 120.85 1.659 . . . . 1.8500000000000001 112.074 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.74 106.63 1.51 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.39 2.06 . . . . 0.56999999999999995 109.537 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.09 -13.41 5.75 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.079 1.323 . . . . 0.25 110.784 171.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 31' ' ' MET . 8.1 p -70.27 160.56 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 O-C-N 121.939 -0.742 . . . . 0.32000000000000001 111.517 171.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.49 -65.7 1.15 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.84 1.256 . . . . 0.56999999999999995 108.212 165.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -144.43 147.43 33.34 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.349 -0.387 . . . . 3.25 111.793 -162.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.27 138.29 50.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.24 1.416 . . . . 0.63 108.587 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -140.0 118.45 12.18 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.975 0.91 . . . . 1.4199999999999999 109.408 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -86.4 136.35 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.99 0.916 . . . . 0.65000000000000002 111.054 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -129.23 69.68 1.41 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.318 1.847 . . . . 1.21 110.994 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.2 mt -64.09 -18.63 64.57 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.848 0.685 . . . . 0.95999999999999996 112.848 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.84 -18.21 8.15 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.124 0.42 . . . . 0.84999999999999998 110.977 170.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.7 m -131.87 18.06 4.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.823 1.249 . . . . 0.68999999999999995 109.872 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 41.12 39.24 0.86 Allowed 'General case' 0 C--N 1.346 0.419 0 C-N-CA 124.895 1.278 . . . . 2.6000000000000001 112.128 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.4 m -129.59 152.46 49.09 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.16 -1.422 . . . . 0.64000000000000001 107.16 -171.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 p -133.85 146.85 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 107.143 -1.429 . . . . 0.52000000000000002 107.143 173.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.75 145.8 46.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 123.93 0.769 . . . . 2.6000000000000001 109.39 173.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -144.0 136.66 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.615 -0.883 . . . . 0.25 108.615 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.0 mt -103.61 118.87 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.704 2.002 . . . . 0.94999999999999996 107.145 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -146.17 169.0 19.63 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.74 0.781 . . . . 1.8999999999999999 110.415 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -96.71 125.3 47.32 Favored Pre-proline 0 N--CA 1.439 -1.003 0 CA-C-N 114.316 -1.311 . . . . 1.3500000000000001 109.502 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.41 6.69 2.56 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.778 2.318 . . . . 0.71999999999999997 113.315 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.19 -54.47 4.59 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 119.358 0.981 . . . . 0.46999999999999997 108.95 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -85.43 -55.86 3.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.312 1.445 . . . . 3.1299999999999999 109.297 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.8 m -86.93 160.16 18.78 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 126.366 1.867 . . . . 2.1000000000000001 112.984 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.24 161.25 35.07 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 104.859 -3.296 . . . . 1.4099999999999999 104.859 168.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 t -51.29 -32.24 24.24 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 117.192 0.496 . . . . 1.1399999999999999 110.288 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -36.26 -61.32 0.51 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.97 1.708 . . . . 0.68999999999999995 114.449 164.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.89 -37.97 73.03 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.938 -1.134 . . . . 0.38 107.938 -172.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.531 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -55.62 -62.29 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-N 114.315 -1.311 . . . . 0.92000000000000004 109.214 177.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -46.9 -54.1 10.75 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.354 1.434 . . . . 1.1899999999999999 110.676 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -41.05 -57.0 2.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.663 0.785 . . . . 2.52 112.767 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.64 -40.46 69.7 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 119.917 -0.713 . . . . 1.8799999999999999 110.046 -176.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.766 HD11 HD11 ' A' ' 28' ' ' LEU . 27.5 mm -52.61 -47.18 49.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 119.188 0.903 . . . . 0.41999999999999998 109.994 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -53.28 -42.54 66.66 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.637 0.375 . . . . 1.6899999999999999 110.754 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -71.04 -38.96 72.56 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.422 -0.799 . . . . 2.9399999999999999 110.915 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -54.96 -25.09 27.24 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.715 0.806 . . . . 1.0800000000000001 110.263 171.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.17 29.66 6.3 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.331 -1.108 . . . . 0.46999999999999997 110.331 172.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.533 ' CD2' HD11 ' A' ' 24' ' ' ILE . 44.0 m-85 -140.76 166.25 25.27 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.968 -1.123 . . . . 1.9399999999999999 107.968 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.17 122.0 38.18 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 104.679 -2.341 . . . . 3.3300000000000001 104.679 -173.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.411 ' HB ' HG21 ' A' ' 64' ' ' ILE . 7.2 p -100.54 142.51 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.182 -0.673 . . . . 0.42999999999999999 109.182 173.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -104.26 151.87 6.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 N-CA-C 108.545 -0.909 . . . . 1.03 108.545 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.0 mm -124.84 67.68 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.388 -1.338 . . . . 0.98999999999999999 107.388 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -87.61 100.81 13.07 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 106.937 -1.505 . . . . 4.6200000000000001 106.937 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 23.77 66.63 0.03 OUTLIER Glycine 0 CA--C 1.53 0.983 0 C-N-CA 127.774 2.607 . . . . 3.5699999999999998 115.509 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.342 0 CA-C-O 115.507 -2.187 . . . . 10.98 109.544 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 mtt . . . . . 0 N--CA 1.472 0.675 0 N-CA-C 106.392 -1.707 . . . . 10.119999999999999 106.392 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 tp -169.61 89.44 0.18 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.534 -0.913 . . . . 7.2300000000000004 108.534 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 p -170.42 81.52 0.1 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.308 -0.997 . . . . 3.1899999999999999 108.308 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -122.47 133.47 54.6 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.816 -1.92 . . . . 3.9700000000000002 105.816 170.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -93.18 163.05 13.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.473 1.109 . . . . 0.60999999999999999 110.697 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -146.14 157.17 43.83 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.013 -0.736 . . . . 3.71 109.013 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.68 127.94 35.59 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.625 1.57 . . . . 3.71 109.5 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 tp -106.73 152.17 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.767 -1.568 . . . . 1.0900000000000001 106.767 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.81 132.65 27.51 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.258 -1.386 . . . . 0.34999999999999998 107.258 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -156.41 163.16 39.8 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.072 0.549 . . . . 1.25 110.68 -170.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.536 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -92.77 154.56 18.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.343 -1.355 . . . . 2.2599999999999998 107.343 178.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.4 163.43 14.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.064 -1.087 . . . . 0.56000000000000005 108.064 173.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.99 142.65 51.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.555 -1.276 . . . . 1.0700000000000001 107.555 173.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.33 -10.96 56.78 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.89 0.757 . . . . 1.4199999999999999 113.722 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.6 157.37 11.78 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.282 1.541 . . . . 3.1800000000000002 110.635 172.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -131.21 33.81 4.08 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.523 0.729 . . . . 4.3200000000000003 109.223 169.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.516 ' HA ' HD13 ' A' ' 41' ' ' LEU . 14.5 t 69.91 -49.39 0.63 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.298 1.839 . . . . 4.2300000000000004 113.633 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.4 86.14 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.358 1.463 . . . . 2.8100000000000001 111.765 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.53 13.56 4.26 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.36 1.864 . . . . 1.1100000000000001 113.63 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.7 m -72.13 -63.9 1.05 Allowed 'General case' 0 CA--C 1.519 -0.236 0 O-C-N 121.78 -0.575 . . . . 1.6599999999999999 110.522 -167.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.65 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -64.85 -27.52 68.93 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.79 -0.364 . . . . 1.1299999999999999 111.064 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.61 -54.94 34.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.725 0.41 . . . . 0.56999999999999995 110.529 169.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -62.79 -48.1 80.58 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 122.89 0.476 . . . . 4.0499999999999998 110.752 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.65 HD12 ' HA ' ' A' ' 21' ' ' ALA . 66.1 mt -49.62 -56.74 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.437 -0.579 . . . . 0.57999999999999996 109.437 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.78 -42.89 76.78 Favored 'General case' 0 C--O 1.219 -0.522 0 C-N-CA 120.208 -0.597 . . . . 3.48 109.567 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -49.51 -36.77 24.23 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.406 -1.434 . . . . 2.04 111.691 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.17 -51.71 39.93 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 112.191 -0.364 . . . . 0.44 112.191 167.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.805 HD11 HD11 ' A' ' 64' ' ' ILE . 90.2 mt -68.4 -28.34 67.01 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 121.401 -1.058 . . . . 0.55000000000000004 113.043 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.281 21.5 ttmt -62.7 -15.04 50.84 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.965 1.257 . . . . 2.29 110.238 175.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -25.63 60.12 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.217 1.192 . . . . 3.8900000000000001 114.217 166.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.549 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -67.18 134.83 93.55 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 120.14 1.336 . . . . 2.52 111.939 -169.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -65.58 100.79 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.303 2.669 . . . . 0.38 109.52 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.6 -17.68 3.48 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.405 -1.078 . . . . 0.23000000000000001 110.405 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 31' ' ' MET . 6.2 p -72.17 154.65 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 121.965 -0.727 . . . . 0.28000000000000003 110.385 169.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.18 -57.22 2.23 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 123.009 0.524 . . . . 0.45000000000000001 109.666 171.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -148.49 157.45 43.48 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.516 -0.55 . . . . 2.5600000000000001 109.516 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.72 136.11 33.85 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 127.232 2.213 . . . . 0.65000000000000002 108.325 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -137.87 117.71 13.23 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 125.222 1.576 . . . . 1.7 107.931 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -84.32 144.15 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.159 0.984 . . . . 0.73999999999999999 110.847 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -137.73 64.36 1.52 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.321 1.449 . . . . 1.25 112.124 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.516 HD13 ' HA ' ' A' ' 17' ' ' CYS . 91.4 mt -65.55 -16.97 64.21 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 112.523 0.564 . . . . 0.96999999999999997 112.523 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.05 59.42 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.227 0.467 . . . . 0.82999999999999996 110.82 168.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.9 m -118.63 16.45 13.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.231 1.412 . . . . 0.75 109.962 176.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 48.28 36.37 6.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.601 1.161 . . . . 2.3300000000000001 111.769 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.4 m -138.04 155.3 48.95 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.747 -1.205 . . . . 0.56000000000000005 107.747 -168.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 p -136.48 150.36 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 108.825 -0.805 . . . . 0.52000000000000002 108.825 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.98 153.01 44.94 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 123.852 0.72 . . . . 2.7200000000000002 110.224 175.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.78 136.8 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.998 -0.742 . . . . 0.37 108.998 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.8 114.14 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.065 -1.457 . . . . 1.01 107.065 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -137.67 167.24 22.09 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.515 0.726 . . . . 1.9299999999999999 111.118 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -102.73 113.91 65.61 Favored Pre-proline 0 N--CA 1.443 -0.805 0 C-N-CA 124.475 1.11 . . . . 1.3100000000000001 110.612 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.8 17.89 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.529 2.819 . . . . 0.56000000000000005 113.724 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.47 -51.76 7.08 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 107.646 -1.242 . . . . 0.52000000000000002 107.646 168.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -81.47 -46.23 14.85 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.257 1.023 . . . . 2.9500000000000002 110.265 172.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.9 m -142.37 129.61 21.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 118.295 2.702 . . . . 0.67000000000000004 118.295 -143.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.08 -160.55 20.88 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.024 -1.23 . . . . 0.55000000000000004 110.024 162.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 t -29.43 -48.73 0.08 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 129.544 3.137 . . . . 0.56000000000000005 112.9 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.2 -55.9 7.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.719 0.808 . . . . 0.31 112.39 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.53 -38.0 65.42 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 122.149 0.976 . . . . 0.26000000000000001 109.432 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.528 HG12 HD22 ' A' ' 28' ' ' LEU . 1.4 mt -63.55 -56.63 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 114.408 -1.269 . . . . 0.67000000000000004 110.017 -169.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.51 -53.49 14.21 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.81 1.186 . . . . 0.77000000000000002 110.41 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -41.81 -54.05 3.51 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.245 1.018 . . . . 2.4399999999999999 112.266 175.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -41.39 68.06 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 118.179 -0.915 . . . . 1.8400000000000001 110.791 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.805 HD11 HD11 ' A' ' 28' ' ' LEU . 41.4 mm -53.75 -46.54 62.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.871 1.214 . . . . 0.40000000000000002 110.216 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -51.83 -42.9 62.89 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.333 0.587 . . . . 1.54 109.946 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -37.19 73.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.594 0.758 . . . . 4.5499999999999998 112.174 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -56.05 -19.95 14.91 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.149 0.579 . . . . 0.89000000000000001 110.731 168.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.51 27.76 12.56 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 110.405 -1.078 . . . . 0.42999999999999999 110.405 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -136.07 169.55 17.42 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 108.256 -1.016 . . . . 2.0 108.256 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.5 123.85 43.02 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.036 -1.098 . . . . 4.5199999999999996 108.036 176.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 p -91.61 153.29 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.969 1.308 . . . . 0.55000000000000004 109.712 173.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.78 104.15 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 122.929 0.492 . . . . 1.26 110.222 178.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mt -107.31 91.2 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 124.02 0.928 . . . . 1.9099999999999999 108.566 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -149.48 115.62 5.74 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.204 -2.146 . . . . 6.8600000000000003 105.204 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.58 -88.53 0.1 OUTLIER Glycine 0 CA--C 1.528 0.875 0 CA-C-N 118.935 0.788 . . . . 3.52 113.005 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.191 -1.385 . . . . 9.9299999999999997 110.255 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.4 mtt . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 107.54 -1.281 . . . . 9.2100000000000009 107.54 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.3 pp -62.36 165.72 5.76 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.14 -0.319 . . . . 5.8099999999999996 110.14 165.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.5 t -124.84 159.62 30.64 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.079 -1.822 . . . . 3.6899999999999999 106.079 167.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -157.47 144.51 18.33 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.507 -1.294 . . . . 3.8599999999999999 107.507 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -84.26 166.02 17.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.569 0.747 . . . . 0.79000000000000004 111.05 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -153.46 159.44 42.32 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.356 0.598 . . . . 2.54 111.697 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -84.87 124.92 32.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.665 2.386 . . . . 2.1600000000000001 108.31 169.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 tp -104.06 147.92 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 106.878 -1.526 . . . . 1.2 106.878 161.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.47 129.35 37.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.651 -1.24 . . . . 0.34000000000000002 107.651 173.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -155.41 170.19 22.51 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.799 -0.445 . . . . 1.6599999999999999 109.799 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -97.1 148.69 22.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.272 1.029 . . . . 3.0899999999999999 108.879 -174.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.431 HG11 HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -122.03 160.57 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 C-N-CA 123.783 0.833 . . . . 0.60999999999999999 109.573 179.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -94.84 149.63 21.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.0 -0.741 . . . . 1.3799999999999999 109.0 165.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.17 82.19 0.26 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.701 -0.56 . . . . 2.71 111.701 173.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.8 ptp -144.57 178.26 8.09 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.906 1.282 . . . . 3.4100000000000001 108.876 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 m 57.92 35.34 25.26 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.346 0.593 . . . . 7.2400000000000002 110.391 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.28 59.47 1.7 Allowed 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 107.904 -1.147 . . . . 7.0 107.904 -174.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 63.31 82.24 0.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.056 1.342 . . . . 3.4700000000000002 111.593 -175.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 57.85 31.59 20.73 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.488 1.115 . . . . 1.3100000000000001 113.232 170.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -70.14 -61.26 1.85 Allowed 'General case' 0 C--O 1.226 -0.159 0 O-C-N 121.677 -0.639 . . . . 1.76 110.474 -173.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -58.26 -36.1 72.72 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 122.255 1.026 . . . . 0.87 110.913 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.4 -49.44 77.79 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.53 -0.759 . . . . 0.52000000000000002 110.615 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -61.8 -48.7 79.45 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.243 0.929 . . . . 3.71 111.415 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 21' ' ' ALA . 47.3 mt -42.34 -62.82 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 124.716 1.206 . . . . 1.1399999999999999 108.388 173.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.482 ' OE1' HG22 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -73.45 -32.71 64.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 119.458 -0.897 . . . . 2.5600000000000001 112.664 -174.18 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -57.16 -37.7 72.46 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.95 -1.094 . . . . 2.1000000000000001 110.434 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.69 -50.7 56.74 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 110.476 -1.05 . . . . 0.46999999999999997 110.476 169.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.555 HD22 HG12 ' A' ' 60' ' ' ILE . 88.7 mt -62.29 -31.57 72.18 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 121.896 -0.767 . . . . 0.47999999999999998 112.12 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -62.51 -15.59 51.24 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 119.155 0.889 . . . . 2.6200000000000001 110.722 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.27 -3.17 44.56 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.043 1.127 . . . . 4.5 114.043 169.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.442 ' O ' HG12 ' A' ' 34' ' ' VAL . 75.1 mmm -74.07 138.91 75.82 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 120.786 1.63 . . . . 2.1000000000000001 111.768 -177.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.64 90.39 0.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.31 2.673 . . . . 0.52000000000000002 110.971 -173.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.99 -9.04 4.19 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.122 1.344 . . . . 0.31 111.347 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 31' ' ' MET . 4.4 p -64.69 161.87 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.399 1.099 . . . . 0.33000000000000002 110.251 164.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.21 -53.61 2.13 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.738 1.215 . . . . 0.42999999999999999 110.373 166.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -148.25 163.77 36.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.467 -0.568 . . . . 3.0499999999999998 109.467 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.24 141.99 26.75 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.979 1.712 . . . . 0.72999999999999998 108.627 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -152.19 119.63 6.0 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.887 0.875 . . . . 1.4299999999999999 108.754 -165.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.541 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.2 p -84.98 145.72 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.318 1.047 . . . . 0.93000000000000005 112.376 -175.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -134.32 69.95 1.45 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.968 1.707 . . . . 1.3 112.345 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.4 mt -61.57 -22.26 65.04 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 112.295 0.48 . . . . 1.46 112.295 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.61 -16.44 25.79 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.406 0.548 . . . . 0.95999999999999996 111.174 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.9 m -132.66 18.24 4.28 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.918 0.887 . . . . 0.75 109.529 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 43.95 45.5 6.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.902 0.881 . . . . 2.4100000000000001 111.505 -175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.8 m -136.37 159.92 40.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.95 1.3 . . . . 0.47999999999999998 108.145 -170.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.541 HG23 ' HA ' ' A' ' 39' ' ' VAL . 12.0 p -139.61 149.65 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.378 -0.971 . . . . 0.60999999999999999 108.378 172.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -117.58 139.45 50.95 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.922 1.289 . . . . 2.5 109.301 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.29 132.85 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.274 0.63 . . . . 0.53000000000000003 109.841 174.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.72 125.12 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.295 1.438 . . . . 0.93000000000000005 107.542 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -146.24 169.72 18.2 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.314 0.646 . . . . 1.95 110.983 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -107.73 121.4 44.24 Favored Pre-proline 0 N--CA 1.447 -0.619 0 C-N-CA 124.726 1.21 . . . . 2.0899999999999999 110.982 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -71.94 10.85 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.349 3.366 . . . . 0.85999999999999999 113.684 -176.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.74 -50.32 12.63 Favored 'General case' 0 N--CA 1.458 -0.037 0 N-CA-C 107.409 -1.33 . . . . 0.84999999999999998 107.409 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -96.03 -40.16 9.39 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.019 1.728 . . . . 3.0 110.557 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.4 m -136.08 131.15 34.46 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 117.929 2.566 . . . . 0.56000000000000005 117.929 -153.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.99 -168.62 24.16 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.866 -1.293 . . . . 0.5 109.866 160.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.1 t -38.69 -40.35 0.59 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.947 2.499 . . . . 0.65000000000000002 112.243 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.17 -56.43 6.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.569 0.748 . . . . 0.28000000000000003 112.593 173.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.25 -34.48 68.3 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 122.562 1.172 . . . . 0.22 109.323 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.555 HG12 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -69.26 -52.51 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 113.943 -1.481 . . . . 0.56000000000000005 111.161 -169.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -50.69 59.39 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.322 1.419 . . . . 0.79000000000000004 109.641 173.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.47 -53.88 16.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.32 1.048 . . . . 4.9199999999999999 111.193 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -67.22 -41.93 84.9 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 121.703 -0.623 . . . . 2.2000000000000002 111.531 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.499 HD11 HD11 ' A' ' 28' ' ' LEU . 4.0 mm -55.19 -45.27 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.054 0.942 . . . . 0.37 110.191 -176.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -48.96 -47.01 44.31 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.305 0.574 . . . . 1.5800000000000001 110.596 171.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -32.71 69.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.378 0.881 . . . . 2.9900000000000002 113.378 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.63 -25.54 18.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.321 0.509 . . . . 0.93999999999999995 110.118 166.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.13 29.67 5.67 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.256 -1.138 . . . . 0.46000000000000002 110.256 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.431 ' CD2' HD11 ' A' ' 24' ' ' ILE . 26.8 m-85 -146.23 159.55 43.18 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 106.84 -1.541 . . . . 1.9299999999999999 106.84 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.79 135.37 54.03 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.776 0.798 . . . . 3.9399999999999999 109.324 171.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.9 p -99.34 152.54 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.478 1.511 . . . . 0.55000000000000004 109.751 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m -115.42 153.62 16.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 N-CA-C 109.4 -0.593 . . . . 0.88 109.4 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.3 mm -109.04 93.5 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 106.425 -1.694 . . . . 1.4099999999999999 106.425 173.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -133.96 138.29 45.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.899 -2.26 . . . . 4.2199999999999998 104.899 168.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.78 52.84 3.73 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 123.819 0.699 . . . . 5.04 113.041 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 . . . . . 0 C--O 1.251 1.136 0 C-N-CA 126.316 1.847 . . . . 8.4399999999999995 110.556 176.365 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.4 mtt . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 109.388 -0.597 . . . . 8.7200000000000006 109.388 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.51 170.18 3.01 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 105.979 -1.86 . . . . 6.1600000000000001 105.979 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.5 m -100.92 148.83 24.54 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.692 -1.225 . . . . 2.5499999999999998 107.692 171.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -153.57 139.67 18.34 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.163 -1.421 . . . . 3.2799999999999998 107.163 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -101.17 164.52 11.75 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.525 0.73 . . . . 0.68000000000000005 111.076 -170.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -146.84 151.53 37.25 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 122.689 1.233 . . . . 3.3399999999999999 112.724 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -84.83 106.08 16.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 131.21 3.804 . . . . 2.4300000000000002 107.858 171.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.09 148.3 4.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 N-CA-C 107.199 -1.408 . . . . 1.21 107.199 165.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.54 126.28 29.01 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 124.775 1.23 . . . . 0.35999999999999999 107.73 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -156.52 165.48 36.17 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.525 -0.546 . . . . 1.0600000000000001 109.525 -170.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.5 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -96.72 155.2 16.87 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 108.827 -0.805 . . . . 2.02 108.827 -174.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.11 163.06 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 108.218 -1.03 . . . . 0.59999999999999998 108.218 175.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.23 135.82 48.54 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.085 -1.45 . . . . 1.0900000000000001 107.085 176.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.33 -12.6 30.97 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.346 0.974 . . . . 1.3400000000000001 113.62 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.4 153.15 16.26 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.051 1.425 . . . . 3.3999999999999999 111.682 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 p -138.17 33.64 2.34 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.255 1.022 . . . . 3.3999999999999999 110.097 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.0 t 53.74 -146.1 0.56 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 117.447 -1.263 . . . . 4.21 111.655 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 37.41 51.72 1.19 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.578 1.551 . . . . 2.5 114.218 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 65.06 14.21 9.21 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.208 1.403 . . . . 1.25 114.262 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.0 m -72.16 -60.79 2.05 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.383 -0.823 . . . . 1.6899999999999999 109.019 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.79 -42.21 62.27 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 122.139 0.971 . . . . 0.93000000000000005 111.448 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.74 -43.02 47.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.064 0.946 . . . . 0.40999999999999998 111.633 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -58.79 -41.49 86.82 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.592 0.633 . . . . 5.6299999999999999 111.145 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.2 mt -54.51 -59.74 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.592 -1.262 . . . . 0.80000000000000004 107.592 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.37 -36.14 73.97 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.431 -0.804 . . . . 2.54 110.501 -171.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -56.12 -36.47 68.25 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.199 -0.938 . . . . 1.77 110.961 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.2 -48.04 48.12 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.007 -0.837 . . . . 0.47999999999999998 111.007 166.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.712 HD11 HD11 ' A' ' 64' ' ' ILE . 44.2 mt -68.01 -30.55 69.83 Favored 'General case' 0 C--O 1.224 -0.241 0 O-C-N 121.351 -1.088 . . . . 0.51000000000000001 111.842 176.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.531 ' HA ' HG11 ' A' ' 34' ' ' VAL . 9.2 ttmt -60.33 -19.1 54.03 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.712 1.142 . . . . 1.21 111.468 172.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -25.21 62.02 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.95 -1.094 . . . . 4.04 113.349 168.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.502 ' O ' HG12 ' A' ' 34' ' ' VAL . 92.1 mmm -72.6 134.02 82.23 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 119.784 1.174 . . . . 2.0099999999999998 112.448 -167.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.03 101.44 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.902 3.068 . . . . 0.38 110.653 -172.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.22 -15.35 3.97 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.667 -0.973 . . . . 0.23000000000000001 110.667 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.3 p -72.48 154.71 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 O-C-N 122.081 -0.658 . . . . 0.29999999999999999 111.158 171.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.65 -53.78 2.08 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.784 1.234 . . . . 0.46999999999999997 109.801 171.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -142.44 153.46 43.73 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 113.606 0.965 . . . . 2.9300000000000002 113.606 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.65 125.4 38.02 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.596 1.958 . . . . 0.80000000000000004 107.971 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.13 109.39 6.88 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.043 1.337 . . . . 1.4199999999999999 108.857 -168.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.3 145.26 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.928 0.891 . . . . 0.60999999999999999 112.372 -172.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -135.6 67.73 1.47 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.121 1.768 . . . . 1.3200000000000001 111.622 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.5 mt -68.0 -14.6 63.09 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 113.159 0.8 . . . . 0.65000000000000002 113.159 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.15 -14.1 3.7 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.822 0.449 . . . . 0.60999999999999999 111.355 166.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 m -137.27 19.34 2.95 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.477 1.111 . . . . 0.55000000000000004 109.422 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 47.44 36.98 5.57 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.262 1.025 . . . . 2.71 111.232 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.9 m -132.22 156.27 46.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.781 -1.192 . . . . 0.46000000000000002 107.781 -168.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.81 148.2 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 108.828 -0.804 . . . . 0.41999999999999998 108.828 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -116.55 138.2 51.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.796 -1.187 . . . . 2.48 107.796 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.87 131.09 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.275 -1.009 . . . . 0.28000000000000003 108.275 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.91 115.76 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.803 -1.554 . . . . 1.28 106.803 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -141.49 170.59 15.43 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.177 0.991 . . . . 2.1499999999999999 110.323 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -104.56 111.47 65.21 Favored Pre-proline 0 N--CA 1.443 -0.814 0 C-N-CA 124.36 1.064 . . . . 1.3700000000000001 110.012 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.06 11.65 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.738 2.959 . . . . 0.68000000000000005 113.852 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.55 -48.0 12.37 Favored 'General case' 0 C--N 1.337 0.051 0 N-CA-C 107.416 -1.327 . . . . 0.60999999999999999 107.416 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -84.28 -47.35 10.87 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.999 1.32 . . . . 2.48 109.471 171.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.6 m -144.22 127.22 16.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 118.509 2.781 . . . . 0.69999999999999996 118.509 -146.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.44 -152.78 7.64 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.687 -0.965 . . . . 0.53000000000000003 110.687 158.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -28.76 -48.78 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 129.08 2.952 . . . . 1.1200000000000001 113.804 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.23 -55.37 18.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.705 0.684 . . . . 0.46000000000000002 112.527 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -40.24 63.78 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 122.425 1.107 . . . . 0.28000000000000003 108.418 -176.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.644 HG13 HD22 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -67.57 -49.98 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-N 114.131 -1.395 . . . . 1.2 111.312 -169.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.08 -51.1 56.62 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.592 1.542 . . . . 0.85999999999999999 110.279 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -45.38 -53.55 8.47 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.057 0.943 . . . . 2.3799999999999999 111.94 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -43.47 71.13 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 118.2 -0.905 . . . . 1.97 111.222 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.712 HD11 HD11 ' A' ' 28' ' ' LEU . 10.7 mm -50.88 -47.35 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.53 1.059 . . . . 0.58999999999999997 109.156 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -51.86 -48.02 64.2 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.978 0.418 . . . . 1.48 110.43 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -69.1 -34.56 75.29 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.437 -0.789 . . . . 3.3199999999999998 112.575 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.95 -21.96 13.46 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 122.97 0.508 . . . . 0.88 110.605 168.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.78 29.93 8.34 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.169 -1.172 . . . . 0.35999999999999999 110.169 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -137.67 170.88 15.3 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.372 -1.344 . . . . 2.0899999999999999 107.372 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.83 127.68 45.36 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.882 0.873 . . . . 4.0899999999999999 108.964 172.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.43 149.38 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 125.911 1.684 . . . . 0.52000000000000002 109.541 172.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.2 m -118.44 134.18 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 C-N-CA 123.797 0.839 . . . . 0.93000000000000005 109.828 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.1 mm -107.17 91.39 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.207 -1.405 . . . . 1.0800000000000001 107.207 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -140.12 149.24 42.8 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.845 -2.28 . . . . 4.6200000000000001 104.845 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 143.68 -65.31 0.47 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.815 -1.314 . . . . 4.0099999999999998 109.815 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 . . . . . 0 C--O 1.25 1.089 0 C-N-CA 126.784 2.034 . . . . 9.0999999999999996 105.565 176.06 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 106.722 -1.585 . . . . 10.890000000000001 106.722 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mp -149.2 171.21 16.84 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 105.658 -1.978 . . . . 5.4800000000000004 105.658 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 p -151.13 153.06 34.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.102 -1.814 . . . . 3.0699999999999998 106.102 172.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -162.96 138.88 7.05 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.76 -1.571 . . . . 3.6400000000000001 106.76 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -106.8 172.69 6.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.465 0.706 . . . . 0.66000000000000003 111.101 -172.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -147.53 162.55 38.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.186 0.517 . . . . 2.4199999999999999 110.752 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -83.07 143.44 30.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 113.596 -1.638 . . . . 2.5899999999999999 107.359 163.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -125.33 148.2 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 105.609 -1.997 . . . . 1.24 105.609 161.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.89 124.34 20.73 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.772 1.229 . . . . 0.40000000000000002 108.543 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -156.33 161.63 40.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.425 0.29 . . . . 1.25 111.62 -170.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.11 146.71 24.43 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.56 1.144 . . . . 1.74 109.934 -169.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.75 141.35 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.094 0.558 . . . . 0.77000000000000002 110.273 -176.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -84.4 117.82 23.86 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.372 -1.344 . . . . 1.05 107.372 170.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.79 77.16 1.25 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.029 -0.828 . . . . 2.6600000000000001 111.029 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.7 ptm -135.42 -171.96 2.96 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.59 1.556 . . . . 4.0800000000000001 107.744 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.0 t 49.12 29.55 2.57 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.955 1.302 . . . . 7.0 114.388 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.1 t -125.65 48.25 2.09 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.28 0.562 . . . . 7.04 110.036 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 84.14 79.52 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.534 2.334 . . . . 3.29 111.794 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 57.34 29.28 16.6 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.956 1.302 . . . . 1.2 112.853 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.5 m -71.27 -62.13 1.51 Allowed 'General case' 0 C--O 1.222 -0.361 0 O-C-N 122.064 -0.398 . . . . 1.5 110.017 -170.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.2 -39.92 67.11 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.089 0.404 . . . . 0.95999999999999996 111.063 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.69 -58.73 6.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 122.929 0.492 . . . . 0.44 110.924 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -58.28 -49.55 76.74 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.339 0.655 . . . . 4.1299999999999999 111.609 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.6 mt -47.38 -59.24 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.094 1.358 . . . . 0.68000000000000005 109.056 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.401 ' OE2' HD12 ' A' ' 28' ' ' LEU . 1.1 tm-20 -68.0 -44.31 76.88 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 119.868 -0.733 . . . . 3.71 109.038 -175.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -50.64 -36.66 36.55 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.701 -1.249 . . . . 1.4299999999999999 112.289 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.22 -48.07 82.89 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 112.011 -0.435 . . . . 0.39000000000000001 112.011 168.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.785 HD11 HD11 ' A' ' 64' ' ' ILE . 39.0 mt -64.38 -30.04 71.09 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 120.846 -1.385 . . . . 0.64000000000000001 112.154 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.554 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.27 16.6 ttmt -59.27 -18.6 38.85 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.821 1.191 . . . . 1.1899999999999999 111.666 171.099 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -17.89 59.95 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.9 -1.125 . . . . 3.3999999999999999 114.022 168.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.493 ' O ' HG12 ' A' ' 34' ' ' VAL . 92.9 mmm -74.65 135.07 75.17 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 120.419 1.463 . . . . 2.04 112.901 -172.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.73 95.21 0.63 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.934 3.089 . . . . 0.46000000000000002 111.737 -171.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.53 -18.95 2.24 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.55 -1.02 . . . . 0.20000000000000001 110.55 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 29' ' ' LYS . 4.2 p -66.88 155.25 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 O-C-N 121.939 -0.741 . . . . 0.28999999999999998 110.817 168.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.7 -59.99 1.76 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.065 0.946 . . . . 0.47999999999999998 109.776 168.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -146.25 142.1 28.02 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 114.309 1.226 . . . . 2.2799999999999998 114.309 -171.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.53 139.44 48.97 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.233 1.813 . . . . 0.79000000000000004 109.888 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -143.77 113.48 7.1 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.864 -0.791 . . . . 1.3100000000000001 108.864 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -81.57 142.25 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.295 0.638 . . . . 0.88 110.414 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -129.79 68.8 1.43 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.582 1.553 . . . . 1.3600000000000001 111.333 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.5 mt -62.09 -21.42 64.96 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 121.896 -0.503 . . . . 1.22 112.353 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.17 -20.21 16.84 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.806 0.442 . . . . 0.94999999999999996 111.179 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 m -130.71 18.5 5.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.316 1.046 . . . . 0.71999999999999997 110.041 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 35.23 55.85 0.81 Allowed 'General case' 0 C--N 1.345 0.382 0 C-N-CA 124.404 1.082 . . . . 3.8399999999999999 111.659 -170.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.5 m -143.89 154.36 43.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.423 -1.695 . . . . 0.5 106.423 -175.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.56 146.97 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.167 -0.679 . . . . 0.52000000000000002 109.167 171.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -115.96 143.87 44.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.999 1.32 . . . . 2.48 108.525 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.39 141.1 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 109.699 -0.482 . . . . 0.39000000000000001 109.699 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.4 mt -100.64 122.26 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.53 1.932 . . . . 0.68999999999999995 106.99 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -146.7 167.52 23.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.681 0.792 . . . . 1.76 110.337 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -100.54 113.02 65.44 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 114.786 -1.097 . . . . 2.1200000000000001 110.432 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -69.26 10.24 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.246 3.297 . . . . 0.66000000000000003 114.107 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.43 -50.76 8.52 Favored 'General case' 0 N--CA 1.458 -0.073 0 N-CA-C 107.436 -1.32 . . . . 0.63 107.436 173.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -92.19 -35.08 14.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.635 1.574 . . . . 3.3199999999999998 111.076 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.9 m -146.4 130.25 17.17 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 117.742 2.497 . . . . 0.54000000000000004 117.742 -157.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.94 -156.66 10.75 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.983 -1.247 . . . . 0.57999999999999996 109.983 155.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -29.21 -51.4 0.1 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.867 2.867 . . . . 0.64000000000000001 112.744 175.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.9 -55.69 9.29 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.074 0.768 . . . . 0.26000000000000001 113.074 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -38.58 64.83 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 122.047 0.927 . . . . 0.20999999999999999 108.726 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.454 HG12 HD22 ' A' ' 28' ' ' LEU . 2.5 mt -65.25 -54.0 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 114.37 -1.286 . . . . 0.68999999999999995 110.894 -169.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.53 -51.86 25.4 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.101 1.319 . . . . 0.73999999999999999 110.158 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -48.53 -47.78 38.87 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.916 1.286 . . . . 4.7300000000000004 112.195 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.66 -42.85 63.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 118.774 -0.631 . . . . 2.6699999999999999 112.479 174.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.785 HD11 HD11 ' A' ' 28' ' ' LEU . 11.1 mm -52.24 -45.13 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 119.544 1.065 . . . . 0.45000000000000001 109.974 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -49.06 -44.38 41.78 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.31 0.576 . . . . 1.5800000000000001 110.71 173.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -38.61 75.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.79 0.836 . . . . 3.6899999999999999 111.799 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.42 -25.71 26.4 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 119.431 -0.318 . . . . 0.96999999999999997 110.636 170.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.1 25.87 5.69 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 124.469 1.033 . . . . 0.40000000000000002 111.264 169.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -145.58 164.81 30.52 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 106.748 -1.575 . . . . 2.1600000000000001 106.748 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 129.12 54.99 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 103.747 -2.686 . . . . 3.1899999999999999 103.747 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.62 139.14 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.106 -0.701 . . . . 0.53000000000000003 109.106 171.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -93.92 164.06 2.15 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 109.212 -0.662 . . . . 1.3700000000000001 109.212 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.6 mm -128.24 77.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.025 -1.102 . . . . 1.1599999999999999 108.025 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -129.44 146.82 51.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.86 1.264 . . . . 4.9900000000000002 108.156 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.46 -69.63 0.07 OUTLIER Glycine 0 CA--C 1.527 0.813 0 N-CA-C 107.447 -2.261 . . . . 4.6900000000000004 107.447 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 116.821 -1.561 . . . . 10.81 110.776 178.552 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.4 mtt . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 118.113 -0.946 . . . . 11.970000000000001 113.492 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 tt -164.56 -49.03 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.978 1.263 . . . . 6.1600000000000001 109.972 -164.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.9 p -140.32 127.48 21.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.333 -1.729 . . . . 2.7599999999999998 106.333 170.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -153.11 141.56 20.73 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.278 -1.008 . . . . 4.2800000000000002 108.278 -175.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -87.97 171.69 10.13 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.252 1.021 . . . . 0.68000000000000005 111.677 -170.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.97 162.5 39.2 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.411 1.1 . . . . 2.6899999999999999 111.685 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -84.24 143.96 29.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 130.252 3.421 . . . . 2.8199999999999998 106.727 170.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 tp -130.1 151.66 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.309 -1.737 . . . . 1.1399999999999999 106.309 162.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.78 129.12 24.03 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.461 1.104 . . . . 0.38 108.981 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.69 173.58 16.75 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 119.384 -0.341 . . . . 1.1299999999999999 111.87 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.64 155.91 18.5 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 109.077 -0.712 . . . . 2.1200000000000001 109.077 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.01 157.35 16.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 N-CA-C 108.124 -1.065 . . . . 0.65000000000000002 108.124 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t -129.07 126.08 38.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.31 -0.996 . . . . 0.92000000000000004 108.31 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.1 -18.05 12.48 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.088 1.328 . . . . 1.4299999999999999 113.205 174.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.82 146.63 10.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.161 0.984 . . . . 3.29 112.384 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.7 p -125.03 29.78 6.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.747 1.219 . . . . 3.5800000000000001 110.769 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.6 t 49.89 -137.63 1.04 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.477 -1.249 . . . . 4.0199999999999996 111.535 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 37.31 55.13 1.36 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.658 1.572 . . . . 2.48 113.051 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.38 20.35 4.65 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.2 1.4 . . . . 1.3400000000000001 114.062 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.6 m -73.67 -60.21 2.36 Favored 'General case' 0 CA--C 1.521 -0.166 0 O-C-N 121.292 -0.88 . . . . 1.6699999999999999 109.81 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.33 -30.89 67.06 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 121.344 0.592 . . . . 0.85999999999999999 111.856 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.28 -42.87 64.08 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 122.014 -0.429 . . . . 0.44 111.023 170.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.7 mtp-105 -63.14 -45.66 90.91 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.583 0.629 . . . . 5.0700000000000003 110.58 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -49.64 -59.63 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 108.192 -1.04 . . . . 0.65000000000000002 108.192 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.94 -35.53 72.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.72 -0.673 . . . . 2.6099999999999999 110.665 -171.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -56.2 -36.1 68.03 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 120.894 -1.129 . . . . 1.24 111.155 171.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.52 -47.34 57.43 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.658 -0.977 . . . . 0.33000000000000002 110.658 167.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.684 HD11 HD11 ' A' ' 64' ' ' ILE . 94.8 mt -67.68 -28.73 67.94 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.384 -1.068 . . . . 0.33000000000000002 112.747 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.558 ' HA ' HG11 ' A' ' 34' ' ' VAL . 2.3 ttmt -58.49 -17.71 23.22 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.403 1.002 . . . . 1.5700000000000001 111.398 169.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -91.42 6.27 46.12 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.97 1.1 . . . . 3.2400000000000002 113.97 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.496 ' O ' HG12 ' A' ' 34' ' ' VAL . 34.4 mmt -85.57 135.28 38.56 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 120.499 1.5 . . . . 2.4500000000000002 112.45 171.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.03 84.11 1.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.666 2.911 . . . . 0.78000000000000003 112.301 -168.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.01 -16.43 0.91 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.486 1.041 . . . . 0.31 111.832 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.558 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.8 p -59.22 154.23 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.647 -0.914 . . . . 0.28999999999999998 111.501 168.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.69 -61.32 1.76 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.787 1.235 . . . . 0.53000000000000003 108.926 169.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -149.77 149.53 30.68 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 114.329 1.233 . . . . 2.5600000000000001 114.329 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.65 119.91 25.57 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.025 1.73 . . . . 0.96999999999999997 109.334 -170.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -134.28 111.72 10.46 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.151 0.98 . . . . 1.3899999999999999 108.431 -172.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -84.28 139.02 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 123.072 0.549 . . . . 0.81999999999999995 110.824 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -125.74 64.6 1.19 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.839 2.056 . . . . 1.25 110.636 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.8 mt -65.9 -16.96 64.32 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 112.67 0.618 . . . . 0.77000000000000002 112.67 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.1 -22.77 11.78 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.69 0.396 . . . . 0.63 110.712 168.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.4 m -127.14 17.78 7.15 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.268 1.427 . . . . 0.48999999999999999 110.163 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 47.66 35.8 4.88 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.138 0.975 . . . . 2.4199999999999999 112.374 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.7 m -131.79 153.29 50.26 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.434 -1.321 . . . . 0.55000000000000004 107.434 -169.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.95 146.48 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.013 -0.736 . . . . 0.48999999999999999 109.013 173.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -115.91 137.44 52.1 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.687 -1.227 . . . . 2.4900000000000002 107.687 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.95 140.69 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 108.683 -0.858 . . . . 0.29999999999999999 108.683 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.6 mt -105.2 132.07 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.814 1.645 . . . . 0.90000000000000002 106.836 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -152.59 163.93 38.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.62 0.768 . . . . 1.8300000000000001 110.774 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -92.82 110.57 46.43 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 124.158 0.983 . . . . 1.45 109.517 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.6 15.56 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.638 2.892 . . . . 0.62 113.501 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.8 -52.72 5.84 Favored 'General case' 0 CA--C 1.526 0.049 0 N-CA-C 107.57 -1.27 . . . . 0.59999999999999998 107.57 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -88.96 -45.75 9.43 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.538 1.535 . . . . 2.9700000000000002 110.406 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.6 m -131.59 129.24 40.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 116.886 2.18 . . . . 0.59999999999999998 116.886 -158.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.83 -162.6 16.2 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 110.181 -1.168 . . . . 0.47999999999999998 110.181 159.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.9 t -35.93 -41.67 0.24 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.523 2.729 . . . . 0.63 112.732 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.19 -56.22 9.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.305 0.642 . . . . 0.28000000000000003 112.46 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.22 -39.03 65.83 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 122.201 1.001 . . . . 0.23999999999999999 108.99 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.536 HG12 HD22 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -61.45 -56.66 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.275 -1.33 . . . . 0.72999999999999998 109.872 -171.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.84 -54.21 8.46 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.557 1.071 . . . . 0.83999999999999997 110.428 174.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 1.4 tm-20 -44.59 -52.1 8.4 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.628 0.728 . . . . 2.1899999999999999 111.547 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -45.06 64.18 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 117.958 -1.02 . . . . 1.9299999999999999 110.735 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.684 HD11 HD11 ' A' ' 28' ' ' LEU . 23.3 mm -51.29 -46.89 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 120.024 1.284 . . . . 0.48999999999999999 110.173 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -52.0 -47.06 65.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.492 0.717 . . . . 1.8 109.753 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.401 ' NZ ' ' OE2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -68.99 -37.61 78.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.275 0.63 . . . . 4.6399999999999997 111.522 -176.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -55.97 -22.38 26.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.068 0.947 . . . . 0.92000000000000004 110.665 170.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.41 29.79 6.52 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 124.289 0.947 . . . . 0.33000000000000002 110.868 173.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -141.4 174.22 10.75 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 108.619 -0.882 . . . . 1.7 108.619 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.13 117.54 18.43 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.815 -1.179 . . . . 4.29 107.815 -175.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 p -84.2 145.29 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.247 -0.888 . . . . 0.62 108.731 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.78 112.37 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 124.649 1.18 . . . . 1.47 110.237 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.8 mt -120.34 96.4 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 126.481 1.913 . . . . 1.73 106.698 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -112.92 117.0 30.88 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.467 -1.308 . . . . 5.1299999999999999 107.467 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.72 -145.29 16.81 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.22 0.914 . . . . 5.3300000000000001 110.949 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.168 0 CA-C-O 116.072 -1.918 . . . . 8.75 106.188 172.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mtt . . . . . 0 N--CA 1.474 0.775 0 CA-C-O 118.655 -0.688 . . . . 9.0 109.659 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 tp -108.58 -79.55 0.58 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.461 -0.94 . . . . 6.4699999999999998 108.461 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 p -166.19 153.04 9.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 105.427 -2.064 . . . . 3.2000000000000002 105.427 171.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -170.2 139.0 1.7 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.195 -2.15 . . . . 3.98 105.195 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -117.95 160.88 20.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.33 0.652 . . . . 0.71999999999999997 109.897 -171.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -146.24 157.66 43.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.573 0.701 . . . . 2.6899999999999999 111.367 -173.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -83.89 144.82 28.96 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 125.469 1.508 . . . . 2.4900000000000002 108.318 167.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 tp -122.13 153.31 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.056 -1.831 . . . . 1.1000000000000001 106.056 160.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.0 126.17 19.89 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.998 1.319 . . . . 0.34000000000000002 107.85 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.26 165.9 35.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.453 0.701 . . . . 2.3199999999999998 112.16 -174.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.66 147.58 23.75 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.608 1.163 . . . . 1.7 109.044 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -115.63 164.11 12.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 123.438 0.695 . . . . 0.64000000000000001 109.776 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -128.27 130.83 48.48 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.538 0.735 . . . . 0.76000000000000001 109.36 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.24 -16.57 24.74 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.538 1.066 . . . . 1.49 113.164 173.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.55 150.89 14.54 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.097 0.948 . . . . 2.9900000000000002 111.724 176.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.8 p -130.0 33.63 4.36 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.761 0.791 . . . . 3.48 110.556 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.5 t 58.47 -130.57 1.29 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 117.776 -1.107 . . . . 4.1500000000000004 110.05 -172.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 29.21 59.16 0.15 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.286 1.834 . . . . 2.4500000000000002 114.441 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 52.58 24.09 2.93 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.32 1.448 . . . . 1.26 114.19 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.9 m -73.51 -61.81 1.7 Allowed 'General case' 0 CA--C 1.521 -0.137 0 O-C-N 121.311 -0.868 . . . . 1.46 110.009 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.05 -28.16 69.9 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 121.586 0.708 . . . . 0.82999999999999996 111.608 -175.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.03 -44.08 41.18 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.09 -0.504 . . . . 0.34000000000000002 111.046 169.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 mtm105 -65.06 -41.45 95.09 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 118.258 0.481 . . . . 6.8300000000000001 111.175 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.0 mt -51.72 -59.13 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.127 -1.064 . . . . 0.56000000000000005 108.127 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.94 -36.77 72.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 120.046 -0.662 . . . . 2.2799999999999998 111.147 -171.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -50.99 -40.33 57.78 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.318 -0.864 . . . . 1.6299999999999999 110.558 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.79 -48.09 57.55 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.127 -0.789 . . . . 0.38 111.127 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 64' ' ' ILE . 96.9 mt -67.93 -32.4 72.83 Favored 'General case' 0 CA--C 1.519 -0.25 0 O-C-N 121.244 -1.15 . . . . 0.34999999999999998 112.693 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.511 ' HA ' HG11 ' A' ' 34' ' ' VAL . 11.5 ttpt -59.54 -17.1 29.45 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.949 0.795 . . . . 1.6599999999999999 110.63 171.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 mtt-85 -91.86 -0.05 57.5 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.747 -1.221 . . . . 3.2200000000000002 113.622 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.511 ' O ' HG12 ' A' ' 34' ' ' VAL . 5.9 mmt -78.67 142.68 61.79 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 120.804 1.638 . . . . 1.97 111.959 174.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.92 102.92 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.942 2.428 . . . . 0.41999999999999998 110.381 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.11 -4.34 6.37 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.326 1.441 . . . . 0.23999999999999999 110.941 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.511 HG11 ' HA ' ' A' ' 29' ' ' LYS . 6.6 p -70.88 157.21 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.848 -0.795 . . . . 0.28999999999999998 110.658 164.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.91 -63.91 1.38 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 107.623 -1.251 . . . . 0.41999999999999998 107.623 165.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -141.85 157.35 45.1 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 112.004 0.372 . . . . 2.8399999999999999 112.004 -170.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.46 137.07 40.02 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.26 1.824 . . . . 0.58999999999999997 107.414 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -139.55 114.89 9.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.902 1.281 . . . . 1.4199999999999999 108.63 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -83.93 138.2 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.96 0.904 . . . . 0.65000000000000002 110.339 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -132.88 63.71 1.63 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.607 1.563 . . . . 1.1699999999999999 111.376 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.1 mt -67.42 -15.56 63.74 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 113.062 0.764 . . . . 0.90000000000000002 113.062 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.66 -25.63 18.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 117.947 0.34 . . . . 0.70999999999999996 110.529 166.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.5 m -122.65 17.33 10.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.303 1.441 . . . . 0.55000000000000004 110.216 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 47.2 38.32 6.74 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.361 0.982 . . . . 2.7400000000000002 111.836 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.1 m -137.34 154.43 50.05 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.432 -1.322 . . . . 0.5 107.432 -171.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.52 152.58 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.238 -1.023 . . . . 0.44 108.238 170.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.44 150.63 48.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 123.58 0.55 . . . . 2.7400000000000002 109.701 174.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.19 138.07 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.398 -0.964 . . . . 0.25 108.398 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.43 119.99 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 126.05 1.74 . . . . 1.22 108.166 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -145.84 172.79 12.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.635 1.174 . . . . 1.8999999999999999 110.631 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -111.87 118.94 45.59 Favored Pre-proline 0 N--CA 1.447 -0.609 0 C-N-CA 124.186 0.994 . . . . 1.3999999999999999 110.815 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.27 9.73 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.91 3.74 . . . . 0.58999999999999997 114.248 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.21 -40.48 37.36 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 108.437 -0.949 . . . . 0.71999999999999997 108.437 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -112.09 -49.54 2.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.716 1.606 . . . . 3.04 110.25 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.6 m -111.04 128.33 55.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.593 2.757 . . . . 0.91000000000000003 117.145 -168.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.21 -175.48 25.48 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.952 -0.859 . . . . 0.56000000000000005 110.952 156.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -29.17 -45.2 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 128.302 2.641 . . . . 0.85999999999999999 112.958 167.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.23 -55.11 13.64 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.756 0.65 . . . . 0.34000000000000002 112.756 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.23 -40.06 65.0 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 122.256 1.026 . . . . 0.20999999999999999 108.91 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.57 HG12 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -62.27 -57.12 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-N 113.918 -1.492 . . . . 0.57999999999999996 110.241 -171.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.45 -51.09 28.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.621 1.1 . . . . 0.78000000000000003 110.595 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -48.51 -50.19 32.9 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.737 0.815 . . . . 2.5099999999999998 111.287 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -46.15 64.96 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 118.638 -0.696 . . . . 2.1699999999999999 110.888 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 28' ' ' LEU . 18.7 mm -49.79 -47.61 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 119.069 0.85 . . . . 0.44 109.875 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -48.3 -50.4 30.2 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.449 0.642 . . . . 1.48 110.03 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.03 -33.22 70.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 121.671 -0.643 . . . . 3.4100000000000001 112.278 -176.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.83 -25.22 10.83 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 119.337 -0.364 . . . . 0.87 110.285 168.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.84 30.58 4.5 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.527 1.06 . . . . 0.29999999999999999 110.675 170.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -148.4 165.75 30.17 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 105.61 -1.996 . . . . 1.6899999999999999 105.61 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -120.63 140.38 51.64 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 119.1 0.864 . . . . 3.2999999999999998 109.113 166.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.6 p -94.94 141.37 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.803 1.641 . . . . 0.46000000000000002 108.581 172.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 m -97.34 165.64 2.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 108.891 -0.781 . . . . 1.5 108.891 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.7 mm -128.42 77.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.353 -0.98 . . . . 1.1299999999999999 108.353 175.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -111.06 129.63 55.85 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 105.401 -2.074 . . . . 4.2999999999999998 105.401 156.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.14 -125.85 1.15 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 108.994 -1.642 . . . . 3.4900000000000002 108.994 -171.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 . . . . . 0 C--O 1.249 1.042 0 N-CA-C 105.036 -2.209 . . . . 10.19 105.036 175.606 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 117.995 -1.002 . . . . 11.869999999999999 108.497 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 mt 168.37 163.84 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 129.24 3.016 . . . . 6.2000000000000002 105.175 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.5 m 63.65 92.2 0.07 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.673 1.189 . . . . 3.0099999999999998 111.363 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -142.5 150.83 41.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.707 -1.22 . . . . 2.9199999999999999 107.707 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -95.61 175.23 6.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.536 1.134 . . . . 1.23 111.068 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -150.47 164.29 36.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.386 0.612 . . . . 3.0299999999999998 111.095 172.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -83.47 144.94 29.22 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.94 -1.482 . . . . 2.4300000000000002 108.019 163.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -124.05 148.85 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 105.145 -2.169 . . . . 1.24 105.145 162.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.53 120.45 15.46 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 125.302 1.441 . . . . 0.46000000000000002 108.097 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.1 ptt? -156.7 165.14 37.08 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.202 0.455 . . . . 1.02 111.117 -169.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.84 151.96 19.16 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.859 0.864 . . . . 1.76 109.239 -171.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.36 164.59 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 123.519 0.728 . . . . 0.68999999999999995 109.582 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -124.88 124.02 41.17 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.866 1.266 . . . . 0.78000000000000003 109.05 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.66 -16.53 14.02 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.724 1.154 . . . . 1.4299999999999999 113.466 170.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.439 ' HG3' HD22 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -55.14 143.15 28.28 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.145 0.973 . . . . 3.0899999999999999 111.916 177.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.0 p -114.0 21.88 14.43 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.804 0.842 . . . . 3.4199999999999999 111.324 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.542 ' HA ' HD13 ' A' ' 41' ' ' LEU . 37.3 t 71.2 -49.13 0.68 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.561 1.545 . . . . 4.1799999999999997 112.794 -175.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.83 81.32 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.979 1.712 . . . . 2.8300000000000001 112.42 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.67 11.43 3.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.995 2.118 . . . . 1.1100000000000001 113.89 171.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.65 -64.11 0.99 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.542 -0.724 . . . . 1.51 110.832 -164.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.681 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -61.3 -28.8 69.46 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.019 -0.537 . . . . 1.05 110.35 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.14 -54.36 47.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 119.117 -0.468 . . . . 0.44 111.18 173.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -63.42 -46.24 87.27 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.22 0.918 . . . . 3.6099999999999999 110.455 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' A' ' 21' ' ' ALA . 54.8 mt -48.47 -58.53 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.172 -0.677 . . . . 0.83999999999999997 109.172 177.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.408 ' HG3' HG21 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -70.6 -37.37 73.87 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.206 -0.452 . . . . 3.8100000000000001 110.579 -172.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -55.7 -33.92 64.61 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 120.727 -1.233 . . . . 1.24 111.404 174.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.45 -48.91 53.83 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 111.301 -0.719 . . . . 0.31 111.301 166.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.62 HD11 HD11 ' A' ' 64' ' ' ILE . 86.1 mt -64.38 -32.75 74.5 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 118.247 1.023 . . . . 0.38 113.202 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.26 8.9 ttmt -56.15 -17.73 8.04 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.105 0.866 . . . . 1.22 111.575 170.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 8.73 44.05 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.506 1.299 . . . . 4.6900000000000004 114.506 172.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.463 ' O ' HG12 ' A' ' 34' ' ' VAL . 4.4 mtp -85.43 140.58 36.27 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 121.085 1.766 . . . . 2.0299999999999998 110.971 167.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.6 106.28 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.701 2.934 . . . . 0.47999999999999998 111.206 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.44 -18.95 3.63 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.48 -1.048 . . . . 0.27000000000000002 110.48 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 29' ' ' LYS . 8.5 p -69.42 152.22 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.595 0.758 . . . . 0.26000000000000001 110.87 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -58.29 2.16 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.679 1.192 . . . . 0.46999999999999997 109.516 171.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -145.25 150.48 36.76 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 113.01 0.745 . . . . 2.7000000000000002 113.01 -175.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.65 148.45 25.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.907 2.083 . . . . 1.21 109.408 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.38 90.23 1.32 Allowed 'General case' 0 CA--C 1.527 0.074 0 CA-C-O 121.965 0.888 . . . . 2.2999999999999998 110.176 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.24 135.5 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.744 0.818 . . . . 0.81000000000000005 110.445 -173.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -136.74 65.96 1.49 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.0 1.32 . . . . 1.26 111.305 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.542 HD13 ' HA ' ' A' ' 17' ' ' CYS . 86.4 mt -64.93 -18.69 65.44 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 115.917 -0.583 . . . . 1.04 112.512 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.58 -27.85 58.92 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.242 0.474 . . . . 0.92000000000000004 110.668 169.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 m -115.94 18.23 15.64 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.347 1.459 . . . . 0.79000000000000004 110.109 177.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 48.6 35.56 6.31 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.515 1.126 . . . . 2.0699999999999998 112.066 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -143.04 151.97 41.38 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.053 -1.091 . . . . 0.51000000000000001 108.053 -165.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.408 HG21 ' HG3' ' A' ' 25' ' ' GLU . 5.5 p -133.18 148.95 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 109.416 -0.587 . . . . 0.5 109.416 173.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.18 126.38 46.88 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.036 1.334 . . . . 2.4900000000000002 108.148 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.35 138.66 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.938 -0.764 . . . . 0.25 108.938 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.4 mt -99.85 126.9 53.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 107.818 -1.179 . . . . 1.02 107.818 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -150.3 170.15 19.69 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.914 0.486 . . . . 1.9099999999999999 111.096 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -108.49 116.22 56.65 Favored Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 124.34 1.056 . . . . 1.3400000000000001 111.13 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -67.58 5.12 1.06 Allowed 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.916 3.077 . . . . 0.56000000000000005 113.875 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.32 -46.9 25.55 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 107.971 -1.122 . . . . 0.41999999999999998 107.971 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -95.41 -33.21 12.57 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.161 1.384 . . . . 3.46 111.027 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.7 m -155.82 129.97 8.76 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 119.447 3.129 . . . . 0.81999999999999995 119.447 -152.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -158.78 -163.14 12.59 Favored Glycine 0 N--CA 1.438 -1.217 0 N-CA-C 108.78 -1.728 . . . . 0.46000000000000002 108.78 154.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 t -34.04 -40.21 0.08 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.976 2.91 . . . . 0.82999999999999996 113.332 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.83 -56.23 7.93 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.081 0.855 . . . . 0.32000000000000001 113.083 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.83 -34.48 66.84 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 123.022 1.392 . . . . 0.20999999999999999 109.261 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.527 ' CG1' HD22 ' A' ' 28' ' ' LEU 0.252 0.9 OUTLIER -70.03 -51.44 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 CA-C-N 113.506 -1.679 . . . . 0.57999999999999996 111.007 -170.5 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -49.66 55.24 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.982 1.719 . . . . 0.82999999999999996 110.348 173.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -42.88 -58.37 2.41 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 121.775 0.798 . . . . 2.3300000000000001 111.971 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.29 -40.93 73.99 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 119.889 -0.724 . . . . 2.3599999999999999 110.974 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.62 HD11 HD11 ' A' ' 28' ' ' LEU . 15.1 mm -52.59 -46.0 48.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.315 1.046 . . . . 0.40999999999999998 110.283 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -51.38 -47.39 62.87 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.52 -0.548 . . . . 1.8700000000000001 109.52 174.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -70.09 -34.44 73.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 121.416 -0.802 . . . . 3.79 112.789 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.96 -22.0 13.68 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.066 0.394 . . . . 0.92000000000000004 110.751 167.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.91 24.5 8.55 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 124.778 1.18 . . . . 0.40000000000000002 110.739 173.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -140.95 167.72 21.51 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.59 -0.893 . . . . 1.79 108.59 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.95 122.44 40.17 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 103.84 -2.652 . . . . 3.6200000000000001 103.84 -175.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.1 p -100.43 141.39 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 109.663 -0.495 . . . . 0.56999999999999995 109.663 170.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.4 m -98.79 161.65 3.0 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 109.199 -0.667 . . . . 1.1699999999999999 109.199 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.1 mm -128.24 77.56 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 107.455 -1.313 . . . . 1.01 107.455 176.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -120.07 118.39 30.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.615 -1.624 . . . . 4.1799999999999997 106.615 174.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.49 141.56 2.82 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.741 1.162 . . . . 4.8499999999999996 111.051 -171.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.122 0 C-N-CA 127.17 2.188 . . . . 8.2699999999999996 106.056 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 106.606 -1.627 . . . . 11.289999999999999 106.606 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.5 174.0 11.79 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.946 0.794 . . . . 7.21 109.149 171.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -55.57 147.34 18.24 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.852 0.461 . . . . 2.5899999999999999 110.667 174.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -139.94 160.41 39.98 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.602 -1.629 . . . . 3.25 106.602 170.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -112.98 169.74 8.7 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.851 1.26 . . . . 0.59999999999999998 109.452 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -145.83 157.0 43.94 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.686 0.755 . . . . 2.3100000000000001 111.077 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.68 145.73 31.46 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.452 1.901 . . . . 2.2999999999999998 108.054 165.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 tp -127.84 157.11 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.138 -1.801 . . . . 1.1200000000000001 106.138 165.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.05 121.33 9.57 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.884 0.874 . . . . 0.46999999999999997 108.952 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -156.74 167.85 29.22 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.264 0.484 . . . . 1.27 111.396 -174.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.59 156.98 16.75 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.807 0.843 . . . . 1.8100000000000001 111.156 -172.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.79 132.66 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 C-N-CA 123.468 0.707 . . . . 0.67000000000000004 110.517 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -84.44 124.19 31.06 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.91 -0.774 . . . . 1.0800000000000001 108.91 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.07 -76.2 0.41 Allowed Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.822 -1.311 . . . . 2.8100000000000001 109.822 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 8.2 tmm? 38.71 70.09 0.23 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.819 1.648 . . . . 4.2199999999999998 112.703 173.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 p -81.68 18.25 1.28 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.509 1.123 . . . . 3.9199999999999999 111.364 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.3 t 54.86 -138.98 1.04 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.422 1.489 . . . . 3.5600000000000001 111.719 175.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 56.07 -83.13 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.472 1.909 . . . . 3.0899999999999999 112.149 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.19 16.61 0.74 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.956 1.302 . . . . 1.24 110.969 176.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.5 m -72.65 -60.56 2.17 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.478 -0.764 . . . . 1.47 110.039 -166.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.75 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -54.24 -40.25 67.55 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.643 0.735 . . . . 0.68000000000000005 111.364 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.93 -53.0 62.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.841 -0.618 . . . . 0.40000000000000002 110.875 173.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -56.8 -49.36 75.59 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 118.926 -0.559 . . . . 5.2400000000000002 111.705 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 21' ' ' ALA . 72.4 mt -48.33 -59.29 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 108.252 -1.018 . . . . 0.79000000000000004 108.252 177.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -70.06 -35.57 74.33 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.864 -0.734 . . . . 2.5499999999999998 110.39 -171.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp -61.02 -27.35 68.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.908 -1.12 . . . . 1.28 111.44 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.19 -52.56 48.65 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.248 -1.141 . . . . 0.46000000000000002 110.248 162.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.779 HD11 HD11 ' A' ' 64' ' ' ILE . 98.8 mt -63.43 -31.8 73.06 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 113.673 0.99 . . . . 0.40000000000000002 113.673 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -51.1 -19.23 1.04 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.98 0.912 . . . . 1.9299999999999999 111.705 169.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -91.25 -7.23 51.78 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.372 0.878 . . . . 4.1399999999999997 113.372 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.507 ' O ' HG12 ' A' ' 34' ' ' VAL . 26.3 mtp -76.07 139.6 69.22 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 120.212 1.369 . . . . 2.1899999999999999 112.43 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.81 88.99 0.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.603 2.869 . . . . 0.46000000000000002 111.363 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.68 -15.36 2.0 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.745 1.164 . . . . 0.23000000000000001 111.125 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 31' ' ' MET . 6.3 p -65.46 154.51 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 O-C-N 121.422 -1.046 . . . . 0.26000000000000001 110.934 169.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.24 -63.93 1.38 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.564 1.146 . . . . 0.5 108.084 167.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -150.55 137.39 19.12 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 112.368 0.507 . . . . 3.1800000000000002 112.368 -168.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.16 150.66 23.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.806 1.642 . . . . 0.94999999999999996 109.664 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.74 105.66 3.45 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.654 1.182 . . . . 1.9199999999999999 108.684 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.37 137.79 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.212 0.605 . . . . 0.56999999999999995 110.698 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -131.76 66.57 1.54 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.701 1.601 . . . . 1.21 111.083 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.1 mt -67.0 -19.09 65.66 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 115.918 -0.583 . . . . 0.72999999999999998 112.17 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.76 -11.66 8.29 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.629 0.772 . . . . 0.65000000000000002 111.665 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 m -135.31 17.82 3.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.37 1.068 . . . . 0.46000000000000002 109.525 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 44.85 39.53 3.64 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.058 1.343 . . . . 3.3100000000000001 111.957 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.1 m -134.37 155.28 50.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.542 -1.281 . . . . 0.48999999999999999 107.542 -170.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 p -131.96 143.13 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 109.136 -0.69 . . . . 0.47999999999999998 109.136 172.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.36 141.68 43.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.651 1.58 . . . . 2.4900000000000002 106.836 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.44 144.19 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 108.501 -0.926 . . . . 0.33000000000000002 108.501 171.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.7 mt -112.13 121.21 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 125.996 1.718 . . . . 0.72999999999999998 107.069 -174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -144.39 166.1 26.05 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.892 0.877 . . . . 1.98 110.818 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -95.38 109.71 46.7 Favored Pre-proline 0 N--CA 1.445 -0.701 0 C-N-CA 124.727 1.211 . . . . 1.45 109.564 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -71.18 12.89 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.688 2.925 . . . . 0.69999999999999996 113.659 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.75 -48.47 10.08 Favored 'General case' 0 C--N 1.337 0.025 0 N-CA-C 107.647 -1.242 . . . . 0.73999999999999999 107.647 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -89.5 -40.33 12.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.886 1.275 . . . . 2.6200000000000001 111.026 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.1 m -143.79 126.85 16.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 117.5 2.407 . . . . 0.56000000000000005 117.5 -152.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.72 -159.55 10.23 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 109.207 -1.557 . . . . 0.55000000000000004 109.207 156.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.4 t -33.71 -42.93 0.12 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.248 2.619 . . . . 0.75 113.134 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.49 -56.25 8.79 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.977 0.808 . . . . 0.33000000000000002 112.683 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.76 -35.89 62.58 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 122.113 0.959 . . . . 0.26000000000000001 109.369 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.642 HG12 HD22 ' A' ' 28' ' ' LEU 0.254 0.8 OUTLIER -64.93 -55.52 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 114.358 -1.292 . . . . 0.57999999999999996 110.245 -174.496 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -49.88 45.83 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 120.553 1.524 . . . . 0.83999999999999997 111.315 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -38.82 -57.35 1.23 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.051 0.929 . . . . 2.7200000000000002 112.902 171.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -71.77 -41.53 68.25 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.606 -0.725 . . . . 2.1299999999999999 109.827 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.779 HD11 HD11 ' A' ' 28' ' ' LEU . 37.8 mm -55.13 -45.09 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 119.413 1.006 . . . . 0.44 110.436 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -52.35 -54.18 34.99 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.547 1.139 . . . . 1.6399999999999999 109.241 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -45.94 85.15 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.479 0.548 . . . . 4.1299999999999999 112.479 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mp -55.07 -19.32 6.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.815 1.646 . . . . 2.3700000000000001 111.789 172.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.72 24.91 7.9 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.343 0.973 . . . . 0.44 111.346 169.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -139.22 175.44 9.56 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 108.879 -0.786 . . . . 2.1699999999999999 108.879 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.29 123.05 27.51 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.51 -1.663 . . . . 4.29 106.51 175.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -87.96 145.42 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.19 -0.67 . . . . 0.72999999999999998 109.19 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.33 166.95 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.904 -0.776 . . . . 1.46 108.904 168.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.1 mm -127.03 89.1 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 107.442 -1.318 . . . . 1.1000000000000001 107.442 168.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -147.39 88.89 1.74 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.341 -1.726 . . . . 4.2000000000000002 106.341 176.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.77 50.58 0.04 OUTLIER Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.612 -0.595 . . . . 5.6100000000000003 111.612 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 . . . . . 0 C--O 1.251 1.168 0 CA-C-O 117.904 -1.046 . . . . 9.9399999999999995 109.728 -169.633 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtm . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 105.893 -1.892 . . . . 9.8699999999999992 105.893 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 mp -95.72 118.27 32.07 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 120.115 1.325 . . . . 6.9500000000000002 109.041 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.5 t -145.27 152.67 40.3 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 104.476 -2.416 . . . . 4.5899999999999999 104.476 161.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -157.4 147.58 20.81 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.114 -1.439 . . . . 4.0899999999999999 107.114 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -84.1 162.45 20.29 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 123.541 0.526 . . . . 1.0 110.609 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -150.54 156.64 41.79 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.372 0.606 . . . . 2.9900000000000002 110.093 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -84.07 114.15 21.55 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.867 2.067 . . . . 2.2999999999999998 106.683 169.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -96.96 155.37 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 106.416 -1.698 . . . . 1.1299999999999999 106.416 167.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.93 137.69 34.99 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.855 -0.794 . . . . 0.5 108.855 170.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.18 169.25 25.2 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.638 0.586 . . . . 1.25 111.995 175.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.429 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -91.56 153.46 19.74 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.498 1.119 . . . . 1.9099999999999999 110.723 -175.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.85 134.99 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 123.098 0.559 . . . . 0.90000000000000002 111.656 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.3 t -92.06 130.96 37.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.112 0.965 . . . . 0.83999999999999997 109.293 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.77 -13.22 24.82 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.324 0.964 . . . . 1.45 113.336 172.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.619 ' HG3' HD22 ' A' ' 41' ' ' LEU . 10.1 tmm? -48.77 114.47 0.99 Allowed 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.225 1.01 . . . . 4.4500000000000002 110.65 172.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -139.98 24.8 2.35 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.797 0.839 . . . . 4.29 110.676 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.4 m -138.98 -154.25 0.51 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.124 1.37 . . . . 6.5099999999999998 108.087 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.65 -3.1 14.37 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.982 0.913 . . . . 4.7699999999999996 112.281 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.79 38.47 0.42 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.873 0.761 . . . . 2.0499999999999998 111.827 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -71.58 -61.99 1.58 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.152 0.581 . . . . 1.8999999999999999 109.549 172.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.486 ' CB ' HD21 ' A' ' 41' ' ' LEU . . . -51.82 -36.49 48.16 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 123.473 0.709 . . . . 1.3600000000000001 111.3 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.02 -54.16 22.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.009 0.523 . . . . 0.68000000000000005 111.598 173.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -69.9 -45.86 66.69 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.488 0.715 . . . . 4.75 110.099 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -50.75 -54.14 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.367 -0.605 . . . . 0.83999999999999997 109.367 177.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -69.62 -42.92 73.69 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.505 -0.554 . . . . 3.79 109.505 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -51.61 -36.93 47.78 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.175 -1.578 . . . . 1.6000000000000001 111.809 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.28 -52.96 37.25 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 111.543 -0.623 . . . . 0.52000000000000002 111.543 166.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 64' ' ' ILE . 87.3 mt -61.3 -29.46 69.89 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.1 -1.236 . . . . 0.63 113.289 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.56 ' HA ' HG11 ' A' ' 34' ' ' VAL . 4.2 ttmm -59.9 -18.75 47.21 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.151 1.342 . . . . 1.49 111.715 172.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -16.55 57.83 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.885 1.068 . . . . 4.5999999999999996 113.885 169.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.496 ' O ' HG12 ' A' ' 34' ' ' VAL . 83.8 mmm -72.12 135.79 82.3 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 120.031 1.287 . . . . 2.0499999999999998 111.431 -174.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.58 101.32 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.042 2.494 . . . . 0.35999999999999999 110.711 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.31 -15.12 3.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 119.459 1.027 . . . . 0.25 110.809 176.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 29' ' ' LYS . 5.2 p -69.17 153.31 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 O-C-N 122.312 -0.523 . . . . 0.26000000000000001 109.941 166.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.65 -61.04 1.76 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.126 -1.064 . . . . 0.45000000000000001 108.126 162.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -141.42 145.98 35.98 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 113.527 0.936 . . . . 3.3900000000000001 113.527 -168.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.64 150.9 26.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.758 1.623 . . . . 1.1699999999999999 108.551 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.86 101.54 2.91 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.77 0.828 . . . . 1.96 108.785 175.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.95 141.54 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.828 0.851 . . . . 1.0700000000000001 110.997 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -139.11 66.04 1.43 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.137 1.375 . . . . 1.27 111.429 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.619 HD22 ' HG3' ' A' ' 15' ' ' MET . 56.2 mt -67.04 -13.82 62.29 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 113.342 0.867 . . . . 1.05 113.342 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.36 -25.52 9.98 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.578 0.351 . . . . 0.96999999999999997 110.886 165.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.8 m -125.17 17.92 8.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.343 1.457 . . . . 0.69999999999999996 110.157 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 48.18 33.39 3.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.414 1.086 . . . . 2.48 112.156 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -131.66 149.24 52.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.29 -1.004 . . . . 0.60999999999999999 108.29 -168.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -134.02 144.45 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 109.399 -0.593 . . . . 0.55000000000000004 109.399 174.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -112.11 145.08 40.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.052 1.741 . . . . 2.3799999999999999 108.096 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.52 136.44 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.011 -0.737 . . . . 0.32000000000000001 109.011 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.36 119.17 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.694 1.597 . . . . 0.98999999999999999 107.535 178.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -144.49 167.81 21.61 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.009 0.923 . . . . 1.79 110.712 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -108.26 122.88 39.16 Favored Pre-proline 0 N--CA 1.451 -0.416 0 O-C-N 124.211 0.944 . . . . 1.47 110.888 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.79 5.05 1.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.931 3.088 . . . . 0.58999999999999997 113.544 -177.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.74 -55.28 6.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.419 -1.326 . . . . 0.40000000000000002 107.419 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -84.04 -42.57 16.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.526 1.13 . . . . 3.6800000000000002 110.54 172.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.8 m -143.27 131.6 22.11 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 119.175 3.028 . . . . 0.64000000000000001 119.175 -143.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.06 -159.55 18.67 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.13 -1.188 . . . . 0.51000000000000001 110.13 159.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -30.66 -47.63 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.839 2.855 . . . . 0.56000000000000005 112.845 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.86 -56.27 7.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.396 0.678 . . . . 0.26000000000000001 112.488 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.65 -38.49 64.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.197 0.999 . . . . 0.17999999999999999 109.393 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.492 HG12 HD13 ' A' ' 28' ' ' LEU . 1.7 mt -64.75 -55.36 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.465 -1.243 . . . . 0.62 110.377 -170.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.98 -50.02 59.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.923 1.238 . . . . 0.77000000000000002 110.695 177.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -43.7 -56.14 3.96 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.712 0.805 . . . . 2.1299999999999999 112.023 175.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -41.48 72.57 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.559 -0.856 . . . . 1.6899999999999999 110.586 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.603 HD11 HD11 ' A' ' 28' ' ' LEU . 14.6 mm -52.42 -46.05 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 119.489 1.04 . . . . 0.34999999999999998 110.019 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -50.82 -46.69 59.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.041 0.448 . . . . 1.8600000000000001 110.098 174.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -32.89 70.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 114.015 1.117 . . . . 3.1299999999999999 114.015 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.65 -21.23 25.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.548 0.613 . . . . 0.88 110.571 166.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.93 27.3 8.4 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.768 -0.933 . . . . 0.32000000000000001 110.768 173.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -140.39 173.67 11.28 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.181 -1.044 . . . . 1.72 108.181 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 122.88 31.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.702 -1.592 . . . . 4.1600000000000001 106.702 176.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 p -89.92 145.78 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.906 -0.776 . . . . 0.55000000000000004 108.906 171.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.81 164.16 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.289 -0.634 . . . . 1.27 109.289 170.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.4 mm -123.17 104.16 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.023 -1.843 . . . . 1.0 106.023 165.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.12 71.16 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.047 1.339 . . . . 7.9900000000000002 112.614 173.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.37 -58.53 0.2 Allowed Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.22 -0.925 . . . . 6.2000000000000002 113.856 169.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.0 ttp85 . . . . . 0 C--O 1.251 1.177 0 CA-C-O 117.249 -1.358 . . . . 12.69 108.531 -168.097 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtm . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 105.893 -1.892 . . . . 9.8699999999999992 105.893 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 mp -95.72 118.27 32.07 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 120.115 1.325 . . . . 6.9500000000000002 109.041 174.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.5 t -145.27 152.67 40.3 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 104.476 -2.416 . . . . 4.5899999999999999 104.476 161.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -157.4 147.58 20.81 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.114 -1.439 . . . . 4.0899999999999999 107.114 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -84.1 162.45 20.29 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 123.541 0.526 . . . . 1.0 110.609 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -150.54 156.64 41.79 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.372 0.606 . . . . 2.9900000000000002 110.093 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -84.07 114.15 21.55 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.867 2.067 . . . . 2.2999999999999998 106.683 169.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -96.96 155.37 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 106.416 -1.698 . . . . 1.1299999999999999 106.416 167.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.93 137.69 34.99 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.855 -0.794 . . . . 0.5 108.855 170.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.18 169.25 25.2 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.638 0.586 . . . . 1.25 111.995 175.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.429 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -91.56 153.46 19.74 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.498 1.119 . . . . 1.9099999999999999 110.723 -175.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.85 134.99 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 123.098 0.559 . . . . 0.90000000000000002 111.656 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.3 t -92.06 130.96 37.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.112 0.965 . . . . 0.83999999999999997 109.293 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.77 -13.22 24.82 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.324 0.964 . . . . 1.45 113.336 172.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.619 ' HG3' HD22 ' A' ' 41' ' ' LEU . 10.1 tmm? -48.77 114.47 0.99 Allowed 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.225 1.01 . . . . 4.4500000000000002 110.65 172.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -139.98 24.8 2.35 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.797 0.839 . . . . 4.29 110.676 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.4 m -138.98 -154.25 0.51 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.124 1.37 . . . . 6.5099999999999998 108.087 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.65 -3.1 14.37 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.982 0.913 . . . . 4.7699999999999996 112.281 171.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.79 38.47 0.42 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.873 0.761 . . . . 2.0499999999999998 111.827 -174.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -71.58 -61.99 1.58 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.152 0.581 . . . . 1.8999999999999999 109.549 172.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.486 ' CB ' HD21 ' A' ' 41' ' ' LEU . . . -51.82 -36.49 48.16 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 123.473 0.709 . . . . 1.3600000000000001 111.3 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.02 -54.16 22.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.009 0.523 . . . . 0.68000000000000005 111.598 173.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -69.9 -45.86 66.69 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.488 0.715 . . . . 4.75 110.099 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -50.75 -54.14 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.367 -0.605 . . . . 0.83999999999999997 109.367 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -69.62 -42.92 73.69 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.505 -0.554 . . . . 3.79 109.505 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -51.61 -36.93 47.78 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.175 -1.578 . . . . 1.6000000000000001 111.809 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.28 -52.96 37.25 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 111.543 -0.623 . . . . 0.52000000000000002 111.543 166.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 64' ' ' ILE . 87.3 mt -61.3 -29.46 69.89 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.1 -1.236 . . . . 0.63 113.289 174.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.56 ' HA ' HG11 ' A' ' 34' ' ' VAL . 4.2 ttmm -59.9 -18.75 47.21 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.151 1.342 . . . . 1.49 111.715 172.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -16.55 57.83 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.885 1.068 . . . . 4.5999999999999996 113.885 169.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.496 ' O ' HG12 ' A' ' 34' ' ' VAL . 83.8 mmm -72.12 135.79 82.3 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 120.031 1.287 . . . . 2.0499999999999998 111.431 -174.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.58 101.32 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.042 2.494 . . . . 0.35999999999999999 110.711 -174.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.31 -15.12 3.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 119.459 1.027 . . . . 0.25 110.809 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 29' ' ' LYS . 5.2 p -69.17 153.31 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 O-C-N 122.312 -0.523 . . . . 0.26000000000000001 109.941 166.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.65 -61.04 1.76 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.126 -1.064 . . . . 0.45000000000000001 108.126 162.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -141.42 145.98 35.98 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 113.527 0.936 . . . . 3.3900000000000001 113.527 -168.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.64 150.9 26.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.758 1.623 . . . . 1.1699999999999999 108.551 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.86 101.54 2.91 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.77 0.828 . . . . 1.96 108.785 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.95 141.54 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.828 0.851 . . . . 1.0700000000000001 110.997 -175.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -139.11 66.04 1.43 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.137 1.375 . . . . 1.27 111.429 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.619 HD22 ' HG3' ' A' ' 15' ' ' MET . 56.2 mt -67.04 -13.82 62.29 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 113.342 0.867 . . . . 1.05 113.342 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.36 -25.52 9.98 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.578 0.351 . . . . 0.96999999999999997 110.886 165.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.8 m -125.17 17.92 8.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.343 1.457 . . . . 0.69999999999999996 110.157 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 48.18 33.39 3.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.414 1.086 . . . . 2.48 112.156 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -131.66 149.24 52.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.29 -1.004 . . . . 0.60999999999999999 108.29 -168.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -134.02 144.45 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 109.399 -0.593 . . . . 0.55000000000000004 109.399 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -112.11 145.08 40.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.052 1.741 . . . . 2.3799999999999999 108.096 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.52 136.44 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.011 -0.737 . . . . 0.32000000000000001 109.011 174.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.36 119.17 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.694 1.597 . . . . 0.98999999999999999 107.535 178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -144.49 167.81 21.61 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.009 0.923 . . . . 1.79 110.712 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -108.26 122.88 39.16 Favored Pre-proline 0 N--CA 1.451 -0.416 0 O-C-N 124.211 0.944 . . . . 1.47 110.888 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.79 5.05 1.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.931 3.088 . . . . 0.58999999999999997 113.544 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.74 -55.28 6.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.419 -1.326 . . . . 0.40000000000000002 107.419 175.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -84.04 -42.57 16.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.526 1.13 . . . . 3.6800000000000002 110.54 172.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.8 m -143.27 131.6 22.11 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 119.175 3.028 . . . . 0.64000000000000001 119.175 -143.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.06 -159.55 18.67 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.13 -1.188 . . . . 0.51000000000000001 110.13 159.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -30.66 -47.63 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.839 2.855 . . . . 0.56000000000000005 112.845 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.86 -56.27 7.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.396 0.678 . . . . 0.26000000000000001 112.488 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.65 -38.49 64.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.197 0.999 . . . . 0.17999999999999999 109.393 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.492 HG12 HD13 ' A' ' 28' ' ' LEU . 1.7 mt -64.75 -55.36 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.465 -1.243 . . . . 0.62 110.377 -170.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.98 -50.02 59.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.923 1.238 . . . . 0.77000000000000002 110.695 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -43.7 -56.14 3.96 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.712 0.805 . . . . 2.1299999999999999 112.023 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -41.48 72.57 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.559 -0.856 . . . . 1.6899999999999999 110.586 -178.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.603 HD11 HD11 ' A' ' 28' ' ' LEU . 14.6 mm -52.42 -46.05 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 119.489 1.04 . . . . 0.34999999999999998 110.019 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -50.82 -46.69 59.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.041 0.448 . . . . 1.8600000000000001 110.098 174.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -32.89 70.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 114.015 1.117 . . . . 3.1299999999999999 114.015 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.65 -21.23 25.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.548 0.613 . . . . 0.88 110.571 166.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.93 27.3 8.4 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.768 -0.933 . . . . 0.32000000000000001 110.768 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -140.39 173.67 11.28 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.181 -1.044 . . . . 1.72 108.181 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.92 122.88 31.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.702 -1.592 . . . . 4.1600000000000001 106.702 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 p -89.92 145.78 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.906 -0.776 . . . . 0.55000000000000004 108.906 171.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.81 164.16 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.289 -0.634 . . . . 1.27 109.289 170.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.4 mm -123.17 104.16 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.023 -1.843 . . . . 1.0 106.023 165.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.12 71.16 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.047 1.339 . . . . 7.9900000000000002 112.614 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.37 -58.53 0.2 Allowed Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.22 -0.925 . . . . 6.2000000000000002 113.856 169.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.0 ttp85 . . . . . 0 C--O 1.251 1.177 0 CA-C-O 117.249 -1.358 . . . . 12.69 108.531 -168.097 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 mtt . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 108.481 -0.933 . . . . 8.5700000000000003 108.481 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 tp -66.53 174.43 2.79 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.155 -0.683 . . . . 6.2400000000000002 109.155 166.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 t -139.27 163.32 32.79 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 105.946 -1.872 . . . . 3.3599999999999999 105.946 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -159.55 152.37 21.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.88 -1.156 . . . . 3.4199999999999999 107.88 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -88.34 174.7 8.01 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.51 -0.768 . . . . 0.93999999999999995 111.289 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.32 161.55 40.07 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.998 -0.371 . . . . 3.6000000000000001 109.998 172.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.41 136.29 33.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.627 -1.17 . . . . 3.3900000000000001 107.935 161.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 tp -107.4 153.91 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.051 -1.833 . . . . 1.1699999999999999 106.051 162.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.58 128.56 17.49 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.589 1.156 . . . . 0.35999999999999999 108.44 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.78 172.33 18.81 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.506 0.594 . . . . 1.3700000000000001 111.939 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.403 ' H ' ' NE2' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -90.62 157.38 17.51 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.278 -0.638 . . . . 2.2799999999999998 109.278 -176.562 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 24' ' ' ILE . 2.1 t -123.34 132.12 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 O-C-N 123.492 0.495 . . . . 0.70999999999999996 110.315 177.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 t -88.22 118.72 28.0 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.922 -1.14 . . . . 0.90000000000000002 107.922 172.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.81 -83.48 0.19 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.252 1.406 . . . . 2.7400000000000002 110.152 175.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 50.61 58.26 5.72 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 122.822 1.296 . . . . 5.5599999999999996 110.82 173.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 m -70.26 -16.14 63.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.476 -1.238 . . . . 4.5300000000000002 111.583 175.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.2 t 74.1 178.77 0.21 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.326 1.451 . . . . 3.5299999999999998 110.073 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 60.3 59.26 2.35 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.681 1.128 . . . . 3.1299999999999999 111.115 -174.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 65.92 15.29 10.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.457 1.503 . . . . 1.1200000000000001 113.408 175.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.66 -58.88 3.09 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.606 -0.887 . . . . 1.4299999999999999 108.606 -173.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -56.69 -28.83 61.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.756 -1.111 . . . . 0.98999999999999999 111.709 176.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.14 -47.0 69.29 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.579 -0.724 . . . . 0.5 110.609 173.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -52.98 -44.38 67.14 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 119.347 0.976 . . . . 5.5999999999999996 111.451 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.568 HD11 ' CD2' ' A' ' 69' ' ' TYR . 71.4 mt -44.66 -61.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 123.494 0.717 . . . . 0.82999999999999996 109.15 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.01 -37.99 66.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.809 -0.632 . . . . 2.3999999999999999 112.177 -175.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -57.5 -34.63 69.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.328 -0.858 . . . . 1.52 110.691 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.81 -49.82 64.23 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 110.781 -0.928 . . . . 0.40000000000000002 110.781 167.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.663 HD22 HG13 ' A' ' 60' ' ' ILE . 92.9 mt -64.41 -32.72 74.45 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 118.302 1.051 . . . . 0.40999999999999998 112.311 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.458 ' HA ' HG11 ' A' ' 34' ' ' VAL . 12.8 ttmm -57.83 -16.43 11.62 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.151 0.887 . . . . 1.51 112.094 171.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -97.85 -0.47 45.03 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.178 0.899 . . . . 3.23 112.744 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.426 ' O ' HG12 ' A' ' 34' ' ' VAL . 53.7 mmm -79.99 135.56 55.03 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 119.895 1.225 . . . . 2.3799999999999999 110.629 174.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.09 116.94 3.89 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.421 2.08 . . . . 0.81999999999999995 109.448 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.35 -17.18 6.61 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.929 1.252 . . . . 0.19 110.146 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' A' ' 29' ' ' LYS . 4.7 p -75.7 158.69 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.305 0.642 . . . . 0.29999999999999999 111.366 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.38 -63.05 1.4 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.581 1.152 . . . . 0.44 108.099 165.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -135.36 151.86 50.89 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 112.441 0.534 . . . . 3.1099999999999999 112.441 -169.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.32 140.09 41.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.928 1.291 . . . . 0.60999999999999999 107.558 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -147.63 129.98 15.7 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.201 -0.666 . . . . 1.74 109.201 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.89 134.87 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 123.98 0.912 . . . . 0.66000000000000003 110.593 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -124.82 65.2 1.11 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.008 1.723 . . . . 1.22 110.201 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.97 -20.36 63.77 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 116.071 -0.513 . . . . 0.91000000000000003 112.334 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.52 -24.69 21.75 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.997 0.519 . . . . 0.78000000000000003 110.996 171.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.4 m -125.61 16.24 8.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.96 1.304 . . . . 0.68000000000000005 109.935 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 45.93 38.39 4.5 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.339 1.056 . . . . 2.0099999999999998 111.44 -175.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.4 m -131.86 153.05 50.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.11 -1.441 . . . . 0.55000000000000004 107.11 -171.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 p -133.2 149.86 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.721 -1.214 . . . . 0.40999999999999998 107.721 174.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.22 148.45 48.64 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 123.967 0.792 . . . . 2.8999999999999999 109.565 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.3 131.26 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 121.576 0.703 . . . . 0.32000000000000001 109.266 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mt -95.38 120.12 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.508 1.923 . . . . 0.94999999999999996 107.361 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -149.33 170.15 19.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.455 0.702 . . . . 1.8200000000000001 110.188 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -104.44 121.29 47.78 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 114.36 -1.291 . . . . 2.0299999999999998 111.22 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.18 2.69 1.67 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.683 3.589 . . . . 0.5 114.203 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.92 -51.16 10.85 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 119.268 0.94 . . . . 0.46999999999999997 108.864 176.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -90.7 -44.27 9.59 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.545 1.538 . . . . 3.04 109.633 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.2 m -127.07 121.83 32.62 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 116.865 2.172 . . . . 0.58999999999999997 116.865 -157.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.09 169.63 27.41 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 106.223 -2.751 . . . . 0.96999999999999997 106.223 173.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.304 0.0 OUTLIER -39.52 -40.05 0.8 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.324 1.849 . . . . 0.70999999999999996 113.248 177.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -38.3 -59.76 0.85 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.331 1.052 . . . . 0.52000000000000002 113.245 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.51 -35.61 65.64 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 122.012 0.911 . . . . 0.28999999999999998 109.246 -173.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.663 HG13 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -60.75 -60.09 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-N 114.189 -1.368 . . . . 1.0600000000000001 108.237 -176.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.72 -51.88 26.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.162 0.892 . . . . 1.1299999999999999 110.436 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.68 -51.31 12.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.929 0.892 . . . . 2.3799999999999999 112.01 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -46.01 65.31 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.911 -0.716 . . . . 1.8999999999999999 110.938 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.651 HD11 HD11 ' A' ' 28' ' ' LEU . 8.3 mm -52.41 -44.53 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 118.94 0.791 . . . . 0.87 110.73 -175.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -48.85 -51.3 30.43 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.327 0.585 . . . . 1.5900000000000001 109.939 173.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -73.31 -28.75 62.26 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.602 0.761 . . . . 4.0499999999999998 112.85 -175.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.46 -25.45 25.29 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.155 0.434 . . . . 0.93999999999999995 110.254 165.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.02 29.93 5.61 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 124.891 1.234 . . . . 0.56999999999999995 110.566 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.568 ' CD2' HD11 ' A' ' 24' ' ' ILE . 58.5 m-85 -144.12 169.26 18.19 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 108.198 -1.038 . . . . 2.0 108.198 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.95 120.47 30.44 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.103 -1.073 . . . . 4.3600000000000003 108.103 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.8 p -87.49 149.64 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.835 -0.432 . . . . 0.42999999999999999 109.835 172.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.48 109.06 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.181 0.992 . . . . 1.28 110.217 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.6 mt -112.53 79.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 124.67 1.188 . . . . 1.9099999999999999 108.299 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -127.75 150.67 49.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.748 -1.945 . . . . 7.3700000000000001 105.748 172.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.44 -49.57 0.14 Allowed Glycine 0 CA--C 1.524 0.618 0 CA-C-N 119.226 0.921 . . . . 4.6600000000000001 112.884 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.315 0 CA-C-O 115.794 -2.05 . . . . 7.5800000000000001 106.312 163.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 109.103 -0.703 . . . . 10.56 109.103 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 39.5 tp -166.63 120.1 1.05 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.697 -1.594 . . . . 6.0599999999999996 106.697 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 p -85.43 149.07 25.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.159 -1.052 . . . . 3.4399999999999999 108.159 169.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -145.55 140.0 27.13 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 104.583 -2.377 . . . . 2.9199999999999999 104.583 168.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -109.96 169.69 8.56 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.702 0.801 . . . . 0.68999999999999995 109.846 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -147.98 162.1 40.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.248 1.023 . . . . 3.2200000000000002 111.395 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.16 146.93 30.28 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 112.647 -2.069 . . . . 3.3399999999999999 107.807 164.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -132.25 158.06 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.401 -2.074 . . . . 1.4299999999999999 105.401 165.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.73 144.1 32.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.062 0.945 . . . . 0.57999999999999996 109.129 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.9 169.82 23.73 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.252 0.621 . . . . 1.3100000000000001 110.609 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.536 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -89.1 155.01 19.72 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.367 -0.975 . . . . 2.3199999999999998 108.367 176.475 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -116.54 160.85 15.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.283 -1.006 . . . . 0.67000000000000004 108.283 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.1 t -126.79 133.44 50.8 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.452 -1.314 . . . . 0.79000000000000004 107.452 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.84 -25.32 14.81 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.435 1.017 . . . . 1.3600000000000001 113.687 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.21 142.78 6.75 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.402 1.101 . . . . 3.1099999999999999 113.29 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.9 p -134.81 39.05 3.01 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.309 1.043 . . . . 3.4300000000000002 110.511 176.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t 52.16 -141.93 0.79 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.171 -1.395 . . . . 4.1200000000000001 110.916 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 38.55 56.01 1.85 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 121.147 1.794 . . . . 2.7200000000000002 112.886 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.67 11.01 3.67 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.456 1.502 . . . . 1.0900000000000001 114.389 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 91.5 m -72.05 -60.24 2.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.737 -1.209 . . . . 1.28 107.737 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.608 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.72 -37.1 70.49 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.432 -0.804 . . . . 0.82999999999999996 110.997 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.78 -47.73 84.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.586 -0.721 . . . . 0.35999999999999999 110.937 172.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.69 -48.33 66.64 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.176 0.898 . . . . 4.0 110.543 172.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.425 HD11 ' CD2' ' A' ' 69' ' ' TYR . 66.0 mt -49.03 -61.13 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.24 0 N-CA-C 109.054 -0.721 . . . . 0.57999999999999996 109.054 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -71.2 -35.1 71.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.077 -0.649 . . . . 2.3700000000000001 110.895 -171.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -54.57 -37.99 66.15 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 121.02 -1.05 . . . . 1.52 110.688 171.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.37 -51.52 36.57 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.584 -1.006 . . . . 0.47999999999999998 110.584 168.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.796 HD11 HD11 ' A' ' 64' ' ' ILE . 96.1 mt -64.79 -29.91 70.9 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 121.702 -0.881 . . . . 0.42999999999999999 112.367 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.652 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -63.1 -18.07 63.01 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 118.984 0.811 . . . . 1.48 109.809 176.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.83 -23.08 63.25 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.219 -1.551 . . . . 3.1800000000000002 113.934 168.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.57 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -69.03 133.19 89.99 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 120.214 1.37 . . . . 1.8500000000000001 110.463 -172.23 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.24 100.12 0.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.822 2.348 . . . . 0.44 110.19 -176.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.57 -21.82 2.37 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.588 -1.005 . . . . 0.29999999999999999 110.588 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.652 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.8 p -67.37 153.7 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 122.293 -0.533 . . . . 0.28000000000000003 110.675 170.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.25 -61.07 1.77 Allowed 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.467 -0.938 . . . . 0.46000000000000002 108.467 167.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.26 152.93 39.12 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.645 0.259 . . . . 2.7599999999999998 111.315 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.13 135.28 46.29 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.901 2.08 . . . . 0.68000000000000005 107.77 -173.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -144.7 121.67 11.36 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.408 0.683 . . . . 1.5700000000000001 109.73 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.608 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.3 p -97.8 137.59 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 112.937 0.717 . . . . 0.97999999999999998 112.937 -176.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -126.33 69.79 1.23 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.401 2.281 . . . . 1.3 111.181 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.9 mt -65.08 -17.98 64.92 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 112.692 0.627 . . . . 0.73999999999999999 112.692 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.89 -10.0 5.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.154 0.434 . . . . 0.63 111.44 169.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 m -138.17 17.18 2.8 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.23 1.012 . . . . 0.45000000000000001 109.758 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mp0 51.2 30.6 5.89 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.048 0.84 . . . . 2.8900000000000001 111.935 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.7 m -128.98 153.66 47.34 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.804 -1.184 . . . . 0.53000000000000003 107.804 -168.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.02 147.46 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.951 -1.129 . . . . 0.46000000000000002 107.951 174.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.46 151.73 41.0 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 124.209 0.943 . . . . 2.8399999999999999 109.154 175.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.5 140.2 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.142 -1.059 . . . . 0.27000000000000002 108.142 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.46 124.89 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.531 1.532 . . . . 0.87 107.438 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -148.46 165.99 29.49 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.387 0.675 . . . . 1.8200000000000001 110.622 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -97.98 110.84 57.42 Favored Pre-proline 0 N--CA 1.447 -0.611 0 C-N-CA 124.673 1.189 . . . . 2.0499999999999998 110.247 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -72.25 13.25 0.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.963 3.108 . . . . 0.60999999999999999 113.716 -177.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.41 -51.26 8.02 Favored 'General case' 0 C--N 1.337 0.059 0 N-CA-C 107.257 -1.386 . . . . 0.59999999999999998 107.257 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -80.83 -47.98 13.06 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.273 1.429 . . . . 2.7400000000000002 109.637 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.5 m -143.04 125.7 15.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 117.252 2.316 . . . . 0.70999999999999996 117.252 -145.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.51 -159.74 13.65 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 109.857 -1.297 . . . . 0.5 109.857 165.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.4 t -29.47 -50.04 0.1 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 129.138 2.975 . . . . 0.72999999999999998 112.632 177.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.05 -56.33 6.68 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.025 0.93 . . . . 0.32000000000000001 112.654 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -38.47 64.88 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 122.248 1.023 . . . . 0.20000000000000001 109.403 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.596 HG12 HD22 ' A' ' 28' ' ' LEU . 1.3 mt -63.29 -56.26 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.242 -1.345 . . . . 0.59999999999999998 110.216 -170.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.21 -52.69 19.87 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.174 1.352 . . . . 0.76000000000000001 110.611 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -44.09 -51.95 7.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.683 1.193 . . . . 2.5099999999999998 111.968 176.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -43.44 68.61 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 118.248 -0.882 . . . . 2.0800000000000001 111.464 177.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.796 HD11 HD11 ' A' ' 28' ' ' LEU . 37.7 mm -52.58 -45.55 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 119.77 1.168 . . . . 0.38 110.075 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -50.38 -49.2 55.05 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.763 0.316 . . . . 1.8200000000000001 110.183 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -70.77 -30.67 67.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 114.279 1.214 . . . . 3.25 114.279 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.27 -21.0 12.75 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.532 0.606 . . . . 0.91000000000000003 110.635 166.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.24 28.74 9.52 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.998 -1.241 . . . . 0.29999999999999999 109.998 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.425 ' CD2' HD11 ' A' ' 24' ' ' ILE . 71.2 m-85 -137.44 168.3 19.91 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.735 -0.839 . . . . 1.71 108.735 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.33 123.1 42.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.746 -1.576 . . . . 4.4900000000000002 106.746 175.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.442 ' HB ' HG21 ' A' ' 64' ' ' ILE . 8.7 p -91.65 152.99 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.46 -0.57 . . . . 0.54000000000000004 109.46 172.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.01 96.61 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-O 121.305 0.574 . . . . 1.4299999999999999 110.305 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.8 mt -95.8 94.35 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.249 -1.019 . . . . 1.74 108.249 172.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.42 166.78 29.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.481 -1.303 . . . . 5.0199999999999996 107.481 167.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.69 -88.06 1.52 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.877 -0.889 . . . . 3.5800000000000001 110.877 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 116.725 -1.607 . . . . 9.3200000000000003 107.122 -172.683 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptt? . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 107.348 -1.353 . . . . 8.3399999999999999 107.348 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.98 147.64 0.59 Allowed 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 105.899 -1.889 . . . . 6.71 105.899 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 p -81.85 145.17 30.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.37 -0.974 . . . . 3.25 108.37 171.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -149.15 154.93 39.9 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.049 -1.463 . . . . 2.79 107.049 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -113.02 170.93 7.85 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.444 1.498 . . . . 0.69999999999999996 109.546 -176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.45 162.22 41.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.238 0.542 . . . . 4.79 110.878 176.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -82.83 155.03 24.38 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.222 1.809 . . . . 3.71 109.765 168.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.7 142.84 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 104.847 -2.279 . . . . 3.2599999999999998 104.847 162.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.52 130.72 51.14 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.689 1.196 . . . . 0.40999999999999998 107.869 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -155.53 174.78 14.77 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.876 0.47 . . . . 1.2 110.381 -173.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.419 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -104.87 150.31 24.96 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.753 -1.203 . . . . 1.8999999999999999 107.753 -176.379 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.42 161.52 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 107.502 -1.296 . . . . 0.64000000000000001 107.502 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.67 131.07 46.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.609 -1.256 . . . . 1.29 107.609 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.0 -15.95 25.64 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.375 0.988 . . . . 1.3999999999999999 113.785 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.38 145.21 18.6 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.575 1.188 . . . . 3.1099999999999999 111.75 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.5 p -125.8 36.36 4.55 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.791 0.836 . . . . 3.5099999999999998 110.28 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.9 t 50.58 -137.62 1.1 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.98 0.912 . . . . 4.0700000000000003 111.914 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 54.95 -80.18 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.607 1.963 . . . . 3.3799999999999999 112.334 -176.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.01 13.57 0.7 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.56 1.144 . . . . 1.22 112.039 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.33 -62.09 1.53 Allowed 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 121.299 -0.876 . . . . 1.23 109.502 -167.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -60.83 -32.87 72.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.891 0.377 . . . . 0.69999999999999996 111.168 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.11 -53.4 57.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 119.489 -0.291 . . . . 0.40000000000000002 110.24 170.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -58.4 -45.14 88.95 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 118.778 -0.629 . . . . 3.6800000000000002 111.997 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 21' ' ' ALA . 82.2 mt -49.06 -60.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.041 -0.725 . . . . 0.62 109.041 176.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.439 ' CD ' HG21 ' A' ' 46' ' ' VAL . 3.4 tp10 -70.86 -33.98 71.17 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.16 0.505 . . . . 2.6400000000000001 110.336 -170.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -60.15 -31.29 69.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.864 -1.147 . . . . 2.29 111.234 171.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.67 -51.82 31.74 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.515 -1.034 . . . . 0.34000000000000002 110.515 162.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 64' ' ' ILE . 93.3 mt -65.2 -32.66 74.45 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 121.253 -1.145 . . . . 0.39000000000000001 113.023 177.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HA ' HG11 ' A' ' 34' ' ' VAL . 13.5 tppt? -54.97 -21.22 11.08 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.373 0.988 . . . . 1.79 111.458 171.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -76.02 -24.32 55.25 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.788 1.033 . . . . 3.0800000000000001 113.788 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.48 ' O ' HG12 ' A' ' 34' ' ' VAL . 1.5 mtp -69.7 132.83 88.82 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 120.375 1.443 . . . . 2.2400000000000002 112.478 -172.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.6 95.38 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.644 2.896 . . . . 0.46000000000000002 110.716 -172.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.44 -20.8 2.23 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.696 -0.962 . . . . 0.26000000000000001 110.696 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 31' ' ' MET . 9.8 p -62.62 144.54 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 121.966 -0.726 . . . . 0.39000000000000001 110.954 171.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.12 -61.79 1.34 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.629 1.172 . . . . 0.81000000000000005 109.269 167.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -149.41 147.98 28.92 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 114.315 1.228 . . . . 2.8700000000000001 114.315 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.415 ' HB1' ' CG ' ' A' ' 25' ' ' GLU . . . -116.46 121.3 41.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.84 2.056 . . . . 0.91000000000000003 108.331 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.99 107.42 6.15 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.921 0.889 . . . . 1.3899999999999999 108.986 -170.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 p -85.4 143.6 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.91 0.884 . . . . 0.60999999999999999 112.058 -172.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -133.49 65.78 1.57 Allowed 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.226 1.811 . . . . 1.29 111.163 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.6 mt -65.61 -16.35 63.63 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 121.685 -0.634 . . . . 0.71999999999999997 112.704 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.4 -19.65 15.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.645 0.378 . . . . 0.52000000000000002 110.902 168.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.4 m -129.19 19.33 5.9 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.088 1.355 . . . . 0.45000000000000001 109.685 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 50.24 35.14 9.84 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.138 0.975 . . . . 2.4399999999999999 111.846 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.89 158.08 44.86 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 108.847 -0.797 . . . . 0.97999999999999998 108.847 -169.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.439 HG21 ' CD ' ' A' ' 25' ' ' GLU . 7.2 p -134.96 148.85 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.081 -0.711 . . . . 0.45000000000000001 109.081 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -115.81 134.41 55.04 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.95 -1.5 . . . . 2.5 106.95 176.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.43 140.07 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.284 -0.635 . . . . 0.37 109.284 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.0 mt -105.58 132.67 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 126.201 1.8 . . . . 0.90000000000000002 106.945 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.01 167.42 28.48 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.959 0.409 . . . . 2.0299999999999998 111.498 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -98.25 114.16 64.86 Favored Pre-proline 0 N--CA 1.442 -0.829 0 C-N-CA 124.752 1.221 . . . . 1.46 109.839 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -69.48 9.87 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 124.289 3.326 . . . . 0.53000000000000003 113.971 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.39 -51.59 8.18 Favored 'General case' 0 N--CA 1.458 -0.058 0 N-CA-C 107.411 -1.329 . . . . 0.46999999999999997 107.411 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -93.67 -29.75 15.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.579 1.552 . . . . 3.1200000000000001 111.289 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.7 m -150.2 130.25 13.5 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 118.031 2.604 . . . . 0.47999999999999998 118.031 -156.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.33 -165.25 17.79 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 110.453 -1.059 . . . . 0.42999999999999999 110.453 156.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.4 t -39.88 -38.31 0.67 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.291 2.636 . . . . 1.04 112.138 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.65 -56.0 9.71 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.181 0.808 . . . . 0.32000000000000001 113.181 174.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.56 -37.82 65.41 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.838 1.304 . . . . 0.19 108.904 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.597 ' CG1' HD22 ' A' ' 28' ' ' LEU 0.269 0.8 OUTLIER -64.04 -53.6 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 113.708 -1.587 . . . . 0.57999999999999996 111.013 -173.749 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.87 -53.07 12.91 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.766 1.621 . . . . 0.96999999999999997 111.048 173.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -39.75 -58.12 1.4 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.829 0.823 . . . . 2.52 113.106 172.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -70.34 -40.28 74.2 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 119.465 -0.894 . . . . 2.9900000000000002 110.224 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.696 HD11 HD11 ' A' ' 28' ' ' LEU . 31.3 mm -54.12 -46.74 67.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.506 1.048 . . . . 0.35999999999999999 110.114 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -53.13 -45.53 68.4 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.289 0.636 . . . . 1.5700000000000001 109.927 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -38.99 86.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.456 -0.778 . . . . 3.9199999999999999 111.23 -177.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.6 -19.85 18.11 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.656 1.182 . . . . 0.96999999999999997 110.898 170.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.01 28.54 9.25 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 124.187 0.899 . . . . 0.34999999999999998 110.938 173.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -138.06 165.31 26.91 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.041 -1.096 . . . . 1.79 108.041 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.69 129.3 55.2 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.752 0.821 . . . . 3.9199999999999999 108.943 173.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.3 p -96.14 148.52 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 125.276 1.431 . . . . 0.41999999999999998 110.22 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 11' ' ' GLN . 2.9 m -116.41 132.76 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 123.594 0.758 . . . . 1.0 110.376 -178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.0 mm -102.91 82.84 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.862 -1.162 . . . . 1.1000000000000001 107.862 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -135.67 151.8 50.57 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 105.945 -1.872 . . . . 4.5 105.945 166.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.18 -113.1 0.72 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 107.763 -2.135 . . . . 3.8300000000000001 107.763 -169.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 . . . . . 0 C--O 1.251 1.175 0 CA-C-O 116.993 -1.479 . . . . 7.8200000000000003 109.952 -172.045 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.0 mtp . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 105.945 -1.872 . . . . 10.789999999999999 105.945 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.05 55.71 9.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.165 0.983 . . . . 5.5099999999999998 110.058 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 p -148.26 118.98 7.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.927 1.691 . . . . 3.23 106.705 -165.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -136.54 147.91 47.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.308 -1.367 . . . . 3.0699999999999998 107.308 176.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -110.68 167.89 9.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.598 1.159 . . . . 0.57999999999999996 111.182 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -143.67 157.0 44.72 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.599 0.714 . . . . 2.4199999999999999 111.399 174.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -84.28 125.68 32.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.244 1.818 . . . . 2.3300000000000001 107.035 163.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 tp -103.64 149.18 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.278 -1.749 . . . . 1.1200000000000001 106.278 163.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.82 129.11 40.06 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.674 -1.232 . . . . 0.40999999999999998 107.674 172.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -155.75 168.63 26.58 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.841 0.456 . . . . 1.02 110.553 -172.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -91.57 151.51 20.69 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.811 -0.811 . . . . 2.8999999999999999 108.811 -173.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -117.96 160.84 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 108.922 -0.769 . . . . 0.67000000000000004 108.922 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -133.49 125.31 28.67 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.839 -1.171 . . . . 0.79000000000000004 107.839 174.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.89 -21.23 6.63 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.035 1.302 . . . . 1.3400000000000001 113.228 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.33 154.48 3.3 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.348 1.074 . . . . 3.1499999999999999 112.809 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.1 p -142.52 39.39 1.55 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.554 0.742 . . . . 3.46 110.728 174.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.3 t 56.03 -147.56 0.52 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 117.404 -1.284 . . . . 4.1299999999999999 110.464 -177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 41.77 47.63 3.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.741 1.61 . . . . 2.6400000000000001 114.138 173.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.95 15.88 6.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.872 1.269 . . . . 1.0600000000000001 113.788 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.1 m -73.11 -60.61 2.16 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.23 -1.396 . . . . 1.5 107.23 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.674 ' HA ' HD13 ' A' ' 24' ' ' ILE . . . -46.75 -39.5 11.8 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.067 1.347 . . . . 1.24 112.031 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.29 -38.51 87.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.385 -0.825 . . . . 0.54000000000000004 111.935 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -57.48 -47.11 82.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.357 0.98 . . . . 3.3999999999999999 110.753 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.674 HD13 ' HA ' ' A' ' 21' ' ' ALA . 3.5 mp -48.7 -61.62 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.413 -0.958 . . . . 1.6100000000000001 108.413 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.56 -33.57 66.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.433 -0.507 . . . . 2.5699999999999998 112.003 -172.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -56.29 -39.8 73.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.149 -0.969 . . . . 1.9399999999999999 110.026 173.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.01 -55.5 11.61 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.937 -1.265 . . . . 0.33000000000000002 109.937 167.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.88 HD11 HD11 ' A' ' 64' ' ' ILE . 96.5 mt -63.5 -31.39 72.54 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 113.439 0.903 . . . . 0.34000000000000002 113.439 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.447 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.26 14.0 ttpt -61.62 -17.14 53.99 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.656 1.116 . . . . 2.0899999999999999 111.116 172.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.92 -12.8 52.6 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.154 1.168 . . . . 3.6000000000000001 114.154 168.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.471 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -71.44 137.58 83.68 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 120.827 1.649 . . . . 3.3799999999999999 111.241 -173.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.48 94.48 0.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.113 2.542 . . . . 0.37 110.433 -175.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.42 -12.78 3.5 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.74 1.162 . . . . 0.23000000000000001 111.193 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 31' ' ' MET . 4.7 p -67.38 160.57 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 117.791 0.795 . . . . 0.26000000000000001 110.526 167.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.77 -55.44 1.9 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.358 1.063 . . . . 0.51000000000000001 110.152 165.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -143.99 162.26 36.64 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.068 0.395 . . . . 2.2599999999999998 111.815 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.44 135.73 28.77 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 126.072 1.749 . . . . 0.62 109.607 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -142.47 110.25 5.83 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 125.439 1.496 . . . . 1.55 108.746 -173.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.0 p -84.14 140.93 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.555 0.742 . . . . 0.62 111.728 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -132.48 69.06 1.48 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.991 1.717 . . . . 1.23 112.328 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.9 mt -63.38 -18.97 64.25 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 113.087 0.773 . . . . 0.79000000000000004 113.087 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.83 -21.93 12.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.264 0.484 . . . . 0.58999999999999997 110.933 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 m -125.65 10.19 7.77 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.919 1.288 . . . . 0.51000000000000001 110.605 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 45.52 44.68 10.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.176 0.991 . . . . 3.29 112.266 -169.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.9 m -134.31 155.29 50.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.411 -1.329 . . . . 0.54000000000000004 107.411 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.3 p -134.12 146.92 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.559 -0.904 . . . . 0.5 108.559 172.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -115.3 134.65 54.93 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 124.498 1.124 . . . . 2.3799999999999999 108.244 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -138.56 135.48 43.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.11 -0.7 . . . . 0.29999999999999999 109.11 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.9 mp -102.02 120.88 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.765 1.626 . . . . 1.1000000000000001 107.178 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -147.28 167.29 24.63 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.484 0.714 . . . . 1.8500000000000001 110.619 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -105.54 119.2 53.5 Favored Pre-proline 0 N--CA 1.443 -0.799 0 O-C-N 124.135 0.897 . . . . 1.3700000000000001 109.677 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -67.95 7.72 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 124.464 3.443 . . . . 0.46999999999999997 113.83 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.44 -57.0 4.12 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.201 -1.407 . . . . 0.46000000000000002 107.201 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.0 mp0 -87.84 -37.14 16.79 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.303 1.041 . . . . 3.7799999999999998 112.161 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.3 m -138.08 129.38 27.6 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 118.649 2.833 . . . . 0.54000000000000004 118.649 -155.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.41 -163.62 17.86 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.475 -1.05 . . . . 0.42999999999999999 110.475 155.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -29.29 -47.91 0.07 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.512 2.725 . . . . 0.88 112.863 172.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.15 -54.41 16.47 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.114 0.565 . . . . 0.40000000000000002 112.487 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.3 -41.62 60.86 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 122.201 1.0 . . . . 0.26000000000000001 109.182 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.708 HG12 HD22 ' A' ' 28' ' ' LEU . 1.6 mt -61.36 -60.25 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 114.137 -1.392 . . . . 0.56000000000000005 109.266 -170.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.98 -53.81 7.28 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.506 1.048 . . . . 0.79000000000000004 110.397 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -44.47 -54.44 5.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.624 1.17 . . . . 2.5899999999999999 111.363 176.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -40.7 76.04 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.987 -0.685 . . . . 2.3900000000000001 111.355 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 28' ' ' LEU . 37.7 mm -55.41 -44.27 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 119.233 0.924 . . . . 0.66000000000000003 109.947 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -52.67 -42.85 65.12 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.109 0.48 . . . . 1.8200000000000001 110.721 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -37.08 73.9 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.008 -1.057 . . . . 3.5899999999999999 111.016 -177.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.83 -21.0 17.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.538 0.735 . . . . 0.89000000000000001 110.911 169.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.08 27.39 16.23 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.588 -1.005 . . . . 0.35999999999999999 110.588 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.547 ' CE2' HD11 ' A' ' 24' ' ' ILE . 41.8 m-85 -135.51 169.51 17.4 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 107.942 -1.133 . . . . 2.02 107.942 176.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.4 114.79 16.0 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 107.84 -1.17 . . . . 4.5199999999999996 107.84 -174.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.41 144.11 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 123.795 0.838 . . . . 0.52000000000000002 108.803 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.18 108.23 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.461 1.104 . . . . 1.5700000000000001 109.373 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.2 mt -106.21 72.69 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.212 1.405 . . . . 1.5600000000000001 108.645 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -90.68 120.33 31.65 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.547 -1.649 . . . . 4.7300000000000004 106.547 163.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.04 161.13 35.04 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.546 0.593 . . . . 4.0800000000000001 112.619 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 . . . . . 0 C--O 1.254 1.304 0 C-N-CA 128.44 2.696 . . . . 9.4600000000000009 104.494 167.488 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 mtp . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 116.977 -1.487 . . . . 9.0 107.082 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mt 29.86 76.19 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.824 1.65 . . . . 5.8200000000000003 112.403 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 t -133.4 143.88 49.19 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.372 -1.714 . . . . 2.9300000000000002 106.372 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -157.51 145.81 19.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.768 -1.568 . . . . 3.3199999999999998 106.768 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -84.73 177.23 8.1 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.909 -0.587 . . . . 1.1100000000000001 111.087 -176.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.47 160.52 43.25 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.318 0.58 . . . . 4.0999999999999996 111.725 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -84.4 127.01 33.75 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.445 1.498 . . . . 2.4900000000000002 108.303 166.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tp -108.8 155.88 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.313 -1.736 . . . . 1.22 106.313 162.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.86 140.27 23.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.091 0.557 . . . . 0.72999999999999998 109.816 175.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.441 ' HG3' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -157.75 169.41 24.68 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 123.647 0.592 . . . . 1.6200000000000001 111.189 -177.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.489 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -84.5 152.85 23.67 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 108.105 -1.072 . . . . 2.4399999999999999 108.105 178.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.424 HG11 HD13 ' A' ' 24' ' ' ILE . 2.2 t -131.17 139.0 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.867 0.365 . . . . 1.0 110.289 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t -101.23 136.77 40.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.512 1.125 . . . . 0.76000000000000001 108.188 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.45 2.76 40.95 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.856 1.217 . . . . 1.4399999999999999 112.741 -173.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.513 ' SD ' HD13 ' A' ' 41' ' ' LEU . 11.0 tmm? -46.11 104.05 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.444 1.898 . . . . 4.7999999999999998 111.507 172.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.89 13.56 17.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.808 1.643 . . . . 3.7799999999999998 110.669 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.8 t 55.68 -145.52 0.62 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.367 1.467 . . . . 3.8500000000000001 111.386 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 54.66 -80.83 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.257 1.823 . . . . 3.46 112.162 -174.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -152.74 18.48 0.6 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.54 1.136 . . . . 1.0600000000000001 111.445 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.62 -59.61 2.66 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 120.864 -1.147 . . . . 1.23 109.304 -168.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -56.52 -34.18 66.76 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.478 -0.783 . . . . 0.71999999999999997 111.312 177.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.85 -47.0 87.51 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 121.88 -0.512 . . . . 0.32000000000000001 110.563 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -57.24 -44.65 84.02 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.965 0.802 . . . . 6.6900000000000004 111.527 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.562 HD11 ' CD2' ' A' ' 69' ' ' TYR . 67.7 mt -46.74 -61.19 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 108.882 -0.784 . . . . 0.81999999999999995 108.882 177.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.14 -35.48 69.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.968 -0.56 . . . . 2.6000000000000001 111.787 -172.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -57.34 -35.68 70.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.094 -1.004 . . . . 1.46 110.786 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.26 -53.57 15.14 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.821 -0.911 . . . . 0.45000000000000001 110.821 165.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.71 HD22 HG12 ' A' ' 60' ' ' ILE . 89.4 mt -65.05 -31.06 72.1 Favored 'General case' 0 C--O 1.223 -0.314 0 O-C-N 121.778 -0.837 . . . . 0.53000000000000003 112.151 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.275 14.1 ttmt -58.87 -17.76 26.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.405 1.002 . . . . 1.21 112.104 171.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -20.24 47.66 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.66 1.118 . . . . 3.3599999999999999 113.726 168.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.474 ' O ' HG12 ' A' ' 34' ' ' VAL . 94.4 mmm -74.33 137.54 75.02 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 119.99 1.268 . . . . 2.0499999999999998 111.924 -169.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.49 91.17 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.671 2.914 . . . . 0.44 111.403 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.59 -13.65 2.23 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.941 1.257 . . . . 0.25 111.522 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 29' ' ' LYS . 6.8 p -66.18 159.68 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 121.709 -0.877 . . . . 0.31 111.635 168.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.22 -56.39 1.63 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.135 1.374 . . . . 0.60999999999999999 110.76 168.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -143.73 157.1 44.63 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 122.299 -0.251 . . . . 2.52 111.62 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.34 131.22 31.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.885 1.274 . . . . 0.69999999999999996 109.389 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -136.98 117.74 14.04 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.639 0.776 . . . . 1.5900000000000001 110.009 -176.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -84.32 140.62 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.448 1.099 . . . . 0.65000000000000002 110.732 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -130.36 65.0 1.53 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.591 1.557 . . . . 1.21 110.777 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.513 HD13 ' SD ' ' A' ' 15' ' ' MET . 20.5 mt -64.37 -15.3 60.17 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 113.201 0.815 . . . . 0.66000000000000003 113.201 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.27 -20.07 3.84 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.274 0.63 . . . . 0.59999999999999998 111.514 167.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.6 m -134.45 18.66 3.64 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.421 1.488 . . . . 0.56000000000000005 109.957 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.8 mp0 47.28 34.84 3.37 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.299 1.04 . . . . 2.8100000000000001 111.815 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -132.5 153.17 51.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.744 -1.576 . . . . 0.5 106.744 -170.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -139.3 153.24 24.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.382 -0.97 . . . . 1.0700000000000001 108.382 173.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.12 151.73 36.98 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 124.342 1.026 . . . . 2.7400000000000002 109.815 176.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.16 136.04 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 108.598 -0.89 . . . . 0.31 108.598 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 mt -101.01 116.64 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.767 2.027 . . . . 0.81999999999999995 106.08 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -144.44 167.48 22.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.682 0.793 . . . . 1.8500000000000001 109.971 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -103.26 115.76 63.36 Favored Pre-proline 0 N--CA 1.443 -0.78 0 CA-C-N 114.726 -1.124 . . . . 1.4099999999999999 110.618 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -69.92 8.86 0.71 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 124.258 3.305 . . . . 0.5 113.953 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.38 -49.06 12.96 Favored 'General case' 0 CA--C 1.526 0.046 0 N-CA-C 107.943 -1.132 . . . . 0.42999999999999999 107.943 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -96.05 -36.22 11.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.979 1.712 . . . . 2.6600000000000001 110.693 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 m -142.19 129.07 20.62 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 117.708 2.484 . . . . 0.5 117.708 -159.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.11 -161.37 13.12 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.885 -0.886 . . . . 0.41999999999999998 110.885 157.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -32.92 -43.68 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 128.379 2.672 . . . . 0.91000000000000003 113.394 176.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.83 -57.19 7.87 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.041 0.536 . . . . 0.40999999999999998 112.145 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.85 -39.79 63.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 122.337 1.065 . . . . 0.26000000000000001 108.88 -177.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.71 HG12 HD22 ' A' ' 28' ' ' LEU . 1.8 mt -63.75 -53.44 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 114.359 -1.292 . . . . 0.55000000000000004 110.551 -169.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -51.67 58.19 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.623 1.101 . . . . 0.80000000000000004 110.454 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -46.29 -54.43 8.92 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.222 1.009 . . . . 2.1800000000000002 111.121 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -43.16 78.9 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 119.475 -0.89 . . . . 2.9300000000000002 111.263 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.432 HD11 HD11 ' A' ' 28' ' ' LEU . 4.9 mm -53.91 -45.17 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 123.822 0.849 . . . . 0.37 110.429 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -48.79 -47.64 41.86 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.915 -0.402 . . . . 1.6200000000000001 109.915 173.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -71.91 -30.04 64.95 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.642 0.979 . . . . 3.4500000000000002 113.642 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.97 -23.11 12.03 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.493 0.588 . . . . 0.84999999999999998 110.56 165.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.67 28.82 8.13 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 109.888 -1.285 . . . . 0.37 109.888 175.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.562 ' CD2' HD11 ' A' ' 24' ' ' ILE . 51.0 m-85 -139.96 164.2 30.64 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 108.122 -1.066 . . . . 1.77 108.122 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.48 121.21 36.04 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.367 -1.346 . . . . 4.5499999999999998 107.367 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.441 HG22 ' HG3' ' A' ' 10' ' ' MET . 1.4 p -86.77 159.35 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 124.838 1.255 . . . . 0.82999999999999996 108.951 174.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.97 95.08 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.412 0.625 . . . . 1.6100000000000001 111.322 176.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 37.9 mt -95.38 97.68 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 124.484 1.114 . . . . 1.6799999999999999 108.296 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -144.23 131.82 21.12 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.431 -2.063 . . . . 5.5999999999999996 105.431 168.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.68 -45.03 0.8 Allowed Glycine 0 CA--C 1.529 0.964 0 CA-C-N 118.639 0.654 . . . . 3.8999999999999999 113.831 175.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.205 0 N-CA-C 104.914 -2.254 . . . . 7.1699999999999999 104.914 -172.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mtm . . . . . 0 N--CA 1.474 0.752 0 CA-C-O 118.618 -0.706 . . . . 10.869999999999999 109.481 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.24 165.72 26.62 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.308 0.643 . . . . 5.96 109.401 174.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 75.64 130.89 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.98 2.112 . . . . 2.79 109.604 -172.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.83 148.57 27.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.311 -1.366 . . . . 2.79 107.311 174.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -90.33 168.67 11.71 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.0 0.92 . . . . 0.64000000000000001 110.248 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -149.22 162.63 39.63 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.198 0.523 . . . . 3.0600000000000001 111.518 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.09 139.4 32.5 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.527 1.931 . . . . 2.2599999999999998 108.269 170.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 tp -118.32 151.7 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.202 -1.777 . . . . 1.1000000000000001 106.202 163.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.57 120.19 11.79 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.249 1.419 . . . . 0.58999999999999997 107.944 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.5 ptt? -156.51 167.71 29.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.296 0.498 . . . . 1.1000000000000001 110.105 -171.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.401 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -98.08 156.95 16.41 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.422 0.689 . . . . 1.79 110.282 -173.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -115.26 160.6 14.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 C-N-CA 123.043 0.537 . . . . 0.73999999999999999 109.919 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 t -126.74 123.24 36.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.933 1.293 . . . . 0.85999999999999999 108.316 174.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.72 -18.58 11.65 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.531 1.062 . . . . 1.4099999999999999 113.221 170.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.81 141.93 3.67 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.944 1.298 . . . . 3.6200000000000001 112.443 175.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.2 p -127.12 23.01 6.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.57 1.148 . . . . 3.4500000000000002 110.718 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.6 t 58.46 -136.42 0.91 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.613 0.765 . . . . 3.9900000000000002 111.049 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 52.91 -81.19 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.829 1.652 . . . . 3.0800000000000001 112.317 -171.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.61 13.78 0.94 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.662 1.185 . . . . 1.54 111.727 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.3 m -71.6 -61.36 1.81 Allowed 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 121.255 -0.903 . . . . 1.27 109.393 -167.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -60.1 -33.26 71.86 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.278 0.561 . . . . 0.66000000000000003 111.552 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.26 -53.41 57.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 119.15 -0.452 . . . . 0.48999999999999999 110.791 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.2 mmt-85 -54.81 -49.79 70.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.683 0.674 . . . . 4.0899999999999999 111.048 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.495 HD11 ' CD2' ' A' ' 69' ' ' TYR . 83.0 mt -48.45 -60.68 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.944 -0.762 . . . . 0.55000000000000004 108.944 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.461 ' HG2' HG21 ' A' ' 46' ' ' VAL . 1.9 tm-20 -69.19 -38.79 78.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 118.8 -1.16 . . . . 3.4199999999999999 109.801 -173.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -58.3 -28.37 64.93 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.086 -1.633 . . . . 1.26 112.365 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.53 -52.08 52.48 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 110.732 -0.947 . . . . 0.37 110.732 165.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.564 HD22 HG12 ' A' ' 60' ' ' ILE . 89.9 mt -64.03 -29.93 71.04 Favored 'General case' 0 C--O 1.223 -0.29 0 O-C-N 121.551 -0.97 . . . . 0.35999999999999999 112.966 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -55.08 -18.7 5.82 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.596 1.089 . . . . 1.9299999999999999 111.957 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -86.18 -14.82 42.85 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.753 1.16 . . . . 2.96 114.042 171.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.446 ' O ' HG12 ' A' ' 34' ' ' VAL . 82.2 mmm -73.12 138.43 79.0 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 120.01 1.277 . . . . 2.1400000000000001 112.313 -170.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.06 91.88 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.801 3.001 . . . . 0.5 111.268 -171.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.57 -11.0 4.03 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.606 -0.998 . . . . 0.22 110.606 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 31' ' ' MET . 6.5 p -61.92 145.97 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 118.286 1.043 . . . . 0.31 110.507 168.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.07 -67.79 0.89 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.09 -1.078 . . . . 0.5 108.09 162.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -149.86 126.83 11.17 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 113.628 0.973 . . . . 3.5299999999999998 113.628 -163.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.14 150.76 21.25 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.367 1.867 . . . . 1.1000000000000001 110.4 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.78 100.06 2.19 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.46 0.704 . . . . 1.8600000000000001 109.266 174.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.83 140.73 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.535 0.734 . . . . 0.81999999999999995 111.476 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -136.79 69.52 1.41 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.701 1.6 . . . . 1.26 111.566 -174.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.6 mt -65.61 -15.58 62.88 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 113.32 0.859 . . . . 0.78000000000000003 113.32 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.93 -17.08 5.68 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.715 0.406 . . . . 0.56999999999999995 111.292 168.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.1 m -136.59 18.91 3.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.923 1.289 . . . . 0.57999999999999996 109.735 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 47.67 32.36 2.51 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.716 1.206 . . . . 3.0299999999999998 112.164 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 m -127.97 151.53 49.01 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.806 -1.183 . . . . 0.53000000000000003 107.806 -168.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.461 HG21 ' HG2' ' A' ' 25' ' ' GLU . 8.9 p -134.0 142.41 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 109.003 -0.74 . . . . 0.65000000000000002 109.003 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -116.59 142.53 46.76 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.294 -1.372 . . . . 2.5699999999999998 107.294 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.38 140.38 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.945 -0.391 . . . . 0.52000000000000002 109.945 172.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.4 mt -100.68 127.47 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.725 -1.583 . . . . 1.01 106.725 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -149.82 171.42 16.77 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.914 0.886 . . . . 1.73 110.565 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -105.11 106.4 55.49 Favored Pre-proline 0 N--CA 1.446 -0.649 0 C-N-CA 124.951 1.3 . . . . 1.79 110.606 -177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -70.79 20.98 0.21 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 124.016 3.144 . . . . 0.53000000000000003 113.322 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.93 -41.38 14.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.926 -1.139 . . . . 0.42999999999999999 107.926 168.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -103.64 -50.04 3.52 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.502 1.521 . . . . 2.7599999999999998 110.433 176.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 m -127.29 131.84 50.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 128.506 2.722 . . . . 0.73999999999999999 117.978 -160.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.65 -161.46 12.26 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 108.998 -1.641 . . . . 0.54000000000000004 108.998 154.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 t -31.5 -44.97 0.08 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.888 2.875 . . . . 0.56000000000000005 113.34 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.37 -56.84 6.09 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.857 0.753 . . . . 0.32000000000000001 112.674 174.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.78 -36.38 65.06 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 122.535 1.16 . . . . 0.23999999999999999 109.261 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.564 HG12 HD22 ' A' ' 28' ' ' LEU . 1.5 mt -64.36 -54.88 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.165 -1.38 . . . . 0.67000000000000004 110.72 -172.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -51.01 37.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.144 1.338 . . . . 0.72999999999999998 110.756 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -42.93 -56.36 3.32 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.09 0.956 . . . . 2.3599999999999999 112.44 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -41.89 74.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.901 -0.719 . . . . 1.8100000000000001 111.189 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.554 HD11 HD11 ' A' ' 28' ' ' LEU . 6.9 mm -53.18 -44.92 53.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.368 0.667 . . . . 0.40999999999999998 110.357 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -50.8 -52.93 36.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.247 0.619 . . . . 1.6100000000000001 110.077 174.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -37.54 87.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.662 0.785 . . . . 5.6399999999999997 112.511 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.44 -19.92 6.57 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.554 0.742 . . . . 2.2000000000000002 111.862 168.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.65 28.69 6.92 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.343 0.973 . . . . 0.33000000000000002 110.844 170.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.495 ' CD2' HD11 ' A' ' 24' ' ' ILE . 72.6 m-85 -142.98 171.51 13.96 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.975 -1.12 . . . . 1.75 107.975 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.07 128.81 47.96 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.679 -1.6 . . . . 4.2300000000000004 106.679 173.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.42 142.25 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 119.021 -0.514 . . . . 0.54000000000000004 109.629 170.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.23 161.65 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.222 -0.658 . . . . 1.1399999999999999 109.222 173.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.1 mm -125.28 90.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.676 1.191 . . . . 1.05 107.976 171.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -145.7 117.08 7.96 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 104.981 -2.229 . . . . 4.5099999999999998 104.981 169.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.86 -49.32 0.49 Allowed Glycine 0 CA--C 1.524 0.631 0 CA-C-N 119.668 1.122 . . . . 4.5499999999999998 113.406 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.23 0 N-CA-C 105.456 -2.053 . . . . 8.0399999999999991 105.456 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.0 mtp . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 107.167 -1.42 . . . . 8.2300000000000004 107.167 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.29 73.65 0.16 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.897 1.279 . . . . 6.4299999999999997 111.71 175.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 m -130.71 134.87 47.28 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.607 -1.257 . . . . 3.0099999999999998 107.607 -177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.17 154.48 30.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.458 -1.312 . . . . 2.8799999999999999 107.458 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -95.27 169.02 10.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.009 0.924 . . . . 0.68999999999999995 110.758 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -149.6 160.89 43.12 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.24 0.543 . . . . 2.3100000000000001 111.466 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -84.61 144.82 28.37 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.399 1.48 . . . . 2.21 109.133 168.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 tp -124.47 154.32 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.234 -1.765 . . . . 1.24 106.234 165.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.0 129.56 21.41 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.498 1.119 . . . . 0.29999999999999999 109.088 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -156.86 173.5 16.89 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.511 0.725 . . . . 1.5 110.756 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -100.67 148.52 24.77 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.045 1.338 . . . . 3.3700000000000001 109.781 -174.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -118.46 161.99 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.19 0.996 . . . . 0.56000000000000005 109.346 -176.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -127.32 128.52 46.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.245 1.018 . . . . 0.75 108.901 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.57 -10.72 21.56 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.438 1.018 . . . . 1.4399999999999999 113.087 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.31 115.66 3.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.919 1.359 . . . . 2.9900000000000002 109.5 174.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.2 t -57.3 -41.28 79.54 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.531 -0.747 . . . . 4.2400000000000002 110.556 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.8 t 148.17 -40.76 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.387 2.275 . . . . 4.0899999999999999 111.359 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.4 -160.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.416 0.686 . . . . 3.77 110.735 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.62 39.26 0.1 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.816 -1.177 . . . . 1.52 113.063 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -72.07 -60.3 2.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.47 1.908 . . . . 1.1299999999999999 109.657 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.416 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -58.27 -33.35 69.31 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.234 0.54 . . . . 0.68999999999999995 111.643 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.77 -47.08 67.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.633 0.373 . . . . 0.42999999999999999 111.508 169.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -64.1 -47.19 81.0 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.21 0.604 . . . . 4.7000000000000002 110.043 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.438 HD11 ' CD2' ' A' ' 69' ' ' TYR . 62.0 mt -48.11 -60.09 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.283 -1.006 . . . . 0.58999999999999997 108.283 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -70.3 -35.63 73.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.168 -0.613 . . . . 2.3399999999999999 110.689 -171.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -58.01 -33.22 68.71 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 120.664 -1.272 . . . . 1.23 111.308 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.3 -47.26 83.61 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 110.366 -1.093 . . . . 0.28999999999999998 110.366 167.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 64' ' ' ILE . 91.7 mt -64.21 -29.22 70.34 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 118.625 1.212 . . . . 0.33000000000000002 112.428 175.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HA ' HG11 ' A' ' 34' ' ' VAL . 6.1 ttmm -59.89 -17.38 36.69 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.513 1.052 . . . . 1.72 111.243 173.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.75 -16.24 57.44 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.067 1.136 . . . . 3.5299999999999998 114.067 169.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.506 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -76.77 136.82 66.74 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 120.809 1.641 . . . . 2.5699999999999998 112.425 -171.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.71 99.32 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.867 3.045 . . . . 0.47999999999999998 110.995 -173.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.66 -15.79 4.08 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.304 -1.119 . . . . 0.22 110.304 177.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 31' ' ' MET . 8.5 p -67.81 150.93 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 O-C-N 122.047 -0.678 . . . . 0.28999999999999998 110.943 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.78 -65.3 1.19 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.812 -1.181 . . . . 0.41999999999999998 107.812 165.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -147.03 132.66 18.8 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 112.702 0.63 . . . . 3.3599999999999999 112.702 -163.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.8 136.77 50.63 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.902 1.681 . . . . 0.58999999999999997 108.55 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -139.73 112.96 8.25 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.591 1.156 . . . . 1.3400000000000001 108.325 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -84.5 141.07 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.183 0.993 . . . . 0.59999999999999998 110.444 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -137.03 65.32 1.51 Allowed 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.544 -1.28 . . . . 2.52 107.544 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 47.6 mt -63.23 -17.38 62.39 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 121.671 -0.643 . . . . 0.68999999999999995 112.281 174.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.28 -16.28 8.16 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.482 0.713 . . . . 0.65000000000000002 111.551 169.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.4 m -136.07 19.16 3.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.626 1.171 . . . . 0.54000000000000004 109.325 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 48.27 40.86 15.12 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.114 0.966 . . . . 3.3999999999999999 111.46 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.8 m -137.85 155.55 48.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.275 -1.38 . . . . 0.56000000000000005 107.275 -171.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.8 p -134.37 148.85 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 107.635 -1.246 . . . . 0.41999999999999998 107.635 170.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.73 150.23 43.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.973 0.796 . . . . 2.6800000000000002 109.273 171.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.99 142.73 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.841 -0.8 . . . . 0.35999999999999999 108.841 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.2 mt -104.01 127.57 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 126.675 1.99 . . . . 1.0 106.781 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -152.14 170.23 20.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.311 0.645 . . . . 1.74 110.143 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -104.21 113.09 65.53 Favored Pre-proline 0 N--CA 1.44 -0.961 0 CA-C-N 115.01 -0.996 . . . . 1.3100000000000001 110.145 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -68.8 10.35 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.799 3.0 . . . . 0.48999999999999999 113.634 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.57 -43.05 21.25 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 108.353 -0.98 . . . . 0.44 108.353 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -98.53 -44.97 6.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.319 1.447 . . . . 2.8500000000000001 110.0 176.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 m -138.04 130.91 29.87 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 118.915 2.931 . . . . 0.77000000000000002 118.915 -155.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.6 -157.82 9.27 Favored Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 108.385 -1.886 . . . . 0.54000000000000004 108.385 155.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.272 0.0 OUTLIER -32.17 -46.09 0.12 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.285 2.634 . . . . 0.53000000000000003 113.504 175.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.81 -57.43 4.9 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.001 0.741 . . . . 0.28999999999999998 113.001 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.02 -38.33 64.09 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 122.091 0.948 . . . . 0.19 109.225 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.616 HG12 HD22 ' A' ' 28' ' ' LEU . 1.3 mt -63.11 -58.87 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 114.347 -1.297 . . . . 0.63 109.601 -172.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.6 -51.74 15.06 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.753 1.16 . . . . 0.81000000000000005 110.971 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -42.81 -55.49 3.64 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.15 0.98 . . . . 2.1699999999999999 112.066 174.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.56 -40.5 73.3 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.146 -0.622 . . . . 2.0699999999999998 110.82 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.813 HD11 HD11 ' A' ' 28' ' ' LEU . 36.5 mm -54.56 -45.99 71.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 118.863 0.756 . . . . 0.42999999999999999 110.007 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -50.49 -51.9 43.15 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.232 0.539 . . . . 2.23 109.792 172.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -42.3 98.91 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.559 0.577 . . . . 3.7000000000000002 112.559 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mp -52.45 -19.69 2.37 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.917 1.287 . . . . 2.3999999999999999 111.875 169.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.21 29.26 9.08 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.327 -1.109 . . . . 0.34999999999999998 110.327 173.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.438 ' CD2' HD11 ' A' ' 24' ' ' ILE . 72.6 m-85 -137.98 162.88 32.95 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.098 -1.445 . . . . 1.7 107.098 177.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.782 ' HE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -115.84 134.6 54.83 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.122 -1.807 . . . . 3.8100000000000001 106.122 171.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.63 150.04 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.604 0.762 . . . . 0.41999999999999998 110.444 168.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.782 HG13 ' HE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -105.29 169.11 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.672 0.789 . . . . 1.1499999999999999 109.532 171.054 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.7 mm -121.82 82.49 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 125.259 1.424 . . . . 1.1299999999999999 108.17 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -135.45 85.75 2.19 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 107.197 -1.409 . . . . 4.8799999999999999 107.197 176.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.52 -120.6 0.55 Allowed Glycine 0 CA--C 1.521 0.453 0 N-CA-C 107.551 -2.219 . . . . 3.7599999999999998 107.551 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.101 0 C-N-CA 126.255 1.822 . . . . 7.3099999999999996 113.663 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ptt? . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 107.374 -1.343 . . . . 10.050000000000001 107.374 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.63 145.43 52.2 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 123.868 0.73 . . . . 5.7999999999999998 110.291 173.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p -88.81 142.23 27.84 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.62 1.168 . . . . 3.27 108.648 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -127.78 106.02 8.84 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.207 1.003 . . . . 3.2999999999999998 109.247 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -83.19 160.13 21.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.036 -0.529 . . . . 0.82999999999999996 111.357 -175.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -149.08 158.55 44.27 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.109 -0.7 . . . . 2.73 109.109 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -91.03 141.0 29.31 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.685 -1.143 . . . . 2.8900000000000001 109.51 168.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.95 138.08 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 105.407 -2.072 . . . . 3.1899999999999999 105.407 170.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.55 125.65 48.35 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.421 1.488 . . . . 0.42999999999999999 108.036 176.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -154.88 164.69 38.48 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.485 0.584 . . . . 1.1899999999999999 110.697 -175.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.419 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -96.47 151.59 19.42 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.09 0.956 . . . . 1.76 109.575 -173.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 t -116.1 161.21 15.01 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 C-N-CA 123.139 0.575 . . . . 0.68999999999999995 109.904 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -127.72 123.28 35.04 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.963 1.305 . . . . 0.83999999999999997 108.711 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.6 -20.03 8.92 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.861 1.22 . . . . 1.4299999999999999 113.057 170.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.47 148.82 1.82 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.98 1.312 . . . . 3.5299999999999998 112.477 175.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.9 p -135.26 40.4 2.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.556 0.742 . . . . 3.4500000000000002 110.582 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.5 t 58.68 -140.05 0.75 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.654 -1.165 . . . . 3.9700000000000002 110.934 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 37.89 48.06 0.97 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.207 1.803 . . . . 2.46 114.818 172.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 57.19 24.34 9.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.549 1.14 . . . . 1.3100000000000001 113.663 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.1 m -72.04 -60.66 2.12 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 123.914 0.886 . . . . 1.3600000000000001 109.153 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -63.43 -23.79 67.56 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.497 -0.752 . . . . 0.80000000000000004 112.218 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.51 -45.24 81.16 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 121.64 -0.663 . . . . 0.34999999999999998 110.798 167.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.3 mmp_? -58.91 -47.91 83.32 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.449 1.022 . . . . 4.8300000000000001 110.321 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 21' ' ' ALA . 77.0 mt -47.21 -60.8 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.809 -0.811 . . . . 0.53000000000000003 108.809 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -72.11 -34.15 68.38 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 119.968 -0.693 . . . . 2.5499999999999998 111.707 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm -55.69 -36.65 67.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 120.858 -1.151 . . . . 2.6200000000000001 111.028 175.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.46 -54.64 12.55 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.187 -1.165 . . . . 0.34000000000000002 110.187 166.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.606 HD22 HG12 ' A' ' 60' ' ' ILE . 89.0 mt -63.74 -32.73 74.32 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 112.885 0.698 . . . . 0.31 112.885 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -57.62 -17.54 15.04 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.229 0.922 . . . . 1.29 111.796 172.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.7 -11.3 48.68 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.694 1.368 . . . . 4.4400000000000004 114.694 170.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.469 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -70.24 138.62 86.96 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 121.278 1.854 . . . . 3.23 111.856 -177.536 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.52 90.69 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.605 2.87 . . . . 0.48999999999999999 111.079 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.82 -7.67 3.57 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.756 1.17 . . . . 0.28000000000000003 111.341 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 31' ' ' MET . 5.2 p -67.4 160.29 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 118.271 1.035 . . . . 0.28999999999999998 110.806 164.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.73 -59.55 1.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.767 1.227 . . . . 0.40000000000000002 108.659 168.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -145.13 162.91 35.9 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 112.477 0.547 . . . . 2.3100000000000001 112.477 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.54 123.51 12.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.086 1.754 . . . . 0.88 109.625 -173.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -135.64 119.62 17.48 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.423 1.489 . . . . 1.5600000000000001 109.284 -172.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -91.93 139.13 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.127 0.971 . . . . 0.66000000000000003 110.545 -176.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -131.08 66.69 1.53 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.833 1.653 . . . . 1.23 111.143 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.4 mt -67.01 -15.92 64.03 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 113.113 0.782 . . . . 0.81000000000000005 113.113 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.81 -24.84 9.74 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.66 0.384 . . . . 0.76000000000000001 110.622 167.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.0 m -128.55 19.99 6.18 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.213 1.405 . . . . 0.60999999999999999 110.044 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 47.58 35.01 3.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.188 0.995 . . . . 2.7999999999999998 112.145 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.4 m -132.52 152.03 51.71 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.118 -1.068 . . . . 0.46999999999999997 108.118 -168.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.2 p -133.96 147.47 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.367 0.667 . . . . 0.45000000000000001 109.389 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -121.34 129.13 52.91 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.1 1.36 . . . . 2.6000000000000001 108.464 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.92 137.1 51.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.021 -0.733 . . . . 0.39000000000000001 109.021 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.4 mp -108.55 120.77 60.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.012 1.325 . . . . 1.26 108.134 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -144.36 171.37 14.42 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.186 0.994 . . . . 1.73 110.877 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -108.39 111.73 61.36 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 124.979 1.312 . . . . 1.79 111.15 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -76.83 30.13 0.41 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.747 2.964 . . . . 0.70999999999999996 112.711 -172.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.96 -50.16 5.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.77 -1.567 . . . . 0.40999999999999998 106.77 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.16 -43.52 7.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.16 1.784 . . . . 2.8700000000000001 110.495 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.6 m -133.93 127.3 32.17 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 116.45 2.019 . . . . 0.53000000000000003 116.45 -159.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.89 -164.23 13.32 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 108.898 -1.681 . . . . 0.46999999999999997 108.898 153.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.2 t -34.78 -40.39 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.706 2.802 . . . . 0.67000000000000004 112.831 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.0 -54.46 8.34 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.907 0.883 . . . . 0.42999999999999999 113.233 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.63 -36.83 65.49 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.924 1.345 . . . . 0.34000000000000002 109.642 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.606 HG12 HD22 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -70.82 -50.16 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 113.309 -1.768 . . . . 0.54000000000000004 110.903 -164.294 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.75 -52.34 49.46 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.388 1.449 . . . . 0.76000000000000001 109.034 172.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.46 -45.66 46.98 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.708 1.203 . . . . 5.04 112.294 -177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -44.59 60.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 120.247 -1.533 . . . . 2.9900000000000002 112.823 172.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.473 HD11 HD11 ' A' ' 28' ' ' LEU . 4.1 mm -51.43 -44.93 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.986 1.315 . . . . 0.42999999999999999 110.707 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -49.73 -47.53 50.64 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.453 0.644 . . . . 1.5600000000000001 110.361 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -32.65 67.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.249 1.02 . . . . 5.5199999999999996 112.292 -177.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.45 -25.62 37.47 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 119.385 -0.34 . . . . 0.93000000000000005 110.239 166.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.31 29.22 5.78 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.542 1.068 . . . . 0.37 110.823 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -142.86 165.73 26.57 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.273 -1.01 . . . . 1.74 108.273 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.95 125.68 48.02 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.267 -1.753 . . . . 4.2999999999999998 106.267 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -96.78 143.06 13.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 O-C-N 123.751 0.657 . . . . 0.46000000000000002 109.894 172.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.3 m -97.21 161.82 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.425 -0.583 . . . . 1.1799999999999999 109.425 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.4 mm -125.74 74.35 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 108.083 -1.08 . . . . 1.0700000000000001 108.083 172.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -125.36 90.19 3.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.798 -1.927 . . . . 4.4900000000000002 105.798 168.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.82 89.24 0.07 OUTLIER Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.058 -2.017 . . . . 4.8499999999999996 108.058 -174.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 C--O 1.253 1.274 0 CA-C-O 116.246 -1.835 . . . . 9.25 107.159 168.043 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 106.175 -1.787 . . . . 9.25 106.175 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.1 tp 75.25 70.81 0.09 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.657 1.223 . . . . 7.2400000000000002 111.876 170.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.2 m -139.56 150.21 44.78 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 106.644 -1.613 . . . . 3.3199999999999998 106.644 170.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -157.27 148.4 21.75 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.003 -1.11 . . . . 4.1299999999999999 108.003 169.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.463 HE22 HG21 ' A' ' 35' ' ' THR . 7.0 pt20 -85.77 162.55 18.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.952 0.901 . . . . 0.96999999999999997 111.437 -177.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -154.68 158.49 39.7 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 122.011 0.91 . . . . 3.3199999999999998 111.177 178.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -84.03 114.13 21.51 Favored 'General case' 0 N--CA 1.452 -0.332 1 C-N-CA 131.984 4.113 . . . . 2.2999999999999998 107.363 174.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.48 149.3 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 105.803 -1.925 . . . . 2.46 105.803 164.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.73 123.73 18.94 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.602 1.561 . . . . 0.38 108.261 176.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -157.49 166.71 32.23 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.941 0.496 . . . . 1.1499999999999999 111.78 -171.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -101.44 140.09 36.2 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.069 1.748 . . . . 3.2799999999999998 108.855 -169.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.92 142.12 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 123.487 0.715 . . . . 0.85999999999999999 110.166 -177.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -86.76 116.46 24.87 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.136 -1.061 . . . . 1.01 108.136 173.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.05 73.24 1.24 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.965 -0.854 . . . . 2.7400000000000002 110.965 179.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -129.82 -174.86 3.43 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.366 1.866 . . . . 3.4199999999999999 107.244 175.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 t 47.25 43.28 14.68 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.59 1.156 . . . . 6.8799999999999999 112.849 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.43 51.54 2.0 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.755 0.788 . . . . 7.0599999999999996 109.794 -175.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 77.79 74.02 0.06 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.75 2.02 . . . . 3.23 110.996 -173.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.72 34.09 17.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.998 1.319 . . . . 1.23 112.67 171.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.2 m -70.74 -63.01 1.18 Allowed 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 121.602 -0.686 . . . . 1.6499999999999999 110.8 -168.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -57.25 -35.14 69.36 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.373 0.533 . . . . 1.0700000000000001 110.688 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.48 -55.94 27.5 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.452 -0.34 . . . . 0.55000000000000004 111.22 173.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -59.08 -49.85 76.33 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.425 0.557 . . . . 3.9500000000000002 110.74 177.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 21' ' ' ALA . 66.7 mt -45.67 -59.88 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.767 1.227 . . . . 0.57999999999999996 108.723 177.392 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -70.84 -35.74 72.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.383 -0.371 . . . . 2.3100000000000001 110.715 -173.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -59.15 -30.44 68.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.06 -1.025 . . . . 1.26 110.872 174.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.56 -52.33 48.8 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 110.743 -0.943 . . . . 0.32000000000000001 110.743 164.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.664 HD11 HD11 ' A' ' 64' ' ' ILE . 95.6 mt -63.0 -29.93 71.2 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.268 -1.136 . . . . 0.32000000000000001 113.13 177.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -54.74 -18.96 5.32 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.246 0.93 . . . . 1.8899999999999999 111.924 170.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.29 -15.03 48.13 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.022 1.119 . . . . 2.98 114.022 171.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.462 ' O ' HG12 ' A' ' 34' ' ' VAL . 93.2 mmm -76.89 137.8 65.94 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 120.252 1.387 . . . . 1.97 112.424 -172.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.71 101.08 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.513 2.808 . . . . 0.55000000000000004 110.922 -173.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.39 -13.29 5.16 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 124.981 1.277 . . . . 0.25 110.151 175.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 31' ' ' MET . 5.8 p -64.01 147.51 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 117.806 0.803 . . . . 0.31 110.676 169.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.463 HG21 HE22 ' A' ' 5' ' ' GLN . 0.1 OUTLIER -110.67 -60.44 1.82 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.986 1.315 . . . . 0.53000000000000003 110.407 168.563 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -154.43 148.88 26.2 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 115.401 1.63 . . . . 2.5299999999999998 115.401 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.3 142.23 42.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.265 1.426 . . . . 0.69999999999999996 110.825 -176.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -145.38 102.3 3.7 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.171 -1.048 . . . . 3.7799999999999998 108.171 -170.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.5 p -83.79 134.32 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.296 0.638 . . . . 0.80000000000000004 110.889 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -131.12 70.12 1.47 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.075 -1.083 . . . . 2.4900000000000002 108.075 -177.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.4 mt -64.02 -24.65 67.79 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.502 -0.749 . . . . 1.2 111.954 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.38 -24.25 28.79 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.08 0.552 . . . . 0.82999999999999996 111.03 171.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.6 m -118.97 11.44 12.5 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.372 1.469 . . . . 1.0600000000000001 110.309 -179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 46.4 47.96 13.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.053 0.842 . . . . 2.23 111.673 -178.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.47 159.02 39.47 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.12 -1.067 . . . . 1.3200000000000001 108.12 -174.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.2 p -125.68 146.92 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 108.558 -0.905 . . . . 0.46000000000000002 108.558 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -117.44 141.5 48.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.711 1.205 . . . . 2.4300000000000002 108.351 176.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.05 132.24 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.695 -0.483 . . . . 0.35999999999999999 109.695 173.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.5 mt -91.86 126.2 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.387 1.875 . . . . 0.71999999999999997 106.871 176.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -147.5 173.86 12.26 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.428 0.691 . . . . 1.95 111.114 176.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -110.44 120.03 45.14 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 124.366 1.066 . . . . 1.4299999999999999 110.965 -178.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -69.33 7.28 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 124.596 3.531 . . . . 0.55000000000000004 113.575 -178.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.49 -37.22 37.27 Favored 'General case' 0 C--O 1.23 0.052 0 N-CA-C 108.644 -0.873 . . . . 0.69999999999999996 108.644 176.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -114.88 -53.82 2.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.571 1.549 . . . . 2.77 110.041 -179.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 m -104.34 129.99 52.2 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 128.233 2.613 . . . . 0.90000000000000002 117.343 -172.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.25 -173.36 22.44 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 109.779 -1.328 . . . . 0.48999999999999999 109.779 151.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.3 t -35.24 -41.14 0.15 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.556 2.742 . . . . 0.57999999999999996 112.414 174.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.77 -57.19 5.9 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.981 0.734 . . . . 0.29999999999999999 112.981 173.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.47 66.43 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 122.338 1.066 . . . . 0.22 108.835 -176.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.589 HG12 HD22 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -62.02 -58.04 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 114.012 -1.449 . . . . 0.62 110.082 -174.4 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.47 -51.1 15.93 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.681 1.128 . . . . 0.78000000000000003 110.823 175.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -45.31 -51.85 10.48 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.406 0.683 . . . . 2.3399999999999999 112.342 177.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -43.68 67.37 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 118.17 -0.919 . . . . 2.0800000000000001 111.667 177.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.664 HD11 HD11 ' A' ' 28' ' ' LEU . 24.7 mm -52.4 -45.71 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 119.698 1.135 . . . . 0.32000000000000001 110.196 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -49.46 -47.04 48.62 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.26 0.624 . . . . 1.6299999999999999 110.11 172.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -36.57 74.2 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.674 0.79 . . . . 4.4400000000000004 112.318 -178.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -54.46 -22.76 13.62 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.837 0.455 . . . . 0.92000000000000004 110.41 169.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.13 28.51 5.81 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 110.444 -1.063 . . . . 0.39000000000000001 110.444 170.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -144.61 169.17 18.49 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.638 -1.245 . . . . 2.0 107.638 -177.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.713 ' HE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -119.08 135.53 54.59 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.358 -1.719 . . . . 3.8300000000000001 106.358 172.038 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -98.36 147.67 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.056 0.942 . . . . 0.46999999999999997 109.549 167.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.713 HG13 ' HE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -101.59 160.92 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.032 -0.729 . . . . 1.0700000000000001 109.032 169.539 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.6 mm -121.32 79.85 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.232 -1.395 . . . . 1.0800000000000001 107.232 172.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -102.19 120.19 40.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 105.433 -2.062 . . . . 4.3200000000000003 105.433 168.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.48 -50.34 0.2 Allowed Glycine 0 C--N 1.338 0.689 0 CA-C-N 118.817 0.735 . . . . 3.6499999999999999 112.507 -176.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.0 tpp85 . . . . . 0 C--O 1.253 1.257 0 CA-C-O 116.785 -1.579 . . . . 7.9100000000000001 107.795 167.893 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.485 -0.561 . . . . 8.0899999999999999 109.485 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mp -65.74 166.36 11.06 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.341 -0.615 . . . . 6.8700000000000001 109.341 171.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.0 m -109.12 158.49 17.73 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.957 1.303 . . . . 2.5899999999999999 107.863 170.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -146.33 148.83 32.79 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.105 -1.443 . . . . 4.1299999999999999 107.105 174.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -107.02 171.78 7.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.329 1.051 . . . . 0.69999999999999996 110.738 -172.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.76 159.88 40.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.764 0.792 . . . . 3.73 111.854 -179.341 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.12 135.77 34.26 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.496 -1.684 . . . . 2.4900000000000002 108.232 169.248 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 tp -109.44 151.04 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 105.843 -1.91 . . . . 1.0900000000000001 105.843 161.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.62 123.65 16.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.997 1.319 . . . . 0.40999999999999998 107.85 176.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.6 ptt? -157.7 172.16 19.01 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.713 0.405 . . . . 1.0800000000000001 110.292 -170.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -102.74 150.08 23.82 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.401 1.08 . . . . 3.2000000000000002 110.123 -171.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.71 167.89 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 C-N-CA 123.684 0.794 . . . . 0.78000000000000003 109.706 -178.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t -136.14 129.89 32.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.287 1.035 . . . . 0.77000000000000002 108.829 176.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.77 -17.89 20.04 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.647 1.117 . . . . 1.4099999999999999 113.628 171.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.4 123.56 12.34 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.457 1.128 . . . . 3.0899999999999999 112.213 178.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 p -96.58 30.47 2.58 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.247 0.619 . . . . 3.6499999999999999 110.747 175.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.473 ' HA ' HD13 ' A' ' 41' ' ' LEU . 1.8 t 70.73 -159.99 0.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.899 1.28 . . . . 3.9199999999999999 111.461 174.345 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 47.02 -136.93 0.79 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.06 0.944 . . . . 3.71 110.567 -173.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.18 7.95 6.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.112 0.782 . . . . 1.1399999999999999 113.112 -175.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.3 m -69.01 -60.08 2.6 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.759 1.163 . . . . 1.45 110.301 -164.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.69 -27.79 69.45 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.88 -0.512 . . . . 0.68999999999999995 112.28 176.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.91 -50.81 67.88 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.686 -0.487 . . . . 0.38 109.686 168.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -59.4 -45.1 92.43 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 118.481 -0.771 . . . . 3.6400000000000001 111.99 174.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.7 mt -46.96 -59.95 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.359 -0.608 . . . . 0.55000000000000004 109.359 176.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -70.13 -41.18 74.26 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 119.634 -0.826 . . . . 3.5800000000000001 109.993 -173.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -52.15 -35.6 48.99 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 120.423 -1.423 . . . . 1.77 112.089 179.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.26 -52.12 33.42 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 110.921 -0.872 . . . . 0.38 110.921 167.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 64' ' ' ILE . 73.1 mt -66.94 -27.76 67.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 118.51 -0.757 . . . . 0.60999999999999999 112.587 177.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -59.87 -16.99 33.43 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 119.614 1.097 . . . . 1.4199999999999999 110.566 171.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.36 -8.83 58.25 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.013 1.116 . . . . 3.3999999999999999 114.013 171.297 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.507 ' O ' HG12 ' A' ' 34' ' ' VAL . 9.5 mmt -71.75 138.67 82.91 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 120.304 1.411 . . . . 2.0699999999999998 111.722 -175.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.28 90.82 0.57 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.263 2.642 . . . . 0.52000000000000002 110.793 -175.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.27 -16.33 2.1 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.483 1.04 . . . . 0.25 111.495 -179.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 31' ' ' MET . 5.5 p -70.82 156.02 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 O-C-N 121.674 -0.897 . . . . 0.28000000000000003 111.409 171.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.22 -62.58 1.57 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.424 1.09 . . . . 0.54000000000000004 109.126 166.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -147.76 142.25 26.45 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 112.502 0.556 . . . . 3.02 112.502 -169.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.86 157.09 17.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.237 1.815 . . . . 1.1299999999999999 109.333 178.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.54 95.82 1.83 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.042 -1.095 . . . . 2.0499999999999998 108.042 177.046 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.12 140.24 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 121.917 -0.49 . . . . 0.73999999999999999 111.449 -178.231 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -137.02 69.94 1.41 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.148 1.379 . . . . 2.48 109.092 -174.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 17' ' ' CYS . 68.7 mt -65.69 -16.56 63.87 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 115.565 -0.743 . . . . 0.76000000000000001 112.932 177.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.6 -22.5 8.72 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.543 0.737 . . . . 0.70999999999999996 110.741 169.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.9 m -133.05 21.22 4.1 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.938 0.895 . . . . 0.75 109.854 179.064 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 50.37 34.7 9.46 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.058 0.844 . . . . 3.0499999999999998 112.069 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.6 m -128.53 152.57 48.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.644 1.178 . . . . 0.55000000000000004 107.876 -168.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 p -135.14 143.57 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.844 -0.798 . . . . 0.64000000000000001 108.844 173.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -119.24 145.27 46.21 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.848 1.259 . . . . 2.4700000000000002 107.969 176.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.86 139.03 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.629 -0.508 . . . . 0.39000000000000001 109.629 174.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.9 mt -101.05 119.2 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 126.96 2.104 . . . . 0.88 107.196 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.448 ' CE2' HD13 ' A' ' 60' ' ' ILE . 2.1 p90 -146.35 168.87 20.06 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.398 1.079 . . . . 2.02 109.593 -178.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -101.65 115.63 64.63 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 118.385 -0.817 . . . . 2.0699999999999998 109.278 177.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -68.63 7.6 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.747 2.965 . . . . 0.77000000000000002 113.646 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.21 -55.54 5.18 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 107.441 -1.318 . . . . 0.75 107.441 172.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -88.18 -30.75 19.53 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.435 1.094 . . . . 3.9300000000000002 112.109 176.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.9 m -148.47 121.4 8.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 117.677 2.473 . . . . 0.72999999999999998 117.677 -157.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.69 -166.79 23.14 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.588 -1.005 . . . . 0.53000000000000003 110.588 159.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 t -29.61 -46.68 0.06 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.499 3.119 . . . . 0.57999999999999996 112.841 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.42 -58.42 3.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.048 0.939 . . . . 0.37 113.155 173.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.18 -34.19 65.86 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 122.511 1.148 . . . . 0.23999999999999999 109.554 -178.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.477 HG12 HD13 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -66.57 -52.86 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 117.199 -1.381 . . . . 0.73999999999999999 110.928 -171.887 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -50.16 40.44 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 121.04 1.746 . . . . 0.83999999999999997 110.922 175.229 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -39.73 -60.27 1.01 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.904 0.882 . . . . 2.6800000000000002 112.634 172.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -70.73 -40.43 72.76 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.202 -0.999 . . . . 1.8799999999999999 110.82 -177.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.604 HD11 HD11 ' A' ' 28' ' ' LEU . 16.8 mm -53.31 -44.68 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 119.034 0.834 . . . . 0.46000000000000002 110.046 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -53.81 -45.66 70.85 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.129 0.49 . . . . 1.8200000000000001 109.772 174.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.62 -39.74 91.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.485 -0.76 . . . . 3.0699999999999998 111.354 -179.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.4 -23.58 16.32 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.443 0.697 . . . . 0.93000000000000005 110.786 171.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.95 26.93 7.25 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 124.466 1.031 . . . . 0.37 110.9 173.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -144.8 176.34 9.52 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 122.025 0.916 . . . . 1.7 109.617 -175.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.68 117.24 23.06 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 106.035 -1.839 . . . . 3.77 106.035 -171.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.9 p -96.13 142.45 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.868 -0.79 . . . . 0.47999999999999998 108.868 165.022 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.23 157.6 10.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 108.764 -0.828 . . . . 1.0900000000000001 108.764 173.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 33.7 mm -118.71 74.66 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.852 -1.166 . . . . 1.1100000000000001 107.852 -177.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -116.78 130.54 56.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.231 -2.137 . . . . 4.1299999999999999 105.231 168.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.94 -104.0 0.37 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 108.059 -2.016 . . . . 3.46 108.059 -169.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 . . . . . 0 C--O 1.251 1.132 0 CA-C-O 117.546 -1.216 . . . . 9.5899999999999999 110.119 -166.529 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ptt? . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 111.844 0.313 . . . . 12.16 111.844 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 29.5 mt -121.17 172.83 7.69 Favored 'General case' 0 CA--C 1.528 0.135 0 N-CA-C 107.29 -1.374 . . . . 6.4000000000000004 107.29 168.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 p -139.97 70.82 1.36 Allowed 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 125.265 1.426 . . . . 3.1299999999999999 107.449 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -134.38 121.76 21.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.628 1.171 . . . . 3.29 107.933 -175.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -84.6 167.25 16.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.092 -0.504 . . . . 0.98999999999999999 111.515 -173.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -139.67 152.83 47.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.521 0.677 . . . . 2.5099999999999998 109.822 179.433 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -90.34 125.92 35.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 127.036 2.134 . . . . 2.25 106.762 168.028 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 tp -109.21 151.29 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.167 -1.42 . . . . 1.1000000000000001 107.167 167.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.52 133.93 36.99 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.731 -1.211 . . . . 0.34999999999999998 107.731 170.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.75 170.92 21.34 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.439 0.462 . . . . 1.4099999999999999 111.195 175.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.443 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -92.65 152.81 19.35 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.854 0.861 . . . . 1.98 110.362 -176.498 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.57 171.56 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 123.7 0.8 . . . . 0.81000000000000005 110.034 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -130.48 131.82 45.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.782 0.833 . . . . 0.71999999999999997 110.603 176.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.15 31.51 10.74 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.667 1.127 . . . . 1.3799999999999999 113.311 169.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.24 91.44 4.74 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.92 0.86 . . . . 3.0899999999999999 110.811 -171.581 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 m -79.53 45.37 0.67 Allowed 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.27 -0.894 . . . . 4.0 112.011 -177.248 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 t 47.27 -130.01 1.52 Allowed 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 126.078 1.751 . . . . 3.8900000000000001 110.14 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 39.4 46.81 1.43 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 121.756 2.071 . . . . 2.75 113.676 178.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.36 18.08 8.94 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.202 1.401 . . . . 0.93999999999999995 114.157 179.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.4 m -71.1 -60.75 2.06 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.279 -1.008 . . . . 1.1799999999999999 108.279 -176.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.13 -43.73 61.23 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.918 0.866 . . . . 0.70999999999999996 111.284 177.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.15 -50.66 68.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.086 -0.961 . . . . 0.31 110.664 174.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -54.63 -45.24 73.7 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.574 -0.726 . . . . 4.3200000000000003 111.444 173.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.4 mt -52.46 -60.89 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.391 -0.966 . . . . 0.76000000000000001 108.391 177.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.62 -33.96 73.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.4 -0.92 . . . . 2.3599999999999999 110.615 -168.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -56.24 -36.76 68.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.092 -1.005 . . . . 1.3899999999999999 111.263 171.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.5 -44.51 90.45 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.054 -0.818 . . . . 0.29999999999999999 111.054 168.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.709 HD11 HD11 ' A' ' 64' ' ' ILE . 97.3 mt -65.6 -30.66 71.41 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 119.407 1.603 . . . . 0.33000000000000002 112.514 175.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.537 ' HA ' HG11 ' A' ' 34' ' ' VAL . 12.9 ttmt -56.62 -18.41 11.97 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.13 0.877 . . . . 1.4399999999999999 112.03 170.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 mtp85 -87.88 -5.29 58.65 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.891 -1.13 . . . . 4.3799999999999999 112.694 174.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.471 ' O ' HG12 ' A' ' 34' ' ' VAL . 95.1 mmm -82.74 136.62 44.69 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 120.389 1.45 . . . . 1.98 111.748 179.203 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.8 100.73 0.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.506 2.804 . . . . 0.35999999999999999 111.262 -173.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.37 -13.03 3.77 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.58 1.086 . . . . 0.20000000000000001 111.173 176.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.0 p -67.9 152.97 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.836 0.854 . . . . 0.27000000000000002 111.182 169.408 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.1 -60.5 1.87 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.582 1.153 . . . . 0.40999999999999998 109.356 166.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -148.66 141.59 24.76 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.239 0.459 . . . . 3.1400000000000001 112.239 -169.138 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.61 136.71 53.11 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.779 1.632 . . . . 0.59999999999999998 108.632 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -142.05 108.9 5.41 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.577 1.151 . . . . 1.3600000000000001 108.5 -177.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.4 p -89.92 142.7 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.742 0.817 . . . . 0.60999999999999999 111.772 -175.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -137.71 68.99 1.4 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.364 1.465 . . . . 1.22 111.011 -175.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.4 mt -66.71 -14.91 63.1 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 112.948 0.721 . . . . 0.75 112.948 177.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.5 -13.34 5.35 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.983 0.356 . . . . 0.53000000000000003 111.221 167.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.5 m -138.38 18.46 2.75 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.387 1.075 . . . . 0.51000000000000001 109.572 177.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 51.76 30.75 7.22 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.14 0.882 . . . . 3.1400000000000001 112.035 -179.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.4 m -129.66 153.42 48.14 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.069 -1.086 . . . . 0.51000000000000001 108.069 -167.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.4 144.47 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 108.802 -0.814 . . . . 0.45000000000000001 108.802 173.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -112.78 139.99 47.94 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.744 1.218 . . . . 2.46 108.055 176.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.44 141.2 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.249 -0.649 . . . . 0.25 109.249 171.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 mt -104.74 127.37 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.971 1.708 . . . . 0.92000000000000004 106.533 -179.054 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -152.3 171.78 17.45 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.946 0.498 . . . . 1.8799999999999999 110.098 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -111.07 120.51 43.1 Favored Pre-proline 0 N--CA 1.448 -0.563 0 O-C-N 123.944 0.777 . . . . 2.0899999999999999 111.187 -177.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.14 19.39 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.072 3.181 . . . . 0.64000000000000001 113.681 -178.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.63 -50.74 7.91 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.256 -1.387 . . . . 0.54000000000000004 107.256 169.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -96.33 -39.81 9.44 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.099 1.36 . . . . 3.5499999999999998 111.4 176.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.5 m -132.41 129.89 39.9 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 117.748 2.499 . . . . 0.54000000000000004 117.748 -155.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.76 -172.09 22.91 Favored Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 110.043 -1.223 . . . . 0.5 110.043 157.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.272 0.1 OUTLIER -29.31 -43.09 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 128.633 2.773 . . . . 0.63 113.902 169.241 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.64 -55.35 16.79 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.868 0.758 . . . . 0.34000000000000002 112.671 175.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.08 -36.24 66.78 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 122.557 1.17 . . . . 0.17999999999999999 108.966 -176.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.541 HG12 HD22 ' A' ' 28' ' ' LEU 0.257 0.9 OUTLIER -65.47 -56.56 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 113.852 -1.522 . . . . 0.55000000000000004 110.351 -172.617 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -49.61 47.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.171 1.35 . . . . 0.73999999999999999 110.913 177.255 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -42.48 -58.4 2.26 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.74 0.816 . . . . 2.2799999999999998 112.094 173.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -42.36 73.39 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 119.548 -0.861 . . . . 2.3199999999999998 111.421 -177.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.709 HD11 HD11 ' A' ' 28' ' ' LEU . 17.3 mm -51.21 -47.6 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.67 0.788 . . . . 0.39000000000000001 109.832 177.594 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -50.6 -53.47 30.38 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 121.426 0.632 . . . . 1.6100000000000001 109.678 175.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -29.3 70.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.028 0.531 . . . . 5.3399999999999999 112.412 -178.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -63.85 -20.02 65.49 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.23 0.612 . . . . 2.0899999999999999 109.783 173.173 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.26 28.76 6.65 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 125.075 1.321 . . . . 0.35999999999999999 110.618 173.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -143.85 168.47 19.88 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.122 -1.436 . . . . 1.6499999999999999 107.122 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.732 ' HE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -119.83 135.97 54.66 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.428 -1.693 . . . . 4.1500000000000004 106.428 169.435 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -100.63 142.92 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.331 1.052 . . . . 0.64000000000000001 109.722 166.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.732 HG13 ' HE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -94.65 168.76 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.692 -0.855 . . . . 1.27 108.692 173.457 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 23.5 mm -127.74 94.92 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.768 -1.567 . . . . 1.0600000000000001 106.768 170.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -47.64 102.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.965 1.306 . . . . 7.6799999999999997 112.232 174.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.87 -105.09 1.53 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.799 -0.92 . . . . 6.1299999999999999 110.799 177.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.026 0 N-CA-C 104.376 -2.453 . . . . 9.5199999999999996 104.376 166.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 mtt . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 108.078 -1.082 . . . . 10.529999999999999 108.078 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.74 173.58 11.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 106.997 -1.483 . . . . 5.5 106.997 179.473 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 p -119.71 149.86 41.31 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.647 -1.612 . . . . 2.3500000000000001 106.647 166.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -157.52 146.18 19.49 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.331 -1.359 . . . . 4.0700000000000003 107.331 173.027 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -84.88 168.96 14.58 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.994 0.918 . . . . 0.65000000000000002 111.518 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -148.8 161.75 41.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.687 -0.857 . . . . 2.8100000000000001 108.687 173.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -82.91 138.46 33.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.522 -1.288 . . . . 2.6299999999999999 107.522 162.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 tp -107.14 153.48 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 1.1100000000000001 105.713 157.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.53 128.21 17.18 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.917 -1.142 . . . . 0.35999999999999999 107.917 173.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.48 175.86 13.41 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.189 0.45 . . . . 1.2 110.866 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -94.19 149.37 21.3 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.287 1.035 . . . . 3.0699999999999998 109.279 -174.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.21 165.59 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.854 -0.795 . . . . 0.69999999999999996 108.854 177.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.42 145.46 50.3 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.643 -1.243 . . . . 1.1000000000000001 107.643 171.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.22 -21.47 35.37 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.204 0.907 . . . . 1.4099999999999999 113.441 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.8 146.17 42.74 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.461 1.13 . . . . 2.98 112.463 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.8 p -133.32 41.14 3.12 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.628 1.171 . . . . 3.4500000000000002 110.15 177.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.0 t 50.28 -140.8 0.78 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 117.538 -1.22 . . . . 4.0099999999999998 111.616 -177.265 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 36.17 57.77 1.01 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 120.564 1.529 . . . . 2.5499999999999998 113.302 177.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.66 16.72 5.65 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.218 1.407 . . . . 0.98999999999999999 114.369 176.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 91.2 m -72.54 -60.79 2.06 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 121.293 -0.88 . . . . 1.3600000000000001 109.433 -177.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.407 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -59.5 -32.18 70.04 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 121.652 0.739 . . . . 0.69999999999999996 111.665 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.4 -42.57 70.6 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 118.757 -0.64 . . . . 0.34999999999999998 111.04 171.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -61.07 -45.42 94.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.279 0.945 . . . . 3.4700000000000002 110.598 176.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.488 HD11 ' CD2' ' A' ' 69' ' ' TYR . 63.9 mt -48.35 -60.94 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.319 -0.993 . . . . 0.67000000000000004 108.319 179.098 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.28 -34.1 67.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 119.945 -0.702 . . . . 2.5800000000000001 111.838 -173.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -55.94 -37.73 69.37 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.121 -0.987 . . . . 1.73 110.736 176.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.5 -52.75 27.49 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.458 -1.057 . . . . 0.38 110.458 167.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 64' ' ' ILE . 87.0 mt -64.62 -31.1 72.17 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.591 -0.946 . . . . 0.38 112.503 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.25 23.3 ttmt -59.03 -13.73 7.52 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 119.209 0.913 . . . . 1.74 111.69 170.514 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 -1.63 40.23 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.553 -1.342 . . . . 5.4100000000000001 114.001 170.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.418 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.91 139.3 61.67 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 120.815 1.643 . . . . 3.0299999999999998 111.489 179.578 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.78 92.78 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.588 2.858 . . . . 0.37 110.429 -174.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.33 -9.65 3.79 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.562 1.077 . . . . 0.20000000000000001 111.633 177.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 31' ' ' MET . 5.8 p -66.73 157.42 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 118.054 0.927 . . . . 0.31 110.884 167.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.74 -56.41 2.12 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.989 1.316 . . . . 0.45000000000000001 110.229 168.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -143.17 157.35 44.59 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 123.081 0.553 . . . . 3.1400000000000001 109.917 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.63 134.84 39.67 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.936 1.694 . . . . 0.67000000000000004 108.165 174.413 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -142.07 116.86 9.82 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.499 1.119 . . . . 1.4199999999999999 108.833 -173.378 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.73 139.54 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.429 1.092 . . . . 0.57999999999999996 111.541 -175.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -132.37 67.77 1.52 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.628 1.571 . . . . 1.23 111.913 179.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.3 mt -65.86 -16.01 63.44 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 113.281 0.845 . . . . 0.73999999999999999 113.281 178.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.16 -19.66 8.31 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.073 0.397 . . . . 0.54000000000000004 110.997 168.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.3 m -130.48 14.9 5.51 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.907 1.283 . . . . 0.48999999999999999 110.373 178.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 51.44 35.28 13.81 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.037 0.835 . . . . 2.75 112.048 -177.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 m -134.01 153.59 51.69 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 107.88 -1.156 . . . . 0.47999999999999998 107.88 -170.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.16 151.38 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.374 -0.973 . . . . 0.42999999999999999 108.374 174.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.17 150.29 42.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 124.178 0.924 . . . . 2.75 109.895 172.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.61 134.0 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.346 -0.983 . . . . 0.32000000000000001 108.346 177.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.5 127.84 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.923 -1.51 . . . . 0.84999999999999998 106.923 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -150.29 170.09 19.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.024 0.529 . . . . 2.04 110.348 -178.142 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.8 120.47 47.06 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 124.311 1.044 . . . . 1.3899999999999999 111.002 -179.493 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -69.93 8.4 0.82 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.48 3.453 . . . . 0.70999999999999996 113.914 -177.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.8 -44.61 26.97 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 108.162 -1.051 . . . . 0.69999999999999996 108.162 175.303 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -102.68 -42.67 5.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.293 1.837 . . . . 3.0299999999999998 110.249 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.6 m -129.53 127.45 40.79 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 117.57 2.433 . . . . 0.52000000000000002 117.57 -158.333 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.42 -173.24 22.42 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 109.607 -1.397 . . . . 0.56000000000000005 109.607 158.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 t -41.64 -34.03 0.55 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.282 2.633 . . . . 0.84999999999999998 112.195 178.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.8 -57.59 7.04 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.915 0.709 . . . . 0.26000000000000001 112.915 171.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.61 -35.88 67.95 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 122.581 1.182 . . . . 0.23000000000000001 108.759 -176.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.598 HG12 HD22 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -63.68 -58.3 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 113.896 -1.502 . . . . 0.53000000000000003 109.551 -173.983 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -50.67 24.6 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.412 1.46 . . . . 0.78000000000000003 111.065 177.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -41.41 -58.45 1.87 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.667 0.787 . . . . 2.46 112.693 173.31 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -41.32 77.63 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 119.31 -0.956 . . . . 1.8400000000000001 111.417 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.783 HD11 HD11 ' A' ' 28' ' ' LEU . 31.0 mm -52.56 -47.0 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.056 0.844 . . . . 0.40000000000000002 110.319 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -51.25 -46.59 62.42 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.217 0.532 . . . . 1.8200000000000001 109.854 173.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -34.6 71.73 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.349 -0.844 . . . . 4.5300000000000002 112.88 -176.454 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.98 -22.5 5.73 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.563 0.745 . . . . 0.85999999999999999 110.486 167.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.56 26.99 8.8 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.315 -1.114 . . . . 0.28999999999999998 110.315 174.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.488 ' CD2' HD11 ' A' ' 24' ' ' ILE . 61.5 m-85 -139.34 160.83 38.9 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.278 -1.008 . . . . 2.0 108.278 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 122.94 43.05 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.008 -1.479 . . . . 4.4900000000000002 107.008 178.144 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.57 151.67 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 124.534 1.134 . . . . 0.47999999999999998 109.793 173.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.27 140.07 46.5 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 N-CA-C 108.815 -0.809 . . . . 0.92000000000000004 108.815 179.126 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.7 mm -104.59 93.84 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 108.055 -1.091 . . . . 1.01 108.055 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -152.36 149.58 28.78 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.156 -1.794 . . . . 5.2000000000000002 106.156 174.278 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.5 -54.71 0.43 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.83 -0.908 . . . . 5.04 110.83 176.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 117.019 -1.467 . . . . 7.4900000000000002 107.6 162.421 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 mtp . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 107.562 -1.273 . . . . 8.6699999999999999 107.562 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -170.31 152.43 4.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.437 -1.69 . . . . 6.7999999999999998 106.437 166.26 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 p 179.2 116.65 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.353 -1.721 . . . . 3.0099999999999998 106.353 -176.164 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.57 155.27 40.03 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.744 -1.576 . . . . 4.25 106.744 175.491 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -99.04 161.85 13.4 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.231 1.012 . . . . 0.71999999999999997 109.584 -177.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -142.37 154.49 44.68 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.848 0.832 . . . . 2.9100000000000001 112.189 176.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -89.78 108.13 19.51 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 128.186 2.594 . . . . 2.5299999999999998 107.322 171.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.64 154.53 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.86 -1.163 . . . . 1.3500000000000001 107.86 165.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.8 132.9 37.31 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.502 -1.666 . . . . 0.40000000000000002 106.502 173.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -155.67 166.44 33.5 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 123.273 0.629 . . . . 1.04 109.781 -173.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -93.56 156.18 16.88 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.026 -0.731 . . . . 2.96 109.026 -172.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.28 161.57 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 120.952 0.406 . . . . 0.73999999999999999 110.656 177.012 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 t -130.5 137.95 50.0 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.946 2.098 . . . . 0.71999999999999997 107.731 172.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.45 -28.03 11.51 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.594 1.093 . . . . 1.3500000000000001 113.183 174.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.03 145.15 1.05 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.398 1.479 . . . . 3.5 113.133 175.093 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.3 p -133.23 23.44 4.12 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.381 0.672 . . . . 3.4700000000000002 111.885 173.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.426 ' HA ' ' CD1' ' A' ' 41' ' ' LEU . 3.8 t 63.25 -150.15 0.33 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 117.744 -1.122 . . . . 4.1200000000000001 111.185 -176.445 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 40.1 51.99 2.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 120.297 1.408 . . . . 2.6000000000000001 113.535 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 65.61 14.35 9.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.086 1.355 . . . . 1.0800000000000001 114.029 177.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.4 m -72.85 -60.18 2.36 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.353 -0.98 . . . . 1.3899999999999999 108.353 179.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.68 -39.03 70.43 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.828 0.823 . . . . 0.91000000000000003 110.95 -177.197 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.69 -37.72 42.85 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 118.913 -0.565 . . . . 0.40999999999999998 112.442 173.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -59.22 -40.79 86.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.197 0.908 . . . . 3.3799999999999999 110.894 176.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.446 HD11 ' CD2' ' A' ' 69' ' ' TYR . 57.2 mt -54.13 -60.6 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.207 -1.405 . . . . 0.80000000000000004 107.207 -177.016 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -32.9 65.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.022 -0.99 . . . . 2.52 112.11 -175.34 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -55.16 -38.79 68.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.083 -1.011 . . . . 1.97 110.478 172.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.1 -51.74 39.43 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.791 -0.923 . . . . 0.48999999999999999 110.791 168.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.725 HD22 HG13 ' A' ' 60' ' ' ILE . 85.5 mt -63.33 -33.97 76.69 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.553 -0.969 . . . . 0.63 112.232 178.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.569 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.259 0.9 OUTLIER -59.99 -18.11 43.39 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 118.986 0.812 . . . . 1.3300000000000001 110.81 172.609 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.22 -14.71 43.07 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.463 -1.398 . . . . 3.5899999999999999 114.384 167.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.3 mtp -74.97 134.85 74.35 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 121.102 1.773 . . . . 2.1299999999999999 111.26 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.06 114.19 2.34 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.06 2.507 . . . . 0.72999999999999998 109.589 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.84 -16.02 6.19 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 124.852 1.215 . . . . 0.20000000000000001 110.09 174.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 29' ' ' LYS . 4.9 p -67.75 154.2 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 O-C-N 122.401 -0.47 . . . . 0.28000000000000003 110.481 169.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.32 -54.24 2.48 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.735 1.214 . . . . 0.35999999999999999 109.571 166.387 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -145.91 157.56 43.89 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.556 0.162 . . . . 2.5800000000000001 110.909 -177.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.76 127.27 16.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.531 1.533 . . . . 0.98999999999999999 108.82 -175.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -143.14 115.69 8.6 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.811 0.844 . . . . 2.0299999999999998 109.537 -168.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -92.1 139.14 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 112.86 0.689 . . . . 1.0600000000000001 112.86 -176.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -128.7 68.79 1.38 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.906 2.083 . . . . 1.2 111.246 -176.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.426 ' CD1' ' HA ' ' A' ' 17' ' ' CYS . 58.3 mt -64.62 -16.81 63.33 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 113.038 0.755 . . . . 0.75 113.038 178.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.76 -19.92 4.92 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.967 0.507 . . . . 0.56000000000000005 111.121 169.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.1 m -136.33 18.0 3.16 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.834 1.253 . . . . 0.54000000000000004 109.976 -178.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 48.46 32.93 3.59 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.19 0.996 . . . . 2.75 112.181 -176.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.9 m -124.73 153.1 42.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.239 -1.393 . . . . 0.60999999999999999 107.239 -169.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 p -134.79 144.58 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.593 -0.892 . . . . 0.58999999999999997 108.593 173.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -108.19 140.34 41.54 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.066 1.347 . . . . 2.8700000000000001 107.822 175.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.83 134.71 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.825 -0.806 . . . . 0.46000000000000002 108.825 167.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.8 mt -103.93 117.73 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 126.2 1.8 . . . . 0.75 106.331 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -145.19 173.24 12.11 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.164 0.586 . . . . 1.8999999999999999 110.115 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -110.59 123.16 36.37 Favored Pre-proline 0 N--CA 1.443 -0.778 0 C-N-CA 124.618 1.167 . . . . 1.49 111.154 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -66.45 3.54 1.36 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.758 3.638 . . . . 0.80000000000000004 114.384 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.07 -44.74 45.81 Favored 'General case' 0 C--N 1.335 -0.057 0 N-CA-C 108.483 -0.932 . . . . 0.87 108.483 176.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -101.37 -37.0 8.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.779 1.631 . . . . 3.2599999999999998 110.366 178.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.3 m -138.64 131.52 29.48 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 118.71 2.855 . . . . 0.56000000000000005 118.71 -150.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.81 -171.76 30.45 Favored Glycine 0 N--CA 1.435 -1.42 0 N-CA-C 109.417 -1.473 . . . . 0.53000000000000003 109.417 164.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -35.04 -43.82 0.21 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.927 2.491 . . . . 0.60999999999999999 112.088 176.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.55 -58.73 3.17 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.249 0.833 . . . . 0.32000000000000001 113.249 173.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.35 -38.14 65.83 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.914 -0.772 . . . . 0.26000000000000001 108.914 -176.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.725 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -61.14 -59.69 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.719 -1.128 . . . . 1.24 108.424 -173.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.92 -52.23 14.99 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.151 0.887 . . . . 0.87 110.644 -178.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -43.36 -55.0 4.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.621 1.168 . . . . 2.5499999999999998 112.632 174.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -43.42 72.67 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 118.434 -0.793 . . . . 1.76 111.338 178.283 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.663 HD11 HD11 ' A' ' 28' ' ' LEU . 37.9 mm -52.32 -46.17 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 119.051 0.841 . . . . 0.46000000000000002 109.725 -177.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -51.17 -50.24 59.37 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.014 0.435 . . . . 1.6100000000000001 110.335 174.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -71.07 -31.37 67.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.42 -0.8 . . . . 3.5499999999999998 112.444 -174.464 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.98 -21.77 12.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 122.967 0.507 . . . . 0.90000000000000002 110.68 167.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.24 26.91 9.71 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 124.532 1.063 . . . . 0.46000000000000002 110.488 174.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.446 ' CD2' HD11 ' A' ' 24' ' ' ILE . 71.2 m-85 -138.88 164.77 28.81 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 117.324 0.562 . . . . 1.71 109.588 -178.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 120.17 37.96 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.576 -1.268 . . . . 4.6799999999999997 107.576 -179.156 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.521 ' HB ' HG21 ' A' ' 64' ' ' ILE . 8.4 p -85.65 150.5 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 109.305 -0.628 . . . . 0.59999999999999998 109.305 170.36 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.69 116.74 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 124.37 1.068 . . . . 1.5800000000000001 108.854 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt -110.34 66.39 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.857 1.263 . . . . 1.72 109.488 -177.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -94.15 125.64 38.9 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.155 0.982 . . . . 5.2699999999999996 108.751 176.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.11 124.71 0.54 Allowed Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.143 -1.183 . . . . 3.77 110.143 -177.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.268 0 CA-C-O 116.196 -1.859 . . . . 7.8600000000000003 107.012 -175.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 106.63 -1.618 . . . . 8.3800000000000008 106.63 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.27 142.65 39.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.829 -1.175 . . . . 6.1500000000000004 107.829 164.609 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.4 m -149.34 146.84 27.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.034 -1.839 . . . . 2.8500000000000001 106.034 173.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -157.66 148.26 20.97 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.431 -1.322 . . . . 3.7200000000000002 107.431 176.572 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -86.8 172.3 10.23 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.711 -0.677 . . . . 0.63 110.84 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -150.45 162.93 39.63 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.835 -0.432 . . . . 2.3700000000000001 109.835 174.29 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -83.75 153.28 24.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.521 -1.218 . . . . 2.9500000000000002 109.112 164.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 tp -131.48 155.07 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 106.416 -1.698 . . . . 1.0900000000000001 106.416 161.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.09 131.88 31.23 Favored 'General case' 0 N--CA 1.458 -0.036 0 C-N-CA 125.139 1.376 . . . . 0.57999999999999996 108.359 175.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.9 ptp -156.5 169.54 24.4 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.899 0.772 . . . . 1.8899999999999999 111.144 -176.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.74 146.04 32.67 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.974 0.91 . . . . 2.1000000000000001 109.477 -171.709 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.09 160.66 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 124.212 1.005 . . . . 0.82999999999999996 111.228 -172.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -88.95 167.25 13.35 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.109 0.48 . . . . 2.1099999999999999 111.381 166.446 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 50.29 33.38 23.53 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.095 1.807 . . . . 1.98 114.501 176.09 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 16.1 ptm -108.31 -160.94 0.75 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.866 1.267 . . . . 4.0199999999999996 109.383 -179.124 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.592 ' HA ' HD13 ' A' ' 41' ' ' LEU . 6.6 t 52.79 20.0 1.46 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.781 2.032 . . . . 7.9699999999999998 113.706 177.003 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.5 t -104.95 -48.33 3.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.838 0.855 . . . . 6.0 109.689 -167.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -159.37 -98.98 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.403 1.081 . . . . 3.5 108.426 166.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -107.81 30.16 6.58 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.15 0.98 . . . . 1.1599999999999999 111.495 -175.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.1 m -70.27 -62.87 1.22 Allowed 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.176 -0.676 . . . . 1.7 109.176 -171.015 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.467 ' CB ' HD21 ' A' ' 41' ' ' LEU . . . -54.96 -36.01 64.87 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 122.763 0.425 . . . . 1.01 111.308 178.417 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.73 -55.34 36.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 119.358 -0.353 . . . . 0.41999999999999998 111.091 175.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -56.0 -52.52 63.92 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.412 0.551 . . . . 3.6299999999999999 110.885 175.673 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.9 mt -45.19 -60.64 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.893 1.277 . . . . 0.59999999999999998 109.12 178.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -71.47 -36.46 71.17 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 120.83 0.348 . . . . 2.3399999999999999 111.153 -172.102 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -56.12 -35.79 67.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.117 -0.989 . . . . 1.28 110.448 173.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.64 -49.6 46.08 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 111.471 -0.651 . . . . 0.33000000000000002 111.471 166.419 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.671 HD22 HG12 ' A' ' 60' ' ' ILE . 94.4 mt -65.83 -30.76 71.43 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 121.107 -1.231 . . . . 0.40000000000000002 112.615 176.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.513 ' HA ' HG11 ' A' ' 34' ' ' VAL . 10.0 ttmt -57.57 -17.72 15.65 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.21 0.913 . . . . 1.53 111.811 170.796 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -88.28 -3.72 58.81 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.164 1.172 . . . . 3.9399999999999999 114.164 171.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.445 ' O ' HG12 ' A' ' 34' ' ' VAL . 95.2 mmm -84.25 135.78 41.3 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 120.45 1.477 . . . . 2.1000000000000001 111.408 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.95 99.43 0.56 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.769 2.98 . . . . 0.39000000000000001 111.135 -172.03 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.2 -12.93 3.82 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.785 -0.926 . . . . 0.22 110.785 177.102 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.513 HG11 ' HA ' ' A' ' 29' ' ' LYS . 8.9 p -68.33 153.68 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 123.523 0.729 . . . . 0.31 111.206 171.393 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.95 -60.16 1.92 Allowed 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.457 1.103 . . . . 0.37 109.027 167.184 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -147.32 142.97 27.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 112.187 0.439 . . . . 3.23 112.187 -169.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.21 136.1 53.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.165 1.786 . . . . 0.59999999999999998 108.27 179.163 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -137.71 111.97 8.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.46 1.104 . . . . 1.45 108.652 -178.443 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.2 141.67 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.438 1.095 . . . . 1.03 111.118 -178.086 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -136.57 65.46 1.52 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.903 1.281 . . . . 1.1499999999999999 111.445 178.156 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.592 HD13 ' HA ' ' A' ' 16' ' ' THR . 36.3 mt -59.63 -23.71 63.24 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.946 -0.471 . . . . 0.93999999999999995 112.115 177.584 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.39 -22.59 43.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.385 0.539 . . . . 0.65000000000000002 111.207 174.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 m -121.75 16.01 11.02 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.802 1.241 . . . . 0.58999999999999997 110.294 179.092 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 44.02 46.24 6.92 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.124 0.969 . . . . 2.8300000000000001 110.876 -174.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.9 m -145.77 154.3 41.89 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.027 -1.472 . . . . 0.64000000000000001 107.027 -171.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -132.69 151.9 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.306 -0.998 . . . . 0.69999999999999996 108.306 170.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.54 150.77 47.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.296 -0.631 . . . . 2.71 109.296 175.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.87 146.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.512 -0.922 . . . . 0.31 108.512 -176.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.2 mt -114.75 125.95 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.523 1.929 . . . . 0.78000000000000003 106.58 -173.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -152.37 170.1 20.93 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.223 0.609 . . . . 1.8500000000000001 110.363 -175.671 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -109.21 115.77 56.13 Favored Pre-proline 0 N--CA 1.44 -0.943 0 O-C-N 124.276 0.985 . . . . 1.48 110.469 -177.064 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.37 8.55 0.5 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.172 3.248 . . . . 0.62 113.752 -178.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.99 -44.73 38.2 Favored 'General case' 0 N--CA 1.458 -0.026 0 N-CA-C 108.087 -1.079 . . . . 0.72999999999999998 108.087 172.36 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -102.05 -38.32 7.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.291 1.436 . . . . 3.02 111.074 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 m -143.56 133.95 24.7 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 119.284 3.068 . . . . 0.59999999999999998 119.284 -156.431 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.31 -149.74 6.28 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 108.88 -1.688 . . . . 0.54000000000000004 108.88 154.34 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -44.82 -35.37 2.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.955 2.102 . . . . 0.68999999999999995 112.833 -175.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.18 -55.1 26.86 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.658 -0.651 . . . . 0.52000000000000002 111.821 174.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.41 -41.78 60.34 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.686 1.231 . . . . 0.32000000000000001 109.323 -175.369 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.671 HG12 HD22 ' A' ' 28' ' ' LEU . 1.9 mt -62.85 -52.57 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 113.967 -1.469 . . . . 0.59999999999999998 111.502 -169.42 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -55.92 -47.04 78.21 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.471 1.032 . . . . 3.0299999999999998 110.429 179.135 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -42.59 -60.06 1.68 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.113 0.965 . . . . 2.23 112.781 171.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -37.54 81.24 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 119.217 -0.993 . . . . 2.5899999999999999 110.726 -177.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.435 HD11 HD11 ' A' ' 28' ' ' LEU . 6.1 mm -56.23 -44.09 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 118.154 0.434 . . . . 0.37 110.301 -178.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -48.06 -49.16 32.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.158 0.504 . . . . 1.53 110.279 172.08 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -71.88 -31.28 66.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.941 0.896 . . . . 3.3599999999999999 113.128 -175.411 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -53.48 -24.35 12.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 119.441 -0.314 . . . . 0.89000000000000001 110.616 165.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.36 29.23 4.58 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.37 0.986 . . . . 0.37 110.778 167.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -148.12 159.55 43.81 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.739 -1.578 . . . . 2.0099999999999998 106.739 -177.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.455 ' CE1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -102.79 147.27 27.07 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 105.819 -1.919 . . . . 3.54 105.819 170.283 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.9 p -110.9 157.56 11.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 125.494 1.518 . . . . 0.90000000000000002 109.804 169.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.455 HG13 ' CE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -126.1 137.16 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.355 1.062 . . . . 1.0600000000000001 111.359 178.333 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.2 mm -102.38 93.47 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 125.368 1.467 . . . . 1.27 107.248 175.53 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -72.02 127.35 32.27 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.842 -1.17 . . . . 5.2000000000000002 107.842 174.067 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.21 68.58 1.71 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.626 -0.99 . . . . 4.8700000000000001 110.626 176.12 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 117.938 -1.029 . . . . 11.039999999999999 111.176 175.373 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 mtt . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 107.661 -1.237 . . . . 9.4100000000000001 107.661 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.6 mp -118.54 147.62 43.5 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 106.831 -1.544 . . . . 6.6100000000000003 106.831 174.341 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 m -67.55 159.34 29.97 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.483 0.713 . . . . 3.4399999999999999 110.115 171.036 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 4.6 tt0 -137.46 132.33 33.2 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.844 1.258 . . . . 3.5099999999999998 107.869 177.037 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -84.39 157.64 21.36 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.608 0.763 . . . . 0.75 111.056 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 28.3 mttp -155.54 168.04 28.42 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.954 0.407 . . . . 4.2999999999999998 110.73 178.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -84.37 133.08 34.53 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.444 2.298 . . . . 2.0899999999999999 109.188 175.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.28 148.73 16.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.067 0 N-CA-C 106.286 -1.746 . . . . 1.47 106.286 162.462 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.78 133.04 44.3 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.256 1.422 . . . . 0.75 108.245 176.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.6 168.84 25.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 122.028 0.918 . . . . 2.77 112.887 -176.168 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.423 HE21 ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -104.06 96.68 6.82 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 104.293 -2.484 . . . . 2.0600000000000001 104.293 -164.201 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.81 141.11 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 108.294 -1.002 . . . . 1.5900000000000001 108.294 175.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -84.65 156.2 21.63 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.678 -0.489 . . . . 1.6599999999999999 109.678 178.337 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.04 67.49 1.95 Allowed Glycine 0 CA--C 1.532 1.112 0 N-CA-C 111.987 -0.445 . . . . 2.48 111.987 175.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 8.1 ptp -141.13 178.57 7.3 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.875 1.27 . . . . 4.0499999999999998 108.653 -179.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 m 56.28 37.08 28.5 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.999 -0.741 . . . . 7.6600000000000001 108.999 -175.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.7 t -121.43 -65.28 1.15 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.48 1.112 . . . . 7.1900000000000004 108.959 -168.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.97 80.04 0.77 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.079 0.552 . . . . 3.6899999999999999 110.501 171.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.06 28.6 11.05 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.633 1.173 . . . . 1.5900000000000001 111.966 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.7 m -72.56 -62.74 1.34 Allowed 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.453 -0.573 . . . . 1.3999999999999999 109.453 -165.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.13 -41.52 36.35 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 123.832 0.853 . . . . 0.79000000000000004 111.807 178.186 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.4 -55.31 36.4 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.547 -0.751 . . . . 0.34000000000000002 111.191 175.334 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -60.94 -47.99 83.86 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.576 0.625 . . . . 4.3600000000000003 111.567 177.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.3 mt -43.36 -60.86 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 125.089 1.356 . . . . 0.56999999999999995 108.324 175.198 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -71.37 -37.43 71.62 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.139 -0.482 . . . . 2.3999999999999999 111.213 -172.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -57.54 -32.61 67.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.261 -0.9 . . . . 1.28 110.857 175.175 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.56 -51.15 54.02 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.663 -0.975 . . . . 0.33000000000000002 110.663 165.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.742 HD11 HD11 ' A' ' 64' ' ' ILE . 96.2 mt -63.6 -28.63 70.05 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 118.967 1.384 . . . . 0.37 112.597 176.17 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.29 21.2 ttmt -61.66 -15.2 37.76 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 119.854 1.206 . . . . 1.23 111.859 171.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -18.18 42.52 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.367 -1.458 . . . . 4.7800000000000002 114.657 165.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.436 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -71.27 128.19 90.52 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 120.332 1.423 . . . . 2.6000000000000001 110.936 -170.722 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -60.87 104.37 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.981 2.454 . . . . 0.59999999999999998 111.032 -176.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.74 -3.45 8.63 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.715 2.103 . . . . 0.27000000000000002 110.555 172.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 31' ' ' MET . 7.3 p -65.88 158.22 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 121.576 -0.955 . . . . 0.28999999999999998 111.361 164.06 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.33 -58.15 1.72 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.251 1.42 . . . . 0.41999999999999998 110.448 169.094 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -139.37 154.25 47.82 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 112.102 0.408 . . . . 3.1299999999999999 112.102 -176.388 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.3 129.72 46.76 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.483 1.913 . . . . 0.63 108.731 174.393 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.65 113.14 7.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.881 1.272 . . . . 1.3700000000000001 109.518 -174.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.78 148.76 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.975 0.91 . . . . 1.1000000000000001 111.689 -174.304 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -140.74 67.55 1.36 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-O 122.789 1.28 . . . . 2.79 108.059 178.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.4 mt -62.14 -16.01 49.71 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.502 -0.772 . . . . 1.26 112.366 175.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.64 -12.55 4.27 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.477 1.111 . . . . 1.0600000000000001 111.467 170.027 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.3 m -144.17 27.25 1.44 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.49 0.716 . . . . 0.78000000000000003 109.201 178.026 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 36.93 59.64 1.04 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 125.213 1.405 . . . . 3.27 111.218 -176.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -156.52 157.51 35.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.021 -1.474 . . . . 1.02 107.021 -172.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.89 154.56 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 109.245 -0.65 . . . . 1.1699999999999999 109.245 171.616 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -119.38 145.85 45.85 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.167 1.387 . . . . 2.5800000000000001 109.247 -178.423 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.15 134.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.911 0.885 . . . . 0.27000000000000002 109.055 179.036 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 78.5 mt -95.2 128.09 46.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.047 -1.464 . . . . 1.1100000000000001 107.047 174.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -149.84 171.96 15.92 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.352 0.661 . . . . 1.77 110.491 177.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -108.02 121.99 42.12 Favored Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 124.002 0.921 . . . . 1.9399999999999999 111.655 -176.358 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.93 23.0 0.35 Allowed 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 124.718 3.612 . . . . 0.81000000000000005 113.489 -176.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.56 -48.93 6.13 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 107.714 -1.217 . . . . 0.41999999999999998 107.714 171.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -99.43 -48.95 4.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.317 1.447 . . . . 2.71 110.687 178.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.2 m -111.11 133.03 53.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.07 1.748 . . . . 0.96999999999999997 114.759 -164.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.1 177.28 32.42 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 108.638 -1.785 . . . . 0.69999999999999996 108.638 163.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -34.15 -47.95 0.3 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.587 1.955 . . . . 0.72999999999999998 111.082 172.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -41.26 -58.35 1.85 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.594 1.158 . . . . 0.46999999999999997 113.402 173.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.05 -38.52 66.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.854 -0.795 . . . . 0.39000000000000001 108.854 -176.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.594 HG13 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -54.78 -61.21 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-N 114.696 -1.138 . . . . 0.87 109.84 179.2 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -45.36 -52.58 9.71 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.003 1.274 . . . . 1.47 110.373 178.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.65 -51.46 12.23 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.573 0.749 . . . . 2.54 112.603 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -48.03 57.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.764 -0.774 . . . . 1.6799999999999999 111.495 174.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.742 HD11 HD11 ' A' ' 28' ' ' LEU . 33.5 mm -49.6 -44.07 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.855 0.862 . . . . 0.38 110.662 -176.364 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -50.86 -52.57 40.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.446 0.698 . . . . 1.5900000000000001 110.027 175.146 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -71.58 -29.12 64.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 114.048 1.129 . . . . 3.3399999999999999 114.048 -178.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -53.9 -25.03 18.19 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.426 0.557 . . . . 0.93999999999999995 110.388 165.455 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.68 27.82 3.94 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 124.507 1.051 . . . . 0.38 111.067 166.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -151.16 174.51 13.15 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.806 -1.183 . . . . 1.8200000000000001 107.806 -173.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.33 141.05 48.79 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.066 -1.087 . . . . 3.3799999999999999 108.066 171.64 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.94 142.3 15.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 113.542 -1.663 . . . . 0.81999999999999995 107.969 162.085 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.7 m -117.52 139.37 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.117 -0.697 . . . . 1.45 109.117 173.612 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.3 mm -120.45 86.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.938 1.295 . . . . 1.3400000000000001 107.519 -164.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -123.96 147.97 47.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.272 -1.381 . . . . 4.5700000000000003 107.272 168.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.24 63.57 3.07 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 119.72 -0.489 . . . . 4.4000000000000004 112.594 173.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.1 ttt85 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.497 1.919 . . . . 8.6699999999999999 110.961 169.385 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mtt . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 106.335 -1.728 . . . . 7.9299999999999997 106.335 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 66.07 54.62 0.97 Allowed 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.419 1.075 . . . . 8.5099999999999998 109.533 175.726 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.2 p -171.97 78.24 0.06 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.199 1.4 . . . . 3.2000000000000002 107.238 -176.231 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.25 121.74 6.31 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.1 0.96 . . . . 4.9900000000000002 108.445 -175.515 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -89.46 172.08 9.26 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.957 0.903 . . . . 0.77000000000000002 112.423 -171.051 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.09 165.87 31.48 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.99 0.9 . . . . 3.21 111.803 169.35 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -82.15 141.12 33.35 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.062 2.145 . . . . 2.2799999999999998 107.721 167.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.68 150.92 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 106.022 -1.844 . . . . 1.5700000000000001 106.022 164.016 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.61 128.3 23.19 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.292 1.437 . . . . 0.46000000000000002 107.955 176.286 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -155.91 173.17 17.17 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.994 0.518 . . . . 1.02 110.251 -172.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.405 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -102.22 152.25 21.26 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.951 0.9 . . . . 1.8300000000000001 109.371 -176.426 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 t -115.02 162.89 12.78 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.06 0 C-N-CA 123.432 0.693 . . . . 0.75 109.834 178.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 t -129.26 125.31 36.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.303 1.441 . . . . 0.81999999999999995 108.565 175.503 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.84 -11.98 20.55 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.835 1.207 . . . . 1.3799999999999999 113.454 173.148 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.62 146.23 17.1 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.134 0.967 . . . . 3.3399999999999999 111.519 178.103 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.1 p -130.32 26.55 5.12 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.65 0.78 . . . . 3.5 110.962 175.418 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.5 t 57.92 -140.01 0.8 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.42 -0.8 . . . . 3.9399999999999999 110.941 -176.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 54.99 -82.25 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.939 1.695 . . . . 3.1899999999999999 111.816 -172.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.0 16.09 0.75 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.606 1.162 . . . . 1.3 111.61 175.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.7 m -71.89 -61.17 1.88 Allowed 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 121.415 -0.803 . . . . 1.25 109.49 -169.446 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.442 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -59.45 -33.54 71.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.767 0.794 . . . . 0.70999999999999996 111.24 -179.599 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.65 -50.53 73.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.946 -0.471 . . . . 0.40000000000000002 110.369 171.32 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -53.93 -45.58 71.26 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 118.817 -0.611 . . . . 3.6499999999999999 111.36 174.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.463 HD11 ' CD2' ' A' ' 69' ' ' TYR . 72.9 mt -49.24 -61.96 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.15 -0.685 . . . . 0.66000000000000003 109.15 177.547 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.466 ' CD ' HG21 ' A' ' 46' ' ' VAL . 1.1 tp10 -72.18 -33.12 67.43 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.015 -0.674 . . . . 2.46 111.017 -170.193 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.5 mmtt -54.42 -39.51 67.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 121.029 -1.045 . . . . 1.74 110.703 170.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.51 -53.04 34.06 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.889 -1.284 . . . . 0.41999999999999998 109.889 168.757 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 64' ' ' ILE . 94.1 mt -60.66 -33.15 72.39 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 117.811 -1.09 . . . . 0.46999999999999997 112.543 178.252 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' HA ' HG11 ' A' ' 34' ' ' VAL 0.285 13.8 ttpt -56.43 -19.33 14.57 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 120.08 1.309 . . . . 2.0699999999999998 111.678 175.499 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.46 -14.94 54.23 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.094 1.516 . . . . 3.21 115.094 170.284 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.6 mmt -73.54 134.59 79.16 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 120.165 1.348 . . . . 2.6400000000000001 111.88 -175.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.85 94.35 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.291 2.661 . . . . 0.40000000000000002 111.549 -176.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.84 -13.7 2.88 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.719 1.152 . . . . 0.44 111.092 171.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -71.23 152.84 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 121.678 -0.896 . . . . 1.1699999999999999 109.121 162.623 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.19 -57.03 2.09 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.668 1.187 . . . . 0.46999999999999997 110.374 169.064 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -154.67 158.07 39.08 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 117.903 0.319 . . . . 2.6899999999999999 111.61 -177.047 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.42 ' HB1' ' CG ' ' A' ' 25' ' ' GLU . . . -129.36 132.43 47.07 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 127.494 2.317 . . . . 0.65000000000000002 109.986 -171.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -138.35 104.34 5.15 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.819 1.248 . . . . 1.3100000000000001 108.798 -176.539 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.9 p -83.67 141.55 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.74 0.816 . . . . 0.82999999999999996 111.371 -178.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -136.83 67.84 1.44 Allowed 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.715 1.606 . . . . 1.1499999999999999 111.535 -175.429 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.81 -16.98 62.63 Favored 'General case' 0 C--O 1.228 -0.045 0 N-CA-C 113.146 0.795 . . . . 0.78000000000000003 113.146 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.45 -26.09 11.84 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.17 0.441 . . . . 0.53000000000000003 110.612 169.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.6 m -125.45 18.56 8.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.319 1.448 . . . . 0.45000000000000001 110.315 -179.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 46.46 39.66 6.95 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.202 1.001 . . . . 2.6600000000000001 111.973 -177.352 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.37 156.82 46.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.596 -0.89 . . . . 0.96999999999999997 108.596 -169.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.466 HG21 ' CD ' ' A' ' 25' ' ' GLU . 7.7 p -131.59 145.66 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.349 -0.841 . . . . 0.53000000000000003 108.809 174.335 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -116.06 139.01 50.72 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.022 -1.473 . . . . 2.48 107.022 176.458 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.59 138.34 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.489 -0.93 . . . . 0.44 108.489 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 79.9 mt -105.11 125.3 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.196 -1.409 . . . . 0.94999999999999996 107.196 -177.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -146.12 166.36 26.38 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 122.945 0.498 . . . . 1.8899999999999999 111.227 -179.418 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -103.68 115.62 63.22 Favored Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 114.31 -1.313 . . . . 1.3400000000000001 110.245 176.324 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -68.46 6.73 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.674 2.916 . . . . 0.47999999999999998 113.706 -179.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.62 -43.24 48.98 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 119.381 0.991 . . . . 0.42999999999999999 108.438 174.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -100.86 -40.82 7.11 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.27 1.828 . . . . 2.9900000000000002 109.906 178.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.6 m -138.82 127.3 23.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 118.568 2.803 . . . . 0.52000000000000002 118.568 -154.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -159.0 -164.68 14.74 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 109.752 -1.339 . . . . 0.45000000000000001 109.752 156.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.273 0.1 OUTLIER -29.28 -44.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 129.357 3.063 . . . . 0.71999999999999997 114.13 173.245 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.48 -57.09 8.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.195 0.907 . . . . 0.34999999999999998 112.546 175.487 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.26 -39.36 63.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 122.181 0.991 . . . . 0.20999999999999999 108.933 -176.12 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.566 HG12 HD22 ' A' ' 28' ' ' LEU . 1.1 mt -60.87 -59.24 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-N 114.149 -1.387 . . . . 0.55000000000000004 109.279 -174.583 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.65 -51.48 12.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.914 1.234 . . . . 0.75 111.279 177.728 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -42.48 -56.07 3.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.893 0.701 . . . . 2.4399999999999999 112.893 174.157 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -44.27 71.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 119.056 -1.058 . . . . 1.9099999999999999 111.347 178.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 28' ' ' LEU . 38.8 mm -51.01 -46.33 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.65 0.78 . . . . 0.47999999999999998 110.456 -178.557 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -50.11 -50.56 48.1 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.328 0.585 . . . . 1.4199999999999999 110.07 174.092 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -72.35 -30.79 65.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.904 0.705 . . . . 3.0699999999999998 112.904 -175.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.51 -25.34 24.97 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.68 0.392 . . . . 0.94999999999999996 110.383 165.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.25 28.78 5.38 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 124.656 1.122 . . . . 0.37 110.859 172.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.463 ' CD2' HD11 ' A' ' 24' ' ' ILE . 64.2 m-85 -145.52 163.52 34.47 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 107.943 -1.132 . . . . 1.97 107.943 -176.228 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.01 126.58 50.28 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.977 -1.49 . . . . 4.3099999999999996 106.977 177.781 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.0 p -94.74 141.58 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 122.92 0.488 . . . . 0.53000000000000003 109.771 172.22 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 11' ' ' GLN . 13.4 m -96.88 158.14 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.987 -0.746 . . . . 1.1000000000000001 108.987 173.393 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.8 mm -125.03 82.2 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 107.421 -1.326 . . . . 1.02 107.421 174.218 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -132.26 132.47 43.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.582 -2.377 . . . . 5.0099999999999998 104.582 172.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.93 -64.91 0.24 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-N 119.378 0.99 . . . . 4.1399999999999997 113.389 -177.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.276 0 N-CA-C 105.636 -1.987 . . . . 10.619999999999999 105.636 -177.792 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 119.123 -0.465 . . . . 11.0 110.056 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 mp 65.84 -174.86 0.18 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.249 0.619 . . . . 10.460000000000001 109.973 -172.477 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 m 65.24 -165.22 0.24 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.749 0.82 . . . . 4.8499999999999996 109.484 -168.407 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 68.93 133.7 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.649 1.98 . . . . 3.21 113.002 177.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -83.05 155.67 23.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.976 -0.556 . . . . 0.82999999999999996 110.962 -175.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -147.9 156.56 42.83 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.982 0.896 . . . . 3.6600000000000001 110.763 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.28 111.14 18.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.848 2.459 . . . . 2.1899999999999999 108.991 173.251 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.02 151.89 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 107.203 -1.406 . . . . 1.6200000000000001 107.203 162.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.02 127.82 19.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.431 1.492 . . . . 0.33000000000000002 107.899 175.317 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -157.03 164.5 37.9 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.163 0.438 . . . . 1.1499999999999999 110.727 -171.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.446 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -100.34 145.89 27.61 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.074 0.95 . . . . 1.8300000000000001 109.066 -172.089 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.71 159.25 19.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 C-N-CA 123.127 0.571 . . . . 0.54000000000000004 110.053 -176.087 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 t -121.34 125.03 46.0 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.909 1.284 . . . . 0.72999999999999998 108.096 177.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.98 -12.25 11.6 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.14 0.876 . . . . 1.3799999999999999 113.486 172.745 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.97 136.25 52.0 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.238 1.519 . . . . 3.46 110.886 176.454 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.7 p -110.77 26.83 10.28 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.606 0.763 . . . . 3.5800000000000001 110.87 175.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.1 t 79.1 -175.92 0.08 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.362 1.465 . . . . 4.0099999999999998 110.348 175.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 53.8 -146.18 0.56 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.784 0.834 . . . . 3.9199999999999999 110.761 179.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.53 15.52 1.64 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.513 -0.742 . . . . 1.3400000000000001 112.66 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.0 m -72.61 -60.19 2.35 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 119.296 0.953 . . . . 2.0 108.762 -177.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.87 -42.2 47.18 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-O 121.583 0.706 . . . . 0.92000000000000004 111.503 175.309 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.19 -40.16 46.14 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.812 -0.613 . . . . 0.44 111.581 177.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -57.98 -43.4 86.53 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.848 0.749 . . . . 3.5 110.696 177.126 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.5 mt -53.47 -59.45 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 107.96 -1.126 . . . . 0.62 107.96 -176.799 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' CG ' HG21 ' A' ' 46' ' ' VAL . 1.5 tm-20 -70.58 -41.17 72.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.818 -0.628 . . . . 3.3599999999999999 109.811 -176.03 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -49.66 -38.49 32.79 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.39 -1.444 . . . . 1.46 112.005 179.084 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.42 -51.79 40.78 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 111.548 -0.621 . . . . 0.37 111.548 169.064 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 64' ' ' ILE . 74.6 mt -67.1 -27.7 67.56 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.639 -0.918 . . . . 0.60999999999999999 112.666 177.476 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -62.09 -15.82 47.81 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.758 1.163 . . . . 2.5099999999999998 110.004 172.146 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -96.89 4.97 51.35 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.162 1.171 . . . . 3.77 114.162 170.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 34' ' ' VAL . 81.5 mmm -83.12 138.81 42.35 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 120.498 1.499 . . . . 2.0699999999999998 111.529 176.024 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.68 94.26 0.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.387 2.724 . . . . 0.40999999999999998 111.228 -172.655 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.87 -13.81 2.87 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.514 1.054 . . . . 0.19 111.327 178.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 31' ' ' MET . 5.3 p -69.22 160.59 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 117.735 0.767 . . . . 0.26000000000000001 110.889 168.076 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.25 -56.37 1.82 Allowed 'General case' 0 C--N 1.335 -0.058 0 C-N-CA 124.055 0.942 . . . . 0.44 109.967 168.793 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -145.01 157.54 44.09 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.968 -0.382 . . . . 2.8500000000000001 109.968 -179.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.22 136.12 39.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.504 2.322 . . . . 0.67000000000000004 107.854 176.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.57 115.19 9.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.658 1.583 . . . . 1.4199999999999999 108.193 -174.155 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.57 143.6 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.859 0.863 . . . . 0.57999999999999996 112.062 -177.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -133.14 67.72 1.52 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.335 1.854 . . . . 1.21 111.86 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.5 mt -67.37 -16.89 64.5 Favored 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 113.085 0.772 . . . . 0.65000000000000002 113.085 -179.046 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.83 -22.06 13.29 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.654 0.382 . . . . 0.58999999999999997 110.875 168.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.1 m -127.82 17.79 6.78 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.741 1.216 . . . . 0.54000000000000004 110.032 178.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 44.68 40.52 4.19 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.558 1.143 . . . . 2.75 111.632 -175.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.8 m -134.72 155.66 50.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.22 -1.4 . . . . 0.46000000000000002 107.22 -169.132 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.4 HG21 ' CG ' ' A' ' 25' ' ' GLU . 7.4 p -134.8 148.9 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.773 -0.825 . . . . 0.41999999999999998 108.773 173.012 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.25 153.11 36.81 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 124.047 0.842 . . . . 2.8300000000000001 110.168 174.374 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.98 133.64 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 123.617 0.767 . . . . 0.33000000000000002 109.382 -177.139 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.5 mt -100.01 112.04 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.755 1.622 . . . . 0.91000000000000003 106.794 179.375 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -135.84 167.41 21.23 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.276 1.03 . . . . 1.8500000000000001 110.998 178.335 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.91 119.85 54.28 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 124.726 1.21 . . . . 1.3400000000000001 110.998 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.14 8.83 1.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.72 2.947 . . . . 0.46000000000000002 113.586 -175.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.4 -53.25 6.78 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 107.585 -1.265 . . . . 0.45000000000000001 107.585 175.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -85.48 -41.87 14.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.273 1.429 . . . . 2.8700000000000001 110.429 175.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.0 m -138.14 126.61 23.34 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 117.925 2.565 . . . . 0.52000000000000002 117.925 -151.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.83 -165.35 19.76 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.909 -1.041 . . . . 0.42999999999999999 110.731 155.458 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.5 t -31.5 -43.22 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 129.386 3.075 . . . . 0.54000000000000004 112.987 176.776 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.0 -56.87 7.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.785 0.72 . . . . 0.34000000000000002 112.831 174.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.57 -37.05 65.65 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 122.29 1.043 . . . . 0.29999999999999999 109.198 -179.517 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.513 HG12 HD22 ' A' ' 28' ' ' LEU . 1.2 mt -64.79 -54.64 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 114.348 -1.296 . . . . 0.51000000000000001 110.338 -171.516 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.74 -51.47 22.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 120.011 1.278 . . . . 0.77000000000000002 110.882 174.711 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -43.42 -53.84 5.13 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 113.025 0.75 . . . . 2.2599999999999998 113.025 173.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.14 -45.56 66.57 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 118.419 -0.8 . . . . 2.1600000000000001 110.862 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.593 HD11 HD11 ' A' ' 28' ' ' LEU . 17.2 mm -50.1 -47.5 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.641 1.176 . . . . 0.41999999999999998 110.384 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -51.22 -47.53 62.31 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.427 0.632 . . . . 1.53 110.053 174.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -33.06 67.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.75 0.82 . . . . 3.4399999999999999 112.42 -177.001 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.64 -22.62 23.65 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.883 0.473 . . . . 0.85999999999999999 110.395 166.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.19 30.88 7.55 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.225 -1.15 . . . . 0.39000000000000001 110.225 175.325 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -137.32 163.62 30.55 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.615 -1.254 . . . . 2.1200000000000001 107.615 178.511 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.24 130.88 56.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.104 -1.443 . . . . 3.9100000000000001 107.104 174.119 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -99.4 146.72 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.629 0.771 . . . . 0.47999999999999998 111.111 171.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.77 149.91 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.987 0.915 . . . . 0.94999999999999996 109.738 171.077 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.1 mm -118.63 97.89 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 106.557 -1.646 . . . . 1.0900000000000001 106.557 168.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.1 157.47 25.84 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.478 1.511 . . . . 4.5 108.624 176.461 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.52 -47.8 0.26 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.486 1.041 . . . . 4.6799999999999997 112.281 177.385 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.194 0 CA-C-O 115.792 -2.051 . . . . 10.949999999999999 106.47 -176.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.1 mtt . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 108.646 -0.872 . . . . 8.4199999999999999 108.646 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 36.4 tp 176.77 -85.44 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.913 2.085 . . . . 7.6200000000000001 105.542 174.294 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 p -169.57 147.13 3.48 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 104.741 -2.318 . . . . 2.98 104.741 175.537 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.462 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 4.8 pt-20 -135.66 154.47 51.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.817 -1.92 . . . . 3.7200000000000002 105.817 165.093 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -115.85 165.74 12.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.916 0.886 . . . . 0.68000000000000005 109.671 178.095 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' A' ' 4' ' ' GLU . 28.1 mttp -149.72 162.98 39.17 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.357 0.599 . . . . 4.4000000000000004 110.56 178.576 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -84.11 133.62 34.62 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.779 1.632 . . . . 2.04 107.768 166.849 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 tp -106.29 154.14 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.104 -1.813 . . . . 1.0900000000000001 106.104 160.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.9 131.45 30.98 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.894 -1.521 . . . . 0.47999999999999998 106.894 171.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -156.46 165.85 35.12 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.278 0.631 . . . . 1.1899999999999999 110.428 -174.005 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.409 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 2.3 mp0 -93.92 148.56 22.03 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.04 1.336 . . . . 2.9900000000000002 107.785 -171.294 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.443 HG11 HD13 ' A' ' 24' ' ' ILE . 2.2 t -116.13 141.07 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 118.956 0.798 . . . . 0.72999999999999998 110.522 178.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t -106.2 124.87 50.25 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.893 -1.521 . . . . 0.90000000000000002 106.893 173.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.22 -74.26 0.35 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.376 -1.09 . . . . 2.4500000000000002 110.376 -179.751 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.408 ' CE ' HD13 ' A' ' 41' ' ' LEU . 0.5 OUTLIER 28.08 82.52 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.285 2.234 . . . . 5.8300000000000001 114.404 179.634 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -95.08 11.45 32.07 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.925 1.69 . . . . 4.1699999999999999 111.396 175.065 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.5 t 62.15 -154.49 0.35 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.928 1.291 . . . . 3.5499999999999998 111.691 179.095 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 41.68 59.09 2.58 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.386 1.448 . . . . 3.1000000000000001 113.338 177.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 59.48 19.46 7.88 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.931 1.292 . . . . 1.0900000000000001 113.462 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.0 m -72.22 -56.94 4.69 Favored 'General case' 0 CA--C 1.514 -0.437 0 O-C-N 121.068 -1.02 . . . . 1.3799999999999999 109.148 -173.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.614 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -61.02 -26.13 67.4 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.291 0.567 . . . . 0.79000000000000004 112.111 177.383 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.24 -47.59 73.29 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 118.587 -0.72 . . . . 0.41999999999999998 110.208 169.026 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -52.41 -48.76 65.52 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.389 0.995 . . . . 4.0999999999999996 111.381 173.168 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.614 HD12 ' HA ' ' A' ' 21' ' ' ALA . 80.1 mt -43.68 -61.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.284 0 N-CA-C 108.856 -0.794 . . . . 0.81999999999999995 108.856 179.78 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -36.08 66.3 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.773 -0.649 . . . . 2.4300000000000002 112.427 -174.473 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -54.72 -37.63 66.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.941 -1.099 . . . . 2.4100000000000001 111.009 176.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.51 -45.09 77.81 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.983 -0.847 . . . . 0.46000000000000002 110.983 169.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.706 HD22 HG12 ' A' ' 60' ' ' ILE . 75.9 mt -67.25 -31.18 71.35 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.128 -1.219 . . . . 0.5 111.517 176.461 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HA ' HG11 ' A' ' 34' ' ' VAL . 6.4 ttmm -60.47 -17.5 45.32 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.221 0.918 . . . . 1.29 111.215 172.257 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -81.38 -16.22 52.91 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.928 -1.107 . . . . 3.3399999999999999 113.674 169.378 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 34' ' ' VAL . 14.8 mmt -73.71 137.73 77.05 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 120.785 1.63 . . . . 2.2599999999999998 112.744 -173.483 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.74 87.82 0.8 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.903 3.069 . . . . 0.79000000000000004 111.284 -172.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.05 -22.82 0.99 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.994 -0.843 . . . . 0.47999999999999998 110.994 -174.302 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 29' ' ' LYS . 5.8 p -68.09 159.65 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 O-C-N 121.845 -0.797 . . . . 0.39000000000000001 111.939 175.265 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.54 -57.36 1.47 Allowed 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.652 1.181 . . . . 0.54000000000000004 109.344 169.49 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -138.97 154.84 48.34 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 113.884 1.068 . . . . 3.0699999999999998 113.884 178.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.13 124.06 18.78 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.071 1.748 . . . . 0.97999999999999998 108.025 -175.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -143.44 119.97 11.04 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.584 0.754 . . . . 1.6399999999999999 109.166 -166.111 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -96.63 128.17 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.466 0.707 . . . . 0.89000000000000001 111.529 -173.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -113.91 69.51 0.71 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.032 -1.47 . . . . 2.5800000000000001 107.032 177.158 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.408 HD13 ' CE ' ' A' ' 15' ' ' MET . 72.9 mt -61.57 -21.79 64.62 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.893 -0.594 . . . . 0.76000000000000001 111.641 175.803 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.71 -25.05 16.67 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.872 0.869 . . . . 0.60999999999999999 111.405 170.461 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 m -124.96 15.39 8.54 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.123 1.369 . . . . 0.69999999999999996 109.886 -179.308 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 47.02 37.04 4.6 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.407 1.083 . . . . 2.46 111.632 -176.348 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.0 m -133.78 150.59 51.45 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.807 -1.553 . . . . 0.70999999999999996 106.807 -170.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.3 p -128.96 146.9 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 107.684 -1.228 . . . . 0.58999999999999997 107.684 174.492 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.32 149.08 44.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 123.895 0.747 . . . . 2.75 109.114 173.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.26 133.78 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.393 -0.965 . . . . 0.28000000000000003 108.393 -179.135 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.2 mt -101.69 120.25 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 127.231 2.212 . . . . 0.69999999999999996 106.501 -176.462 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -149.68 166.15 30.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.656 0.782 . . . . 1.77 110.548 -177.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -95.22 108.08 36.45 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 125.228 1.411 . . . . 2.2599999999999998 110.611 175.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -70.34 12.82 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.229 3.286 . . . . 0.81999999999999995 114.117 -179.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.97 -49.66 6.92 Favored 'General case' 0 N--CA 1.459 0.023 0 N-CA-C 107.105 -1.443 . . . . 0.73999999999999999 107.105 171.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -85.6 -34.09 21.51 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.18 1.392 . . . . 2.4700000000000002 111.037 178.267 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.9 m -154.39 122.15 5.87 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 117.112 2.264 . . . . 0.76000000000000001 117.112 -156.601 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.97 -171.68 24.2 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 121.69 -0.631 . . . . 0.5 112.222 165.383 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.96 -44.66 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.942 2.897 . . . . 0.55000000000000004 112.531 176.499 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.4 -55.78 9.91 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.062 0.764 . . . . 0.35999999999999999 113.062 175.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.18 -38.7 63.59 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 122.644 1.211 . . . . 0.37 109.127 178.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.706 HG12 HD22 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -64.95 -48.61 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 114.407 -1.27 . . . . 0.54000000000000004 110.619 -169.063 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -50.53 60.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.164 1.347 . . . . 0.90000000000000002 110.355 173.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -43.32 -57.95 2.78 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.852 0.834 . . . . 2.3999999999999999 112.879 171.846 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -42.27 83.66 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 118.595 -0.717 . . . . 1.79 111.418 -178.228 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.403 HD11 HD11 ' A' ' 28' ' ' LEU . 5.7 mm -52.47 -47.8 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 119.355 0.98 . . . . 0.56000000000000005 110.047 177.654 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -51.72 -46.29 63.91 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.103 0.478 . . . . 1.6599999999999999 110.026 173.083 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -37.7 84.27 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.482 -0.761 . . . . 3.6200000000000001 112.01 -178.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.97 -21.95 34.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.75 0.82 . . . . 0.94999999999999996 110.517 170.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.83 28.5 7.8 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 124.409 1.004 . . . . 0.51000000000000001 110.97 173.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.577 ' CD2' HD11 ' A' ' 24' ' ' ILE . 47.5 m-85 -141.23 175.11 9.91 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.042 -1.095 . . . . 2.1699999999999999 108.042 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 111.43 7.39 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.232 -1.025 . . . . 4.5899999999999999 108.232 -171.525 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.49 147.21 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.466 -0.788 . . . . 0.46000000000000002 109.74 -179.007 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.12 131.57 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.449 1.499 . . . . 1.55 110.15 -174.424 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.8 mt -119.84 91.85 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.437 1.495 . . . . 1.72 108.142 -177.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -72.41 71.19 0.91 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 122.185 0.993 . . . . 5.2800000000000002 112.167 -177.356 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.01 -47.0 3.73 Favored Glycine 0 CA--C 1.528 0.848 0 O-C-N 121.343 -0.848 . . . . 4.4299999999999997 112.685 168.658 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 116.996 -1.478 . . . . 9.1600000000000001 108.105 169.87 . . . . . . . . 0 0 . 1 stop_ save_